Predicate ID,Triple,Sentence ID,Sentence,Is Correct,Question,Answer
24413653,Fenbendazole treats helminthiasis,1001,"This study investigated worm control practices by free-range egg farmers and the efficacy of the commercial anthelmintics levamisole (LEV), piperazine (PIP), flubendazole (FLBZ) and fenbendazole (FBZ) against gastrointestinal nematodes on two free-range layer farms in Australia.",True,"Is the triple 'Fenbendazole treats helminthiasis' supported by the sentence: 'This study investigated worm control practices by free-range egg farmers and the efficacy of the commercial anthelmintics levamisole (LEV), piperazine (PIP), flubendazole (FLBZ) and fenbendazole (FBZ) against gastrointestinal nematodes on two free-range layer farms in Australia.'?","Yes, the statement does provide indirect support for the claim that ""Fenbendazole treats helminthiasis."" Helminthiasis is a condition characterized by parasitic worm infestation, often in the gastrointestinal tract. The study mentioned investigates the efficacy of several commercial anthelmintics (deworming agents) against gastrointestinal nematodes (a type of parasitic worm) on two free-range layer farms in Australia. Fenbendazole (FBZ) is one of the anthelmintics tested in the study.

         The fact that fenbendazole was included in the study implies that it has some potential for treating helminthiasis caused by gastrointestinal nematodes since it is being tested for its efficacy against these parasites. However, it is important to note that indirect support does not equate to definitive proof that fenbendazole treats helminthiasis; further investigation and evidence would be required for such a conclusion."
9783282,Thiabendazole treats helminthiasis,1002,[The treatment of helminthiasis with thiabendazole].,True,Is the triple 'Thiabendazole treats helminthiasis' supported by the sentence: '[The treatment of helminthiasis with thiabendazole].'?,"Yes, the phrase ""Thiabendazole treats helminthiasis"" does receive indirect support from the statement: ""[The treatment of helminthiasis with thiabendazole].""

        

        The given statement explicitly mentions that thiabendazole is used in treating helminthiasis, an infection caused by parasitic worms (helminths). The phrase ""treats helminthiasis"" implies that thiabendazole has some therapeutic effect on helminthiasis.

        

        Although the provided statement does not explicitly state that thiabendazole treats helminthiasis, it does contain information that supports that claim indirectly by specifying thiabendazole as a treatment for helminthiasis.

        

        This interpretation is consistent with established medical knowledge, as thiabendazole has been widely used as an anthelmintic drug for treating various helminthiases such as strongyloidiasis and ascariasis. Therefore, it is reasonable to infer that thiabendazole indeed treats helminthias"
22678969,Albendazole treats Infection,1003,The control of STH infections is based on preventive chemotherapy using either albendazole or mebendazole.,True,Is the triple 'Albendazole treats Infection' supported by the sentence: 'The control of STH infections is based on preventive chemotherapy using either albendazole or mebendazole.'?,"Yes, the phrase ""Albendazole treats Infection"" does receive indirect support from the statement: ""The control of STH (Soil-transmitted helminthiasis) infections is based on preventive chemotherapy using either albendazole or mebendazole.""

        

        The given statement suggests that albendazole is one of the primary medications used in preventive chemotherapy for STH infections. Preventive chemotherapy typically involves administering drugs to entire populations or high-risk groups without prior diagnosis to reduce infection prevalence (WHO). In order for albendazole to be effective in preventive chemotherapy for STH infections, it must have therapeutic properties that can treat existing infections as well as prevent new ones.

        

        Therefore, even though the statement does not explicitly claim that albendazole treats infections, its use in preventive chemotherapy implies that albendazole has infection-treating properties. This inference is further supported by existing literature; albendazole is indeed used for treating various parasitic worm infections (CDC)."
10750815,Albendazole treats onchocerciasis,1004,"A double-blind clinical trial was conducted in Monagas State, Venezuela to assess the tolerance and efficacy of albendazole in the therapy of Onchocerca volvulus infection.",True,"Is the triple 'Albendazole treats onchocerciasis' supported by the sentence: 'A double-blind clinical trial was conducted in Monagas State, Venezuela to assess the tolerance and efficacy of albendazole in the therapy of Onchocerca volvulus infection.'?","Yes, the statement does provide indirect support for the claim that Albendazole treats onchocerciasis (Onchocerca volvulus infection). A double-blind clinical trial is a rigorous evaluation method that suggests that there is substantial evidence supporting Albendazole's efficacy in treating Onchocerca volvulus infection if conducted in Monagas State, Venezuela, where onchocerciasis is endemic.

         However, it is essential to note that while indirect support is offered by this statement, it does not definitively prove that Albendazole treats onchocerciasis; it only indicates that there is evidence suggesting its efficacy in treating Onchocerca volvulus infection under specific conditions (i.e., in Monagas State, Venezuela). To make a more definitive conclusion about Albendazole treating onchocerciasis, it would be necessary to review the actual study results and consider other relevant studies examining Albendazole's efficacy in various populations and contexts."
10114050,Albendazole treats toxocariasis,1005,"The treatment of cutaneous larva migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin.",True,"Is the triple 'Albendazole treats toxocariasis' supported by the sentence: 'The treatment of cutaneous larva migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin.'?","Yes, the statement does provide indirect support for the phrase ""Albendazole treats toxocariasis"". The reason is that both albendazole and thiabendazole are mentioned as antihelminthic agents used in treating cutaneous larva migrans and Toxocara infection. Since Toxocara infection is another term for toxocariasis, it indicates that albendazole is indeed used in treating this condition. However, it should be noted that direct evidence confirming albendazole as an effective treatment for toxocariasis would still be required for a definitive conclusion."
9588560,Albendazole treats trichuriasis,1006,"Three randomized clinical studies were conducted in 2000 to evaluate the efficacy of nitazoxanide paediatric suspension compared to albendazole in the treatment of ascariasis and trichuriasis and praziquantel in the treatment of hymenolepiasis in children from Cajamarca, Peru.",True,"Is the triple 'Albendazole treats trichuriasis' supported by the sentence: 'Three randomized clinical studies were conducted in 2000 to evaluate the efficacy of nitazoxanide paediatric suspension compared to albendazole in the treatment of ascariasis and trichuriasis and praziquantel in the treatment of hymenolepiasis in children from Cajamarca, Peru.'?","Yes, the statement does provide indirect support for the phrase ""Albendazole treats trichuriasis"". The randomized clinical studies mentioned in the statement compared albendazole to other treatments for various parasitic infections including trichuriasis. The fact that these studies were conducted implies that albendazole is considered an appropriate treatment for trichuriasis, otherwise it would not have been included in these comparative studies. However, it is important to note that while this statement provides indirect evidence, it does not constitute direct evidence that albendazole treats trichuriasis. For direct evidence, one would need to refer to the results or conclusions of these studies, which are not provided in the statement."
9492446,Albendazole treats filariasis,1007,"Today, the only way is the prophylactic control of Onchocerca vovulus infections and treating lymphatic filariosis with ivermectin, diethylcarbamacine, ivermectin/diethylcarbamazine. or ivermectin/albendazole combinations.",True,"Is the triple 'Albendazole treats filariasis' supported by the sentence: 'Today, the only way is the prophylactic control of Onchocerca vovulus infections and treating lymphatic filariosis with ivermectin, diethylcarbamacine, ivermectin/diethylcarbamazine. or ivermectin/albendazole combinations.'?","Yes, the statement does provide indirect support for the claim that Albendazole treats filariasis (lymphatic filariosis). The statement lists several treatment options for lymphatic filariosis, which includes ivermectin/albendazole combinations. Since albendazole is part of an approved treatment regimen for filariasis, it suggests that albendazole does indeed have some therapeutic effect in treating the disease. However, it is important to note that albendazole is not mentioned alone as a treatment option in the statement but rather in combination therapy, implying that its effectiveness against filariasis might be enhanced when used in conjunction with other drugs like ivermectin."
8712067,Albendazole treats helminthiasis,1008,The study population was assessed for helminthic infection and those found to be positive were randomly assigned to either an albendazole treatment group or a control group who received a placebo.,True,Is the triple 'Albendazole treats helminthiasis' supported by the sentence: 'The study population was assessed for helminthic infection and those found to be positive were randomly assigned to either an albendazole treatment group or a control group who received a placebo.'?,"Yes, the statement does provide indirect support for the claim that Albendazole treats helminthiasis. The study design described involves randomly assigning participants who tested positive for helminthic infection into either an albendazole treatment group or a control group receiving a placebo. This experimental setup allows for the comparison of outcomes between these two groups, enabling researchers to assess whether albendazole has an effect on treating helminthic infection (helminthiasis).

         However, it is important to note that while this statement supports the idea that albendazole may be an effective treatment for helminthiasis, it does not definitively prove that albendazole treats helminthiasis. Further information about the study results would be needed to make such a conclusion. Specifically, it would be necessary to see evidence that those in the albendazole treatment group showed significantly improved outcomes compared to those in the control group in order to claim that albendazole treats helminthiasis."
7789677,Albendazole treats strongyloidiasis,1009,"To determine the host factors involved in response to treatment, 46 patients with strongyloidiasis were treated with albendazole, followed-up for 1 year, and separated into two groups: cured and non-cured.",True,"Is the triple 'Albendazole treats strongyloidiasis' supported by the sentence: 'To determine the host factors involved in response to treatment, 46 patients with strongyloidiasis were treated with albendazole, followed-up for 1 year, and separated into two groups: cured and non-cured.'?","Yes, the statement does provide indirect support for the claim that Albendazole treats strongyloidiasis. The fact that 46 patients diagnosed with strongyloidiasis were treated with Albendazole indicates that it is being used as a treatment option for this parasitic infection. The follow-up period of one year and separation into cured and non-cured groups suggests an evaluation of treatment efficacy. However, it is important to note that while this supports Albendazole as a potential treatment for strongyloidiasis, it does not constitute definitive proof; further analysis would be required (e.g., statistical analysis comparing cure rates between treatment and control groups) in order to make stronger conclusions about its effectiveness in treating strongyloidiasis."
7640018,Albendazole treats filarial elephantiasis,1010,The role of albendazole in programmes to eliminate lymphatic filariasis.,True,Is the triple 'Albendazole treats filarial elephantiasis' supported by the sentence: 'The role of albendazole in programmes to eliminate lymphatic filariasis.'?,"Yes, the statement ""The role of albendazole in programmes to eliminate lymphatic filariasis"" does provide indirect support for the phrase ""Albendazole treats filarial elephantiasis.""

        

        Filarial elephantiasis is caused by parasitic filarial worms that spread through mosquito bites, leading to severe swelling in affected areas such as legs and arms (WHO 2021). Albendazole is an anthelmintic drug often used in mass drug administration (MDA) programs for controlling lymphatic filariasis (WHO 2018).

        

        Although the original statement does not explicitly mention filarial elephantiasis by name, it still implies that albendazole plays an essential role in managing lymphatic filariasis—the same condition responsible for filarial elephantiasis when left untreated (WHO 2021).

        

        Moreover, by acknowledging albendazole as an integral component in eliminating lymphatic filariasis programs, it is plausible"
7620262,Albendazole treats Hookworm Infections,1011,On the basis of our results the single 400 mg dose of albendazole is the treatment of choice for hookworm infections in this region of Mali.,True,Is the triple 'Albendazole treats Hookworm Infections' supported by the sentence: 'On the basis of our results the single 400 mg dose of albendazole is the treatment of choice for hookworm infections in this region of Mali.'?,"Yes, the phrase ""Albendazole treats Hookworm Infections"" does receive indirect support from the statement: ""On the basis of our results the single 400 mg dose of albendazole is the treatment of choice for hookworm infections in this region of Mali.""

         The statement suggests that albendazole is an effective treatment for hookworm infections in a specific region of Mali, based on their research results. This implies that albendazole has some therapeutic effect on hookworm infections, providing indirect support for the claim that albendazole treats hookworm infections in general. However, it is important to note that the claim is not directly supported by the statement as it refers only to a specific region in Mali and does not necessarily generalize to other regions or populations without further evidence."
7226097,Albendazole treats cysticercosis,1012,The efficacy of albendazole (15 mg/kg/d for 1 week) was compared with praziquantel (100 mg/kg in three divided doses at 2-hour intervals) for therapy of parenchymal brain cysticercosis.,True,Is the triple 'Albendazole treats cysticercosis' supported by the sentence: 'The efficacy of albendazole (15 mg/kg/d for 1 week) was compared with praziquantel (100 mg/kg in three divided doses at 2-hour intervals) for therapy of parenchymal brain cysticercosis.'?,"Yes, the statement does provide indirect support for the claim that albendazole treats cysticercosis. The study compares the efficacy of albendazole and praziquantel in treating parenchymal brain cysticercosis, which indicates that albendazole is being used as a potential treatment for this condition. However, it is important to note that indirect support does not equate to definitive proof. The statement does not explicitly confirm that albendazole successfully treats cysticercosis, but it does suggest that it is being investigated for this purpose in clinical trials."
25678577,Latamoxef treats bacterial infectious disease,1013,"Clinical efficacy and safety of a new oxacephem, moxalactam, in serious bacterial infections.",True,"Is the triple 'Latamoxef treats bacterial infectious disease' supported by the sentence: 'Clinical efficacy and safety of a new oxacephem, moxalactam, in serious bacterial infections.'?","Yes, indirectly it does lend support. The statement mentions ""moxalactam"", which is an oxacephem antibiotic similar to latamoxef. Both drugs belong to the class of beta-lactam antibiotics that are used for treating bacterial infections. Therefore, if moxalactam has been shown to be clinically effective and safe in treating serious bacterial infections, it suggests that other drugs in the same class, like latamoxef, could potentially have similar effects. However, direct clinical trials would be needed to confirm this for latamoxef specifically."
26824955,Ibuprofen treats spondylosis,1014,A comparison of the short-term effects of ibuprofen and diclofenac in spondylosis.,False,Is the triple 'Ibuprofen treats spondylosis' supported by the sentence: 'A comparison of the short-term effects of ibuprofen and diclofenac in spondylosis.'?,"No, the statement ""A comparison of the short-term effects of ibuprofen and diclofenac in spondylosis"" does not provide direct support for the claim ""Ibuprofen treats spondylosis."" The study referenced only compares ibuprofen to diclofenac in terms of their short-term effects on spondylosis patients; it does not establish that ibuprofen is an effective treatment for spondylosis on its own. To make a stronger case for ibuprofen as an effective treatment for spondylosis, one would need additional evidence demonstrating its positive impact on patients suffering from this condition."
25670779,Ibuprofen treats sunburn,1015,"The data suggest that ibuprofen is more effective than placebo for the relief of symptoms associated with UV-B-induced inflammation after high dose UV-B phototherapy for psoriasis, but the drug has limited usefulness in the treatment of sunburn reaction from these same doses.",False,"Is the triple 'Ibuprofen treats sunburn' supported by the sentence: 'The data suggest that ibuprofen is more effective than placebo for the relief of symptoms associated with UV-B-induced inflammation after high dose UV-B phototherapy for psoriasis, but the drug has limited usefulness in the treatment of sunburn reaction from these same doses.'?","No, the statement does not provide indirect support for the phrase ""Ibuprofen treats sunburn."" While it is true that ibuprofen has been found to be more effective than placebo for relieving symptoms associated with UV-B-induced inflammation after high-dose UV-B phototherapy for psoriasis, it specifically mentions that ibuprofen has ""limited usefulness in the treatment of sunburn reaction from these same doses."" Therefore, based on the information provided in this statement, one cannot infer that ibuprofen is an effective treatment for sunburn.

         To further elaborate on why there is no indirect support for this claim:

        - The study population in question received high-dose UV-B phototherapy for psoriasis, which is not equivalent to sunburn from natural sunlight exposure.
        - The statement explicitly mentions limited usefulness for sunburn reactions from these doses, which contradicts the claim that ibuprofen treats sunburn.

         It is crucial as scientists and researchers that we critically evaluate statements like these to ensure that we do not overstate or misinterpret our findings, which could lead to inaccurate conclusions or mis"
25518118,Ibuprofen treats Fractured ankle,1016,"Huoxue Huayu Recipe combined with ibuprofen can reduce inflammatory factors levels in patients with ankle fracture, improve isokinetic muscle strength and ankle function, and accelerate the recovery of patients.",True,"Is the triple 'Ibuprofen treats Fractured ankle' supported by the sentence: 'Huoxue Huayu Recipe combined with ibuprofen can reduce inflammatory factors levels in patients with ankle fracture, improve isokinetic muscle strength and ankle function, and accelerate the recovery of patients.'?","Yes, while the statement does not explicitly confirm that ibuprofen treats fractured ankles, it does provide indirect support for its efficacy in managing symptoms associated with ankle fractures. The study suggests that ibuprofen, when combined with a traditional Chinese medicine recipe, can reduce inflammatory factors levels in patients with ankle fractures. This implies that ibuprofen could potentially alleviate pain and inflammation resulting from a fractured ankle, which is part of the treatment process. However, it is important to note that the statement does not confirm that ibuprofen can heal fractured ankles; it only supports its use in managing symptoms during recovery."
25321029,Ibuprofen treats bronchopulmonary dysplasia,1017,"Treatment of newborn rat pups with ibuprofen reduced pulmonary vessel density in the developing lung, but also attenuated experimental BPD by reducing lung inflammation, alveolar enlargement, alveolar septum thickness and small arteriolar wall thickening.",True,"Is the triple 'Ibuprofen treats bronchopulmonary dysplasia' supported by the sentence: 'Treatment of newborn rat pups with ibuprofen reduced pulmonary vessel density in the developing lung, but also attenuated experimental BPD by reducing lung inflammation, alveolar enlargement, alveolar septum thickness and small arteriolar wall thickening.'?","Yes, indirect support can be inferred from the statement provided. Bronchopulmonary dysplasia (BPD) is characterized by impaired alveolar development, inflammation and vascular remodeling in the lungs. The statement indicates that ibuprofen treatment in newborn rat pups led to reduced pulmonary vessel density (which is related to vascular remodeling), as well as attenuated experimental BPD through mechanisms that include reduction in lung inflammation, alveolar enlargement, alveolar septum thickness and small arteriolar wall thickening. These mechanisms suggest that ibuprofen may have beneficial effects in treating bronchopulmonary dysplasia by addressing some of its key pathological features. However, further investigation is required in order to establish direct support for the claim that ibuprofen treats bronchopulmonary dysplasia in humans, as animal studies do not always translate to human outcomes."
22125431,Ibuprofen treats preeclampsia,1018,Introduction:     The comparison of ibuprofen with acetaminophen for blood pressure (BP) in preeclampsia remains controversial.,False,Is the triple 'Ibuprofen treats preeclampsia' supported by the sentence: 'Introduction:     The comparison of ibuprofen with acetaminophen for blood pressure (BP) in preeclampsia remains controversial.'?,"No, the statement does not provide indirect support for the phrase ""Ibuprofen treats preeclampsia."" The statement introduces a controversy regarding whether ibuprofen is more effective than acetaminophen in managing blood pressure in preeclampsia patients. It does not imply that ibuprofen is an effective treatment for preeclampsia itself.

        To clarify, preeclampsia is a pregnancy complication characterized by high blood pressure and potential damage to organs such as the liver and kidneys (1). While ibuprofen may have some effect on blood pressure management in preeclampsia patients (as suggested by the statement), it does not necessarily mean that ibuprofen is treating preeclampsia itself.

        To further illustrate this point, consider that many medications can temporarily lower blood pressure but would not be considered treatments for preeclampsia if they did not target its underlying causes (2). Therefore, although ibuprofen may be useful in managing symptoms in preeclampsia patients, more evidence is required before concluding that it treats preeclampsia effectively.

        References:
        1."
21268743,Ibuprofen treats glioma,1019,"Taken together, our findings reveal that ibuprofen could induce ferroptosis of glioblastoma cells via downregulation of Nrf2 signaling pathway and is a potential drug for glioma treatment.",True,"Is the triple 'Ibuprofen treats glioma' supported by the sentence: 'Taken together, our findings reveal that ibuprofen could induce ferroptosis of glioblastoma cells via downregulation of Nrf2 signaling pathway and is a potential drug for glioma treatment.'?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats glioma."" The statement suggests that ibuprofen could induce ferroptosis (a form of programmed cell death) in glioblastoma cells (a type of glioma) via downregulation of the Nrf2 signaling pathway. This implies that ibuprofen may have therapeutic potential in treating glioma by targeting specific cellular processes in glioblastoma cells. However, it is important to note that in vitro (cell culture) or in vivo (animal model) studies do not always translate into successful human treatments; thus further clinical trials would be necessary before making definitive conclusions about ibuprofen as an effective glioma treatment in humans."
20821983,Ibuprofen treats common cold,1020,Ibuprofen (IBU) and phenylephrine hydrochloride (PE) were commonly used for common cold due to their different effects in relieving fever and the main symptoms such as nasal congestion and high sinus pressure.,False,Is the triple 'Ibuprofen treats common cold' supported by the sentence: 'Ibuprofen (IBU) and phenylephrine hydrochloride (PE) were commonly used for common cold due to their different effects in relieving fever and the main symptoms such as nasal congestion and high sinus pressure.'?,"No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen treats common cold."" While it is true that ibuprofen can alleviate some symptoms associated with the common cold such as fever, it does not imply that ibuprofen treats the underlying cause or cures the common cold. It is essential to differentiate between treating symptoms and treating/curing an illness itself."
20285347,Ibuprofen treats periodontitis,1021,"Therefore, the objective of this study was to investigate the local delivery of the NSAIDs model drug ibuprofen to treat periodontitis using different types of gel formulations (hydrogel, oleogel, and bigel).",True,"Is the triple 'Ibuprofen treats periodontitis' supported by the sentence: 'Therefore, the objective of this study was to investigate the local delivery of the NSAIDs model drug ibuprofen to treat periodontitis using different types of gel formulations (hydrogel, oleogel, and bigel).'?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats periodontitis"". The objective of the study, as stated, is to investigate the local delivery of ibuprofen as an NSAID (non-steroidal anti-inflammatory drug) for treating periodontitis using different types of gel formulations (hydrogel, oleogel, and bigel). This implies that ibuprofen is being used as a treatment for periodontitis in the context of this study, thereby providing indirect support for the claim that ibuprofen treats periodontitis.

         However, it is important to note that while this statement suggests that ibuprofen is being used as a treatment for periodontitis in the context of this study, it does not provide direct evidence for its efficacy in treating periodontitis. The study might be investigating the feasibility or efficiency of different gel formulations for delivering ibuprofen locally in treating periodontitis, but it does not necessarily mean that ibuprofen is effective in treating periodontitis per se. Therefore, further investigation is necessary to establish whether ibuprofen indeed treats periodontitis effectively."
19270581,Ibuprofen treats bone fracture,1022,Does the Use of Ibuprofen in Children with Extremity Fractures Increase their Risk for Bone Healing Complications?,False,Is the triple 'Ibuprofen treats bone fracture' supported by the sentence: 'Does the Use of Ibuprofen in Children with Extremity Fractures Increase their Risk for Bone Healing Complications?'?,"No, the statement ""Does the Use of Ibuprofen in Children with Extremity Fractures Increase their Risk for Bone Healing Complications?"" does not provide indirect support for the phrase ""Ibuprofen treats bone fracture."" In fact, it suggests quite the opposite. The study appears to investigate whether ibuprofen use in children with fractures might negatively impact bone healing by increasing complications risk. This implies that ibuprofen does not inherently treat bone fractures but may influence how fractures heal under specific circumstances.

         To provide indirect support for ""Ibuprofen treats bone fracture,"" one might encounter statements that demonstrate ibuprofen's efficacy in reducing pain, swelling, or inflammation during bone healing, shortening recovery time, enhancing callus formation, or improving overall fracture healing outcomes in either preclinical studies (animal models) or clinical trials (human subjects). However, it is essential to approach all scientific claims with skepticism and carefully examine both methodologies and results before accepting any conclusions as factual."
17621968,Ibuprofen treats Cognitive impairment,1023,"Finally, anti-inflammatory drug ibuprofen ameliorated the peripheral surgical wounding-induced cognitive impairment in 18 month-old mice.",False,"Is the triple 'Ibuprofen treats Cognitive impairment' supported by the sentence: 'Finally, anti-inflammatory drug ibuprofen ameliorated the peripheral surgical wounding-induced cognitive impairment in 18 month-old mice.'?","No, the statement does not provide direct support for the phrase ""Ibuprofen treats cognitive impairment"" in humans. The study was conducted on 18-month-old mice, which is equivalent to middle age in humans, not on individuals suffering from cognitive impairment. Additionally, while it suggests that ibuprofen may have alleviated surgical wounding-induced cognitive impairment in mice, it does not demonstrate that ibuprofen can treat cognitive impairment in general. Further investigation involving clinical trials in human subjects would be necessary before making such a claim."
17292168,Ibuprofen treats Chronic pain,1024,"In the last several years, several topical NSAIDs including either diclofenac ibuprofen or salicylates for chronic pain have been approved in the United States while similar drugs have been available in Europe for years.",True,"Is the triple 'Ibuprofen treats Chronic pain' supported by the sentence: 'In the last several years, several topical NSAIDs including either diclofenac ibuprofen or salicylates for chronic pain have been approved in the United States while similar drugs have been available in Europe for years.'?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats Chronic pain"". The approval of topical NSAIDs including ibuprofen for chronic pain in the United States suggests that these drugs have been found effective in treating chronic pain. However, it is important to note that while this indicates therapeutic potential for ibuprofen in managing chronic pain, it does not constitute direct evidence of its efficacy, as it refers to topical formulations rather than ibuprofen specifically. Moreover, correlation does not imply causation; therefore, additional studies would be required to establish a definitive causal relationship between ibuprofen use and chronic pain relief."
15258520,Ibuprofen treats cardiovascular disorder,1025,Patent ductus arteriosus (PDA) is the most common cardiovascular abnormality of the preterm infant usually treated with ibuprofen (IBU).,False,Is the triple 'Ibuprofen treats cardiovascular disorder' supported by the sentence: 'Patent ductus arteriosus (PDA) is the most common cardiovascular abnormality of the preterm infant usually treated with ibuprofen (IBU).'?,"No, the statement does not provide direct support for the claim that ibuprofen treats cardiovascular disorders. However, it does offer indirect evidence suggesting that ibuprofen can be used in treating patent ductus arteriosus (PDA), which is indeed a cardiovascular abnormality in preterm infants.

         The nuance here lies in understanding that treating PDA is not equivalent to treating all cardiovascular disorders. Ibuprofen is used off-label as a therapeutic option for PDA closure in preterm infants due to its anti-inflammatory properties; however, its effectiveness in treating other cardiovascular disorders may not be similar since different underlying mechanisms could be involved in various cardiovascular conditions.

         In summary, while ibuprofen is used in managing one specific cardiovascular abnormality (PDA), it does not necessarily mean that ibuprofen treats all cardiovascular disorders as claimed in the original statement."
13826476,"Ibuprofen treats osteoarthritis, spine",1026,"In an open three-center pilot study, 17 patients suffering from chronic persistent pain syndrome, due to osteoarthritis of the hip and knee or spondylarthrosis, were treated orally with 1800-2400 mg Ibuprofen per day for 3 weeks.",True,"Is the triple 'Ibuprofen treats osteoarthritis, spine' supported by the sentence: 'In an open three-center pilot study, 17 patients suffering from chronic persistent pain syndrome, due to osteoarthritis of the hip and knee or spondylarthrosis, were treated orally with 1800-2400 mg Ibuprofen per day for 3 weeks.'?","Yes, indirectly it does support that Ibuprofen may be used for treating osteoarthritis pain in the spine (spondylarthrosis) based on the provided statement from a pilot study. The study involved patients suffering from chronic persistent pain due to osteoarthritis in the hip and knee or spondylarthrosis (spine osteoarthritis). These patients were treated with 1800-2400 mg Ibuprofen per day for 3 weeks. If patients experienced reduced pain as a result of Ibuprofen treatment, it could suggest that Ibuprofen is effective in alleviating osteoarthritis pain in both limbs and spine osteoarthritis (spondylarthrosis). However, we should note that as an indirect inference based on pilot study results, further investigation is needed for stronger evidence on Ibuprofen treating spondylarthrosis specifically, as well as potential side-effects and long-term consequences."
13722152,Ibuprofen treats Neck pain,1027,"The patient presented with a 6-month history of neck pain with radiation into the shoulder and arm on the left side, which was relieved by ibuprofen.",True,"Is the triple 'Ibuprofen treats Neck pain' supported by the sentence: 'The patient presented with a 6-month history of neck pain with radiation into the shoulder and arm on the left side, which was relieved by ibuprofen.'?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats Neck pain"". The patient's symptoms were alleviated after taking ibuprofen, indicating that it had a therapeutic effect on their neck pain. However, it is important to note that this is an observational finding from a single patient, which doesn't constitute definitive proof due to the lack of a controlled environment and potential confounding factors. To make stronger conclusions, randomized controlled trials would be needed."
11790277,Ibuprofen treats hypertensive disorder,1028,"Treatment with nonselective anti-inflammatory drugs ibuprofen, indomethacin, or salicylic acid did not show any effect on angiotensin II-induced superoxide production, hypertension, or cardiac hypertrophy.",False,"Is the triple 'Ibuprofen treats hypertensive disorder' supported by the sentence: 'Treatment with nonselective anti-inflammatory drugs ibuprofen, indomethacin, or salicylic acid did not show any effect on angiotensin II-induced superoxide production, hypertension, or cardiac hypertrophy.'?","No, the statement does not provide indirect support for the phrase ""Ibuprofen treats hypertensive disorder"". In fact, it suggests that ibuprofen does not have an impact on angiotensin II-induced hypertension or cardiac hypertrophy since there is no significant effect observed in animals treated with ibuprofen compared to those not treated. However, it is important to note that hypertensive disorder is multifactorial; hence, one study may not cover all aspects related to hypertension treatment. Therefore, further investigation is needed before making any definitive conclusions about ibuprofen's efficacy in treating hypertensive disorders."
11536369,Ibuprofen treats seasonal allergic rhinitis,1029,Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis.,True,Is the triple 'Ibuprofen treats seasonal allergic rhinitis' supported by the sentence: 'Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis.'?,"Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats seasonal allergic rhinitis."" The addition of ibuprofen to other treatments (pseudoephedrine and chlorpheniramine) implies that ibuprofen has therapeutic value in managing seasonal allergic rhinitis symptoms. However, it is important to note that indirect support does not equate to definitive proof; further investigation would be necessary to establish the specific efficacy of ibuprofen as a standalone treatment for seasonal allergic rhinitis."
11381904,Ibuprofen treats Premature birth,1030,This should be considered to assess pharmacokinetic-pharmacodynamic relationships of ibuprofen in premature neonates and subsequently to understand and refine the use of ibuprofen in managing PDA either as a prophylactic or curative treatment.,False,Is the triple 'Ibuprofen treats Premature birth' supported by the sentence: 'This should be considered to assess pharmacokinetic-pharmacodynamic relationships of ibuprofen in premature neonates and subsequently to understand and refine the use of ibuprofen in managing PDA either as a prophylactic or curative treatment.'?,"No, the statement does not provide direct support for the phrase ""Ibuprofen treats Premature birth."" The statement discusses assessing pharmacokinetic-pharmacodynamic relationships of ibuprofen in premature neonates, which refers to how ibuprofen is absorbed, distributed, metabolized, and excreted in that specific population, as well as its effects on their bodies (pharmacodynamics). This information is crucial for understanding how ibuprofen can be effectively used in managing Patent Ductus Arteriosus (PDA), which is a common complication in premature neonates where there is failure of closure of the ductus arteriosus after birth. While understanding these relationships could potentially lead to better treatment strategies for PDA (prophylactic or curative), it does not necessarily indicate that ibuprofen treats premature birth itself."
11239637,Ibuprofen treats Back pain,1031,"A 57-year-old woman believed that ibuprofen, prescribed for back pain, improved her idiopathic chronic cough that had been resistant to inhaled and oral corticosteroids.",False,"Is the triple 'Ibuprofen treats Back pain' supported by the sentence: 'A 57-year-old woman believed that ibuprofen, prescribed for back pain, improved her idiopathic chronic cough that had been resistant to inhaled and oral corticosteroids.'?","No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen treats Back pain"". The woman in question experienced relief from an idiopathic chronic cough that was resistant to corticosteroids after taking ibuprofen prescribed for back pain. This suggests that ibuprofen may have an effect on cough suppression in certain conditions, but it does not provide evidence that ibuprofen is effective in treating back pain. The improvement could be coincidental, or it could be due to ibuprofen's anti-inflammatory properties that might have an effect on cough reflexes. However, to establish that ibuprofen treats back pain, we would need evidence specifically demonstrating its efficacy in treating back pain."
10195210,Ibuprofen treats influenza,1032,"A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms.",False,"Is the triple 'Ibuprofen treats influenza' supported by the sentence: 'A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms.'?","No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen treats influenza."" The study mentioned is comparing diclofenac-K and ibuprofen for treating adults with influenza-like symptoms, not proving that ibuprofen can treat influenza itself."
9950431,Ibuprofen treats rheumatic disorder,1033,"Eight preparations contained synthetic drugs (e.g. benzodiazepines and tricyclic antidepressants in sedative preparations, cyproheptadine in a remedy to gain bodyweight, ibuprofen and dipyrone in herbal capsules used to treat rheumatism).",True,"Is the triple 'Ibuprofen treats rheumatic disorder' supported by the sentence: 'Eight preparations contained synthetic drugs (e.g. benzodiazepines and tricyclic antidepressants in sedative preparations, cyproheptadine in a remedy to gain bodyweight, ibuprofen and dipyrone in herbal capsules used to treat rheumatism).'?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats rheumatic disorder"". The key piece of information here is that ibuprofen is mentioned as being present in herbal capsules used to treat rheumatism. This implies that ibuprofen has been used in a therapeutic context for treating rheumatic disorders. However, it is important to note that this does not constitute direct evidence; rather, it suggests that ibuprofen could be an effective treatment for rheumatic disorders based on its observed use in certain preparations. It would be necessary to examine clinical trials or other forms of direct evidence in order to make stronger conclusions about its efficacy in treating rheumatism."
9913360,Ibuprofen treats Myalgia,1034,Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness management.,True,Is the triple 'Ibuprofen treats Myalgia' supported by the sentence: 'Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness management.'?,"Yes, the statement ""Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness management"" does lend indirect support to the phrase ""Ibuprofen treats Myalgia"". The study mentioned in the statement compares two substances (bromelain and ibuprofen) for managing delayed onset muscle soreness (myalgia), implying that ibuprofen has been used in treating muscle soreness. However, it is essential to note that indirect support does not equate to definitive proof, as more extensive clinical trials would be required for concluding that ibuprofen effectively treats myalgia."
9550056,Ibuprofen treats Acute Pain,1035,"BACKGROUND: Rofecoxib is a selective cyclooxygenase-2 inhibitor indicated for the treatment of acute pain, with similar analgesic efficacy to ibuprofen and naproxen sodium.",True,"Is the triple 'Ibuprofen treats Acute Pain' supported by the sentence: 'BACKGROUND: Rofecoxib is a selective cyclooxygenase-2 inhibitor indicated for the treatment of acute pain, with similar analgesic efficacy to ibuprofen and naproxen sodium.'?","Yes, indirect support can be inferred from the statement provided. The background information indicates that Rofecoxib is used for treating acute pain, similar in efficacy to Ibuprofen and Naproxen Sodium. Given that Rofecoxib, Ibuprofen, and Naproxen Sodium all belong to the same class of non-steroidal anti-inflammatory drugs (NSAIDs) known for their analgesic effects on acute pain, it is reasonable to infer that Ibuprofen does treat acute pain based on its similar efficacy compared to Rofecoxib as stated in the background. However, it is important to note that such an inference is based on indirect evidence from the provided statement alone; further investigation including direct evidence would strengthen such conclusions regarding Ibuprofen's effects on acute pain."
9536612,Ibuprofen treats Low back pain,1036,CONCLUSION: Continuous low-level heat wrap therapy was superior to both acetaminophen and ibuprofen for treating low back pain.,True,Is the triple 'Ibuprofen treats Low back pain' supported by the sentence: 'CONCLUSION: Continuous low-level heat wrap therapy was superior to both acetaminophen and ibuprofen for treating low back pain.'?,"Yes, indirectly it does support the phrase ""Ibuprofen treats Low back pain"". The conclusion states that continuous low-level heat wrap therapy was superior to both acetaminophen and ibuprofen for treating low back pain. However, it does not mean that ibuprofen is ineffective for treating low back pain; rather, it suggests that there might be other treatments that are more effective. The fact that ibuprofen was mentioned as one of the treatments compared in the study implies that it does have some level of efficacy in treating low back pain, thus providing indirect support for the phrase ""Ibuprofen treats Low back pain""."
9444914,Ibuprofen treats Arthralgia,1037,"To determine the effectiveness of oral glucosamine with ibuprofen for the relief of joint pain in osteoarthritis a mini-review (Griffiths, 2002) of double-blind randomized controlled trials comparing the two was undertaken.",False,"Is the triple 'Ibuprofen treats Arthralgia' supported by the sentence: 'To determine the effectiveness of oral glucosamine with ibuprofen for the relief of joint pain in osteoarthritis a mini-review (Griffiths, 2002) of double-blind randomized controlled trials comparing the two was undertaken.'?","No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen treats Arthralgia"". The mini-review conducted by Griffiths (2002) focuses on comparing oral glucosamine and ibuprofen for joint pain relief in osteoarthritis patients specifically. It does not evaluate the effectiveness of ibuprofen in treating arthralgia (joint pain) generally. Therefore, we cannot infer from this statement that ibuprofen is an effective treatment for arthralgia beyond osteoarthritis-related joint pain."
9436288,Ibuprofen treats Alzheimer disease,1038,"In conclusion, NCX-2216 is more efficacious than ibuprofen or celecoxib in clearing Abeta deposits from the brains of Tg mice, implying potential benefit in the treatment of Alzheimer's dementia.",False,"Is the triple 'Ibuprofen treats Alzheimer disease' supported by the sentence: 'In conclusion, NCX-2216 is more efficacious than ibuprofen or celecoxib in clearing Abeta deposits from the brains of Tg mice, implying potential benefit in the treatment of Alzheimer's dementia.'?","No, the statement does not provide indirect support for the claim that ibuprofen treats Alzheimer disease. The conclusion in question discusses the efficacy of NCX-2216 in clearing Abeta deposits in Tg mice brains, implying potential benefits in treating Alzheimer's dementia. While it does mention ibuprofen as being less efficacious than NCX-2216 in clearing Abeta deposits, it does not provide evidence that ibuprofen has any direct positive effects on Alzheimer disease treatment. In fact, it may suggest that ibuprofen is less effective than NCX-2216 in addressing one particular aspect (Abeta deposits) of Alzheimer disease progression.

         To provide indirect support for ibuprofen treating Alzheimer disease from this statement would require evidence showing that clearing Abeta deposits is causally linked to improvements in Alzheimer disease symptoms or progression; however, no such causal link has been established in the statement provided."
9104501,Ibuprofen treats injury,1039,"Ibuprofen attenuates early lung injury in endotoxemic, neutropenic rats.",False,"Is the triple 'Ibuprofen treats injury' supported by the sentence: 'Ibuprofen attenuates early lung injury in endotoxemic, neutropenic rats.'?","No, the statement ""Ibuprofen attenuates early lung injury in endotoxemic, neutropenic rats"" does not provide direct or indirect support for the phrase ""Ibuprofen treats injury."" The original statement refers specifically to lung injury in endotoxemic, neutropenic rats, which is not equivalent to injury in general terms. To provide indirect support for ""Ibuprofen treats injury,"" there should be evidence indicating that ibuprofen has similar protective effects across different injury models in various organisms, including humans. Therefore, further investigation is required for making generalized conclusions about ibuprofen as an injury treatment based on that statement alone."
8748381,Ibuprofen treats Dysmenorrhea,1040,CONCLUSION: Continuous low-level topical heat therapy was as effective as ibuprofen for the treatment of dysmenorrhea.,True,Is the triple 'Ibuprofen treats Dysmenorrhea' supported by the sentence: 'CONCLUSION: Continuous low-level topical heat therapy was as effective as ibuprofen for the treatment of dysmenorrhea.'?,"Yes, indirectly it does support the claim that ibuprofen treats dysmenorrhea. The conclusion states that continuous low-level topical heat therapy is as effective as ibuprofen for treating dysmenorrhea, which implies that ibuprofen is indeed an effective treatment for dysmenorrhea. However, it is important to note that this conclusion is based on a specific study design (topical heat therapy vs ibuprofen), and other factors such as dosage, route of administration, side effects etc., may influence ibuprofen's efficacy in treating dysmenorrhea in different contexts."
8698382,Ibuprofen treats Tension-type headache,1041,Is the combination of ibuprofen and caffeine effective for the treatment of a tension-type headache?,True,Is the triple 'Ibuprofen treats Tension-type headache' supported by the sentence: 'Is the combination of ibuprofen and caffeine effective for the treatment of a tension-type headache?'?,"Yes, indirectly it does lend support. The statement ""Is the combination of ibuprofen and caffeine effective for the treatment of a tension-type headache?"" implies that ibuprofen alone (without caffeine) could also be effective for treating tension-type headaches. This is because if ibuprofen was not effective on its own, there would be no reason to test it in combination with caffeine for treating tension-type headaches. Therefore, the statement provides indirect support for the claim that ""Ibuprofen treats Tension-type headache."" However, it is important to note that more direct evidence would be required for definitive conclusions regarding ibuprofen's effectiveness in treating tension-type headaches without any other substances (such as caffeine)."
8452594,Ibuprofen treats migraine disorder,1042,"Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study.",True,"Is the triple 'Ibuprofen treats migraine disorder' supported by the sentence: 'Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study.'?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats migraine disorder"". The study mentioned is a randomized, double-blind, placebo-controlled, dose-ranging study - all indicators of high-quality clinical research. The fact that ibuprofen was evaluated specifically in the context of treating migraine headaches suggests that it has potential therapeutic effects for migraines. However, it is important to note that while this study may provide evidence for ibuprofen as an effective treatment for migraines under certain conditions (e.g., specific dosages), it does not necessarily confirm that ibuprofen definitively ""treats"" migraine disorder in all cases. Further investigation would be required to make such a claim conclusively."
8420965,Ibuprofen treats Hemorrhage,1043,"A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.",False,"Is the triple 'Ibuprofen treats Hemorrhage' supported by the sentence: 'A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.'?","No, the statement ""Ibuprofen treats Hemorrhage"" does not receive direct or indirect support from the provided statement: ""A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.""

         The reason for my decision is that while the study does involve ibuprofen, it does not explicitly test its efficacy in treating hemorrhage. The outcome measured in this trial is fecal blood loss in healthy subjects, which may not necessarily correlate with hemorrhage treatment efficacy. Moreover, even though ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) like rofecoxib, their mechanisms of action might differ in treating various conditions. Therefore, without further information on how ibuprofen performs in relation to hemorrhage treatment specifically in this trial, it would be inappropriate to infer support for that claim."
8397426,Ibuprofen treats rheumatoid arthritis,1044,Ibuprofen or aspirin in rheumatoid arthritis therapy.,True,Is the triple 'Ibuprofen treats rheumatoid arthritis' supported by the sentence: 'Ibuprofen or aspirin in rheumatoid arthritis therapy.'?,"Yes, indirect support can be inferred from the statement ""Ibuprofen or aspirin in rheumatoid arthritis therapy."" This statement implies that ibuprofen is used in the treatment of rheumatoid arthritis as part of therapy regimens; however, it does not explicitly demonstrate that ibuprofen treats rheumatoid arthritis on its own. It is essential to consider that ibuprofen is often used in conjunction with other medications for rheumatoid arthritis management rather than as a standalone treatment for curing the disease. Therefore, although there is some level of support for the initial claim based on the provided statement, it is crucial to be cautious when interpreting these results as causal relationships between ibuprofen use and treating rheumatoid arthritis have not necessarily been established."
7887942,Ibuprofen treats osteoarthritis,1045,"DESIGN: Ginger extract was compared to placebo and Ibuprofen in patients with osteoarthritis of the hip or knee in a controlled, double blind, double dummy, cross-over study with a wash-out period of one week followed by three treatment periods in a randomized sequence, each of three weeks duration.",True,"Is the triple 'Ibuprofen treats osteoarthritis' supported by the sentence: 'DESIGN: Ginger extract was compared to placebo and Ibuprofen in patients with osteoarthritis of the hip or knee in a controlled, double blind, double dummy, cross-over study with a wash-out period of one week followed by three treatment periods in a randomized sequence, each of three weeks duration.'?","Yes, the statement does provide indirect support for the claim that ibuprofen treats osteoarthritis. The reason is that ibuprofen is included in the study as an active comparator alongside ginger extract for treating osteoarthritis in patients. By including ibuprofen in such a rigorous study design (controlled, double blind, double dummy, cross-over), it implies that ibuprofen has some recognized therapeutic effect on osteoarthritis that is worth comparing against other potential treatments like ginger extract.

        

        However, it is essential to acknowledge that this statement does not offer direct evidence that ibuprofen treats osteoarthritis since it does not explicitly report the results of the comparison between ibuprofen and placebo in treating osteoarthritis symptoms. To draw definitive conclusions about ibuprofen's efficacy in treating osteoarthritis based on this statement alone would require accessing the complete study results, including outcome measures and statistical analyses comparing ibuprofen against placebo."
7852264,Ibuprofen treats Headache,1046,"Besides oxygen, acetazolamide, dexamethasone and especially inhibitors of prostaglandin synthesis such as ibuprofen and naproxen are approved for the treatment of HAH.",True,"Is the triple 'Ibuprofen treats Headache' supported by the sentence: 'Besides oxygen, acetazolamide, dexamethasone and especially inhibitors of prostaglandin synthesis such as ibuprofen and naproxen are approved for the treatment of HAH.'?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats Headache"". The text mentions that ibuprofen is an approved treatment for HAH (High Altitude Headache), which is a type of headache. This implies that ibuprofen is indeed used for treating headaches, thus supporting the initial phrase. However, it is important to note that ibuprofen is not universally effective for all types of headaches, but it has been shown to be beneficial for certain kinds such as tension headaches and headaches caused by inflammation."
7851777,Ibuprofen treats patent ductus arteriosus,1047,OBJECTIVE: To evaluate the effect of intravenous ibuprofen and indomethacin for treatment of patent ductus arteriosus (PDA) on mesenteric and renal blood flow velocity in preterm infants.,False,Is the triple 'Ibuprofen treats patent ductus arteriosus' supported by the sentence: 'OBJECTIVE: To evaluate the effect of intravenous ibuprofen and indomethacin for treatment of patent ductus arteriosus (PDA) on mesenteric and renal blood flow velocity in preterm infants.'?,"No, the phrase ""Ibuprofen treats patent ductus arteriosus"" does not receive direct support from the statement provided. The objective statement discusses an evaluation of ibuprofen's effect on mesenteric and renal blood flow velocity in preterm infants with patent ductus arteriosus (PDA). However, it does not explicitly state that ibuprofen treats PDA; it only implies that ibuprofen may be used as a potential treatment option for managing PDA in preterm infants by influencing blood flow velocity in certain blood vessels.

         It is important to note that while ibuprofen has been used in treating PDA in preterm infants, its mechanism is not solely limited to altering blood flow velocity in mesenteric and renal vessels. Ibuprofen is known to act as a cyclooxygenase inhibitor, thereby reducing prostaglandin synthesis, which plays an essential role in maintaining PDA patency. Therefore, more direct evidence would be required to unequivocally support the claim that ibuprofen treats PDA, such as clinical trials demonstrating its efficacy in closing PDAs in preterm"
7732956,Ibuprofen treats Pain,1048,"The WOMAC detected significant differences between ibuprofen and placebo for pain and physical functioning, whereas the SF-36 detected differences for the bodily pain subscale.",True,"Is the triple 'Ibuprofen treats Pain' supported by the sentence: 'The WOMAC detected significant differences between ibuprofen and placebo for pain and physical functioning, whereas the SF-36 detected differences for the bodily pain subscale.'?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats Pain"". The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) detected significant differences between ibuprofen and placebo for pain and physical functioning. This suggests that ibuprofen has an effect on pain reduction compared to a placebo, providing evidence that it can be used as a treatment for pain management. However, it is important to note that while this statement supports ibuprofen's effectiveness in treating pain, it does not necessarily mean that ibuprofen is the only treatment option for pain relief or that it is effective in all types of pain conditions."
7686895,Ibuprofen treats arthritic joint disease,1049,"I take ibuprofen regularly for my arthritis, but I've heard that it may lead to kidney damage.",False,"Is the triple 'Ibuprofen treats arthritic joint disease' supported by the sentence: 'I take ibuprofen regularly for my arthritis, but I've heard that it may lead to kidney damage.'?","No, the statement ""I take ibuprofen regularly for my arthritis, but I've heard that it may lead to kidney damage"" does not provide indirect support for the phrase ""Ibuprofen treats arthritic joint disease."" 

         While it is true that ibuprofen is often used for managing pain associated with arthritis, stating that it ""treats"" arthritic joint disease would imply that it addresses the underlying cause or pathophysiology of the disease, rather than merely providing symptomatic relief. The potential side effect mentioned in the statement (kidney damage) does not contradict this more limited claim about symptom management, but it also does not provide any evidence supporting the broader claim that ibuprofen treats arthritic joint disease. 

         Furthermore, it is important to note that while ibuprofen can be effective for managing pain in arthritis, long-term use can have potential side effects such as kidney damage, as well as other issues like gastrointestinal bleeding and cardiovascular risks. Therefore, while it is a useful tool in managing arthritis symptoms, it should be used"
7258310,Ibuprofen treats Fever,1050,Paracetamol or ibuprofen in febrile children.,True,Is the triple 'Ibuprofen treats Fever' supported by the sentence: 'Paracetamol or ibuprofen in febrile children.'?,"Yes, the statement ""Paracetamol or ibuprofen in febrile children"" does lend indirect support to the claim that ibuprofen treats fever. The statement suggests that both paracetamol (also known as acetaminophen) and ibuprofen can be used in febrile children, which implies that ibuprofen has some efficacy in reducing fever symptoms in children. However, it is important to note that this is an indirect inference based on a general recommendation for fever management in children; direct experimental evidence would provide stronger support for the specific claim that ibuprofen treats fever."
7210912,Ibuprofen treats Toothache,1051,"A double-blind, parallel-group study compared the analgesic efficacy of rofecoxib to placebo and ibuprofen in 102 patients with dental pain.",True,"Is the triple 'Ibuprofen treats Toothache' supported by the sentence: 'A double-blind, parallel-group study compared the analgesic efficacy of rofecoxib to placebo and ibuprofen in 102 patients with dental pain.'?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats Toothache"". The study mentioned compares the analgesic efficacy (pain-relieving ability) of ibuprofen in patients with dental pain. By comparing ibuprofen to placebo (a treatment that has no therapeutic effect), it implies that ibuprofen is more effective at relieving dental pain than no treatment at all. Therefore, it supports the idea that ibuprofen can be used to treat toothache as it has been shown to alleviate dental pain in this study.

         However, it is important to note that while this study provides evidence for ibuprofen as an effective treatment for toothache, it does not necessarily mean that ibuprofen is the best treatment option compared to other pain-relieving medications specifically designed for dental pain. Further studies would be required for such comparisons."
25984950,Cefmenoxime treats bacterial infectious disease,1052,Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections.,True,Is the triple 'Cefmenoxime treats bacterial infectious disease' supported by the sentence: 'Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections.'?,"Yes, the phrase ""Cefmenoxime treats bacterial infectious disease"" does receive indirect support from the statement: ""Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections."" This is because Cefmenoxime is being compared specifically to another antibiotic (cefoxitin) in treating serious bacterial infections, implying that Cefmenoxime has some efficacy in treating bacterial infections. However, it is important to note that indirect support does not equate to definitive proof, as more context and empirical evidence would be needed for a stronger conclusion regarding its specific therapeutic benefits compared to other antibiotics for bacterial infections in general."
21500374,Ivabradine treats hypotensive disorder,1053,"These are: the association of dobutamine infusion with amiodarone or ivabradine in patients with symptomatic hypotension, and high-dose furosemide associated to hypertonic saline solution, levosimendan, hydralazine/isosorbide dinitrate, sodium nitroprusside or ivabradine in hemodynamically stable patients.",False,"Is the triple 'Ivabradine treats hypotensive disorder' supported by the sentence: 'These are: the association of dobutamine infusion with amiodarone or ivabradine in patients with symptomatic hypotension, and high-dose furosemide associated to hypertonic saline solution, levosimendan, hydralazine/isosorbide dinitrate, sodium nitroprusside or ivabradine in hemodynamically stable patients.'?","No, the phrase ""Ivabradine treats hypotensive disorder"" does not receive direct support from the statement provided. The statement mentions that ivabradine is associated with amiodarone or dobutamine infusion in patients who have symptomatic hypotension, but it does not explicitly indicate that ivabradine is used as a treatment for hypotensive disorder itself. Furthermore, in hemodynamically stable patients, ivabradine is mentioned alongside other medications in specific situations, which does not necessarily imply that ivabradine is being used as a primary treatment for hypotensive disorder in those cases either.

         However, it is important to note that indirect support might be inferred from the fact that ivabradine is used in conjunction with other medications in treating hypotensive patients. This could imply that ivabradine has some beneficial effect on hypotension when used in combination therapy; however, more direct evidence would be required for definitive conclusions about its efficacy as a standalone treatment for hypotensive disorder."
18841652,Ivabradine treats toxic shock syndrome,1054,If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock.,False,Is the triple 'Ivabradine treats toxic shock syndrome' supported by the sentence: 'If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock.'?,"No, the statement ""If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock"" does not provide indirect support for the claim that ""Ivabradine treats toxic shock syndrome."" The statement is actually negatively framed; it asserts that ivabradine does not improve cardiac and vascular function in experimental septic shock, which is not indicative of treating toxic shock syndrome. Septic shock is one possible severe complication of toxic shock syndrome but is not equivalent to it. Furthermore, even if ivabradine were shown to improve cardiac and vascular function in septic shock, it would not necessarily imply that it treats toxic shock syndrome as a whole since sepsis is a systemic inflammatory response that affects multiple organ systems beyond the cardiovascular system."
18126606,Ivabradine treats mitral valve stenosis,1055,Ivabradine thus can be used effectively and safely in patients with MS in normal sinus rhythm who are intolerant or contraindicated for beta-blocker therapy.,False,Is the triple 'Ivabradine treats mitral valve stenosis' supported by the sentence: 'Ivabradine thus can be used effectively and safely in patients with MS in normal sinus rhythm who are intolerant or contraindicated for beta-blocker therapy.'?,"No, the phrase ""Ivabradine treats mitral valve stenosis"" does not receive indirect support from the statement provided. The statement indicates that Ivabradine can be used effectively and safely in patients with mitral valve stenosis (MS) who have normal sinus rhythm and cannot tolerate or have contraindications for beta-blocker therapy. However, it does not imply that Ivabradine treats mitral valve stenosis itself; rather, it suggests an alternative treatment option for certain patients suffering from MS."
17604342,Ivabradine treats atrial fibrillation,1056,Ivabradine is ineffective in atrial fibrillation.,False,Is the triple 'Ivabradine treats atrial fibrillation' supported by the sentence: 'Ivabradine is ineffective in atrial fibrillation.'?,"No, the statement ""Ivabradine is ineffective in atrial fibrillation"" does not provide indirect support for the claim that ""Ivabradine treats atrial fibrillation."" In fact, it suggests the opposite: that ivabradine has no significant impact on atrial fibrillation, which contradicts the idea that it is an effective treatment for the condition.

         The statement implies that ivabradine does not produce a desirable outcome (treating atrial fibrillation) based on some experimental context or evidence. Therefore, it does not support but rather challenges the notion that ivabradine could be used as a treatment for atrial fibrillation.

         It is important to differentiate between indirect support and lack thereof when interpreting statements like these in order to maintain accuracy in understanding scientific literature and evidence."
17604340,Ivabradine treats diastolic heart failure,1057,The aim of the study was to compare the therapeutic effects of ivabradine in diastolic heart failure with preserved left ventricular systolic function.,True,Is the triple 'Ivabradine treats diastolic heart failure' supported by the sentence: 'The aim of the study was to compare the therapeutic effects of ivabradine in diastolic heart failure with preserved left ventricular systolic function.'?,"Yes, the statement does provide indirect support for the phrase ""Ivabradine treats diastolic heart failure"". The aim of the study is focused on comparing the therapeutic effects of ivabradine in diastolic heart failure patients with preserved left ventricular systolic function. The fact that they chose ivabradine as the drug for investigation suggests that there might be some prior evidence or rationale supporting its potential therapeutic benefits for diastolic heart failure patients. However, it is important to note that the statement does not provide direct evidence that ivabradine treats diastolic heart failure; it only implies that researchers might have reasons to investigate its potential therapeutic effects in these patients. To draw definitive conclusions about ivabradine treating diastolic heart failure, one would need to review the full study results for evidence that ivabradine led to improvements in patients' conditions compared to placebo or standard care."
15681673,Ivabradine treats multiple organ dysfunction syndrome,1058,CONCLUSIONS: The MODI (f)Y trial is the first application of ivabradine as a pure heart rate reducing agent in MODS patients.,True,Is the triple 'Ivabradine treats multiple organ dysfunction syndrome' supported by the sentence: 'CONCLUSIONS: The MODI (f)Y trial is the first application of ivabradine as a pure heart rate reducing agent in MODS patients.'?,"Yes, indirectly it does lend some support. The conclusion states that ivabradine was used as a heart rate reducing agent in patients with multiple organ dysfunction syndrome (MODS) for the first time in the MODI (f)Y trial. This implies that there is an exploration into the potential benefits of ivabradine for treating MODS, even though the statement does not explicitly confirm that ivabradine successfully treats MODS. The fact that ivabradine has been applied in this context suggests that further investigation into its therapeutic potential for MODS is warranted. However, it is crucial to consider additional evidence from well-designed studies before making definitive conclusions about its efficacy in treating MODS."
15641743,Ivabradine treats systolic heart failure,1059,Ivabradine added to guidelines-based therapy in systolic heart failure patients.,True,Is the triple 'Ivabradine treats systolic heart failure' supported by the sentence: 'Ivabradine added to guidelines-based therapy in systolic heart failure patients.'?,"Yes, the statement ""Ivabradine added to guidelines-based therapy in systolic heart failure patients"" does provide indirect support for the claim that ""Ivabradine treats systolic heart failure"". This is because adding ivabradine to guidelines-based therapy implies that ivabradine has some therapeutic effect in treating systolic heart failure patients when used in conjunction with other established treatments. However, it is important to note that indirect support does not equate to definitive proof and further evidence would be needed for a more robust conclusion about ivabradine's effectiveness in treating systolic heart failure."
13559450,Ivabradine treats Tachycardia,1060,"Clinical studies proved the efficacy of ivabradine in patients with stable angina, while clinical data are awaited to verify its probable value in the treatment of atrial tachyarrhythmias and tachycardia due to ventricular dysfunction.",False,"Is the triple 'Ivabradine treats Tachycardia' supported by the sentence: 'Clinical studies proved the efficacy of ivabradine in patients with stable angina, while clinical data are awaited to verify its probable value in the treatment of atrial tachyarrhythmias and tachycardia due to ventricular dysfunction.'?","No, the phrase ""Ivabradine treats Tachycardia"" does not receive direct support from the statement provided. The statement indicates that clinical studies have proven the efficacy of ivabradine in patients with stable angina, but it also mentions that clinical data is still awaited to verify its probable value in the treatment of atrial tachyarrhythmias and tachycardia due to ventricular dysfunction. Therefore, while there is potential support for ivabradine treating tachycardia, it is not yet proven by clinical studies as stated in the given information."
12424888,Ivabradine treats coronary artery disorder,1061,"The effective drug, ivabradine, has demonstrated anti-anginal, anti-ischemic efficacy and now is being tested for its effect on survival in patients with coronary artery disease and impaired left ventricular function, as well as for heart failure.",True,"Is the triple 'Ivabradine treats coronary artery disorder' supported by the sentence: 'The effective drug, ivabradine, has demonstrated anti-anginal, anti-ischemic efficacy and now is being tested for its effect on survival in patients with coronary artery disease and impaired left ventricular function, as well as for heart failure.'?","Yes, the statement does provide indirect support for the phrase ""Ivabradine treats coronary artery disorder"". The statement mentions that ivabradine has demonstrated anti-anginal and anti-ischemic efficacy in patients with coronary artery disease (CAD) who have impaired left ventricular function. These properties suggest that ivabradine can help manage symptoms associated with CAD such as angina (chest pain) and ischemia (reduced blood flow). While the statement does not explicitly say that ivabradine treats CAD, its positive effects on CAD-related symptoms imply that it can help manage the disorder. However, it is important to note that further studies on ivabradine's impact on survival in patients with CAD and heart failure are needed for more definitive conclusions about its therapeutic potential in treating CAD."
12164130,Ivabradine treats Stable angina,1062,New agent ivabradine (Procoralan) for treatment of chronic stable angina.,True,Is the triple 'Ivabradine treats Stable angina' supported by the sentence: 'New agent ivabradine (Procoralan) for treatment of chronic stable angina.'?,"Yes, the statement ""New agent ivabradine (Procoralan) for treatment of chronic stable angina"" does provide indirect support for the phrase ""Ivabradine treats Stable angina"". The statement implies that Ivabradine is a new agent being used in the treatment of chronic stable angina, which suggests that it has some therapeutic effect on the condition. However, it is important to note that indirect support does not equate to definitive proof. More detailed studies would be required to establish the precise nature and extent of Ivabradine's therapeutic benefits for stable angina."
11342280,Ivabradine treats cardiovascular disorder,1063,Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.,True,Is the triple 'Ivabradine treats cardiovascular disorder' supported by the sentence: 'Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.'?,"Yes, the statement ""Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease"" does lend indirect support to the claim that Ivabradine treats cardiovascular disorders. This is because it suggests that Ivabradine has been found to lower heart rate through specific and selective I(f) current inhibition, which implies that it may have therapeutic potential for treating cardiovascular diseases. However, it is important to note that while this statement supports the idea that Ivabradine may be useful in treating cardiovascular disorders, it does not provide direct evidence that it is an effective treatment for these conditions. Further research would be needed to confirm its therapeutic efficacy for cardiovascular disorders specifically."
26843374,Cefixime treats tonsillitis,1064,These results show that cefixime once daily is at least as effective as penicillin V t.i.d. in pharyngitis and tonsillitis in children.,True,Is the triple 'Cefixime treats tonsillitis' supported by the sentence: 'These results show that cefixime once daily is at least as effective as penicillin V t.i.d. in pharyngitis and tonsillitis in children.'?,"Yes, the statement ""These results show that cefixime once daily is at least as effective as penicillin V t.i.d. in pharyngitis and tonsillitis in children"" does lend indirect support to the claim that ""Cefixime treats tonsillitis."" The reason for this is that tonsillitis is one of the conditions specified in the statement (pharyngitis and tonsillitis), and it is stated that cefixime is at least as effective as another treatment (penicillin V) in treating these conditions in children. This suggests that cefixime does have some therapeutic effect on tonsillitis, thus indirectly supporting the claim that it treats tonsillitis. However, it is important to note that ""treats"" can be interpreted in different ways - for instance, it may not necessarily mean that cefixime is a first-line treatment for tonsillitis. Therefore, while there is some support for the claim, it is not unconditional or direct support."
23970374,Cefixime treats Infection,1065,The aim of this study is to evaluate cefixime for the treatment of osteoarticular infections in pediatric SCD patients by retrospective design.,True,Is the triple 'Cefixime treats Infection' supported by the sentence: 'The aim of this study is to evaluate cefixime for the treatment of osteoarticular infections in pediatric SCD patients by retrospective design.'?,"Yes, the statement ""Cefixime treats Infections"" does receive indirect support from the provided statement. The aim of the study is to evaluate cefixime for treating osteoarticular infections in pediatric SCD (Sickle Cell Disease) patients. This implies that cefixime is being considered as a potential treatment for infections in these patients. However, it is important to note that direct support would require evidence from within the study itself showing cefixime's efficacy in treating infections, rather than just being studied for such use."
22544340,Cefixime treats pharyngitis,1066,Purpose: To report a case of Acute bilateral angle closure and Myopia following oral Cefixime therapy for pharyngitis.,False,Is the triple 'Cefixime treats pharyngitis' supported by the sentence: 'Purpose: To report a case of Acute bilateral angle closure and Myopia following oral Cefixime therapy for pharyngitis.'?,"No, the statement does not provide direct or indirect support for the phrase ""Cefixime treats pharyngitis."" The statement describes an adverse reaction (acute bilateral angle closure and myopia) following oral Cefixime therapy for pharyngitis. It does not suggest that Cefixime is an effective treatment for pharyngitis. In fact, it implies potential caution when prescribing Cefixime due to possible side effects."
22138225,Cefixime treats syphilis,1067,DISCUSSION: Demonstration of efficacy of cefixime in the treatment of active syphilis in this Phase 2 trial among non-pregnant women will inform a proposed randomized controlled trial to evaluate cefixime as an alternative treatment for pregnant women with active syphilis to evaluate prevention of congenital syphilis.,True,Is the triple 'Cefixime treats syphilis' supported by the sentence: 'DISCUSSION: Demonstration of efficacy of cefixime in the treatment of active syphilis in this Phase 2 trial among non-pregnant women will inform a proposed randomized controlled trial to evaluate cefixime as an alternative treatment for pregnant women with active syphilis to evaluate prevention of congenital syphilis.'?,"Yes, indirectly it does support the claim that ""Cefixime treats syphilis"". The statement discusses a Phase 2 trial demonstrating the efficacy of cefixime in treating active syphilis in non-pregnant women. This suggests that cefixime has shown promise in treating syphilis, hence providing indirect support for the claim that cefixime can be used to treat syphilis. However, it is important to note that more rigorous testing in pregnant women is required before definitively stating that cefixime can treat syphilis in all populations as the effects could potentially be different due to various factors such as pregnancy hormones which could impact drug absorption rates among other things."
20619094,Cefixime treats bronchitis,1068,"Two weeks following her return to France, the patient presented with an episode of bronchitis and received 5 days of treatment with cefixime (a third-generation cephalosporin).",False,"Is the triple 'Cefixime treats bronchitis' supported by the sentence: 'Two weeks following her return to France, the patient presented with an episode of bronchitis and received 5 days of treatment with cefixime (a third-generation cephalosporin).'?","No, the statement ""Two weeks following her return to France, the patient presented with an episode of bronchitis and received 5 days of treatment with cefixime (a third-generation cephalosporin)"" does not provide direct or indirect support for the phrase ""Cefixime treats bronchitis."" This is because correlation does not imply causation; even though the patient took cefixime during her bronchitis episode, it does not necessarily mean that cefixime was responsible for treating her bronchitis. The statement only indicates that cefixime was administered during the bronchitis episode, but it does not provide any information about its therapeutic effect on bronchitis. Additional evidence such as clinical trials, observational studies, or experimental results would be required to support such a claim."
12941415,Cefixime treats otitis media,1069,Efficacy and tolerability of cefixime in otitis media.,True,Is the triple 'Cefixime treats otitis media' supported by the sentence: 'Efficacy and tolerability of cefixime in otitis media.'?,"Yes, the statement ""Efficacy and tolerability of cefixime in otitis media"" does provide indirect support for the claim that ""Cefixime treats otitis media."" The term ""efficacy"" implies that cefixime has a positive effect on treating otitis media, while ""tolerability"" refers to its safety profile during treatment. However, it is important to note that indirect support does not equate to definitive proof. Further investigation would be necessary to fully establish the relationship between cefixime and otitis media treatment outcomes."
8827692,Cefixime treats gonorrhea,1070,A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.,True,Is the triple 'Cefixime treats gonorrhea' supported by the sentence: 'A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.'?,"Yes, the statement does provide indirect support for the claim that ""Cefixime treats gonorrhea."" The randomized trial mentioned in the statement compares two antibiotics, ciprofloxacin and cefixime, for treating gonorrhea in a population where ciprofloxacin resistance has emerged rapidly. The fact that cefixime is being tested as an alternative treatment for gonorrhea in this trial suggests that it has some efficacy against gonorrhea infections. However, it is important to note that direct evidence demonstrating cefixime's effectiveness in treating gonorrhea would still be necessary for making strong conclusions about its therapeutic value in treating gonorrhea infections.

        

        In summary, while the statement does provide some level of support for cefixime treating gonorrhea, it is indirect in nature, as it does not explicitly demonstrate cefixime's efficacy in treating gonorrhea infections but rather implies that cefixime could be an alternative treatment option when other antibiotics have become ineffective due to resistance"
7594422,Cefixime treats bacterial infectious disease,1071,A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections.,False,Is the triple 'Cefixime treats bacterial infectious disease' supported by the sentence: 'A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections.'?,"No, the statement does not provide direct support for the phrase ""Cefixime treats bacterial infectious disease"". The clinical study mentioned in the statement compares cefetamet pivoxil (CAT) with cefixime (CFX) in terms of safety and efficacy for treating bacterial infections. It does not specifically test or make claims about cefixime's ability to treat bacterial infectious diseases on its own. However, indirectly, it can be inferred that cefixime has been studied in the context of treating bacterial infections, contributing to the overall body of evidence supporting its use for that purpose."
26078551,Ceftizoxime treats bacterial infectious disease,1072,"Eighteen children with the following bacterial infections were treated with ceftizoxime; respiratory tract infection (13), acute otitis media (1), acute intervertebral chondritis and tonsillitis (1), chronic cystitis (1), subcutaneous abscess (1) and chronic bacteremia (1).",True,"Is the triple 'Ceftizoxime treats bacterial infectious disease' supported by the sentence: 'Eighteen children with the following bacterial infections were treated with ceftizoxime; respiratory tract infection (13), acute otitis media (1), acute intervertebral chondritis and tonsillitis (1), chronic cystitis (1), subcutaneous abscess (1) and chronic bacteremia (1).'?","Yes, based on the provided statement, there is indirect support for the claim that ceftizoxime treats bacterial infectious disease. The statement indicates that eighteen children diagnosed with various bacterial infections were treated using ceftizoxime. The fact that these patients were treated for their infections implies that ceftizoxime was used as an antibiotic agent to combat these bacterial infections. Therefore, it can be inferred that ceftizoxime has some therapeutic effect on bacterial infectious diseases. However, it is important to note that such evidence does not constitute direct proof that ceftizoxime treats bacterial infectious diseases since it does not involve controlled experiments designed specifically to test its efficacy for such treatments.

         It is also crucial to acknowledge that demonstrating causality between ceftizoxime usage and successful treatment would require further investigation through rigorous clinical trials that control for confounding factors such as disease severity, patient characteristics, dosage regimens, and potential interactions with other medications. Nonetheless, based on the given information, it is reasonable to infer that ceftizoxime has some therapeutic effect on bacterial infections in these patients."
25661332,Ceftizoxime treats osteomyelitis,1073,"Experience with imipenem/cilastatin and that reported for cefotaxime, ceftazidime, and ceftizoxime in the treatment of biopsy-proved osteomyelitis was compared, using data from published reports from five centers.",True,"Is the triple 'Ceftizoxime treats osteomyelitis' supported by the sentence: 'Experience with imipenem/cilastatin and that reported for cefotaxime, ceftazidime, and ceftizoxime in the treatment of biopsy-proved osteomyelitis was compared, using data from published reports from five centers.'?","Yes, indirectly it does support the statement that Ceftizoxime treats osteomyelitis. The provided statement mentions that experience with Ceftizoxime in the treatment of biopsy-proved osteomyelitis was reported in published studies from five centers. This implies that Ceftizoxime has been used in treating osteomyelitis in these studies, which suggests its potential therapeutic value for osteomyelitis treatment. However, it is important to note that indirect support does not equate to definitive proof, as more thorough evaluation of these studies would be required for stronger evidence."
23911647,Trimetazidine treats diabetic kidney disease,1074,"In DIN and diabetic kidney diseases,TMZ treatment prevents renal injury by inactivating immune cells, attenuating renal fibrosis, inflammation, apoptosis, and histological abnormalities.",True,"Is the triple 'Trimetazidine treats diabetic kidney disease' supported by the sentence: 'In DIN and diabetic kidney diseases,TMZ treatment prevents renal injury by inactivating immune cells, attenuating renal fibrosis, inflammation, apoptosis, and histological abnormalities.'?","Yes, indirectly it does lend some support. The statement suggests that Trimetazidine (TMZ) treatment has beneficial effects on various aspects related to diabetic kidney disease (DKD), such as inactivating immune cells, reducing renal fibrosis, inflammation, apoptosis, and histological abnormalities. While not explicitly stating that TMZ treats DKD, these improvements in related pathological processes can be indicative of an overall positive impact on disease progression and thus provide indirect support for TMZ being helpful in managing DKD. However, it is crucial to note that further investigation is necessary for more definitive conclusions as the provided statement does not represent a complete body of evidence required for making clinical recommendations regarding TKM use in DKD treatment."
17755056,Trimetazidine treats Cardiotoxicity,1075,Concomitant administration of trimetazidine attenuates significantly the cardiotoxicity and hepatotoxity induced by doxorubicin.,True,Is the triple 'Trimetazidine treats Cardiotoxicity' supported by the sentence: 'Concomitant administration of trimetazidine attenuates significantly the cardiotoxicity and hepatotoxity induced by doxorubicin.'?,"Yes, indirectly it does support the claim that Trimetazidine treats Cardiotoxicity. The statement provided suggests that when Trimetazidine is administered concurrently with doxorubicin, it significantly reduces the cardiotoxicity induced by doxorubicin. This implies that Trimetazidine has protective effects against cardiotoxicity, which aligns with the claim that Trimetazidine treats Cardiotoxicity. However, it is important to note that direct treatment (reversing existing damage) is not explicitly stated in the provided evidence; therefore, further investigation would be required for a definitive conclusion on its direct therapeutic effects on existing cardiotoxicity."
17682787,Trimetazidine treats cardiovascular disorder,1076,Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.,True,Is the triple 'Trimetazidine treats cardiovascular disorder' supported by the sentence: 'Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.'?,"Yes, based on the information provided in the statement, it can be inferred that Trimetazidine does have some involvement in treating cardiovascular disorders. However, this statement doesn't provide direct evidence that Trimetazidine is an effective treatment for these disorders, but rather it suggests that there is a discussion or investigation into its role in heart failure and peripheral artery disease. Therefore, while there is indirect support for the claim, more rigorous studies would be needed to confirm its efficacy as a treatment."
19370408,Cefodizime treats bacterial infectious disease,1077,[Clinical experience with cefodizime in bacterial infection of children].,False,Is the triple 'Cefodizime treats bacterial infectious disease' supported by the sentence: '[Clinical experience with cefodizime in bacterial infection of children].'?,"No, the statement ""Clinical experience with cefodizime in bacterial infection of children"" does not provide direct support for the claim that ""Cefodizime treats bacterial infectious disease."" However, it could be considered as indirect support because it suggests that cefodizime has been used in treating bacterial infections in children, which implies some level of efficacy in treating bacterial infections.

        

        Direct support would require more explicit evidence that cefodizime is responsible for treating bacterial infections. Indirect support can be useful in forming hypotheses but should not be considered conclusive evidence on its own. Further investigation would be needed to establish whether cefodizime effectively treats bacterial infections in children or other populations.

        

        The distinction between direct and indirect support is important in order to avoid overstating conclusions based on limited evidence, which is essential for maintaining integrity in both scientific inquiry and communication."
9968932,Acadesine treats B-cell chronic lymphocytic leukemia,1078,These results suggest a new pathway involving AMPK in the control of apoptosis in B-CLL cells and raise the possibility of using acadesine in B-CLL treatment.,True,Is the triple 'Acadesine treats B-cell chronic lymphocytic leukemia' supported by the sentence: 'These results suggest a new pathway involving AMPK in the control of apoptosis in B-CLL cells and raise the possibility of using acadesine in B-CLL treatment.'?,"Yes, the statement does provide indirect support for the phrase ""Acadesine treats B-cell chronic lymphocytic leukemia"" (B-CLL). The statement suggests that Acadesine (5-aminoimidazole-4-carboxamide ribonucleotide) affects apoptosis in B-CLL cells through an AMPK-mediated pathway. Apoptosis is programmed cell death, which is one mechanism by which cancer treatments can eliminate malignant cells. Therefore, if Acadesine can indeed induce apoptosis in B-CLL cells, it could potentially be used as a treatment for B-CLL. However, it is important to note that further investigation is required before making definitive conclusions about its therapeutic efficacy in treating B-CLL. Additional factors such as toxicity, pharmacokinetics, dosage requirements, and clinical trial outcomes need to be taken into consideration before Acadesine can be considered as a viable treatment option for B-CLL."
24441273,Ranolazine treats amyotrophic lateral sclerosis,1079,DISCUSSION: Ranolazine was well tolerated in ALS up to 2000 mg daily with gastrointestinal side effects being the most frequent.,False,Is the triple 'Ranolazine treats amyotrophic lateral sclerosis' supported by the sentence: 'DISCUSSION: Ranolazine was well tolerated in ALS up to 2000 mg daily with gastrointestinal side effects being the most frequent.'?,"No, the phrase ""Ranolazine treats amyotrophic lateral sclerosis"" does not receive indirect support from the statement provided. The statement discusses the tolerability and side effects of Ranolazine in ALS patients but it does not provide evidence that Ranolazine is effective in treating ALS. Therefore, it does not support the claim that Ranolazine is a treatment for ALS."
16822044,Ranolazine treats type 2 diabetes mellitus,1080,Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).,False,Is the triple 'Ranolazine treats type 2 diabetes mellitus' supported by the sentence: 'Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).'?,"No, the statement does not provide direct support for the claim that ""Ranolazine treats type 2 diabetes mellitus."" The TERISA randomized clinical trial primarily focuses on patients with type 2 diabetes mellitus and chronic stable angina, not solely on ranolazine as a treatment for type 2 diabetes mellitus.

        

        However, it is possible that there could be indirect evidence in favor of ranolazine as a treatment for type 2 diabetes mellitus within the study results. For example, if patients taking ranolazine experienced significant improvements in their blood glucose levels compared to those not taking ranolazine, that could be interpreted as indirect evidence supporting its use in treating type 2 diabetes mellitus.

        

        Nevertheless, without more detailed information about the specific outcomes measured in the TERISA trial regarding glycemic control or other diabetes-related parameters, we cannot definitively conclude that ranolazine treats type 2 diabetes mellitus based on this statement alone."
15243162,Ranolazine treats diastolic heart failure,1081,"Moreover, ranolazine holds potential promise to be effective in treatment of atrial fibrillation and diastolic heart failure.",True,"Is the triple 'Ranolazine treats diastolic heart failure' supported by the sentence: 'Moreover, ranolazine holds potential promise to be effective in treatment of atrial fibrillation and diastolic heart failure.'?","Yes, the statement ""Moreover, ranolazine holds potential promise to be effective in treatment of atrial fibrillation and diastolic heart failure"" does lend indirect support to the phrase ""Ranolazine treats diastolic heart failure."" 

         The key term here is ""potential promise,"" which suggests that there is some evidence pointing towards ranolazine being an effective treatment for diastolic heart failure, even though it may not be conclusive yet. This implies that further studies might strengthen this claim. However, it should be noted that the statement also includes atrial fibrillation as one of the conditions that ranolazine may treat; therefore, it does not specifically endorse ranolazine solely for diastolic heart failure. 

         As a computational biologist interpreting such statements, it is essential always to consider the context in which they appear and remain aware that correlation does not necessarily imply causation. While there may be an association between ranolazine and improved diastolic heart failure outcomes, additional evidence would be needed to establish ranolazine as an effective treatment for diastolic heart failure conclusively."
14672486,Ranolazine treats long QT syndrome,1082,"Small clinical trials suggest that ranolazine may have a role in the treatment of patients with non-ST-elevation acute coronary syndrome, atrial fibrillation, long QT syndromes, and sinus node dysfunction.",True,"Is the triple 'Ranolazine treats long QT syndrome' supported by the sentence: 'Small clinical trials suggest that ranolazine may have a role in the treatment of patients with non-ST-elevation acute coronary syndrome, atrial fibrillation, long QT syndromes, and sinus node dysfunction.'?","Yes, the statement does provide indirect support for the claim that ""Ranolazine treats long QT syndrome"". The reason is that in the list of conditions that small clinical trials suggest ranolazine may have a role in treating, long QT syndromes is explicitly mentioned. However, it is important to note that ""treats"" might be too strong a word here, as the original statement only suggests that ranolazine ""may have a role"" in treatment, implying that more research is needed before definitive conclusions can be drawn about its efficacy in treating long QT syndromes."
13891593,Ranolazine treats atrial fibrillation,1083,"Recent studies have increased interest in fast-unbinding Na(+) channel blockers like vernakalant (RSD1235) and ranolazine for AF therapy, but the mechanism of efficacy is poorly understood.",False,"Is the triple 'Ranolazine treats atrial fibrillation' supported by the sentence: 'Recent studies have increased interest in fast-unbinding Na(+) channel blockers like vernakalant (RSD1235) and ranolazine for AF therapy, but the mechanism of efficacy is poorly understood.'?","No, the statement does not provide direct or indirect support for the claim that ""Ranolazine treats atrial fibrillation."" The statement only mentions that recent studies have increased interest in fast-unbinding Na(+) channel blockers like vernakalant (RSD1235) and ranolazine for atrial fibrillation (AF) therapy without specifying whether these drugs have been proven effective in treating AF. Furthermore, it highlights that the mechanism by which these drugs may be effective is poorly understood. Therefore, there is no solid evidence provided in the statement that supports the therapeutic effect of ranolazine on atrial fibrillation."
12975239,Ranolazine treats coronary artery disorder,1084,Ranolazine for the management of coronary artery disease.,True,Is the triple 'Ranolazine treats coronary artery disorder' supported by the sentence: 'Ranolazine for the management of coronary artery disease.'?,"Yes, the statement ""Ranolazine for the management of coronary artery disease"" does provide indirect support for the phrase ""Ranolazine treats coronary artery disorder."" This is because ranolazine is mentioned as a management option for coronary artery disease (CAD), which implies that it has some therapeutic effect on CAD. However, it does not directly confirm that ranolazine treats coronary artery disorder as ""treats"" generally implies a more causative relationship than ""manages"" which could be referring to symptom relief rather than cure. It is important to note that further investigation would be required to establish the precise nature of ranolazine's impact on CAD progression and treatment."
10629663,Ranolazine treats Angina pectoris,1085,"Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.",True,"Is the triple 'Ranolazine treats Angina pectoris' supported by the sentence: 'Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.'?","Yes, the statement does provide indirect support for the claim that ""Ranolazine treats Angina pectoris."" The study mentioned investigates the effects of Ranolazine on exercise tolerance in angina pectoris patients who were already being treated with beta-blocker or diltiazem. This implies that ranolazine was administered in addition to these standard treatments, suggesting that it has potential therapeutic benefits for angina pectoris patients.

         However, it is important to note that while this study suggests that ranolazine may be beneficial for treating angina pectoris symptoms in certain patients, it does not necessarily prove that ranolazine is an effective treatment for angina pectoris on its own. Further studies would be required to establish ranolazine as a standalone treatment for angina pectoris.

         Moreover, it should also be considered that even if ranolazine proves effective in treating angina pectoris symptoms, it may have side effects or interactions with other medications that could limit its utility as a treatment option. Therefore, while the statement does provide some support for the claim that ""Ranolazine treats Angina pectoris,"" it is not definitive proof and further investigation is warrant"
9302562,Ranolazine treats myocardial ischemia,1086,Ranolazine has been shown to improve exercise-induced myocardial ischaemia and to lessen the severity of angina in the setting of chronic ischaemic heart disease.,True,Is the triple 'Ranolazine treats myocardial ischemia' supported by the sentence: 'Ranolazine has been shown to improve exercise-induced myocardial ischaemia and to lessen the severity of angina in the setting of chronic ischaemic heart disease.'?,"Yes, the statement does provide indirect support for the phrase ""Ranolazine treats myocardial ischemia."" The statement indicates that ranolazine has been shown to improve exercise-induced myocardial ischaemia, which is a form of myocardial ischemia. Furthermore, it mentions that ranolazine lessens the severity of angina in chronic ischaemic heart disease, suggesting that it has a therapeutic effect on ischaemic conditions. However, it is important to note that direct causation cannot be inferred from this statement alone, as further investigation and clinical trials would be required to confirm these observations and establish ranolazine as a definitive treatment for myocardial ischemia."
9302560,Ranolazine treats cardiovascular disorder,1087,Ranolazine is a novel drug that has shown promise in the treatment of cardiovascular disease.,True,Is the triple 'Ranolazine treats cardiovascular disorder' supported by the sentence: 'Ranolazine is a novel drug that has shown promise in the treatment of cardiovascular disease.'?,"Yes, the statement ""Ranolazine is a novel drug that has shown promise in the treatment of cardiovascular disease"" does lend indirect support to the phrase ""Ranolazine treats cardiovascular disorder."" The key term here is ""treatment,"" which implies that there is some therapeutic benefit derived from using ranolazine in managing cardiovascular disease (CVD). The statement highlights ranolazine as a promising drug in treating CVD, suggesting that it has demonstrated some efficacy in addressing symptoms or underlying pathophysiological mechanisms related to CVD.

        However, it is important to note that ""showing promise"" does not necessarily equate to ""proven treatment."" Further rigorous clinical trials and investigations may be required before ranolazine can be definitively stated as an effective treatment for cardiovascular disorders. Nonetheless, the statement does provide some level of support for the assertion that ranolazine has some involvement in managing CVDs."
27475554,Prednisolone treats microscopic polyangiitis,1088,Microscopic polyarteritis nodosa was diagnosed and therapy with prednisolone was begun.,True,Is the triple 'Prednisolone treats microscopic polyangiitis' supported by the sentence: 'Microscopic polyarteritis nodosa was diagnosed and therapy with prednisolone was begun.'?,"Yes, the statement ""Microscopic polyarteritis nodosa was diagnosed and therapy with prednisolone was begun"" does provide indirect support for the claim that ""Prednisolone treats microscopic polyangiitis"". This is because microscopic polyarteritis nodosa is considered a form of microscopic polyangiitis (MPA). The treatment for MPA often involves corticosteroids such as prednisolone to control inflammation and manage symptoms. However, it is important to note that correlation does not imply causation; therefore, while prednisolone is used in treating MPA, it does not necessarily mean that prednisolone is solely responsible for treating MPA as there might be other contributing factors in an individual patient's treatment plan."
26307899,Prednisolone treats eye disorder,1089,A short trial with high doses of prednisolone to treat a 62 year-old woman with malignant ophthalmopathy due to Graves disease yielded an unsatisfactory improvement after 5-6 days.,False,Is the triple 'Prednisolone treats eye disorder' supported by the sentence: 'A short trial with high doses of prednisolone to treat a 62 year-old woman with malignant ophthalmopathy due to Graves disease yielded an unsatisfactory improvement after 5-6 days.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone treats eye disorder"". In fact, it seems to suggest that prednisolone may not be effective in treating malignant ophthalmopathy due to Graves disease in this particular case. However, it is important to note that one case does not necessarily negate prednisolone as a potential treatment for eye disorders in general. Further studies would be needed to make such a determination."
25942811,Prednisolone treats sympathetic ophthalmia,1090,"[""Abolishment"" syndrome in prednisolone treatment of patients with sympathetic ophthalmia].",True,"Is the triple 'Prednisolone treats sympathetic ophthalmia' supported by the sentence: '[""Abolishment"" syndrome in prednisolone treatment of patients with sympathetic ophthalmia].'?","Yes, the phrase ""Prednisolone treats sympathetic ophthalmia"" does receive indirect support from the statement: ""Abolishment syndrome in prednisolone treatment of patients with sympathetic ophthalmia.""

         The key term here is ""abolishment syndrome,"" which implies that something (in this case, prednisolone) is being used as an agent to eliminate or significantly reduce symptoms (in this case, sympathetic ophthalmia). Therefore, it can be inferred that prednisolone is being used as a treatment for sympathetic ophthalmia in the given statement. However, it is important to note that more direct evidence would be needed for a definitive conclusion as indirect evidence may not cover all potential confounding factors or contexts."
24297743,Prednisolone treats exfoliative dermatitis,1091,"A 60-year-old Aboriginal man with underlying severe exfoliative dermatitis, treated with oral azathioprine and oral prednisolone, presented with left painful red eye for ten days.",True,"Is the triple 'Prednisolone treats exfoliative dermatitis' supported by the sentence: 'A 60-year-old Aboriginal man with underlying severe exfoliative dermatitis, treated with oral azathioprine and oral prednisolone, presented with left painful red eye for ten days.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats exfoliative dermatitis. The patient in question has exfoliative dermatitis and is being treated with both azathioprine and prednisolone. The fact that they were prescribed prednisolone suggests that it is an appropriate treatment for their condition, in this case exfoliative dermatitis. However, it should be noted that correlation does not imply causation, so while prednisolone is being used in treatment for exfoliative dermatitis in this instance, it does not definitively prove that prednisolone is solely responsible for treating the condition. Other factors, such as azathioprine, could also be contributing to the treatment."
24291326,Prednisolone treats Anti-neutrophil cytoplasmic antibody-associated vasculitis,1092,"These findings were consistent with a diagnosis of ANCA-associated vasculitis, and treatment with prednisolone markedly improved her condition.",True,"Is the triple 'Prednisolone treats Anti-neutrophil cytoplasmic antibody-associated vasculitis' supported by the sentence: 'These findings were consistent with a diagnosis of ANCA-associated vasculitis, and treatment with prednisolone markedly improved her condition.'?","Yes, the phrase ""Prednisolone treats Anti-neutrophil cytoplasmic antibody-associated vasculitis (ANCA-associated vasculitis)"" does receive indirect support from the statement: ""These findings were consistent with a diagnosis of ANCA-associated vasculitis, and treatment with prednisolone markedly improved her condition.""

         The statement suggests that a patient was diagnosed with ANCA-associated vasculitis and received treatment in the form of prednisolone, which resulted in significant improvement in her condition. This implies that prednisolone has therapeutic efficacy in treating ANCA-associated vasculitis.

         However, it is important to note that indirect support does not equate to definitive proof. While these findings suggest that prednisolone may be an effective treatment for ANCA-associated vasculitis, further investigation would be required to establish causation conclusively. Additionally, potential side effects and long-term impacts should also be taken into consideration when interpreting these results."
24042094,Prednisolone treats biliary atresia,1093,"In 2010, a study on the advantages of budesonide compared to prednisolone in autoimmune hepatitis gave rise to experimental therapy using budesonide as an adjuvant BA treatment.",False,"Is the triple 'Prednisolone treats biliary atresia' supported by the sentence: 'In 2010, a study on the advantages of budesonide compared to prednisolone in autoimmune hepatitis gave rise to experimental therapy using budesonide as an adjuvant BA treatment.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats biliary atresia"". The study mentioned is about comparing budesonide and prednisolone in autoimmune hepatitis treatment. Although it mentions budesonide as an adjuvant in biliary atresia treatment in 2010, it does not provide any information on prednisolone being used for treating biliary atresia specifically.

        
        To provide indirect support for ""Prednisolone treats biliary atresia"", there should be some evidence suggesting that prednisolone has been studied in relation to biliary atresia treatment, even if not as a primary treatment approach in that specific study from 2010. However, in this case, no such evidence is presented in the statement provided.

        
        It is important to ensure that information used in formulating conclusions is accurate, relevant, and adequately supports the claim being made. In this instance, the statement does not provide sufficient evidence for prednisolone being used in biliary atresia treatment."
23981131,Prednisolone treats mycosis fungoides,1094,Prednisolone was initially used alone as an alternative treatment for CEL.,False,Is the triple 'Prednisolone treats mycosis fungoides' supported by the sentence: 'Prednisolone was initially used alone as an alternative treatment for CEL.'?,"No, the statement does not provide direct or indirect support for the claim that ""Prednisolone treats mycosis fungoides."" The statement only indicates that prednisolone was used alone as an alternative treatment for Cutaneous Eosinophilic Leukemia (CEL). While both conditions involve skin abnormalities, they are distinct diseases that require separate treatment approaches. Therefore, evidence from one condition cannot be automatically extrapolated to support treatment efficacy in another condition without additional empirical evidence specifically addressing mycosis fungoides."
23374627,Prednisolone treats trichinellosis,1095,"This study assessed the antiparasitic and anti-inflammatory effects of Citrus limon and Capsicum frutescens on murine trichinellosis and compared them with those of albendazole and prednisolone, which are conventionally used to treat trichinellosis.",True,"Is the triple 'Prednisolone treats trichinellosis' supported by the sentence: 'This study assessed the antiparasitic and anti-inflammatory effects of Citrus limon and Capsicum frutescens on murine trichinellosis and compared them with those of albendazole and prednisolone, which are conventionally used to treat trichinellosis.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats trichinellosis. The study mentioned assesses the effects of prednisolone in treating murine trichinellosis in comparison to other conventional treatments such as albendazole. The fact that prednisolone is being studied in relation to trichinellosis indicates that it is being considered for its potential therapeutic effects against this condition. However, it is important to note that indirect support does not equate to definitive proof, as further investigation would be required to establish a direct causal relationship between prednisolone use and successful treatment outcomes for trichinellosis in humans."
22580782,Prednisolone treats interstitial lung disease 2,1096,Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined With Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis.A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis.,False,Is the triple 'Prednisolone treats interstitial lung disease 2' supported by the sentence: 'Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined With Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis.A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis.'?,"No, the statement does not provide indirect support for the claim that Prednisolone treats interstitial lung disease 2. The statement mentions that a patient with idiopathic pulmonary fibrosis was treated with prednisolone and cyclosporine A, but it does not provide any information about the outcome of the treatment specifically for interstitial lung disease 2. Furthermore, it mentions cyclosporine A in combination with prednisolone, which suggests that prednisolone may not be acting alone in treating the condition. Therefore, it is not possible to draw any conclusions about the efficacy of prednisolone in treating interstitial lung disease 2 based on this statement alone."
22500116,Prednisolone treats HIV infectious disease,1097,"The most common coexisting conditions were HIV infection (30%), prednisolone therapy (16.9%), and diabetes mellitus (15.7%).",False,"Is the triple 'Prednisolone treats HIV infectious disease' supported by the sentence: 'The most common coexisting conditions were HIV infection (30%), prednisolone therapy (16.9%), and diabetes mellitus (15.7%).'?","No, the statement does not provide direct or indirect support for the claim that prednisolone treats HIV infectious disease. The provided information only indicates an association between HIV infection and prednisolone therapy; it does not imply that prednisolone has any therapeutic effect on HIV infection. In fact, using corticosteroids like prednisolone in HIV patients could be part of treating other comorbidities (like inflammatory conditions) rather than being an antiretroviral treatment itself. Additionally, it is important to consider that association does not imply causation; thus, we cannot infer any treatment effect from this statement alone."
22130331,Prednisolone treats schizophrenia,1098,"Therefore, the effect of prednisolone can be studied as a proof of concept for immune modulation as a treatment for schizophrenia.",False,"Is the triple 'Prednisolone treats schizophrenia' supported by the sentence: 'Therefore, the effect of prednisolone can be studied as a proof of concept for immune modulation as a treatment for schizophrenia.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats schizophrenia."" The statement suggests that prednisolone can be used as a model for studying immune modulation as a potential treatment for schizophrenia. However, it does not imply that prednisolone itself is an effective treatment for schizophrenia.

        The key phrase here is ""proof of concept."" This terminology is often used in research to indicate that a particular approach or intervention is worth further investigation due to promising initial results. It does not necessarily mean that the treatment is effective or ready for widespread use.

        In this case, the statement suggests that studying prednisolone could provide insights into immune modulation as a potential treatment strategy for schizophrenia. However, it does not confirm that prednisolone is an effective treatment for schizophrenia. Therefore, further research would be needed to establish whether prednisolone has therapeutic potential in treating schizophrenia."
21634207,Prednisolone treats chronic primary adrenal insufficiency,1099,The patient started insulin therapy and treatment for AD with prednisolone and fludrocortisone with good clinical response.,True,Is the triple 'Prednisolone treats chronic primary adrenal insufficiency' supported by the sentence: 'The patient started insulin therapy and treatment for AD with prednisolone and fludrocortisone with good clinical response.'?,"Yes, there is indirect support for the claim that prednisolone treats chronic primary adrenal insufficiency (AD) based on the provided statement. The patient in question started insulin therapy as well as treatment for AD using prednisolone and fludrocortisone, which resulted in a good clinical response.

         Prednisolone is a synthetic glucocorticoid hormone that is often used in treating various conditions such as AD due to its anti-inflammatory properties and its ability to replace deficient adrenal hormones (corticosteroids) in patients suffering from AD (1). Fludrocortisone is another medication commonly used for treating AD because it is an aldosterone analogue that can help manage electrolyte imbalances that occur in AD (2).

         Although insulin therapy is not typically associated with AD treatment, it could be necessary for managing concurrent conditions like diabetes mellitus that may coexist in some AD patients (3). Therefore, we cannot infer whether insulin therapy contributed to the good clinical response in this specific case.

         However, given that prednisolone is one of the medications used for treating AD and"
21254689,Prednisolone treats hypersensitivity pneumonitis,1100,We aimed to determine the effect of mycophenolate mofetil (MMF) and azathioprine (AZA) on lung function and prednisolone dose in cHP patients.,False,Is the triple 'Prednisolone treats hypersensitivity pneumonitis' supported by the sentence: 'We aimed to determine the effect of mycophenolate mofetil (MMF) and azathioprine (AZA) on lung function and prednisolone dose in cHP patients.'?,"No, the statement does not provide direct or indirect support for the phrase ""Prednisolone treats hypersensitivity pneumonitis."" The study aims to determine the effect of mycophenolate mofetil (MMF) and azathioprine (AZA) on lung function and prednisolone dose in chronic hypersensitivity pneumonitis (cHP) patients. While prednisolone is mentioned in the context of dose adjustment in these patients, there is no information provided about its efficacy in treating hypersensitivity pneumonitis."
20836940,Prednisolone treats juvenile idiopathic arthritis,1101,"Here, we report the case of an 8-year-old girl with a 5-year history of multiple subcutaneous nodules on her extremities and a right wrist joint contracture who had been previously diagnosed with juvenile idiopathic arthritis and treated with salazosulfapyridine, low-dose prednisolone (PSL) and methotrexate.",True,"Is the triple 'Prednisolone treats juvenile idiopathic arthritis' supported by the sentence: 'Here, we report the case of an 8-year-old girl with a 5-year history of multiple subcutaneous nodules on her extremities and a right wrist joint contracture who had been previously diagnosed with juvenile idiopathic arthritis and treated with salazosulfapyridine, low-dose prednisolone (PSL) and methotrexate.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats juvenile idiopathic arthritis. The patient in question was diagnosed with juvenile idiopathic arthritis and had been treated with low-dose prednisolone in addition to other medications. The fact that prednisolone was included in her treatment regimen suggests that it is considered an effective treatment for juvenile idiopathic arthritis. However, it is important to note that correlation does not necessarily imply causation; while prednisolone may be part of an effective treatment plan for juvenile idiopathic arthritis, it does not automatically mean that prednisolone is solely responsible for any improvements in the patient's condition. Other factors, such as the patient's overall health status, other medications she was taking (salazosulfapyridine and methotrexate), and the natural progression of her disease could also have played a role in her clinical outcome."
20612701,Prednisolone treats myocarditis,1102,This is a case of EGPA relapse presenting as myocarditis despite treatment with prednisolone.,True,Is the triple 'Prednisolone treats myocarditis' supported by the sentence: 'This is a case of EGPA relapse presenting as myocarditis despite treatment with prednisolone.'?,"Yes, there is indirect support for the statement ""Prednisolone treats myocarditis"" in the provided statement: ""This is a case of EGPA relapse presenting as myocarditis despite treatment with prednisolone.""

        

        The key here is understanding that eosinophilic granulomatosis with polyangiitis (EGPA) is a rare autoimmune condition that can affect various organs in the body, including the heart (myocarditis) when it relapses. Prednisolone is often used as a treatment for EGPA because it helps manage inflammation, which is one of the primary characteristics of this condition.

        

        In this case, myocarditis has presented despite prednisolone treatment, but that doesn't necessarily mean that prednisolone is ineffective at treating myocarditis itself. Instead, it could indicate that the patient experienced a relapse of EGPA despite being on prednisolone therapy.

        

        However, it is essential to note that while prednisolone might help manage inflammation associated with myocarditis in some cases"
17604301,Prednisolone treats cataract,1103,"Her visual acuity remained stable, despite development of a cataract from prednisolone therapy.",False,"Is the triple 'Prednisolone treats cataract' supported by the sentence: 'Her visual acuity remained stable, despite development of a cataract from prednisolone therapy.'?","No, the statement ""Her visual acuity remained stable, despite development of a cataract from prednisolone therapy"" does not provide direct or indirect support for the claim that ""Prednisolone treats cataract."" In fact, it suggests the opposite: that prednisolone therapy may cause cataracts (as evidenced by its development in this case). The patient's stable visual acuity despite cataract development implies that some other factor or treatment is maintaining their visual acuity, not prednisolone itself treating the cataract."
17312178,Prednisolone treats type 2 diabetes mellitus,1104,"In this study, we hypothesized that concomitant administration of the dipeptidyl peptidase-4 inhibitor sitagliptin and prednisolone in men at high risk to develop type 2 diabetes could protect against the GC-induced diabetogenic effects.",False,"Is the triple 'Prednisolone treats type 2 diabetes mellitus' supported by the sentence: 'In this study, we hypothesized that concomitant administration of the dipeptidyl peptidase-4 inhibitor sitagliptin and prednisolone in men at high risk to develop type 2 diabetes could protect against the GC-induced diabetogenic effects.'?","No, the statement does not provide direct support for the claim that prednisolone treats type 2 diabetes mellitus. The study in question investigates whether prednisolone, when administered concomitantly with sitagliptin (a dipeptidyl peptidase-4 inhibitor), can protect against glucocorticoid (GC)-induced diabetogenic effects in men at high risk for type 2 diabetes. The focus is on the potential protective effects of combining sitagliptin and prednisolone against diabetes development rather than on prednisolone as a standalone treatment for type 2 diabetes mellitus.

         However, it is important to note that studies like these can provide valuable insights into potential therapeutic approaches for managing type 2 diabetes mellitus or preventing its onset in high-risk populations. In this case, further investigation would be necessary to determine whether prednisolone has any direct therapeutic benefits for individuals already diagnosed with type 2 diabetes mellitus."
17184322,Prednisolone treats croup,1105,"Although common practice, evidence to support treatment of croup with prednisolone is scant.",False,"Is the triple 'Prednisolone treats croup' supported by the sentence: 'Although common practice, evidence to support treatment of croup with prednisolone is scant.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats croup."" In fact, it suggests quite the opposite. The statement indicates that while using prednisolone to treat croup is common practice, there is limited evidence to back up its effectiveness. This implies that more research is needed to definitively say that prednisolone is an effective treatment for croup."
16852549,Prednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma,1106,"Treatment of peripheral T cell lymphoma with an intensive protocol ACEP (adriamycin, cyclophosphamide, etoposide and prednisolone) and ifosfamide showing an important response and overall survival rates.",True,"Is the triple 'Prednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma' supported by the sentence: 'Treatment of peripheral T cell lymphoma with an intensive protocol ACEP (adriamycin, cyclophosphamide, etoposide and prednisolone) and ifosfamide showing an important response and overall survival rates.'?","Yes, there is indirect support for the claim that prednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma based on the statement provided. The statement mentions an intensive protocol called ACEP (adriamycin, cyclophosphamide, etoposide, and prednisolone) used in treating peripheral T cell lymphoma (a subtype of mature T-cell non-Hodgkin lymphoma). The fact that patients show important responses and overall survival rates suggests that prednisolone contributes positively towards treating this type of lymphoma as part of the ACEP regimen.

         However, it is essential to acknowledge that prednisolone is not acting alone in this treatment protocol; it is part of a multi-drug regimen that includes adriamycin, cyclophosphamide, etoposide, and ifosfamide. Therefore, it is impossible to attribute the positive outcomes solely to prednisolone based on the given statement alone. Further investigation would be required to fully understand prednisolone's specific effects on mature T-cell and NK-cell non"
16360878,Prednisolone treats ophthalmic herpes zoster,1107,"Herpes zoster ophthalmicus was suspected and treatment with i.v. acyclovir and prednisolone was commenced, which led to a gradual improvement of the clinical condition.",True,"Is the triple 'Prednisolone treats ophthalmic herpes zoster' supported by the sentence: 'Herpes zoster ophthalmicus was suspected and treatment with i.v. acyclovir and prednisolone was commenced, which led to a gradual improvement of the clinical condition.'?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats ophthalmic herpes zoster"". The clinical improvement observed in the patient after initiating treatment that includes prednisolone suggests that prednisolone could be contributing to the positive outcome. However, it is important to note that this statement alone does not provide definitive proof because it is possible that other treatments (like i.v. acyclovir) or factors could also be influencing the patient's improvement. A more rigorous evaluation would require controlled clinical trials where prednisolone is administered either alone or in comparison to other treatments in similar patient groups to establish its efficacy in treating ophthalmic herpes zoster."
15441636,Prednisolone treats lipoma,1108,"Lipomas responded with less lipolysis to isoproterenol than subcutaneous fat during microdialysis, and prednisolone treatment increased lipolysis in both lipomas and subcutaneous fat.",False,"Is the triple 'Prednisolone treats lipoma' supported by the sentence: 'Lipomas responded with less lipolysis to isoproterenol than subcutaneous fat during microdialysis, and prednisolone treatment increased lipolysis in both lipomas and subcutaneous fat.'?","No, the statement ""Prednisolone treats lipoma"" does not receive direct support from the provided evidence. The statement only suggests that prednisolone may influence lipolysis (the breakdown of fat) in both lipomas (fatty tumors) and subcutaneous fat. It does not explicitly claim that prednisolone treats lipomas. Further research would be necessary to establish whether prednisolone can effectively treat lipomas in clinical settings."
15369817,Prednisolone treats pericarditis,1109,Treatment with prednisolone improved the pericarditis and motor nerve disturbance and the treatment with intravenous immunoglobulin improved the sensory nerve disturbance.,True,Is the triple 'Prednisolone treats pericarditis' supported by the sentence: 'Treatment with prednisolone improved the pericarditis and motor nerve disturbance and the treatment with intravenous immunoglobulin improved the sensory nerve disturbance.'?,"Yes, the statement does provide indirect support for the claim that prednisolone treats pericarditis. The reason is that it mentions treatment with prednisolone improved pericarditis symptoms in an individual who had both pericarditis and motor nerve disturbance. Therefore, while not explicitly stating that prednisolone is solely responsible for treating pericarditis in all cases, it does suggest that prednisolone can have a positive impact on pericarditis symptoms in some instances. However, further investigation would be required before making any definitive conclusions about prednisolone's effectiveness in treating pericarditis as there could be other factors contributing to symptom improvement in addition to prednisolone treatment."
15104714,Prednisolone treats pulmonary eosinophilia,1110,"Airway macrophage median percentage of red-hued area in stained sputum cytospin preparations was assessed by means of image analysis from (1) subjects with mild-to-severe asthma, subjects with nonasthmatic eosinophilic bronchitis, and healthy control subjects; (2) subjects with eosinophilic severe asthma after treatment with prednisolone; and (3) subject with noneosinophilic asthma before corticosteroid withdrawal.",False,"Is the triple 'Prednisolone treats pulmonary eosinophilia' supported by the sentence: 'Airway macrophage median percentage of red-hued area in stained sputum cytospin preparations was assessed by means of image analysis from (1) subjects with mild-to-severe asthma, subjects with nonasthmatic eosinophilic bronchitis, and healthy control subjects; (2) subjects with eosinophilic severe asthma after treatment with prednisolone; and (3) subject with noneosinophilic asthma before corticosteroid withdrawal.'?","No, the statement does not provide direct support for the claim that prednisolone treats pulmonary eosinophilia. The statement describes an experimental design where image analysis was used to assess airway macrophage median percentage of red-hued area in stained sputum cytospin preparations from various subject groups including those with eosinophilic severe asthma after treatment with prednisolone.

        However, it does not provide information on how treatment with prednisolone affected pulmonary eosinophilia specifically in these subjects nor does it indicate whether prednisolone led to any improvements in their condition compared to their baseline measurements or relative to other groups in the study. Therefore, it is not possible to infer from this statement that prednisolone treats pulmonary eosinophilia based on the provided information alone."
14992803,Prednisolone treats aplastic anemia,1111,"We report a case of subcutaneous abscess caused by Nocardia farcinica in a 44-year-old man, who had been treated with systemic prednisolone and cyclosporin for aplastic anemia.",True,"Is the triple 'Prednisolone treats aplastic anemia' supported by the sentence: 'We report a case of subcutaneous abscess caused by Nocardia farcinica in a 44-year-old man, who had been treated with systemic prednisolone and cyclosporin for aplastic anemia.'?","Yes, there is indirect support for the claim that prednisolone treats aplastic anemia in the provided statement. The context suggests that the 44-year-old man was being treated for aplastic anemia using prednisolone when he developed a subcutaneous abscess caused by Nocardia farcinica. The treatment of his primary condition, aplastic anemia, with prednisolone implies that prednisolone is used as a therapeutic agent for managing this disorder.

         However, it is important to note that correlation does not imply causation. While prednisolone is used in treating aplastic anemia, it does not necessarily mean that prednisolone is solely responsible for treating the condition. Other factors such as cyclosporin (also mentioned in the statement) may contribute to its treatment as well. Moreover, it is also crucial to consider potential side effects and complications associated with prednisolone use in treating aplastic anemia.

         In summary, while there is some level of support for prednisolone being used in treating aplastic anemia based on the given statement, it is essential to consider"
14742554,Prednisolone treats psoriasis,1112,Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment.,True,Is the triple 'Prednisolone treats psoriasis' supported by the sentence: 'Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment.'?,"Yes, indirectly it does support that prednisolone may have some effect on psoriasis, but it doesn't conclusively prove that prednisolone treats psoriasis. The statement suggests that there is an association between prednisolone treatment and the occurrence of psoriasis in an HIV-negative patient who also had Kaposi sarcoma. However, it doesn't provide enough information to determine if prednisolone was used as a treatment for psoriasis, if the psoriasis was alleviated by prednisolone, or if prednisolone had any causative relationship with the psoriasis in this specific case. Therefore, while there is some suggestion of a connection, more direct evidence would be needed to definitively state that prednisolone treats psoriasis."
14676056,Prednisolone treats habitual spontaneous abortion,1113,Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium.,True,Is the triple 'Prednisolone treats habitual spontaneous abortion' supported by the sentence: 'Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium.'?,"Yes, indirectly. The statement does not explicitly confirm that prednisolone treats habitual spontaneous abortion (also known as recurrent miscarriage). However, it does provide evidence for a clinical trial investigating the effects of prednisolone on women experiencing recurrent miscarriage who have raised levels of uterine natural killer (uNK) cells in the endometrium. This implies that there is some biological rationale for investigating prednisolone as a potential treatment for recurrent miscarriage, given its potential impact on uNK cells in the endometrium. While indirect, it does lend some support for prednisolone as a potential therapeutic option in treating habitual spontaneous abortion. However, it is essential to await the results and conclusions from such trials before making definitive conclusions about its efficacy in treating recurrent miscarriage."
14345678,Prednisolone treats thrombotic thrombocytopenic purpura,1114,"The second was a 6-year-old boy with acquired relapsing TTP previously managed with plasmapheresis and prednisolone, who presented with a third relapse that was treated with plasmapheresis and rituximab; he remains in remission 17 months after treatment.",True,"Is the triple 'Prednisolone treats thrombotic thrombocytopenic purpura' supported by the sentence: 'The second was a 6-year-old boy with acquired relapsing TTP previously managed with plasmapheresis and prednisolone, who presented with a third relapse that was treated with plasmapheresis and rituximab; he remains in remission 17 months after treatment.'?","Yes, the statement does provide indirect support for the claim that Prednisolone treats thrombotic thrombocytopenic purpura (TTP). The case describes a patient who has had multiple relapses of TTP, each time being treated successfully with plasmapheresis and prednisolone. This suggests that prednisolone is an effective treatment for TTP in this individual. However, it does not provide direct evidence that prednisolone is solely responsible for treating TTP as plasmapheresis was also used in all treatments. Additionally, the patient was later treated with rituximab during their third relapse, making it difficult to definitively attribute their remission solely to prednisolone. Therefore, while there is some support for the claim, it is not unequivocal evidence that prednisolone treats TTP."
14012190,Prednisolone treats angioimmunoblastic T-cell lymphoma,1115,"Three months later, AILD relapsed in spite of prednisolone treatment.",False,"Is the triple 'Prednisolone treats angioimmunoblastic T-cell lymphoma' supported by the sentence: 'Three months later, AILD relapsed in spite of prednisolone treatment.'?","No, the statement ""Prednisolone treats angioimmunoblastic T-cell lymphoma"" does not receive indirect support from ""Three months later, AILD relapsed in spite of prednisolone treatment.""

         The second statement suggests that prednisolone was not successful in treating AILD (angioimmunoblastic T-cell lymphoma) in this particular case, as the disease relapsed despite treatment. This implies that prednisolone may not be an effective treatment for AILD in all cases, which contradicts the claim that prednisolone treats angioimmunoblastic T-cell lymphoma. Therefore, the second statement does not provide indirect support for the first claim but rather suggests a lack of efficacy.

         However, it is important to note that the effectiveness of prednisolone in treating AILD may vary depending on individual patient characteristics, disease stage, and other factors. Therefore, while this specific case does not support the claim, it does not necessarily disprove it either. Further research involving larger sample sizes would be needed to make more definitive conclusions about the efficacy of prednisolone in treating AILD."
13758030,Prednisolone treats optic neuritis,1116,Acute generalized exanthematous pustulosis induced by high-dose prednisolone in a young woman with optic neuritis owing to disseminated encephalomyelitis.,True,Is the triple 'Prednisolone treats optic neuritis' supported by the sentence: 'Acute generalized exanthematous pustulosis induced by high-dose prednisolone in a young woman with optic neuritis owing to disseminated encephalomyelitis.'?,"Yes, there is indirect support for the statement ""Prednisolone treats optic neuritis"" in the provided passage. The key piece of evidence lies in the phrase ""high-dose prednisolone in a young woman with optic neuritis."" This implies that prednisolone was administered as part of treatment for optic neuritis in this specific case report.

        However, it is important to note that correlation does not imply causation; therefore, we cannot definitively say that prednisolone was solely responsible for treating optic neuritis in this case based solely on this passage alone. Additional evidence from clinical trials and studies would be needed for more robust support for that claim.

        Furthermore, adverse reactions like acute generalized exanthematous pustulosis can occur even when medications like prednisolone are used appropriately for treatment purposes, as seen in the case described here. This underscores the need for careful monitoring during such treatments and highlights that individual responses can vary significantly when using pharmacological interventions such as prednisolone."
13566191,Prednisolone treats follicular lymphoma,1117,"The addition of rituximab to cyclophosphamide, vincristine and prednisolone (CVP) for advanced follicular lymphoma increases median time to progression by 17 months.",False,"Is the triple 'Prednisolone treats follicular lymphoma' supported by the sentence: 'The addition of rituximab to cyclophosphamide, vincristine and prednisolone (CVP) for advanced follicular lymphoma increases median time to progression by 17 months.'?","No, the statement does not provide direct support for the claim that prednisolone treats follicular lymphoma. The statement only indicates that adding rituximab to cyclophosphamide, vincristine and prednisolone (CVP) increases median time to progression in advanced follicular lymphoma by 17 months. It does not imply that prednisolone alone has any effect on follicular lymphoma.

         However, it is important to note that prednisolone is part of the CVP treatment regimen mentioned in the statement. Prednisolone is a corticosteroid often used in combination therapies for various types of cancer due to its anti-inflammatory properties and potential immune-modulating effects that may enhance the overall treatment efficacy.

         Nonetheless, attributing therapeutic efficacy solely to prednisolone based on the provided statement would be an oversimplification and not supported by available evidence. Further investigation into clinical trials specifically testing prednisolone as monotherapy for follicular lymphoma would be required for definitive conclusions about its efficacy in treating follicular lymph"
13327146,Prednisolone treats allergic bronchopulmonary aspergillosis,1118,"Here 2 cases of allergic bronchopulmonary aspergillosis in a family (brother and sister), treated with prednisolone with complete remission are reported.",True,"Is the triple 'Prednisolone treats allergic bronchopulmonary aspergillosis' supported by the sentence: 'Here 2 cases of allergic bronchopulmonary aspergillosis in a family (brother and sister), treated with prednisolone with complete remission are reported.'?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats allergic bronchopulmonary aspergillosis."" The case report mentions that two siblings suffering from allergic bronchopulmonary aspergillosis were treated with prednisolone and experienced complete remission. However, it is important to note that anecdotal evidence from case reports does not equate to definitive proof due to factors such as potential confounding variables and small sample sizes. Further studies would be required for stronger evidence."
13311736,Prednisolone treats neoplasm,1119,FDG-PET was performed in rats bearing BCG granulomas or tumors before and after prednisolone treatment.,False,Is the triple 'Prednisolone treats neoplasm' supported by the sentence: 'FDG-PET was performed in rats bearing BCG granulomas or tumors before and after prednisolone treatment.'?,"No, the statement ""Prednisolone treats neoplasm"" does not receive direct support from the provided evidence. The statement ""FDG-PET was performed in rats bearing BCG granulomas or tumors before and after prednisolone treatment"" only indicates that prednisolone was used in conjunction with FDG-PET scans in rats that had either granulomas or tumors. It does not provide evidence that prednisolone was used as a treatment for neoplasm (tumors).

        To provide direct support for the claim that prednisolone treats neoplasm, we would need evidence showing that prednisolone was administered as a treatment for tumors specifically, and that it led to an improvement in the condition. The provided statement does not contain information about the effects of prednisolone on tumors, nor does it specify that prednisolone was used as a treatment for tumors rather than granulomas. Therefore, it does not provide direct support for the claim in question.

        However, it is important to note that indirect support could potentially be inferred from such a statement if additional evidence were provided showing that prednisol"
12767794,Prednisolone treats pneumonia,1120,"After recovering from pneumonia, she was treated initially with prednisolone, 30 mg/day, and remained well until she developed hemoptysis at age 34 years.",True,"Is the triple 'Prednisolone treats pneumonia' supported by the sentence: 'After recovering from pneumonia, she was treated initially with prednisolone, 30 mg/day, and remained well until she developed hemoptysis at age 34 years.'?","Yes, while not explicitly stated in the provided text, there is indirect support for the claim that prednisolone treats pneumonia. This is based on the information that after recovering from pneumonia, the patient was treated with prednisolone, suggesting that prednisolone may have been used as part of her treatment regimen for pneumonia. However, it is important to note that correlation does not imply causation, meaning that even though prednisolone was administered after pneumonia recovery does not necessarily mean it was responsible for her recovery. Furthermore, prednisolone is primarily used as an anti-inflammatory drug rather than an antibiotic; therefore its primary mechanism for treating pneumonia would be through reducing inflammation rather than eliminating pathogens causing pneumonia."
12190701,Prednisolone treats castration-resistant prostate carcinoma,1121,Fifteen patients 60 to 80 years old (a mean of 72 years) with hormone-refractory prostate cancer were treated with low dose prednisolone.,True,Is the triple 'Prednisolone treats castration-resistant prostate carcinoma' supported by the sentence: 'Fifteen patients 60 to 80 years old (a mean of 72 years) with hormone-refractory prostate cancer were treated with low dose prednisolone.'?,"Yes, indirectly. The statement does provide some support for the claim that prednisolone may be used in treating prostate cancer, specifically in patients who have become refractory to hormone therapy. However, it does not explicitly state that prednisolone treats castration-resistant prostate carcinoma, which is a specific type of hormone-refractory prostate cancer. Therefore, while there is some correlation suggested by the statement, it does not directly support the specific claim made in the question.

        
        The study referenced in the statement is also quite small (only 15 patients), which limits its statistical power and generalizability. Furthermore, it does not provide any information about the efficacy of prednisolone in treating these patients, only that they were treated with it. To more definitively support the claim that prednisolone treats castration-resistant prostate carcinoma, more robust studies with larger sample sizes and clear outcomes would be needed."
11988157,Prednisolone treats diffuse large B-cell lymphoma,1122,"CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) has been the standard chemotherapy regimen used for diffuse large cell lymphomas for over 30 years.",True,"Is the triple 'Prednisolone treats diffuse large B-cell lymphoma' supported by the sentence: 'CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) has been the standard chemotherapy regimen used for diffuse large cell lymphomas for over 30 years.'?","Yes, indirectly it does. The statement provided mentions that CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) has been used as a standard chemotherapy regimen for diffuse large B-cell lymphoma for over 30 years. This implies that each component of the CHOP regimen, including prednisolone, contributes to its effectiveness in treating this type of lymphoma. However, it is important to note that prednisolone alone may not be effective in treating diffuse large B-cell lymphoma; it is typically used in combination with other drugs as part of the CHOP regimen."
11889996,Prednisolone treats mucocutaneous lymph node syndrome,1123,"Six patients with Kawasaki disease (KD) were treated with prednisolone (1 to 2 mg/kg/day) for 3 days (from days 10 to 12 after the onset of the illness) after apparently unsuccessful treatment with intravenous immunoglobulin (IVIG, 2 g/kg/dose and additional 1 g/kg/dose).",True,"Is the triple 'Prednisolone treats mucocutaneous lymph node syndrome' supported by the sentence: 'Six patients with Kawasaki disease (KD) were treated with prednisolone (1 to 2 mg/kg/day) for 3 days (from days 10 to 12 after the onset of the illness) after apparently unsuccessful treatment with intravenous immunoglobulin (IVIG, 2 g/kg/dose and additional 1 g/kg/dose).'?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats mucocutaneous lymph node syndrome."" The reason is that Kawasaki disease (KD) is a form of mucocutaneous lymph node syndrome, so treating KD with prednisolone can be interpreted as treating mucocutaneous lymph node syndrome. However, it is important to note that this is an indirect inference based on the treatment of KD as a specific instance of mucocutaneous lymph node syndrome. A direct claim would require evidence from studies specifically investigating prednisolone as a treatment for mucocutaneous lymph node syndrome beyond KD cases."
11813573,Prednisolone treats focal segmental glomerulosclerosis,1124,"RESULTS: Of 136 patients with primary FSGS and nephrotic range proteinuria, 76 (56%) were treated with prednisolone and of this group, 59% were treated with additional immunosuppression.",False,"Is the triple 'Prednisolone treats focal segmental glomerulosclerosis' supported by the sentence: 'RESULTS: Of 136 patients with primary FSGS and nephrotic range proteinuria, 76 (56%) were treated with prednisolone and of this group, 59% were treated with additional immunosuppression.'?","No, the statement does not provide direct support for the claim that prednisolone treats focal segmental glomerulosclerosis (FSGS). However, it does offer some indirect evidence suggesting that prednisolone might be an effective treatment option for FSGS patients.

         The statement indicates that 56% of primary FSGS patients with nephrotic range proteinuria were treated with prednisolone. Of those treated with prednisolone, 59% received additional immunosuppression therapy. It is important to note that correlation does not imply causation; therefore, we cannot definitively conclude that prednisolone is an effective treatment for FSGS based solely on these results.

         Nonetheless, it is plausible that prednisolone may play a role in managing FSGS symptoms due to its immunosuppressive properties. To strengthen support for prednisolone as an FSGS treatment, further studies should be conducted that include control groups, randomization, blinding, and long-term follow-up assessments. These measures would help establish whether prednisolone has therapeutic benefits for FSGS patients independent of other treatments or"
11810617,Prednisolone treats congenital adrenal hyperplasia,1125,"METHODS: Growth parameters of twelve children (8 m, 4 f) with congenital adrenal hyperplasia were retrospectively studied while on treatment with prednisolone (PR) earlier and then hydrocortisone (HC) after it became freely available in India.",True,"Is the triple 'Prednisolone treats congenital adrenal hyperplasia' supported by the sentence: 'METHODS: Growth parameters of twelve children (8 m, 4 f) with congenital adrenal hyperplasia were retrospectively studied while on treatment with prednisolone (PR) earlier and then hydrocortisone (HC) after it became freely available in India.'?","Yes, indirect support can be inferred from the statement provided. The methodology describes a retrospective study on growth parameters of children diagnosed with congenital adrenal hyperplasia (CAH) who were treated with prednisolone (PR) before hydrocortisone (HC) became available in India. Since PR is a glucocorticoid medication commonly used in treating CAH, it suggests that PR could have alleviating effects on the condition. However, it is important to note that indirect support does not equate to definitive evidence; further investigation is necessary for drawing more robust conclusions about PR's therapeutic potential in treating CAH."
11808057,Prednisolone treats keratitis,1126,Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.,True,Is the triple 'Prednisolone treats keratitis' supported by the sentence: 'Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.'?,"Yes, the statement ""Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis"" does lend indirect support to the claim that prednisolone treats keratitis.

         Keratitis is an inflammation of the cornea (the clear front part of the eye), often caused by bacterial infections like Pseudomonas aeruginosa (Experimental Pseudomonas keratitis in this case). Prednisolone is a corticosteroid that reduces inflammation by suppressing the immune system response. It is often used in conjunction with antibiotics like ciprofloxacin, which targets specific bacteria causing infection.

         The statement ""Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis"" implies that both ciprofloxacin (to treat infection) and prednisolone (to reduce inflammation) were used in treating an experimental Pseudomonas keratitis model. This suggests that prednisolone plays an active role in addressing keratitis symptoms (inflammation), providing indirect evidence supporting its"
11527350,"Prednisolone treats dermatitis, atopic",1127,"Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflammatory skin diseases, for example atopic dermatitis.",False,"Is the triple 'Prednisolone treats dermatitis, atopic' supported by the sentence: 'Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflammatory skin diseases, for example atopic dermatitis.'?","No, the statement does not provide direct support for the phrase ""Prednisolone treats dermatitis, atopic"". The statement discusses Prednicarbate, which is a derivative of Prednisolone, but it does not mention or imply that Prednisolone itself is an effective treatment for atopic dermatitis. However, given that Prednicarbate is derived from Prednisolone and is used for treating atopic dermatitis, it can be inferred that Prednisolone might have similar properties, but this would require separate evidence."
11526277,Prednisolone treats kidney disorder,1128,"AIM: To evaluate the efficacy of prednisolone, warfarin, and dipyridamole therapy combined with mizoribine (PWDM) in the treatment of diffuse immunoglobulin A (IgA) nephropathy in comparison with prednisolone, warfarin, and dipyridamole therapy without mizoribine (PWD) and with methylprednisolone pulse therapy (PWD pulse).",False,"Is the triple 'Prednisolone treats kidney disorder' supported by the sentence: 'AIM: To evaluate the efficacy of prednisolone, warfarin, and dipyridamole therapy combined with mizoribine (PWDM) in the treatment of diffuse immunoglobulin A (IgA) nephropathy in comparison with prednisolone, warfarin, and dipyridamole therapy without mizoribine (PWD) and with methylprednisolone pulse therapy (PWD pulse).'?","No, the statement does not provide direct support for the claim that ""Prednisolone treats kidney disorder"". However, it does offer indirect evidence suggesting that prednisolone may be an effective treatment for diffuse immunoglobulin A (IgA) nephropathy when used in combination therapies (PWDM and PWD). This is still not conclusive proof that prednisolone alone can treat kidney disorders since IgA nephropathy is only one type of kidney disease. Moreover, prednisolone is used as part of these combination therapies, which may contribute to their efficacy. Therefore, further investigation would be necessary to establish whether prednisolone can indeed treat kidney disorders independently."
11497678,Prednisolone treats infertility disorder,1129,"In this double blind cross-over study, 20 infertile men, who had sperm antibodies detected by the mixed antiglobulin reaction (MAR test) in the ejaculate and by the tray agglutination test (TAT) in serum, were treated with 40 mg/day prednisolone or placebo from days 1 to 10 of the partners' menstrual cycle.",False,"Is the triple 'Prednisolone treats infertility disorder' supported by the sentence: 'In this double blind cross-over study, 20 infertile men, who had sperm antibodies detected by the mixed antiglobulin reaction (MAR test) in the ejaculate and by the tray agglutination test (TAT) in serum, were treated with 40 mg/day prednisolone or placebo from days 1 to 10 of the partners' menstrual cycle.'?","No, the statement does not provide direct support for the claim that ""Prednisolone treats infertility disorder"". However, it does offer indirect support for the potential use of prednisolone in addressing certain aspects of infertility in specific cases.

         The study mentions that 20 infertile men with sperm antibodies detected by MAR test in the ejaculate and TAT in serum were treated with prednisolone. This suggests that prednisolone may have an effect on sperm antibodies, which could potentially improve fertility in men with such antibodies. However, it is important to note that infertility is a complex issue that can be caused by many factors beyond sperm antibodies, such as hormonal imbalances, structural issues, genetic factors, and lifestyle factors. Therefore, while prednisolone may be beneficial in certain cases of infertility related to sperm antibodies, it cannot be concluded that it ""treats infertility disorder"" in general.

         Furthermore, the study design is also a crucial factor to consider. This is a double-blind cross-over study, which is a robust design for comparing two interventions"
11373326,Prednisolone treats prostate cancer,1130,BACKGROUND: We conducted this retrospective study to analyze a modified dose schedule of mitoxantrone and prednisolone (MP) in patients with androgen-independent prostate cancer.,False,Is the triple 'Prednisolone treats prostate cancer' supported by the sentence: 'BACKGROUND: We conducted this retrospective study to analyze a modified dose schedule of mitoxantrone and prednisolone (MP) in patients with androgen-independent prostate cancer.'?,"No, the statement does not provide direct or indirect support for the claim that prednisolone treats prostate cancer. The provided background information is about a retrospective study analyzing a modified dose schedule of mitoxantrone and prednisolone (MP) in patients with androgen-independent prostate cancer. However, it does not mention any therapeutic effects specific to prednisolone in treating prostate cancer. Additionally, there is no control group for comparing mitoxantrone plus prednisolone against either drug alone, making it impossible to attribute any observed effects solely to prednisolone."
11166363,Prednisolone treats canker sore,1131,"It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.",True,"Is the triple 'Prednisolone treats canker sore' supported by the sentence: 'It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats canker sores (aphthous ulcers of the mouth). The phrase ""with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth"" indicates that prednisolone has been used in treating canker sores (aphthous ulcers) in combination with other drugs. This suggests that prednisolone has some efficacy in treating canker sores, although it does not provide direct evidence that prednisolone is solely responsible for treating canker sores in these cases. It is essential to consider other factors such as dosage, duration, side effects, potential interactions with other drugs, and overall effectiveness when interpreting these results in clinical settings."
11166362,Prednisolone treats lichen planus,1132,"It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.",True,"Is the triple 'Prednisolone treats lichen planus' supported by the sentence: 'It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats lichen planus. The text explicitly mentions that prednisolone is used in combination with other drugs for treating lichen planus, which implies that prednisolone plays an active role in treating this condition. However, it is important to note that this evidence is indirect; for a more definitive conclusion, direct evidence from clinical trials or experimental studies would be required. Additionally, context is crucial when interpreting such statements; for example, it should be taken into account whether the source is reputable, whether there may be conflicts of interest, and whether the statement is consistent with other evidence in the field."
11166361,Prednisolone treats erythema multiforme,1133,"It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.",True,"Is the triple 'Prednisolone treats erythema multiforme' supported by the sentence: 'It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.'?","Yes, the phrase ""Prednisolone treats erythema multiforme"" does receive indirect support from the statement provided. The statement mentions that prednisolone has been used in combination with other drugs for treating certain dermatologic disorders, including erythema multiforme. This implies that prednisolone has some efficacy in treating erythema multiforme, even though it may not be used as a standalone treatment. However, it is important to note that this is an indirect inference based on a single statement, so further evidence would be needed for a more definitive conclusion."
10782301,Prednisolone treats adrenocortical insufficiency,1134,Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.,True,Is the triple 'Prednisolone treats adrenocortical insufficiency' supported by the sentence: 'Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.'?,"Yes, the phrase ""Prednisolone treats adrenocortical insufficiency"" does receive indirect support from the statement: ""Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency."" 

         The title of the study alone suggests that prednisolone is being considered for the treatment of adrenal insufficiency, also known as adrenocortical insufficiency. The study is not merely discussing prednisolone in general but specifically in relation to its use in treating adrenal insufficiency. Therefore, it lends indirect support to the claim that prednisolone is used for treating adrenocortical insufficiency. However, for a more definitive conclusion, it would be necessary to review the full study content to understand its specific findings and conclusions about prednisolone's efficacy in treating adrenocortical insufficiency."
10757066,Prednisolone treats atopic eczema,1135,[Results of prednisolone therapy of eczemas in very young and older infants].,True,Is the triple 'Prednisolone treats atopic eczema' supported by the sentence: '[Results of prednisolone therapy of eczemas in very young and older infants].'?,"Yes, the statement ""Prednisolone treats atopic eczema"" can receive indirect support from the provided context: ""[Results of prednisolone therapy of eczemas in very young and older infants].""

        

        The statement ""Results of prednisolone therapy of eczemas in very young and older infants"" implies that there have been studies conducted on the effects of prednisolone therapy on eczema in different age groups of infants. This suggests that there is some level of investigation into prednisolone as a potential treatment for eczema.

        

        However, it is essential to emphasize that indirect support does not equate to definitive proof. To solidify the claim that ""Prednisolone treats atopic eczema,"" more specific information is required from peer-reviewed literature regarding prednisolone's efficacy in treating eczema symptoms, potential side effects, dosage recommendations, etc.

        

        In summary, while the statement provides some level of support for prednisolone being used as a treatment for atopic eczema in infants, further investigation is required before making any"
10671990,Prednisolone treats Headache,1136,"We report a patient with neuro-Behcet's syndrome presenting with headache and personality change in whom CT and MRI brain imaging was normal, but regional cerebral blood flow imaging using single photon emission tomography with the tracer HMPAO showed extensive perfusion deficits which partially reversed after 3 months of prednisolone therapy.",True,"Is the triple 'Prednisolone treats Headache' supported by the sentence: 'We report a patient with neuro-Behcet's syndrome presenting with headache and personality change in whom CT and MRI brain imaging was normal, but regional cerebral blood flow imaging using single photon emission tomography with the tracer HMPAO showed extensive perfusion deficits which partially reversed after 3 months of prednisolone therapy.'?","Yes, indirect support can be inferred from the statement provided for the claim ""Prednisolone treats Headache"". The statement describes a patient with neuro-Behcet's syndrome who presented with headache among other symptoms. The patient was treated with prednisolone for 3 months, during which time there was a partial reversal in regional cerebral blood flow deficits as shown by single photon emission tomography (SPECT) imaging. While headache is not explicitly mentioned as improving, it is reasonable to infer that improvements in cerebral blood flow might alleviate headache symptoms given that headache is often associated with impaired cerebral blood flow in various conditions. However, it is important to note that this does not provide direct evidence as headache is not specifically evaluated for improvement post-treatment. Additionally, correlation does not necessarily imply causation; it is possible that other factors might have contributed to the improvement in cerebral blood flow and headache symptoms."
10574410,Prednisolone treats synovitis,1137,Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis.,True,Is the triple 'Prednisolone treats synovitis' supported by the sentence: 'Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis.'?,"Yes, the phrase ""Prednisolone treats synovitis"" does receive indirect support from the statement: ""Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis."" This is because synovitis is explicitly mentioned as one of the conditions treated by prednisolone in the provided statement. However, it is important to note that meticortelone is also mentioned alongside prednisolone, which may have different properties or indications for use than prednisolone alone. Nonetheless, based on the provided information, prednisolone is associated with treating synovitis, thus providing indirect support for the original phrase."
10574409,Prednisolone treats epicondylitis,1138,Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis.,True,Is the triple 'Prednisolone treats epicondylitis' supported by the sentence: 'Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis.'?,"Yes, the phrase ""Prednisolone treats epicondylitis"" does receive indirect support from the statement: ""Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis.""

        The statement explicitly mentions prednisolone as one of the treatments for epicondylitis. Although meticortelone is also mentioned in conjunction with prednisolone, it does not detract from prednisolone being listed as a treatment for epicondylitis. Therefore, based on the provided information, it is reasonable to infer that prednisolone is indeed used in treating epicondylitis.

        However, it is important to note that further investigation would be necessary to fully understand the context in which prednisolone is used for epicondylitis treatment, such as dosage, duration, potential side effects, and contraindications. Additionally, evidence from multiple sources should be considered before making definitive conclusions about medical treatments."
10565149,Prednisolone treats osteoarthritis,1139,"Intra-articular injections of hydrocortisone prednisolone, and their tertiary-butylacetate derivatives in patients with rheumatoid arthritis and osteoarthritis.",True,"Is the triple 'Prednisolone treats osteoarthritis' supported by the sentence: 'Intra-articular injections of hydrocortisone prednisolone, and their tertiary-butylacetate derivatives in patients with rheumatoid arthritis and osteoarthritis.'?","Yes, there is indirect support for the claim that prednisolone treats osteoarthritis based on the provided statement. The rationale behind this is that prednisolone belongs to the same class of drugs as hydrocortisone - both being corticosteroids - which can be used interchangeably in some cases depending on their potency and formulation.

        

        The statement mentions that intra-articular injections (injecting medication into joint space) containing hydrocortisone prednisolone along with their tertiary-butylacetate derivatives were administered in patients suffering from rheumatoid arthritis as well as osteoarthritis. This implies that these corticosteroids were employed as therapeutic agents for treating these conditions.

        

        Although the statement does not explicitly state that prednisolone alone treats osteoarthritis, its use within an intra-articular injection formulation for treating osteoarthritis suggests that prednisolone could also potentially be effective in managing osteoarthritis symptoms when used in an appropriate manner. However, it should"
10557390,Prednisolone treats peptic ulcer disease,1140,On the development of peptic ulcers in patients treated with prednisone or prednisolone.,False,Is the triple 'Prednisolone treats peptic ulcer disease' supported by the sentence: 'On the development of peptic ulcers in patients treated with prednisone or prednisolone.'?,"No, the statement does not provide direct or indirect support for the claim that prednisolone treats peptic ulcer disease. The provided statement discusses the development of peptic ulcers in patients treated with prednisone or prednisolone. However, it does not establish any causal relationship between prednisolone treatment and improvement in peptic ulcer disease symptoms. To support the claim that prednisolone treats peptic ulcer disease, there should be evidence demonstrating that prednisolone use leads to healing or alleviation of peptic ulcers."
10513879,Prednisolone treats celiac disease,1141,The simultaneous correction of plain-water deficit and extracellular fluid volume loss in non-tropical sprue treated with prednisolone.,False,Is the triple 'Prednisolone treats celiac disease' supported by the sentence: 'The simultaneous correction of plain-water deficit and extracellular fluid volume loss in non-tropical sprue treated with prednisolone.'?,"No, the statement does not provide direct or indirect support for the claim that prednisolone treats celiac disease. The statement mentions non-tropical sprue (which is another term for celiac disease) being treated with prednisolone, but it only refers to the correction of plain-water deficit and extracellular fluid volume loss, not treating celiac disease itself. Therefore, it does not establish a cause-and-effect relationship between prednisolone use and treating celiac disease.

        To provide some context, prednisolone is a type of corticosteroid medication that can reduce inflammation in the body by mimicking the effects of hormones produced by the adrenal glands. It has been used off-label in certain cases of celiac disease when patients experience refractory sprue (a severe form of celiac disease that does not respond to a gluten-free diet). However, prednisolone is not considered a primary treatment for celiac disease due to its potential side effects and limited efficacy compared to other available treatments such as strict adherence to a gluten-free diet.

        In summary, while prednisolone might be used"
10509017,Prednisolone treats hepatocellular carcinoma,1142,"One had received four weekly cycles of prednisolone, Adriamycin, vincristine and 5-fluorouracil for an inoperable HCC with a 10-cm diameter, and the other had received localised synchronised hepatic irradiation and Adriamycin.",False,"Is the triple 'Prednisolone treats hepatocellular carcinoma' supported by the sentence: 'One had received four weekly cycles of prednisolone, Adriamycin, vincristine and 5-fluorouracil for an inoperable HCC with a 10-cm diameter, and the other had received localised synchronised hepatic irradiation and Adriamycin.'?","No, the statement does not provide direct or indirect support for the claim that prednisolone treats hepatocellular carcinoma (HCC). The statement only mentions that one patient had received prednisolone as part of a four-drug regimen for treating an inoperable HCC, but it does not provide any information about the outcome of that treatment specifically related to prednisolone. Therefore, it is not possible to draw any conclusions about prednisolone's effectiveness in treating HCC based on this information alone."
10502737,Prednisolone treats hemolytic anemia,1143,"[A case of hemolytic anemia with generalized agglutination, treated with ACTH, cortisone, and prednisolone].",True,"Is the triple 'Prednisolone treats hemolytic anemia' supported by the sentence: '[A case of hemolytic anemia with generalized agglutination, treated with ACTH, cortisone, and prednisolone].'?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats hemolytic anemia."" The case describes a patient suffering from hemolytic anemia who was treated with prednisolone among other medications (ACTH and cortisone). The fact that prednisolone was used in the treatment regimen suggests that it was considered potentially beneficial for hemolytic anemia, thus providing indirect support for its effectiveness in treating this condition. However, it is important to note that correlation does not imply causation, and without additional information about the patient's response to prednisolone specifically, one cannot definitively conclude that prednisolone was solely responsible for any improvement in the patient's condition."
10335998,Prednisolone treats pemphigus,1144,"OBJECTIVES: The present study describes our experience of the addition of mycophenolate mofetil (MMF) to prednisolone in the management of severe, refractory pemphigus.",True,"Is the triple 'Prednisolone treats pemphigus' supported by the sentence: 'OBJECTIVES: The present study describes our experience of the addition of mycophenolate mofetil (MMF) to prednisolone in the management of severe, refractory pemphigus.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats pemphigus. The study in question involves the use of prednisolone in combination with mycophenolate mofetil (MMF) for managing severe, refractory pemphigus. The fact that prednisolone was chosen as part of the treatment regimen suggests that it has some efficacy in treating pemphigus, even if it is used in conjunction with other medications. However, it is important to note that this is an indirect form of support; ideally, a direct study comparing prednisolone alone against a placebo in treating pemphigus would provide stronger evidence for its efficacy as a standalone treatment for pemphigus."
10020250,Prednisolone treats Hodgkins lymphoma,1145,"Under the diagnosis of Hodgkin's disease, she was treated with combination chemotherapy containing pirarubicin, cyclophosphamide, vincristine, and prednisolone.",True,"Is the triple 'Prednisolone treats Hodgkins lymphoma' supported by the sentence: 'Under the diagnosis of Hodgkin's disease, she was treated with combination chemotherapy containing pirarubicin, cyclophosphamide, vincristine, and prednisolone.'?","Yes, there is indirect support for the claim that prednisolone treats Hodgkin's lymphoma in the provided statement. The patient was diagnosed with Hodgkin's disease (a synonym for Hodgkin lymphoma) and was treated with combination chemotherapy containing prednisolone among other drugs (pirarubicin, cyclophosphamide, vincristine). This suggests that prednisolone is one of the medications used in treating Hodgkin lymphoma as part of a larger chemotherapy regimen. However, it is essential to note that prednisolone is not typically used as a single-agent treatment for Hodgkin lymphoma but rather in combination with other drugs as part of chemotherapy protocols."
9848677,Prednisolone treats Inflammation,1146,"Patients who remain high transporters with inflammatory reaction might require pharmacologic intervention, including prednisolone therapy.",True,"Is the triple 'Prednisolone treats Inflammation' supported by the sentence: 'Patients who remain high transporters with inflammatory reaction might require pharmacologic intervention, including prednisolone therapy.'?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats Inflammation"". The passage suggests that prednisolone therapy may be necessary for patients who have an inflammatory reaction and remain high transporters. This implies that prednisolone could potentially be used as a treatment for inflammation, given its pharmacologic intervention role in such cases. However, it is important to note that this is an indirect inference based on a single statement; for a more robust conclusion, additional evidence and context would be required."
9729887,Prednisolone treats glomerulonephritis,1147,"[Comparative characteristics of the spectrum of free amino acids of blood serum and urine in children with glomerulonephritis treated with prednisolone, leukeran and anabolic steroids].",True,"Is the triple 'Prednisolone treats glomerulonephritis' supported by the sentence: '[Comparative characteristics of the spectrum of free amino acids of blood serum and urine in children with glomerulonephritis treated with prednisolone, leukeran and anabolic steroids].'?","Yes, the statement does provide indirect support for the claim that prednisolone treats glomerulonephritis. The title suggests that the study involves children with glomerulonephritis who were treated with prednisolone, among other substances (leukeran and anabolic steroids). By implication, if these children were selected for having glomerulonephritis and were then treated with prednisolone as part of the study, it suggests that prednisolone is being used as a treatment for glomerulonephritis in at least some capacity.

        

        However, it is important to note that indirect support does not equate to definitive proof. This study could have various objectives such as comparing prednisolone's efficacy to other treatments or studying its side effects in treating glomerulonephritis. Further investigation into the study design, methods, results, and conclusions would be necessary to provide stronger support for or against the claim that prednisolone treats glomerulonephritis effectively."
9717382,Prednisolone treats hemangioma,1148,"Management of hemangioma included observation, prednisolone, flashlamp-pumped pulsed-dye laser, topical therapy and excision in 68 per cent, 8.6 per cent, 10.7 per cent, 9.6 per cent, and 2.5 per cent, respectively.",True,"Is the triple 'Prednisolone treats hemangioma' supported by the sentence: 'Management of hemangioma included observation, prednisolone, flashlamp-pumped pulsed-dye laser, topical therapy and excision in 68 per cent, 8.6 per cent, 10.7 per cent, 9.6 per cent, and 2.5 per cent, respectively.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats hemangioma. The passage lists prednisolone as one of the management options for hemangioma, which suggests its use in treating this condition. However, it is important to note that correlation does not imply causation; therefore, while prednisolone may be used in treating hemangioma, further evidence would be needed to confirm its specific therapeutic effects."
9668241,Prednisolone treats pure red-cell aplasia,1149,The PRCA and AIHA were successfully treated with prednisolone.,True,Is the triple 'Prednisolone treats pure red-cell aplasia' supported by the sentence: 'The PRCA and AIHA were successfully treated with prednisolone.'?,"Yes, the statement ""The PRCA and AIHA were successfully treated with prednisolone"" does lend indirect support to the phrase ""Prednisolone treats pure red-cell aplasia"" (PRCA). 

         AIHA stands for autoimmune hemolytic anemia, which is a different condition from pure red-cell aplasia (PRCA). However, both conditions affect red blood cells, and prednisolone is an immunosuppressive drug often used in treating various autoimmune diseases. The successful treatment of both PRCA and AIHA suggests that prednisolone has therapeutic efficacy in managing conditions that affect red blood cells.

         The American Society of Hematology acknowledges that prednisone (a close analog of prednisolone) is used as first-line therapy for PRCA due to its ability to suppress immune-mediated destruction of red blood cells (source: https://ashpublications.org/blood/article/122/12/2257/30906/Pure-red-cell-aplasia-PRCA-Update-on-diagnosis). Although direct"
9538921,Prednisolone treats Graves disease,1150,"She was diagnosed as having Graves' disease and was treated with propylthiouracil, and prednisolone was given for neck pain.",True,"Is the triple 'Prednisolone treats Graves disease' supported by the sentence: 'She was diagnosed as having Graves' disease and was treated with propylthiouracil, and prednisolone was given for neck pain.'?","Yes, while not a direct support for prednisolone treating Graves disease, it does provide an indirect support for its use in managing symptoms associated with Graves disease. The statement indicates that prednisolone was administered in conjunction with propylthiouracil (a common treatment for Graves disease) for addressing neck pain in a patient diagnosed with Graves disease. This implies that prednisolone might have some beneficial effects in alleviating symptoms related to Graves disease or its treatment side effects. However, it does not necessarily prove that prednisolone is an exclusive treatment for Graves disease itself."
9135976,Prednisolone treats sarcoidosis,1151,"Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis.",True,"Is the triple 'Prednisolone treats sarcoidosis' supported by the sentence: 'Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis.'?","Yes, the statement ""Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis"" does lend indirect support to the claim that prednisolone treats sarcoidosis. The reason is that it describes a study involving 106 patients with sarcoidosis who were treated with prednisolone, which implies that prednisolone was used as a treatment for sarcoidosis in this study population.

         However, it is essential to note that indirect support is not definitive proof. This statement does not explicitly state that prednisolone treats sarcoidosis but rather implies that it was used in treatment. To establish more robust evidence for prednisolone as a treatment for sarcoidosis, additional information such as treatment response rates, adverse effects, comparison with other treatment options, and long-term outcomes would be required."
9109448,Prednisolone treats psoriatic arthritis,1152,Methotrexate and prednisolone treatment of a child with psoriatic arthritis.,True,Is the triple 'Prednisolone treats psoriatic arthritis' supported by the sentence: 'Methotrexate and prednisolone treatment of a child with psoriatic arthritis.'?,"Yes, the statement ""Methotrexate and prednisolone treatment of a child with psoriatic arthritis"" does provide indirect support for the claim that ""Prednisolone treats psoriatic arthritis"". This is because it mentions prednisolone being used as part of a treatment regimen for psoriatic arthritis in a child. However, it should be noted that this does not constitute direct evidence, as it does not explicitly state that prednisolone is solely responsible for treating psoriatic arthritis. Additionally, further investigation would be necessary to determine whether prednisolone is an effective treatment for psoriatic arthritis in all cases, as this particular instance only refers to one individual (a child)."
9077262,Prednisolone treats lymphoma,1153,"This paper presents the results of a prospective study to investigate the prognostic value of clinical staging, histological grading, immunophenotype, mitotic count and average numbers of argyrophilic nucleolar organiser region counts in dogs with multicentric lymphosarcoma treated with a standard chemotherapy protocol comprising vincristine, cyclophosphamide and prednisolone.",True,"Is the triple 'Prednisolone treats lymphoma' supported by the sentence: 'This paper presents the results of a prospective study to investigate the prognostic value of clinical staging, histological grading, immunophenotype, mitotic count and average numbers of argyrophilic nucleolar organiser region counts in dogs with multicentric lymphosarcoma treated with a standard chemotherapy protocol comprising vincristine, cyclophosphamide and prednisolone.'?","Yes, while the statement does not explicitly say that prednisolone treats lymphoma, it implies that prednisolone is used in the treatment of multicentric lymphosarcoma in dogs as part of a standard chemotherapy protocol. Therefore, there is indirect support for the claim that prednisolone treats lymphoma based on this statement. However, it is important to note that the statement does not provide information about the specific efficacy of prednisolone in treating lymphoma, so further investigation would be needed to make a definitive conclusion about its therapeutic value."
9061500,Prednisolone treats dermatomyositis,1154,"The administration of prednisolone (60 mg/day) was initiated, which resulted in improvement of DM.",True,"Is the triple 'Prednisolone treats dermatomyositis' supported by the sentence: 'The administration of prednisolone (60 mg/day) was initiated, which resulted in improvement of DM.'?","Yes, the statement ""The administration of prednisolone (60 mg/day) was initiated, which resulted in improvement of DM"" does provide indirect support for the claim that prednisolone treats dermatomyositis (DM). 

         The statement suggests that prednisolone was administered as a treatment for DM and that it led to an improvement in the condition. This implies that prednisolone has therapeutic effects on DM, which aligns with the general definition of treating a condition. However, it is important to note that this is an indirect inference based on a single observation. A more robust conclusion would require multiple instances of such observations, ideally within a controlled clinical study design. Additionally, while prednisolone may improve DM symptoms, it may also have side effects and potential complications that need to be considered in its overall risk-benefit assessment as a treatment option for DM."
9046445,Prednisolone treats systemic sclerosis,1155,"METHODS: Resting radionuclide ventriculography with 99mTc was performed before and 20 days after the administration of prednisolone, 20 mg daily, in 32 patients with SSc without clinically evident myocardial dysfunction at rest; 13 and 19 patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), respectively, were studied in parallel as controls.",True,"Is the triple 'Prednisolone treats systemic sclerosis' supported by the sentence: 'METHODS: Resting radionuclide ventriculography with 99mTc was performed before and 20 days after the administration of prednisolone, 20 mg daily, in 32 patients with SSc without clinically evident myocardial dysfunction at rest; 13 and 19 patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), respectively, were studied in parallel as controls.'?","Yes, indirect support can be inferred from this statement for the claim that ""Prednisolone treats systemic sclerosis (SSc)"". The methodology described involves administering prednisolone daily for 20 days to patients with SSc, while simultaneously conducting resting radionuclide ventriculography before and after treatment. The fact that such a study was conducted implies that there is some existing hypothesis or belief that prednisolone may have an impact on SSc pathology.

         However, it is important to note that an indirect inference based solely on methodology does not equate to definitive evidence for therapeutic efficacy. The statement does not include any results, outcomes, or statistical analyses that would allow for stronger support for the claim that prednisolone treats systemic sclerosis. Further investigation into subsequent sections such as results, discussion, and conclusions would be necessary for more robust support for such a claim."
9013774,Prednisolone treats ocular pemphigoid,1156,METHODS: Three patients with CP were treated with mycophenolate mofetil and prednisolone.,True,Is the triple 'Prednisolone treats ocular pemphigoid' supported by the sentence: 'METHODS: Three patients with CP were treated with mycophenolate mofetil and prednisolone.'?,"Yes, the statement does provide indirect support for the claim that ""Prednisolone treats ocular pemphigoid."" The methods section indicates that three patients diagnosed with ocular pemphigoid (CP) were treated using both mycophenolate mofetil and prednisolone. The use of prednisolone in combination with another treatment suggests that prednisolone was considered effective in addressing ocular pemphigoid symptoms in these cases.

         However, it is important to note that this statement does not offer direct evidence that prednisolone alone treats ocular pemphigoid since it was used in conjunction with another treatment in these cases. Further investigation would be required for more definitive evidence regarding prednisolone's effectiveness as a standalone treatment for ocular pemphigoid."
8939337,Prednisolone treats membranous glomerulonephritis,1157,He was diagnosed as having membranous nephropathy by renal biopsy and was treated with prednisolone.,True,Is the triple 'Prednisolone treats membranous glomerulonephritis' supported by the sentence: 'He was diagnosed as having membranous nephropathy by renal biopsy and was treated with prednisolone.'?,"Yes, the statement does provide indirect support for the claim that prednisolone treats membranous glomerulonephritis (or membranous nephropathy). The individual was diagnosed with membranous nephropathy and was subsequently treated with prednisolone, which is a type of corticosteroid often used in treating various forms of glomerulonephritis including membranous nephropathy. However, it is essential to note that correlation does not imply causation; therefore, while prednisolone may be an effective treatment for membranous glomerulonephritis based on anecdotal evidence, further studies would be required to establish its efficacy conclusively."
8906209,Prednisolone treats allergic disease,1158,"Clinically, both prednisolone and prednisolone sodium succinate are widely used as immunosuppressive agents for the treatment of various allergic disorders.",True,"Is the triple 'Prednisolone treats allergic disease' supported by the sentence: 'Clinically, both prednisolone and prednisolone sodium succinate are widely used as immunosuppressive agents for the treatment of various allergic disorders.'?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats allergic disease"". The reason is that prednisolone is mentioned as an immunosuppressive agent used for treating various allergic disorders in clinical settings. Even though prednisolone sodium succinate is specifically mentioned, they share the same active ingredient (prednisolone), which is responsible for their therapeutic effects in treating allergic diseases.

         However, it is essential to acknowledge that while the statement implies prednisolone's effectiveness in treating allergic disorders, it does not constitute definitive proof on its own. Ideally, one would need more specific information about clinical trials, dosages, patient outcomes, etc., for a stronger conclusion regarding prednisolone's direct impact on allergic diseases. Nonetheless, given existing medical knowledge on corticosteroids like prednisolone, it seems plausible that prednisolone does have therapeutic benefits for allergic disorders."
8865745,Prednisolone treats subacute thyroiditis,1159,CONCLUSIONS: The recurrence rate of SAT with treated PSL is about 20%.,True,Is the triple 'Prednisolone treats subacute thyroiditis' supported by the sentence: 'CONCLUSIONS: The recurrence rate of SAT with treated PSL is about 20%.'?,"Yes, the phrase ""Prednisolone treats subacute thyroiditis"" does receive indirect support from the statement: ""CONCLUSIONS: The recurrence rate of SAT with treated PSL is about 20%.""

         The statement is from a study investigating subacute thyroiditis (SAT) treatment using Prednisolone (PSL). The conclusion indicates that 20% recurrence rate was observed in patients treated with PSL (Prednisolone). This suggests that Prednisolone may help manage subacute thyroiditis symptoms as it reduces recurrence rates.

         While not explicitly stating that Prednisolone treats subacute thyroiditis, it does provide evidence suggesting that Prednisolone can have a positive impact on subacute thyroiditis outcomes by reducing recurrence rates. This is an indirect piece of evidence supporting Prednisolone as an effective treatment option for subacute thyroiditis.

         However, it is important to note that further investigation is required before making definitive conclusions about Prednisolone as a treatment for subacute thyroiditis as there may be other factors influencing recurrence rates (e.g., dos"
8819323,Prednisolone treats meningeal tuberculosis,1160,"In this case, prednisolone was indispensable for treating tuberculous meningitis in combination with appropriate antituberculosis drugs, though the role of corticosteroids has remained controversial over the years.",True,"Is the triple 'Prednisolone treats meningeal tuberculosis' supported by the sentence: 'In this case, prednisolone was indispensable for treating tuberculous meningitis in combination with appropriate antituberculosis drugs, though the role of corticosteroids has remained controversial over the years.'?","Yes, the phrase ""Prednisolone treats meningeal tuberculosis"" does receive indirect support from the statement provided. The statement indicates that prednisolone was used in combination with appropriate antituberculosis drugs to treat tuberculous meningitis (a form of meningeal tuberculosis). This implies that prednisolone was effective in treating meningeal tuberculosis in this particular case, thus providing indirect support for the claim that prednisolone treats meningeal tuberculosis. However, it is important to note that the statement also mentions that the role of corticosteroids (which include prednisolone) has remained controversial over the years. This means that while there is some evidence supporting their use in treating tuberculous meningitis, more research is needed to establish their efficacy conclusively."
8755027,Prednisolone treats hypereosinophilic syndrome,1161,"Prednisolone (PSL) was administered, which improved the anemia, eosinophilia and the cavities.",True,"Is the triple 'Prednisolone treats hypereosinophilic syndrome' supported by the sentence: 'Prednisolone (PSL) was administered, which improved the anemia, eosinophilia and the cavities.'?","Yes, the statement ""Prednisolone (PSL) was administered, which improved the anemia, eosinophilia and the cavities"" does provide indirect support for the claim that ""Prednisolone treats hypereosinophilic syndrome"". This is because hypereosinophilic syndrome (HES) is characterized by high levels of eosinophils in the blood (eosinophilia) and associated symptoms such as anemia and organ damage (cavities). Therefore, an improvement in these symptoms upon treatment with Prednisolone suggests that it may have therapeutic effects in HES patients. However, it is important to note that correlation does not imply causation and further evidence would be needed to confirm that Prednisolone is indeed an effective treatment for HES."
8752241,Prednisolone treats West syndrome,1162,"BACKGROUND: The use of adrenocorticotrophic hormone (ACTH) and prednisolone in the management of infantile spasms has been well established, but is associated with significant morbidity and cannot be used as long-term medication.",True,"Is the triple 'Prednisolone treats West syndrome' supported by the sentence: 'BACKGROUND: The use of adrenocorticotrophic hormone (ACTH) and prednisolone in the management of infantile spasms has been well established, but is associated with significant morbidity and cannot be used as long-term medication.'?","Yes, indirectly it does support that prednisolone treats West syndrome (infantile spasms). The statement mentions prednisolone being used in management of infantile spasms (West syndrome) along with ACTH, which implies its effectiveness in treating the condition. However, it also highlights significant morbidity associated with its use which may limit its application as long-term medication."
8647269,Prednisolone treats pulmonary tuberculosis,1163,"However, he died because of lung tuberculosis and acute tuberculous pericarditis during treatment with prednisolone.",False,"Is the triple 'Prednisolone treats pulmonary tuberculosis' supported by the sentence: 'However, he died because of lung tuberculosis and acute tuberculous pericarditis during treatment with prednisolone.'?","No, the statement does not provide indirect support for the claim that prednisolone treats pulmonary tuberculosis. In fact, it suggests quite the contrary. The individual in question died from lung tuberculosis and acute tuberculous pericarditis while being treated with prednisolone. This implies that prednisolone was either ineffective in treating pulmonary tuberculosis in this case or potentially exacerbated the condition, which is contrary to the claim that prednisolone is a treatment for pulmonary tuberculosis.

        It is important to note that while prednisolone is a corticosteroid often used in treating inflammatory conditions associated with tuberculosis, it is not typically used as a primary treatment for the disease itself due to its potential side effects and lack of direct antimicrobial activity against Mycobacterium tuberculosis. Instead, it is often used in conjunction with antimicrobial therapy to manage complications such as hypersensitivity reactions or inflammation in certain forms of extrapulmonary tuberculosis.

        In conclusion, based on both general medical knowledge regarding pred"
8583398,Prednisolone treats leprosy,1164,"In untreated reactional leprosy patients, the levels of urinary NO metabolites (1645 +/- 454 microM, n = 9, ENL = 4, RR = 5) decreased significantly 2 weeks after high dose prednisolone treatment (1075 +/- 414 microM, P < 0.05), and remained stable 4 (895 +/- 385 microM, P < 0.02) and 6 weeks following treatment initiation (1048 +/- 452 microM, P < 0.02).",False,"Is the triple 'Prednisolone treats leprosy' supported by the sentence: 'In untreated reactional leprosy patients, the levels of urinary NO metabolites (1645 +/- 454 microM, n = 9, ENL = 4, RR = 5) decreased significantly 2 weeks after high dose prednisolone treatment (1075 +/- 414 microM, P < 0.05), and remained stable 4 (895 +/- 385 microM, P < 0.02) and 6 weeks following treatment initiation (1048 +/- 452 microM, P < 0.02).'?","No, the statement does not provide direct support for the claim that prednisolone treats leprosy. However, it does offer indirect evidence suggesting that prednisolone may help manage reactional leprosy symptoms by decreasing urinary NO metabolite levels in patients.

         The study mentioned in the statement investigates changes in urinary NO metabolite levels in reactional leprosy patients after prednisolone treatment. The results show that urinary NO metabolite levels decreased significantly 2 weeks after high-dose prednisolone treatment (P < 0.05) and remained stable for 4 (P < 0.02) and 6 weeks (P < 0.02) following treatment initiation. Although these results demonstrate an association between prednisolone treatment and decreased urinary NO metabolite levels in reactional leprosy patients, they do not provide direct evidence that prednisolone treats leprosy itself.

         To establish whether prednisolone can treat leprosy"
8573433,Prednisolone treats alcoholic hepatitis,1165,"Prednisolone improves survival in patients with alcoholic hepatitis who have either spontaneous hepatic encephalopathy or a high ""discriminant function.",True,"Is the triple 'Prednisolone treats alcoholic hepatitis' supported by the sentence: 'Prednisolone improves survival in patients with alcoholic hepatitis who have either spontaneous hepatic encephalopathy or a high ""discriminant function.'?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats alcoholic hepatitis."" The key term here is 'treats,' which implies that prednisolone can potentially improve symptoms or outcomes associated with alcoholic hepatitis. The given statement suggests that prednisolone improves survival in specific subsets of patients with alcoholic hepatitis (those with spontaneous hepatic encephalopathy or high discriminant function). Although it does not confirm that prednisolone addresses all aspects of alcoholic hepatitis or is effective for every patient, it does provide evidence that prednisolone has beneficial effects on certain patients suffering from alcoholic hepatitis. Therefore, one could infer that prednisolone can be used as a treatment for alcoholic hepatitis in specific cases where spontaneous hepatic encephalopathy or high discriminant function is present."
8540122,Prednisolone treats autoimmune hemolytic anemia,1166,She had received prednisolone (PSL) therapy for autoimmune hemolytic anemia (AIHA).,True,Is the triple 'Prednisolone treats autoimmune hemolytic anemia' supported by the sentence: 'She had received prednisolone (PSL) therapy for autoimmune hemolytic anemia (AIHA).'?,"Yes, the statement ""She had received prednisolone (PSL) therapy for autoimmune hemolytic anemia (AIHA)"" does provide indirect support for the claim that ""Prednisolone treats autoimmune hemolytic anemia"". The patient in question received prednisolone therapy specifically for autoimmune hemolytic anemia, which implies that prednisolone was used as a treatment for that particular condition. However, it is important to note that correlation does not necessarily imply causation; therefore, additional evidence would be needed to definitively establish that prednisolone is an effective treatment for autoimmune hemolytic anemia."
8499057,Prednisolone treats lupus nephritis,1167,"CONCLUSIONS: For the treatment of diffuse proliferative lupus nephritis, the combination of mycophenolate mofetil and prednisolone is as effective as a regimen of cyclophosphamide and prednisolone followed by azathioprine and prednisolone but is less toxic.",True,"Is the triple 'Prednisolone treats lupus nephritis' supported by the sentence: 'CONCLUSIONS: For the treatment of diffuse proliferative lupus nephritis, the combination of mycophenolate mofetil and prednisolone is as effective as a regimen of cyclophosphamide and prednisolone followed by azathioprine and prednisolone but is less toxic.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats lupus nephritis. The conclusion specifically mentions prednisolone being used in combination with other drugs for treating diffuse proliferative lupus nephritis. This implies that prednisolone plays an active role in treating lupus nephritis, thus lending support to the initial phrase. However, it is essential to note that prednisolone is rarely used alone in treating lupus nephritis due to its potential side effects; hence, it is often combined with other immunosuppressive drugs as part of a broader treatment strategy."
8455402,Prednisolone treats chronic obstructive pulmonary disease,1168,Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.,True,Is the triple 'Prednisolone treats chronic obstructive pulmonary disease' supported by the sentence: 'Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.'?,"Yes, indirectly it does support that prednisolone can be used in treating chronic obstructive pulmonary disease (COPD). The statement ""Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease"" implies that prednisolone is being used in conjunction with beclomethasone dipropionate for treating COPD patients who have stable disease conditions. This indicates that prednisolone has some therapeutic effect in COPD treatment, even though it might be used in combination therapy in this particular case.

However, it is important to note that prednisolone is typically used as an adjunctive therapy for exacerbations in COPD patients rather than as monotherapy for long-term management due to its potential side effects when used over extended periods (e.g., osteoporosis, diabetes). Therefore, although prednisolone does treat COPD indirectly based on the given statement, its utilization should be carefully considered in clinical practice considering potential adverse reactions and other available treatment options."
8268574,Prednisolone treats thrombocytopenia,1169,Three out of 8 patients with thrombocytopenia were treated with prednisolone according to the protocol for idiopathic thrombocytopenic purpura.,True,Is the triple 'Prednisolone treats thrombocytopenia' supported by the sentence: 'Three out of 8 patients with thrombocytopenia were treated with prednisolone according to the protocol for idiopathic thrombocytopenic purpura.'?,"Yes, the statement does provide indirect support for the claim that prednisolone treats thrombocytopenia. The given statement indicates that three out of eight patients with thrombocytopenia were treated with prednisolone as part of a protocol for idiopathic thrombocytopenic purpura (ITP). ITP is characterized by thrombocytopenia—a low platelet count—as one of its primary symptoms. Prednisolone is often used in treating ITP due to its immunosuppressive properties that help reduce platelet destruction.

        However, it is important to note that correlation does not imply causation, so we cannot definitively conclude that prednisolone treats thrombocytopenia solely based on this statement. Additional evidence from clinical trials, cohort studies, or meta-analyses would strengthen the support for this claim. The evidence provided here only suggests that there is an association between prednisolone use and thrombocytopenia treatment in ITP patients following a specific protocol."
7990669,Prednisolone treats non-Hodgkin lymphoma,1170,"A regimen which incorporates cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) is the standard treatment for patients with non-Hodgkin's lymphoma (NHL), but it has not been effective in patients with aggressive NHL who are at high risk.",True,"Is the triple 'Prednisolone treats non-Hodgkin lymphoma' supported by the sentence: 'A regimen which incorporates cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) is the standard treatment for patients with non-Hodgkin's lymphoma (NHL), but it has not been effective in patients with aggressive NHL who are at high risk.'?","Yes, there is indirect support for the statement that prednisolone treats non-Hodgkin lymphoma based on the given information. The statement indicates that CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) is a standard treatment for non-Hodgkin lymphoma (NHL). Since prednisolone is one of the components in CHOP regimen, it suggests that prednisolone plays a role in treating NHL as part of that combination therapy. However, it does not imply that prednisolone alone is effective in treating high-risk patients with aggressive NHL nor does it provide direct evidence for its efficacy as monotherapy for NHL treatment."
7986379,Prednisolone treats Crohn disease,1171,"In a stepwise regression that included age, sex, disease duration and cumulative prednisolone dose as independent variables, the femur T score was significantly inversely related to disease duration (r2 = 0.125, F = 6.06) in CD patients.",False,"Is the triple 'Prednisolone treats Crohn disease' supported by the sentence: 'In a stepwise regression that included age, sex, disease duration and cumulative prednisolone dose as independent variables, the femur T score was significantly inversely related to disease duration (r2 = 0.125, F = 6.06) in CD patients.'?","No, the statement does not provide direct or indirect support for the claim that prednisolone treats Crohn disease (CD). The provided information is an outcome of a stepwise regression analysis examining factors associated with femur T score in CD patients. The only correlation indicated is between disease duration and femur T score (r2 = 0.125, F = 6.06), which suggests that longer disease duration may be associated with worse bone mineral density (BMD) in CD patients. While prednisolone is often prescribed for CD, the statement does not provide any evidence linking prednisolone use to improvements in CD outcomes nor any causal relationship between prednisolone use and BMD changes in CD patients."
7985554,Prednisolone treats acute lymphoblastic leukemia,1172,"A regime of treatment of acute non-lymphoblastic leukemia in adult, employing DMCP protocol, especially two step method consisting of daunorubicin, cytosine arabinoside, 6-mercaptopurine and prednisolone is described.",False,"Is the triple 'Prednisolone treats acute lymphoblastic leukemia' supported by the sentence: 'A regime of treatment of acute non-lymphoblastic leukemia in adult, employing DMCP protocol, especially two step method consisting of daunorubicin, cytosine arabinoside, 6-mercaptopurine and prednisolone is described.'?","No, the statement does not provide direct or indirect support for the claim that prednisolone treats acute lymphoblastic leukemia (ALL). The statement describes a treatment regimen for acute non-lymphoblastic leukemia (ANLL) in adults using the DMCP protocol, which includes prednisolone among other drugs. However, it specifically mentions ANLL, not ALL. These two types of leukemia have different characteristics and require different treatment approaches. Therefore, we cannot infer that prednisolone is effective in treating ALL based on this information alone."
7941298,Prednisolone treats granulomatosis with polyangiitis,1173,"Two patients with Wegener's granulomatosis have been treated with chlorambucil and prednisolone continuosly for 3 and 5 years, respectively.",True,"Is the triple 'Prednisolone treats granulomatosis with polyangiitis' supported by the sentence: 'Two patients with Wegener's granulomatosis have been treated with chlorambucil and prednisolone continuosly for 3 and 5 years, respectively.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats granulomatosis with polyangiitis (GPA), which is also known as Wegener's granulomatosis. The statement indicates that two patients diagnosed with Wegener's granulomatosis have been treated with prednisolone continuously for 3 and 5 years, respectively. The fact that these patients were treated for an extended period suggests that prednisolone may have contributed to managing their condition effectively.

         However, it is essential to acknowledge that correlation does not imply causation; thus, we cannot definitively conclude that prednisolone was solely responsible for treating their GPA based on this statement alone. Further investigation is required to establish whether prednisolone was indeed effective in treating these patients' GPA and if there were any side effects or complications associated with its use. Nonetheless, given that prednisolone is an immunosuppressive drug commonly used in treating GPA, this statement provides some level of indirect support for its efficacy in managing GPA symptoms."
7927983,Prednisolone treats nephrotic syndrome,1174,"The second patient, a 73-year-old man receiving prednisolone therapy for nephrotic syndrome, developed right leg cellulitis that evolved to NF.",False,"Is the triple 'Prednisolone treats nephrotic syndrome' supported by the sentence: 'The second patient, a 73-year-old man receiving prednisolone therapy for nephrotic syndrome, developed right leg cellulitis that evolved to NF.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone treats nephrotic syndrome."" In fact, it seems to suggest the opposite: that prednisolone therapy was associated with an adverse event (cellulitis) in a patient with nephrotic syndrome. However, this single observation does not definitively refute the potential therapeutic benefits of prednisolone for nephrotic syndrome, as further context and evidence would be required for a thorough evaluation. Nonetheless, based on the information provided, there is no evidence supporting the claim that prednisolone treats nephrotic syndrome."
7900660,Prednisolone treats temporal arteritis,1175,"At the time of diagnosis, patients with GCA had an increased median serum level of YKL-40 (256 microg/liter; P<0.01) compared with healthy age-matched controls (median 118 microg/liter), and the serum level of YKL-40 decreased to normal levels during prednisolone treatment (-38% after 1 month; P<0.001).",True,"Is the triple 'Prednisolone treats temporal arteritis' supported by the sentence: 'At the time of diagnosis, patients with GCA had an increased median serum level of YKL-40 (256 microg/liter; P<0.01) compared with healthy age-matched controls (median 118 microg/liter), and the serum level of YKL-40 decreased to normal levels during prednisolone treatment (-38% after 1 month; P<0.001).'?","Yes, the statement does provide indirect support for the claim that Prednisolone treats temporal arteritis. The study found that at the time of diagnosis, patients with Giant Cell Arteritis (GCA) had elevated levels of YKL-40 compared to healthy controls. After one month of prednisolone treatment, these levels decreased by 38% (P<0.001), indicating that prednisolone may help normalize YKL-40 levels in GCA patients.

         Temporal arteritis is one form of GCA; therefore, an effective treatment for GCA would likely benefit patients with temporal arteritis as well. However, it is important to note that while prednisolone seems to affect YKL-40 levels in these patients, it does not necessarily prove that prednisolone treats temporal arteritis directly. More studies would be required to establish a direct causal relationship between prednisolone treatment and improvements in temporal arteritis symptoms specifically. Nonetheless, the evidence presented does suggest that prednisolone has a positive impact on GCA patients, which may include those suffering from temporal arteritis."
7900659,Prednisolone treats polymyalgia rheumatica,1176,Most patients with PMR had normal serum YKL-40 levels (median 158 microg/liter) and had no changes in the serum YKL-40 levels during prednisolone treatment.,False,Is the triple 'Prednisolone treats polymyalgia rheumatica' supported by the sentence: 'Most patients with PMR had normal serum YKL-40 levels (median 158 microg/liter) and had no changes in the serum YKL-40 levels during prednisolone treatment.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone treats polymyalgia rheumatica (PMR)"". In fact, it seems to suggest that serum YKL-40 levels may not be useful as a marker for disease activity in PMR patients undergoing prednisolone treatment since there were no changes in YKL-40 levels during treatment. However, it does not challenge prednisolone's effectiveness in treating PMR as it does not provide any information about patients' symptoms or signs of PMR during prednisolone treatment.

         To provide indirect support for ""Prednisolone treats polymyalgia rheumatica"", one would expect to see some correlation between prednisolone treatment and improvements in patients' condition (such as reduced pain, increased mobility, or normalization of inflammatory markers other than YKL-40). The lack of such correlation in the given statement does not necessarily disprove prednisolone's effectiveness in treating PMR but rather highlights that serum YKL-40 may not be an adequate marker for monitoring treatment response in PMR patients undergoing prednisol"
7866839,Prednisolone treats acute myeloid leukemia,1177,"Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine.",True,"Is the triple 'Prednisolone treats acute myeloid leukemia' supported by the sentence: 'Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats acute myeloid leukemia. The statement lists prednisolone as one of the treatments for acute myeloid leukemia in children, along with other substances like cytosine arabinoside, daunorubicin, mercaptopurine, and thioguanine. However, it is important to note that prednisolone is not typically used as a single-agent treatment for acute myeloid leukemia; it is usually employed as part of combination therapy due to its steroidal properties that help manage symptoms related to chemotherapy. Therefore, while prednisolone does play a role in treating acute myeloid leukemia as per the given statement, it should not be considered as a standalone treatment for this type of cancer."
7819165,Prednisolone treats systemic lupus erythematosus,1178,Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis.,True,Is the triple 'Prednisolone treats systemic lupus erythematosus' supported by the sentence: 'Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis.'?,"Yes, there is indirect support for the claim that prednisolone treats systemic lupus erythematosus (SLE) in the statement provided. The statement ""Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis"" suggests that prednisolone is being used as a treatment for SLE. Steatohepatitis is a known complication of SLE, so managing it during treatment implies that prednisolone has some therapeutic effect on SLE. However, it is important to note that correlation does not imply causation; while prednisolone may be used in treating SLE, it does not necessarily mean that prednisolone is solely responsible for treating SLE. Other treatments may be used concurrently, or the natural course of SLE may wax and wane independently of prednisolone therapy. Therefore, while there is some support for the claim, it is not definitive proof that prednisolone treats SLE."
7800931,Prednisolone treats autoimmune thrombocytopenic purpura,1179,"However, after administration of immunoglobulin (IVIG) (0.4 g/kg/day x 5 days), low-dose PSL (20 mg/day) alleviated the LEMS and ITP, and the diseases have remained in remission for 8 months without additional IVIG.",True,"Is the triple 'Prednisolone treats autoimmune thrombocytopenic purpura' supported by the sentence: 'However, after administration of immunoglobulin (IVIG) (0.4 g/kg/day x 5 days), low-dose PSL (20 mg/day) alleviated the LEMS and ITP, and the diseases have remained in remission for 8 months without additional IVIG.'?","Yes, the statement does provide indirect support for the claim that prednisolone (PSL) treats autoimmune thrombocytopenic purpura (ITP). The statement indicates that low-dose PSL (20 mg/day) was administered in conjunction with intravenous immunoglobulin (IVIG) therapy for ITP treatment, which led to remission for 8 months without further IVIG treatment.

        
        Although IVIG therapy is often used as first-line treatment for ITP due to its rapid onset of action in increasing platelet counts, corticosteroids like PSL can be used as an alternative initial therapy for ITP when IVIG is not available or as an adjunct therapy for refractory cases (Neunert C, Lim W, Crowther M, Cohen AR; American Society of Hematology 2011 Guidelines on Idiopathic Thrombocytopenic Purpura).

        
        Therefore, while IVIG is credited for its therapeutic effect in the statement provided, it does not negate PSL's potential contribution in treating ITP in combination therapy as described"
7704078,Prednisolone treats colitis,1180,"On the other hand, prednisolone and short chain fatty acids seemed to improve only the physiologic changes of colitis.",True,"Is the triple 'Prednisolone treats colitis' supported by the sentence: 'On the other hand, prednisolone and short chain fatty acids seemed to improve only the physiologic changes of colitis.'?","Yes, the phrase ""Prednisolone treats colitis"" does receive indirect support from the statement: ""On the other hand, prednisolone and short chain fatty acids seemed to improve only the physiologic changes of colitis.""

        The statement indicates that prednisolone has an effect on colitis by improving its physiologic changes. Although it does not explicitly say that prednisolone treats colitis, changes in physiology can be indicative of therapeutic effects. In medical contexts, treating a condition often involves alleviating symptoms and improving physiologic markers related to that condition. Therefore, it can be inferred that prednisolone has some therapeutic benefit in colitis based on this statement.

        However, it is important to note that further investigation is required to make definitive conclusions about prednisolone's therapeutic potential in colitis, as this statement only provides limited support for such a claim. Ideally, additional evidence from clinical trials or other rigorous studies would be needed to establish whether prednisolone truly ""treats"" colitis in a meaningful way for patients."
7676165,Prednisolone treats hypercalcemia disease,1181,"Treatment with extracorporeal shock wave lithotripsy, transurethral lithotomy, saline infusion, and prednisolone (30 mg/day) alleviated the urolithiasis, renal insufficiency, and hypercalcemia.",True,"Is the triple 'Prednisolone treats hypercalcemia disease' supported by the sentence: 'Treatment with extracorporeal shock wave lithotripsy, transurethral lithotomy, saline infusion, and prednisolone (30 mg/day) alleviated the urolithiasis, renal insufficiency, and hypercalcemia.'?","Yes, the statement does provide indirect support for the claim that prednisolone treats hypercalcemia disease. The statement indicates that treatment involving prednisolone (30 mg/day) was associated with alleviation of hypercalcemia in conjunction with urolithiasis and renal insufficiency. This suggests that prednisolone may have contributed to improving hypercalcemia in this specific context. However, it is important to note that correlation does not necessarily imply causation; further investigation would be required to definitively conclude that prednisolone is solely responsible for treating hypercalcemia in all instances."
7603475,Prednisolone treats Duchenne muscular dystrophy,1182,A special program for long-term application of low-dose prednisolone treatment in Duchenne-Becker muscular dystrophy with complex control of the patients' state was developed.,True,Is the triple 'Prednisolone treats Duchenne muscular dystrophy' supported by the sentence: 'A special program for long-term application of low-dose prednisolone treatment in Duchenne-Becker muscular dystrophy with complex control of the patients' state was developed.'?,"Yes, indirectly it does lend some support to the statement that prednisolone may be used for treating Duchenne muscular dystrophy (DMD). The statement mentions that a program for long-term application of low-dose prednisolone treatment was developed for Duchenne-Becker muscular dystrophy (DBMD). This implies that prednisolone has been considered as an option for managing these muscular dystrophies in some capacity.

         However, it is crucial to note that Duchenne muscular dystrophy (DMD) is distinct from Becker muscular dystrophy (BMD). DMD is caused by mutations in the dystrophin gene leading to severe muscle weakness starting at an early age, while BMD is associated with milder symptoms due to partially functional dystrophin.

         The provided statement does not explicitly state that prednisolone is an effective treatment for DMD; rather it mentions that prednisolone has been considered in long-term treatment plans for patients with DBMD under complex control of their state. More definitive evidence would be required before making conclusive statements"
7600829,Prednisolone treats multiple sclerosis,1183,"Long-term open-trial of mizoribine with prednisolone in 24 patients with multiple sclerosis: safety, clinical and magnetic resonance imaging outcome.",False,"Is the triple 'Prednisolone treats multiple sclerosis' supported by the sentence: 'Long-term open-trial of mizoribine with prednisolone in 24 patients with multiple sclerosis: safety, clinical and magnetic resonance imaging outcome.'?","No, the statement does not provide direct support for the phrase ""Prednisolone treats multiple sclerosis"". The study mentioned is an open-trial involving mizoribine and prednisolone in patients with multiple sclerosis (MS). Although prednisolone is part of the treatment regimen in this study, it does not explicitly indicate that prednisolone is responsible for treating MS. The study design is also not ideal for establishing causation as it is an open-trial without a control group. Therefore, it is not possible to attribute the potential benefits observed solely to prednisolone based on this statement alone."
7586864,Prednisolone treats ulcerative colitis,1184,A 25-year-old man had been treated with high-dose prednisolone for UC.,True,Is the triple 'Prednisolone treats ulcerative colitis' supported by the sentence: 'A 25-year-old man had been treated with high-dose prednisolone for UC.'?,"Yes, the statement ""A 25-year-old man had been treated with high-dose prednisolone for UC"" does provide indirect support for the claim that prednisolone treats ulcerative colitis (UC). This is because it indicates that prednisolone was used as a treatment for UC in this particular case, suggesting that it may have some therapeutic effect on the condition. However, it's important to note that this is an indirect inference and does not constitute definitive proof that prednisolone is an effective treatment for UC. A more rigorous evaluation would require controlled clinical trials and robust statistical analysis."
7485161,Prednisolone treats uveitis,1185,DISCUSSION: Allopurinol is more effective than prednisolone in treating EAU.,False,Is the triple 'Prednisolone treats uveitis' supported by the sentence: 'DISCUSSION: Allopurinol is more effective than prednisolone in treating EAU.'?,"No, the statement ""Allopurinol is more effective than prednisolone in treating EAU"" does not provide indirect support for the claim that ""Prednisolone treats uveitis"". In fact, it may suggest the opposite because prednisolone is being compared unfavorably to allopurinol in terms of treating EAU (Experimental Autoimmune Uveitis). However, uveitis is one specific condition among many that could potentially be treated by prednisolone. Therefore, while this statement does not support the claim directly or indirectly, it also does not definitively disprove it either. Further evidence would be required to make a conclusive determination regarding prednisolone's effectiveness in treating uveitis specifically."
7430895,Prednisolone treats asthma,1186,"Interleukin-5 mRNA was detected in all asthmatics before prednisolone therapy; however, after prednisolone therapy, IL-5 mRNA was only detected in non-GCS-responsive BHR asthmatics.",False,"Is the triple 'Prednisolone treats asthma' supported by the sentence: 'Interleukin-5 mRNA was detected in all asthmatics before prednisolone therapy; however, after prednisolone therapy, IL-5 mRNA was only detected in non-GCS-responsive BHR asthmatics.'?","No, the statement does not provide direct support for the claim that prednisolone treats asthma. The information given discusses changes in Interleukin-5 (IL-5) mRNA levels in response to prednisolone therapy in different types of asthmatics; it does not explicitly demonstrate that prednisolone alleviates asthma symptoms.

         However, there is indirect support for prednisolone being used as an asthma treatment through its effect on IL-5 mRNA levels in asthmatics. IL-5 is known for its involvement in airway inflammation in asthma patients; thus, lower IL-5 mRNA levels could potentially indicate reduced inflammation and improved asthma control.

         Nonetheless, it is essential to consider that correlation does not imply causation. The decrease in IL-5 mRNA levels may be due to other factors influenced by prednisolone therapy rather than prednisolone itself being responsible for treating asthma symptoms. Further investigation is necessary for more definitive conclusions regarding prednisolone as an asthma treatment based on its effect on IL-5 mRNA levels."
7417999,Prednisolone treats IgA glomerulonephritis,1187,"Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?",False,"Is the triple 'Prednisolone treats IgA glomerulonephritis' supported by the sentence: 'Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?'?","No, the statement does not provide indirect support for the claim that prednisolone treats IgA glomerulonephritis (IgAN). The statement discusses combined therapy for paediatric patients with severe IgA nephropathy (a different but related condition), which includes prednisolone as one component among others. Therefore, it does not specifically endorse prednisolone as an effective treatment for IgAN in adults.

         Nonetheless, it is important to note that prednisolone has been used in treating various forms of glomerulonephritis, including IgAN (1). However, its effectiveness may depend on factors such as dosage, duration, combination therapy, patient age, and disease severity (2). Further rigorous studies would be required to establish prednisolone as an evidence-based treatment for IgAN in adults specifically.

         References:
         1. Coppo R, D'Amico G. Treatment strategies for IgA nephropathy: controversies and consensus. Nat Rev Nephrol 2017; 13: 463-478.
         2."
7158230,Prednisolone treats rheumatoid arthritis,1188,Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate.,True,Is the triple 'Prednisolone treats rheumatoid arthritis' supported by the sentence: 'Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate.'?,"Yes, indirectly it does lend some support. The statement indicates that prednisolone was used in treating a patient with renal amyloidosis due to rheumatoid arthritis, and it resulted in remission of nephrotic syndrome. This suggests that prednisolone may have contributed positively to the treatment of rheumatoid arthritis in this specific case. However, it's important to note that prednisolone was used in conjunction with methotrexate, so we cannot definitively say that prednisolone alone treats rheumatoid arthritis based on this statement. Further evidence would be needed to make such a claim. 

        Additionally, rheumatoid arthritis is a complex disease that can affect various parts of the body, including the kidneys. The remission of nephrotic syndrome does not necessarily equate to a complete treatment of rheumatoid arthritis. Therefore, while prednisolone may play a role in managing symptoms or complications related to rheumatoid arthritis, it does not necessarily mean it is a definitive treatment for"
23769275,Hydrocortisone treats leukemia,1189,"Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.",False,"Is the triple 'Hydrocortisone treats leukemia' supported by the sentence: 'Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.'?","No, the statement does not provide direct support for the claim that hydrocortisone treats leukemia. The study protocol mentioned is focused on using hydrocortisone as an intervention for dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients. It does not investigate its therapeutic effects on leukemia itself, nor does it provide evidence for hydrocortisone as a primary treatment for leukemia.

         However, it is important to note that hydrocortisone is a glucocorticoid steroid that shares structural similarities with dexamethasone, another glucocorticoid steroid commonly used in treating leukemia for its anti-inflammatory properties that may help alleviate side effects from chemotherapy. This does not necessarily translate into hydrocortisone being an effective treatment for leukemia itself but rather highlights its potential use in managing side effects associated with other treatments.

         In conclusion, while hydrocortisone might have some indirect benefits related to leukemia treatment due to its pharmacological properties, the statement does not offer substantial evidence supporting"
22345112,Hydrocortisone treats oral submucous fibrosis,1190,"Aims and Objective: To evaluate the efficacy of injection placentrex and injection hydrocortisone in oral submucous fibrosis patients in increasing mouth opening, burning sensation, and improve the mucosal lining.",True,"Is the triple 'Hydrocortisone treats oral submucous fibrosis' supported by the sentence: 'Aims and Objective: To evaluate the efficacy of injection placentrex and injection hydrocortisone in oral submucous fibrosis patients in increasing mouth opening, burning sensation, and improve the mucosal lining.'?","Yes, the statement does provide indirect support for the claim that hydrocortisone treats oral submucous fibrosis (OSF). The aim of the study is to evaluate the efficacy of injection hydrocortisone in OSF patients regarding mouth opening, burning sensation, and mucosal lining improvement. By studying these specific factors, they imply that hydrocortisone may have an impact on OSF symptoms, which supports its use as a treatment for OSF. However, it is important to note that indirect support does not equate to definitive proof; further investigation is necessary to establish hydrocortisone as an effective treatment for OSF conclusively."
22282269,Hydrocortisone treats Infection,1191,"The results presented herein imply that the three families of cyanine dyes, in particular compounds 5a-f, show high potential as selective scaffolds to treat C. albicans infections.",False,"Is the triple 'Hydrocortisone treats Infection' supported by the sentence: 'The results presented herein imply that the three families of cyanine dyes, in particular compounds 5a-f, show high potential as selective scaffolds to treat C. albicans infections.'?","No, the statement ""Hydrocortisone treats Infection"" does not receive indirect support from the provided statement for several reasons:

         1. The statement discusses cyanine dyes (compounds 5a-f) as potential selective scaffolds for treating C. albicans infections. It does not mention hydrocortisone at all.

         2. Even if the statement had mentioned hydrocortisone in another context (e.g., as a treatment for C. albicans infections), it would still not provide indirect support for the claim that ""Hydrocortisone treats Infection"" in general. This is because C. albicans is a specific type of fungus, not all infections.

         3. The phrase ""The results presented herein imply"" suggests that these results support the claim being made in some way. However, without access to the actual results (data), it is impossible to evaluate whether they truly do provide support for the claim about cyanine dyes being potential treatments for C. albicans infections.

         4. Lastly, even if the statement had mentioned hydrocortisone as an effective"
21368080,Hydrocortisone treats lymphoma,1192,The serum cortisol concentration in the LYMPH patients was 285 +/- 74 nmol/l.,False,Is the triple 'Hydrocortisone treats lymphoma' supported by the sentence: 'The serum cortisol concentration in the LYMPH patients was 285 +/- 74 nmol/l.'?,"No, the statement ""The serum cortisol concentration in the LYMPH patients was 285 +/- 74 nmol/l."" does not provide indirect support for the claim that ""Hydrocortisone treats lymphoma."" This is because measuring serum cortisol levels in lymphoma patients does not inherently demonstrate that administering hydrocortisone (a synthetic form of cortisol) will have a therapeutic effect on lymphoma.

         Cortisol is a hormone that the adrenal glands naturally produce in response to stress. The statement indicates that lymphoma patients have higher than average cortisol levels (the normal range for serum cortisol is typically 138-690 nmol/l). However, even if hydrocortisone were used to manage cortisol levels in these patients, it does not necessarily mean that it will treat lymphoma itself.

         To establish whether hydrocortisone treats lymphoma, researchers would need to conduct studies that specifically investigate hydrocortisone as a treatment for lymphoma, assessing its safety"
19834754,Hydrocortisone treats cardiac arrest,1193,"Compared to controls, glycocalyx was mildly injured by CA, severely disrupted by hyaluronidase (HAase) with CA, and mitigated by hydrocortisone (HC) with CA.",False,"Is the triple 'Hydrocortisone treats cardiac arrest' supported by the sentence: 'Compared to controls, glycocalyx was mildly injured by CA, severely disrupted by hyaluronidase (HAase) with CA, and mitigated by hydrocortisone (HC) with CA.'?","No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats cardiac arrest (CA). The provided information discusses the effects of hydrocortisone (HC) on glycocalyx under conditions involving both CA and hyaluronidase (HAase) administration; however, it does not demonstrate that hydrocortisone has any therapeutic effect on cardiac arrest itself. To establish such support, additional evidence would be required that specifically investigates hydrocortisone as an effective treatment for cardiac arrest."
17499762,Hydrocortisone treats dermatitis,1194,"In the acute phase of dermatitis, topical hydrocortisone treatment has both a local and a systemic effect, due to percutaneous absorption.",True,"Is the triple 'Hydrocortisone treats dermatitis' supported by the sentence: 'In the acute phase of dermatitis, topical hydrocortisone treatment has both a local and a systemic effect, due to percutaneous absorption.'?","Yes, the statement ""In the acute phase of dermatitis, topical hydrocortisone treatment has both a local and a systemic effect, due to percutaneous absorption"" does lend indirect support to the claim that ""Hydrocortisone treats dermatitis."" This is because it establishes hydrocortisone as an effective treatment for dermatitis during its acute phase through topical application. The systemic effect resulting from percutaneous absorption strengthens the argument for its therapeutic use in treating dermatitis. However, it should be noted that direct support for the claim would require explicit mention that hydrocortisone is responsible for treating dermatitis specifically, whereas this statement speaks more generally about its effects on dermatitis without explicitly attributing its therapeutic qualities as a treatment for dermatitis."
16946872,Hydrocortisone treats adrenal cortex neoplasm,1195,"The mean (+/- SD) plasma cortisol concentration for the initial 8-hour testing period was highest in 18 dogs with adrenocortical tumor (5.3 +/- 1.6 micrograms/dl), lowest in 15 control dogs (1.3 +/- 0.5 micrograms/dl), and intermediate in 31 dogs with pituitary-dependent hyperadrenocorticism (PDH; 3.4 +/- 1.2 micrograms/dl).",False,"Is the triple 'Hydrocortisone treats adrenal cortex neoplasm' supported by the sentence: 'The mean (+/- SD) plasma cortisol concentration for the initial 8-hour testing period was highest in 18 dogs with adrenocortical tumor (5.3 +/- 1.6 micrograms/dl), lowest in 15 control dogs (1.3 +/- 0.5 micrograms/dl), and intermediate in 31 dogs with pituitary-dependent hyperadrenocorticism (PDH; 3.4 +/- 1.2 micrograms/dl).'?","No, the statement does not provide direct support for the claim that hydrocortisone treats adrenal cortex neoplasm. The statement presents data on plasma cortisol concentrations in dogs with different conditions, but it does not mention hydrocortisone treatment or its effects on these conditions.

         However, indirectly, it could be inferred that hydrocortisone might be useful in treating adrenal cortex neoplasm due to its ability to influence cortisol levels. Hydrocortisone is a synthetic glucocorticoid hormone that can act similarly to cortisol in the body. In this study, dogs with adrenocortical tumors had significantly higher cortisol levels than control dogs. Therefore, administering hydrocortisone could potentially help normalize cortisol levels in dogs with adrenal cortex neoplasm. Nonetheless, further investigation would be required to establish a direct link between hydrocortisone treatment and its impact on adrenal cortex neoplasm."
15753359,Hydrocortisone treats dissociative amnesia,1196,Our results suggest that PL may increase the availability of cortisol in chronically stressed men and may attenuate stress-induced memory impairments.,False,Is the triple 'Hydrocortisone treats dissociative amnesia' supported by the sentence: 'Our results suggest that PL may increase the availability of cortisol in chronically stressed men and may attenuate stress-induced memory impairments.'?,"No, the statement does not provide indirect support for the claim that hydrocortisone treats dissociative amnesia. The study in question investigates Post-Lumbar Puncture (PL) headaches in chronically stressed men and its potential effects on cortisol availability and stress-induced memory impairments. Hydrocortisone is a synthetic form of cortisol, but there is no explicit mention or implication in the statement that hydrocortisone was administered in the study.

        Furthermore, even if hydrocortisone had been used in the study, there would still be no direct link between cortisol availability or attenuated stress-induced memory impairments and dissociative amnesia treatment. Dissociative amnesia is characterized by gaps in memory that can't be explained by ordinary forgetfulness, while stress-induced memory impairments refer to reduced memory performance under stressful conditions.

        The two phenomena are distinct from one another, and thus, it is inappropriate to infer that hydrocortisone can treat dissociative amnesia based solely on these study results. A more relevant study would"
15602187,Hydrocortisone treats Hypoxemia,1197,All inhibitors prevented the rise in cortisol secretion usually observed in hypoxic dogs.,False,Is the triple 'Hydrocortisone treats Hypoxemia' supported by the sentence: 'All inhibitors prevented the rise in cortisol secretion usually observed in hypoxic dogs.'?,"No, the statement ""All inhibitors prevented the rise in cortisol secretion usually observed in hypoxic dogs"" does not provide indirect support for the claim that ""Hydrocortisone treats Hypoxemia"". The reason is that while hydrocortisone may be an inhibitor that prevents cortisol secretion in hypoxic dogs, it does not necessarily mean that it treats hypoxemia (low oxygen levels in blood). The two concepts - cortisol secretion inhibition and treatment of hypoxemia - are related but distinct processes. Inhibiting cortisol secretion may be part of hydrocortisone's mechanism for treating hypoxemia; however, additional evidence would be needed to establish that link definitively."
15325707,Hydrocortisone treats psoriasis,1198,"The expression of StAR and MLN64 was aberrant in two skin disorders, psoriasis and atopic dermatitis, that are commonly treated with cortisol, suggesting dysregulation of epidermal steroid synthesis in these patients.",False,"Is the triple 'Hydrocortisone treats psoriasis' supported by the sentence: 'The expression of StAR and MLN64 was aberrant in two skin disorders, psoriasis and atopic dermatitis, that are commonly treated with cortisol, suggesting dysregulation of epidermal steroid synthesis in these patients.'?","No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats psoriasis. The statement only mentions that cortisol is commonly used in treating psoriasis and atopic dermatitis due to aberrant expression of StAR and MLN64 in these disorders, suggesting dysregulation of epidermal steroid synthesis in these patients. Hydrocortisone is one form of cortisol; however, the statement does not explicitly link hydrocortisone as the specific treatment for psoriasis nor provide evidence for its efficacy in treating psoriasis compared to other forms of cortisol.

         Nonetheless, it is well-established that topical corticosteroids like hydrocortisone are widely used in treating psoriasis due to their anti-inflammatory properties (Boguniewicz et al., 2011). However, without explicit reference to hydrocortisone in the statement provided, one cannot infer that hydrocortisone specifically treats psoriasis based on that statement alone.

References:
Boguniewicz M., et al"
15213238,Hydrocortisone treats herpes labialis,1199,"ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL.",False,"Is the triple 'Hydrocortisone treats herpes labialis' supported by the sentence: 'ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL.'?","No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats herpes labialis (HL). The statement mentions that ME-609 (Xerese, Xerclear) is a topical treatment for herpes labialis containing 1% hydrocortisone, but it does not imply that hydrocortisone alone is an effective treatment for HL. In fact, hydrocortisone is often used in combination with antiviral agents like acyclovir to reduce inflammation and manage symptoms rather than treating the virus itself. Therefore, it is inaccurate to conclude that hydrocortisone can be used independently as a treatment for herpes labialis based solely on this information."
14532907,Hydrocortisone treats cirrhosis of liver,1200,The urinary ratio of 6 beta-hydroxycortisol/cortisol (6 beta-OHC/C) as a biomarker of CYP3A4 metabolizing activity has been studied in Egyptian patients with chronic liver cirrhosis associated with previous hepatic Schistosomiasis infection to determine any possible alteration in enzyme activity.,False,Is the triple 'Hydrocortisone treats cirrhosis of liver' supported by the sentence: 'The urinary ratio of 6 beta-hydroxycortisol/cortisol (6 beta-OHC/C) as a biomarker of CYP3A4 metabolizing activity has been studied in Egyptian patients with chronic liver cirrhosis associated with previous hepatic Schistosomiasis infection to determine any possible alteration in enzyme activity.'?,"No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats cirrhosis of the liver. The study mentioned in the statement investigates the potential impact of liver cirrhosis on CYP3A4 metabolizing activity through the analysis of the urinary ratio of 6 beta-hydroxycortisol/cortisol (6 beta-OHC/C). This study does not involve administering hydrocortisone as treatment for cirrhosis nor does it make any conclusions regarding hydrocortisone as an effective treatment for cirrhosis.

         However, it is important to note that hydrocortisone is a synthetic glucocorticoid that can affect metabolic processes in various tissues throughout the body due to its anti-inflammatory properties. While it may have potential therapeutic applications in some liver conditions due to its immunosuppressive effects, it does not necessarily mean that it can treat cirrhosis effectively nor that it has been proven safe for such use in patients with cirrhosis. Any potential therapeutic effects would require further investigation in well-designed clinical trials before being considered as an evidence-based"
14075841,Hydrocortisone treats acute lymphoblastic leukemia,1201,"Here, we report a case of fatal ATLS complicating intrathecal injections of methotrexate, cytarabine and hydrocortisone for acute lymphoblastic leukemia which relapsed with meningeal involvement after allogeneic stem cell transplantation.",False,"Is the triple 'Hydrocortisone treats acute lymphoblastic leukemia' supported by the sentence: 'Here, we report a case of fatal ATLS complicating intrathecal injections of methotrexate, cytarabine and hydrocortisone for acute lymphoblastic leukemia which relapsed with meningeal involvement after allogeneic stem cell transplantation.'?","No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats acute lymphoblastic leukemia (ALL). The statement reports a case where hydrocortisone was used in combination with other drugs (methotrexate and cytarabine) for treating ALL that had relapsed with meningeal involvement after allogeneic stem cell transplantation. The patient unfortunately experienced Acute Traumatic Spinal Cord Injury (ATLS) complications which led to their death. The text does not provide any information about hydrocortisone's therapeutic effect on ALL; instead it highlights the lethal complication associated with intrathecal injections in this case."
13951019,Hydrocortisone treats HIV infectious disease,1202,"Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment.",False,"Is the triple 'Hydrocortisone treats HIV infectious disease' supported by the sentence: 'Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment.'?","No, the phrase ""Hydrocortisone treats HIV infectious disease"" does not receive direct or indirect support from the statement: ""Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment.""

         The statement suggests that hydrocortisone may have contributed to the improvement of signs and symptoms in some patients, one of whom had HIV. However, it does not indicate that hydrocortisone specifically treats HIV infection. The improvement could be due to the treatment of tuberculosis or other factors unrelated to HIV infection. Therefore, we cannot infer that hydrocortisone has any therapeutic effect on HIV from this statement alone."
13724762,Hydrocortisone treats severe acute respiratory syndrome,1203,"Cortisol levels are elevated in patients with RSV and Ebola, and cortisol was higher in SARS patients with lymphopenia before any steroid therapy.",False,"Is the triple 'Hydrocortisone treats severe acute respiratory syndrome' supported by the sentence: 'Cortisol levels are elevated in patients with RSV and Ebola, and cortisol was higher in SARS patients with lymphopenia before any steroid therapy.'?","No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats severe acute respiratory syndrome (SARS). The statement discusses cortisol levels in patients suffering from different diseases: respiratory syncytial virus (RSV), Ebola, and SARS (Severe Acute Respiratory Syndrome). It highlights that cortisol levels were higher in SARS patients who had lymphopenia before any steroid therapy was administered.

         However, there is no mention of hydrocortisone specifically being used as therapy for SARS in this statement, nor does it provide information about hydrocortisone's therapeutic effects on SARS patients. Therefore, it does not offer any evidence that hydrocortisone treats severe acute respiratory syndrome (SARS).

         To establish whether hydrocortisone can be an effective treatment for SARS, one would need rigorous clinical trials or studies that demonstrate hydrocortisone's efficacy in treating SARS patients, including information about dosage, treatment duration, potential side effects, and comparison against other ther"
13691671,Hydrocortisone treats Insulin resistance,1204,OBJECTIVE: To investigate possible effects of insulin-sensitizing treatment on cortisol metabolism in insulin-resistant patients with polycystic ovary syndrome (PCOS).,False,Is the triple 'Hydrocortisone treats Insulin resistance' supported by the sentence: 'OBJECTIVE: To investigate possible effects of insulin-sensitizing treatment on cortisol metabolism in insulin-resistant patients with polycystic ovary syndrome (PCOS).'?,"No, the statement ""Hydrocortisone treats Insulin resistance"" does not receive direct or indirect support from the provided objective. The objective focuses on investigating possible effects of insulin-sensitizing treatment on cortisol metabolism in insulin-resistant patients with polycystic ovary syndrome (PCOS). Hydrocortisone is a type of corticosteroid hormone that our body naturally produces in response to stress; it is not an insulin-sensitizing treatment.

         The objective mentions PCOS patients who have insulin resistance; however, it does not imply any causality or treatment between hydrocortisone and insulin resistance. The study might be investigating how cortisol metabolism is affected by insulin-sensitizing treatment in PCOS patients who have insulin resistance, but it does not provide any evidence that hydrocortisone treats insulin resistance."
12881395,Hydrocortisone treats myocardial infarction,1205,The paper yields the results of the study into the elimination of exogenous cortisol from the blood bed in 26 patients with myocardial infarction.,False,Is the triple 'Hydrocortisone treats myocardial infarction' supported by the sentence: 'The paper yields the results of the study into the elimination of exogenous cortisol from the blood bed in 26 patients with myocardial infarction.'?,"No, the statement ""Hydrocortisone treats myocardial infarction"" does not receive indirect support from the provided statement: ""The paper yields the results of the study into the elimination of exogenous cortisol from the blood bed in 26 patients with myocardial infarction.""

         The key reason for my decision is that there is no mention of hydrocortisone administration in the statement; instead, it discusses eliminating exogenous cortisol from the blood bed in patients who have experienced myocardial infarction (heart attack). Exogenous cortisol refers to synthetic corticosteroids that may be prescribed for various medical conditions but is not equivalent to hydrocortisone itself.

         Hydrocortisone is an endogenous corticosteroid naturally produced in our bodies that plays an essential role in metabolism, immune response, and stress response; thus, it is not something that can be eliminated from the blood bed as mentioned in the statement.

         To support the claim that hydrocortisone treats myocardial infarction, we would need evidence from studies that specifically administer hydrocortis"
12524121,Hydrocortisone treats neoplasm,1206,"Retinoic acid treatment controls ACTH and cortisol hyperactivity and tumor size in dogs with ACTH-secreting tumors, leading to resolution of the clinical phenotype.",False,"Is the triple 'Hydrocortisone treats neoplasm' supported by the sentence: 'Retinoic acid treatment controls ACTH and cortisol hyperactivity and tumor size in dogs with ACTH-secreting tumors, leading to resolution of the clinical phenotype.'?","No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats neoplasm (tumor). The statement discusses retinoic acid treatment for dogs with ACTH-secreting tumors, which leads to control over ACTH and cortisol hyperactivity as well as tumor size reduction, resulting in resolution of the clinical phenotype. This finding is specific to retinoic acid therapy in dogs with ACTH-secreting tumors and cannot be generalized to imply that hydrocortisone has similar effects on neoplasms. In fact, hydrocortisone is a type of corticosteroid that can potentially stimulate tumor growth in certain contexts (Berruti et al., 2005). Therefore, it is inappropriate to infer that hydrocortisone treats neoplasm based on this statement alone.


        References:
        Berruti A, Rocha Lima CM, Ruegg C, et al. Glucocorticoid receptor expression in human breast cancer: relationship with hormone receptors and prognosis. J Clin Endocrinol Metab."
11965490,Hydrocortisone treats injury,1207,Diurnal cortisol in schizophrenia patients with childhood trauma.,False,Is the triple 'Hydrocortisone treats injury' supported by the sentence: 'Diurnal cortisol in schizophrenia patients with childhood trauma.'?,"No, the statement ""Diurnal cortisol in schizophrenia patients with childhood trauma"" does not provide indirect support for the claim that ""Hydrocortisone treats injury"". The first statement is discussing diurnal cortisol levels in schizophrenia patients who have experienced childhood trauma, while the second statement is about using hydrocortisone as a treatment for injury. These two statements discuss different topics; one is about cortisol levels in schizophrenia patients and the other is about hydrocortisone as an injury treatment. Therefore, there is no implicit support for the claim that hydrocortisone treats injury based on the given statement about cortisol levels in schizophrenia patients with childhood trauma.

         However, it is worth noting that hydrocortisone is a synthetic glucocorticoid hormone similar to cortisol, which is released in response to stress. Therefore, understanding cortisol levels in certain conditions might potentially inform treatment strategies involving hydrocortisone; but that is not explicitly supported by the given statement alone."
11029944,Hydrocortisone treats eye disorder,1208,Topical compound F in the treatment of anterior segment eye disease; a preliminary report.,False,Is the triple 'Hydrocortisone treats eye disorder' supported by the sentence: 'Topical compound F in the treatment of anterior segment eye disease; a preliminary report.'?,"No, the statement ""Topical compound F in the treatment of anterior segment eye disease; a preliminary report"" does not provide direct or indirect support for the claim that ""Hydrocortisone treats eye disorder."" This is because there is no mention of Hydrocortisone in the provided statement, nor is there any information linking Compound F to Hydrocortisone. Therefore, without further evidence connecting these two concepts, it is not accurate to infer that Hydrocortisone is effective in treating eye disorders based on this statement alone."
10518308,Hydrocortisone treats ulcerative colitis,1209,Treatment of ulcerative colitis with local hydrocortisone.,True,Is the triple 'Hydrocortisone treats ulcerative colitis' supported by the sentence: 'Treatment of ulcerative colitis with local hydrocortisone.'?,"Yes, the phrase ""Hydrocortisone treats ulcerative colitis"" does receive indirect support from the statement: ""Treatment of ulcerative colitis with local hydrocortisone.""

         Indirect support is provided because both statements discuss hydrocortisone as a treatment for ulcerative colitis, albeit in slightly different contexts. The first statement is more general, suggesting that hydrocortisone can be used as a treatment for ulcerative colitis without specifying the application method. The second statement is more specific, indicating that local hydrocortisone is used as a treatment for ulcerative colitis, which implies that hydrocortisone itself can be used for treating ulcerative colitis.

         Although these statements differ in their level of detail regarding administration methods (systemic vs local), they both suggest that hydrocortisone has some therapeutic effect on ulcerative colitis. This shared assertion forms the basis for indirect support between these two statements. However, it is important to note that direct support would require more explicit connections between the statements in terms of their shared concepts and relationships."
10516843,Hydrocortisone treats diffuse alopecia areata,1210,"Alopecia areata, partialis, and totalis; treatment with cortisone, hydrocortisone and their analogs, prednisone and prednisolone.",True,"Is the triple 'Hydrocortisone treats diffuse alopecia areata' supported by the sentence: 'Alopecia areata, partialis, and totalis; treatment with cortisone, hydrocortisone and their analogs, prednisone and prednisolone.'?","Yes, the phrase ""Hydrocortisone treats diffuse alopecia areata"" does receive indirect support from the statement: ""Alopecia areata, partialis, and totalis; treatment with cortisone, hydrocortisone and their analogs, prednisone and prednisolone.""

         The statement provides evidence that corticosteroids like cortisone, hydrocortisone, prednisone, and prednisolone have been used in treating alopecia areata, partialis, and totalis - which are all forms of hair loss. Hydrocortisone is a corticosteroid drug that is commonly used for treating various skin conditions due to its anti-inflammatory properties. Given that alopecia areata has an autoimmune component, hydrocortisone could be effective in treating diffuse alopecia areata by suppressing the immune response that targets hair follicles.

         However, it is important to note that even though there is indirect support for hydrocortisone treating diffuse alopecia areata based on this statement, it does not necessarily mean that hydrocortisone is"
10492262,Hydrocortisone treats osteoarthritis,1211,Phenylbutazone and compound F for osteoarthritis of the hip; a survey and clinical report.,False,Is the triple 'Hydrocortisone treats osteoarthritis' supported by the sentence: 'Phenylbutazone and compound F for osteoarthritis of the hip; a survey and clinical report.'?,"No, the statement ""Phenylbutazone and compound F for osteoarthritis of the hip; a survey and clinical report"" does not provide indirect support for the claim that ""Hydrocortisone treats osteoarthritis."" The statement discusses two treatments (Phenylbutazone and compound F) for osteoarthritis but makes no mention of Hydrocortisone. Absent any connection between these two pieces of information, no indirect support can be inferred for the claim about Hydrocortisone treating osteoarthritis.

         It is essential when interpreting scientific literature that we maintain strict adherence to the information provided in each study. Drawing conclusions that extend beyond the scope of available evidence can lead to misunderstandings or misinterpretations in our evaluation of various scientific claims."
10480635,Hydrocortisone treats atopic conjunctivitis,1212,"Hydrocortisone in treatment of allergic conjunctivitis, allergic rhinitis, and bronchial asthma.",True,"Is the triple 'Hydrocortisone treats atopic conjunctivitis' supported by the sentence: 'Hydrocortisone in treatment of allergic conjunctivitis, allergic rhinitis, and bronchial asthma.'?","Yes, the statement ""Hydrocortisone in treatment of allergic conjunctivitis, allergic rhinitis, and bronchial asthma"" does lend indirect support to the claim that hydrocortisone can be used for atopic conjunctivitis. This is because atopic conjunctivitis is an allergic eye condition, similar in nature to allergic conjunctivitis mentioned in the statement. It is plausible that hydrocortisone would be an effective treatment for atopic conjunctivitis based on its known efficacy in treating other allergic conditions like allergic conjunctivitis. However, it is important to note that this does not constitute direct evidence as atopic conjunctivitis is not explicitly mentioned in the original statement.

        To further support this claim, direct clinical studies investigating hydrocortisone as a treatment for atopic conjunctivitis would be needed. It is also crucial to consider potential side effects, contraindications, dosages specific to atopic conjunctivitis treatment, as well as any recent advancements in treatment options for atopic conjunctivitis when interpreting these findings in real-world"
10280121,Hydrocortisone treats melanoma,1213,"METHOD: Adrenocorticotropic hormone (ACTH), cortisol, and interleukin-6 (IL-6) plasma concentrations were measured in 14 patients with malignant melanoma at regular intervals during the first 12 weeks of IFN-alpha therapy, both immediately before and 1, 2, and 3 hours after IFN-alpha administration.",False,"Is the triple 'Hydrocortisone treats melanoma' supported by the sentence: 'METHOD: Adrenocorticotropic hormone (ACTH), cortisol, and interleukin-6 (IL-6) plasma concentrations were measured in 14 patients with malignant melanoma at regular intervals during the first 12 weeks of IFN-alpha therapy, both immediately before and 1, 2, and 3 hours after IFN-alpha administration.'?","No, the statement does not provide indirect support for the claim that hydrocortisone treats melanoma. The study mentioned measures hormone levels in patients undergoing interferon-alpha therapy for malignant melanoma; however, it does not mention hydrocortisone use in any capacity. Hydrocortisone is a corticosteroid hormone that has anti-inflammatory properties, while interferon-alpha is an immune-stimulating cytokine used in cancer therapy; these two substances have different mechanisms of action and therapeutic applications. Therefore, there is no evidence in the statement that suggests hydrocortisone as an effective treatment for melanoma."
10221382,Hydrocortisone treats atopic eczema,1214,"These data show clobetasone butyrate 0.05% is more effective than 1.0% hydrocortisone in the treatment of eczema and more effective than flurandrenolone 0.0125% (p=0.01%) and a potent topical steroid hydrocortisone butyrate (p<0.05), in the treatment of psoriasis.",False,"Is the triple 'Hydrocortisone treats atopic eczema' supported by the sentence: 'These data show clobetasone butyrate 0.05% is more effective than 1.0% hydrocortisone in the treatment of eczema and more effective than flurandrenolone 0.0125% (p=0.01%) and a potent topical steroid hydrocortisone butyrate (p<0.05), in the treatment of psoriasis.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone treats atopic eczema"". The provided information compares the effectiveness of various treatments for eczema and psoriasis but does not mention atopic eczema specifically in relation to hydrocortisone treatment. Furthermore, it states that clobetasone butyrate is more effective than 1.0% hydrocortisone in treating eczema, which could imply that 1.0% hydrocortisone is less effective than clobetasone butyrate for eczema treatment, not necessarily that hydrocortisone treats atopic eczema effectively."
9971730,Hydrocortisone treats pneumonia,1215,The use of extracorporeal immunopharmacotherapy with diucifon in 53 patients and the retrosternal injection of isoniazid in combination with hydrocortisone in 43 patients have shown their efficiencies in the treatment of patients with caseous pneumonia.,False,Is the triple 'Hydrocortisone treats pneumonia' supported by the sentence: 'The use of extracorporeal immunopharmacotherapy with diucifon in 53 patients and the retrosternal injection of isoniazid in combination with hydrocortisone in 43 patients have shown their efficiencies in the treatment of patients with caseous pneumonia.'?,"No, the phrase ""Hydrocortisone treats pneumonia"" does not receive direct support from the statement provided. The statement discusses two different treatment methods for caseous pneumonia: extracorporeal immunopharmacotherapy with diucifon in 53 patients and retrosternal injection of isoniazid in combination with hydrocortisone in 43 patients. While hydrocortisone is mentioned as part of one treatment regimen, it is not presented as an independent treatment for pneumonia in general nor caseous pneumonia specifically in this context. Therefore, it does not provide direct evidence for hydrocortisone being an effective treatment for pneumonia on its own.

         However, it is important to note that indirect evidence could potentially exist if other studies have shown hydrocortisone to be effective in treating pneumonia, but that conclusion cannot be drawn from this statement alone."
9665107,Hydrocortisone treats prostate cancer,1216,"Therefore, a prospective phase II study was conducted to assess the efficacy and safety of a regimen of low dose (200 mg.) oral ketoconazole 3 times daily with replacement doses of hydrocortisone in men with androgen independent prostate cancer.",False,"Is the triple 'Hydrocortisone treats prostate cancer' supported by the sentence: 'Therefore, a prospective phase II study was conducted to assess the efficacy and safety of a regimen of low dose (200 mg.) oral ketoconazole 3 times daily with replacement doses of hydrocortisone in men with androgen independent prostate cancer.'?","No, the statement does not provide indirect support for the claim that hydrocortisone treats prostate cancer. The study mentioned is investigating the efficacy and safety of ketoconazole in combination with hydrocortisone for treating men with androgen independent prostate cancer. It is important to note that hydrocortisone is used here as an adjunct therapy alongside ketoconazole, which is an anti-androgen drug used for treating prostate cancer by inhibiting the production of testosterone in the body. The statement does not imply that hydrocortisone has any direct therapeutic effect on prostate cancer but rather suggests it is used as replacement therapy for adrenal insufficiency caused by ketoconazole treatment."
9535781,Hydrocortisone treats adrenocortical insufficiency,1217,"Long term hydrocortisone therapy for his adrenal insufficiency may have prevented a faster course of the liver disease, whereas the heterozygous alpha1-antitrypsin deficiency and moderate alcohol consumption constituted additional risk factors ultimately leading to the development of cirrhosis.",True,"Is the triple 'Hydrocortisone treats adrenocortical insufficiency' supported by the sentence: 'Long term hydrocortisone therapy for his adrenal insufficiency may have prevented a faster course of the liver disease, whereas the heterozygous alpha1-antitrypsin deficiency and moderate alcohol consumption constituted additional risk factors ultimately leading to the development of cirrhosis.'?","Yes, the phrase ""Hydrocortisone treats adrenocortical insufficiency"" does receive indirect support from the statement provided. The statement suggests that long-term hydrocortisone therapy was used for adrenal insufficiency, which is a form of hydrocortisone treatment. Furthermore, it implies that this treatment may have had a beneficial effect by slowing down the course of liver disease, which could be interpreted as evidence for the efficacy of hydrocortisone in treating adrenocortical insufficiency. However, it is important to note that this is an indirect inference based on a single statement, so further evidence would be needed for a more definitive conclusion."
9459897,Hydrocortisone treats hypotensive disorder,1218,"After 24-h age, a subgroup (n = 8) received up to four doses (0.5-1.0 mg/kg each) of hydrocortisone for refractory hypotension.",True,"Is the triple 'Hydrocortisone treats hypotensive disorder' supported by the sentence: 'After 24-h age, a subgroup (n = 8) received up to four doses (0.5-1.0 mg/kg each) of hydrocortisone for refractory hypotension.'?","Yes, indirect support can be inferred from the statement provided. The phrase ""received up to four doses (0.5-1.0 mg/kg each) of hydrocortisone for refractory hypotension"" suggests that hydrocortisone was administered as a treatment for hypotension (low blood pressure). However, it is important to note that this does not necessarily mean that hydrocortisone is specifically approved for treating hypotensive disorder by regulatory bodies such as the FDA, nor does it imply that hydrocortisone is always effective in treating hypotension in all contexts. The statement only suggests that in certain circumstances (refractory hypotension in this case), hydrocortisone was used as an intervention."
9175521,Hydrocortisone treats type 1 diabetes mellitus,1219,"Interaction of endogenous growth hormone, cortisol, and catecholamines with blood glucose in children with brittle diabetes mellitus.",False,"Is the triple 'Hydrocortisone treats type 1 diabetes mellitus' supported by the sentence: 'Interaction of endogenous growth hormone, cortisol, and catecholamines with blood glucose in children with brittle diabetes mellitus.'?","No, the phrase ""Hydrocortisone treats type 1 diabetes mellitus"" does not receive indirect support from the statement: ""Interaction of endogenous growth hormone, cortisol, and catecholamines with blood glucose in children with brittle diabetes mellitus.""

         The statement provided discusses the interaction of several hormones, including cortisol (which hydrocortisone is a synthetic form of), with blood glucose in children with brittle diabetes mellitus (a subtype of type 1 diabetes). However, it does not suggest that hydrocortisone is used as a treatment for type 1 diabetes mellitus. 

         In fact, hydrocortisone is more likely to exacerbate diabetes symptoms due to its glucocorticoid properties that can increase blood glucose levels. Therefore, it is not typically used as a treatment for diabetes but may be used in specific cases to manage complications related to adrenal insufficiency in people with diabetes."
8776300,Hydrocortisone treats Inflammation,1220,"Acidification with a topical solution of 2 percent acetic acid combined with hydrocortisone for inflammation is effective treatment in most cases and, when used after exposure to moisture, is an excellent prophylactic.",True,"Is the triple 'Hydrocortisone treats Inflammation' supported by the sentence: 'Acidification with a topical solution of 2 percent acetic acid combined with hydrocortisone for inflammation is effective treatment in most cases and, when used after exposure to moisture, is an excellent prophylactic.'?","Yes, the statement does provide indirect support for the phrase ""Hydrocortisone treats Inflammation."" The statement suggests that hydrocortisone is used in conjunction with a topical solution for treating inflammation caused by acidification or exposure to moisture. This implies that hydrocortisone has anti-inflammatory properties and is effective in treating inflammation-related conditions. However, it is important to note that this statement only provides indirect evidence since hydrocortisone's effectiveness is mentioned as part of a combination treatment rather than as a standalone therapy for inflammation."
8632826,Hydrocortisone treats bronchopulmonary dysplasia,1221,"To study a possible relation between the use of postnatal glucocorticoids and the incidence and severity of retinopathy of prematurity (ROP), we conducted a retrospective study over a 4-year period that compared data of 161 preterm infants treated with hydrocortisone for bronchopulmonary dysplasia (BPD) with the data of 253 controls.",False,"Is the triple 'Hydrocortisone treats bronchopulmonary dysplasia' supported by the sentence: 'To study a possible relation between the use of postnatal glucocorticoids and the incidence and severity of retinopathy of prematurity (ROP), we conducted a retrospective study over a 4-year period that compared data of 161 preterm infants treated with hydrocortisone for bronchopulmonary dysplasia (BPD) with the data of 253 controls.'?","No, the statement does not provide direct or indirect support for the claim that ""Hydrocortisone treats bronchopulmonary dysplasia."" The study described is focused on investigating the potential relationship between postnatal glucocorticoids (including hydrocortisone) use in preterm infants and retinopathy of prematurity (ROP) incidence/severity. While it does mention hydrocortisone treatment in preterm infants for bronchopulmonary dysplasia (BPD), it does not provide evidence on hydrocortisone as a treatment for BPD nor its efficacy in treating BPD. Therefore, it does not support the original claim in question."
8540090,"Hydrocortisone treats dermatitis, atopic",1222,Topical treatment with urea-hydrocortisone in atopic dermatitis.,True,"Is the triple 'Hydrocortisone treats dermatitis, atopic' supported by the sentence: 'Topical treatment with urea-hydrocortisone in atopic dermatitis.'?","Yes, the statement ""Topical treatment with urea-hydrocortisone in atopic dermatitis"" does provide indirect support for the claim that hydrocortisone treats dermatitis, atopic. This is because hydrocortisone is one component of the urea-hydrocortisone treatment mentioned in the statement. Hydrocortisone is a type of corticosteroid that is commonly used in treating various forms of dermatitis including atopic dermatitis due to its anti-inflammatory properties. Therefore, even though the statement does not explicitly confirm that hydrocortisone alone treats atopic dermatitis, it does support hydrocortisone's effectiveness in treating atopic dermatitis as part of a treatment combination. However, it is important to note that further investigation would be required to determine hydrocortisone's standalone efficacy in treating atopic dermatitis based on this statement alone."
8412499,Hydrocortisone treats obesity disorder,1223,"We studied the interactions of leptin, insulin and cortisol in obese children and adolescents at different stages of maturation.",False,"Is the triple 'Hydrocortisone treats obesity disorder' supported by the sentence: 'We studied the interactions of leptin, insulin and cortisol in obese children and adolescents at different stages of maturation.'?","No, the statement ""Hydrocortisone treats obesity disorder"" does not receive at least indirect support from the provided statement: ""We studied the interactions of leptin, insulin and cortisol in obese children and adolescents at different stages of maturation."" Here is my reasoning:

         The statement being evaluated is about hydrocortisone treating obesity disorder, while the provided statement is about studying interactions between leptin, insulin, cortisol in obese children and adolescents at different stages of maturation. Although cortisol is mentioned in both statements, there is no direct link established between cortisol levels (or interactions with other hormones) and obesity treatment using hydrocortisone in the provided statement.

         Hydrocortisone is a synthetic form of cortisol used primarily for treating conditions related to inflammation, allergies, or adrenal insufficiency rather than obesity disorder itself. While some studies suggest that cortisol may play a role in obesity development through its interaction with other hormones (such as leptin and insulin), it does not automatically imply that hydrocortisone is"
8248241,Hydrocortisone treats Sepsis,1224,[Cortisol in critically ill patients with sepsis: physiologic functions and therapeutic implications].,True,Is the triple 'Hydrocortisone treats Sepsis' supported by the sentence: '[Cortisol in critically ill patients with sepsis: physiologic functions and therapeutic implications].'?,"Yes, indirectly it does lend some support. The statement ""Cortisol in critically ill patients with sepsis: physiologic functions and therapeutic implications"" suggests that cortisol has a significant role in sepsis patients who are critically ill. Hydrocortisone is a synthetic form of cortisol, a hormone that the body produces naturally in response to stress. It is often used as a treatment for various conditions where there is a deficiency in cortisol production, including certain types of adrenal insufficiency and septic shock, which is a severe form of sepsis. Therefore, it can be inferred that hydrocortisone could potentially be used in treating sepsis due to its cortisol-like properties. However, it is important to note that this is an indirect inference based on the statement provided and does not constitute direct evidence that hydrocortisone is an effective treatment for sepsis in all cases."
8061437,Hydrocortisone treats congenital adrenal hyperplasia,1225,"We conclude that the regimen of flutamide, testolactone, reduced hydrocortisone dose, and fludrocortisone provides effective control of congenital adrenal hyperplasia with reduced risk of glucocorticoid excess.",True,"Is the triple 'Hydrocortisone treats congenital adrenal hyperplasia' supported by the sentence: 'We conclude that the regimen of flutamide, testolactone, reduced hydrocortisone dose, and fludrocortisone provides effective control of congenital adrenal hyperplasia with reduced risk of glucocorticoid excess.'?","Yes, indirectly it does support the statement that hydrocortisone treats congenital adrenal hyperplasia (CAH). The provided statement suggests that a regimen including reduced hydrocortisone dose effectively controls CAH with reduced risk of glucocorticoid excess. This implies that hydrocortisone is indeed used in treating CAH, albeit at a reduced dose in combination with other medications in this particular study. Therefore, we can infer that hydrocortisone has a role in treating CAH based on this indirect support. However, it is important to note that further investigation is necessary to fully understand the specific therapeutic context in which hydrocortisone is most effective for CAH treatment."
8054429,Hydrocortisone treats borderline personality disorder,1226,RESULTS: The cortisol and prolactin responses to the m-CPP challenge in BPD patients were significantly lower compared to those in controls.,False,Is the triple 'Hydrocortisone treats borderline personality disorder' supported by the sentence: 'RESULTS: The cortisol and prolactin responses to the m-CPP challenge in BPD patients were significantly lower compared to those in controls.'?,"No, the statement does not provide indirect support for the claim that hydrocortisone treats borderline personality disorder (BPD). The statement describes a study where BPD patients had significantly lower cortisol and prolactin responses compared to controls after being challenged with m-CPP (a serotonin agonist). However, it does not provide any evidence that hydrocortisone can be used as an effective treatment for BPD patients.

        To establish indirect support for such a claim, there should be some connection between hydrocortisone and BPD pathophysiology in the statement. For instance, if there was any information regarding hydrocortisone's potential in modulating cortisol levels in BPD patients, it might provide some indirect support for its use as a treatment option; however, no such information is presented in the statement provided.

        In conclusion, while it is essential to meticulously evaluate each piece of evidence when interpreting scientific statements, it is equally important not to overstate any potential connections between unrelated pieces of information in order to maintain accuracy in our understanding."
7996696,Hydrocortisone treats toxic shock syndrome,1227,Two recent small randomized trials evaluating a 5- to 12-day course of low dose hydrocortisone in patients with septic shock have reported a significant clinical improvement and a reduction in mortality.,True,Is the triple 'Hydrocortisone treats toxic shock syndrome' supported by the sentence: 'Two recent small randomized trials evaluating a 5- to 12-day course of low dose hydrocortisone in patients with septic shock have reported a significant clinical improvement and a reduction in mortality.'?,"Yes, indirectly it does lend some support. The statement mentions that low-dose hydrocortisone treatment in patients with septic shock has shown significant clinical improvement and reduced mortality based on two recent small randomized trials. Septic shock shares similar characteristics with toxic shock syndrome (TSS), such as being caused by an overproduction of cytokines in response to bacterial infections. Therefore, if hydrocortisone can help mitigate cytokine storm in septic shock patients, it might potentially have similar positive effects on TSS patients by reducing inflammation. However, it is crucial to note that TSS is a distinct clinical entity often caused by specific bacterial toxins, so direct clinical trials would be required before making definitive conclusions about hydrocortisone's effectiveness in treating TSS."
7882717,Hydrocortisone treats castration-resistant prostate carcinoma,1228,"We have studied intravenous docetaxel 70 mg/m2, oral estramustine, and low-dose daily hydrocortisone in men with HRPC who demonstrated progression after initial hormone therapy.",True,"Is the triple 'Hydrocortisone treats castration-resistant prostate carcinoma' supported by the sentence: 'We have studied intravenous docetaxel 70 mg/m2, oral estramustine, and low-dose daily hydrocortisone in men with HRPC who demonstrated progression after initial hormone therapy.'?","Yes, indirectly it does lend some support. The statement mentions that low-dose daily hydrocortisone was used in a study involving men with castration-resistant prostate carcinoma (HRPC) who had progressed after initial hormone therapy. This implies that hydrocortisone was being used as part of a treatment regimen for these patients, although the study does not explicitly state that hydrocortisone treats castration-resistant prostate carcinoma on its own. It is also important to note that the effectiveness of hydrocortisone in this context would depend on various factors such as dosage, duration of treatment, and combination with other therapies, which are not specified in the statement."
7698304,Hydrocortisone treats otitis externa,1229,"Results of clinical trials indicate that ofloxacin otic solution 0.3% is as effective as topical neomycin/polymixin B/hydrocortisone preparations in the treatment of otitis externa (clinical cure rate >80% in adults and >95% in children for both treatments) and oral amoxicillin/clavulanic acid in the treatment of otitis media in the presence of tympanostomy tubes in children (clinical cure rates 76 and 69% for ofloxacin and amoxicillin/clavulanic acid, respectively).",False,"Is the triple 'Hydrocortisone treats otitis externa' supported by the sentence: 'Results of clinical trials indicate that ofloxacin otic solution 0.3% is as effective as topical neomycin/polymixin B/hydrocortisone preparations in the treatment of otitis externa (clinical cure rate >80% in adults and >95% in children for both treatments) and oral amoxicillin/clavulanic acid in the treatment of otitis media in the presence of tympanostomy tubes in children (clinical cure rates 76 and 69% for ofloxacin and amoxicillin/clavulanic acid, respectively).'?","No, the statement does not provide direct support for the claim that ""Hydrocortisone treats otitis externa"". The statement does mention that topical neomycin/polymixin B/hydrocortisone preparations are effective in treating otitis externa, but it does not specifically attribute the efficacy to hydrocortisone. It could be any of the components in the preparation that is contributing to its effectiveness. Therefore, we cannot infer from this statement that hydrocortisone alone is effective in treating otitis externa."
7584436,Hydrocortisone treats Crohn disease,1230,CONCLUSIONS: The observed increase in albumin binding might limit the bioactivity of cortisol in patients with Crohn's disease and contribute to the decreased effectiveness and weaker side effects of glucocorticoid therapy in these patients.,False,Is the triple 'Hydrocortisone treats Crohn disease' supported by the sentence: 'CONCLUSIONS: The observed increase in albumin binding might limit the bioactivity of cortisol in patients with Crohn's disease and contribute to the decreased effectiveness and weaker side effects of glucocorticoid therapy in these patients.'?,"No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats Crohn disease. The conclusion in fact suggests that cortisol (which hydrocortisone is a synthetic form of) may be less effective in patients with Crohn disease due to increased albumin binding, which could limit its bioactivity. However, it does not negate the fact that glucocorticoids like hydrocortisone can be used as a treatment option for Crohn disease, although they may not be as effective in some patients due to factors such as increased albumin binding. Therefore, while there is some relevance in terms of understanding potential mechanisms of glucocorticoid resistance in Crohn disease patients, it does not provide evidence that hydrocortisone treats Crohn disease."
7432481,Hydrocortisone treats pancreatitis,1231,"The amount of N-acetyl D-glucosamine in the zymogen granule membrane was not altered by caerulein acute pancreatitis induced under continuous hydrocortisone treatment, but it was decreased by the administration of L-364,718 over 7 days after pancreatitis induction.",False,"Is the triple 'Hydrocortisone treats pancreatitis' supported by the sentence: 'The amount of N-acetyl D-glucosamine in the zymogen granule membrane was not altered by caerulein acute pancreatitis induced under continuous hydrocortisone treatment, but it was decreased by the administration of L-364,718 over 7 days after pancreatitis induction.'?","No, the statement does not provide indirect support for the claim that hydrocortisone treats pancreatitis. The statement discusses the effects of hydrocortisone on N-acetyl D-glucosamine levels in zymogen granule membranes in relation to pancreatitis induced by caerulein, but it does not provide any information about the therapeutic effects of hydrocortisone on pancreatitis itself. Therefore, it does not offer any evidence to suggest that hydrocortisone is effective in treating pancreatitis."
7402054,Hydrocortisone treats fibromyalgia,1232,Graded ACTH infusion revealed similar increases in cortisol in women with fibromyalgia and healthy controls.,False,Is the triple 'Hydrocortisone treats fibromyalgia' supported by the sentence: 'Graded ACTH infusion revealed similar increases in cortisol in women with fibromyalgia and healthy controls.'?,"No, the statement ""Graded ACTH infusion revealed similar increases in cortisol in women with fibromyalgia and healthy controls"" does not provide direct or indirect support for the claim that ""Hydrocortisone treats fibromyalgia.""

         The statement provided discusses an experiment involving graded ACTH (Adrenocorticotropic hormone) infusion in women with fibromyalgia compared to healthy controls, which resulted in similar increases in cortisol levels in both groups. Cortisol is a hormone that is released in response to stress and is involved in regulating various metabolic processes in the body; it is not equivalent to hydrocortisone.

         Hydrocortisone is a synthetic form of cortisol that is used as an anti-inflammatory medication in various medical conditions; its effectiveness in treating fibromyalgia has not been firmly established in clinical trials. The study mentioned does not provide information about hydrocortisone administration in fibromyalgia patients; therefore, it does not offer any support for the claim that hydrocortisone is an effective treatment for fibromyalgia."
7378370,Hydrocortisone treats chronic primary adrenal insufficiency,1233,The effects of endogenous opioids and cortisol on thyrotropin and prolactin secretion in patients with Addison's disease.,False,Is the triple 'Hydrocortisone treats chronic primary adrenal insufficiency' supported by the sentence: 'The effects of endogenous opioids and cortisol on thyrotropin and prolactin secretion in patients with Addison's disease.'?,"No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats chronic primary adrenal insufficiency (often referred to as Addison's disease). The statement focuses on endogenous opioids and cortisol's effects on thyrotropin and prolactin secretion in patients with Addison's disease but does not mention hydrocortisone as a treatment option for chronic primary adrenal insufficiency.

        Hydrocortisone is indeed commonly used as replacement therapy for patients suffering from adrenal insufficiency (AI) due to its glucocorticoid properties that help manage AI symptoms such as fatigue, weakness, and low blood pressure (Nieman et al., 2015). However, there is no reference in the provided statement that suggests hydrocortisone as an effective treatment for AI.

        To support the claim that hydrocortisone treats chronic primary adrenal insufficiency, one would need evidence specifically addressing hydrocortisone as an effective treatment for AI rather than relying on indirect inferences from studies focused on opioids and cortisol in AI"
7363431,Hydrocortisone treats asthma,1234,[Dynamics of the cortisol content in the blood plasma in specific hyposensibilization in children with bronchial asthma].,False,Is the triple 'Hydrocortisone treats asthma' supported by the sentence: '[Dynamics of the cortisol content in the blood plasma in specific hyposensibilization in children with bronchial asthma].'?,"No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats asthma. The statement ""Dynamics of the cortisol content in the blood plasma in specific hyposensibilization in children with bronchial asthma"" refers to changes in cortisol levels during hyposensibilization in children with bronchial asthma. Cortisol is a natural hormone produced by the adrenal gland that has anti-inflammatory effects and helps regulate immune responses in the body. Hydrocortisone is a synthetic form of cortisol often used as a medication for various conditions including asthma.

         However, the statement only addresses cortisol dynamics during hyposensibilization in children with asthma but does not mention hydrocortisone use as a treatment for asthma explicitly or implicitly. Therefore, it does not offer any support for the claim that hydrocortisone treats asthma.

         To provide indirect support for such a claim, one would need evidence showing that administering hydrocortisone (or synthetic corticosteroids) has beneficial effects on asthma symptoms or inflamm"
27127545,Methylprednisolone treats lymphoproliferative syndrome,1235,Treatment of X-linked lymphoproliferative disease (Duncan disease) with high-dose methylprednisolone and etoposide (VP-16).,True,Is the triple 'Methylprednisolone treats lymphoproliferative syndrome' supported by the sentence: 'Treatment of X-linked lymphoproliferative disease (Duncan disease) with high-dose methylprednisolone and etoposide (VP-16).'?,"Yes, indirectly it does. The statement provides evidence that methylprednisolone has been used in the treatment of X-linked lymphoproliferative disease (Duncan disease), which is a type of lymphoproliferative syndrome. However, it should be noted that this is not a direct claim about methylprednisolone treating all forms of lymphoproliferative syndrome, but rather one specific type. Therefore, while there is some support for the idea that methylprednisolone can be an effective treatment for certain types of lymphoproliferative syndrome, it would be inaccurate and misleading to extrapolate from this single study that methylprednisolone is a universal treatment for all forms of lymphoproliferative syndrome. It is also important to note that the treatment regimen includes etoposide (VP-16), suggesting that perhaps the combination of drugs is more effective than methylprednisolone alone. As always, any conclusions drawn should be based on a thorough review of all available evidence."
26450412,Methylprednisolone treats leukemia,1236,"Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.",True,"Is the triple 'Methylprednisolone treats leukemia' supported by the sentence: 'Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.'?","Yes, indirectly it does support that Methylprednisolone is used in treating leukemia as part of a larger treatment regimen that includes other drugs such as 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, and vincristine. However, it does not explicitly state that Methylprednisolone alone treats leukemia. The statement only confirms its use in treating L1210 leukemia when used in combination with other drugs in an optimized circadian rhythm manner."
26339812,Methylprednisolone treats alcoholic hepatitis,1237,Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis.,True,Is the triple 'Methylprednisolone treats alcoholic hepatitis' supported by the sentence: 'Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis.'?,"Yes, the statement does provide indirect support for the claim that methylprednisolone treats alcoholic hepatitis. The controlled trial mentioned in the statement implies that there has been an experimental investigation into the effects of methylprednisolone therapy on severe acute alcoholic hepatitis. This type of study is designed to test hypotheses, which in this case could be that methylprednisolone has beneficial effects on alcoholic hepatitis.

        
        However, it is important to note that while an experimental study such as this can provide evidence for a treatment effect, it does not definitively prove causality. Other factors such as sample size, randomization methods, blinding procedures, and potential confounders can influence the validity of the results. Furthermore, even if the study finds significant results, these would typically be interpreted as preliminary evidence that would need to be replicated in further studies before making definitive conclusions about treatment efficacy.

        
        Therefore, while the statement does lend some support to the claim that methylprednisolone treats alcoholic hepatitis, it should be interpreted within the context of the broader literature on this topic. A single study is rarely sufficient"
26307075,Methylprednisolone treats psoriatic arthritis,1238,"1 The present study was undertaken to characterize the spectrum of arachidonic acid metabolites present in synovial effusions of patients with rheumatoid or psoriatic arthritis, and to compare changes in their concentration following a short-term treatment with 6alpha-methyl-prednisolone (6-MeP: 4-8 mg/day) or indoprofen (1.2 g/day), a nonsteroidal anti-inflammatory agent with proven synovial prostaglandin inhibitory effect.2 Measurements of prostaglandin E(2) (PGE(2)), thromboxane (TX) B(2), 6-keto-PGF(1alpha) and PGF(2alpha) were performed by radioimmunoassay techniques in synovial effusions obtained from 23 patients, and validated by thin-layer chromatographic analysis of the extracted immunoreactivity.3 PGE(2) and TXB(2) accounted for more than 60% of the total immunoreactivity in untreated patients.",False,"Is the triple 'Methylprednisolone treats psoriatic arthritis' supported by the sentence: '1 The present study was undertaken to characterize the spectrum of arachidonic acid metabolites present in synovial effusions of patients with rheumatoid or psoriatic arthritis, and to compare changes in their concentration following a short-term treatment with 6alpha-methyl-prednisolone (6-MeP: 4-8 mg/day) or indoprofen (1.2 g/day), a nonsteroidal anti-inflammatory agent with proven synovial prostaglandin inhibitory effect.2 Measurements of prostaglandin E(2) (PGE(2)), thromboxane (TX) B(2), 6-keto-PGF(1alpha) and PGF(2alpha) were performed by radioimmunoassay techniques in synovial effusions obtained from 23 patients, and validated by thin-layer chromatographic analysis of the extracted immunoreactivity.3 PGE(2) and TXB(2) accounted for more than 60% of the total immunoreactivity in untreated patients.'?","No, the statement does not provide direct support for the claim that methylprednisolone treats psoriatic arthritis. However, it does offer indirect evidence suggesting that methylprednisolone may have some effect on inflammatory markers associated with arthritis.

         The study is primarily designed to characterize arachidonic acid metabolites in synovial effusions of patients with rheumatoid or psoriatic arthritis, and to compare changes in their concentration following"
26279366,Methylprednisolone treats angioimmunoblastic T-cell lymphoma,1239,Pulse methylprednisolone therapy in angioimmunoblastic lymphadenopathy.,True,Is the triple 'Methylprednisolone treats angioimmunoblastic T-cell lymphoma' supported by the sentence: 'Pulse methylprednisolone therapy in angioimmunoblastic lymphadenopathy.'?,"Yes, based on the information provided in the statement ""Pulse methylprednisolone therapy in angioimmunoblastic lymphadenopathy,"" there is indirect support for the claim that methylprednisolone treats angioimmunoblastic T-cell lymphoma (AITL). The term ""angioimmunoblastic lymphadenopathy"" is often used interchangeably with angioimmunoblastic T-cell lymphoma (AITL) as it represents an early stage in the disease progression. The use of pulse methylprednisolone therapy implies that methylprednisolone has some therapeutic effect on either angioimmunoblastic lymphadenopathy or AITL itself.

         However, it is essential to note that angioimmunoblastic T-cell lymphoma is an aggressive form of non-Hodgkin lymphoma (NHL), which typically involves multiple treatment modalities beyond corticosteroids alone. Therefore, while methylprednisolone may play a role in treating AITL as part of a broader treatment regimen, it"
25738014,Methylprednisolone treats ankylosing spondylitis,1240,Seven patients with active AS and insufficient efficacy of NSAID for three months were treated with one gram methylprednisolone daily given intravenously for three successive days.,True,Is the triple 'Methylprednisolone treats ankylosing spondylitis' supported by the sentence: 'Seven patients with active AS and insufficient efficacy of NSAID for three months were treated with one gram methylprednisolone daily given intravenously for three successive days.'?,"Yes, the statement does provide indirect support for the claim that methylprednisolone treats ankylosing spondylitis (AS). The statement describes seven patients with active AS who were treated with methylprednisolone for three successive days due to insufficient efficacy of NSAIDs for three months. The fact that methylprednisolone was used as a treatment for these AS patients suggests that it has potential therapeutic benefits for the condition, even though it does not explicitly confirm that methylprednisolone treats AS. However, it is important to note that a more definitive conclusion would require additional information such as clinical outcomes, adverse effects, comparison with other treatment options, and statistical significance of any observed effects in larger patient cohorts."
25734987,Methylprednisolone treats non-Hodgkin lymphoma,1241,"Peptichemio, a new oncolytic drug with alkylating and antimetabolic properties was employed in combination with vincristine and 6-methylprednisolone (PVP) for the treatment of diffuse non-Hodgkin's lymphomas (NHL), stages III and IV.",False,"Is the triple 'Methylprednisolone treats non-Hodgkin lymphoma' supported by the sentence: 'Peptichemio, a new oncolytic drug with alkylating and antimetabolic properties was employed in combination with vincristine and 6-methylprednisolone (PVP) for the treatment of diffuse non-Hodgkin's lymphomas (NHL), stages III and IV.'?","No, the phrase ""Methylprednisolone treats non-Hodgkin lymphoma"" does not receive direct support from the statement provided. The statement mentions that 6-methylprednisolone was used in combination with other drugs for treating diffuse non-Hodgkin's lymphomas; however, it does not explicitly claim that 6-methylprednisolone alone is responsible for treating non-Hodgkin lymphoma. Therefore, indirect support can only be inferred if additional evidence supports the efficacy of 6-methylprednisolone specifically in treating non-Hodgkin lymphoma when used alone.

        

        To further clarify, methylprednisolone is a synthetic glucocorticoid hormone used in various medical treatments such as inflammation reduction and immunosuppression in conditions like arthritis or asthma [1]. In oncology settings, glucocorticoids like methylprednisolone may be used as palliative care for symptoms like edema, pain, or anorexia in l"
25642231,Methylprednisolone treats heart disorder,1242,High-dose MP may be contraindicated in patients with known heart disease.,True,Is the triple 'Methylprednisolone treats heart disorder' supported by the sentence: 'High-dose MP may be contraindicated in patients with known heart disease.'?,"Yes, indirectly it does support the claim that Methylprednisolone (MP) has an impact on heart disorders. The statement ""High-dose MP may be contraindicated in patients with known heart disease"" implies that there is a risk associated with using high-dose MP in patients who already have heart disease. This suggests that MP could potentially affect heart health negatively in some way, which indirectly supports the claim that it could have some involvement in treating heart disorders. However, it's important to note that contraindication doesn't necessarily mean treatment; it could also mean exacerbation of existing conditions or side effects. Therefore, more direct evidence would be needed to definitively say that MP treats heart disorders."
25366540,Methylprednisolone treats myopathy,1243,PURPOSE: To report the therapeutic efficacy of intravenous methylprednisolone (IVMP) in patients with restrictive myopathy caused by thyroid eye disease (TED).,True,Is the triple 'Methylprednisolone treats myopathy' supported by the sentence: 'PURPOSE: To report the therapeutic efficacy of intravenous methylprednisolone (IVMP) in patients with restrictive myopathy caused by thyroid eye disease (TED).'?,"Yes, the statement ""PURPOSE: To report the therapeutic efficacy of intravenous methylprednisolone (IVMP) in patients with restrictive myopathy caused by thyroid eye disease (TED)"" does provide indirect support for the claim that methylprednisolone treats myopathy. The study specifically investigates IVMP in patients with restrictive myopathy caused by TED, which indicates that methylprednisolone has been employed as a potential therapeutic intervention for myopathy symptoms in TED patients.

         However, it is crucial to note that myopathy is an umbrella term for several muscle disorders that can have diverse causes, including inflammatory processes, inherited genetic mutations, infections, metabolic disorders, and drug side effects. The study at hand focuses on myopathy caused specifically by TED; therefore, it is essential to be cautious when extrapolating these results beyond the context of TED-related myopathy, as methylprednisolone may not be universally effective for all forms of myopathy.

         Additionally, it is worth mentioning that therapeutic efficacy does not necessarily"
24273559,Methylprednisolone treats Abdominal pain,1244,"After 2 months of treatment with systemic methylprednisolone, cyclophosphamide, and prednisone, the patient's abdominal pain was relieved.",True,"Is the triple 'Methylprednisolone treats Abdominal pain' supported by the sentence: 'After 2 months of treatment with systemic methylprednisolone, cyclophosphamide, and prednisone, the patient's abdominal pain was relieved.'?","Yes, indirectly it does support the claim that methylprednisolone treats abdominal pain. The statement provided indicates that after two months of treatment with methylprednisolone (among other medications), the patient's abdominal pain was relieved. This suggests a correlation between the administration of methylprednisolone and the alleviation of abdominal pain. However, it's important to note that correlation does not imply causation, and other factors could have contributed to the relief of abdominal pain. These factors could include the effects of cyclophosphamide and prednisone, as well as any changes in the patient's lifestyle or diet during the treatment period. Therefore, while there is some support for the claim, it is not direct or definitive proof that methylprednisolone alone is responsible for treating abdominal pain. Further studies would be needed to establish such causation."
23772707,Methylprednisolone treats cardiac arrest,1245,Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial.,True,Is the triple 'Methylprednisolone treats cardiac arrest' supported by the sentence: 'Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial.'?,"Yes, indirectly it does support that statement. The randomized clinical trial mentioned in the title is investigating the effects of vasopressin and methylprednisolone on return of spontaneous circulation in patients with in-hospital cardiac arrest. The fact that methylprednisolone is included in this study suggests that there is some basis for considering it as a potential treatment for cardiac arrest, even though it may not be the primary focus of the study.

        However, it is important to note that this study does not prove that methylprednisolone treats cardiac arrest definitively. The study could find that it has no significant effect, a negative effect, or that it is less effective than other treatments. Therefore, while there is some indirect support for the idea that methylprednisolone could be used to treat cardiac arrest based on this study, further investigation would be required to make any definitive conclusions about its efficacy in treating cardiac arrest."
23209303,Methylprednisolone treats respiratory system disorder,1246,"Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high-flow nasal cannula oxygen therapy.",False,"Is the triple 'Methylprednisolone treats respiratory system disorder' supported by the sentence: 'Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high-flow nasal cannula oxygen therapy.'?","No, the statement does not provide direct support for the phrase ""Methylprednisolone treats respiratory system disorder"". The provided evidence suggests that methylprednisolone may have had some positive effect on the patient's respiratory condition, but it does not confirm that it is a treatment for respiratory system disorders in general. The patient's condition still deteriorated significantly despite taking methylprednisolone, necessitating high-flow nasal cannula oxygen therapy. Therefore, one cannot infer from this statement that methylprednisolone is an effective treatment for respiratory system disorders without further evidence."
23116362,Methylprednisolone treats pneumocystosis,1247,"Caspofungin, TMP-SMX, clindamycin and MP were used to treat    P. jirovecii     pneumonia (PJP).",True,"Is the triple 'Methylprednisolone treats pneumocystosis' supported by the sentence: 'Caspofungin, TMP-SMX, clindamycin and MP were used to treat    P. jirovecii     pneumonia (PJP).'?","Yes, indirectly it does support that Methylprednisolone (MP) is used in treating pneumocystosis caused by P. jirovecii (PJP). The statement provided mentions MP along with other drugs for treating PJP, implying its use in treating pneumocystosis indirectly. However, it should be noted that MP is primarily used as an adjunct therapy for PJP in order to manage inflammation and prevent immune reconstitution inflammatory syndrome (IRIS), rather than as an antimicrobial agent itself."
22495912,Methylprednisolone treats myocarditis,1248,"Although, not described in the literature, we have found conjunctive use of milrinone and methylprednisolone effective in patient with SARS-CoV-2 fulminant myocarditis.",True,"Is the triple 'Methylprednisolone treats myocarditis' supported by the sentence: 'Although, not described in the literature, we have found conjunctive use of milrinone and methylprednisolone effective in patient with SARS-CoV-2 fulminant myocarditis.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats myocarditis. The statement suggests that methylprednisolone has been used in conjunction with milrinone for treating a patient with SARS-CoV-2 fulminant myocarditis, which is a form of myocarditis (heart inflammation). Although there is no direct mention of methylprednisolone being solely responsible for treating myocarditis in literature, its use in combination therapy implies potential benefits for managing inflammation in such cases. This observation supports further investigation into methylprednisolone as an option for treating myocarditis in similar contexts; however, it does not definitively establish its standalone therapeutic efficacy for myocarditis based on this statement alone."
19962298,Methylprednisolone treats Hodgkins lymphoma,1249,High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone.,False,Is the triple 'Methylprednisolone treats Hodgkins lymphoma' supported by the sentence: 'High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone.'?,"No, the statement does not provide direct or indirect support for the claim that ""Methylprednisolone treats Hodgkins lymphoma."" The statement discusses an association between methylprednisolone use in Hodgkin lymphoma patients treated with escalated BEACOPP (a specific chemotherapy regimen) and an increased incidence of aseptic hip necrosis (a specific complication). It does not imply that methylprednisolone is an effective treatment for Hodgkin lymphoma.

        The misconception arises from conflating two distinct concepts: treatment efficacy and side effects/complications. While methylprednisolone may be used in treating Hodgkin lymphoma as part of a chemotherapy regimen like BEACOPP (possibly for its immunosuppressive properties), it does not imply that it is an effective treatment for Hodgkin lymphoma on its own.

        To establish whether methylprednisolone treats Hodgkin lymphoma effectively, one would need clinical trial results specifically investigating its therapeutic efficacy in treating"
19674675,Methylprednisolone treats microscopic polyangiitis,1250,Six newly diagnosed patients with MPA were initially treated with methylprednisolone and a single dose of RTX (375 mg/m2).,True,Is the triple 'Methylprednisolone treats microscopic polyangiitis' supported by the sentence: 'Six newly diagnosed patients with MPA were initially treated with methylprednisolone and a single dose of RTX (375 mg/m2).'?,"Yes, the statement does provide indirect support for the claim that methylprednisolone treats microscopic polyangiitis (MPA). The fact that six newly diagnosed patients with MPA were treated with methylprednisolone suggests that it is considered an appropriate treatment option for this condition. However, it is important to note that correlation does not imply causation; therefore, while methylprednisolone may be used in treating MPA, it does not necessarily mean that it is solely responsible for treating MPA in these patients. Other factors such as concomitant medications (in this case RTX) could also play a role in disease management. Additionally, since this is not a controlled study, other confounding variables may exist that could influence treatment outcomes. Therefore, further investigation would be required to make more definitive conclusions regarding methylprednisolone's specific therapeutic effect on MPA."
19534575,Methylprednisolone treats anterior ischemic optic neuropathy,1251,Early Methylprednisolone Treatment Can Stabilize the Blood-Optic Nerve Barrier in a Rat Model of Anterior Ischemic Optic Neuropathy (rAION).,True,Is the triple 'Methylprednisolone treats anterior ischemic optic neuropathy' supported by the sentence: 'Early Methylprednisolone Treatment Can Stabilize the Blood-Optic Nerve Barrier in a Rat Model of Anterior Ischemic Optic Neuropathy (rAION).'?,"Yes, indirectly it does lend some support. The statement suggests that methylprednisolone treatment can stabilize the blood-optic nerve barrier in a rat model of anterior ischemic optic neuropathy (rAION). This implies that methylprednisolone may have some therapeutic effect on anterior ischemic optic neuropathy (AION). However, it is important to note that this does not necessarily mean that methylprednisolone treats AION in humans, as further research including clinical trials would be needed to make such a claim. The blood-optic nerve barrier in rats may not respond identically to humans, and there may be other factors at play in human AION that were not addressed in this rat study. Therefore, while there is some indirect support for the idea that methylprednisolone may treat AION, more evidence is needed before making a definitive claim."
18427985,Methylprednisolone treats osteoarthritis,1252,"We report a case of a 68-year-old woman who presented with severe abdominal pain, nausea and vomiting, 3 days after the initiation of low-dose methylprednisolone for osteoarthritis.",False,"Is the triple 'Methylprednisolone treats osteoarthritis' supported by the sentence: 'We report a case of a 68-year-old woman who presented with severe abdominal pain, nausea and vomiting, 3 days after the initiation of low-dose methylprednisolone for osteoarthritis.'?","No, the statement does not provide direct or indirect support for the claim that methylprednisolone treats osteoarthritis. The statement reports an adverse event in a patient who started taking methylprednisolone for osteoarthritis treatment. The negative side effect does not imply that methylprednisolone is an effective treatment for osteoarthritis. In fact, it raises concerns about potential side effects associated with methylprednisolone use in osteoarthritis patients."
18276332,Methylprednisolone treats plantar fasciitis,1253,OBJECTIVES: To compare the effectiveness of oral nonsteroidal antiinflammatory drugs (NSAIDs) and locally injectable steroid (methylprednisolone) in the treatment of plantar fasciitis.,True,Is the triple 'Methylprednisolone treats plantar fasciitis' supported by the sentence: 'OBJECTIVES: To compare the effectiveness of oral nonsteroidal antiinflammatory drugs (NSAIDs) and locally injectable steroid (methylprednisolone) in the treatment of plantar fasciitis.'?,"Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats plantar fasciitis."" The objective of the study mentioned is to compare the effectiveness of nonsteroidal antiinflammatory drugs (NSAIDs) and locally injectable steroid (methylprednisolone) in treating plantar fasciitis. By stating methylprednisolone as one of the treatments being compared in relation to plantar fasciitis, it suggests that methylprednisolone is indeed used for treating plantar fasciitis in some capacity. However, it is important to note that indirect support does not equate to definitive proof; further investigation would be required to establish the effectiveness and safety of methylprednisolone specifically for treating plantar fasciitis based on the results from that particular study."
18008318,Methylprednisolone treats dermatomyositis,1254,A Japanese woman was treated with injectable methylprednisolone and oral prednisolone for dermatomyositis.,True,Is the triple 'Methylprednisolone treats dermatomyositis' supported by the sentence: 'A Japanese woman was treated with injectable methylprednisolone and oral prednisolone for dermatomyositis.'?,"Yes, the statement does provide indirect support for the claim that methylprednisolone treats dermatomyositis. The Japanese woman in question was administered methylprednisolone as part of her treatment regimen for dermatomyositis. The administration of methylprednisolone in this context suggests that it was considered an effective treatment for her condition by her medical team. However, it is important to note that correlation does not imply causation; while methylprednisolone was used in her treatment, it does not necessarily mean that it was solely responsible for her improvement. Other factors, such as concurrent treatments (in this case, oral prednisolone), individual patient characteristics, and disease severity may also have played a role in her response to treatment. Therefore, while there is some level of support for the claim based on this statement, further evidence would be required for a more definitive conclusion."
17478785,Methylprednisolone treats nasal cavity polyp,1255,"The study by Van Zele et al reports positive results for a randomized, double-blind, placebo-controlled trial that used either 20 days of doxycycline (200 mg the first day, followed by 100 mg daily) or 20 days of a tapering schedule of methyl prednisolone (32 mg on days 1-5, 16 mg on days 6-10, and 8 mg on days 11-20) for the treatment of nasal polyps.",True,"Is the triple 'Methylprednisolone treats nasal cavity polyp' supported by the sentence: 'The study by Van Zele et al reports positive results for a randomized, double-blind, placebo-controlled trial that used either 20 days of doxycycline (200 mg the first day, followed by 100 mg daily) or 20 days of a tapering schedule of methyl prednisolone (32 mg on days 1-5, 16 mg on days 6-10, and 8 mg on days 11-20) for the treatment of nasal polyps.'?","Yes, the statement by Van Zele et al does provide indirect support for the claim that methylprednisolone treats nasal cavity polyps. The study is a randomized, double-blind, placebo-controlled trial, which is considered the gold standard for clinical trials as it minimizes bias and ensures robustness in results interpretation. The trial involved administering methylprednisolone in tapering doses over 20 days for patients suffering from nasal polyps. A positive result would imply an improvement in symptoms or reduction in polyp size for patients who received methylprednisolone compared to those who received placebo treatment.

         However, it is important to note that while the statement supports methylprednisolone as a potential treatment for nasal polyps, it does not necessarily confirm that methylprednisolone is solely responsible for treating nasal cavity polyps. Additional factors such as concomitant medications, lifestyle changes, or other interventions could have contributed to the positive results observed in the trial. Additionally, further studies would be required to establish methylprednisolone as an effective treatment option for nas"
15407991,Methylprednisolone treats radiculopathy,1256,"Herein, we present our experience of management of such cases with a single epidural injection of local anaesthetic, tramadol and methylprednisolone, and table tilt for management of both radiculopathies.",True,"Is the triple 'Methylprednisolone treats radiculopathy' supported by the sentence: 'Herein, we present our experience of management of such cases with a single epidural injection of local anaesthetic, tramadol and methylprednisolone, and table tilt for management of both radiculopathies.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats radiculopathy. The key word here is ""treats,"" which implies direct causality between the drug and resolution of symptoms. While the statement does not explicitly state that methylprednisolone treats radiculopathy on its own, it does mention its use in conjunction with other treatments (local anaesthetic and tramadol) for managing radiculopathies. This suggests that methylprednisolone is being utilized as part of a treatment regimen for radiculopathy, providing some level of indirect support for its use in treating this condition. However, it is important to note that correlation does not imply causation, and further evidence would be needed to definitively conclude that methylprednisolone treats radiculopathy specifically."
14897628,Methylprednisolone treats neuromyelitis optica,1257,Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.,True,Is the triple 'Methylprednisolone treats neuromyelitis optica' supported by the sentence: 'Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.'?,"Yes, the statement does provide indirect support for the claim that methylprednisolone treats neuromyelitis optica (NMO). The study indicates that early high-dose intravenous methylprednisolone therapy preserves retinal nerve fiber layer thickness in NMO patients. This suggests that methylprednisolone has neuroprotective effects in NMO patients, which aligns with the general understanding that it is used to treat NMO. However, it is important to note that ""treating"" implies not only amelioration of symptoms but also prevention or alteration of disease progression; hence, further studies would be required for a more definitive conclusion on methylprednisolone's disease-modifying properties in NMO."
14825096,Methylprednisolone treats West syndrome,1258,The authors report their experience with intravenous methylprednisolone for the treatment of infantile spasms.,True,Is the triple 'Methylprednisolone treats West syndrome' supported by the sentence: 'The authors report their experience with intravenous methylprednisolone for the treatment of infantile spasms.'?,"Yes, the statement ""The authors report their experience with intravenous methylprednisolone for the treatment of infantile spasms"" does lend indirect support to the claim that ""Methylprednisolone treats West syndrome."" West syndrome is an eponym for infantile spasms, which is a specific type of seizure disorder in infants and children. The statement from the authors indicates their use of methylprednisolone as a treatment for infantile spasms, suggesting its potential efficacy in managing West syndrome symptoms. However, it is important to note that indirect support does not equate to definitive proof; further studies would be required to establish methylprednisolone as an evidence-based treatment for West syndrome."
14690661,Methylprednisolone treats Meniere disease,1259,OBJECTIVE: To describe the long-term efficacy of transtympanic steroids (TTS) using methyl-prednisolone in the treatment of Meniere's disease (MD).,True,Is the triple 'Methylprednisolone treats Meniere disease' supported by the sentence: 'OBJECTIVE: To describe the long-term efficacy of transtympanic steroids (TTS) using methyl-prednisolone in the treatment of Meniere's disease (MD).'?,"Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats Meniere disease"". The objective of the study explicitly mentions using methylprednisolone as part of transtympanic steroids (TTS) therapy for Meniere's disease (MD). By describing its long-term efficacy, it implies that methylprednisolone could be an effective treatment for Meniere disease within that therapeutic context. However, it is essential to consider that further investigation is necessary to establish direct support for methylprednisolone as an independent treatment for Meniere disease based on this statement alone."
14636779,Methylprednisolone treats neoplasm,1260,"Rats with stereotactically implanted Walker 256 tumors were treated with methylprednisolone, U-74006F, U-78517F, or vehicle (0.05 N HCl) on Days 6 through 10 following implantation.",False,"Is the triple 'Methylprednisolone treats neoplasm' supported by the sentence: 'Rats with stereotactically implanted Walker 256 tumors were treated with methylprednisolone, U-74006F, U-78517F, or vehicle (0.05 N HCl) on Days 6 through 10 following implantation.'?","No, the statement does not provide direct or indirect support for the claim that methylprednisolone treats neoplasm (a type of tumor). The provided information only states that rats with Walker 256 tumors were treated with methylprednisolone during specific days following implantation but does not mention any effects on tumor growth, reduction, or treatment outcomes.

         To provide indirect support for the claim that methylprednisolone treats neoplasm, there should be some evidence suggesting that tumor growth was reduced, controlled, or eliminated in rats treated with methylprednisolone compared to those in control groups (rats treated with vehicle). The statement only describes the treatment regimen without any further context on tumor progression or response to treatment.

         It is important to note that while methylprednisolone is used in clinical settings for various applications such as anti-inflammatory purposes and organ transplantation, its direct use as an anti-cancer treatment remains limited in scope and warrants further investigation before making any definitive conclusions on its therapeutic potential for neoplasm treatment based on the given statement alone."
14398238,Methylprednisolone treats IgA glomerulonephritis,1261,"CONCLUSIONS: Methylprednisolone and cyclophosphamide in children with Grade IV IgA nephropathy stabilized renal function and significantly reduced hematuria, proteinuria, mesangial IgA deposition, and the renal pathological activity index.",True,"Is the triple 'Methylprednisolone treats IgA glomerulonephritis' supported by the sentence: 'CONCLUSIONS: Methylprednisolone and cyclophosphamide in children with Grade IV IgA nephropathy stabilized renal function and significantly reduced hematuria, proteinuria, mesangial IgA deposition, and the renal pathological activity index.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats IgA glomerulonephritis (IgAN), given that IgAN is often referred to as IgA nephropathy in medical literature. The study indicates that methylprednisolone, when used in combination with cyclophosphamide in children with severe IgAN (Grade IV), led to stabilized renal function and significantly reduced hematuria, proteinuria, mesangial IgA deposition, and renal pathological activity index.

         However, it is important to note that correlation does not imply causation, so while these results suggest that methylprednisolone has beneficial effects for patients suffering from IgAN, they do not definitively prove that methylprednisolone is solely responsible for these improvements or that it would yield similar results in all cases of IgAN. Additional studies would be required for stronger evidence supporting methylprednisolone as an effective treatment for IgA glomerulonephritis."
14232595,Methylprednisolone treats membranous glomerulonephritis,1262,"MN was treated with methylprednisolone as first-line therapy, then she was changed to rituximab for a relapse.",True,"Is the triple 'Methylprednisolone treats membranous glomerulonephritis' supported by the sentence: 'MN was treated with methylprednisolone as first-line therapy, then she was changed to rituximab for a relapse.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats membranous glomerulonephritis (MN). The patient was initially treated with methylprednisolone as first-line therapy for MN, suggesting that methylprednisolone was considered effective for treating MN at some stage of her treatment plan. However, it is important to note that the statement only indicates methylprednisolone as a first-line treatment for MN; it does not necessarily imply that methylprednisolone is exclusively effective for treating MN nor does it establish it as the most effective treatment option for MN.

         The subsequent change in therapy from methylprednisolone to rituximab suggests that either the patient relapsed despite initial treatment success or that methylprednisolone was not as effective in treating her MN as rituximab in later stages of her disease progression. Nonetheless, the initial use of methylprednisolone does provide some level of support for its efficacy in treating MN even if it might not be suitable for every patient or stage of MN progression."
14027935,Methylprednisolone treats diffuse large B-cell lymphoma,1263,"This study evaluated the influence of prior exposure to rituximab on response rates and survival in patients with diffuse large B-cell lymphoma treated with rituximab plus etoposide, cytarabine, cisplatinum and methylprednisolone (R-ESHAP).",False,"Is the triple 'Methylprednisolone treats diffuse large B-cell lymphoma' supported by the sentence: 'This study evaluated the influence of prior exposure to rituximab on response rates and survival in patients with diffuse large B-cell lymphoma treated with rituximab plus etoposide, cytarabine, cisplatinum and methylprednisolone (R-ESHAP).'?","No, the statement does not provide direct or indirect support for the claim that methylprednisolone treats diffuse large B-cell lymphoma (DLBCL). The study is investigating the impact of prior rituximab exposure on response rates and survival in patients treated with R-ESHAP (a combination therapy that includes methylprednisolone), not specifically examining methylprednisolone as a standalone treatment for DLBCL. Therefore, it does not provide any insights into methylprednisolone's effectiveness in treating DLBCL when used alone."
13679356,Methylprednisolone treats hemophagocytic syndrome,1264,"A 46 year old woman who presented with severe multiorgans involvement including liver brain, cardio-pulmonary failure, gastrointestinal bleeding, progressive cytopenia, DIC and hemophagocytic syndrome during the convalescent phase of Dengue type II has been successfully treated primarily with pulse methyl prednisolone and high dose intravenous immunoglobulin G.",True,"Is the triple 'Methylprednisolone treats hemophagocytic syndrome' supported by the sentence: 'A 46 year old woman who presented with severe multiorgans involvement including liver brain, cardio-pulmonary failure, gastrointestinal bleeding, progressive cytopenia, DIC and hemophagocytic syndrome during the convalescent phase of Dengue type II has been successfully treated primarily with pulse methyl prednisolone and high dose intravenous immunoglobulin G.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats hemophagocytic syndrome. The case described involves a patient suffering from hemophagocytic syndrome among other serious conditions during the convalescent phase of Dengue type II. The patient was primarily treated with pulse methylprednisolone and high dose intravenous immunoglobulin G, and the text states that she was successfully treated. Therefore, it can be inferred that methylprednisolone was effective in treating the hemophagocytic syndrome in this particular case. However, it is important to note that this is only one case study, and further research with larger sample sizes would be needed to make more definitive conclusions about the effectiveness of methylprednisolone in treating hemophagocytic syndrome. Additionally, it is crucial to consider other factors such as potential side effects and contraindications when interpreting these results."
13619118,Methylprednisolone treats chronic obstructive pulmonary disease,1265,"In conclusion, methylprednisolone in combination with conventional medical therapy not only improved lung function values but also mean nocturnal oxyhemoglobin saturation and sleep duration in clinically stabilized COPD patients who experience nocturnal oxyhemoglobin desaturation.",True,"Is the triple 'Methylprednisolone treats chronic obstructive pulmonary disease' supported by the sentence: 'In conclusion, methylprednisolone in combination with conventional medical therapy not only improved lung function values but also mean nocturnal oxyhemoglobin saturation and sleep duration in clinically stabilized COPD patients who experience nocturnal oxyhemoglobin desaturation.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats chronic obstructive pulmonary disease (COPD). The study indicates that methylprednisolone, when used in combination with conventional medical therapy, has beneficial effects on lung function values, nocturnal oxyhemoglobin saturation, and sleep duration in clinically stabilized COPD patients who experience nocturnal oxyhemoglobin desaturation. These improvements suggest that methylprednisolone may help alleviate symptoms and potentially slow disease progression in some COPD patients. However, it is essential to acknowledge that treating COPD involves managing various factors contributing to disease severity; therefore, methylprednisolone should be considered as an adjunctive therapy rather than a standalone treatment for COPD.

        
        In summary, while methylprednisolone does not directly cure COPD based on available evidence, it does contribute positively towards symptom management in specific patient populations experiencing nocturnal oxyhemoglobin desaturation. Further studies would be required to evaluate its long-term benefits, potential side effects, and optimal usage in COP"
13533673,Methylprednisolone treats macrophage activation syndrome,1266,"Following treatment with etanercept, ibuprofen, methylprednisolone, and phenylbutazone for 3 weeks, MAS deteriorated and fatal cerebral edema occurred within only 24 h.",False,"Is the triple 'Methylprednisolone treats macrophage activation syndrome' supported by the sentence: 'Following treatment with etanercept, ibuprofen, methylprednisolone, and phenylbutazone for 3 weeks, MAS deteriorated and fatal cerebral edema occurred within only 24 h.'?","No, the statement does not provide indirect support for the claim that ""Methylprednisolone treats macrophage activation syndrome (MAS)"". In fact, it seems to suggest the opposite: despite receiving methylprednisolone as part of their treatment regimen for MAS, the patient experienced deterioration and subsequently died due to cerebral edema within 24 hours. This suggests that methylprednisolone was not effective in treating MAS in this particular case. However, it is important to note that treatment response can vary among patients due to factors such as disease severity, individual genetic variation, and concomitant medications. Therefore, while this evidence does not support the claim that methylprednisolone treats MAS, it does not definitively rule out its potential therapeutic value in other contexts either. Further investigation would be required to draw more definitive conclusions about methylprednisolone's efficacy in treating MAS."
13161419,Methylprednisolone treats systemic sclerosis,1267,"CONCLUSION: The results of this pilot study suggest that the combination of MMF, IV MP and low-dose GC might achieve good clinical, functional and radiological results in patients suffering from severe early SSc.",True,"Is the triple 'Methylprednisolone treats systemic sclerosis' supported by the sentence: 'CONCLUSION: The results of this pilot study suggest that the combination of MMF, IV MP and low-dose GC might achieve good clinical, functional and radiological results in patients suffering from severe early SSc.'?","Yes, indirectly it does lend some support. The statement concludes that a combination therapy including intravenous Methylprednisolone (MP) has shown promising results in treating severe early Systemic Sclerosis (SSc). However, this does not explicitly prove that Methylprednisolone alone treats SSc, as other components like MMF and low-dose GC were also part of the treatment regimen. Nonetheless, it suggests a potential beneficial effect of Methylprednisolone in treating SSc as part of a combination therapy."
13096165,Methylprednisolone treats optic nerve disorder,1268,"Dysthyroid optic neuropathy is best treated with intravenous pulsed methylprednisolone; if visual functions do not recover, urgent surgical decompression is indicated.",True,"Is the triple 'Methylprednisolone treats optic nerve disorder' supported by the sentence: 'Dysthyroid optic neuropathy is best treated with intravenous pulsed methylprednisolone; if visual functions do not recover, urgent surgical decompression is indicated.'?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats optic nerve disorder"". The statement suggests that dysthyroid optic neuropathy, which is an optic nerve disorder, is best treated with intravenous pulsed methylprednisolone. Therefore, it implies that methylprednisolone can be an effective treatment for certain optic nerve disorders. However, it's important to note that this is an indirect inference based on a specific type of optic nerve disorder (dysthyroid optic neuropathy). The effectiveness of methylprednisolone may vary for different types of optic nerve disorders."
12975348,Methylprednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma,1269,"Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.",True,"Is the triple 'Methylprednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma' supported by the sentence: 'Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.'?","Yes, indirect support can be inferred from the statement. The article cited does not explicitly state that methylprednisolone alone treats mature T-cell and NK-cell non-Hodgkin lymphoma. However, it does mention that methylprednisolone is part of a treatment regimen (gemcitabine, cisplatin, and methylprednisolone) used for peripheral T-cell lymphoma, which falls under the category of non-Hodgkin lymphoma. This implies that methylprednisolone may have some therapeutic benefit in treating these types of lymphomas as part of a combination therapy.

        

        To further support this inference, it is worth noting that corticosteroids like methylprednisolone are commonly used in treating various types of lymphomas due to their ability to suppress immune response and reduce inflammation. However, more specific studies focusing on methylprednisolone's efficacy in treating mature T-cell and NK-cell non-Hodgkin lymphoma would be required to provide direct support for the statement in question"
12450216,Methylprednisolone treats bronchopulmonary dysplasia,1270,Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.,True,Is the triple 'Methylprednisolone treats bronchopulmonary dysplasia' supported by the sentence: 'Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.'?,"Yes, there is indirect support for the claim that methylprednisolone treats bronchopulmonary dysplasia (BPD) based on the statement provided. The statement mentions methylprednisolone being used in preterm infants for treating hypertrophic cardiomyopathy in conjunction with BPD, which implies that methylprednisolone may have beneficial effects in managing BPD symptoms since it is administered in that context.

        
        However, it is essential to note that correlation does not imply causation, so while methylprednisolone may help improve BPD-related symptoms when treating hypertrophic cardiomyopathy in preterm infants, it does not necessarily mean that it is specifically used for treating BPD itself. Further investigation is required through additional studies focusing explicitly on methylprednisolone as a treatment for bronchopulmonary dysplasia to establish more robust support for that claim."
11895116,Methylprednisolone treats plasma cell myeloma,1271,Multiple myeloma of Stage IIa was diagnosed and she was given cytostatic therapy with 17.5 mg melphalan and 112 mg methylprednisolone daily by mouth (for 4 days at intervals of 6 weeks).,True,Is the triple 'Methylprednisolone treats plasma cell myeloma' supported by the sentence: 'Multiple myeloma of Stage IIa was diagnosed and she was given cytostatic therapy with 17.5 mg melphalan and 112 mg methylprednisolone daily by mouth (for 4 days at intervals of 6 weeks).'?,"Yes, the statement does provide indirect support for the claim that methylprednisolone treats plasma cell myeloma (a type of multiple myeloma). The patient was diagnosed with multiple myeloma and was given methylprednisolone as part of her cytostatic therapy regimen. However, it is important to note that correlation does not imply causation; we cannot definitively conclude that methylprednisolone was solely responsible for treating her myeloma based on this information alone. Further evidence would be required to make such a claim."
11882768,Methylprednisolone treats Cognitive impairment,1272,One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis.,True,Is the triple 'Methylprednisolone treats Cognitive impairment' supported by the sentence: 'One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis.'?,"Yes, while the statement does not explicitly confirm that methylprednisolone alone treats cognitive impairment, it does provide indirect support for its potential efficacy in cognitive dysfunction treatment. This is because cyclophosphamide treatment combined with methylprednisolone improving cognitive dysfunction suggests that methylprednisolone could be having an effect. However, further investigation would be needed to confirm whether methylprednisolone is solely responsible for treating cognitive impairment in multiple sclerosis patients or if it works in conjunction with other treatments like cyclophosphamide. It is also important to consider that cognitive dysfunction in progressive forms of multiple sclerosis may not be equivalent to cognitive impairment in other contexts."
11547088,Methylprednisolone treats thrombotic thrombocytopenic purpura,1273,"The hematologic evaluations and her clinical course revealed the diagnosis of TTP, so plasma exchange and methyl-prednisolone therapy were initiated.",True,"Is the triple 'Methylprednisolone treats thrombotic thrombocytopenic purpura' supported by the sentence: 'The hematologic evaluations and her clinical course revealed the diagnosis of TTP, so plasma exchange and methyl-prednisolone therapy were initiated.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats thrombotic thrombocytopenic purpura (TTP). The statement indicates that after diagnosing TTP in a patient, plasma exchange and methylprednisolone therapy were initiated. Since methylprednisolone is part of the treatment regimen for TTP, it suggests that methylprednisolone is used in an attempt to treat TTP symptoms or manifestations.

         However, it is essential to note that correlation does not imply causation. The statement does not explicitly establish that methylprednisolone effectively treats TTP; it only shows that methylprednisolone is used in treating TTP patients as part of an overall therapy plan that may include plasma exchange as well as other medications and interventions.

         Further studies would be required to definitively establish that methylprednisolone treats TTP effectively. Randomized controlled trials (RCTs) would provide stronger evidence for causation compared to observational studies alone due to their ability to control for confounding variables that could impact treatment outcomes.

         In summary, while the statement does provide some indirect support for"
11313619,Methylprednisolone treats vestibular neuronitis,1274,"METHODS: We performed a prospective, randomized, double-blind, two-by-two factorial trial in which patients with acute vestibular neuritis were randomly assigned to treatment with placebo, methylprednisolone, valacyclovir, or methylprednisolone plus valacyclovir.",True,"Is the triple 'Methylprednisolone treats vestibular neuronitis' supported by the sentence: 'METHODS: We performed a prospective, randomized, double-blind, two-by-two factorial trial in which patients with acute vestibular neuritis were randomly assigned to treatment with placebo, methylprednisolone, valacyclovir, or methylprednisolone plus valacyclovir.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats vestibular neuronitis. The methodology described in the statement includes a clinical trial where patients diagnosed with acute vestibular neuritis were randomly assigned treatments that include methylprednisolone (either alone or in combination with valacyclovir).

         The fact that methylprednisolone is used in such a trial implies that there is prior evidence or hypothesis supporting its potential therapeutic effect on vestibular neuronitis. However, it is important to note that indirect support does not equate to definitive proof; one must wait for the outcomes and analyses from such trials before making conclusive statements regarding treatment efficacy."
10801960,Methylprednisolone treats B-cell chronic lymphocytic leukemia,1275,High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities.,False,Is the triple 'Methylprednisolone treats B-cell chronic lymphocytic leukemia' supported by the sentence: 'High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities.'?,"No, the statement ""High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities"" does not provide direct support for the claim that ""Methylprednisolone treats B-cell chronic lymphocytic leukemia"" (CLL). The original statement is more specific in that it only refers to CLL patients who have p53 abnormalities, which is not representative of all CLL patients. Furthermore, achieving remission does not necessarily mean that the disease is being treated effectively in the long term; remission is merely an absence of disease symptoms at that particular moment. Therefore, additional evidence would be required to substantiate the broader claim that methylprednisolone can treat B-cell chronic lymphocytic leukemia in general."
10634179,Methylprednisolone treats Crohn disease,1276,An example of acute pancreatitis developing five weeks after initial treatment with 5-aminosalicylic acid (5-ASA) and methylprednisolone for severe Crohn's disease is reported in a 37 year old female patient.,False,Is the triple 'Methylprednisolone treats Crohn disease' supported by the sentence: 'An example of acute pancreatitis developing five weeks after initial treatment with 5-aminosalicylic acid (5-ASA) and methylprednisolone for severe Crohn's disease is reported in a 37 year old female patient.'?,"No, the statement does not provide direct or indirect support for the claim that methylprednisolone treats Crohn disease. The statement describes an adverse event (acute pancreatitis) that occurred in a patient being treated for Crohn's disease with both 5-aminosalicylic acid (5-ASA) and methylprednisolone. While methylprednisolone is sometimes used as part of a treatment regimen for Crohn disease due to its anti-inflammatory properties, it does not imply that methylprednisolone treats Crohn disease. The statement focuses on an adverse effect rather than therapeutic outcomes."
10341065,Methylprednisolone treats severe acute respiratory syndrome,1277,Twenty-nine of the 30 SARS patients were treated by methylprednisolone.,True,Is the triple 'Methylprednisolone treats severe acute respiratory syndrome' supported by the sentence: 'Twenty-nine of the 30 SARS patients were treated by methylprednisolone.'?,"Yes, the statement does provide indirect support for the claim that methylprednisolone treats severe acute respiratory syndrome (SARS). The fact that 29 out of 30 SARS patients were treated by methylprednisolone suggests that there is an association between methylprednisolone use and SARS treatment. However, it does not definitively prove causation; other factors could be influencing these results. Therefore, while it provides some level of support for the claim, further investigation would be required to make a definitive conclusion about methylprednisolone's effectiveness in treating SARS."
10289517,Methylprednisolone treats graft versus host disease,1278,"CASE SUMMARY: A 2-year-old white boy with a history of relapsed acute lymphoblastic leukemia underwent a bone marrow transplant and developed graft-versus-host disease, which was treated with methylprednisolone.",True,"Is the triple 'Methylprednisolone treats graft versus host disease' supported by the sentence: 'CASE SUMMARY: A 2-year-old white boy with a history of relapsed acute lymphoblastic leukemia underwent a bone marrow transplant and developed graft-versus-host disease, which was treated with methylprednisolone.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats graft versus host disease (GvHD). The case summary mentions that a patient who developed GvHD after a bone marrow transplant was treated with methylprednisolone. The fact that methylprednisolone was used as a treatment suggests that it is an accepted therapeutic option for GvHD. However, it is important to note that correlation does not imply causation; additional evidence would be needed to definitively establish that methylprednisolone is an effective treatment for GvHD.

         In the medical field, randomized controlled trials (RCTs) are often considered the gold standard for establishing causality between treatments and outcomes due to their ability to control for confounding factors. While the case summary provides some evidence for methylprednisolone as a treatment for GvHD, it does not have the same level of rigor as an RCT. Therefore, while it suggests that methylprednisolone may be an effective treatment for GvHD, further investigation would be needed to confirm its efficacy.

         It is also worth noting that methylprednisol"
10221573,Methylprednisolone treats myeloproliferative neoplasm,1279,The effects of HDMP should be explored in patients with other subtypes of AML who present with MT.,False,Is the triple 'Methylprednisolone treats myeloproliferative neoplasm' supported by the sentence: 'The effects of HDMP should be explored in patients with other subtypes of AML who present with MT.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone treats myeloproliferative neoplasm"". 

         The statement ""The effects of HDMP should be explored in patients with other subtypes of AML who present with MT"" is discussing High-Dose Methylprednisolone (HDMP) treatment in patients with certain subtypes of Acute Myeloid Leukemia (AML) who have Measurable Residual Disease (MRD). Myeloproliferative Neoplasms (MPNs) are a different type of hematological malignancy, unrelated to AML. Methylprednisolone is indeed a corticosteroid used in various medical treatments, but its use in treating MPNs is not supported by this statement."
10136260,Methylprednisolone treats acute lymphoblastic leukemia,1280,"We examined the effect of high-dose methylprednisolone (HDMP) on blast reduction rate and compared it to conventional dose steroid treatment, administered during the first 7+ days of the induction remission period in patients with acute lymphoblastic leukemia (ALL).",True,"Is the triple 'Methylprednisolone treats acute lymphoblastic leukemia' supported by the sentence: 'We examined the effect of high-dose methylprednisolone (HDMP) on blast reduction rate and compared it to conventional dose steroid treatment, administered during the first 7+ days of the induction remission period in patients with acute lymphoblastic leukemia (ALL).'?","Yes, indirectly it does lend some support to the claim that methylprednisolone treats acute lymphoblastic leukemia (ALL). The statement suggests that there was an examination of high-dose methylprednisolone (HDMP) on blast reduction rate in patients with ALL during the induction remission period. This implies that methylprednisolone is being used as a treatment for ALL since blast reduction is one of the primary goals in treating leukemia.

         However, it is important to note that while the statement supports methylprednisolone as part of the treatment regimen for ALL, it does not necessarily mean that methylprednisolone alone treats ALL. It is likely used in combination with other treatments as part of standard care for ALL patients during induction remission therapy.

         Furthermore, we don't have information about whether HDMP is more effective than conventional dose steroid treatment in terms of outcomes like overall survival rate, progression-free survival rate, etc., which could also impact our interpretation of methylprednisolone as an effective treatment for ALL."
10049014,"Methylprednisolone treats dermatitis, atopic",1281,"The objective of this multicentre, parallel, blinded, randomized controlled study was to evaluate the efficacy and the safety of cyclosporine (CsA group, 117 dogs) in comparison with methylprednisolone (MP group, 59 dogs) in the treatment of atopic dermatitis for 4 months.",True,"Is the triple 'Methylprednisolone treats dermatitis, atopic' supported by the sentence: 'The objective of this multicentre, parallel, blinded, randomized controlled study was to evaluate the efficacy and the safety of cyclosporine (CsA group, 117 dogs) in comparison with methylprednisolone (MP group, 59 dogs) in the treatment of atopic dermatitis for 4 months.'?","Yes, the statement does provide indirect support for the claim that ""Methylprednisolone treats dermatitis, atopic"". The study mentioned is designed to compare the efficacy and safety of cyclosporine and methylprednisolone in treating atopic dermatitis in dogs over four months. By participating in such a study as one of the treatment groups (MP group), methylprednisolone is being evaluated for its potential benefits in treating atopic dermatitis, implying its relevance for treating that condition.

         However, it is essential to highlight that indirect support does not equate to definitive proof that methylprednisolone is an effective treatment for atopic dermatitis. To establish such certainty, additional information such as the study results (statistical significance, effect size), potential side effects, and comparative analysis between methylprednisolone and other available treatments is necessary.

         In summary, while there is some level of support for methylprednisolone being useful for treating atopic dermatitis based on its inclusion in such a study, it does not definitively prove its efficacy without further contextual information about the"
9980473,Methylprednisolone treats immunoglobulin a vasculitis,1282,"CASE DESCRIPTION: A 33-year-old woman previously treated with methylprednisolone and cyclophosphamide for Henoch-Schonlein purpura was transferred from a referring hospital because of sore throat, fever, and chills.",False,"Is the triple 'Methylprednisolone treats immunoglobulin a vasculitis' supported by the sentence: 'CASE DESCRIPTION: A 33-year-old woman previously treated with methylprednisolone and cyclophosphamide for Henoch-Schonlein purpura was transferred from a referring hospital because of sore throat, fever, and chills.'?","No, the statement does not provide direct or indirect support for the claim that methylprednisolone treats immunoglobulin A vasculitis (IgAV), which is also known as Henoch-Schonlein purpura in some contexts. The statement describes a patient who has been previously treated for Henoch-Schonlein purpura using methylprednisolone and cyclophosphamide but does not provide information about the effectiveness of these treatments or their impact on IgAV specifically.

         The primary issue here is that correlation does not imply causation. While methylprednisolone may have been administered as part of treatment for IgAV in this particular case, it does not necessarily indicate that methylprednisolone was responsible for any positive effects observed in her condition. Additionally, since there is no mention of subsequent treatment response in the statement provided, it is impossible to infer any relationship between methylprednisolone use and IgAV improvement in this case.

         It is essential to base medical conclusions on rigorous clinical trials that demonstrate causality between treatments and outcomes rather than individual case descriptions alone. This helps ensure that any recommendations made for patient care are"
9720542,Methylprednisolone treats lupus nephritis,1283,The last significant breakthrough in the treatment of systemic lupus erythematosus (SLE) was the use of cyclophosphamide and methylprednisolone in the treatment of lupus nephritis.,True,Is the triple 'Methylprednisolone treats lupus nephritis' supported by the sentence: 'The last significant breakthrough in the treatment of systemic lupus erythematosus (SLE) was the use of cyclophosphamide and methylprednisolone in the treatment of lupus nephritis.'?,"Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats lupus nephritis"". The reason is that it mentions methylprednisolone as part of a significant breakthrough in treating lupus nephritis, which implies that methylprednisolone has some therapeutic effect on lupus nephritis. However, it should be noted that methylprednisolone is typically used in conjunction with other medications like cyclophosphamide for optimal treatment outcomes in lupus nephritis patients. Therefore, while methylprednisolone does have some efficacy in treating lupus nephritis, it is not usually used as a standalone treatment."
8761529,Methylprednisolone treats asthma,1284,Methylprednisolone suleptanate (Promedrol) is a prodrug of methylprednisolone being developed by Pharmacia Corp (formerly Pharmacia & Upjohn) for the treatment of asthma.,True,Is the triple 'Methylprednisolone treats asthma' supported by the sentence: 'Methylprednisolone suleptanate (Promedrol) is a prodrug of methylprednisolone being developed by Pharmacia Corp (formerly Pharmacia & Upjohn) for the treatment of asthma.'?,"Yes, there is indirect support for the claim that ""Methylprednisolone treats asthma"" based on the statement provided.

        

        Methylprednisolone is a corticosteroid medication commonly used for its anti-inflammatory effects in treating various conditions such as asthma, rheumatoid arthritis, and severe allergies. The statement mentions that Pharmacia Corp (formerly Pharmacia & Upjohn) is developing Methylprednisolone suleptanate (Promedrol), which is a prodrug of methylprednisolone. A prodrug is an inactive form of a drug that can be metabolically converted into its active form in the body after administration.

        

        Since Methylprednisolone suleptanate is being developed for treating asthma and it metabolizes into methylprednisolone in the body, it suggests that methylprednisolone has therapeutic benefits for asthma treatment. Thus, while not direct evidence, the statement does provide indirect support for the claim that methylprednisolone treats"
8588816,Methylprednisolone treats Bell's palsy,1285,"On these basis, we have studied the efficacity of parenteral association of 30 mg/Kg/j of Aciclovir and 1 mg/Kg/j of Methylprednisolone in the treatment of Bell's palsy with less than 12 days of evolution.",True,"Is the triple 'Methylprednisolone treats Bell's palsy' supported by the sentence: 'On these basis, we have studied the efficacity of parenteral association of 30 mg/Kg/j of Aciclovir and 1 mg/Kg/j of Methylprednisolone in the treatment of Bell's palsy with less than 12 days of evolution.'?","Yes, indirectly it does support that Methylprednisolone can be used in treating Bell's palsy, but it doesn't confirm that Methylprednisolone alone treats Bell's palsy. The statement provided mentions a study where patients with Bell's palsy of less than 12 days duration were treated with both Aciclovir (an antiviral medication) and Methylprednisolone (a corticosteroid). The fact that both these treatments were used together implies that Methylprednisolone may be an effective treatment for Bell's palsy when used in combination with other treatments, but it does not conclusively prove that Methylprednisolone is the sole effective treatment for Bell's palsy. 

         To establish whether Methylprednisolone treats Bell's palsy, one would need evidence from studies where Methylprednisolone was used alone as a treatment for Bell's palsy. The current statement does not provide such evidence, so while it suggests that Methylprednisolone may be an effective part of treatment for Bell's palsy"
8568939,Methylprednisolone treats myasthenia gravis,1286,"Treatment with methylprednisolone for myasthenia gravis was associated with a marked decrease in both biochemical markers of bone formation and resorption without any changes in endogenous cAMP and serum levels of calcium, PTH, and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3].",False,"Is the triple 'Methylprednisolone treats myasthenia gravis' supported by the sentence: 'Treatment with methylprednisolone for myasthenia gravis was associated with a marked decrease in both biochemical markers of bone formation and resorption without any changes in endogenous cAMP and serum levels of calcium, PTH, and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3].'?","No, the statement does not provide direct or indirect support for the claim that methylprednisolone treats myasthenia gravis. The statement focuses on changes in bone formation markers, endogenous cAMP, calcium, PTH (parathyroid hormone), and 1,25-(OH)2D3 levels in response to methylprednisolone treatment for myasthenia gravis patients. While these changes could be relevant for understanding methylprednisolone's side effects on bone health in treating myasthenia gravis, they do not provide evidence that methylprednisolone effectively treats myasthenia gravis itself.

         To provide indirect support for the claim that methylprednisolone treats myasthenia gravis, we would need evidence suggesting that patients experience an improvement in symptoms or overall well-being after taking methylprednisolone for myasthenia gravis treatment. However, the provided statement does not contain any information about patient outcomes in response to methylprednisolone treatment for myasthenia gravis."
8562694,Methylprednisolone treats endocrine exophthalmos,1287,PATIENTS AND METHODS: Fourteen euthyroid patients with severe Graves' ophthalmopathy were treated with high-dose intravenous methylprednisolone during 6 months and followed-up for 24-48 months by clinical and ophthalmological assessment.,True,Is the triple 'Methylprednisolone treats endocrine exophthalmos' supported by the sentence: 'PATIENTS AND METHODS: Fourteen euthyroid patients with severe Graves' ophthalmopathy were treated with high-dose intravenous methylprednisolone during 6 months and followed-up for 24-48 months by clinical and ophthalmological assessment.'?,"Yes, the statement does provide indirect support for the claim that methylprednisolone treats endocrine exophthalmos (a symptom of Graves' ophthalmopathy). The study mentions that 14 euthyroid patients with severe Graves' ophthalmopathy were treated with high-dose intravenous methylprednisolone over six months, followed by clinical and ophthalmological assessment for 24-48 months. The fact that such a study was conducted suggests that there is some basis for believing that methylprednisolone may have therapeutic effects on Graves' ophthalmopathy or its symptoms like endocrine exophthalmos.

        
        However, it is important to note that an observational study like this cannot definitively prove causation between methylprednisolone treatment and improvement in endocrine exophthalmos symptoms due to several possible confounding factors that were not controlled for in the study design. To establish more robust evidence for methylprednisolone as an effective treatment for endocrine exophthalmos, further randomized controlled trials would be necessary."
8503951,Methylprednisolone treats ulcerative colitis,1288,The current study evaluated the efficacy and safety of unfractionated heparin in the treatment of ulcerative colitis in comparison with methylprednisolone.,True,Is the triple 'Methylprednisolone treats ulcerative colitis' supported by the sentence: 'The current study evaluated the efficacy and safety of unfractionated heparin in the treatment of ulcerative colitis in comparison with methylprednisolone.'?,"Yes, based on the statement provided, there is indirect support for the claim that methylprednisolone treats ulcerative colitis. The study in question compared unfractionated heparin with methylprednisolone in treating ulcerative colitis, implying that methylprednisolone is being used as a treatment option for this condition. However, it is important to note that indirect support does not equate to definitive proof; further investigation would be necessary to establish a direct causal relationship between methylprednisolone use and improvement in ulcerative colitis symptoms."
8464737,Methylprednisolone treats kidney disorder,1289,"Post partum acute renal failure and type IV lupus nephropathy were treated with hemodialysis, methylprednisolone, cyclophosphamide and prednisone.",True,"Is the triple 'Methylprednisolone treats kidney disorder' supported by the sentence: 'Post partum acute renal failure and type IV lupus nephropathy were treated with hemodialysis, methylprednisolone, cyclophosphamide and prednisone.'?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats kidney disorder"". The fact that methylprednisolone was used in the treatment regimen for post partum acute renal failure and type IV lupus nephropathy suggests that it was considered beneficial in managing these kidney disorders. However, it is important to note that methylprednisolone was not used alone; it was part of a combination therapy that included hemodialysis, cyclophosphamide, and prednisone. This means that while methylprednisolone may have contributed to the treatment of the kidney disorders, its specific effects cannot be isolated from those of the other treatments. Additionally, it is unclear from the statement whether methylprednisolone was primarily responsible for treating the kidney disorders, or if it was used to manage other symptoms associated with lupus nephropathy. Therefore, while there is some support for the claim that methylprednisolone can treat kidney disorders based on this statement, it is indirect and qualified by these considerations."
8427466,Methylprednisolone treats sinusitis,1290,"To resolve the controversy over whether corticosteroids promote or inhibit the resolution of sinusitis, we present a prospective study of 80 rabbits with surgically introduced pseudomonal sinusitis that were then treated in one of four arms: control, ceftazidime, methylprednisolone, and ceftazidime with methylprednisolone.",False,"Is the triple 'Methylprednisolone treats sinusitis' supported by the sentence: 'To resolve the controversy over whether corticosteroids promote or inhibit the resolution of sinusitis, we present a prospective study of 80 rabbits with surgically introduced pseudomonal sinusitis that were then treated in one of four arms: control, ceftazidime, methylprednisolone, and ceftazidime with methylprednisolone.'?","No, the statement does not provide direct support for the claim that ""Methylprednisolone treats sinusitis."" The study examines the effects of corticosteroids on sinusitis resolution but does not specifically investigate methylprednisolone as a standalone treatment for sinusitis. Therefore, it only provides indirect evidence at best.

         The study investigates four different treatment arms (control, ceftazidime, methylprednisolone, and ceftazidime with methylprednisolone) in rabbits suffering from pseudomonal sinusitis. While it does provide valuable insights into how methylprednisolone may interact within these treatment regimens, it does not offer concrete evidence that methylprednisolone alone is an effective treatment for sinusitis in humans.

         Moreover, since rabbits do not naturally develop sinusitis like humans do, extrapolating these results directly to human patients should be done cautiously. Further investigation would be necessary before making any definitive conclusions regarding methylprednisolone as an effective treatment for sinusitis in humans."
8330903,Methylprednisolone treats systemic lupus erythematosus,1291,MAIN RESULTS: We found no randomised controlled trials comparing cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in the systemic lupus erythematosus.,False,Is the triple 'Methylprednisolone treats systemic lupus erythematosus' supported by the sentence: 'MAIN RESULTS: We found no randomised controlled trials comparing cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in the systemic lupus erythematosus.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone treats systemic lupus erythematosus."" The statement only mentions that there were no randomized controlled trials comparing cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus (SLE). It does not provide information about methylprednisolone's efficacy in treating SLE itself.

        To further elaborate on the nuances involved in interpreting such evidence:

        - The statement refers specifically to neuropsychiatric involvement in SLE, which may require different treatment approaches compared to SLE as a whole.
        - The lack of randomized controlled trials does not automatically imply that methylprednisolone is ineffective for treating SLE; it only highlights gaps in existing clinical trial data comparing methylprednisolone and cyclophosphamide for neuropsychiatric involvement in SLE.
        - A definitive assessment of methylprednisolone as an effective treatment for SLE would necessitate analyzing clinical trial results, observational studies, meta-analyses,"
8291810,Methylprednisolone treats pneumonia,1292,High-dose methylprednisolone was administered for treatment of the pneumonitis.,True,Is the triple 'Methylprednisolone treats pneumonia' supported by the sentence: 'High-dose methylprednisolone was administered for treatment of the pneumonitis.'?,"Yes, there is indirect support for the statement ""Methylprednisolone treats pneumonia"" in the provided statement ""High-dose methylprednisolone was administered for treatment of the pneumonitis.""

        The reason behind this is that pneumonitis is an inflammation of lung tissue which can be caused by infections like pneumonia (though not always). Methylprednisolone is a corticosteroid often used to reduce inflammation in various conditions including pneumonitis. While it does not directly kill bacteria or viruses causing pneumonia, it can help manage symptoms by controlling inflammation.

        Therefore, although not definitively proving that methylprednisolone treats pneumonia, it does suggest that methylprednisolone could play a therapeutic role in managing complications arising from pneumonia-induced pneumonitis. However, it is important to note that further investigation would be necessary to establish a direct causal relationship between methylprednisolone usage and recovery from pneumonia itself."
8227578,Methylprednisolone treats mucocutaneous lymph node syndrome,1293,"Additional antiinflammatory therapy, such as IV methylprednisolone and IV cyclophosphamide, may be helpful in treating persistent KD.",True,"Is the triple 'Methylprednisolone treats mucocutaneous lymph node syndrome' supported by the sentence: 'Additional antiinflammatory therapy, such as IV methylprednisolone and IV cyclophosphamide, may be helpful in treating persistent KD.'?","Yes, the statement ""Additional antiinflammatory therapy, such as IV methylprednisolone and IV cyclophosphamide, may be helpful in treating persistent KD"" does lend indirect support to the claim that ""Methylprednisolone treats mucocutaneous lymph node syndrome."" Kawasaki disease (KD) is an illness that can present mucocutaneous lymph node syndrome symptoms; therefore, using methylprednisolone as an antiinflammatory therapy for persistent KD suggests that it may be an effective treatment for mucocutaneous lymph node syndrome symptoms experienced in KD patients. However, it is essential to acknowledge that mucocutaneous lymph node syndrome is not exclusive to KD; therefore, further investigation is required before definitively concluding that methylprednisolone is an effective treatment for all instances of mucocutaneous lymph node syndrome."
8095661,Methylprednisolone treats carpal tunnel syndrome,1294,Injection with methylprednisolone for carpal tunnel syndrome.,True,Is the triple 'Methylprednisolone treats carpal tunnel syndrome' supported by the sentence: 'Injection with methylprednisolone for carpal tunnel syndrome.'?,"Yes, the statement ""Injection with methylprednisolone for carpal tunnel syndrome"" does provide indirect support for the phrase ""Methylprednisolone treats carpal tunnel syndrome."" The use of methylprednisolone in an injection form is a treatment method often employed in managing carpal tunnel syndrome symptoms. This implies that methylprednisolone has some therapeutic effect on carpal tunnel syndrome, thus lending support to the broader claim that it treats the condition. However, it is essential to consider that treatment and cure are two different concepts; while methylprednisolone may alleviate symptoms and provide temporary relief for carpal tunnel syndrome sufferers, it may not necessarily constitute a definitive cure for the condition."
8083160,Methylprednisolone treats thrombocytopenia,1295,"After a course of high-dose methylprednisolone therapy with a diagnosis of Evans syndrome, complete response for thrombocytopenia and partial response for anemia was achieved.",True,"Is the triple 'Methylprednisolone treats thrombocytopenia' supported by the sentence: 'After a course of high-dose methylprednisolone therapy with a diagnosis of Evans syndrome, complete response for thrombocytopenia and partial response for anemia was achieved.'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats thrombocytopenia. The statement indicates that a patient diagnosed with Evans syndrome (a disorder characterized by low platelet count or thrombocytopenia) received high-dose methylprednisolone therapy and achieved a complete response for thrombocytopenia. This suggests that methylprednisolone may have contributed to improving thrombocytopenia in this case. However, it is essential to note that correlation does not imply causation; thus, further studies would be required to establish methylprednisolone as an effective treatment for thrombocytopenia in general."
8063034,Methylprednisolone treats granulomatosis with polyangiitis,1296,We describe a 44-year-old man with Wegener's granulomatosis who was treated with cyclophosphamide and methylprednisolone and who subsequently developed bilateral CMVR.,True,Is the triple 'Methylprednisolone treats granulomatosis with polyangiitis' supported by the sentence: 'We describe a 44-year-old man with Wegener's granulomatosis who was treated with cyclophosphamide and methylprednisolone and who subsequently developed bilateral CMVR.'?,"Yes, there is indirect support for the claim that methylprednisolone treats granulomatosis with polyangiitis (GPA) from the statement provided. The patient in question was diagnosed with Wegener's granulomatosis (WG), which is a form of GPA, and was treated with both cyclophosphamide and methylprednisolone. The fact that they were administered these medications suggests that they were being used as part of a treatment regimen for GPA.

        

        However, it is important to note that correlation does not imply causation. The statement does not explicitly state that methylprednisolone was responsible for treating GPA in this case; it could have been cyclophosphamide, or both medications could have contributed to treating GPA in combination. Additionally, since GPA is an autoimmune disorder that can have severe complications such as bilateral cytomegalovirus retinitis (CMVR) in advanced stages, it is possible that methylprednisolone was used for managing symptoms related to GPA rather than as a direct treatment for GPA itself.

        

        Nonetheless,"
8018847,Methylprednisolone treats Pain,1297,A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.,True,Is the triple 'Methylprednisolone treats Pain' supported by the sentence: 'A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.'?,"Yes, based on the provided statement, there is indirect support for the claim that Methylprednisolone treats pain. The statement mentions a comparative trial between botulinum toxin type A and methylprednisolone for treating myofascial pain syndrome and pain from chronic muscle spasm. The fact that methylprednisolone is being compared in a trial for pain-related conditions suggests that it has some potential in treating pain. However, it is important to note that this does not constitute direct evidence as the statement does not explicitly state that methylprednisolone treats pain; it only implies it. Furthermore, the effectiveness of methylprednisolone in treating pain would depend on various factors such as dosage, duration of treatment, and the specific type of pain being addressed. Therefore, while there is some indirect support for the claim based on the provided statement, further investigation would be necessary to make a definitive conclusion."
7905007,Methylprednisolone treats chronic progressive multiple sclerosis,1298,OBJECTIVE: To determine if there are variables linked to responsiveness to pulse cyclophosphamide/methylprednisolone therapy in progressive Multiple Sclerosis (MS).,False,Is the triple 'Methylprednisolone treats chronic progressive multiple sclerosis' supported by the sentence: 'OBJECTIVE: To determine if there are variables linked to responsiveness to pulse cyclophosphamide/methylprednisolone therapy in progressive Multiple Sclerosis (MS).'?,"No, the statement does not provide direct or indirect support for the claim that ""Methylprednisolone treats chronic progressive multiple sclerosis"". The objective in question is focused on determining variables linked to responsiveness to pulse cyclophosphamide/methylprednisolone therapy in progressive Multiple Sclerosis (MS). This statement is about understanding factors influencing treatment response rather than providing evidence that methylprednisolone alone treats chronic progressive MS."
7853881,Methylprednisolone treats rheumatoid arthritis,1299,Oral low-dose glucocorticosteroids as compared with intravenous methylprednisolone pulses in the treatment of rheumatoid arthritis.,False,Is the triple 'Methylprednisolone treats rheumatoid arthritis' supported by the sentence: 'Oral low-dose glucocorticosteroids as compared with intravenous methylprednisolone pulses in the treatment of rheumatoid arthritis.'?,"No, the statement ""Oral low-dose glucocorticosteroids as compared with intravenous methylprednisolone pulses in the treatment of rheumatoid arthritis"" does not provide indirect support for the claim that ""Methylprednisolone treats rheumatoid arthritis.""

        

        The statement compares two different treatment methods for rheumatoid arthritis: oral low-dose glucocorticosteroids (GCs) versus intravenous methylprednisolone pulses (MPs). The study is not designed to evaluate the efficacy of methylprednisolone alone in treating rheumatoid arthritis but rather assesses its performance in comparison to another treatment option (oral GCs). Therefore, it does not offer any evidence supporting methylprednisolone as an effective monotherapy for rheumatoid arthritis.

        

        This interpretation is crucial when assessing scientific statements because misinterpreting evidence can lead to inaccurate conclusions that might negatively impact patient care or further research initiatives. In this case,"
7827490,Methylprednisolone treats optic neuritis,1300,CONCLUSIONS: The ONTT has led to a dramatic reduction in the use of oral prednisone without a preceding course of intravenous methylprednisolone in the treatment of acute optic neuritis.,True,Is the triple 'Methylprednisolone treats optic neuritis' supported by the sentence: 'CONCLUSIONS: The ONTT has led to a dramatic reduction in the use of oral prednisone without a preceding course of intravenous methylprednisolone in the treatment of acute optic neuritis.'?,"Yes, indirectly it does support that Methylprednisolone treats optic neuritis. The statement ""The ONTT has led to a dramatic reduction in the use of oral prednisone without a preceding course of intravenous methylprednisolone in the treatment of acute optic neuritis"" implies that intravenous methylprednisolone is an effective treatment for optic neuritis as its use has increased due to reduced use of oral prednisone. However, direct causality cannot be inferred from this statement alone as other factors may have contributed to this change in treatment approach."
7808987,Methylprednisolone treats autoimmune thrombocytopenic purpura,1301,CONCLUSION: A short intravenous course of high-dose methylprednisolone is effective as initial treatment of adults with ITP.,True,Is the triple 'Methylprednisolone treats autoimmune thrombocytopenic purpura' supported by the sentence: 'CONCLUSION: A short intravenous course of high-dose methylprednisolone is effective as initial treatment of adults with ITP.'?,"Yes, the statement ""A short intravenous course of high-dose methylprednisolone is effective as initial treatment of adults with ITP"" does lend indirect support to the claim that methylprednisolone treats autoimmune thrombocytopenic purpura (ITP). This is because autoimmune thrombocytopenic purpura is characterized by low platelet counts (thrombocytopenia) due to an immune system attack on platelets, making ITP an autoimmune disorder. Therefore, if high-dose methylprednisolone is effective in treating ITP as suggested by this conclusion, it implies that methylprednisolone has therapeutic value in addressing autoimmune conditions like ITP, providing indirect support for its utility in treating autoimmune thrombocytopenic purpura.

         However, it is important to note that direct support for treating autoimmune thrombocytopenic purpura would require more specific evidence targeting that particular condition rather than general autoimmune disorders in adults."
7700869,Methylprednisolone treats Edema,1302,"Lipid peroxidation and oedema in experimental brain injury: comparison of treatment with methylprednisolone, tirilazad mesylate and vitamin E.",True,"Is the triple 'Methylprednisolone treats Edema' supported by the sentence: 'Lipid peroxidation and oedema in experimental brain injury: comparison of treatment with methylprednisolone, tirilazad mesylate and vitamin E.'?","Yes, indirectly it does support the statement that Methylprednisolone treats Edema. The study mentioned compares different treatments for brain injury including Methylprednisolone, which suggests that Methylprednisolone was used in an attempt to treat edema (brain swelling) in experimental conditions. However, it doesn't provide direct evidence that Methylprednisolone is effective in treating edema under all circumstances. It is important to note that while animal studies can provide valuable insights, they do not always translate directly to human health outcomes due to differences in biological systems and responses. Therefore, further clinical studies would be needed to confirm Methylprednisolone's efficacy in treating edema in humans."
7668594,Methylprednisolone treats multiple sclerosis,1303,The same determinations were repeated on plasma and on CSF samples that were collected after the MS patients had ended a six-day treatment with high-dose methylprednisolone (MP).,False,Is the triple 'Methylprednisolone treats multiple sclerosis' supported by the sentence: 'The same determinations were repeated on plasma and on CSF samples that were collected after the MS patients had ended a six-day treatment with high-dose methylprednisolone (MP).'?,"No, the statement does not provide direct or indirect support for the claim that ""Methylprednisolone treats multiple sclerosis."" The statement only mentions that MS patients had undergone treatment with high-dose methylprednisolone (MP) for six days and that plasma and cerebrospinal fluid (CSF) samples were collected after treatment. It does not provide information about the treatment outcomes or whether methylprednisolone was responsible for any observed effects. To support the claim that methylprednisolone treats multiple sclerosis, there would need to be evidence showing that treatment leads to improvements in patients' conditions compared to no treatment or another form of treatment."
7649490,Methylprednisolone treats aplastic anemia,1304,"Neutropenic infections are the major cause of morbidity and mortality in the treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG), cyclosporin A (CSA), and methylprednisolone (MP).",True,"Is the triple 'Methylprednisolone treats aplastic anemia' supported by the sentence: 'Neutropenic infections are the major cause of morbidity and mortality in the treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG), cyclosporin A (CSA), and methylprednisolone (MP).'?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats aplastic anemia (AA). The key phrase here is ""and methylprednisolone (MP)"", which implies that methylprednisolone is one of the treatments used in managing AA alongside ALG and CSA. 

         However, it does not explicitly state that methylprednisolone treats AA directly but rather that it is part of the treatment regimen for AA. The statement is primarily discussing neutropenic infections as a major cause of morbidity and mortality in AA treatment, but it also inadvertently supports methylprednisolone's use in AA treatment due to its inclusion in the list of medications used.

         It is important to note that further investigation would be required to fully understand methylprednisolone's specific role in treating AA, as well as its efficacy compared to other treatments. This statement alone does not provide enough information for a definitive conclusion about methylprednisolone's therapeutic effect on AA."
7552935,Methylprednisolone treats Inflammation,1305,Methylprednisolone treatment resulted in the greatest reduction in the inflammatory cell infiltrate but the numbers of infected neurons did not increase concomitantly.,True,Is the triple 'Methylprednisolone treats Inflammation' supported by the sentence: 'Methylprednisolone treatment resulted in the greatest reduction in the inflammatory cell infiltrate but the numbers of infected neurons did not increase concomitantly.'?,"Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats Inflammation"". The statement indicates that Methylprednisolone treatment led to a reduction in inflammatory cell infiltrate. This suggests that Methylprednisolone has an anti-inflammatory effect, which aligns with the general understanding that it is used to treat inflammation. However, it's important to note that this doesn't necessarily mean that Methylprednisolone is specifically treating inflammation in this particular context, as the statement doesn't provide information about the overall condition or disease state being studied."
7483648,Methylprednisolone treats adult acute respiratory distress syndrome,1306,Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy.,True,Is the triple 'Methylprednisolone treats adult acute respiratory distress syndrome' supported by the sentence: 'Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy.'?,"Yes, the statement does provide indirect support for the claim that methylprednisolone treats adult acute respiratory distress syndrome (ARDS). The statement discusses a case where high-dose pulse methylprednisolone therapy was used to treat severe systemic inflammatory response syndrome (SIRS) with shock and ARDS resulting from Still's disease. This suggests that methylprednisolone may be an effective treatment for ARDS in certain contexts, such as when it is caused by Still's disease. However, it does not directly support the claim for all cases of adult ARDS, as the underlying cause and individual patient factors can significantly influence treatment outcomes. Therefore, while there is some support for the claim, it is not unconditional or universally applicable based on this statement alone."
7432980,Methylprednisolone treats myelodysplastic syndrome,1307,Eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia treated with pulsed methylprednisolone and antihistamines.,True,Is the triple 'Methylprednisolone treats myelodysplastic syndrome' supported by the sentence: 'Eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia treated with pulsed methylprednisolone and antihistamines.'?,"Yes, there is indirect support for the claim that methylprednisolone treats myelodysplastic syndrome (MDS) in this statement. The statement mentions that pulsed methylprednisolone was used to treat eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia. Myelodysplastic syndrome is one of the conditions listed in the statement, which suggests that methylprednisolone was used as part of the treatment regimen for MDS in this specific case. However, it is important to note that methylprednisolone may not be solely responsible for treating MDS in this context, as it was used in combination with antihistamines and in the presence of other conditions like autoimmune thyroid disease and eosinophilic fasciitis. Therefore, while there is some support for the claim that methylprednisolone can be used in treating MDS, further evidence is needed to establish its efficacy as a standalone treatment for MDS."
16097513,Cefotaxime treats osteomyelitis,1308,Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.,True,Is the triple 'Cefotaxime treats osteomyelitis' supported by the sentence: 'Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.'?,"Yes, the phrase ""Cefotaxime treats osteomyelitis"" does receive indirect support from the statement: ""Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.""

         The statement explicitly mentions Cefotaxime being used in the treatment of osteomyelitis, specifically chronic osteomyelitis caused by gram-negative bacilli. While it does not directly state that Cefotaxime treats osteomyelitis in general, it does support the claim that Cefotaxime can be used as an effective treatment for osteomyelitis under certain conditions (i.e., when caused by gram-negative bacilli). Therefore, we can infer that there is indirect support for the claim that Cefotaxime treats osteomyelitis based on this statement.

         However, it is important to note that osteomyelitis can be caused by various microorganisms, not only gram-negative bacilli but also gram-positive bacteria, fungi, and other pathogens. Therefore, while Cefotaxime has been shown to be effective in treating oste"
15119078,Cefotaxime treats peritonitis,1309,Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis.,False,Is the triple 'Cefotaxime treats peritonitis' supported by the sentence: 'Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis.'?,"No, the phrase ""Cefotaxime treats peritonitis"" does not receive direct support from the statement: ""Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis."" The statement only indicates that cefotaxime was part of a comparative study involving gram-negative spontaneous peritonitis in cirrhotic patients, but it does not explicitly claim that cefotaxime treats peritonitis nor provide evidence for its efficacy in treating peritonitis compared to other treatments like Aztreonam in the study. To make such an inference, one would need more information about the outcomes of the study and whether cefotaxime was found to be effective in treating peritonitis compared to Aztreonam or other treatments."
11176033,Cefotaxime treats Sepsis,1310,"Due to the apparent volumes of distribution obtained (ranging from 0.48 to 0.51 L/kg), considering the overall clinical efficacy obtained (90% for the 10 mg/kg dose and 75% for the 20 mg/kg dose), and due to the rapid improvement observed after a few doses of the drug (1.8 to 2.5 doses to 'clinical improvement'), it is safe to postulate such doses of cefotaxime as excellent choices for the treatment of septicaemia in dogs.",True,"Is the triple 'Cefotaxime treats Sepsis' supported by the sentence: 'Due to the apparent volumes of distribution obtained (ranging from 0.48 to 0.51 L/kg), considering the overall clinical efficacy obtained (90% for the 10 mg/kg dose and 75% for the 20 mg/kg dose), and due to the rapid improvement observed after a few doses of the drug (1.8 to 2.5 doses to 'clinical improvement'), it is safe to postulate such doses of cefotaxime as excellent choices for the treatment of septicaemia in dogs.'?","Yes, the statement does provide indirect support for the phrase ""Cefotaxime treats Sepsis"". The statement discusses a study where cefotaxime was administered to dogs with septicaemia (a type of sepsis) at two different doses. The results showed that both doses had high clinical efficacy (90% for 10 mg/kg dose and 75% for 20 mg/kg dose) and rapid improvement was observed after a few doses (1.8 to 2.5 doses for clinical improvement). The volumes of distribution obtained also fall within an acceptable range (0.48-0.51 L/kg). This suggests that cefotaxime is effective in treating septicaemia in dogs, thus providing indirect support for the claim that cefotaxime treats sepsis.

        
        However, it is important to note that while sepsis is often used interchangeably with septicaemia in veterinary medicine, they technically have slightly different meanings in human medicine. Sepsis is defined as life-th"
8153267,Cefotaxime treats bacterial infectious disease,1311,These results suggest that amoxicillin-clavulanic acid is an effective alternative to cefotaxime for the empirical treatment of bacterial infections in cirrhosis.,False,Is the triple 'Cefotaxime treats bacterial infectious disease' supported by the sentence: 'These results suggest that amoxicillin-clavulanic acid is an effective alternative to cefotaxime for the empirical treatment of bacterial infections in cirrhosis.'?,"No, the statement does not provide direct or indirect support for the phrase ""Cefotaxime treats bacterial infectious disease."" The statement discusses an alternative treatment option (amoxicillin-clavulanic acid) to cefotaxime in treating bacterial infections in cirrhosis patients specifically. This information does not confirm that cefotaxime is effective in treating bacterial infections in general, nor does it imply that cefotaxime is not an effective treatment for bacterial infections in other patient populations."
26980543,Ceftriaxone treats Lyme disease,1312,"Most children had received prolonged and repeated courses of oral antimicrobials and/or home intravenous infusion of antimicrobials; 79% had been hospitalized for treatment of suspected LD or management of treatment complications, most notably drug-induced symptoms of gallbladder disease occurring in patients receiving ceftriaxone (Rocephin), and bloodstream infections associated with intravenous catheters.",False,"Is the triple 'Ceftriaxone treats Lyme disease' supported by the sentence: 'Most children had received prolonged and repeated courses of oral antimicrobials and/or home intravenous infusion of antimicrobials; 79% had been hospitalized for treatment of suspected LD or management of treatment complications, most notably drug-induced symptoms of gallbladder disease occurring in patients receiving ceftriaxone (Rocephin), and bloodstream infections associated with intravenous catheters.'?","No, the statement does not provide indirect support for the claim that Ceftriaxone treats Lyme disease (LD). The passage describes symptoms and treatments experienced by children suspected of having Lyme disease, but it does not establish a causal link between Ceftriaxone (Rocephin) administration and successful treatment of Lyme disease.

        Although it is true that 79% of children in the study had received Ceftriaxone as part of their treatment regimen, there is no direct correlation made between those who received Ceftriaxone and recovery from Lyme disease. The passage also highlights potential side effects associated with Ceftriaxone use such as gallbladder disease symptoms and bloodstream infections related to intravenous catheters.

        Furthermore, it is important to base medical conclusions on rigorous clinical trials designed explicitly to test causal relationships between treatments (in this case Ceftriaxone) and specific outcomes (resolution of Lyme disease). Therefore, without more robust evidence linking Ceftriaxone use to successful treatment of Lyme disease, it would be inappropriate to make such assertions based solely on this passage."
26401802,Ceftriaxone treats Sepsis,1313,"Clinical study of Rocephin, a 3d generation cephalosporin, in various septicaemias.",True,"Is the triple 'Ceftriaxone treats Sepsis' supported by the sentence: 'Clinical study of Rocephin, a 3d generation cephalosporin, in various septicaemias.'?","Yes, indirectly it does lend some support. Rocephin is another name for Ceftriaxone, which is a third-generation cephalosporin antibiotic. The statement indicates that Rocephin has been studied in various septicaemias (a synonym for sepsis). However, it's important to note that while Ceftriaxone may be used to treat sepsis, it is not a definitive treatment for all cases. The appropriateness of its use would depend on various factors including the specific type of bacteria causing the sepsis, antibiotic resistance patterns, and the patient's overall health status. Therefore, while there is some support for the claim, it is not unequivocal and should be considered in context."
18413392,Ceftriaxone treats bacterial pneumonia,1314,"The objectives of this open, prospective, randomized and comparative study were to evaluate and compare the efficacy and safety of intravenous ceftriaxone (active ingredient of Rocephin) and cefotaxime in treatment of bacterial pneumoniae.",True,"Is the triple 'Ceftriaxone treats bacterial pneumonia' supported by the sentence: 'The objectives of this open, prospective, randomized and comparative study were to evaluate and compare the efficacy and safety of intravenous ceftriaxone (active ingredient of Rocephin) and cefotaxime in treatment of bacterial pneumoniae.'?","Yes, the statement does provide indirect support for the claim that Ceftriaxone treats bacterial pneumonia. The study mentioned in the statement is designed to evaluate and compare the efficacy (effectiveness) and safety of intravenous Ceftriaxone (active ingredient in Rocephin) and cefotaxime in treating bacterial pneumoniae. This implies that Ceftriaxone is being used as an intervention for bacterial pneumonia in the study design which suggests that it has potential therapeutic benefits for treating bacterial pneumonia. However, it is important to note that indirect support does not equate to definitive proof that Ceftriaxone treats bacterial pneumonia as further information about the study results is needed for such conclusions."
25810060,Gefarnate treats gastric ulcer,1315,Clinical trial of Gefarnate in the treatment of gastric ulcer disease.,True,Is the triple 'Gefarnate treats gastric ulcer' supported by the sentence: 'Clinical trial of Gefarnate in the treatment of gastric ulcer disease.'?,"Yes, the phrase ""Gefarnate treats gastric ulcer"" does receive indirect support from the statement: ""Clinical trial of Gefarnate in the treatment of gastric ulcer disease."" 

         The conduct of a clinical trial implies that there is some level of investigation into the potential therapeutic effects of Gefarnate on gastric ulcer disease. While this does not constitute definitive proof that Gefarnate is an effective treatment for gastric ulcers, it does suggest that there is some basis for such a claim, warranting further investigation. However, it is important to note that the effectiveness of Gefarnate for treating gastric ulcers would ultimately need to be determined by examining the results and methodology of the clinical trial in question, as well as any subsequent studies on the subject."
25784688,Gefarnate treats duodenal ulcer,1316,[Clinicobiological evolution of duodenal ulcer treated with gefarnate].,True,Is the triple 'Gefarnate treats duodenal ulcer' supported by the sentence: '[Clinicobiological evolution of duodenal ulcer treated with gefarnate].'?,"Yes, the phrase ""Gefarnate treats duodenal ulcer"" does receive indirect support from the statement: ""[Clinicobiological evolution of duodenal ulcer treated with gefarnate].""

         The title ""Clinicobiological evolution of duodenal ulcer treated with gefarnate"" suggests that gefarnate is being used as a treatment for duodenal ulcers in a clinical setting (clinical) and that there is some sort of biological response (biological) being studied over time (evolution). This implies that gefarnate may have some effect on duodenal ulcers; otherwise, it would not be included in the title of this study. However, it is important to note that indirect support does not equate to definitive proof, and further investigation would be necessary to draw concrete conclusions about gefarnate's efficacy in treating duodenal ulcers based solely on this statement."
19702373,Gefarnate treats peptic ulcer disease,1317,"One hundred and thirty-nine patients with endoscopically confirmed peptic ulcers (gastric and duodenal) entered a double blind comparative evaluation of alprazolam (1.2 mg/day), gefarnate (300 mg/day) and their combination in treatment of peptic ulcer.",True,"Is the triple 'Gefarnate treats peptic ulcer disease' supported by the sentence: 'One hundred and thirty-nine patients with endoscopically confirmed peptic ulcers (gastric and duodenal) entered a double blind comparative evaluation of alprazolam (1.2 mg/day), gefarnate (300 mg/day) and their combination in treatment of peptic ulcer.'?","Yes, the statement does provide indirect support for the claim that gefarnate treats peptic ulcer disease. The reason is that the patients in the study were diagnosed with peptic ulcers (gastric and duodenal) and were given gefarnate as part of their treatment regimen in a double-blind comparative evaluation against other treatments (alprazolam and their combination). The fact that gefarnate was used in a clinical trial for treating peptic ulcers implies that it has some potential therapeutic effect on peptic ulcers. However, it is essential to consider that indirect support does not equate to definitive proof; further investigation is necessary to establish gefarnate as an effective treatment for peptic ulcer disease conclusively."
22023951,Regadenoson treats coronary artery disorder,1318,CONCLUSIONS: Regadenoson may be a safe vasodilator for CTP and MR MPI in CAD patients.,True,Is the triple 'Regadenoson treats coronary artery disorder' supported by the sentence: 'CONCLUSIONS: Regadenoson may be a safe vasodilator for CTP and MR MPI in CAD patients.'?,"Yes, there is indirect support for the phrase ""Regadenoson treats coronary artery disorder"" in the statement: ""CONCLUSIONS: Regadenoson may be a safe vasodilator for CTP and MR MPI in CAD patients.""

        The statement suggests that Regadenoson is used as a vasodilator in patients with Coronary Artery Disease (CAD) for two medical imaging procedures: Cardiac Magnetic Resonance (MR) Myocardial Perfusion Imaging (MPI) and Computed Tomography Perfusion (CTP). A vasodilator like Regadenoson works by dilating blood vessels around the heart, which increases blood flow through the coronary arteries during imaging procedures.

        Indirectly, it implies that Regadenoson plays a crucial role in managing coronary artery disorder by improving blood flow in those vessels during diagnostic tests like CTP and MR MPI in CAD patients. However, it does not explicitly state that Regadenoson treats coronary artery disorder; rather it implies that Regadenoson is used as part of diagnostic procedures for CAD patients and"
13297277,Meldonium treats Ischemic stroke,1319,A study is presented of the clinico-hemodynamic efficacy of mildronate in 38 patients with ischemic stroke.,False,Is the triple 'Meldonium treats Ischemic stroke' supported by the sentence: 'A study is presented of the clinico-hemodynamic efficacy of mildronate in 38 patients with ischemic stroke.'?,"No, the statement does not provide direct or indirect support for the phrase ""Meldonium treats Ischemic stroke"". The study refers to mildronate, which is a different compound from meldonium. While both compounds share some similarities in their mechanisms of action, they cannot be used interchangeably in clinical contexts without further investigation into their specific effects on ischemic stroke patients. Therefore, it is inappropriate to infer that meldonium has been shown to treat ischemic stroke based solely on this information about mildronate."
25624167,Neobiotic treats pneumonia,1320,Use of neomycin for treatment of Rhodococcus equi pneumonia in foals.,True,Is the triple 'Neobiotic treats pneumonia' supported by the sentence: 'Use of neomycin for treatment of Rhodococcus equi pneumonia in foals.'?,"Yes, indirectly it does provide some support for the statement that ""Neobiotic treats pneumonia"". Neomycin is indeed an antibiotic (a type of neobiotic) and it is used in treating pneumonia caused by Rhodococcus equi in foals as per the statement provided. However, it is crucial to note that antibiotics are not universally effective against all types of pneumonia; their effectiveness depends on the specific causative agent. Therefore, while this statement supports the idea that neobiotics can be used to treat certain types of pneumonia, it does not necessarily mean that all neobiotics will be effective against all strains of pneumonia-causing pathogens."
11022701,Neobiotic treats bacterial infectious disease with sepsis,1321,Osteomyelitis of the cervical vertebras as a complication of urinary tract disease; Proteus bacteremia treated with neomycin.,True,Is the triple 'Neobiotic treats bacterial infectious disease with sepsis' supported by the sentence: 'Osteomyelitis of the cervical vertebras as a complication of urinary tract disease; Proteus bacteremia treated with neomycin.'?,"Yes, there is indirect support for the claim that ""Neobiotic treats bacterial infectious disease with sepsis"" based on the statement ""Osteomyelitis of the cervical vertebras as a complication of urinary tract disease; Proteus bacteremia treated with neomycin.""

        
        The statement indicates that Proteus bacteremia (a type of blood infection caused by Proteus bacteria) was treated using neomycin, which is an antibiotic (a type of Neobiotic). The infection in question is bacterial in nature, as it is caused by bacteria (Proteus), which falls under the category of infectious diseases.

        
        Although sepsis is not explicitly mentioned in the statement, bacteremia can lead to sepsis in severe cases as it involves bacterial infection in the bloodstream (as in bacteremia). Therefore, we can infer that neomycin was used to treat an infectious disease caused by bacteria (Proteus), which indirectly supports the claim that Neobiotics can treat bacterial infectious diseases with sepsis as a potential complication.

        
        However, it is important to note that this evidence"
24398401,BLINATUMOMAB treats B-cell chronic lymphocytic leukemia,1322,Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.,True,Is the triple 'BLINATUMOMAB treats B-cell chronic lymphocytic leukemia' supported by the sentence: 'Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.'?,"Yes, there is indirect support for the statement that ""BLINATUMOMAB treats B-cell chronic lymphocytic leukemia"" based on the provided reference ""Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy."" However, it is important to note that B-cell chronic lymphocytic leukemia (B-CLL) is not explicitly mentioned in this study; instead, it focuses on B-cell precursor acute leukemia (BCP-ALL).

        The study discusses how Blinatumomab therapy can lead to lineage conversion in BCP-ALL patients. Blinatumomab is an immunotherapy drug designed to target CD19-positive cells, which includes B-cells found in both BCP-ALL and B-CLL. Although B-CLL is not mentioned specifically in this study, it is possible that Blinatumomab may have similar effects on B-cells in B-CLL patients due to its mechanism of action against CD19-positive cells.

        Nonetheless,"
23073290,BLINATUMOMAB treats Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,1323,"We report on the Australian experience of blinatumomab for treatment of 24 children with relapsed/refractory precursor B-cell acute lymphoblastic leukaemia (B-ALL) and high-risk genetics, resulting in a minimal residual disease (MRD) response rate of 58%, 2-year progression-free survival (PFS) of 39% and 2-year overall survival of 63%.",True,"Is the triple 'BLINATUMOMAB treats Precursor B-Cell Lymphoblastic Leukemia-Lymphoma' supported by the sentence: 'We report on the Australian experience of blinatumomab for treatment of 24 children with relapsed/refractory precursor B-cell acute lymphoblastic leukaemia (B-ALL) and high-risk genetics, resulting in a minimal residual disease (MRD) response rate of 58%, 2-year progression-free survival (PFS) of 39% and 2-year overall survival of 63%.'?","Yes, the statement does provide indirect support for the claim that blinatumomab treats Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (B-ALL). The report details a study conducted on 24 children with relapsed/refractory B-ALL and high-risk genetics who were treated with blinatumomab. The results showed that 58% achieved minimal residual disease (MRD) response, which is indicative of treatment efficacy. Furthermore, 39% maintained progression-free survival (PFS) after two years, while 63% survived overall after two years. These findings suggest that blinatumomab has a positive impact on treating B-ALL in high-risk patients, providing support for the claim in question.

         However, it is important to note that while these results indicate that blinatumomab can be an effective treatment for B-ALL in certain cases, they do not definitively prove that blinatumomab ""treats"" B-ALL in all instances. Further studies would be"
21932754,BLINATUMOMAB treats acute lymphoblastic leukemia,1324,"Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.On November 15, 2018, the Committee for Medicinal Products for Human Use (CHMP) recommended the extension of indication for blinatumomab to include the treatment of adults with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukemia (ALL).",True,"Is the triple 'BLINATUMOMAB treats acute lymphoblastic leukemia' supported by the sentence: 'Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.On November 15, 2018, the Committee for Medicinal Products for Human Use (CHMP) recommended the extension of indication for blinatumomab to include the treatment of adults with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukemia (ALL).'?","Yes, the statement does provide indirect support for the claim that Blinatumomab treats acute lymphoblastic leukemia (ALL). The statement indicates that Blinatumomab has been approved by the European Medicines Agency (EMA) for treating adults with minimal residual disease (MRD) positive B-cell precursor ALL. This suggests that Blinatumomab is an effective treatment for ALL as it can eliminate residual disease in patients who have already undergone initial treatment. However, it is important to note that the statement does not explicitly state that Blinatumomab can cure ALL, but rather that it is effective in treating MRD positive B-cell precursor ALL."
21720587,BLINATUMOMAB treats lymphoma,1325,"Cytokine storm was reported in four patients (19%).In conclusion, treatment with blinatumomab is effective and tolerable in adult patients with relapsed/refractory B-ALL outside of a clinical trial stetting.",True,"Is the triple 'BLINATUMOMAB treats lymphoma' supported by the sentence: 'Cytokine storm was reported in four patients (19%).In conclusion, treatment with blinatumomab is effective and tolerable in adult patients with relapsed/refractory B-ALL outside of a clinical trial stetting.'?","Yes, the phrase ""BLINATUMOMAB treats lymphoma"" does receive indirect support from the statement provided. 

         The statement is from a study investigating the use of blinatumomab in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) outside of a clinical trial setting. Blinatumomab is a bispecific T-cell engager (BiTE) antibody construct that binds CD3-positive T cells to CD19-positive malignant B cells, thereby facilitating immune-mediated destruction of cancer cells.

         Although lymphoma is not explicitly mentioned in either the question or the statement, B-ALL is a type of hematological malignancy that originates from B lymphocytes—a subtype of lymphocytes that play a crucial role in the immune system. Therefore, it is reasonable to infer that blinatumomab may also have potential applications in treating lymphomas derived from B lymphocytes (e.g., B-cell non-Hodgkin lymph"
9387116,Ciprofloxacin physically interacts with DNA Gyrase,1326,"UNLABELLED: Ciprofloxacin, a quinolone antibiotic drug, binds to DNA topoisomerase IV and DNA gyrase of various bacteria.",True,"Is the triple 'Ciprofloxacin physically interacts with DNA Gyrase' supported by the sentence: 'UNLABELLED: Ciprofloxacin, a quinolone antibiotic drug, binds to DNA topoisomerase IV and DNA gyrase of various bacteria.'?","Yes, the phrase ""Ciprofloxacin physically interacts with DNA Gyrase"" does receive indirect support from the statement: ""UNLABELLED: Ciprofloxacin, a quinolone antibiotic drug, binds to DNA topoisomerase IV and DNA gyrase of various bacteria.""

        
        The key term here is ""binds,"" which implies a physical interaction between Ciprofloxacin and DNA gyrase (as well as topoisomerase IV). The statement does not provide explicit evidence for the nature of the interaction (e.g., covalent bonding versus non-covalent interactions), but it does indicate that Ciprofloxacin interacts physically with DNA gyrase in some capacity.

        
        This finding is significant because DNA gyrase plays an essential role in DNA replication by introducing negative supercoils into DNA molecules; thus, interference with its function can disrupt bacterial cell division and growth (Maxwell, 1997). Therefore, understanding how Ciprofloxacin interacts with DNA gyrase can help elucidate its"
8212496,Ciprofloxacin physically interacts with DNA Gyrase,1327,Topoisomerase IV and DNA gyrase were purified from a ciprofloxacin-sensitive Streptococcus pneumoniae strain and from two clinical isolates of S. pneumoniae with high-level resistance to ciprofloxacin by means of a gene cloning method in Escherichia coli.,False,Is the triple 'Ciprofloxacin physically interacts with DNA Gyrase' supported by the sentence: 'Topoisomerase IV and DNA gyrase were purified from a ciprofloxacin-sensitive Streptococcus pneumoniae strain and from two clinical isolates of S. pneumoniae with high-level resistance to ciprofloxacin by means of a gene cloning method in Escherichia coli.'?,"No, the statement does not provide direct support for the phrase ""Ciprofloxacin physically interacts with DNA Gyrase."" The provided information discusses the purification of topoisomerase IV and DNA gyrase from ciprofloxacin-sensitive and ciprofloxacin-resistant strains of Streptococcus pneumoniae using a gene cloning method in Escherichia coli. This statement demonstrates that these enzymes can be isolated from different strains of S. pneumoniae (sensitive and resistant) but does not offer any evidence regarding physical interactions between ciprofloxacin and DNA gyrase.

        However, it is important to note that ciprofloxacin is known to target DNA gyrase in bacteria as part of its antibiotic mechanism (it is a fluoroquinolone). This information is not provided in the statement but is based on prior knowledge in the field. To confirm whether ciprofloxacin physically interacts with DNA gyrase in these specific strains mentioned in the statement would require additional experiments such as in"
7781719,Ciprofloxacin affects DNA Gyrase,1328,"The concentrations of ciprofloxacin, sparfloxacin, levofloxacin, or ofloxacin required to inhibit wild-type topoisomerase IV were 8 to 16 times lower than those required to inhibit wild-type DNA gyrase.",True,"Is the triple 'Ciprofloxacin affects DNA Gyrase' supported by the sentence: 'The concentrations of ciprofloxacin, sparfloxacin, levofloxacin, or ofloxacin required to inhibit wild-type topoisomerase IV were 8 to 16 times lower than those required to inhibit wild-type DNA gyrase.'?","Yes, the statement does provide indirect support for the phrase ""Ciprofloxacin affects DNA Gyrase"". The statement indicates that ciprofloxacin is one of the drugs that inhibits wild-type topoisomerase IV at lower concentrations than those required to inhibit wild-type DNA gyrase. This suggests that ciprofloxacin has an effect on DNA gyrase, but it does so at higher concentrations compared to topoisomerase IV. Therefore, while the statement does not directly confirm that ciprofloxacin affects DNA gyrase, it provides indirect evidence supporting this claim."
18400322,Ciprofloxacin affects DNA Gyrase,1329,Plasmid-encoded protein QnrB1 protects DNA gyrase from ciprofloxacin inhibition.,True,Is the triple 'Ciprofloxacin affects DNA Gyrase' supported by the sentence: 'Plasmid-encoded protein QnrB1 protects DNA gyrase from ciprofloxacin inhibition.'?,"Yes, indirect support can be inferred from the statement ""Plasmid-encoded protein QnrB1 protects DNA gyrase from ciprofloxacin inhibition."" This implies that ciprofloxacin indeed targets DNA gyrase as suggested in the phrase ""Ciprofloxacin affects DNA Gyrase."" The protective action of QnrB1 against ciprofloxacin-induced inhibition indicates that ciprofloxacin typically inhibits DNA gyrase under normal circumstances in the absence of QnrB1. However, it is important to note that direct experimental evidence showing ciprofloxacin interacting with DNA gyrase would provide stronger support for the claim that ciprofloxacin affects DNA gyrase."
24010235,Ciprofloxacin treats chronic bronchitis,1330,"Thirty four patients with acute purulent exacerbations of chronic bronchitis were treated with 500 mg ciprofloxacin twice daily, orally, for ten days.",True,"Is the triple 'Ciprofloxacin treats chronic bronchitis' supported by the sentence: 'Thirty four patients with acute purulent exacerbations of chronic bronchitis were treated with 500 mg ciprofloxacin twice daily, orally, for ten days.'?","Yes, the statement does provide indirect support for the claim that ""Ciprofloxacin treats chronic bronchitis"". The reason is that it mentions 34 patients with acute purulent exacerbations of chronic bronchitis being treated with Ciprofloxacin for ten days. However, it is important to note that treating acute exacerbations does not necessarily mean that Ciprofloxacin treats chronic bronchitis itself; it may only help manage symptoms during exacerbations. Furthermore, it is crucial to consider other studies examining Ciprofloxacin's effectiveness in treating chronic bronchitis before making any definitive conclusions about its therapeutic utility in that context."
22484062,Ciprofloxacin treats amyotrophic lateral sclerosis,1331,"OBJECTIVE: To evaluate the efficacy of a fixed-dose combination of two approved drugs, Ciprofloxacin and Celecoxib, as a potential therapeutic treatment for amyotrophic lateral sclerosis (ALS).",False,"Is the triple 'Ciprofloxacin treats amyotrophic lateral sclerosis' supported by the sentence: 'OBJECTIVE: To evaluate the efficacy of a fixed-dose combination of two approved drugs, Ciprofloxacin and Celecoxib, as a potential therapeutic treatment for amyotrophic lateral sclerosis (ALS).'?","No, the statement ""Ciprofloxacin treats amyotrophic lateral sclerosis"" does not receive indirect support from the provided objective. The objective only mentions that researchers aim to evaluate the efficacy of a fixed-dose combination of Ciprofloxacin and Celecoxib as a potential therapeutic treatment for amyotrophic lateral sclerosis (ALS). It does not confirm that Ciprofloxacin treats ALS by itself nor does it provide evidence suggesting that Ciprofloxacin has any effect on ALS. Therefore, it is not appropriate to draw such conclusions based solely on this objective statement."
21488232,Ciprofloxacin treats Infection,1332,Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against    Mycobacterium tuberculosis    .The development of new antitubercular agents for the treatment of infections caused by multidrug-resistant (MDR)    Mycobacterium tuberculosis     is an urgent priority.,False,Is the triple 'Ciprofloxacin treats Infection' supported by the sentence: 'Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against    Mycobacterium tuberculosis    .The development of new antitubercular agents for the treatment of infections caused by multidrug-resistant (MDR)    Mycobacterium tuberculosis     is an urgent priority.'?,"No, the phrase ""Ciprofloxacin treats Infection"" does not receive direct support from the statement provided. The statement discusses a noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate that has activity against Mycobacterium tuberculosis, which is an important development in addressing infections caused by multidrug-resistant strains. However, it does not explicitly state that Ciprofloxacin itself treats infection in general; it only refers specifically to its potential use against Mycobacterium tuberculosis when conjugated with Pyrrolobenzodiazepine in a specific experimental context."
20040173,Ciprofloxacin treats lymphoma,1333,Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.,False,Is the triple 'Ciprofloxacin treats lymphoma' supported by the sentence: 'Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.'?,"No, the statement does not provide indirect support for the claim that ""Ciprofloxacin treats lymphoma."" The study mentioned is about antibacterial prophylaxis using ciprofloxacin for patients undergoing autologous haematopoietic cell transplantation, which includes patients with multiple myeloma and lymphoma. However, it does not imply that ciprofloxacin has any therapeutic effect on lymphoma itself. The purpose of administering ciprofloxacin in this context is to prevent bacterial infections during transplantation rather than treating lymphoma."
19067853,Ciprofloxacin treats B-cell chronic lymphocytic leukemia,1334,A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemia.,False,Is the triple 'Ciprofloxacin treats B-cell chronic lymphocytic leukemia' supported by the sentence: 'A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemia.'?,"No, the statement does not provide direct or indirect support for the claim that Ciprofloxacin treats B-cell chronic lymphocytic leukemia (B-CLL). 

         The statement describes a case of septic arthritis in a patient with chronic lymphatic leukemia (B-CLL), where the infecting Mycoplasma salivarium strain is resistant to Ciprofloxacin and Clarithromycin. This information suggests that Ciprofloxacin was ineffective against the Mycoplasma salivarium strain in this particular case, not that it has any therapeutic effect on B-CLL itself.

         In fact, it emphasizes that Ciprofloxacin is not effective against certain strains of bacteria in patients with B-CLL, which is an important distinction when discussing treatment options for patients with B-CLL infections. Therefore, this statement does not support, but rather contradicts, the claim that Ciprofloxacin is an effective treatment for B-cell chronic lymphocytic leukemia."
14572951,Ciprofloxacin treats hearing loss disorder,1335,Treatment with ciprofloxacin and ceftazidime improved the hearing loss significantly.,False,Is the triple 'Ciprofloxacin treats hearing loss disorder' supported by the sentence: 'Treatment with ciprofloxacin and ceftazidime improved the hearing loss significantly.'?,"No, the phrase ""Ciprofloxacin treats hearing loss disorder"" does not receive atertiary support from the statement: ""Treatment with ciprofloxacin and ceftazidime improved the hearing loss significantly."" The statement only indicates that there is an improvement in hearing loss after using both ciprofloxacin and ceftazidime together; it does not provide evidence that ciprofloxacin alone is responsible for treating hearing loss disorder. The claim should be limited to stating that ciprofloxacin may contribute to improving hearing loss when used in combination with other treatments like ceftazidime."
14398199,Ciprofloxacin treats sinusitis,1336,"CASE SUMMARY: A 24-year-old woman was admitted to the hospital because of convulsions, severe myopathy, and acute renal failure after taking ciprofloxacin for sinusitis, and urinary tract infections.",False,"Is the triple 'Ciprofloxacin treats sinusitis' supported by the sentence: 'CASE SUMMARY: A 24-year-old woman was admitted to the hospital because of convulsions, severe myopathy, and acute renal failure after taking ciprofloxacin for sinusitis, and urinary tract infections.'?","No, the statement does not provide indirect support for the claim that ""Ciprofloxacin treats sinusitis."" In fact, it suggests quite the opposite: that ciprofloxacin may have contributed to severe adverse effects in this patient who was taking it for sinusitis.

         The case summary describes a patient who experienced significant complications after taking ciprofloxacin for sinusitis and urinary tract infections. While ciprofloxacin is an antibiotic commonly used to treat various bacterial infections, including sinusitis, it is important to consider both its benefits and potential risks when evaluating its utility in any given situation.

         In this case, the patient developed severe complications that may be linked to ciprofloxacin use, including convulsions, myopathy (muscle weakness), and acute renal failure (kidney damage). These adverse effects highlight the importance of carefully considering each patient's unique health profile before prescribing ciprofloxacin or any other antibiotic.

         Therefore, based on the provided case summary, there is no evidence supporting"
14311974,Ciprofloxacin treats liver abscess (disease),1337,Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin.,True,Is the triple 'Ciprofloxacin treats liver abscess (disease)' supported by the sentence: 'Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin.'?,"Yes, indirectly it does support that statement because Ciprofloxacin was used in combination with Meropenem to treat Chromobacterium violaceum endocarditis and hepatic (liver) abscesses successfully in the given case study. However, it does not necessarily mean that Ciprofloxacin alone treats liver abscesses since it was used in conjunction with Meropenem for treatment in this particular instance.

        The statement ""Ciprofloxacin treats liver abscess (disease)"" is more definitive than what can be inferred from the original statement provided. In order to make such an assertion, we would need more extensive evidence demonstrating that Ciprofloxacin is an effective treatment for liver abscesses independent from other medications.

        In summary, while there is some evidence suggesting that Ciprofloxacin may be helpful in treating liver abscesses when used in combination with other drugs like Meropenem, it does not provide sufficient proof for claiming that Ciprofloxacin is an independent treatment for liver abscesses (dise"
14284683,Ciprofloxacin treats gastroenteritis,1338,"A patient is reported who had previously maintained a stable prothrombin time on Coumadin for 5 years, and who exhibited a marked prolongation of prothrombin time when placed on ciprofloxacin for gastroenteritis.",False,"Is the triple 'Ciprofloxacin treats gastroenteritis' supported by the sentence: 'A patient is reported who had previously maintained a stable prothrombin time on Coumadin for 5 years, and who exhibited a marked prolongation of prothrombin time when placed on ciprofloxacin for gastroenteritis.'?","No, the statement does not provide direct or indirect support for the claim that ""Ciprofloxacin treats gastroenteritis."" The statement describes an incident where a patient on Coumadin developed a prolonged prothrombin time after being administered Ciprofloxacin for gastroenteritis. This information relates to an adverse drug reaction between Ciprofloxacin and Coumadin but does not suggest that Ciprofloxacin has any therapeutic effect on gastroenteritis.

         To provide indirect support for the claim that ""Ciprofloxacin treats gastroenteritis,"" there would need to be evidence suggesting that Ciprofloxacin improved symptoms related to gastroenteritis or had an impact on its progression. The provided statement only discusses an unintended side effect associated with Ciprofloxacin use in this particular patient population.

         It is essential to differentiate between potential adverse drug reactions and therapeutic effects when interpreting such evidence. Misinterpreting an adverse drug reaction as evidence for therapeutic efficacy could lead to incorrect conclusions and"
14141218,Ciprofloxacin treats castration-resistant prostate carcinoma,1339,"Doxorubicin and docetaxel, two standard antineoplastic agents in hormone-refractory prostate cancer (HRPC) therapy and ciprofloxacin were evaluated singly and in several simultaneous and sequential drug combination schemes, against PC-3 and LNCaP cell lines.",False,"Is the triple 'Ciprofloxacin treats castration-resistant prostate carcinoma' supported by the sentence: 'Doxorubicin and docetaxel, two standard antineoplastic agents in hormone-refractory prostate cancer (HRPC) therapy and ciprofloxacin were evaluated singly and in several simultaneous and sequential drug combination schemes, against PC-3 and LNCaP cell lines.'?","No, the statement does not provide direct or indirect support for the claim that ""Ciprofloxacin treats castration-resistant prostate carcinoma."" The statement only mentions that ciprofloxacin was evaluated along with other drugs (doxorubicin and docetaxel) against PC-3 and LNCaP cell lines, which are models for prostate cancer, but it does not specify any results or effects of ciprofloxacin on castration-resistant prostate carcinoma. Therefore, further investigation and evidence would be required to establish such a claim."
14005051,Ciprofloxacin treats acute myeloid leukemia,1340,"Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.",False,"Is the triple 'Ciprofloxacin treats acute myeloid leukemia' supported by the sentence: 'Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.'?","No, the statement ""Ciprofloxacin treats acute myeloid leukemia"" does not receive indirect support from the provided statement: ""Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.""

         The reason is that while ciprofloxacin is indeed mentioned as part of the combination therapy being studied in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), the statement does not specify which component(s) of the therapy contribute(s) to its efficacy nor does it imply that ciprofloxacin is an effective treatment for AML when used alone.

         In fact, ciprofloxacin is an antibiotic primarily used for treating bacterial infections; it is not typically used as a primary treatment for AML. Therefore, without further information about how ciprofloxacin contributes to the therapy's effectiveness in treating AML"
13846017,Ciprofloxacin treats lung disorder,1341,High dose parenteral ciprofloxacin in pleuro-pulmonary disease: a comparative pharmacolinetics of 400 and 200 mg intravenous.,False,Is the triple 'Ciprofloxacin treats lung disorder' supported by the sentence: 'High dose parenteral ciprofloxacin in pleuro-pulmonary disease: a comparative pharmacolinetics of 400 and 200 mg intravenous.'?,"No, the statement ""High dose parenteral ciprofloxacin in pleuro-pulmonary disease: a comparative pharmacokinetics of 400 and 200 mg intravenous"" does not provide direct or indirect support for the phrase ""Ciprofloxacin treats lung disorder"". 

        The statement in question is a comparative pharmacokinetics study on different doses of Ciprofloxacin administered intravenously in pleuro-pulmonary disease patients. This study investigates how Ciprofloxacin is absorbed, distributed, metabolized, and excreted in the body at different doses in patients suffering from pleuro-pulmonary diseases. It does not provide any information about whether Ciprofloxacin is effective in treating lung disorders; it only studies its pharmacokinetic behavior in these patients.

        Therefore, further studies investigating Ciprofloxacin's therapeutic efficacy in treating lung disorders would be required for supporting the claim that ""Ciprofloxacin treats lung disorder""."
13663890,Ciprofloxacin treats otitis media,1342,[Pneumococcal meningitis during ciprofloxacin therapy for otitis media].,False,Is the triple 'Ciprofloxacin treats otitis media' supported by the sentence: '[Pneumococcal meningitis during ciprofloxacin therapy for otitis media].'?,"No, the statement does not provide direct or indirect support for the claim that ""Ciprofloxacin treats otitis media."" The provided statement discusses an incident where pneumococcal meningitis occurred during ciprofloxacin therapy for otitis media, but it does not imply that ciprofloxacin is an effective treatment for otitis media. In fact, ciprofloxacin is not commonly used as a first-line treatment for otitis media due to its higher cost and broader spectrum compared to other antibiotics more specific for common otitis media pathogens (e.g., amoxicillin for Streptococcus pneumoniae). The statement could even be interpreted as suggesting that ciprofloxacin may not be an optimal choice for treating otitis media if it allows for complications like pneumococcal meningitis in certain cases. Therefore, it is essential to base conclusions on direct evidence rather than assuming indirect support from potentially unrelated observations."
11840711,Ciprofloxacin treats cataract,1343,"CONCLUSIONS: Ofloxacin has higher corneal penetration and ability to exceed MIC90 of common ocular contaminants than ciprofloxacin, and would be a more appropriate prophylactic choice for canine cataract patients.",False,"Is the triple 'Ciprofloxacin treats cataract' supported by the sentence: 'CONCLUSIONS: Ofloxacin has higher corneal penetration and ability to exceed MIC90 of common ocular contaminants than ciprofloxacin, and would be a more appropriate prophylactic choice for canine cataract patients.'?","No, the statement does not provide indirect support for the claim that ""Ciprofloxacin treats cataract."" The conclusion drawn in the statement is about Ofloxacin being a more appropriate prophylactic choice for canine cataract patients due to its higher corneal penetration and ability to exceed minimum inhibitory concentrations (MIC90) of common ocular contaminants compared to Ciprofloxacin. This information is related to Ofloxacin's antibacterial properties and its effectiveness in preventing infections in canine cataract patients rather than treating cataracts itself. Cataracts are primarily treated through surgical intervention rather than antibiotics like Ciprofloxacin."
11684450,Ciprofloxacin treats cystitis,1344,Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.,True,Is the triple 'Ciprofloxacin treats cystitis' supported by the sentence: 'Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.'?,"Yes, the statement ""Ciprofloxacin treats cystitis"" does receive indirect support from the title ""Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial."" This is because it mentions ciprofloxacin as one of the treatment options for cystitis in its title. However, it is important to note that direct support would require analyzing the results and conclusions drawn from that specific study as well as any other relevant evidence in order to determine if ciprofloxacin is indeed an effective treatment for cystitis compared to other antibiotics like Amoxicillin-clavulanate."
11679354,Ciprofloxacin treats Pseudomonas infection,1345,We used a simple Wood's light examination and culture to establish the diagnosis of Pseudomonas toe web infection and achieved rapid resolution with oral ciprofloxacin treatment and local application of Castellani's paint.,True,Is the triple 'Ciprofloxacin treats Pseudomonas infection' supported by the sentence: 'We used a simple Wood's light examination and culture to establish the diagnosis of Pseudomonas toe web infection and achieved rapid resolution with oral ciprofloxacin treatment and local application of Castellani's paint.'?,"Yes, the statement does provide indirect support for the claim that ""Ciprofloxacin treats Pseudomonas infection"". The statement mentions that oral ciprofloxacin treatment was used in conjunction with local application of Castellani's paint to achieve rapid resolution of a Pseudomonas toe web infection. This implies that the ciprofloxacin was effective in treating the infection, which aligns with the claim that ciprofloxacin can treat Pseudomonas infections. However, it's important to note that this is an observational study involving a single case, so further research involving larger sample sizes would be needed to confirm these results."
11628762,Ciprofloxacin treats endophthalmitis,1346,Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!,True,Is the triple 'Ciprofloxacin treats endophthalmitis' supported by the sentence: 'Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!'?,"Yes, the statement ""Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!"" does lend indirect support to the phrase ""Ciprofloxacin treats endophthalmitis."" The title suggests that ciprofloxacin can be used as an alternative treatment for endophthalmitis, which implies that it has some efficacy in treating this condition. However, it is important to note that direct support would require more specific evidence demonstrating the positive effects of ciprofloxacin on endophthalmitis in controlled studies. This statement only suggests that it may be considered as an alternative treatment option among other antibiotics like ceftazidime and amikacin for endophthalmitis patients."
11564697,Ciprofloxacin treats chronic obstructive pulmonary disease,1347,Reported here is the case of a patient with underlying chronic obstructive pulmonary disease (COPD) in whom ciprofloxacin treatment of a lower respiratory tract infection failed subsequent to ciprofloxacin treatment of an exacerbation of COPD several weeks earlier.,False,Is the triple 'Ciprofloxacin treats chronic obstructive pulmonary disease' supported by the sentence: 'Reported here is the case of a patient with underlying chronic obstructive pulmonary disease (COPD) in whom ciprofloxacin treatment of a lower respiratory tract infection failed subsequent to ciprofloxacin treatment of an exacerbation of COPD several weeks earlier.'?,"No, the statement does not provide indirect support for the claim that ciprofloxacin treats chronic obstructive pulmonary disease (COPD). In fact, it suggests quite the contrary. The statement describes a patient with COPD who received ciprofloxacin treatment for lower respiratory tract infections on two separate occasions; however, it points out that ciprofloxacin treatment failed during the second instance. This implies that ciprofloxacin may not be effective in treating COPD exacerbations in some cases and does not offer any evidence supporting its use as a treatment for COPD itself.

        
        To further clarify, ciprofloxacin is an antibiotic commonly used to treat bacterial infections but has not been established as a primary treatment for COPD. COPD is primarily managed through lifestyle modifications (such as smoking cessation), bronchodilators, corticosteroids, and pulmonary rehabilitation programs. Antibiotics like ciprofloxacin may be prescribed if there is evidence of bacterial infection in COPD exacerbations; however, they"
11304087,Ciprofloxacin treats eye infectious disorder,1348,This PK-MB model may be very useful in optimizing treatments of various eye infections with ciprofloxacin.,True,Is the triple 'Ciprofloxacin treats eye infectious disorder' supported by the sentence: 'This PK-MB model may be very useful in optimizing treatments of various eye infections with ciprofloxacin.'?,"Yes, indirectly it does lend support to that statement because both statements discuss ciprofloxacin as an effective treatment for eye infections. The first statement suggests that ciprofloxacin can treat eye infectious disorders while the second statement implies that understanding pharmacokinetics (PK) and pharmacodynamics (MB) would help optimize ciprofloxacin treatments for various eye infections.

         However, it is important to note that while these statements suggest ciprofloxacin may be useful for treating eye infections based on its antimicrobial properties, they do not provide direct evidence that ciprofloxacin is effective in treating specific eye infections in clinical settings. Further investigation involving controlled clinical trials would be required to provide more robust evidence on its effectiveness for treating various eye infections."
11059709,Ciprofloxacin treats abscess,1349,"The patient was asymptomatic for a month, but the abscess reactivated and was treated with Vancomycin and Ciprofloxacin administered intravenously.",True,"Is the triple 'Ciprofloxacin treats abscess' supported by the sentence: 'The patient was asymptomatic for a month, but the abscess reactivated and was treated with Vancomycin and Ciprofloxacin administered intravenously.'?","Yes, the statement does provide indirect support for the phrase ""Ciprofloxacin treats abscess"". This is because Ciprofloxacin was used as part of the treatment regimen for an abscess that had reactivated in the patient mentioned in the statement. However, it is important to note that Ciprofloxacin was used in conjunction with Vancomycin, which suggests that Ciprofloxacin may not be effective as a sole treatment for abscesses under certain circumstances. Additionally, it is not clear from the statement whether the reactivation was due to antibiotic resistance or failure of initial treatment. Therefore, while there is some support for the claim, it is not unequivocal and should be interpreted in the context of other available evidence."
10087799,Ciprofloxacin treats bacterial infectious disease,1350,"Fluoroquinolones such as ciprofloxacin, levofloxacin, moxifloxacin and gatifloxacin are widely used for the treatment of bacterial infections.",True,"Is the triple 'Ciprofloxacin treats bacterial infectious disease' supported by the sentence: 'Fluoroquinolones such as ciprofloxacin, levofloxacin, moxifloxacin and gatifloxacin are widely used for the treatment of bacterial infections.'?","Yes, the statement ""Fluoroquinolones such as ciprofloxacin, levofloxacin, moxifloxacin and gatifloxacin are widely used for the treatment of bacterial infections"" does provide indirect support for the claim that ""Ciprofloxacin treats bacterial infectious disease."" This is because ciprofloxacin is explicitly listed as one of the fluoroquinolones used for treating bacterial infections. However, it is important to note that saying ciprofloxacin treats bacterial infections is more specific than what is supported by the given statement; therefore, it is an indirect support rather than direct evidence for that claim."
10013051,Ciprofloxacin treats plague,1351,There are no previous reports of plague being successfully treated with ciprofloxacin.,False,Is the triple 'Ciprofloxacin treats plague' supported by the sentence: 'There are no previous reports of plague being successfully treated with ciprofloxacin.'?,"No, the statement ""There are no previous reports of plague being successfully treated with ciprofloxacin"" does not provide indirect support for the claim that ""Ciprofloxacin treats plague."" In fact, it suggests the opposite: that there is no established evidence supporting the use of ciprofloxacin as an effective treatment for plague. This is an important distinction when interpreting scientific evidence: the absence of proof is not equivalent to proof of absence. Therefore, further investigation would be required before making any definitive conclusions about ciprofloxacin as a potential treatment for plague."
10002223,Ciprofloxacin treats anthrax infection,1352,Treatment and post-exposure prophylaxis for anthrax are ciprofloxacin or doxycycline.,True,Is the triple 'Ciprofloxacin treats anthrax infection' supported by the sentence: 'Treatment and post-exposure prophylaxis for anthrax are ciprofloxacin or doxycycline.'?,"Yes, the phrase ""Ciprofloxacin treats anthrax infection"" does receive indirect support from the statement: ""Treatment and post-exposure prophylaxis for anthrax are ciprofloxacin or doxycycline."" The statement implies that ciprofloxacin is an approved treatment for anthrax infections since it is listed as an option for both treatment and post-exposure prophylaxis. However, it is essential to acknowledge that ciprofloxacin is not exclusively used for treating anthrax infections; other drugs like doxycycline can also be employed for treatment.

         In summary, while the evidence does not provide direct support for ciprofloxacin specifically treating anthrax infections, it does suggest that ciprofloxacin is an approved treatment option for anthrax infections as part of a larger group of antibiotics used for treatment."
9704134,Ciprofloxacin treats bronchiectasis,1353,"He had severe airway obstruction and focal bronchiectasis, and responded to treatment with ciprofloxacin and clarithromycin.",True,"Is the triple 'Ciprofloxacin treats bronchiectasis' supported by the sentence: 'He had severe airway obstruction and focal bronchiectasis, and responded to treatment with ciprofloxacin and clarithromycin.'?","Yes, while not explicitly stated, the provided statement does lend indirect support to the claim that ""Ciprofloxacin treats bronchiectasis"". The patient in question had bronchiectasis as well as severe airway obstruction, which improved after treatment involving ciprofloxacin and clarithromycin. The improvement in symptoms after treatment suggests that ciprofloxacin was effective in treating the bronchiectasis to some degree. However, it is important to note that ciprofloxacin was used in conjunction with clarithromycin, making it difficult to attribute the positive outcome solely to ciprofloxacin without further investigation.

        
        Bronchiectasis is often associated with bacterial infections, which ciprofloxacin - an antibiotic - is designed to treat. The drug is known for its activity against various bacteria that can cause respiratory tract infections (RTI). By targeting these infectious agents, ciprofloxacin can potentially reduce inflammation in airways caused by bacterial infections, thereby alleviating symptoms related to bronchie"
9552171,Ciprofloxacin treats otitis externa,1354,"The objective of this study was to evaluate and compare the efficacy of topical otic powder, tobramycin drops and ciprofloxacin drops in patients suffering from AEO.",True,"Is the triple 'Ciprofloxacin treats otitis externa' supported by the sentence: 'The objective of this study was to evaluate and compare the efficacy of topical otic powder, tobramycin drops and ciprofloxacin drops in patients suffering from AEO.'?","Yes, the statement ""Ciprofloxacin treats otitis externa"" does receive indirect support from the provided statement. The study in question was designed to compare the efficacy of various treatments for Acute External Otitis (AEO), one of which is ciprofloxacin drops. The fact that ciprofloxacin was included in a study investigating treatments for otitis externa suggests that it has some therapeutic potential for this condition. However, it is important to note that indirect support does not equate to definitive proof. To establish a stronger causal link between ciprofloxacin and treatment of otitis externa, one would need to examine additional evidence such as clinical trial results, meta-analyses, or systematic reviews demonstrating its efficacy compared to other treatments or placebo controls."
9504629,Ciprofloxacin treats Sepsis,1355,Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?,False,Is the triple 'Ciprofloxacin treats Sepsis' supported by the sentence: 'Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?'?,"No, the statement ""Ciprofloxacin treats Sepsis"" does not receive direct or indirect support from the title ""Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?"" 

         The title discusses pharmacokinetic profiles, which refers to how a drug is absorbed, distributed, metabolized, and excreted in the body (often abbreviated as ADME). It focuses on paediatric sepsis patients specifically. The title does not provide any information about Ciprofloxacin treating sepsis; it only raises questions about dosing in paediatric sepsis patients.

         It is important to note that while Ciprofloxacin is an antibiotic used for various bacterial infections, sepsis is not typically treated with antibiotics alone but rather through broader supportive care that may include antibiotics among other treatments. Therefore, even if there was evidence in the paper linking Ciprofloxacin dosing in sepsis patients, it would not necessarily imply"
9281470,Ciprofloxacin treats prostatitis,1356,The emergence and evolution of quinolone-resistant Escherichia coli in faeces of patients with prostatitis treated with high-dose oral ciprofloxacin for 1 month were studied.,False,Is the triple 'Ciprofloxacin treats prostatitis' supported by the sentence: 'The emergence and evolution of quinolone-resistant Escherichia coli in faeces of patients with prostatitis treated with high-dose oral ciprofloxacin for 1 month were studied.'?,"No, the statement does not provide indirect support for the claim that ""Ciprofloxacin treats prostatitis."" The study investigates the emergence and evolution of quinolone-resistant Escherichia coli in faeces of patients treated with high-dose oral ciprofloxacin for one month in relation to prostatitis. It does not evaluate or provide evidence for the effectiveness of Ciprofloxacin in treating prostatitis itself. The statement only highlights potential side-effects (development of resistant bacterial strains) associated with the use of Ciprofloxacin in treating prostatitis patients without addressing its therapeutic benefits for treating prostatitis symptoms."
8956827,Ciprofloxacin treats Abdominal Infection,1357,"Ciprofloxacin is effective in the treatment of serious, non-self-limiting intra-abdominal infections, peritonitis in CAPD, pelvic inflammatory disease, endometritis and gall-bladder infections.",True,"Is the triple 'Ciprofloxacin treats Abdominal Infection' supported by the sentence: 'Ciprofloxacin is effective in the treatment of serious, non-self-limiting intra-abdominal infections, peritonitis in CAPD, pelvic inflammatory disease, endometritis and gall-bladder infections.'?","Yes, the phrase ""Ciprofloxacin treats Abdominal Infection"" does receive indirect support from the statement: ""Ciprofloxacin is effective in the treatment of serious, non-self-limiting intra-abdominal infections, peritonitis in CAPD, pelvic inflammatory disease, endometritis and gall-bladder infections."" 

         The statement includes ""serious, non-self-limiting intra-abdominal infections"" as one of the conditions treated by Ciprofloxacin. Intra-abdominal infections can include abdominal infections such as appendicitis, peritonitis, and cholecystitis among others. Therefore, it can be inferred that Ciprofloxacin is indeed used for treating certain types of abdominal infections based on this information. However, it is important to note that not all abdominal infections would be treated by Ciprofloxacin as it depends on the specific bacterial infection causing the abdominal issue."
8754779,Ciprofloxacin treats rhinoscleroma,1358,We report on a young patient with nasal rhinoscleroma who achieved resolution after treatment with oral ciprofloxacin.,True,Is the triple 'Ciprofloxacin treats rhinoscleroma' supported by the sentence: 'We report on a young patient with nasal rhinoscleroma who achieved resolution after treatment with oral ciprofloxacin.'?,"Yes, the statement ""We report on a young patient with nasal rhinoscleroma who achieved resolution after treatment with oral ciprofloxacin"" does provide indirect support for the claim that ""Ciprofloxacin treats rhinoscleroma."" This is because it describes an instance where ciprofloxacin was used in the treatment of a patient with rhinoscleroma, and the patient experienced resolution of their symptoms following treatment.

         However, it is important to note that while this provides some evidence for the effectiveness of ciprofloxacin in treating rhinoscleroma, it does not definitively prove that ciprofloxacin is an effective treatment for rhinoscleroma in all cases. A single case report like this does not provide enough evidence to make broad generalizations about treatment efficacy due to factors such as individual variability in patient response to treatment, potential confounding factors in treatment outcomes, and other methodological considerations that may impact the interpretation of results from an individual case report.

         Therefore, while this statement does provide some support for the claim that ciprofloxacin treats rhinos"
8350437,Ciprofloxacin treats pyelonephritis,1359,Is a 7-day course of ciprofloxacin effective in the treatment of uncomplicated pyelonephritis in women?,True,Is the triple 'Ciprofloxacin treats pyelonephritis' supported by the sentence: 'Is a 7-day course of ciprofloxacin effective in the treatment of uncomplicated pyelonephritis in women?'?,"Yes, the phrase ""Ciprofloxacin treats pyelonephritis"" does receive indirect support from the statement: ""Is a 7-day course of ciprofloxacin effective in the treatment of uncomplicated pyelonephritis in women?""

        

        The statement implies that ciprofloxacin is an effective treatment for uncomplicated pyelonephritis in women when given in a 7-day course. Pyelonephritis is a type of kidney infection that falls under the broader category of urinary tract infections (UTIs). Ciprofloxacin is an antibiotic commonly used to treat various types of bacterial infections, including UTIs caused by susceptible organisms like Escherichia coli (E. coli).

        

        Although the statement does not explicitly mention that ciprofloxacin treats pyelonephritis, it supports the idea that ciprofloxacin can be an effective treatment for pyelonephritis by demonstrating its efficacy in treating uncomplicated cases"
8337570,Ciprofloxacin treats bacterial infectious disease with sepsis,1360,"Despite prolonged bacteremia, the response to long-term therapy with ciprofloxacin and rifampin was excellent.",True,"Is the triple 'Ciprofloxacin treats bacterial infectious disease with sepsis' supported by the sentence: 'Despite prolonged bacteremia, the response to long-term therapy with ciprofloxacin and rifampin was excellent.'?","Yes, indirectly it does support that statement. Ciprofloxacin is an antibiotic that belongs to the class of fluoroquinolones which are known for their effectiveness against various types of bacterial infections. Sepsis is one such condition where bacteremia (bacteria in blood) occurs leading to life-threatening organ dysfunction if not treated promptly.

         In the provided statement, despite the presence of prolonged bacteremia (which implies severe infection), treatment using ciprofloxacin along with rifampin led to an excellent response. This suggests that ciprofloxacin contributes positively towards managing bacterial infectious diseases including sepsis as it helps in clearing bacterial infections in the body when used appropriately in combination therapy as seen here in conjunction with rifampin.

         However, it is important to note that while ciprofloxacin can be used for treating sepsis caused by certain bacteria, it may not be effective against all types of bacteria causing sepsis due to antimicrobial resistance issues. Also, like all medications, ciprofloxacin can"
8194797,Ciprofloxacin treats neutropenia,1361,The proportion of patients who developed neutropenia and fever was 87% in the group treated with ciprofloxacin and 78% in the group treated with ciprofloxacin and rifampin (P =.25).,False,Is the triple 'Ciprofloxacin treats neutropenia' supported by the sentence: 'The proportion of patients who developed neutropenia and fever was 87% in the group treated with ciprofloxacin and 78% in the group treated with ciprofloxacin and rifampin (P =.25).'?,"No, the statement does not provide indirect support for the phrase ""Ciprofloxacin treats neutropenia."" The provided information is about a study where two groups of patients were treated with either ciprofloxacin alone or ciprofloxacin combined with rifampin. The statement highlights that there is no significant difference (P = .25) in the proportion of patients who developed neutropenia and fever between these two groups.

         In fact, it can be inferred that ciprofloxacin alone might not be effective in treating neutropenia since there is no significant difference between the group receiving only ciprofloxacin and the group receiving both ciprofloxacin and rifampin. To support the claim that ""Ciprofloxacin treats neutropenia,"" there should be evidence showing that ciprofloxacin reduces the incidence or severity of neutropenia compared to a placebo or no treatment."
8190776,Ciprofloxacin treats peritonitis,1362,"Peritonitis due to S. aureus ESI was significantly less frequent among patients treated with ciprofloxacin (1 vs 9 cases, p = 0.001).",True,"Is the triple 'Ciprofloxacin treats peritonitis' supported by the sentence: 'Peritonitis due to S. aureus ESI was significantly less frequent among patients treated with ciprofloxacin (1 vs 9 cases, p = 0.001).'?","Yes, the statement ""Peritonitis due to S. aureus ESI was significantly less frequent among patients treated with ciprofloxacin (1 vs 9 cases, p = 0.001)"" does provide indirect support for the claim that ""Ciprofloxacin treats peritonitis."" The key here is that there is a lower incidence rate (1 case vs 9 cases) in patients treated with ciprofloxacin compared to those not treated with it, which suggests that ciprofloxacin has an impact on peritonitis. However, it is important to note that correlation does not imply causation, so further studies would be needed to definitively establish that ciprofloxacin treats peritonitis based on these results alone. Additionally, it should be considered that peritonitis can be caused by various organisms, not solely S. aureus ESI, so additional studies would need to evaluate ciprofloxacin's effectiveness against other causative agents as well."
8088120,Ciprofloxacin treats Fever,1363,"In the current study, the authors examined the use of ciprofloxacin as outpatient management in selected patients with fever during an episode of neutropenia.",False,"Is the triple 'Ciprofloxacin treats Fever' supported by the sentence: 'In the current study, the authors examined the use of ciprofloxacin as outpatient management in selected patients with fever during an episode of neutropenia.'?","No, the phrase ""Ciprofloxacin treats Fever"" does not receive direct support from the statement: ""In the current study, the authors examined the use of ciprofloxacin as outpatient management in selected patients with fever during an episode of neutropenia."" 

         The statement indicates that ciprofloxacin was used in managing fever during neutropenia episodes, but it does not explicitly state that ciprofloxacin treats fever. The study might have been focused on its use for preventing infections due to neutropenia rather than treating fever itself. Furthermore, fever can be a symptom of various conditions, so treating fever does not necessarily mean treating its underlying cause. Therefore, more specific information is needed to conclude that ciprofloxacin treats fever based on this statement alone."
7880629,Ciprofloxacin treats osteomyelitis,1364,"The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) for the treatment of chronic osteomyelitis were analyzed.",True,"Is the triple 'Ciprofloxacin treats osteomyelitis' supported by the sentence: 'The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) for the treatment of chronic osteomyelitis were analyzed.'?","Yes, the statement does provide indirect support for the claim that ""Ciprofloxacin treats osteomyelitis."" The reason is that the statement mentions ciprofloxacin as one of the oral fluoroquinolones that were analyzed for their efficacy and safety in treating chronic osteomyelitis. This suggests that ciprofloxacin is being considered in the context of treating osteomyelitis, providing indirect support for its use in this capacity. However, it is important to note that indirect support does not equate to definitive proof; for that, one would need to examine the results and conclusions of the study being referenced."
7798648,Ciprofloxacin treats cystic fibrosis,1365,"As juveniles are especially sensitive, use of these drugs in paediatrics should be restricted to carefully selected indications (such as the use of ciprofloxacin in cystic fibrosis).",True,"Is the triple 'Ciprofloxacin treats cystic fibrosis' supported by the sentence: 'As juveniles are especially sensitive, use of these drugs in paediatrics should be restricted to carefully selected indications (such as the use of ciprofloxacin in cystic fibrosis).'?","Yes, the statement does provide indirect support for the phrase ""Ciprofloxacin treats cystic fibrosis."" The key phrase indicating this is ""the use of ciprofloxacin in cystic fibrosis."" This implies that ciprofloxacin has been identified as having some therapeutic benefit in treating cystic fibrosis, even if it is not a primary treatment method. However, it should be noted that the statement also suggests that its use should be restricted to carefully selected indications, implying that while it may have some positive effects, its use should be approached with caution due to potential side effects or other concerns."
7544699,Ciprofloxacin treats diarrheal disease,1366,The aim of this study was to investigate clinical importance of ciprofloxacin efficacy in treatment of massive diarrhoea in patients after extensional bowel resection with removing of ileo-coecal valve (EBR + ICVR).,False,Is the triple 'Ciprofloxacin treats diarrheal disease' supported by the sentence: 'The aim of this study was to investigate clinical importance of ciprofloxacin efficacy in treatment of massive diarrhoea in patients after extensional bowel resection with removing of ileo-coecal valve (EBR + ICVR).'?,"No, the statement does not provide direct support for the claim that ""Ciprofloxacin treats diarrheal disease"". The study mentioned aims to investigate the clinical importance of Ciprofloxacin efficacy in treating massive diarrhea in specific patients who have undergone certain surgical procedures (EBR + ICVR). This is not equivalent to stating that Ciprofloxacin is a treatment for diarrheal disease in general because it does not cover all types of diarrheal diseases or patients who have not undergone these specific surgical procedures.

         However, if positive results were found in this study, it could potentially provide indirect evidence supporting Ciprofloxacin as an effective treatment for diarrhea in patients who have undergone EBR + ICVR procedures. But even in that case, further studies would be required before making generalized statements about Ciprofloxacin treating diarrheal diseases beyond that specific context."
7423320,Ciprofloxacin treats typhoid fever,1367,"To compare clinical and bacteriological efficacies of azithromycin and ciprofloxacin for typhoid fever, 123 adults with fever and signs of uncomplicated typhoid fever were entered into a randomized trial.",False,"Is the triple 'Ciprofloxacin treats typhoid fever' supported by the sentence: 'To compare clinical and bacteriological efficacies of azithromycin and ciprofloxacin for typhoid fever, 123 adults with fever and signs of uncomplicated typhoid fever were entered into a randomized trial.'?","No, the statement does not provide direct support for the claim that ""Ciprofloxacin treats typhoid fever."" The provided statement describes a randomized trial comparing clinical and bacteriological efficacies between azithromycin and ciprofloxacin for treating typhoid fever in adults. The statement does not explicitly claim that ciprofloxacin treats typhoid fever; it only mentions its use in comparison to another antibiotic for treating typhoid fever patients in the trial.

        
        To establish more robust support for the claim that ciprofloxacin treats typhoid fever, one would need additional evidence from the study (such as positive outcomes in ciprofloxacin-treated patients) or other sources that demonstrate ciprofloxacin's efficacy in treating typhoid fever specifically."
7337248,Ciprofloxacin treats pneumonia,1368,Initial treatment of severe pneumonia with ciprofloxacin resulted in significantly less subsequent gram-negative infection and was associated with substantially lower curative costs.,True,Is the triple 'Ciprofloxacin treats pneumonia' supported by the sentence: 'Initial treatment of severe pneumonia with ciprofloxacin resulted in significantly less subsequent gram-negative infection and was associated with substantially lower curative costs.'?,"Yes, the statement ""Initial treatment of severe pneumonia with ciprofloxacin resulted in significantly less subsequent gram-negative infection and was associated with substantially lower curative costs"" does lend indirect support to the claim that ""Ciprofloxacin treats pneumonia."" 

         The statement suggests that ciprofloxacin is an effective treatment for severe pneumonia as it leads to less subsequent gram-negative infection, which is often a complication in pneumonia cases. Furthermore, it is associated with lower curative costs, implying that it may be a cost-effective treatment option for severe pneumonia. However, it is important to note that while this statement suggests that ciprofloxacin can be an effective treatment for pneumonia, it does not necessarily prove that it is the sole treatment agent as pneumonia can be caused by various pathogens, some of which may not respond to ciprofloxacin."
7228759,Ciprofloxacin treats infectious disease,1369,"Ciprofloxacin (CIP), a fluoroquinolone antibacterial drug, is widely used in the treatment of serious infections in humans.",True,"Is the triple 'Ciprofloxacin treats infectious disease' supported by the sentence: 'Ciprofloxacin (CIP), a fluoroquinolone antibacterial drug, is widely used in the treatment of serious infections in humans.'?","Yes, the phrase ""Ciprofloxacin treats infectious disease"" does receive indirect support from the statement: ""Ciprofloxacin (CIP), a fluoroquinolone antibacterial drug, is widely used in the treatment of serious infections in humans.""

         The statement indicates that Ciprofloxacin is an antibacterial drug used for treating serious infections in humans. Antibacterial drugs like Ciprofloxacin function by inhibiting bacterial growth or killing bacteria; thus, they can be used in treating infectious diseases caused by bacteria. The term ""infections"" implies that there is an invasion by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites; however, in the given context, it is clear that Ciprofloxacin is specifically used for treating bacterial infections, which constitute infectious diseases treatable by Ciprofloxacin.

         Nonetheless, it is essential to highlight that Ciprofloxacin is not effective against infections caused by viruses, fungi, or parasites; hence its use should be"
7163480,Ciprofloxacin treats Crohn disease,1370,Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.,True,Is the triple 'Ciprofloxacin treats Crohn disease' supported by the sentence: 'Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.'?,"Yes, indirect support can be inferred from the statement ""Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin."" This suggests that ciprofloxacin has been used in treating active Crohn's disease, but it does not explicitly state that ciprofloxacin treats Crohn disease. The use of antibiotics like ciprofloxacin in treating active Crohn's disease is supported by various clinical trials that demonstrate short-term benefits in treating fistulizing disease (Haberman et al., 2014). However, more recent evidence suggests that long-term use may not be beneficial (Sands et al., 2019).

        Haberman et al., (2014) Antibiotics for inducing and maintaining remission in Crohn’s disease. Cochrane Database Syst Rev., 11:CD004826

        Sands BE et al., (2019) Maintenance Antibiotic Therapy in Crohn’s Disease: A System"
10607698,Chloramphenicol treats bacterial infectious disease,1371,[Experiences with a chloramphenicol preparation for intramuscular injection in bacterial infections of the CNS].,True,Is the triple 'Chloramphenicol treats bacterial infectious disease' supported by the sentence: '[Experiences with a chloramphenicol preparation for intramuscular injection in bacterial infections of the CNS].'?,"Yes, the statement does provide indirect support for the phrase ""Chloramphenicol treats bacterial infectious disease"". The reason is that it mentions chloramphenicol being used in bacterial infections specifically located in the Central Nervous System (CNS). This implies that chloramphenicol was administered as a treatment for bacterial infections in general, thus lending some support to its efficacy in treating bacterial infectious diseases. However, it is important to note that direct support would require more specific evidence regarding its effectiveness in treating bacterial infections, such as clinical trial results, dosage information, and more detailed accounts of its impact on patients' health outcomes."
9528501,Chloramphenicol treats osteomyelitis,1372,A 2-month-old infant with Enterobacter osteomyelitis complicating total parenteral nutrition was successfully treated with rifampicin and chloramphenicol.,True,Is the triple 'Chloramphenicol treats osteomyelitis' supported by the sentence: 'A 2-month-old infant with Enterobacter osteomyelitis complicating total parenteral nutrition was successfully treated with rifampicin and chloramphenicol.'?,"Yes, indirectly it does support that statement because chloramphenicol was used in combination with rifampicin to treat an infant suffering from Enterobacter osteomyelitis associated with total parenteral nutrition (TPN). The success of treatment in this case suggests that chloramphenicol has some therapeutic effect on osteomyelitis caused by Enterobacter species. However, it is essential to note that chloramphenicol was not used alone in treating osteomyelitis in this case; hence its specific efficacy cannot be definitively concluded from this statement alone.

        
        The use of chloramphenicol for osteomyelitis treatment is not widespread due to its adverse side effects, such as bone marrow suppression and grey baby syndrome in neonates; hence other antibiotics like rifampicin might be preferred in clinical settings1. Nevertheless, based on the information provided in the statement, chloramphenicol can be considered as one of the antibiotics that can be used for treating osteomyelitis caused by Enterobacter species when administered in combination therapy2.

        
        In summary, while chlor"
7351604,Chloramphenicol treats eye infectious disorder,1373,"The writers consult a wide range of American, European and British research from 1950 to the present to reassure readers that ophthalmic chloramphenicol is a demonstrably effective, safe, cost-effective treatment for most superficial eye infections.",True,"Is the triple 'Chloramphenicol treats eye infectious disorder' supported by the sentence: 'The writers consult a wide range of American, European and British research from 1950 to the present to reassure readers that ophthalmic chloramphenicol is a demonstrably effective, safe, cost-effective treatment for most superficial eye infections.'?","Yes, the statement does provide indirect support for the phrase ""Chloramphenicol treats eye infectious disorder"". The writers consulted a wide range of research from 1950 to present, covering American, European, and British studies on ophthalmic chloramphenicol as an effective treatment for most superficial eye infections. This implies that chloramphenicol has been studied extensively in various contexts over several decades and has demonstrated efficacy in treating eye infections. However, it is important to note that further investigation is necessary for more direct support since the statement does not explicitly mention chloramphenicol treating eye infectious disorders but rather its effectiveness as a treatment for superficial eye infections specifically.

         To strengthen the claim that chloramphenicol treats eye infectious disorders more generally, additional evidence should be gathered from primary sources that specifically focus on chloramphenicol's impact on various eye infections, as well as its potential side effects and cost-effectiveness compared to alternative treatments. Additionally, understanding the specific mechanisms through which chloramphenicol combats eye infections would contribute valuable insight into its utility as an infection treatment.

         In conclusion, while there is"
24500158,Rebamipide treats gastroesophageal reflux disease,1374,Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease.,False,Is the triple 'Rebamipide treats gastroesophageal reflux disease' supported by the sentence: 'Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease.'?,"No, the statement does not provide direct or indirect support for the claim that rebamipide treats gastroesophageal reflux disease (GERD). The provided statement only mentions rebamipide as one of the drugs used for peptic ulcer and GERD, focusing on its adverse events compared to other drugs, not its therapeutic efficacy in treating GERD.

         To provide indirect support for the claim that rebamipide treats GERD, we would need evidence suggesting its superiority over other drugs in treating GERD symptoms or unique therapeutic properties specifically targeting GERD pathophysiology. However, since no such information is provided in the given statement, we cannot infer any support for rebamipide as an effective treatment for GERD based on it alone."
19949890,Rebamipide treats osteoarthritis,1375,We also discuss the potential role of rebamipide to serve as a new strategy for the treatment of TMJ-OA.,True,Is the triple 'Rebamipide treats osteoarthritis' supported by the sentence: 'We also discuss the potential role of rebamipide to serve as a new strategy for the treatment of TMJ-OA.'?,"Yes, the statement ""We also discuss the potential role of rebamipide to serve as a new strategy for the treatment of TMJ-OA"" does provide indirect support for the claim that ""Rebamipide treats osteoarthritis."" This is because osteoarthritis (OA) is a specific type of joint disorder that can affect various parts of the body including temporomandibular joints (TMJ), which is what TMJ-OA refers to. Since rebamipide is being discussed as having potential therapeutic benefits for TMJ-OA, it suggests that rebamipide may help manage osteoarthritis symptoms in general. However, it is important to note that more direct evidence would be required to definitively conclude that rebamipide treats osteoarthritis in all cases, as TMJ-OA might have unique characteristics that make rebamipide particularly suitable for it."
19364844,Rebamipide treats dry eye syndrome,1376,CONCLUSIONS: REB and DQS may be effective for the management of dry eye syndrome after PK in terms of ocular surface findings.,True,Is the triple 'Rebamipide treats dry eye syndrome' supported by the sentence: 'CONCLUSIONS: REB and DQS may be effective for the management of dry eye syndrome after PK in terms of ocular surface findings.'?,"Yes, there is indirect support for the statement ""Rebamipide treats dry eye syndrome"" based on the conclusion provided in the study involving REB (Rebamipide) and DQS (Diquafosol sodium). The conclusion states that REB and DQS may be effective for managing dry eye syndrome after photorefractive keratectomy (PRK) in terms of ocular surface findings.

         However, it is important to note that while this study demonstrates potential benefits for Rebamipide in treating dry eye syndrome in specific circumstances (i.e., after PK), it does not necessarily confirm that Rebamipide is an effective treatment for dry eye syndrome in all cases. Further studies would be required to make such an assertion.

         Additionally, it is crucial to consider that Rebamipide may not be the sole active ingredient in treating dry eye syndrome in this study as Diquafosol sodium is also mentioned as an effective compound for managing dry eye syndrome in combination with Rebamipide.

         In summary, while there is some evidence pointing towards Rebamipide being an effective treatment for dry eye syndrome based on this study, more extensive investigations should"
13211904,Rebamipide treats ulcerative colitis,1377,"OBJECTIVE AND DESIGN: Since rebamipide is effective for the treatment of ulcerative colitis (UC), we examined the involvement of hepatocyte growth factor (HGF) in the action of rebamipide.",True,"Is the triple 'Rebamipide treats ulcerative colitis' supported by the sentence: 'OBJECTIVE AND DESIGN: Since rebamipide is effective for the treatment of ulcerative colitis (UC), we examined the involvement of hepatocyte growth factor (HGF) in the action of rebamipide.'?","Yes, based on the statement provided, there is indirect support for the claim that rebamipide treats ulcerative colitis (UC). The objective of the study mentioned in the statement is to examine the involvement of hepatocyte growth factor (HGF) in the action of rebamipide, which implies that rebamipide has an action in UC - thus treating it. However, it is important to note that indirect support does not equate to definitive proof, and further investigation would be necessary to fully substantiate this claim."
12062800,Rebamipide treats peptic ulcer disease,1378,"Rebamipide, a gastro-protective drug, was developed in Japan for the treatment of peptic ulcer disease.",True,"Is the triple 'Rebamipide treats peptic ulcer disease' supported by the sentence: 'Rebamipide, a gastro-protective drug, was developed in Japan for the treatment of peptic ulcer disease.'?","Yes, the statement ""Rebamipide treats peptic ulcer disease"" does receive indirect support from the statement: ""Rebamipide, a gastro-protective drug, was developed in Japan for the treatment of peptic ulcer disease.""

         The key term here is ""gastro-protective,"" which refers to substances that protect the stomach lining from damage or ulcers. Rebamipide has been specifically developed for treating peptic ulcer disease as per the given statement. Therefore, it can be inferred that rebamipide does indeed treat peptic ulcer disease based on its gastro-protective properties and its intended purpose for development. However, it is important to note that while indirect support is provided through this statement alone, direct evidence from clinical trials or other empirical studies would be necessary for definitive proof."
10368387,Rebamipide treats gastric ulcer,1379,Rebamipide is a mucoprotective drug used for the treatment of gastric ulcers.,True,Is the triple 'Rebamipide treats gastric ulcer' supported by the sentence: 'Rebamipide is a mucoprotective drug used for the treatment of gastric ulcers.'?,"Yes, the statement ""Rebamipide is a mucoprotective drug used for the treatment of gastric ulcers"" does provide indirect support for the phrase ""Rebamipide treats gastric ulcer."" 

         The key term here is ""used for the treatment,"" which implies that Rebamipide has been demonstrated to have beneficial effects in treating gastric ulcers. The mucoprotective property of Rebamipide suggests that it works by forming a protective layer on the gastric mucosa, thereby promoting healing and preventing further damage from gastric acid and pepsin. This mechanism of action supports the claim that Rebamipide treats gastric ulcers. However, it is important to note that indirect support is not as strong as direct evidence from clinical trials specifically designed to test the efficacy of Rebamipide in treating gastric ulcers."
8102739,Rebamipide treats gastritis,1380,"In conclusion, rebamipide may attenuate H. pylori-induced gastric inflammation by inhibiting lipid peroxidation and oxidant-mediated activation of NF-kappaB and thereby decreasing IL-8 production.",True,"Is the triple 'Rebamipide treats gastritis' supported by the sentence: 'In conclusion, rebamipide may attenuate H. pylori-induced gastric inflammation by inhibiting lipid peroxidation and oxidant-mediated activation of NF-kappaB and thereby decreasing IL-8 production.'?","Yes, the statement does provide indirect support for the claim that rebamipide treats gastritis. The conclusion suggests that rebamipide may attenuate H. pylori-induced gastric inflammation by inhibiting lipid peroxidation and oxidant-mediated activation of NF-kappaB, which in turn decreases IL-8 production. This implies that rebamipide has anti-inflammatory properties that could potentially be beneficial in treating gastritis, an inflammation of the stomach lining often caused by H. pylori infections. However, it is important to note that while this evidence supports rebamipide's potential therapeutic use in gastritis, it does not definitively prove that rebamipide treats gastritis as it does not mention any clinical improvements in patients diagnosed with gastritis."
27610972,DINUTUXIMAB treats bone osteosarcoma,1381,Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.,False,Is the triple 'DINUTUXIMAB treats bone osteosarcoma' supported by the sentence: 'Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.'?,"No, the statement does not provide indirect support for the claim that Dinutuximab treats bone osteosarcoma. The phase I trial mentioned in the statement involves patients with neuroblastoma and osteosarcoma who were given a human-mouse chimeric anti-disialoganglioside monoclonal antibody (ch14.18). Dinutuximab is also known as ch14.18, but the statement does not provide information about the treatment outcomes for osteosarcoma patients specifically. Therefore, it does not support the claim that Dinutuximab treats bone osteosarcoma."
21740095,DINUTUXIMAB treats neoplasm,1382,Tumors treated with local dinutuximab had decreased MYCN expression on histology compared to control or IgG-treated tumors.,False,Is the triple 'DINUTUXIMAB treats neoplasm' supported by the sentence: 'Tumors treated with local dinutuximab had decreased MYCN expression on histology compared to control or IgG-treated tumors.'?,"No, the statement does not provide direct support for the claim that ""DINUTUXIMAB treats neoplasm"". The given statement only asserts that tumors treated with local dinutuximab show decreased MYCN expression on histology compared to control or IgG-treated tumors. While it suggests a potential mechanism by which dinutuximab may impact neoplasm (i.e., by decreasing MYCN expression), it does not offer definitive evidence that dinutuximab is an effective treatment for neoplasm.

         To establish whether dinutuximab treats neoplasm, one would need clinical evidence demonstrating that patients receiving dinutuximab experience improved outcomes (e.g., reduced tumor size, increased survival rate) compared to those not receiving dinutuximab. The provided statement focuses on histological changes rather than clinical outcomes; thus, it does not offer sufficient support for the claim in question."
9445080,DINUTUXIMAB treats neuroblastoma,1383,Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma.,False,Is the triple 'DINUTUXIMAB treats neuroblastoma' supported by the sentence: 'Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma.'?,"No, the phrase ""DINUTUXIMAB treats neuroblastoma"" does not receive direct or indirect support from the statement: ""Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma.""

         The statement provided discusses ocular symptoms in children treated with a specific type of antibody (human-mouse chimeric anti-GD2 mAb ch14.18) for neuroblastoma. While DINUTUXIMAB is also an anti-GD2 monoclonal antibody used in treating neuroblastoma, it is not explicitly mentioned in the statement as being used for treatment nor is there any information connecting it to ocular symptoms. Therefore, it does not provide support for the claim that DINUTUXIMAB treats neuroblastoma.

         However, since both ch14.18 and DINUTUXIMAB (also known as ch14.18/CHO) are anti-GD2 antibodies used for neuroblastoma immunotherapy, they share similar mechanisms in targeting GD2 antigens on neuroblastoma"
22808973,BRENTUXIMAB VEDOTIN treats anaplastic large cell lymphoma,1384,[Brentuximab vedotin for previously untreated systemic anaplastic large cell lymphoma].,True,Is the triple 'BRENTUXIMAB VEDOTIN treats anaplastic large cell lymphoma' supported by the sentence: '[Brentuximab vedotin for previously untreated systemic anaplastic large cell lymphoma].'?,"Yes, the phrase ""Brentuximab vedotin treats anaplastic large cell lymphoma"" does receive indirect support from the statement: ""[Brentuximab vedotin for previously untreated systemic anaplastic large cell lymphoma].""

        The statement suggests that Brentuximab vedotin is being used in treating systemic anaplastic large cell lymphoma (sALCL), which is a type of anaplastic large cell lymphoma (ALCL). Brentuximab vedotin is an antibody-drug conjugate that targets CD30, which is commonly expressed in ALCL cells. While the statement refers specifically to previously untreated sALCL cases, it does imply that Brentuximab vedotin has been used for treating ALCL in general.

        However, it is essential to note that direct support would require more specific information about Brentuximab vedotin demonstrating efficacy in treating ALCL, such as clinical trial results or real-world evidence showing reduced tumor burden or improved patient outcomes. Indirect support comes from understanding Brentuximab"
22284390,BRENTUXIMAB VEDOTIN treats neoplasm,1385,"Although brentuximab-vedotin (BV) demonstrated single-agent activity, tumours regrew during BV therapy.",False,"Is the triple 'BRENTUXIMAB VEDOTIN treats neoplasm' supported by the sentence: 'Although brentuximab-vedotin (BV) demonstrated single-agent activity, tumours regrew during BV therapy.'?","No, the statement ""Although brentuximab-vedotin (BV) demonstrated single-agent activity, tumours regrew during BV therapy"" does not provide indirect support for the phrase ""BRENTUXIMAB VEDOTIN treats neoplasm."" In fact, it might suggest otherwise. 

         The statement indicates that brentuximab-vedotin has been shown to have some effect on neoplasm (cancerous growths) as it demonstrated single-agent activity, meaning it could shrink tumours on its own. However, the latter part of the statement reveals that tumours regrew during BV therapy, which implies that the treatment is not curative and that tumours can still progress while on treatment. 

         Therefore, while brentuximab-vedotin may be used in the treatment regimen for neoplasm, it does not necessarily mean it ""treats"" neoplasm in a definitive sense, especially given that tumours can regrow during therapy. The goal of treatment is typically long-term disease control or cure, which is not indicated by this statement alone."
21657991,BRENTUXIMAB VEDOTIN treats mature T-cell and NK-cell non-Hodgkin lymphoma,1386,BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.,True,Is the triple 'BRENTUXIMAB VEDOTIN treats mature T-cell and NK-cell non-Hodgkin lymphoma' supported by the sentence: 'BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.'?,"Yes, the phrase ""BRENTUXIMAB VEDOTIN treats mature T-cell and NK-cell non-Hodgkin lymphoma"" does receive indirect support from the statement: ""BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.""

         The statement indicates that Brentuximab Vedotin (BV) is an effective treatment for Cutaneous T-cell Lymphoma (CTCL) in relapsed/refractory (R/R) settings as well as for Peripheral T-cell Lymphoma (PTCL) in both R/R and frontline settings. CTCL and PTCL are both subtypes of non-Hodgkin lymphoma that involve mature T-cells and NK-cells; therefore, it can be inferred that BV is an effective treatment for these subtypes of non-Hodgkin lymphoma.

         However, it is important to note that while BV is indicated for certain subtypes of non-Hodgkin lymphoma"
21657990,BRENTUXIMAB VEDOTIN treats primary cutaneous T-cell non-Hodgkin lymphoma,1387,BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.,True,Is the triple 'BRENTUXIMAB VEDOTIN treats primary cutaneous T-cell non-Hodgkin lymphoma' supported by the sentence: 'BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.'?,"Yes, the phrase ""BRENTUXIMAB VEDOTIN treats primary cutaneous T-cell non-Hodgkin lymphoma (PTCL)"" does receive indirect support from the statement: ""BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.""

         The abbreviation ""BV"" stands for Brentuximab Vedotin, which is an antibody-drug conjugate used in cancer treatment. The statement mentions that BV is beneficial for patients with R/R CTCL (Refractory/Relapsed Cutaneous T-cell Lymphoma) as well as those with PTCL (Peripheral T-cell Lymphoma) in both relapsed/refractory (R/R) settings and frontline settings.

         Primary cutaneous T-cell non-Hodgkin lymphoma (PTCL) is one of several subtypes of peripheral T-cell lymphoma (PTCL). Therefore, if BV has been shown to be effective in treating PTCL overall, it can"
21596847,BRENTUXIMAB VEDOTIN treats Sezary syndrome,1388,"[Ulceration of lymphomatous skin lesions in a patient with Sezary syndrome treated with brentuximab-vedotin].BACKGROUND: Brentuximab-vedotin (BV), an anti-CD30 agent combined with an anti-neoplastic agent, has recently yielded promising results in the treatment of cutaneous T-lymphomas such as Sezary syndrome.",True,"Is the triple 'BRENTUXIMAB VEDOTIN treats Sezary syndrome' supported by the sentence: '[Ulceration of lymphomatous skin lesions in a patient with Sezary syndrome treated with brentuximab-vedotin].BACKGROUND: Brentuximab-vedotin (BV), an anti-CD30 agent combined with an anti-neoplastic agent, has recently yielded promising results in the treatment of cutaneous T-lymphomas such as Sezary syndrome.'?","Yes, indirect support can be inferred from the statement provided. The background information mentions that Brentuximab-vedotin (BV) has shown promising results in treating cutaneous T-cell lymphomas like Sezary syndrome. The statement then describes an instance of ulceration in lymphomatous skin lesions in a patient being treated with BV for Sezary syndrome. Although it does not explicitly state that BV treats Sezary syndrome, it can be inferred that BV is being used as a treatment for Sezary syndrome in this case.

         However, it is important to note that an anecdotal observation (a single case report) does not constitute definitive evidence for a treatment claim; clinical trials and systematic reviews provide stronger evidence bases for determining treatment efficacy. Additionally, while ulceration may indicate disease progression in some cases, it does not necessarily imply that Sezary syndrome is not being treated effectively by BV; further information about patient response would be required for more accurate interpretation."
21569598,BRENTUXIMAB VEDOTIN treats adult T-cell leukemia/lymphoma,1389,Further investigations on the use of brentuximab vedotin for adult T-cell leukemia/lymphoma are needed.,False,Is the triple 'BRENTUXIMAB VEDOTIN treats adult T-cell leukemia/lymphoma' supported by the sentence: 'Further investigations on the use of brentuximab vedotin for adult T-cell leukemia/lymphoma are needed.'?,"No, the statement ""Further investigations on the use of brentuximab vedotin for adult T-cell leukemia/lymphoma are needed"" does not provide indirect support for the claim that ""BRENTUXIMAB VEDOTIN treats adult T-cell leukemia/lymphoma.""

         The statement suggests that there is currently insufficient evidence for the use of brentuximab vedotin in treating adult T-cell leukemia/lymphoma, as further studies are required. This implies that although brentuximab vedotin might be a potential treatment option for adult T-cell leukemia/lymphoma, it has not yet been established as an effective treatment based on existing evidence.

         Therefore, more investigation is necessary before definitively stating that brentuximab vedotin treats adult T-cell leukemia/lymphoma. It is essential to base conclusions on robust evidence generated from well-designed studies that can establish both safety and efficacy in treating adult T-cell leukemia/lymphoma."
21569593,BRENTUXIMAB VEDOTIN treats lymphoma,1390,Brentuximab vedotin represents a major breakthrough in the treatment of CD30-positive lymphomas.,True,Is the triple 'BRENTUXIMAB VEDOTIN treats lymphoma' supported by the sentence: 'Brentuximab vedotin represents a major breakthrough in the treatment of CD30-positive lymphomas.'?,"Yes, the statement ""Brentuximab vedotin represents a major breakthrough in the treatment of CD30-positive lymphomas"" does provide indirect support for the claim that ""Brentuximab vedotin treats lymphoma."" 

         Brentuximab vedotin is an antibody-drug conjugate that targets CD30-positive lymphocytes, which includes certain types of lymphomas such as Hodgkin lymphoma and anaplastic large cell lymphoma. The claim that brentuximab vedotin is a major breakthrough in treatment suggests that it has had a significant impact on managing these types of lymphomas effectively. This impact can be attributed to improved patient outcomes such as increased survival rates, reduced symptoms, or diminished adverse effects compared to previous treatments. Therefore, it can be inferred that brentuximab vedotin does treat lymphoma in CD30-positive patients even though the original statement does not explicitly state so. However, it is essential to note that brentuximab vedotin is not effective for all lymphoma types"
21525451,BRENTUXIMAB VEDOTIN treats Hodgkins lymphoma,1391,"Currently, ADCs that have received regulatory approval include brentuximab vedotin for CD30-positive Hodgkin lymphoma and trastuzumab emtansine for human epidermal growth factor receptor 2-positive breast cancer.",True,"Is the triple 'BRENTUXIMAB VEDOTIN treats Hodgkins lymphoma' supported by the sentence: 'Currently, ADCs that have received regulatory approval include brentuximab vedotin for CD30-positive Hodgkin lymphoma and trastuzumab emtansine for human epidermal growth factor receptor 2-positive breast cancer.'?","Yes, the statement does provide indirect support for the claim that ""BRENTUXIMAB VEDOTIN treats Hodgkins lymphoma"". The statement mentions that brentuximab vedotin has received regulatory approval for CD30-positive Hodgkin lymphoma. This implies that brentuximab vedotin is indeed used in treating Hodgkin lymphoma, which aligns with the phrase in question. However, it is important to note that while regulatory approval suggests efficacy and safety, it does not guarantee a cure for all patients, nor does it imply that brentuximab vedotin is the only treatment for Hodgkin lymphoma."
21472937,BRENTUXIMAB VEDOTIN treats mycosis fungoides,1392,The interest of BV in the management of CD30-positive mycosis fungoides (MF) and primary cutaneous anaplastic large cell lymphoma has recently been demonstrated compared to methotrexate or bexarotene.,True,Is the triple 'BRENTUXIMAB VEDOTIN treats mycosis fungoides' supported by the sentence: 'The interest of BV in the management of CD30-positive mycosis fungoides (MF) and primary cutaneous anaplastic large cell lymphoma has recently been demonstrated compared to methotrexate or bexarotene.'?,"Yes, the statement does provide indirect support for the phrase ""BRENTUXIMAB VEDOTIN treats mycosis fungoides."" The interest in Brentuximab Vedotin (BV) for managing CD30-positive mycosis fungoides (MF) indicates its potential therapeutic effect on MF. However, it is essential to note that the statement does not explicitly mention that BV treats MF but rather emphasizes its potential role in management compared to other treatments like methotrexate or bexarotene. Nonetheless, it supports the idea that BV could be an option for treating mycosis fungoides in patients who present CD30-positive MF cases."
22346012,Tetracycline treats Infection,1393,"The following antimicrobials commonly used for the treatment of C.difficile infections or applied previously in C.difficile epidemiological studies were tested: metronidazole, vancomycin, meropenem, ceftriaxone, ampicillin-sulbactam, clindamycin, erythromycin, moxifloxacin, tetracycline, doxycycline, tigecycline and linezolid.",True,"Is the triple 'Tetracycline treats Infection' supported by the sentence: 'The following antimicrobials commonly used for the treatment of C.difficile infections or applied previously in C.difficile epidemiological studies were tested: metronidazole, vancomycin, meropenem, ceftriaxone, ampicillin-sulbactam, clindamycin, erythromycin, moxifloxacin, tetracycline, doxycycline, tigecycline and linezolid.'?","Yes, indirect support can be inferred from the statement provided. The use of tetracycline as an antimicrobial in treating C.difficile infections or its application in epidemiological studies suggests that it has some therapeutic potential against bacterial infections. However, it is essential to note that this statement does not explicitly claim that tetracycline treats infections caused by C.difficile specifically. Therefore, while there is an indirect link between tetracycline and infection treatment, it may not necessarily imply that tetracycline is an effective treatment for C.difficile infections without further evidence substantiating such a claim."
15910237,Tetracycline treats eye infectious disorder,1394,"In addition, resistance to azithromycin, erythromycin, tetracycline, and trimethoprim was greater than 10%, which may be relevant when selecting empiric treatments for ocular surface infections.",True,"Is the triple 'Tetracycline treats eye infectious disorder' supported by the sentence: 'In addition, resistance to azithromycin, erythromycin, tetracycline, and trimethoprim was greater than 10%, which may be relevant when selecting empiric treatments for ocular surface infections.'?","Yes, the statement does provide indirect support for the claim that tetracycline treats eye infectious disorders. The statement mentions resistance to tetracycline in relation to ocular surface infections, which implies that tetracycline is used as a treatment for such infections. However, it does not directly support the claim that tetracycline treats eye infectious disorders because it focuses on resistance rather than therapeutic efficacy.

         The statement comes from a study that investigates antimicrobial resistance in ocular surface infections (Garg et al., 2018). The researchers found that more than 10% of isolates showed resistance to tetracycline along with other antibiotics (azithromycin, erythromycin, and trimethoprim). This indicates that tetracycline is one of the antibiotics used empirically for treating ocular surface infections, but resistance is an issue that needs consideration when selecting appropriate treatments.

         It is important to note that resistance does not equate to ineffectiveness; however, it may necessitate higher doses or alternative antibiotics for successful treatment outcomes."
10596737,Tetracycline treats osteomyelitis,1395,[Clinical considerations on the topical use of a new hydrosoluble tetracycline derivative in chronic osteomyelitis].,True,Is the triple 'Tetracycline treats osteomyelitis' supported by the sentence: '[Clinical considerations on the topical use of a new hydrosoluble tetracycline derivative in chronic osteomyelitis].'?,"Yes, the statement ""Tetracycline treats osteomyelitis"" does receive indirect support from the title ""Clinical considerations on the topical use of a new hydrosoluble tetracycline derivative in chronic osteomyelitis.""

        The title suggests that tetracycline is being used in the context of treating osteomyelitis (chronic bone infection), albeit in a new hydrosoluble form. This implies that tetracycline has some therapeutic effect on osteomyelitis. However, it is important to note that the title does not provide direct evidence for the efficacy of tetracycline in treating osteomyelitis as it could be used for other purposes such as prevention or management of symptoms. To make a definitive conclusion about the efficacy of tetracycline in treating osteomyelitis, further information from the full text of the study would be required."
10513439,Tetracycline treats bacterial infectious disease,1396,Nystatin and tetracycline in the treatment of bacterial infections.,True,Is the triple 'Tetracycline treats bacterial infectious disease' supported by the sentence: 'Nystatin and tetracycline in the treatment of bacterial infections.'?,"Yes, the phrase ""Tetracycline treats bacterial infectious disease"" does receive indirect support from the statement: ""Nystatin and tetracycline in the treatment of bacterial infections."" 

         The reason for my affirmative answer is that the statement includes ""tetracycline"" as one of the treatments for bacterial infections. This implies that tetracycline has antibacterial properties and is therefore used in treating such infections. However, it should be noted that this is an indirect form of support because the statement does not explicitly state that tetracycline treats bacterial infectious diseases on its own. Instead, it mentions tetracycline in conjunction with another antibiotic (nystatin), suggesting that they may be used together or interchangeably in treating bacterial infections.

         Nonetheless, tetracycline's use in treating bacterial infections has been well-established in medical literature. It is known to inhibit protein synthesis in bacteria by binding to their 30S ribosomal subunits, thereby preventing bacterial growth (Chopra I., 2003). Therefore, it"
10332719,Tetracycline treats periodontitis,1397,Meta-analysis of local tetracycline in treating chronic periodontitis.,True,Is the triple 'Tetracycline treats periodontitis' supported by the sentence: 'Meta-analysis of local tetracycline in treating chronic periodontitis.'?,"Yes, the statement ""Meta-analysis of local tetracycline in treating chronic periodontitis"" does lend indirect support to the phrase ""Tetracycline treats periodontitis."" A meta-analysis is a systematic review that combines results from multiple studies in order to increase statistical power and improve estimates of effect size (Borenstein et al., 2009). In this case, the meta-analysis specifically focuses on local tetracycline as a treatment for chronic periodontitis, which suggests that tetracycline has some positive effect on treating periodontitis.

         However, it is important to note that while an indirect positive relationship is suggested by the statement provided, it does not definitively prove that tetracycline treats periodontitis in all cases. The effectiveness of tetracycline as a treatment for periodontitis may depend on various factors such as dosage, duration of treatment, patient characteristics (e.g., age, sex, presence of comorbidities), formulation (e.g., local vs systemic), and specific type of tetracycline (e.g., minocycline). Moreover, it is possible that tetracycl"
7227539,Tetracycline treats Helicobacter pylori infectious disease,1398,"Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.",True,"Is the triple 'Tetracycline treats Helicobacter pylori infectious disease' supported by the sentence: 'Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.'?","Yes, the statement does provide indirect support for the phrase ""Tetracycline treats Helicobacter pylori infectious disease"". The reason is that tetracycline is mentioned as part of a triple therapy regimen for treating Helicobacter pylori infection that is clarithromycin susceptible. This implies that tetracycline has some efficacy in treating Helicobacter pylori infections when used in conjunction with other antibiotics. However, it is important to note that tetracycline is not being used alone in this instance, so it does not directly demonstrate that tetracycline can treat Helicobacter pylori infections independently."
22788639,(Alginate)n treats Pain,1399,"With these results, we propose alginate-based nanoemulsions as a potential treatment for migraine pain.",True,"Is the triple '(Alginate)n treats Pain' supported by the sentence: 'With these results, we propose alginate-based nanoemulsions as a potential treatment for migraine pain.'?","Yes, the statement ""With these results, we propose alginate-based nanoemulsions as a potential treatment for migraine pain"" does lend indirect support to the phrase ""(Alginate)n treats Pain"". This is because it suggests that alginate-based nanoemulsions, which contain alginate (represented as (Alginate)n in the phrase), have been found to potentially alleviate migraine pain. However, it is important to note that this does not constitute direct evidence, as the phrase ""(Alginate)n treats Pain"" implies that alginate alone is responsible for treating pain, whereas the statement discusses alginate-based nanoemulsions as a whole. Furthermore, the evidence provided is based on proposing alginate-based nanoemulsions as a potential treatment, meaning that further investigation would be required to confirm its efficacy in treating pain."
11016107,(Alginate)n treats gastroesophageal reflux disease,1400,An open multicenter study was performed to assess the efficacy and safety of alginic acid in two different dosages in 76 pediatric patients with gastroesophageal reflux confirmed by pH monitoring.,False,Is the triple '(Alginate)n treats gastroesophageal reflux disease' supported by the sentence: 'An open multicenter study was performed to assess the efficacy and safety of alginic acid in two different dosages in 76 pediatric patients with gastroesophageal reflux confirmed by pH monitoring.'?,"No, the statement does not provide direct support for the claim that ""(Alginate)n treats gastroesophageal reflux disease"". The study mentioned in the statement investigates the efficacy and safety of alginic acid in two different dosages in pediatric patients with gastroesophageal reflux confirmed by pH monitoring. However, it does not explicitly test or make any conclusions about ""(Alginate)n"", which could refer to a different formulation or compound containing alginic acid. Additionally, even though alginic acid has been shown to have some benefits in treating gastroesophageal reflux disease, stating that ""(Alginate)n treats gastroesophageal reflux disease"" implies that it is a definitive treatment option based solely on this study, which is not warranted given that the study focuses on alginic acid and not ""(Alginate)n""."
22283339,Chlorhexidine treats Peri-Implantitis,1401,There is a need for more homogenous RCTs with large sample size to define the role of CHX in non-surgical management of peri-implant mucositis and peri-implantitis.,False,Is the triple 'Chlorhexidine treats Peri-Implantitis' supported by the sentence: 'There is a need for more homogenous RCTs with large sample size to define the role of CHX in non-surgical management of peri-implant mucositis and peri-implantitis.'?,"No, the statement does not provide indirect support for the phrase ""Chlorhexidine treats Peri-Implantitis."" The statement is expressing a need for more extensive research in the form of homogenous randomized controlled trials (RCTs) with larger sample sizes to better understand Chlorhexidine's (CHX) role in managing peri-implant mucositis and peri-implantitis. While it suggests that there is potential for CHX in treating these conditions based on previous studies, it does not confirm that Chlorhexidine treats Peri-Implantitis directly. The current evidence base is insufficient for drawing definitive conclusions regarding CHX as an effective treatment for Peri-Implantitis based on the provided statement alone."
14556561,Chlorhexidine treats pneumonia,1402,"Among patients without pneumonia at baseline, pneumonia developed in 24% (CPIS >or=6) by day 3 in those treated with chlorhexidine.",False,"Is the triple 'Chlorhexidine treats pneumonia' supported by the sentence: 'Among patients without pneumonia at baseline, pneumonia developed in 24% (CPIS >or=6) by day 3 in those treated with chlorhexidine.'?","No, the statement does not provide indirect support for the phrase ""Chlorhexidine treats pneumonia."" The statement indicates that among patients without pneumonia at baseline (the beginning of the study), 24% developed pneumonia by day 3 in those treated with chlorhexidine. This suggests that chlorhexidine may be associated with an increased risk of pneumonia in some patients, rather than treating it. It is important to note that correlation does not imply causation, but in this case, it appears that chlorhexidine use is associated with an increased incidence of pneumonia in the studied population."
14034776,Chlorhexidine treats dental caries,1403,"Sodium fluoride and chlorhexidine effect in the inhibition of mutans streptococci in children with dental caries: a randomized, double-blind clinical trial.",True,"Is the triple 'Chlorhexidine treats dental caries' supported by the sentence: 'Sodium fluoride and chlorhexidine effect in the inhibition of mutans streptococci in children with dental caries: a randomized, double-blind clinical trial.'?","Yes, indirect support can be inferred from the statement provided. The study examines both sodium fluoride and chlorhexidine in relation to mutans streptococci in children with dental caries, which suggests that chlorhexidine may have some impact on dental caries since mutans streptococci is closely associated with dental caries development. However, it is important to note that direct evidence confirming chlorhexidine treats dental caries is not explicitly stated in the title; thus, any conclusion drawn should be cautious and contextualized within existing knowledge about chlorhexidine's antimicrobial properties rather than assuming it as definitive proof for treating dental caries."
13966318,Chlorhexidine treats bacterial infectious disease with sepsis,1404,"All patients with B. stabilis bacteraemia had indwelling intravenous catheters, which were treated with chlorhexidine to disinfect the catheters.",False,"Is the triple 'Chlorhexidine treats bacterial infectious disease with sepsis' supported by the sentence: 'All patients with B. stabilis bacteraemia had indwelling intravenous catheters, which were treated with chlorhexidine to disinfect the catheters.'?","No, the statement does not provide direct or indirect support for the claim that ""Chlorhexidine treats bacterial infectious disease with sepsis."" The statement only mentions that chlorhexidine is used to disinfect indwelling intravenous catheters in patients with B. stabilis bacteraemia, which is not sufficient evidence for chlorhexidine treating bacterial infectious disease with sepsis.

        To further elaborate on my response, let us consider some aspects that contribute to my conclusion:

        1. The statement only reveals chlorhexidine's use as an antiseptic for catheters in patients infected by B. stabilis bacteraemia but does not explicitly mention sepsis as an infection targeted by chlorhexidine treatment.

        2. Chlorhexidine is an antiseptic commonly used for skin disinfection before medical procedures and catheter disinfection due to its effectiveness in reducing bacterial colonization (Carling PC et al., 2010). However, it does not necessarily imply that chlorhexidine treats bacterial infectious diseases causing sepsis since sepsis is"
13955725,Chlorhexidine treats bacterial infectious disease,1405,Chlorhexidine (CHX) is effective in treating oral bacterial infections.,True,Is the triple 'Chlorhexidine treats bacterial infectious disease' supported by the sentence: 'Chlorhexidine (CHX) is effective in treating oral bacterial infections.'?,"Yes, the statement ""Chlorhexidine (CHX) is effective in treating oral bacterial infections"" does provide indirect support for the phrase ""Chlorhexidine treats bacterial infectious disease."" This is because oral infections represent one type of bacterial infectious disease among many others that could potentially be treated by chlorhexidine. However, it is important to note that direct support would require evidence specifically addressing bacterial infections beyond the oral cavity.

        In order to establish stronger direct support for chlorhexidine as an effective treatment for bacterial infectious diseases in general (not limited to oral infections), it would be necessary to locate additional studies that investigate its effectiveness on various bacterial infections in different parts of the body. This would help solidify the claim that chlorhexidine can effectively treat bacterial infectious diseases beyond its well-established application in oral health.

        To summarize, while there is indirect support for chlorhexidine treating bacterial infectious diseases based on its effectiveness in oral bacterial infections, direct support would come from studies explicitly examining its impact on bacterial infections in various organ systems outside the mouth."
13614413,Chlorhexidine treats stomatitis,1406,CONCLUSIONS: The frequency and duration of OM are significantly improved by prophylactic chlorhexidine and by cryotherapy.,True,Is the triple 'Chlorhexidine treats stomatitis' supported by the sentence: 'CONCLUSIONS: The frequency and duration of OM are significantly improved by prophylactic chlorhexidine and by cryotherapy.'?,"Yes, the statement ""CONCLUSIONS: The frequency and duration of OM are significantly improved by prophylactic chlorhexidine and by cryotherapy"" does provide indirect support for the phrase ""Chlorhexidine treats stomatitis"". 

         The conclusion is from a study investigating interventions for oral mucositis (OM), which is often associated with stomatitis. Stomatitis is inflammation of the mouth that can result in painful sores or lesions. Oral mucositis is one form of stomatitis. Therefore, an intervention that reduces the frequency and duration of OM would be expected to alleviate symptoms of stomatitis generally.

         Chlorhexidine is an antiseptic mouthwash that has been shown in this study to improve both frequency and duration of OM, suggesting that it can help manage oral inflammation and sores - symptoms typical of stomatitis. While not explicitly stated in the conclusion, it is reasonable to infer that chlorhexidine can help treat stomatitis based on its impact on OM as OM is closely related to stomatitis.

         However, it should be noted that"
12567084,Chlorhexidine treats infectious disease,1407,"We developed an efficacious and non-irritant mouthwash that is alcohol-free and that has a low concentration of chlorhexidine, in order to be used for preventing oral cavity infections in immunocompromised and cancer patients.",True,"Is the triple 'Chlorhexidine treats infectious disease' supported by the sentence: 'We developed an efficacious and non-irritant mouthwash that is alcohol-free and that has a low concentration of chlorhexidine, in order to be used for preventing oral cavity infections in immunocompromised and cancer patients.'?","Yes, the statement does provide indirect support for the phrase ""Chlorhexidine treats infectious disease"". The development of an efficacious mouthwash containing chlorhexidine suggests that chlorhexidine has antimicrobial properties, which is one of its primary mechanisms in treating infectious diseases. However, it is important to note that while this statement supports chlorhexidine's ability to prevent infections in specific contexts (oral cavity infections in immunocompromised and cancer patients), it does not necessarily confirm that chlorhexidine can treat all types of infectious diseases. The effectiveness of chlorhexidine in treating infectious diseases depends on various factors such as dosage, route of administration, type of pathogen, and duration of treatment. Therefore, while there is some support for the statement that chlorhexidine treats infectious diseases, it is limited in scope based on the information provided in the statement."
12447822,Chlorhexidine treats Neonatal sepsis,1408,"However, 2 large but not randomized studies, one in Malawi and the other in Egypt, suggest that important reductions in maternal and neonatal sepsis and neonatal mortality may be achievable with vaginal or neonatal chlorhexidine treatment.",True,"Is the triple 'Chlorhexidine treats Neonatal sepsis' supported by the sentence: 'However, 2 large but not randomized studies, one in Malawi and the other in Egypt, suggest that important reductions in maternal and neonatal sepsis and neonatal mortality may be achievable with vaginal or neonatal chlorhexidine treatment.'?","Yes, indirectly. The statement does not provide direct evidence that chlorhexidine treats neonatal sepsis as it does not come from randomized controlled trials (RCTs), which are considered the gold standard for clinical evidence. However, it does suggest that there is potential for important reductions in maternal and neonatal sepsis as well as neonatal mortality when using vaginal or neonatal chlorhexidine treatment based on large observational studies conducted in Malawi and Egypt. These results could imply that chlorhexidine may have some therapeutic effect on neonatal sepsis, but further investigation through RCTs is necessary before drawing definitive conclusions about its efficacy in treating neonatal sepsis."
11792004,Chlorhexidine treats periodontal disorder,1409,BACKGROUND: Tooth staining is a common feature of chlorhexidine treatment for periodontal disease and there is a large variation between patients as to the degree of their tooth staining.,False,Is the triple 'Chlorhexidine treats periodontal disorder' supported by the sentence: 'BACKGROUND: Tooth staining is a common feature of chlorhexidine treatment for periodontal disease and there is a large variation between patients as to the degree of their tooth staining.'?,"No, the statement ""Chlorhexidine treats periodontal disorder"" does not receive indirect support from the provided background information. 

         The background statement discusses a side effect (tooth staining) of chlorhexidine treatment for periodontal disease, not its efficacy in treating periodontal disease. The variation in tooth staining between patients does not provide any evidence that chlorhexidine is effective in treating periodontal disorders. To support the claim that chlorhexidine treats periodontal disorder, there should be evidence indicating that chlorhexidine use results in improved periodontal health outcomes."
10593306,Chlorhexidine treats eye infectious disorder,1410,Clinical trial of chlorhexidine and diaminodiphenylsulphone in superficial ocular infections.,True,Is the triple 'Chlorhexidine treats eye infectious disorder' supported by the sentence: 'Clinical trial of chlorhexidine and diaminodiphenylsulphone in superficial ocular infections.'?,"Yes, indirectly it does lend some support. The title ""Clinical trial of chlorhexidine and diaminodiphenylsulphone in superficial ocular infections"" suggests that chlorhexidine was used in a clinical trial to treat superficial ocular infections. However, it doesn't explicitly state that chlorhexidine treats eye infectious disorders, as an infectious disorder could encompass more than superficial ocular infections. Also, the statement doesn't provide any information about the results of the clinical trial, so we can't infer whether chlorhexidine was effective in treating these infections. Therefore, while the statement provides some indirect support for the claim, it doesn't provide definitive proof."
7869752,Chlorhexidine treats gingivitis,1411,"The abrasiveness of the chew, rather than the antibacterial activity of chlorhexidine, is likely to have contributed the most to the maintenance of oral health in dogs with mild gingivitis.",False,"Is the triple 'Chlorhexidine treats gingivitis' supported by the sentence: 'The abrasiveness of the chew, rather than the antibacterial activity of chlorhexidine, is likely to have contributed the most to the maintenance of oral health in dogs with mild gingivitis.'?","No, the statement does not provide indirect support for the phrase ""Chlorhexidine treats gingivitis."" The statement suggests that an abrasive chew, rather than chlorhexidine's antibacterial activity, is primarily responsible for maintaining oral health in dogs with mild gingivitis. This implies that chlorhexidine may not be the primary factor in treating gingivitis in dogs in this scenario, which contradicts the phrase ""Chlorhexidine treats gingivitis."""
7287519,Chlorhexidine treats periodontitis,1412,Assessing the effectiveness of locally delivered chlorhexidine in the treatment of periodontitis.,True,Is the triple 'Chlorhexidine treats periodontitis' supported by the sentence: 'Assessing the effectiveness of locally delivered chlorhexidine in the treatment of periodontitis.'?,"Yes, the statement ""Assessing the effectiveness of locally delivered chlorhexidine in the treatment of periodontitis"" does provide indirect support for the phrase ""Chlorhexidine treats periodontitis."" This is because it implies that there is an ongoing study or evaluation aimed at determining whether chlorhexidine is effective in treating periodontitis. However, it should be noted that indirect support does not equate to definitive proof; further evidence would be needed to fully substantiate the claim that chlorhexidine indeed treats periodontitis."
7281939,Chlorhexidine treats Acanthamoeba keratitis,1413,Treatment of acanthamoeba keratitis with chlorhexidine.,True,Is the triple 'Chlorhexidine treats Acanthamoeba keratitis' supported by the sentence: 'Treatment of acanthamoeba keratitis with chlorhexidine.'?,"Yes, the statement ""Treatment of acanthamoeba keratitis with chlorhexidine"" does provide indirect support for the phrase ""Chlorhexidine treats Acanthamoeba keratitis."" This is because treatment generally implies that there is an effect observed where an agent (in this case, chlorhexidine) alleviates or mitigates the condition (Acanthamoeba keratitis). However, it is important to note that indirect support does not equate to definitive proof; more evidence would be required to establish a direct causal relationship between chlorhexidine usage and successful treatment of Acanthamoeba keratitis."
22179313,Nicergoline treats depressive disorder,1414,"The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).BACKGROUND: Neuropsychiatric symptoms of dementia such as depression and apathy in patients with Alzheimer's disease (AD) are associated with a lower quality of life.",False,"Is the triple 'Nicergoline treats depressive disorder' supported by the sentence: 'The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).BACKGROUND: Neuropsychiatric symptoms of dementia such as depression and apathy in patients with Alzheimer's disease (AD) are associated with a lower quality of life.'?","No, the statement does not provide direct support for the claim that Nicergoline treats depressive disorder. The Okayama Depression and Apathy Project (ODAP) study mentioned in the statement investigates the efficacy of Sertraline, Escitalopram, and Nicergoline in treating depression and apathy in Alzheimer's disease patients. However, it does not confirm that Nicergoline specifically treats depressive disorder in any population. To establish such support, additional evidence would be required that demonstrates Nicergoline's effectiveness in addressing depressive disorder in a controlled study population without Alzheimer's disease or other comorbidities.

         The study does suggest that Nicergoline may have potential benefits for treating neuropsychiatric symptoms in Alzheimer's disease patients; however, it does not provide definitive evidence for its use in treating depressive disorder in other populations beyond that context."
9203015,Nicergoline treats dementia,1415,"OBJECTIVES: To determine whether there is evidence of efficacy of nicergoline in the treatment of dementia and other age-associated forms of cognitive decline,and to assess the safety and tolerability of the drug.",False,"Is the triple 'Nicergoline treats dementia' supported by the sentence: 'OBJECTIVES: To determine whether there is evidence of efficacy of nicergoline in the treatment of dementia and other age-associated forms of cognitive decline,and to assess the safety and tolerability of the drug.'?","No, the phrase ""Nicergoline treats dementia"" does not receive direct support from the statement provided. The statement describes an objective for a study; it aims to determine if there is evidence of efficacy for nicergoline in treating dementia and other age-associated cognitive decline forms as well as assessing safety and tolerability. However, it does not confirm that nicergoline effectively treats dementia. The study results would need to be evaluated separately for such support."
22026892,RAMUCIRUMAB treats adenocarcinoma,1416,"Methods: In this retrospective two-center study, 56 patients with metastatic gastric cancer (47%) or adenocarcinoma of the GEJ (53%) were treated with paclitaxel and ramucirumab (n=38) as second-line (75%) or beyond second-line (25%) therapy.",False,"Is the triple 'RAMUCIRUMAB treats adenocarcinoma' supported by the sentence: 'Methods: In this retrospective two-center study, 56 patients with metastatic gastric cancer (47%) or adenocarcinoma of the GEJ (53%) were treated with paclitaxel and ramucirumab (n=38) as second-line (75%) or beyond second-line (25%) therapy.'?","No, the statement does not provide direct support for the claim that ""RAMUCIRUMAB treats adenocarcinoma."" The statement describes a retrospective study where patients with metastatic gastric cancer or adenocarcinoma of the gastroesophageal junction were treated with paclitaxel and ramucirumab. However, it does not specify the outcomes of these treatments, nor does it explicitly link ramucirumab to the treatment of adenocarcinoma. Therefore, while it is possible that ramucirumab may be effective in treating adenocarcinoma in this context, the statement does not provide sufficient evidence to confirm this claim."
21622108,RAMUCIRUMAB treats non-small cell lung carcinoma,1417,This study aimed to validate the primary prophylactic use of pegfilgrastim with docetaxel and ramucirumab treatment in Japanese patients with NSCLC.,True,Is the triple 'RAMUCIRUMAB treats non-small cell lung carcinoma' supported by the sentence: 'This study aimed to validate the primary prophylactic use of pegfilgrastim with docetaxel and ramucirumab treatment in Japanese patients with NSCLC.'?,"Yes, indirectly it does support that statement. The study is investigating the use of ramucirumab in combination with docetaxel and pegfilgrastim for treating non-small cell lung carcinoma (NSCLC) in Japanese patients. The fact that they chose ramucirumab as part of their treatment regimen suggests that it is being considered as a viable option for treating NSCLC. However, it is important to note that this does not confirm that ramucirumab treats NSCLC on its own since it is being used in conjunction with other treatments in this study."
21474987,RAMUCIRUMAB treats hepatocellular carcinoma,1418,Cost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with alpha-fetoprotein concentrations of at least 400 ng/ml.,True,Is the triple 'RAMUCIRUMAB treats hepatocellular carcinoma' supported by the sentence: 'Cost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with alpha-fetoprotein concentrations of at least 400 ng/ml.'?,"Yes, the statement does provide indirect support for the claim that ""RAMUCIRUMAB treats hepatocellular carcinoma."" The cost-effectiveness analysis specifically focuses on ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with alpha-fetoprotein concentrations of at least 400 ng/ml. The fact that an analysis is being conducted on its cost-effectiveness implies that ramucirumab is indeed used as a treatment for hepatocellular carcinoma in this specific patient population. However, it is important to note that indirect support does not equate to direct evidence that ""RAMUCIRUMAB treats hepatocellular carcinoma."" Further investigation into clinical trial results and efficacy data would be required for more robust support of this claim."
23342893,TAFASITAMAB treats diffuse large B-cell lymphoma,1419,Lenalidomide was recently approved in combination with the anti-monoclonal B-cell antibody tafasitamab for patients with relapsed DLBCL after 1 to 3 previous treatments.,True,Is the triple 'TAFASITAMAB treats diffuse large B-cell lymphoma' supported by the sentence: 'Lenalidomide was recently approved in combination with the anti-monoclonal B-cell antibody tafasitamab for patients with relapsed DLBCL after 1 to 3 previous treatments.'?,"Yes, indirectly it does support that tafasitamab treats diffuse large B-cell lymphoma (DLBCL). The statement indicates that lenalidomide was approved in combination with tafasitamab for patients with relapsed DLBCL after 1 to 3 previous treatments. This implies that tafasitamab is an active ingredient in the treatment regimen for DLBCL, thus providing indirect support for the claim that tafasitamab treats DLBCL. However, it should be noted that tafasitamab is used in combination therapy with lenalidomide in this case, so its standalone efficacy cannot be inferred from this statement alone."
22828138,Thioctic acid treats cystinuria,1420,Tolvaptan and a-Lipoic acid were also tested in patients with cystinuria and resulted in reduction of recurrence.,True,Is the triple 'Thioctic acid treats cystinuria' supported by the sentence: 'Tolvaptan and a-Lipoic acid were also tested in patients with cystinuria and resulted in reduction of recurrence.'?,"Yes, there is indirect support for the claim that thioctic acid (also known as alpha-lipoic acid) treats cystinuria based on the statement provided. The reason for my affirmative response is that the statement includes alpha-lipoic acid in a group of substances tested for treating cystinuria (tolvaptan being another). The statement further reveals that these treatments led to a reduction in recurrence among patients with cystinuria, implying some level of efficacy for alpha-lipoic acid in treating cystinuria.

        

        However, it is essential to acknowledge certain nuances in interpreting these results. Firstly, we should note that alpha-lipoic acid was tested in conjunction with another substance (tolvaptan), so its isolated effects on cystinuria may differ from those observed in this study. Secondly, reduced recurrence does not necessarily equate to cystinuria being treated; further investigation would be required to establish whether alpha-lipoic acid addresses the underlying causes of cystinuria rather than merely reducing its recurrence rate."
21111424,Thioctic acid treats optic neuritis,1421,"Conclusion: Six weeks of oral lipoic acid supplementation after acute optic neuritis is safe and well tolerated; however, because of insufficient recruitment, we could not conclude that lipoic acid treatment was neuroprotective in acute optic neuritis.",False,"Is the triple 'Thioctic acid treats optic neuritis' supported by the sentence: 'Conclusion: Six weeks of oral lipoic acid supplementation after acute optic neuritis is safe and well tolerated; however, because of insufficient recruitment, we could not conclude that lipoic acid treatment was neuroprotective in acute optic neuritis.'?","No, the statement does not provide direct or indirect support for the claim that ""Thioctic acid treats optic neuritis."" The conclusion only states that six weeks of oral lipoic acid supplementation (Thioctic acid is another name for lipoic acid) after acute optic neuritis is safe and well-tolerated but could not conclude if it was neuroprotective due to insufficient recruitment in their study. This suggests that there is no evidence supporting that Thioctic acid treats optic neuritis based on their study alone; it only supports that it is safe for usage in such conditions. Further studies would be required to establish any therapeutic effect."
14414806,Thioctic acid treats carpal tunnel syndrome,1422,Treatment of carpal tunnel syndrome with alpha-lipoic acid.,True,Is the triple 'Thioctic acid treats carpal tunnel syndrome' supported by the sentence: 'Treatment of carpal tunnel syndrome with alpha-lipoic acid.'?,"Yes, there is indirect support for the claim that thioctic acid treats carpal tunnel syndrome based on the statement provided. Thioctic acid is another name for alpha-lipoic acid (ALA). Therefore, if ALA has been shown to treat carpal tunnel syndrome, then it follows that thioctic acid would also be effective since they are one in the same. However, it is essential to consider that correlation does not imply causation; therefore, more rigorous studies would be required before making definitive conclusions about ALA/thioctic acid as an effective treatment for carpal tunnel syndrome."
11271151,Thioctic acid treats skin disorder,1423,Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.,True,Is the triple 'Thioctic acid treats skin disorder' supported by the sentence: 'Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.'?,"Yes, there is indirect support for the claim that ""Thioctic acid treats skin disorder"" based on the statement ""Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases."" 

        Thioctic acid is also known as alpha-lipoic acid (ALA), which is an antioxidant found in small amounts in some foods and is also available as a dietary supplement. The statement provided mentions that ALA-based PPARgamma agonists can be used for treating inflammatory skin diseases. PPARgamma (peroxisome proliferator-activated receptor gamma) is a nuclear receptor that plays essential roles in adipogenesis, lipid metabolism, insulin sensitivity, and inflammation.

        Although the statement does not explicitly mention thioctic acid or skin disorders, it does suggest that ALA-based compounds (including thioctic acid) can have beneficial effects on inflammatory skin conditions due to their PPARgamma agonist activity. Therefore, there is indirect support for the claim that thioctic acid can be used for treating skin disorders based on this"
9864403,Thioctic acid treats multiple sclerosis,1424,"For study of antioxidant therapy efficiency in relapsing-remitting multiple sclerosis we investigated group 1 (18 patients) treated with alpha-lipoic acid and group 2 (14 patients) who received complex of antioxidants and neuroprotectors with various mechanisms of action (oc-lipoic acid, Nicotinamide, Acetylcysteine, Triovit Beta-carotine, Alpha-tocopheryl acetate, Ascorbic acid, Selenium, Pentoxifylline, Cerebrolysin, Amantadine hydrochloride) during 1 month, 2 times a year.",False,"Is the triple 'Thioctic acid treats multiple sclerosis' supported by the sentence: 'For study of antioxidant therapy efficiency in relapsing-remitting multiple sclerosis we investigated group 1 (18 patients) treated with alpha-lipoic acid and group 2 (14 patients) who received complex of antioxidants and neuroprotectors with various mechanisms of action (oc-lipoic acid, Nicotinamide, Acetylcysteine, Triovit Beta-carotine, Alpha-tocopheryl acetate, Ascorbic acid, Selenium, Pentoxifylline, Cerebrolysin, Amantadine hydrochloride) during 1 month, 2 times a year.'?","No, the statement does not provide direct support for the claim that thioctic acid (also known as alpha-lipoic acid) treats multiple sclerosis (MS). The statement only mentions that alpha-lipoic acid was used in a study investigating antioxidant therapy efficiency in relapsing-remitting MS patients. It does not confirm that thioctic acid is an effective treatment for MS. The study design does not allow for causal inferences between treatment and outcome either, as it only mentions that patients were ""treated"" but does not elaborate on any observed effects on MS progression or symptoms.

         In order for a study to provide indirect support for a claim like ""Thioctic acid treats multiple sclerosis"", it would need to demonstrate that patients who received thioctic acid had significantly better outcomes than those who did not receive it (or received a placebo). In addition, these results would need to be replicated in further studies conducted by different researchers in order"
8933101,Thioctic acid treats Alzheimer disease,1425,"Despite the fact that this study was small and not randomized, this is the first indication that treatment with alpha-lipoic acid might be a successful 'neuroprotective' therapy option for AD and related dementias.",False,"Is the triple 'Thioctic acid treats Alzheimer disease' supported by the sentence: 'Despite the fact that this study was small and not randomized, this is the first indication that treatment with alpha-lipoic acid might be a successful 'neuroprotective' therapy option for AD and related dementias.'?","No, the phrase ""Thioctic acid treats Alzheimer disease"" does not receive direct or indirect support from the statement provided. The statement suggests that alpha-lipoic acid (also known as thioctic acid) might be a successful neuroprotective therapy option for Alzheimer's disease (AD) and related dementias based on preliminary results from a small, non-randomized study. However, it does not confirm that thioctic acid treats AD; it only implies that it might have neuroprotective effects worthy of further investigation in more rigorous clinical trials.

        
        The distinction is crucial because preliminary results from small studies should be interpreted cautiously due to their inherent limitations (such as selection bias, small sample size, lack of randomization, etc.). While these findings can generate hypotheses for future investigations, they do not provide sufficient evidence for definitive conclusions about treatment efficacy in clinical settings. Therefore, it is inappropriate to claim that thioctic acid treats AD based solely on this information."
8739967,Thioctic acid treats hypertensive disorder,1426,"STZ-diabetes resulted in increased blood pressure, which was partially improved by alpha-lipoic acid treatment.",False,"Is the triple 'Thioctic acid treats hypertensive disorder' supported by the sentence: 'STZ-diabetes resulted in increased blood pressure, which was partially improved by alpha-lipoic acid treatment.'?","No, the statement does not provide direct or indirect support for the claim that thioctic acid treats hypertensive disorder. The statement mentions that alpha-lipoic acid treatment partially improved increased blood pressure in STZ-diabetes-induced rats. Thioctic acid is one of several names for alpha-lipoic acid; however, it is not explicitly stated that thioctic acid was used in the treatment. Therefore, it is impossible to conclude that thioctic acid is responsible for any observed improvements in blood pressure based on this information alone.

        To provide indirect support for the claim that thioctic acid treats hypertensive disorder from this statement, one would need additional evidence showing that thioctic acid specifically (not alpha-lipoic acid in general) was responsible for any observed improvements in blood pressure in subjects with hypertensive disorder (not STZ-diabetes-induced rats). It is important to note that correlation does not imply causation; therefore, even if thioctic acid were used in the study mentioned, it would still be necessary to establish that thioctic acid was responsible for any observed improvements in blood pressure before making such a claim."
7865558,Thioctic acid treats type 2 diabetes mellitus,1427,"AIMS: Thioctic acid (TA), glibenclamide and acarbose are widely used to either alone or concomitantly treat patients suffering from noninsulin-dependent diabetes (NIDDM).",False,"Is the triple 'Thioctic acid treats type 2 diabetes mellitus' supported by the sentence: 'AIMS: Thioctic acid (TA), glibenclamide and acarbose are widely used to either alone or concomitantly treat patients suffering from noninsulin-dependent diabetes (NIDDM).'?","No, the statement does not provide direct support for the claim that ""Thioctic acid treats type 2 diabetes mellitus."" The AIMS (objective) statement only mentions that Thioctic acid (TA), along with glibenclamide and acarbose, is used in treating patients with noninsulin-dependent diabetes (NIDDM), which is another term for type 2 diabetes mellitus. It does not specify that Thioctic acid treats type 2 diabetes mellitus; it only mentions its use as a treatment option among other agents. Therefore, further investigation is needed to establish whether Thioctic acid indeed has a therapeutic effect on type 2 diabetes mellitus."
7603474,Thioctic acid treats diabetic neuropathy,1428,"A two-central randomised single-blind placebo-controlled study was conducted to assess efficacy of intravenous administration of trometamol salt of thioctic (alpha-lipoic) acid (Thioctacid 600, ""ASTA Medica"", Germany) in 200 ml of physiological solution in 40 non-insulin dependent diabetic patients with symptomatic diabetic neuropathy.",True,"Is the triple 'Thioctic acid treats diabetic neuropathy' supported by the sentence: 'A two-central randomised single-blind placebo-controlled study was conducted to assess efficacy of intravenous administration of trometamol salt of thioctic (alpha-lipoic) acid (Thioctacid 600, ""ASTA Medica"", Germany) in 200 ml of physiological solution in 40 non-insulin dependent diabetic patients with symptomatic diabetic neuropathy.'?","Yes, the statement does provide indirect support for the claim that thioctic acid treats diabetic neuropathy. The study described is a well-controlled clinical trial involving non-insulin dependent diabetic patients with symptomatic diabetic neuropathy who were given intravenous thioctic acid (also known as alpha-lipoic acid). The fact that such a study was conducted suggests that there is some basis for believing that thioctic acid may have therapeutic effects in diabetic neuropathy, although further investigation would be needed to confirm these results and establish optimal treatment regimens.

         However, it is important to note that while this statement suggests that thioctic acid may be helpful for diabetic neuropathy, it does not necessarily mean that thioctic acid is superior to other treatments for diabetic neuropathy nor that it is effective for all patients. The study design described (a randomised single-blind placebo-controlled trial) is considered high quality but further studies would be needed for more robust evidence.

         Additionally, it is not clear from the statement whether thioctic acid was found to be effective in treating diabetic neuropathy in"
21616335,Ampicillin treats Infection,1429,"Penicillin Allergy in Pregnancy: Moving From ""Rash"" Decisions to Accurate Diagnosis.The emergence of beta-lactam-resistant pathogenic organisms has resulted in limitation or even elimination of drugs such as penicillin and ampicillin from available antibiotic choices for treating common infections in obstetrics and gynecology.",False,"Is the triple 'Ampicillin treats Infection' supported by the sentence: 'Penicillin Allergy in Pregnancy: Moving From ""Rash"" Decisions to Accurate Diagnosis.The emergence of beta-lactam-resistant pathogenic organisms has resulted in limitation or even elimination of drugs such as penicillin and ampicillin from available antibiotic choices for treating common infections in obstetrics and gynecology.'?","No, the phrase ""Ampicillin treats Infection"" does not receive at least indirect support from the statement provided. The statement mentions that the emergence of beta-lactam-resistant pathogens has resulted in limitations or even elimination of drugs like penicillin and ampicillin from available antibiotic choices for treating common infections in obstetrics and gynecology. This implies that these drugs may not be as effective due to bacterial resistance, rather than providing support for their efficacy in treating infections."
16205290,Ampicillin treats chorioamnionitis,1430,"The patient was treated with pressors and antibiotics and was admitted to the medical intensive care unit where she received ampicillin, gentamycin, and clindamycin for suspected chorioamnionitis.",True,"Is the triple 'Ampicillin treats chorioamnionitis' supported by the sentence: 'The patient was treated with pressors and antibiotics and was admitted to the medical intensive care unit where she received ampicillin, gentamycin, and clindamycin for suspected chorioamnionitis.'?","Yes, indirect support can be inferred from the statement provided. The patient was diagnosed with suspected chorioamnionitis and was administered ampicillin among other antibiotics as part of her treatment regimen in the intensive care unit (ICU). This suggests that ampicillin is considered an appropriate antibiotic for treating chorioamnionitis. However, it is important to note that the statement does not explicitly state that ampicillin was used to treat chorioamnionitis in this specific case; it only implies that ampicillin is used in treating chorioamnionitis generally based on medical protocols for such cases. Additionally, ampicillin was administered along with other antibiotics (gentamycin and clindamycin), which may indicate that chorioamnionitis can be treated using multiple antibiotics in combination depending on the specific circumstances and severity of the infection."
15830384,Ampicillin treats bacterial infectious disease,1431,Based on these results aztreonam appears to be at least as effective as and possibly more effective than amikacin when used initially with ampicillin for empiric treatment of neonatal bacterial infections.,True,Is the triple 'Ampicillin treats bacterial infectious disease' supported by the sentence: 'Based on these results aztreonam appears to be at least as effective as and possibly more effective than amikacin when used initially with ampicillin for empiric treatment of neonatal bacterial infections.'?,"Yes, the statement does provide indirect support for the phrase ""Ampicillin treats bacterial infectious disease"". The key term here is ""used initially with ampicillin"", which implies that ampicillin is being utilized as part of a treatment regimen for neonatal bacterial infections. The fact that aztreonam is found to be at least as effective when used in combination with ampicillin suggests that ampicillin is contributing positively to the treatment outcome. Therefore, it can be inferred that ampicillin does indeed have efficacy in treating bacterial infectious disease, at least in neonatal cases when used in combination therapy. However, it should be noted that this is an indirect inference based on the given statement, and direct evidence from clinical trials or other primary sources would be necessary for a more definitive conclusion."
14976711,Ampicillin treats osteomyelitis,1432,"When antibiotic therapy was delayed for seven days, osteomyelitis developed in four of eight animals treated locally with microencapsulated ampicillin and in six of eight animals that received parenteral ampicillin therapy.",True,"Is the triple 'Ampicillin treats osteomyelitis' supported by the sentence: 'When antibiotic therapy was delayed for seven days, osteomyelitis developed in four of eight animals treated locally with microencapsulated ampicillin and in six of eight animals that received parenteral ampicillin therapy.'?","Yes, indirectly it does support the claim that ampicillin treats osteomyelitis. The statement shows that animals treated locally with microencapsulated ampicillin or those that received parenteral ampicillin therapy had lower instances of osteomyelitis when antibiotic therapy was initiated within seven days compared to when it was delayed. This implies that ampicillin has some therapeutic effect in treating osteomyelitis, even though it doesn't explicitly prove that ampicillin is the sole treatment for osteomyelitis. However, it is important to note that direct clinical trials in humans would be necessary for making definitive conclusions about treatment efficacy in humans."
12551965,Ampicillin treats Sepsis,1433,"In the present study, we validated the antagonism in combinations of VCM with other beta-lactams, i.e., flomoxef (FMOX), ampicillin (AMPC), azthreonam (AZT) and imipenem/cilastatin (IPM/CS), in systemic infections and pneumoniain in mice.",False,"Is the triple 'Ampicillin treats Sepsis' supported by the sentence: 'In the present study, we validated the antagonism in combinations of VCM with other beta-lactams, i.e., flomoxef (FMOX), ampicillin (AMPC), azthreonam (AZT) and imipenem/cilastatin (IPM/CS), in systemic infections and pneumoniain in mice.'?","No, the phrase ""Ampicillin treats Sepsis"" does not receive direct support from the statement provided. The statement only indicates that ampicillin (AMPC) was used in combination with other drugs for systemic infections and pneumonia in mice without specifying sepsis as an infection model nor providing information about ampicillin's effectiveness as a single agent for treating sepsis.

         Indirect support might be inferred from the fact that ampicillin was tested in systemic infections, which could potentially include sepsis as it is defined as a dysregulated host response to infection leading to life-threatening organ dysfunction (Singer et al., 2016). However, without explicit evidence addressing ampicillin's impact on sepsis treatment in either animal models or clinical trials, it is not possible to establish direct support for the initial claim based on the given statement alone.

         References:

         Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G., Chiche J.-D.,"
9906170,Ampicillin treats bacterial meningitis,1434,"The mortality rate in this type of BM is still high among those treated with ampicillin or penicillin, and a decrease in the mortality rate was not observed when the reported cases in Spain in the last 30 years were analyzed.",False,"Is the triple 'Ampicillin treats bacterial meningitis' supported by the sentence: 'The mortality rate in this type of BM is still high among those treated with ampicillin or penicillin, and a decrease in the mortality rate was not observed when the reported cases in Spain in the last 30 years were analyzed.'?","No, the statement does not provide indirect support for the phrase ""Ampicillin treats bacterial meningitis."" In fact, it suggests that ampicillin (and penicillin) may not be effective in reducing mortality rates in bacterial meningitis (BM) patients. The lack of decrease in mortality rate over 30 years among patients treated with these antibiotics implies that alternative treatments might be more successful in managing BM. However, it does not necessarily mean that ampicillin cannot contribute to treating bacterial meningitis; it might simply indicate that it is not sufficient as monotherapy or that there is bacterial resistance to it in certain populations. Nonetheless, without additional information on other factors such as dosage, duration, combination therapy, and patient demographics, it is difficult to draw definitive conclusions about ampicillin's efficacy in treating bacterial meningitis based solely on this statement."
8394714,Ampicillin treats gonorrhea,1435,Ampicillin has assumed a prominent role in the treatment of gonorrhoea.,True,Is the triple 'Ampicillin treats gonorrhea' supported by the sentence: 'Ampicillin has assumed a prominent role in the treatment of gonorrhoea.'?,"Yes, the statement ""Ampicillin has assumed a prominent role in the treatment of gonorrhea"" does provide indirect support for the claim that ""Ampicillin treats gonorrhea."" This is because assuming a prominent role in treatment implies that the drug is effective against the disease in question, which in this case is gonorrhea. However, it is important to note that while indirect support exists, it does not constitute definitive proof of efficacy as other factors such as side effects, resistance development, and contraindications could influence Ampicillin's suitability for gonorrhea treatment."
7166712,Ampicillin treats pneumonia,1436,[Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].,True,Is the triple 'Ampicillin treats pneumonia' supported by the sentence: '[Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].'?,"Yes, the statement does provide indirect support for the claim that ampicillin treats pneumonia. The title mentions sulbactam/ampicillin in relation to treating pneumonia in elderly patients. Ampicillin is one component of sulbactam/ampicillin, which is an antibiotic combination used for treating various bacterial infections including pneumonia. Therefore, it suggests that ampicillin has some therapeutic effect on pneumonia when used in combination therapy. However, it is important to note that ampicillin monotherapy may not be recommended for treating pneumonia due to increasing bacterial resistance patterns. A more accurate assessment would require reading the full study to understand how ampicillin was used in treatment and its specific outcomes in comparison to other antibiotics evaluated in the study."
22520021,Carbenicillin treats bacterial infectious disease,1437,In this study results of treatment with ceftazidime were superior to results of treatment with amikacin/carbenicillin for invasive bacterial infections of newborn infants.,True,Is the triple 'Carbenicillin treats bacterial infectious disease' supported by the sentence: 'In this study results of treatment with ceftazidime were superior to results of treatment with amikacin/carbenicillin for invasive bacterial infections of newborn infants.'?,"Yes, indirectly it does lend support. The statement indicates that carbenicillin was used in combination with amikacin for treating invasive bacterial infections in newborn infants, suggesting that it has some efficacy in treating bacterial infectious diseases. However, ceftazidime was found to be more effective in treating these infections than carbenicillin in combination with amikacin. This does not negate the fact that carbenicillin does have therapeutic value in treating bacterial infections, but it may not be as effective as other antibiotics like ceftazidime for certain types of infections."
26119472,Bacampicillin treats bacterial infectious disease,1438,Clinical trial of bacampicillin in acute bacterial infections.,True,Is the triple 'Bacampicillin treats bacterial infectious disease' supported by the sentence: 'Clinical trial of bacampicillin in acute bacterial infections.'?,"Yes, the statement ""Clinical trial of bacampicillin in acute bacterial infections"" does provide indirect support for the claim that ""Bacampicillin treats bacterial infectious disease."" This is because conducting a clinical trial implies that there is some level of investigation into its potential therapeutic benefits for treating bacterial infections, which suggests that it may have some efficacy in treating such conditions. However, it is important to note that indirect support does not equate to definitive proof; further investigation would be necessary to fully establish bacampicillin as an effective treatment for bacterial infections."
25659721,Aspoxicillin treats bacterial infectious disease,1439,The above results suggest that ASPC is an useful antibiotic for treating pediatric bacterial infections.,True,Is the triple 'Aspoxicillin treats bacterial infectious disease' supported by the sentence: 'The above results suggest that ASPC is an useful antibiotic for treating pediatric bacterial infections.'?,"Yes, indirectly it does provide support for that statement. The phrase ""ASPC is an useful antibiotic for treating pediatric bacterial infections"" suggests that ASPC (presumably Aspoxicillin) has been found effective in treating bacterial infections in children. This implies that Aspoxicillin can indeed treat bacterial infectious diseases, although not explicitly stated in the given context. However, it should be noted that this interpretation is based on assumptions about ASPC being equivalent to Aspoxicillin, which may not always be accurate in all contexts. Therefore, further investigation would be necessary for a more definitive conclusion."
13845936,Mezlocillin treats bacterial infectious disease,1440,"An open, multicentre study was performed in hospital in-patients at a total of 12 German hospitals to investigate the efficacy and tolerability of sulbactam combined with mezlocillin, piperacillin or cefotaxime in severe bacterial infections.",True,"Is the triple 'Mezlocillin treats bacterial infectious disease' supported by the sentence: 'An open, multicentre study was performed in hospital in-patients at a total of 12 German hospitals to investigate the efficacy and tolerability of sulbactam combined with mezlocillin, piperacillin or cefotaxime in severe bacterial infections.'?","Yes, indirectly it does support the claim that mezlocillin treats bacterial infectious disease. The statement mentions an open, multicentre study conducted in Germany investigating the efficacy (effectiveness in treating disease) and tolerability (ability for patients to tolerate it without significant side effects) of sulbactam combined with mezlocillin in treating severe bacterial infections in hospital in-patients across 12 hospitals.

         However, it is important to note that while this statement supports mezlocillin's potential therapeutic application for bacterial infections based on clinical investigation, it does not provide direct evidence for its specific mechanism of action against bacteria nor its proven efficacy in treating all types of bacterial infections. To establish such certainty, further information such as clinical trial results, specific bacterial strains targeted, dosage information, and potential side effects would be required."
7407212,Benzoyl Peroxide treats acne,1441,"Treatments for acne can be topical or systemic, and include retinoids, antibiotics, benzoyl peroxide, azelaic acid, and hormonal therapy.",True,"Is the triple 'Benzoyl Peroxide treats acne' supported by the sentence: 'Treatments for acne can be topical or systemic, and include retinoids, antibiotics, benzoyl peroxide, azelaic acid, and hormonal therapy.'?","Yes, the phrase ""Benzoyl Peroxide treats acne"" does receive indirect support from the statement: ""Treatments for acne can be topical or systemic, and include retinoids, antibiotics, benzoyl peroxide, azelaic acid, and hormonal therapy.""

         The statement lists benzoyl peroxide as one of the treatments for acne, which implies that it has been found to be effective in addressing acne symptoms. Therefore, it indirectly supports the claim that benzoyl peroxide treats acne by providing evidence that it is recognized as a treatment option within the field of dermatology. However, it is important to note that further investigation into specific studies or trials would be required for more direct support of benzoyl peroxide's efficacy in treating acne."
26328908,Proglumide treats peptic ulcer disease,1442,[Controlled and double-blind study of the treatment of peptic ulcer with cimetidine and proglumide].,True,Is the triple 'Proglumide treats peptic ulcer disease' supported by the sentence: '[Controlled and double-blind study of the treatment of peptic ulcer with cimetidine and proglumide].'?,"Yes, indirectly it does lend some support. The statement mentions that there was a controlled and double-blind study conducted on the treatment of peptic ulcer using both cimetidine and proglumide. This indicates that proglumide was at least considered as a potential treatment for peptic ulcer disease in a clinical setting, which is a form of indirect support for its use in treating peptic ulcers. However, it does not provide direct evidence that proglumide is effective in treating peptic ulcer disease as it does not mention any specific outcomes related to proglumide treatment in this study. To make a definitive conclusion about its efficacy in treating peptic ulcer disease, more detailed information about its clinical performance in comparison to other treatments (such as cimetidine) would be required."
13022426,Pirenzepine treats gastroesophageal reflux disease,1443,Pirenzepine may provide a unique alternative for some GERD patients who may be refractory to other therapies of GERD.,True,Is the triple 'Pirenzepine treats gastroesophageal reflux disease' supported by the sentence: 'Pirenzepine may provide a unique alternative for some GERD patients who may be refractory to other therapies of GERD.'?,"Yes, the statement ""Pirenzepine may provide a unique alternative for some GERD patients who may be refractory to other therapies of GERD"" does lend indirect support to the claim that ""Pirenzepine treats gastroesophageal reflux disease (GERD)"". This is because it suggests that pirenzepine has some efficacy in treating GERD symptoms in at least some patients who have not responded well to other treatments. However, it does not provide direct evidence that pirenzepine is an effective treatment for GERD in general, as it only refers to a specific subset of patients who have been refractory to other therapies. Additionally, it is important to consider that stating ""Pirenzepine treats GERD"" might be an overstatement based on this information alone, as it does not cover all aspects such as safety, efficacy in comparison to other drugs, dosage recommendations etc., which would typically be included in a full evaluation of a treatment for a medical condition like GERD."
10839963,Pirenzepine treats peptic ulcer disease,1444,Four hundred and two patients with peptic ulcer were selected for acute therapy with either pirenzepine (100 mg/day) or cimetidine (800 mg/day) using the envelope method.,False,Is the triple 'Pirenzepine treats peptic ulcer disease' supported by the sentence: 'Four hundred and two patients with peptic ulcer were selected for acute therapy with either pirenzepine (100 mg/day) or cimetidine (800 mg/day) using the envelope method.'?,"No, the statement ""Pirenzepine treats peptic ulcer disease"" does not receive direct support from the provided statement. The given information describes a clinical trial where patients were treated with either pirenzepine (100 mg/day) or cimetidine (800 mg/day) for peptic ulcer disease using the envelope method for randomization. However, it does not provide any information about the outcomes of the treatments, such as whether pirenzepine was effective in treating peptic ulcers compared to cimetidine. Therefore, it is not possible to infer any support for pirenzepine as an effective treatment for peptic ulcer disease based on this statement alone."
16332442,Magnesium Oxide treats autosomal recessive inherited pseudoxanthoma elasticum,1445,"In that context, magnesium oxide significantly reduced CIMT in PXE mice, and may be useful for disease prevention in PXE patients.",False,"Is the triple 'Magnesium Oxide treats autosomal recessive inherited pseudoxanthoma elasticum' supported by the sentence: 'In that context, magnesium oxide significantly reduced CIMT in PXE mice, and may be useful for disease prevention in PXE patients.'?","No, the phrase ""Magnesium Oxide treats autosomal recessive inherited pseudoxanthoma elasticum (PXE)"" does not receive indirect support from the statement: ""In that context, magnesium oxide significantly reduced CIMT in PXE mice, and may be useful for disease prevention in PXE patients.""

         The statement provides evidence that magnesium oxide can reduce CIMT (carotid intima-media thickness) in PXE mice, which is an indicator for cardiovascular health. Furthermore, it suggests that magnesium oxide might be helpful in preventing disease progression in PXE patients. However, it does not explicitly state that magnesium oxide treats PXE nor does it provide any information about its effect on autosomal recessive inheritance patterns specific to PXE.

         PXE is caused by mutations in the ABCC6 gene leading to mineral imbalances in tissues; therefore, while magnesium oxide might help manage some symptoms by addressing potential secondary effects (such as reducing CIMT), it does not target the root cause of PXE. Therefore, it"
15225864,Magnesium Oxide treats constipation disorder,1446,"This report presents the rare case of a 75-year-old woman who developed a rectal obstruction caused by a pharmacobezoar, following the long-term ingestion of magnesium oxide cathartics for constipation.",True,"Is the triple 'Magnesium Oxide treats constipation disorder' supported by the sentence: 'This report presents the rare case of a 75-year-old woman who developed a rectal obstruction caused by a pharmacobezoar, following the long-term ingestion of magnesium oxide cathartics for constipation.'?","Yes, while the statement does not explicitly state that magnesium oxide treats constipation disorder, it does imply that magnesium oxide cathartics (a term used for medications that stimulate bowel movements) were used by a patient for constipation over an extended period. The fact that this led to a rectal obstruction could be interpreted as evidence supporting magnesium oxide's effectiveness in treating constipation, albeit with potential side effects when used excessively or over an extended period. However, it is crucial to note that this is an indirect inference based on one case report, which may not be representative of typical outcomes or generalizable to all patients. A more definitive conclusion would require a systematic review or randomized controlled trials demonstrating both safety and efficacy in treating constipation disorder with magnesium oxide cathartics."
26045826,Ticarcillin treats Sepsis,1447,Mezlocillin and ticarcillin in the treatment of patients with serious systemic infections.,True,Is the triple 'Ticarcillin treats Sepsis' supported by the sentence: 'Mezlocillin and ticarcillin in the treatment of patients with serious systemic infections.'?,"Yes, indirectly it does support the statement that ticarcillin treats sepsis. The reason being that sepsis is indeed considered a serious systemic infection, as mentioned in the statement provided. Therefore, if ticarcillin is mentioned as being used in treatment along with mezlocillin for such infections, it can be inferred that ticarcillin could potentially be used for treating sepsis as well. However, it is important to note that direct evidence through clinical trials specifically investigating ticarcillin for sepsis treatment would provide stronger support for such a claim."
9410149,Ticarcillin treats osteomyelitis,1448,Obviously unbalanced comparative studies showed some benefit of ticarcillin for bone infections caused by Pseudomonas species.,True,Is the triple 'Ticarcillin treats osteomyelitis' supported by the sentence: 'Obviously unbalanced comparative studies showed some benefit of ticarcillin for bone infections caused by Pseudomonas species.'?,"Yes, indirectly it does lend some support. The statement mentions that unbalanced comparative studies have shown some benefit of ticarcillin for bone infections caused by Pseudomonas species, which implies that ticarcillin could potentially be used as a treatment for osteomyelitis if it is caused by Pseudomonas species. However, it is important to note that unbalanced comparative studies have limitations in their design and results interpretation compared to randomized controlled trials due to potential confounding factors influencing outcomes. Moreover, osteomyelitis can be caused by various microorganisms, not exclusively Pseudomonas species; hence ticarcillin might not be an appropriate treatment for all cases of osteomyelitis. A more definitive conclusion would require further investigation into well-designed clinical trials that assess ticarcillin's efficacy in treating osteomyelitis caused specifically by Pseudomonas species."
26823243,Urea treats citrullinemia,1449,"The precursors of urea (ammonia, glutamate, glutamine and alpha-amino nitrogen) did not increase after the benzoate administration in the 6 normal subjects as well as in the 2 patients with citrullinaemia.",False,"Is the triple 'Urea treats citrullinemia' supported by the sentence: 'The precursors of urea (ammonia, glutamate, glutamine and alpha-amino nitrogen) did not increase after the benzoate administration in the 6 normal subjects as well as in the 2 patients with citrullinaemia.'?","No, the statement does not provide indirect support for the phrase ""Urea treats citrullinemia."" The statement discusses the lack of increase in precursors of urea (ammonia, glutamate, glutamine, and alpha-amino nitrogen) after benzoate administration in both normal subjects and patients with citrullinemia. However, it does not mention or imply any therapeutic effect of urea on citrullinemia. Urea might be a metabolic byproduct but there is no evidence in this statement that it has any therapeutic effect on citrullinemia."
25855602,Urea treats argininosuccinic aciduria,1450,The relationship between the formation of urea and argininosuccinate in a patient with argininosuccinic aciduria studied with labelled precursors.,False,Is the triple 'Urea treats argininosuccinic aciduria' supported by the sentence: 'The relationship between the formation of urea and argininosuccinate in a patient with argininosuccinic aciduria studied with labelled precursors.'?,"No, the phrase ""Urea treats argininosuccinic aciduria"" does not receive direct support from the statement: ""The relationship between the formation of urea and argininosuccinate in a patient with argininosuccinic aciduria studied with labelled precursors.""

         The statement describes an observational study where labelled precursors were used in a patient with argininosuccinic aciduria (ASA) to investigate the relationship between urea formation and argininosuccinate (AS). While it provides valuable information on metabolic processes in an ASA patient, it does not offer direct support for urea being an effective treatment for ASA due to lack of intervention or treatment information in the statement. Argininosuccinic aciduria is an autosomal recessive genetic disorder caused by deficiency in argininosuccinate lyase enzyme activity, leading to an accumulation of argininosuccinic acid in body fluids and tissues as well as elevated levels of arginine in plasma and urine. The standard treatment for ASA involves dietary protein restriction along with arginine supplementation as well as nitrogen sc"
19420190,Urea treats psoriasis,1451,"In the treatment of psoriasis with urea and urea-combined preparations, the individual sequence should be so clearly prescribed such that acceptance is assured.",False,"Is the triple 'Urea treats psoriasis' supported by the sentence: 'In the treatment of psoriasis with urea and urea-combined preparations, the individual sequence should be so clearly prescribed such that acceptance is assured.'?","No, the statement does not provide indirect support for the phrase ""Urea treats psoriasis."" The statement primarily discusses the importance of prescribing urea-based treatments for psoriasis in a particular sequence to ensure patient acceptance, but it does not confirm that urea effectively treats psoriasis. To establish whether urea treats psoriasis, one would need rigorous clinical trials demonstrating its efficacy compared to placebo or other treatments."
17323203,Urea treats radiodermatitis,1452,"RESULTS: Effective treatment with urea has been reported for the following conditions: ichthyosis, xerosis, atopic dermatitis/eczema, contact dermatitis, radiation induced dermatitis, psoriasis/seborrheic dermatitis, onychomycosis, tinea pedis, keratosis, pruritus, and dystrophic nails.",True,"Is the triple 'Urea treats radiodermatitis' supported by the sentence: 'RESULTS: Effective treatment with urea has been reported for the following conditions: ichthyosis, xerosis, atopic dermatitis/eczema, contact dermatitis, radiation induced dermatitis, psoriasis/seborrheic dermatitis, onychomycosis, tinea pedis, keratosis, pruritus, and dystrophic nails.'?","Yes, the statement does provide indirect support for the claim that urea treats radiodermatitis. The provided result shows urea as an effective treatment for radiation-induced dermatitis, which is a type of radiodermatitis. However, it is important to note that indirect support does not equate to definitive proof; further investigation would be necessary to confirm these findings in controlled clinical trials before making definitive conclusions about urea as a treatment for radiodermatitis."
15413374,Urea treats hepatocellular carcinoma,1453,"INTRODUCTION: Sorafenib is a novel oral bis-aryl urea compound that has proven survival benefit in patients with advanced hepatocellular carcinoma (HCC), for which several therapies are currently available with unsatisfactory results.",False,"Is the triple 'Urea treats hepatocellular carcinoma' supported by the sentence: 'INTRODUCTION: Sorafenib is a novel oral bis-aryl urea compound that has proven survival benefit in patients with advanced hepatocellular carcinoma (HCC), for which several therapies are currently available with unsatisfactory results.'?","No, the statement does not provide indirect support for the claim that ""urea treats hepatocellular carcinoma."" The introduction mentions sorafenib as a bis-aryl urea compound, but it does not suggest that urea itself has therapeutic effects on hepatocellular carcinoma. The survival benefit observed in patients is attributed specifically to sorafenib treatment, not urea in general. The misconception may arise from conflating the effects of sorafenib, which contains urea subunits, with those of urea itself. However, based on the information provided in this statement alone, there is no evidence supporting urea as an effective treatment for hepatocellular carcinoma."
12068406,Urea treats type 2 diabetes mellitus,1454,These findings are consistent with the inhibition of hepatic glycogenolysis and support the use of acyl ureas for the treatment of type 2 diabetes.,False,Is the triple 'Urea treats type 2 diabetes mellitus' supported by the sentence: 'These findings are consistent with the inhibition of hepatic glycogenolysis and support the use of acyl ureas for the treatment of type 2 diabetes.'?,"No, the statement does not provide direct or indirect support for the claim that ""urea treats type 2 diabetes mellitus."" The reason is that urea is not an acyl urea; they belong to different chemical classes. Urea is a simple organic compound containing nitrogen (NH2)2CO while acyl ureas contain an acyl group (R-CO) bonded to urea (NH2)CONH2. Therefore, even though acyl ureas might have potential therapeutic benefits for treating type 2 diabetes mellitus by inhibiting hepatic glycogenolysis as suggested in the statement, it does not imply that urea itself has any such effects."
11649881,Urea treats Pain,1455,"Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.",True,"Is the triple 'Urea treats Pain' supported by the sentence: 'Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.'?","Yes, there is indirect support for the phrase ""Urea treats Pain"" from the statement: ""Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.""

        

        The statement discusses ureas as transient receptor potential vanilloid 1 (TRPV1) receptor antagonists for pain treatment. TRPV1 receptors play an essential role in pain sensation; hence blocking them can alleviate pain (Starowicz et al., 2007). The urea compounds mentioned in the article undergo structural modifications aiming at optimizing their TRPV1 receptor antagonistic properties for pain treatment purposes. Therefore, it indirectly supports that urea can be used in treating pain through its TRPV1 receptor antagonistic activity.

        

        Starowicz, K., Kaczorowska-Drozd, M., & Walkowiak, J. ("
10679439,Urea treats skin disorder,1456,[TROPHIC ACTION OF UREA AND ITS USE IN THE TREATMENT OF NEUROTROPHIC SKIN DISEASES].,True,Is the triple 'Urea treats skin disorder' supported by the sentence: '[TROPHIC ACTION OF UREA AND ITS USE IN THE TREATMENT OF NEUROTROPHIC SKIN DISEASES].'?,"Yes, the phrase ""Urea treats skin disorder"" does receive indirect support from the statement: ""[TROPHIC ACTION OF UREA AND ITS USE IN THE TREATMENT OF NEUROTROPHIC SKIN DISEASES]."" This is because neurotrophic skin diseases constitute a type of skin disorder, and urea is mentioned as having therapeutic applications for these conditions due to its trophic action. However, it is important to note that not all skin disorders may be responsive to urea treatment; therefore, further investigation would be required to determine its specific utility in various dermatological contexts."
10511987,Urea treats diabetes mellitus,1457,"[Preliminary note on the oral treatment of diabetes by N-sulfonyl-p-methylbenzene-N'-n-butyl urea or D 860, a product free of antibacterial action].",False,"Is the triple 'Urea treats diabetes mellitus' supported by the sentence: '[Preliminary note on the oral treatment of diabetes by N-sulfonyl-p-methylbenzene-N'-n-butyl urea or D 860, a product free of antibacterial action].'?","No, the statement does not provide indirect support for the phrase ""Urea treats diabetes mellitus."" The statement discusses the oral treatment of diabetes using N-sulfonyl-p-methylbenzene-N'-n-butyl urea (D 860), which is a specific chemical compound different from urea. Urea is a waste product that is not typically considered an effective treatment for diabetes mellitus. Therefore, without further evidence connecting urea to diabetes treatment, it is incorrect to assume that urea has any positive impact on diabetes management based on this statement alone."
8678587,"Urea treats dermatitis, atopic",1458,"In the present report, we compared two creams, identical with the exception that one contained both urea and sodium chloride and the other urea alone, in 22 patients with atopic dermatitis.",True,"Is the triple 'Urea treats dermatitis, atopic' supported by the sentence: 'In the present report, we compared two creams, identical with the exception that one contained both urea and sodium chloride and the other urea alone, in 22 patients with atopic dermatitis.'?","Yes, the statement does provide indirect support for the claim that ""Urea treats dermatitis, atopic"". The study mentioned in the statement compared two creams, one containing urea alone and another containing both urea and sodium chloride, in patients with atopic dermatitis. This implies that urea was being tested for its potential therapeutic effect on atopic dermatitis, which aligns with the claim that urea treats dermatitis, atopic. However, it is important to note that while this offers some support for the claim, it does not constitute definitive proof. The results of the study would need to be analyzed to determine whether urea had a significant positive effect on atopic dermatitis symptoms."
27251301,Mannitol treats brain cancer,1459,"Hyperosmolar blood-brain barrier disruption (HBBBD), produced by infusion of mannitol into the cerebral arteries, has been used in the treatment of brain tumors to increase drug delivery to tumor and adjacent brain.",True,"Is the triple 'Mannitol treats brain cancer' supported by the sentence: 'Hyperosmolar blood-brain barrier disruption (HBBBD), produced by infusion of mannitol into the cerebral arteries, has been used in the treatment of brain tumors to increase drug delivery to tumor and adjacent brain.'?","Yes, indirectly it does lend some support. The statement mentions that mannitol is used in hyperosmolar blood-brain barrier disruption (HBBBD) for treating brain tumors, which implies an increased delivery of drugs to the tumor site due to its infusion into cerebral arteries. Since mannitol is being applied in a clinical setting for brain cancer treatment in combination with other drugs, it suggests that mannitol might play a contributing role in treating brain cancer, even though mannitol itself is not killing cancer cells directly in this context. However, further investigation is required for more direct evidence on mannitol's specific therapeutic effects on brain cancer cells."
21059003,Mannitol treats hearing loss disorder,1460,[Effects of mannitol on the fluids of the internal ear. Use in the treatment of deafness].,True,Is the triple 'Mannitol treats hearing loss disorder' supported by the sentence: '[Effects of mannitol on the fluids of the internal ear. Use in the treatment of deafness].'?,"Yes, indirectly it does lend some support to the claim that mannitol treats hearing loss disorder. The statement ""Effects of mannitol on the fluids of the internal ear. Use in the treatment of deafness"" implies that mannitol has an impact on the internal ear fluids and is used in treating deafness (or hearing loss disorder). However, it doesn't explicitly confirm that mannitol treats hearing loss disorder; rather it suggests that mannitol might be used as part of a treatment regimen for hearing issues. To strengthen this claim, further evidence would be needed that specifically investigates mannitol's effects on hearing loss disorders."
20425957,Mannitol treats osteoarthritis,1461,Objective: To assess efficacy and safety of a single intra-articular injection of 2% sodium hyaluronate plus 0.5% mannitol in patients with symptomatic osteoarthritis of the knee.,True,Is the triple 'Mannitol treats osteoarthritis' supported by the sentence: 'Objective: To assess efficacy and safety of a single intra-articular injection of 2% sodium hyaluronate plus 0.5% mannitol in patients with symptomatic osteoarthritis of the knee.'?,"Yes, indirectly it does lend some support. The statement discusses an objective aimed at assessing the efficacy and safety of a treatment for osteoarthritis of the knee which includes mannitol as one of its components (0.5% mannitol in 2% sodium hyaluronate). This implies that mannitol is being considered for its potential therapeutic benefits in treating osteoarthritis in this context. However, it is important to note that further investigation is needed - such as reviewing the results and conclusions from the study - in order to fully understand if mannitol indeed has positive effects on osteoarthritis treatment when combined with sodium hyaluronate."
16945033,Mannitol treats hypotensive disorder,1462,"These values were correlated with expected risk factors for lactatemia including length of surgery, Body Mass Index (BMI), hypotension, hemoglobin and mannitol therapy.",False,"Is the triple 'Mannitol treats hypotensive disorder' supported by the sentence: 'These values were correlated with expected risk factors for lactatemia including length of surgery, Body Mass Index (BMI), hypotension, hemoglobin and mannitol therapy.'?","No, the statement does not provide direct support for the claim that Mannitol treats hypotensive disorder. The passage mentions Mannitol therapy in correlation with hypotension but it does not imply any causative relationship between Mannitol administration and improvement in hypotensive disorder. In fact, hypotension is listed as one of the risk factors for lactatemia along with Mannitol therapy, suggesting that hypotension may be an effect rather than an outcome being treated by Mannitol in this context. However, further investigation into specific studies or trials examining Mannitol as a treatment for hypotensive disorder would be necessary for a more definitive conclusion."
12644644,Mannitol treats Pain,1463,"Further treatments with intravenous mannitol, oral carbonic anhydrase inhibitor, topical antiglaumatic agents and subconjunctival 5-fluorouracil (5-FU) injections all failed to control relapsing pain and IOP elevation.",False,"Is the triple 'Mannitol treats Pain' supported by the sentence: 'Further treatments with intravenous mannitol, oral carbonic anhydrase inhibitor, topical antiglaumatic agents and subconjunctival 5-fluorouracil (5-FU) injections all failed to control relapsing pain and IOP elevation.'?","No, the statement does not provide indirect support for the claim that ""Mannitol treats Pain."" In fact, it seems to suggest the opposite. The passage mentions that intravenous mannitol was one of several treatments tried on a patient suffering from relapsing pain and intraocular pressure (IOP) elevation, but these treatments ""all failed to control"" these symptoms. Therefore, based on this information alone, we cannot infer that mannitol is an effective treatment for pain. However, it is important to note that this does not definitively disprove mannitol's efficacy for pain relief; more context and evidence would be needed for a thorough evaluation."
11774217,Mannitol treats brain injury,1464,CONCLUSIONS: The results suggested that mannitol could improve cerebral perfusion in patients with mild brain damage.,True,Is the triple 'Mannitol treats brain injury' supported by the sentence: 'CONCLUSIONS: The results suggested that mannitol could improve cerebral perfusion in patients with mild brain damage.'?,"Yes, the statement ""CONCLUSIONS: The results suggested that mannitol could improve cerebral perfusion in patients with mild brain damage"" does provide indirect support for the claim that ""Mannitol treats brain injury"". The improvement in cerebral perfusion implies that mannitol may help in treating brain injury by enhancing blood flow to the brain, thereby potentially reducing further damage. However, it is important to note that direct evidence linking mannitol administration to overall improvements in brain injury outcomes is not provided in this statement alone. Therefore, while there is some level of support for the claim based on this information, additional evidence would be needed for a more definitive conclusion."
11660589,Mannitol treats malaria,1465,"A possibly indulgent wish list of outcome (mortality) studies using currently known treatment modalities, however, includes the loading dose of quinine, vigorous fluid replacement, ET, the artemisinins, mannitol, and N-acetylcysteine in the treatment of severe malaria.",True,"Is the triple 'Mannitol treats malaria' supported by the sentence: 'A possibly indulgent wish list of outcome (mortality) studies using currently known treatment modalities, however, includes the loading dose of quinine, vigorous fluid replacement, ET, the artemisinins, mannitol, and N-acetylcysteine in the treatment of severe malaria.'?","Yes, while indirectly, the statement does lend some support to the claim that mannitol treats malaria. The text mentions mannitol as part of a list of treatment modalities for severe malaria. However, it is crucial to note that this does not explicitly confirm that mannitol is an effective treatment for malaria on its own. The statement merely implies that mannitol is one of several treatments being considered for severe malaria cases in an outcome study.

        To further clarify mannitol's potential role in treating malaria, additional information is required regarding its mechanism of action against the disease. For instance, if mannitol is shown to have antimalarial properties or enhance the efficacy of other established treatments when used in combination, it could be considered as an adjunct therapy for malaria treatment.

        Nonetheless, based on the provided statement alone, one cannot definitively conclude that mannitol is an independently proven treatment for malaria. Further investigation involving experimental evidence is necessary to substantiate such a claim conclusively."
11613595,Mannitol treats chronic obstructive pulmonary disease,1466,CONCLUSION: We propose that AHR to mannitol could predict ICS-responsiveness in mild to moderately severe COPD patients.,False,Is the triple 'Mannitol treats chronic obstructive pulmonary disease' supported by the sentence: 'CONCLUSION: We propose that AHR to mannitol could predict ICS-responsiveness in mild to moderately severe COPD patients.'?,"No, the statement does not provide indirect support for the phrase ""Mannitol treats chronic obstructive pulmonary disease"" (COPD). The conclusion is derived from a study that investigates airway hyperresponsiveness (AHR) to mannitol as a predictor for inhaled corticosteroids (ICS) responsiveness in mild to moderately severe COPD patients. The conclusion suggests that mannitol challenge tests may help identify patients who would benefit from ICS treatment; however, it does not imply that mannitol itself treats COPD.

        The statement focuses on using mannitol as a diagnostic tool for determining ICS-responsiveness in certain COPD patients rather than as a therapeutic agent for treating COPD symptoms. Therefore, it does not support the idea that mannitol has any direct therapeutic effects on COPD patients."
10724016,Mannitol treats acute kidney failure,1467,MANNITOL THERAPY IN ACUTE RENAL FAILURE.,True,Is the triple 'Mannitol treats acute kidney failure' supported by the sentence: 'MANNITOL THERAPY IN ACUTE RENAL FAILURE.'?,"Yes, the statement ""MANNITOL THERAPY IN ACUTE RENAL FAILURE"" does lend indirect support to the phrase ""Mannitol treats acute kidney failure"". This is because mannitol is a type of therapy that is being discussed in relation to acute renal failure (also known as acute kidney failure). However, it is important to note that while this statement suggests there may be some benefit in using mannitol for treating acute kidney failure, it does not definitively prove that mannitol treats acute kidney failure as it could also imply that mannitol is being used for diagnostic purposes or as part of a comparative study between different treatment methods. Therefore, further investigation would be necessary to confirm the therapeutic effect of mannitol on acute kidney failure."
10707564,Mannitol treats injury,1468,Mannitol has a beneficial effect on ischemic injury following a short-duration forebrain ischemic insult in rats.,True,Is the triple 'Mannitol treats injury' supported by the sentence: 'Mannitol has a beneficial effect on ischemic injury following a short-duration forebrain ischemic insult in rats.'?,"Yes, the phrase ""Mannitol treats injury"" does receive indirect support from the statement: ""Mannitol has a beneficial effect on ischemic injury following a short-duration forebrain ischemic insult in rats."" This is because mannitol is known for its ability to reduce brain swelling by drawing excess fluid away from the site of injury, thereby alleviating some symptoms related to injury. However, it is essential to note that ""treats injury"" is a more general term than ""has a beneficial effect on ischemic injury,"" which specifically refers to an experimental condition in rats involving ischemic insults in the forebrain region. More studies would be needed to confirm mannitol's efficacy in treating various types of injuries in different organisms thoroughly."
9454905,Mannitol treats ciguatera fish poisoning,1469,IV mannitol is considered the treatment of choice for CP but has not been evaluated in a double-blind randomized trial.,True,Is the triple 'Mannitol treats ciguatera fish poisoning' supported by the sentence: 'IV mannitol is considered the treatment of choice for CP but has not been evaluated in a double-blind randomized trial.'?,"Yes, while not providing direct support, the statement does lend some indirect credibility to the claim that mannitol treats ciguatera fish poisoning (CP). The reason is that intravenous (IV) mannitol is considered the treatment of choice for ciguatera fish poisoning according to current knowledge and practice. However, it should be noted that there has not been a double-blind randomized trial conducted to evaluate its efficacy in treating CP. This lack of rigorous evaluation does not disprove mannitol's effectiveness; rather, it highlights the need for further investigation into its therapeutic potential for CP.

        Nonetheless, it is important to exercise caution when interpreting such statements since they do not constitute definitive proof due to the absence of rigorous clinical trials. The ultimate evaluation of any medical treatment should ideally be based on high-quality evidence from robust clinical trials; however, in certain cases where such evidence is lacking, expert opinion and observational data can provide some support for therapeutic interventions while awaiting more rigorous investigations."
9438138,Mannitol treats stroke disorder,1470,Effects of intravenous mannitol on EEG recordings in stroke patients.,False,Is the triple 'Mannitol treats stroke disorder' supported by the sentence: 'Effects of intravenous mannitol on EEG recordings in stroke patients.'?,"No, the statement ""Effects of intravenous mannitol on EEG recordings in stroke patients"" does not provide direct or indirect support for the claim ""Mannitol treats stroke disorder."" This is because the provided statement only discusses the effects of mannitol on EEG recordings in stroke patients, which is an observational finding rather than an interventional one that demonstrates mannitol improves stroke outcomes.

         The statement does suggest that mannitol may have an impact on brain activity in stroke patients as evidenced by EEG recordings; however, it does not confirm whether mannitol treatment results in improved stroke outcomes or reduced disorder severity. Further investigation would be necessary to establish such a link through clinical trials that measure stroke outcomes in patients receiving mannitol treatment compared to those who do not receive such treatment."
8850005,Mannitol treats coronary artery disorder,1471,"The data suggest the need to further evaluate the physiological importance of the increase in coronary blood flow produced by mannitol in patients with coronary artery disease and indicate the possibility that mannitol might be of value in treating certain problems in patients with coronary artery disease,",True,"Is the triple 'Mannitol treats coronary artery disorder' supported by the sentence: 'The data suggest the need to further evaluate the physiological importance of the increase in coronary blood flow produced by mannitol in patients with coronary artery disease and indicate the possibility that mannitol might be of value in treating certain problems in patients with coronary artery disease,'?","Yes, the statement does provide indirect support for the phrase ""Mannitol treats coronary artery disorder"". The passage suggests that mannitol increases coronary blood flow in patients with coronary artery disease, implying potential therapeutic value for certain problems associated with the disease. While it does not explicitly state that mannitol treats coronary artery disorder, it does imply that mannitol could have beneficial effects on coronary artery health, which aligns with the concept of treatment. However, it is important to note that further evaluation is needed to establish the physiological importance and therapeutic efficacy of mannitol in treating coronary artery disease, as stated in the passage."
8674974,Mannitol treats bronchiectasis,1472,The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis.,True,Is the triple 'Mannitol treats bronchiectasis' supported by the sentence: 'The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis.'?,"Yes, the statement ""The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis"" does provide indirect support for the claim that ""Mannitol treats bronchiectasis"". This is because improved mucus clearance is generally associated with better disease outcomes in bronchiectasis patients, suggesting that mannitol may have therapeutic benefits in treating bronchiectasis by addressing one of its key symptoms (mucus buildup). However, it is important to note that indirect support does not equate to definitive evidence; further studies would be needed to establish mannitol as an effective treatment for bronchiectasis."
8007841,"Mannitol treats chronic myelogenous leukemia, BCR-ABL1 positive",1473,Treatment of chronic myelocytic leukaemia with dibromo-mannitol (myelobromol).,False,"Is the triple 'Mannitol treats chronic myelogenous leukemia, BCR-ABL1 positive' supported by the sentence: 'Treatment of chronic myelocytic leukaemia with dibromo-mannitol (myelobromol).'?","No, the statement ""Treatment of chronic myelocytic leukaemia with dibromo-mannitol (myelobromol)"" does not provide indirect support for the claim that ""Mannitol treats chronic myelogenous leukemia, BCR-ABL1 positive.""

         The key difference lies in the chemical compound mentioned in the original statement - dibromo-mannitol (myelobromol) - which is distinct from mannitol alone. Dibromo-mannitol is a brominated derivative of mannitol that has been studied in some cancer treatments due to its potential cytotoxic effects on malignant cells. However, mannitol itself is primarily used as an osmotic diuretic in clinical settings due to its ability to reduce intracranial pressure and improve water excretion in patients suffering from conditions like cerebral edema.

         In summary, while dibromo-mannitol (myelobromol) might have potential implications in chronic myelocytic leukemia treatment, as suggested by some preclinical studies, mannitol itself does not have any established ther"
7780960,Mannitol treats cystic fibrosis,1474,Inhaled mannitol is a potential mucoactive agent in cystic fibrosis patients.,True,Is the triple 'Mannitol treats cystic fibrosis' supported by the sentence: 'Inhaled mannitol is a potential mucoactive agent in cystic fibrosis patients.'?,"Yes, indirectly it does lend some support. The statement ""Inhaled mannitol is a potential mucoactive agent in cystic fibrosis patients"" suggests that mannitol could be used as a therapeutic agent for cystic fibrosis patients due to its mucoactive properties - meaning it helps reduce mucus viscosity or clear mucus from the airways. However, it does not explicitly state that mannitol treats cystic fibrosis but implies that it might be beneficial in managing some symptoms associated with the disease.

        
        To further support this implication, several studies have investigated mannitol's potential therapeutic effects on cystic fibrosis patients. A randomized controlled trial published in The Lancet Respiratory Medicine in 2013 showed that inhaled mannitol improved lung function in cystic fibrosis patients compared to placebo (1). This evidence strengthens the idea that mannitol may play a role in treating cystic fibrosis symptoms but falls short of definitively stating that mannitol treats cystic fibrosis as more extensive clinical trials would be required for such a"
7352141,Mannitol treats intracranial hypertension,1475,"CONCLUSION: Hypertonic saline, in both 3 and 23.4% concentrations, is as effective as mannitol in the treatment of intracranial hypertension observed in association with ICH.",True,"Is the triple 'Mannitol treats intracranial hypertension' supported by the sentence: 'CONCLUSION: Hypertonic saline, in both 3 and 23.4% concentrations, is as effective as mannitol in the treatment of intracranial hypertension observed in association with ICH.'?","Yes, indirectly it does support the phrase ""Mannitol treats intracranial hypertension"". The conclusion states that mannitol is as effective as hypertonic saline in treating intracranial hypertension associated with ICH (Intracerebral Hemorrhage). This implies that mannitol does indeed have therapeutic effects in managing intracranial hypertension, which aligns with the statement ""Mannitol treats intracranial hypertension"". However, it is crucial to note that this does not necessarily mean mannitol is superior or preferable over other treatments like hypertonic saline; it simply indicates that mannitol is an effective option for managing intracranial hypertension in the context of ICH."
7084538,Mannitol treats brain edema,1476,CONCLUSIONS: Acute mannitol used in patients with cerebral edema after a large hemispheric infarction does not alter midline tissue shifts or worsen neurologic status.,False,Is the triple 'Mannitol treats brain edema' supported by the sentence: 'CONCLUSIONS: Acute mannitol used in patients with cerebral edema after a large hemispheric infarction does not alter midline tissue shifts or worsen neurologic status.'?,"No, the statement does not provide indirect support for the phrase ""Mannitol treats brain edema"". In fact, it seems to suggest that mannitol does not have a significant effect on cerebral edema in certain situations. The conclusion is based on a study where patients with cerebral edema after a large hemispheric infarction were treated with acute mannitol, but no alterations in midline tissue shifts or improvements in neurologic status were observed. This suggests that mannitol may not be an effective treatment for brain edema in these cases, contrary to the claim that mannitol treats brain edema."
23769437,Temocillin treats bacterial infectious disease with sepsis,1477,The objective is to investigate if temocillin is non-inferior to carbapenems in the targeted treatment of bacteraemia due to 3GCR-E.,False,Is the triple 'Temocillin treats bacterial infectious disease with sepsis' supported by the sentence: 'The objective is to investigate if temocillin is non-inferior to carbapenems in the targeted treatment of bacteraemia due to 3GCR-E.'?,"No, the statement does not provide direct or indirect support for the phrase ""Temocillin treats bacterial infectious disease with sepsis."" The objective in the statement is focused on comparing temocillin to carbapenems in treating bacteraemia due to 3GCR-E specifically (a type of bacterial infection causing bloodstream infections), rather than providing evidence for temocillin treating bacterial infectious diseases associated with sepsis in general. Sepsis is a severe complication caused by an overwhelming immune response to infection, which can be initiated by various types of pathogens (including bacteria), but it is not equivalent to bacterial infectious diseases themselves. Therefore, further evidence would be required to support temocillin as an effective treatment for bacterial infectious diseases associated with sepsis."
17734631,Artesunic acid treats hepatocellular carcinoma,1478,CONCLUSION: These findings indicate that artesunate could offer a new approach to the therapy of hepatocellular carcinoma.,True,Is the triple 'Artesunic acid treats hepatocellular carcinoma' supported by the sentence: 'CONCLUSION: These findings indicate that artesunate could offer a new approach to the therapy of hepatocellular carcinoma.'?,"Yes, the phrase ""Artesunic acid treats hepatocellular carcinoma"" does receive indirect support from the statement: ""CONCLUSION: These findings indicate that artesunate could offer a new approach to the therapy of hepatocellular carcinoma."" 

         The conclusion from the study suggests that artesunate, which is a derivative of artemisinin (the active ingredient in artesunic acid), could be an effective approach in treating hepatocellular carcinoma (HCC). While artesunic acid itself was not tested in the study mentioned, artesunate is a closely related compound that shares similar biological activities, including anticancer effects.

         Therefore, it is reasonable to infer that since artesunate has shown potential in treating HCC, artesunic acid (given its structural similarity and shared mechanisms) might also have similar therapeutic effects on HCC. However, further experimental validation is required before making any definitive conclusions about artesunic acid's specific efficacy against HCC since studies on artesunic acid in treating HCC may have different experimental designs, drug formulations, pharmacokinetics, and pharmacodynamics"
16415826,Artesunic acid treats Crohn disease,1479,Our data suggest a novel clinical application of artesunate as a potential therapy for Crohn's disease.,True,Is the triple 'Artesunic acid treats Crohn disease' supported by the sentence: 'Our data suggest a novel clinical application of artesunate as a potential therapy for Crohn's disease.'?,"Yes, the statement ""Our data suggest a novel clinical application of artesunate as a potential therapy for Crohn's disease"" does provide indirect support for the phrase ""Artesunic acid treats Crohn disease."" The key term here is ""potential therapy,"" which implies that artesunate could have therapeutic effects on Crohn's disease. While it does not confirm that artesunate definitively treats Crohn disease, it does lend credence to the idea that it may be an effective treatment option worth further investigation. It is important to note that more rigorous clinical trials and studies would be necessary to confirm such a claim conclusively."
15681287,Artesunic acid treats breast neoplasm,1480,Taken together our in vitro and in vivo results correlate well showing for the first time that artesunate induces resistance in highly metastatic breast tumors.,False,Is the triple 'Artesunic acid treats breast neoplasm' supported by the sentence: 'Taken together our in vitro and in vivo results correlate well showing for the first time that artesunate induces resistance in highly metastatic breast tumors.'?,"No, the phrase ""Artesunic acid treats breast neoplasm"" does not receive indirect support from the statement provided. In fact, it suggests quite the opposite. The statement indicates that artesunic acid (artesunate) may induce resistance in highly metastatic breast tumors. This implies that artesunic acid might not be an effective treatment for breast neoplasm (breast cancer), but rather could potentially exacerbate the issue by encouraging resistance in aggressive breast tumors. This is an important distinction to make when interpreting scientific findings, as it can significantly impact the potential therapeutic applications of artesunic acid in treating breast cancer."
13704055,Artesunic acid treats cytomegalovirus infection,1481,"This is the first report of treatment of cytomegalovirus infection with artesunate, for a stem cell transplant recipient with a newly identified foscarnet-resistant and ganciclovir-resistant DNA polymerase L776M mutation.",True,"Is the triple 'Artesunic acid treats cytomegalovirus infection' supported by the sentence: 'This is the first report of treatment of cytomegalovirus infection with artesunate, for a stem cell transplant recipient with a newly identified foscarnet-resistant and ganciclovir-resistant DNA polymerase L776M mutation.'?","Yes, indirect support can be inferred from the statement provided. The text indicates that artesunate was used to treat a case of cytomegalovirus (CMV) infection in a patient who had developed resistance to both foscarnet and ganciclovir - two commonly used antiviral drugs for CMV treatment. The successful treatment of such a case suggests that artesunate may have therapeutic potential for CMV infections, particularly in cases where conventional treatments have proven ineffective due to resistance. However, it is important to note that this is based on a single case report and further studies would be required to establish artesunate as a reliable treatment for CMV infections."
13022850,Artesunic acid treats neoplasm,1482,The anticancer activity of artesunate has also been shown in human xenograft tumors in mice.,True,Is the triple 'Artesunic acid treats neoplasm' supported by the sentence: 'The anticancer activity of artesunate has also been shown in human xenograft tumors in mice.'?,"Yes, indirectly it does lend some support. The statement ""The anticancer activity of artesunate has also been shown in human xenograft tumors in mice"" suggests that artesunic acid (often referred to as artesunate in the literature) has been observed to have anticancer effects in preclinical models (human tumors transplanted into mice). This does not definitively prove that artesunic acid treats neoplasm (a type of new and abnormal growth in some part of the body) in humans, but it does provide evidence for its potential anticancer properties, which could be further investigated in clinical trials involving human patients."
10539481,Artesunic acid treats Fever,1483,The 2 groups that received artesunate experienced considerably more rapid reduction in parasitemia and in fever than the group that received only mefloquine (p.002).,True,Is the triple 'Artesunic acid treats Fever' supported by the sentence: 'The 2 groups that received artesunate experienced considerably more rapid reduction in parasitemia and in fever than the group that received only mefloquine (p.002).'?,"Yes, indirectly it does support the statement that artesunic acid treats fever. The statement provided mentions artesunate (not artesunic acid specifically), but they share similar properties as both derive from artemisinin which is an antimalarial compound extracted from Artemisia annua L (Sweet wormwood). Artesunate is more soluble in water than artemisinin and artesunic acid, making it easier for administration in clinical settings (Efferth et al., 2008).

        The study result indicates that malaria patients who received artesunate experienced faster fever reduction compared to those who received mefloquine alone (p=0.002). Although fever reduction is not a direct measurement for artesunic acid/artesunate efficacy against fever, it can be inferred as an indicator for improvement in patients suffering from malaria-induced fever since parasitemia reduction is linked with fever reduction in malaria (WHO, 2009).

        However, it is important to note that further investigation is required before making definitive conclusions about artesunic acid treating fever specifically because:"
10009785,Artesunic acid treats schistosomiasis,1484,CONCLUSION: A mass chemotherapy in conjunction with health education and oral artesunate for preventing reinfection in transmission season is effective for the control of schistosomiasis in lake regions.,True,Is the triple 'Artesunic acid treats schistosomiasis' supported by the sentence: 'CONCLUSION: A mass chemotherapy in conjunction with health education and oral artesunate for preventing reinfection in transmission season is effective for the control of schistosomiasis in lake regions.'?,"Yes, the phrase ""Artesunic acid treats schistosomiasis"" does receive indirect support from the statement provided. The conclusion states that mass chemotherapy using oral artesunate is effective for controlling schistosomiasis in lake regions. Artesunic acid is one formulation of artesunate, which is a derivative of artemisinin—a potent antimalarial compound that has also been found effective against schistosomiasis (Helmholtz Centre for Infection Research, n.d.).

         However, it is important to note that artesunic acid is not explicitly mentioned in the conclusion; therefore, the support is indirect rather than direct. Additionally, artesunate is typically administered in combination therapy due to its short half-life (Keiser et al., 2004). Therefore, further investigation would be required to confirm whether artesunic acid is specifically used in the mentioned mass chemotherapy approach for treating schistosomiasis.

         References:
         Helmholtz Centre for Infection Research. (n.d.). Schistosomiasis: Drug resistance – Artemisinin derivatives as an alternative? Retrieved"
9194607,Artesunic acid treats urinary schistosomiasis,1485,"Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.",True,"Is the triple 'Artesunic acid treats urinary schistosomiasis' supported by the sentence: 'Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.'?","Yes, indirectly it does lend support. The statement mentions a double-blind, randomized, placebo-controlled study involving Artesunate (which is very similar to Artesunic acid in its chemical structure and mechanism of action) used for treating Schistosoma haematobium infections, which is a type of urinary schistosomiasis. Therefore, even though Artesunic acid is not specifically mentioned in the study, its close relation to Artesunate suggests that it could potentially have similar effects on treating urinary schistosomiasis caused by Schistosoma haematobium. However, it is important to note that further direct studies investigating Artesunic acid for urinary schistosomiasis treatment would be required for more definitive conclusions."
7990355,Artesunic acid treats Plasmodium vivax malaria,1486,"To define the current efficacy of Fansidar (F. Hoffmann-La Roche Ltd., Basel Switzerland) (pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating acute Plasmodium vivax malaria, we conducted a comparative clinical trial of these 3 drugs in an open-label study.",False,"Is the triple 'Artesunic acid treats Plasmodium vivax malaria' supported by the sentence: 'To define the current efficacy of Fansidar (F. Hoffmann-La Roche Ltd., Basel Switzerland) (pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating acute Plasmodium vivax malaria, we conducted a comparative clinical trial of these 3 drugs in an open-label study.'?","No, the statement does not provide direct support for the claim that ""Artesunic acid treats Plasmodium vivax malaria"". The clinical trial mentioned in the statement compares Fansidar (a combination of pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating acute Plasmodium vivax malaria. However, it does not mention artesunic acid at all. Artesunic acid and artesunate share similarities as they both contain artemisinin derivatives, but they remain distinct compounds with different pharmacokinetic profiles. Thus, evidence from this trial cannot be generalized to artesunic acid without further investigation into its efficacy against Plasmodium vivax malaria specifically."
7595063,Artesunic acid treats malaria,1487,Artemether and artesunate have also been administered by the rectal route with highly promising results for treatment of severe malaria.,True,Is the triple 'Artesunic acid treats malaria' supported by the sentence: 'Artemether and artesunate have also been administered by the rectal route with highly promising results for treatment of severe malaria.'?,"Yes, there is indirect support for the statement ""Artesunic acid treats malaria"" based on the provided information. Artemether and artesunate are both derivatives of artemisinin, which is a naturally occurring compound found in the sweet wormwood plant (Artemisia annua). Artesunic acid is another derivative of artemisinin that has been used in malaria treatment as well.

         The statement ""Artemether and artesunate have also been administered by the rectal route with highly promising results for treatment of severe malaria"" suggests that artemisinin derivatives can be effective in treating malaria. Since artesunic acid is also an artemisinin derivative, it is reasonable to infer that artesunic acid may have similar efficacy in treating malaria.

         However, it is important to note that while there is indirect support for artesunic acid treating malaria based on the provided statement, further investigation is needed for more direct evidence. Clinical trials and studies specifically involving artesunic acid would provide stronger support for its use in malaria treatment."
7113713,Artesunic acid treats Plasmodium falciparum malaria,1488,Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.,False,Is the triple 'Artesunic acid treats Plasmodium falciparum malaria' supported by the sentence: 'Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.'?,"No, the statement does not provide direct or indirect support for the claim that artesunic acid treats Plasmodium falciparum malaria. The statement only mentions that dihydroartemisinin concentrations decline during 5-day oral treatment with artesunate for Falciparum malaria. Artesunate is a form of artemisinin, which is converted into dihydroartemisinin in the body. The decline in dihydroartemisinin concentrations may be due to various factors such as metabolism, excretion, or therapeutic response but it does not necessarily imply that artesunic acid is effective in treating Plasmodium falciparum malaria. Further evidence is required to establish such a claim."
7264251,Artemether treats malaria,1489,These data demonstrate the equality of artemether and quinine for severe malaria and indicate a trend toward greater effectiveness of artemether in regions where there is recognized quinine resistance.,True,Is the triple 'Artemether treats malaria' supported by the sentence: 'These data demonstrate the equality of artemether and quinine for severe malaria and indicate a trend toward greater effectiveness of artemether in regions where there is recognized quinine resistance.'?,"Yes, the statement does provide indirect support for the claim that artemether treats malaria. The statement indicates that artemether has been compared to quinine in treating severe malaria and shows equal effectiveness, if not a trend towards greater effectiveness in regions where quinine resistance is recognized. This suggests that artemether can be an alternative treatment for malaria, supporting its effapeutic role in treating the disease. However, it is important to note that further investigation is required to establish artemether as an effective treatment for malaria in different settings and against various strains of the parasite."
7168046,Artemether treats Plasmodium falciparum malaria,1490,"The spectrum of falciparum malaria treatment has recently broadened to include new drugs such as artemisinin, artemether or atovaquone/proguanil, the latter being as yet unauthorized in France.",True,"Is the triple 'Artemether treats Plasmodium falciparum malaria' supported by the sentence: 'The spectrum of falciparum malaria treatment has recently broadened to include new drugs such as artemisinin, artemether or atovaquone/proguanil, the latter being as yet unauthorized in France.'?","Yes, the statement does provide indirect support for the claim that Artemether treats Plasmodium falciparum malaria. The reason is that it mentions Artemether as one of the new drugs in the spectrum of falciparum malaria treatment. However, it should be noted that indirect support does not equate to definitive proof; further investigation into specific studies or clinical trials would be necessary to confirm Artemether's efficacy in treating Plasmodium falciparum malaria."
25827221,Isoproterenol treats obstructive lung disease,1491,Investigation into isoprenaline resistance in patients with obstructive lung disease.,False,Is the triple 'Isoproterenol treats obstructive lung disease' supported by the sentence: 'Investigation into isoprenaline resistance in patients with obstructive lung disease.'?,"No, the statement ""Investigation into isoprenaline resistance in patients with obstructive lung disease"" does not provide direct or indirect support for the claim that ""Isoproterenol treats obstructive lung disease."" Isoprenaline (also known as isoproterenol) is indeed a medication used in treating obstructive lung diseases such as asthma and COPD (Chronic Obstructive Pulmonary Disease). However, the statement provided is about an investigation into isoprenaline resistance in patients with obstructive lung disease, which does not necessarily imply that isoproterenol treats obstructive lung disease. In fact, it could suggest that some patients might be resistant to isoproterenol treatment. Therefore, further information would be required to establish whether isoproterenol is an effective treatment for obstructive lung disease."
15441635,Isoproterenol treats lipoma,1492,AIM: The aim of this study was to evaluate the efficacy of isoproterenol and prednisolone in the treatment of subcutaneous lipomas.,True,Is the triple 'Isoproterenol treats lipoma' supported by the sentence: 'AIM: The aim of this study was to evaluate the efficacy of isoproterenol and prednisolone in the treatment of subcutaneous lipomas.'?,"Yes, the statement ""AIM: The aim of this study was to evaluate the efficacy of isoproterenol and prednisolone in the treatment of subcutaneous lipomas"" does provide indirect support for the phrase ""Isoproterenol treats lipoma"". The fact that isoproterenol is being studied in relation to lipomas suggests that it has some potential therapeutic effect on these types of tumors. However, it is important to note that indirect support does not equate to definitive proof. The study would need to be conducted and its results analyzed to determine whether isoproterenol indeed has a significant impact on lipoma treatment. Additionally, it is crucial to consider other factors such as side effects, dosage, and long-term effects before making any definitive conclusions about isoproterenol's efficacy in treating lipomas."
13881275,Isoproterenol treats orthostatic hypotension,1493,"Microdialysate concentrations of the main neuronal metabolite of norepinephrine (NE) and dihydroxyphenylglycol (DHPG) were measured in skeletal muscle, and plasma concentrations of NE and DHPG were measured in response to i.v. tyramine, yohimbine, and isoproterenol, in patients with PD+NOH, patients with pure autonomic failure (PAF), which is characterized by generalized catecholaminergic denervation, and control subjects.",False,"Is the triple 'Isoproterenol treats orthostatic hypotension' supported by the sentence: 'Microdialysate concentrations of the main neuronal metabolite of norepinephrine (NE) and dihydroxyphenylglycol (DHPG) were measured in skeletal muscle, and plasma concentrations of NE and DHPG were measured in response to i.v. tyramine, yohimbine, and isoproterenol, in patients with PD+NOH, patients with pure autonomic failure (PAF), which is characterized by generalized catecholaminergic denervation, and control subjects.'?","No, the statement does not provide direct support for the claim that ""Isoproterenol treats orthostatic hypotension"". The study measures various concentrations in response to different compounds including isoproterenol but it does not provide any information about orthostatic hypotension symptoms or their treatment in any patient group. Therefore, while isoproterenol is mentioned in the context of the study, it does not indirectly support the claim that isoproterenol treats orthostatic hypotension based on the provided statement alone."
11481186,Isoproterenol treats atrial fibrillation,1494,"RESULTS: LAP series analysis shows a reduction of both LP and R index during isoproterenol infusion in SR and AF (RSR = 0.75 +/- 0.07 RSRISO = 0.69 +/- 0.10, p < 0.0001; RAF = 0.31 +/- 0.08 RAFISO = 0.26 +/- 0.09, p < 0.0001; LPSR = 99.99 +/- 0.001 LPSRISO = 99.97 +/- 0.03, p < 0.0001; LPAF = 69.46 +/- 21.55 LPAFISO = 55 +/- 24.75; p < 0.0001).",False,"Is the triple 'Isoproterenol treats atrial fibrillation' supported by the sentence: 'RESULTS: LAP series analysis shows a reduction of both LP and R index during isoproterenol infusion in SR and AF (RSR = 0.75 +/- 0.07 RSRISO = 0.69 +/- 0.10, p < 0.0001; RAF = 0.31 +/- 0.08 RAFISO = 0.26 +/- 0.09, p < 0.0001; LPSR = 99.99 +/- 0.001 LPSRISO = 99.97 +/- 0.03, p < 0.0001; LPAF = 69.46 +/- 21.55 LPAFISO = 55 +/- 24.75; p < 0.0001).'?","No, the statement does not provide direct support for the claim that Isoproterenol treats atrial fibrillation (AF). The provided results show that during Isoproterenol infusion in both sinus rhythm (SR) and AF, there is a reduction in both LP and R index (p < 0.0001). However, these results indicate an effect of Isoproterenol on electrical properties in both SR and AF states but do not demonstrate that Isoproterenol is used as a treatment for AF. Further investigation would be required to establish such a claim."
9565866,Isoproterenol treats obesity disorder,1495,Decreased responsiveness to isoproterenol in obesity may be due to defects downstream of adenylyl cyclase activation of cyclic AMP.,False,Is the triple 'Isoproterenol treats obesity disorder' supported by the sentence: 'Decreased responsiveness to isoproterenol in obesity may be due to defects downstream of adenylyl cyclase activation of cyclic AMP.'?,"No, the statement ""Decreased responsiveness to isoproterenol in obesity may be due to defects downstream of adenylyl cyclase activation of cyclic AMP"" does not provide indirect support for the claim that ""Isoproterenol treats obesity disorder."" 

         The original statement suggests that obese individuals have decreased responsiveness to isoproterenol, which implies that isoproterenol may not be an effective treatment for obesity. In fact, it suggests that obesity may be characterized by defects downstream of isoproterenol's primary mechanism of action (adenylyl cyclase activation of cyclic AMP). This is in contrast to the claim that isoproterenol treats obesity. Therefore, these two statements seem to contradict each other, making it unlikely that the first statement provides indirect support for the second one."
8710440,Isoproterenol treats postural orthostatic tachycardia syndrome,1496,the responses of heart rate and the plasma cyclic AMP (cAMP) level to isoproterenol infusion in the supine position were evaluated in 10 POTS patients and 10 age-matched controls.,True,Is the triple 'Isoproterenol treats postural orthostatic tachycardia syndrome' supported by the sentence: 'the responses of heart rate and the plasma cyclic AMP (cAMP) level to isoproterenol infusion in the supine position were evaluated in 10 POTS patients and 10 age-matched controls.'?,"Yes, indirect support can be inferred from the statement provided. The experiment conducted measures the responses of heart rate and plasma cyclic AMP (cAMP) level to isoproterenol infusion in both POTS patients and age-matched controls while in the supine position. The purpose of isoproterenol is to stimulate β-adrenergic receptors non-selectively, thereby increasing heart rate and contractility in addition to causing vasodilation due to its potent β2-adrenergic effects.

        Although the statement does not explicitly mention postural orthostatic tachycardia syndrome (POTS) treatment outcomes, it does evaluate isoproterenol infusion in POTS patients, implying an interest in its potential therapeutic effects on heart rate regulation in POTS patients. Therefore, if improvements in heart rate regulation were observed in POTS patients compared to controls following isoproterenol infusion, then one could infer indirect support for its use as a treatment for POTS. However, further investigation would be necessary for drawing definitive conclusions about isoproterenol as an effective treatment for P"
10687311,Metaproterenol treats obstructive lung disease,1497,ORCIPRENALINE IN TREATMENT OF AIRWAYS OBSTRUCTION IN CHRONIC BRONCHITIS.,True,Is the triple 'Metaproterenol treats obstructive lung disease' supported by the sentence: 'ORCIPRENALINE IN TREATMENT OF AIRWAYS OBSTRUCTION IN CHRONIC BRONCHITIS.'?,"Yes, there is indirect support for the statement ""Metaproterenol treats obstructive lung disease"" based on the provided information ""ORCIPRENALINE IN TREATMENT OF AIRWAYS OBSTRUCTION IN CHRONIC BRONCHITIS."" The reason behind this is that Orciprenaline (also known as Metaproterenol) is a medication used primarily for treating obstructive lung diseases such as asthma and chronic bronchitis by relaxing muscles in airways and increasing airflow to the lungs. Therefore, although not explicitly stated in the given text, it indirectly supports the claim that Metaproterenol treats obstructive lung disease through its use as Orciprenaline in treating airways obstruction in chronic bronchitis."
21781034,Bacitracin A treats Infection,1498,"Based on these observations, the combination of CBD and BAC is suggested to be a putative novel treatment in clinical settings for treatment of infections with antibiotic resistant Gram-positive bacteria.",False,"Is the triple 'Bacitracin A treats Infection' supported by the sentence: 'Based on these observations, the combination of CBD and BAC is suggested to be a putative novel treatment in clinical settings for treatment of infections with antibiotic resistant Gram-positive bacteria.'?","No, the phrase ""Bacitracin A treats Infection"" does not receive direct support from the statement provided. The statement suggests that a combination of CBD (cannabidiol) and BAC (Bacitracin A) could be a potential novel treatment for infections caused by antibiotic-resistant Gram-positive bacteria. However, it does not specifically assert that Bacitracin A treats infections on its own. Indirectly, one might infer that Bacitracin A has some efficacy against infections since it is mentioned as part of the proposed treatment; however, this is not an explicit claim in the statement. It is important to differentiate between direct and indirect support when interpreting scientific statements."
17678351,Bacitracin A treats bacterial infectious disease,1499,"Thus, the bacitracin and gramicidin S-based self-assembled nanopeptide ribbon may be a successful ointment formulation for bacterial infection control.",True,"Is the triple 'Bacitracin A treats bacterial infectious disease' supported by the sentence: 'Thus, the bacitracin and gramicidin S-based self-assembled nanopeptide ribbon may be a successful ointment formulation for bacterial infection control.'?","Yes, the statement does provide indirect support for the phrase ""Bacitracin A treats bacterial infectious disease"". The reason is that bacitracin is mentioned as part of a self-assembled nanopeptide ribbon formulation that could potentially control bacterial infections. This implies that bacitracin has antibacterial properties, which is consistent with treating bacterial infectious diseases. However, it is important to note that while this statement suggests bacitracin might be useful in treating bacterial infections, it does not constitute direct evidence of its efficacy in such cases. Further investigation and clinical trials would be necessary for making stronger claims about its therapeutic use in treating bacterial infections."
11891842,Bacitracin A treats burn,1500,"Consensus was found regarding most local (topical) wound care, (SSD for clean non-facial burns, Sulfamylon (mafenide-acetate) for contaminated non-facial burns, Threolone (chloramphenicol 3% and prednisolone 0.5%) or Bacitracin for facial burns, Paraffin gauzes with or without Sulfamylon for donor and graft sites).",True,"Is the triple 'Bacitracin A treats burn' supported by the sentence: 'Consensus was found regarding most local (topical) wound care, (SSD for clean non-facial burns, Sulfamylon (mafenide-acetate) for contaminated non-facial burns, Threolone (chloramphenicol 3% and prednisolone 0.5%) or Bacitracin for facial burns, Paraffin gauzes with or without Sulfamylon for donor and graft sites).'?","Yes, the statement does provide indirect support for the claim that ""Bacitracin A treats burn"". The provided statement lists Bacitracin as one of the recommended topical treatments for facial burns, which implies that it has some efficacy in treating burns. However, it's important to note that the statement does not provide direct evidence of Bacitracin's effectiveness in treating burns, as it does not mention any specific studies or clinical trials that support this claim. Furthermore, the statement suggests that Bacitracin is recommended for facial burns specifically, so it may not be applicable to all types of burns. Therefore, while the statement does lend some support to the claim, it does not conclusively prove that Bacitracin is an effective treatment for burns."
26452786,Fenbendazole causes helminthiasis,101,The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease.,False,Is the triple 'Fenbendazole causes helminthiasis' supported by the sentence: 'The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease.'?,"No, the statement ""Fenbendazole causes helminthiasis"" does not receive any direct or indirect support from the provided statement: ""The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease.""

         The statement about ranolazine pertains specifically to its use in treating stable ischemic heart disease by reducing ischemia through an unspecified mechanism of action. This information has no connection whatsoever to fenbendazole nor its potential to cause helminthiasis (a condition characterized by infection by parasitic worms).

         Fenbendazole is an anthelmintic drug commonly used for treating various parasitic worm infestations in animals; hence it does not cause but rather treats helminthiasis. To make any valid conclusions regarding fenbendazole causing helminthiasis, one would need evidence derived from relevant studies assessing adverse effects associated with fenbendazole administration, which is not provided in the given statement about ranolazine in stable ischemic heart disease treatment."
22762728,Fenbendazole prevents helminthiasis,102,Atrial-selective/predominant sodium channel blockers such as ranolazine effectively suppress AF in experimental models of AF involving canine isolated right atrial preparations at concentrations that produce little to no effect on ventricular electrophysiologic parameters.,False,Is the triple 'Fenbendazole prevents helminthiasis' supported by the sentence: 'Atrial-selective/predominant sodium channel blockers such as ranolazine effectively suppress AF in experimental models of AF involving canine isolated right atrial preparations at concentrations that produce little to no effect on ventricular electrophysiologic parameters.'?,"No, the statement does not provide indirect support for the phrase ""Fenbendazole prevents helminthiasis"". The two statements discuss entirely different subjects: one pertains to the effects of atrial-selective sodium channel blockers on atrial fibrillation (AF) in canine models, while the other refers to the potential impact of Fenbendazole on helminthiasis (a parasitic infection).

        To provide indirect support, there should be some connection between the two subjects in terms of shared mechanisms, similar methodologies, or related biological processes; however, no such link exists between these two statements. Therefore, it is inappropriate to infer any support for Fenbendazole preventing helminthiasis based on the provided statement about ranolazine and atrial fibrillation in canine models."
21848143,Albendazole causes helminthiasis,103,Ranolazine has been shown to decrease angina pectoris frequency and nitroglycerin consumption.,False,Is the triple 'Albendazole causes helminthiasis' supported by the sentence: 'Ranolazine has been shown to decrease angina pectoris frequency and nitroglycerin consumption.'?,"No, the statement ""Ranolazine has been shown to decrease angina pectoris frequency and nitroglycerin consumption"" does not provide any direct or indirect support for the claim ""Albendazole causes helminthiasis."" The two statements discuss different drugs (Ranolazine and Albendazole) and their respective effects on completely unrelated conditions (angina pectoris frequency/nitroglycerin consumption and helminthiasis).

        To further clarify, Ranolazine is a medication used for treating chronic angina while Albendazole is an anthelmintic drug used for treating various parasitic worm infestations (helminthiasis). The fact that one drug decreases angina pectoris frequency does not provide any evidence for another drug causing helminthiasis. The two drugs have different therapeutic indications and mechanisms of action; therefore, they should be evaluated independently based on their own merit and evidence related specifically to them."
25735916,Albendazole affects trichuriasis,104,BACKGROUND: Ranolazine has been shown to reduce myocardial ischemia and symptom severity among selected patients with chronic angina.,False,Is the triple 'Albendazole affects trichuriasis' supported by the sentence: 'BACKGROUND: Ranolazine has been shown to reduce myocardial ischemia and symptom severity among selected patients with chronic angina.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Albendazole affects trichuriasis."" The statement discusses Ranolazine's effect on myocardial ischemia and chronic angina patients, whereas Albendazole is an anthelmintic medication used to treat various parasitic worm infestations such as trichuriasis (whipworm infections). Therefore, there is no connection between these two pieces of information."
24685635,Albendazole affects filarial elephantiasis,105,"Dominant frequency (DF) of AF was reduced by ranolazine in left atrium from 11.7 (10.7-20.5) Hz to 7.6 (2.9-8.8) Hz (P = 0.02, n = 6).",False,"Is the triple 'Albendazole affects filarial elephantiasis' supported by the sentence: 'Dominant frequency (DF) of AF was reduced by ranolazine in left atrium from 11.7 (10.7-20.5) Hz to 7.6 (2.9-8.8) Hz (P = 0.02, n = 6).'?","No, the statement does not provide indirect support for the phrase ""Albendazole affects filarial elephantiasis."" The statement discusses the effect of ranolazine on the dominant frequency (DF) of atrial fibrillation (AF) in humans, which is unrelated to albendazole or filarial elephantiasis. Filarial elephantiasis is a condition caused by parasitic filarial worms, while albendazole is an antihelmintic drug used to treat various parasitic worm infections. The provided statement does not contain any information about albendazole, filarial elephantiasis, or their relationship; therefore, it does not offer any indirect support for the claim in question."
18452252,Albendazole affects toxocariasis,106,"After adjusting for potential sources of bias through propensity-score matched-pair analysis and conditional logistic regression, ranolazine was an independent predictor of preventing POAF (p < 0.0001).",False,"Is the triple 'Albendazole affects toxocariasis' supported by the sentence: 'After adjusting for potential sources of bias through propensity-score matched-pair analysis and conditional logistic regression, ranolazine was an independent predictor of preventing POAF (p < 0.0001).'?","No, the statement does not provide indirect support for the phrase ""Albendazole affects toxocariasis"". The statement discusses the results of a study investigating ranolazine as an independent predictor for preventing postoperative atrial fibrillation (POAF). Although both albendazole and ranolazine are drugs used in medical treatments, there is no mention of albendazole in the statement nor any connection established between these two drugs or their respective therapeutic areas (toxocariasis and POAF). Therefore, it is not reasonable to infer support for the given phrase based on the provided statement."
16658505,Albendazole affects malaria,107,Prednisolone furthers T-cell immunodeficiency and also reduces the intensity of autoimmune reactions in multiple sclerosis.,False,Is the triple 'Albendazole affects malaria' supported by the sentence: 'Prednisolone furthers T-cell immunodeficiency and also reduces the intensity of autoimmune reactions in multiple sclerosis.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Albendazole affects malaria."" The two statements discuss different subjects: one is about Prednisolone's impact on T-cell immunodeficiency and multiple sclerosis while the other is about Albendazole potentially affecting Malaria.

        

        To further illustrate why these statements do not support each other, let us examine their components:

        

        - Prednisolone is an immunosuppressive drug used in treating various conditions like multiple sclerosis by reducing autoimmune reactions through its effects on T-cell immunodeficiency.

        - Albendazole is an anthelmintic medication used primarily for treating parasitic worm infestations like roundworms, hookworms, pinworms, tapeworms, etc., but it has also been studied in combination therapies for malaria due to its potential ability to inhibit malaria parasite development in the liver stage (pre-erythrocytic stages).

        

        The connection between Prednisolone and Malaria"
13946207,Albendazole affects helminthiasis,108,[Pharmacokinetics of prednisolone in adrenal insufficiency ].,False,Is the triple 'Albendazole affects helminthiasis' supported by the sentence: '[Pharmacokinetics of prednisolone in adrenal insufficiency ].'?,"No, the statement ""Pharmacokinetics of prednisolone in adrenal insufficiency"" does not provide direct or indirect support for the claim that ""Albendazole affects helminthiasis"". The two statements discuss different topics: one pertains to pharmacokinetics (the process by which a drug is absorbed, distributed, metabolized, and excreted) in relation to adrenal insufficiency, while the other refers to an antiparasitic drug (Albendazole) impacting helminthiasis (a parasitic infection caused by helminths). To establish support between these two statements would require additional evidence connecting pharmacokinetics, adrenal insufficiency, Albendazole, and helminthiasis in some meaningful way."
11239060,Albendazole affects filariasis,109,It is concluded that VAP is effective therapy in AIL.,False,Is the triple 'Albendazole affects filariasis' supported by the sentence: 'It is concluded that VAP is effective therapy in AIL.'?,"No, the statement ""It is concluded that VAP is effective therapy in AIL"" does not provide indirect support for the phrase ""Albendazole affects filariasis"". 

        The conclusion that VAP (presumably Veterinary Anthelmintic Products) is an effective therapy in AIL (Ancylostoma Infection in Livestock) does not necessarily imply that Albendazole, specifically, affects filariasis. Filariasis is a parasitic disease caused by nematode worms of the Filarioidea superfamily, while AIL is an infection caused by hookworms from the Ancylostoma genus. Although both are parasitic diseases, they are caused by different organisms, which means that a treatment effective for one does not automatically imply effectiveness for the other. 

        Furthermore, Albendazole is not explicitly mentioned in the statement as being part of VAP or as a treatment for AIL. Therefore, without additional information linking Albendazole to filariasis, it is not possible to infer that Albendazole affects filariasis based on this statement alone."
24729219,Albendazole disrupts helminthiasis,110,A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis.,False,Is the triple 'Albendazole disrupts helminthiasis' supported by the sentence: 'A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis.'?,"No, the statement ""A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis"" does not provide indirect support for the phrase ""Albendazole disrupts helminthiasis."" The two statements discuss different topics: one is about assessing prednisolone analogues in rheumatoid synovitis using thermography, while the other refers to albendazole impacting helminthiasis (a parasitic infection). There is no overlap between these ideas that would allow for indirect support from one statement for the other."
16658503,Albendazole disrupts malaria,111,The effect of small doses of prednisolone on the incidence of subcutaneous sarcomas induced by 3-methylcholanthrene in virgin female Swiss mice.,False,Is the triple 'Albendazole disrupts malaria' supported by the sentence: 'The effect of small doses of prednisolone on the incidence of subcutaneous sarcomas induced by 3-methylcholanthrene in virgin female Swiss mice.'?,"No, the statement ""The effect of small doses of prednisolone on the incidence of subcutaneous sarcomas induced by 3-methylcholanthrene in virgin female Swiss mice"" does not provide indirect support for the phrase ""Albendazole disrupts malaria."" The two statements discuss different substances (prednisolone versus albendazole) and different diseases (sarcomas versus malaria). The connection between them is too tenuous to establish any meaningful support for the claim about albendazole and malaria based on the provided statement about prednisolone and sarcomas in mice."
13637338,Albendazole disrupts Hookworm Infections,112,[Effects of chromocarb diethylamine and prednisolone in experimental uveitis induced by clove oil in rabbits].,False,Is the triple 'Albendazole disrupts Hookworm Infections' supported by the sentence: '[Effects of chromocarb diethylamine and prednisolone in experimental uveitis induced by clove oil in rabbits].'?,"No, the statement ""Albendazole disrupts Hookworm Infections"" does not receive indirect support from the title ""[Effects of chromocarb diethylamine and prednisolone in experimental uveitis induced by clove oil in rabbits]."" The title discusses an experiment involving chromocarb diethylamine, prednisolone, clove oil, and uveitis in rabbits - there is no mention of albendazole or hookworm infections in the title provided. Therefore, it does not offer any indirect support for the claim about albendazole and hookworm infections."
15248433,Albendazole prevents filariasis,113,[Effect of prednisolone and heparin on circulating T- and B-lymphocytes in glomerulonephritis and systemic lupus erythematosus].,False,Is the triple 'Albendazole prevents filariasis' supported by the sentence: '[Effect of prednisolone and heparin on circulating T- and B-lymphocytes in glomerulonephritis and systemic lupus erythematosus].'?,"No, the statement does not provide any direct or indirect support for the claim that Albendazole prevents filariasis. The provided statement discusses the effects of prednisolone and heparin on circulating T- and B-lymphocytes in glomerulonephritis and systemic lupus erythematosus, which is unrelated to Albendazole or filariasis. Filariasis is a parasitic disease caused by threadlike parasitic worms, while prednisolone is a synthetic glucocorticoid drug used for its anti-inflammatory effects, heparin is an anticoagulant used for various purposes such as preventing blood clots, and lymphocytes are types of white blood cells involved in immune responses. Therefore, these topics do not intersect in any meaningful way that would provide support for the initial claim."
13732336,Albendazole prevents helminthiasis,114,[Effects of prednisolone on thyroidal-123I uptake in subacute thyroiditis].,False,Is the triple 'Albendazole prevents helminthiasis' supported by the sentence: '[Effects of prednisolone on thyroidal-123I uptake in subacute thyroiditis].'?,"No, the statement does not provide any direct or indirect support for the claim that Albendazole prevents helminthiasis. The statement is about the effects of prednisolone on thyroidal-123I uptake in subacute thyroiditis, which is not related to Albendazole or its preventive effects on helminthiasis. Helminthiasis is a condition caused by parasitic worms, while prednisolone is a corticosteroid medication used for various conditions including subacute thyroiditis, an inflammation of the thyroid gland. Albendazole is an anthelmintic drug used to treat helminthiases but is not mentioned in the provided statement. Therefore, there is no connection between the two statements."
15316470,Ibuprofen subclass of 2-Hydroxyibuprofen,115,"Blood Eosinophil Depletion with Mepolizumab, Benralizumab and Prednisolone in Eosinophilic Asthma.",False,"Is the triple 'Ibuprofen subclass of 2-Hydroxyibuprofen' supported by the sentence: 'Blood Eosinophil Depletion with Mepolizumab, Benralizumab and Prednisolone in Eosinophilic Asthma.'?","No, the statement ""Blood Eosinophil Depletion with Mepolizumab, Benralizumab and Prednisolone in Eosinophilic Asthma"" does not provide indirect support for the phrase ""Ibuprofen subclass of 2-Hydroxyibuprofen"". The statement discusses eosinophil depletion in asthma using specific medications, while the phrase ""Ibuprofen subclass of 2-Hydroxyibuprofen"" refers to a subgroup within non-steroidal anti-inflammatory drugs (NSAIDs) without any direct connection to eosinophils or asthma treatment."
16265626,Ibuprofen related to Arthralgia,116,[Prednisolone and aspirin combination therapy in habitual abortion with autoantibodies].,False,Is the triple 'Ibuprofen related to Arthralgia' supported by the sentence: '[Prednisolone and aspirin combination therapy in habitual abortion with autoantibodies].'?,"No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen related to Arthralgia"". The statement discusses prednisolone and aspirin combination therapy in habitual abortion with autoantibodies, which does not mention ibuprofen or arthralgia (joint pain). Therefore, it does not offer any relevant evidence or implications that could be used to infer a relationship between ibuprofen and arthralgia."
14582794,Ibuprofen related to Pain,117,"To illustrate this, we used an example of cost-effectiveness analysis for docetaxel in combination with prednisolone in metastatic hormone-refractory prostate cancer.",False,"Is the triple 'Ibuprofen related to Pain' supported by the sentence: 'To illustrate this, we used an example of cost-effectiveness analysis for docetaxel in combination with prednisolone in metastatic hormone-refractory prostate cancer.'?","No, the statement ""Ibuprofen related to Pain"" does not receive indirect support from the provided passage about cost-effectiveness analysis for docetaxel in combination with prednisolone in metastatic hormone-refractory prostate cancer. The passage discusses a specific treatment regimen for prostate cancer without making any reference or connection to ibuprofen, which is a non-prescription analgesic commonly used for pain relief. Therefore, there is no basis for inferring any relationship between ibuprofen and pain from this statement."
11440746,Ibuprofen related to Toothache,118,Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency.,False,Is the triple 'Ibuprofen related to Toothache' supported by the sentence: 'Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency.'?,"No, the statement ""Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency"" does not provide indirect support for the phrase ""Ibuprofen related to Toothache."" The two statements discuss different subjects: one is about an association between prednisolone use and bone mineral density in primary adrenal insufficiency, while the other is about ibuprofen potentially being related to toothache.

         To establish indirect support between these two statements, there would need to be some common ground between them - for instance, if both statements discussed ibuprofen use but related it to different outcomes (bone mineral density instead of toothache). However, in their current form, they do not share any overlapping concepts that would allow for indirect support to be inferred.

         To clarify further: although ibuprofen is also a medication like prednisolone, their effects on health outcomes can be vastly different due to differences in their mechanisms of action (ibuprofen is primarily an NSAID that targets inflammation; prednisolone is a glucocorticoid used for its immunosuppressive properties). Therefore, even if one medication"
9106384,Ibuprofen related to osteoarthritis,119,CONCLUSIONS: Prednisolone was more effective in inducing response than itraconazole in acute-stage ABPA.,False,Is the triple 'Ibuprofen related to osteoarthritis' supported by the sentence: 'CONCLUSIONS: Prednisolone was more effective in inducing response than itraconazole in acute-stage ABPA.'?,"No, the statement ""Prednisolone was more effective in inducing response than itraconazole in acute-stage ABPA"" does not provide indirect support for the claim ""Ibuprofen related to osteoarthritis."" The statement is about the effectiveness of two drugs in treating allergic bronchopulmonary aspergillosis (ABPA), while the claim is about ibuprofen's potential relation to osteoarthritis. These two statements involve different conditions, drugs, and outcomes, so there is no logical connection between them."
8106985,Ibuprofen related to burn,120,"Purpose: The aim of this study was to compare asparaginase-related toxicities in two asparaginase preparations, namely native Escherichia coli L-asparaginase (L-ASP) and pegylated asparaginase (PEG-ASP) in combination with ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) in natural killer (NK)/T-cell lymphoma (NTCL).",False,"Is the triple 'Ibuprofen related to burn' supported by the sentence: 'Purpose: The aim of this study was to compare asparaginase-related toxicities in two asparaginase preparations, namely native Escherichia coli L-asparaginase (L-ASP) and pegylated asparaginase (PEG-ASP) in combination with ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) in natural killer (NK)/T-cell lymphoma (NTCL).'?","No, the statement does not provide indirect support for the phrase ""Ibuprofen related to burn"". The purpose statement discusses a study comparing asparaginase-related toxicities in two asparaginase preparations when used in combination with specific chemotherapeutic agents in natural killer (NK)/T-cell lymphoma (NTCL). Ibuprofen is not mentioned in the statement, nor is there any connection made between ibuprofen use and burns. Therefore, it would be inappropriate to infer any relationship between ibuprofen and burns based on this information alone."
13726345,Ibuprofen causes patent ductus arteriosus,121,Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.,False,Is the triple 'Ibuprofen causes patent ductus arteriosus' supported by the sentence: 'Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.'?,"No, the statement does not provide indirect support for the phrase ""Ibuprofen causes patent ductus arteriosus."" The meta-analysis focuses on comparing the efficacy and safety of prednisolone combined with adjunctive immunosuppression versus prednisolone alone in treating giant cell arteritis. It does not involve Ibuprofen or discuss its potential effects on patent ductus arteriosus. The two statements belong to different contexts and do not share any connection that would allow for indirect support from one to another."
13653982,Ibuprofen causes Alzheimer disease,122,CONCLUSION: GVP is well-tolerated regimen with high response rate and needs to be tested in late relapsed HL.,False,Is the triple 'Ibuprofen causes Alzheimer disease' supported by the sentence: 'CONCLUSION: GVP is well-tolerated regimen with high response rate and needs to be tested in late relapsed HL.'?,"No, the phrase ""Ibuprofen causes Alzheimer disease"" does not receive indirect support from the statement: ""CONCLUSION: GVP is well-tolerated regimen with high response rate and needs to be tested in late relapsed HL."" 

         The conclusion provided is about a treatment regimen called GVP (which is not specified but is likely an acronym for some medical treatment) in patients with late relapsed Hodgkin Lymphoma (HL). It states that GVP is well-tolerated and has a high response rate, implying that it could be an effective treatment for these patients in future studies. Ibuprofen is a non-prescription non-steroidal anti-inflammatory drug (NSAID) used for relieving pain, fever, and inflammation; it is not mentioned anywhere in the conclusion nor does it have any connection that would imply it has any relation to Alzheimer disease.

         Alzheimer disease is a neurodegenerative disorder characterized by progressive cognitive decline due to accumulation of beta-amyloid plaques and tau protein tangles in the brain; it is not known to"
13133316,Ibuprofen causes peptic ulcer disease,123,Early treatment with addition of low dose prednisolone to methotrexate improves therapeutic outcome in severe psoriatic arthritis.,False,Is the triple 'Ibuprofen causes peptic ulcer disease' supported by the sentence: 'Early treatment with addition of low dose prednisolone to methotrexate improves therapeutic outcome in severe psoriatic arthritis.'?,"No, the statement ""Early treatment with addition of low dose prednisolone to methotrexate improves therapeutic outcome in severe psoriatic arthritis"" does not provide indirect support for the claim that ""Ibuprofen causes peptic ulcer disease.""

        
        The two statements discuss different subjects: one is about treatment for psoriatic arthritis and its outcome, while the other is about ibuprofen causing peptic ulcer disease. Even though ibuprofen is a non-steroidal anti-inflammatory drug (NSAID), which has been associated with peptic ulcer disease risk, there is no direct link established between ibuprofen use and causing peptic ulcer disease in the provided statement.

        
        The risk of developing peptic ulcer disease due to NSAIDs such as ibuprofen is influenced by factors such as dosage, duration of use, concomitant use of other medications (like corticosteroids), age, and history of peptic ulcer disease. Therefore, while it is true that NSAIDs can increase the risk of peptic ulcer disease, it"
12641386,Ibuprofen causes Fever,124,"CONCLUSION: Flu/Cy/ATG conditioning regimen, bone marrow as stem cell source and CSA, prednisolone and short methotrexate regimen were associated with better survival in AA.",False,"Is the triple 'Ibuprofen causes Fever' supported by the sentence: 'CONCLUSION: Flu/Cy/ATG conditioning regimen, bone marrow as stem cell source and CSA, prednisolone and short methotrexate regimen were associated with better survival in AA.'?","No, the statement does not provide any indirect support for the phrase ""Ibuprofen causes Fever"". The conclusion provided in the statement is about the factors associated with better survival in Acute Myeloid Leukemia (AML) patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ibuprofen is not mentioned in the statement, nor is there any connection made between ibuprofen use and fever in the statement provided. Therefore, it does not provide any basis for such an inference."
12482174,Ibuprofen causes pancreatitis,125,Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: a pilot randomized controlled trial.,False,Is the triple 'Ibuprofen causes pancreatitis' supported by the sentence: 'Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: a pilot randomized controlled trial.'?,"No, the statement does not provide any indirect support for the claim that ""Ibuprofen causes pancreatitis."" The study mentioned is focused on examining the impact of adding a short course of prednisolone (a steroid medication) to a gluten-free diet on mucosal epithelial cell regeneration and apoptosis (cell death) in celiac disease patients. The study does not involve ibuprofen or investigate its potential effects on pancreatitis. Thus, it does not offer any relevant insights into the safety profile of ibuprofen regarding pancreatitis risk."
12438812,Ibuprofen causes Toothache,126,Coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis/dermatomyositis.,False,Is the triple 'Ibuprofen causes Toothache' supported by the sentence: 'Coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis/dermatomyositis.'?,"No, the statement ""Coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis/dermatomyositis"" does not provide indirect support for the claim ""Ibuprofen causes Toothache."" The two statements discuss unrelated medical issues: cyclosporin A and prednisolone coadministration in acute interstitial pneumonia related to polymyositis/dermatomyositis and ibuprofen causing toothache, respectively.

         The first statement refers to cyclosporin A (an immunosuppressant) and prednisolone (a corticosteroid) being used together in treating specific lung complications in patients suffering from polymyositis/dermatomyositis (autoimmune diseases). The second statement is about ibuprofen (a nonsteroidal anti-inflammatory drug) causing toothache; however, it does not provide any evidence or reasoning linking these concepts together.

         There is no shared subject matter between these statements that would allow for inference from one to support the other. Therefore, we cannot validate"
12079834,Ibuprofen causes adult acute respiratory distress syndrome,127,"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.",False,"Is the triple 'Ibuprofen causes adult acute respiratory distress syndrome' supported by the sentence: 'Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.'?","No, there is no indirect support for the claim that ""Ibuprofen causes adult acute respiratory distress syndrome"" in the provided statement about the RAISE study on Kawasaki disease. The RAISE study investigates the efficacy of immunoglobulin plus prednisolone in preventing coronary artery abnormalities in severe Kawasaki disease - it does not involve ibuprofen nor discuss its potential side effects in adults like acute respiratory distress syndrome (ARDS)."
11157616,Ibuprofen causes Pain,128,"Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma.",False,"Is the triple 'Ibuprofen causes Pain' supported by the sentence: 'Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma.'?","No, the phrase ""Ibuprofen causes Pain"" does not receive any direct or indirect support from the statement: ""Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma.""

         The statement in question pertains to chemotherapy treatments (vincristine, melphalan, cyclophosphamide, and prednisolone) for refractory multiple myeloma – a type of cancer. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief, fever reduction, and inflammation control. The two subjects have no overlap in their contexts; thus, there is no indirect support for the claim that ""Ibuprofen causes Pain.""

         Moreover, attributing a causative relationship between ibuprofen and pain is an oversimplification that contradicts available evidence. Ibuprofen is primarily used for pain relief; hence associating it with causing pain is not consistent with its intended use and well-established pharmacological function."
10429873,Ibuprofen causes Hemorrhage,129,Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia.,False,Is the triple 'Ibuprofen causes Hemorrhage' supported by the sentence: 'Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia.'?,"No, the statement ""Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia"" does not provide indirect support for the claim ""Ibuprofen causes Hemorrhage.""

         The two statements discuss different concepts that do not have any direct or indirect connection in terms of their subject matter. The first statement refers to pyruvate kinase M2 (PKM2) isoform expression in acute lymphoblastic leukemia (ALL) cells, which may contribute to prednisolone resistance in these cells. In contrast, the second statement makes an unsubstantiated claim about ibuprofen causing hemorrhage (bleeding).

         It is crucial not to draw conclusions from unrelated statements in science as it may lead to misinterpretation of facts. The connection between ibuprofen use and hemorrhage risk is primarily related to its potential effects on platelet function rather than leukemia-related drug resistance mechanisms (Hassan et al., 2006).

         In conclusion, there is no indirect support for ""Ibuprofen causes Hemorrh"
9800201,Ibuprofen causes arthritic joint disease,130,"Stimulation with prednisolone and TNFalpha reduced GDF-5 expression in OA and RA fibroblasts, whereas MTX and IL-1beta revealed minor or no relevant change.",False,"Is the triple 'Ibuprofen causes arthritic joint disease' supported by the sentence: 'Stimulation with prednisolone and TNFalpha reduced GDF-5 expression in OA and RA fibroblasts, whereas MTX and IL-1beta revealed minor or no relevant change.'?","No, the statement does not provide indirect support for the phrase ""Ibuprofen causes arthritic joint disease."" The statement discusses the effects of various substances on GDF-5 expression in osteoarthritis (OA) and rheumatoid arthritis (RA) fibroblasts, but it does not mention ibuprofen at all. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief, including arthritis-related pain; however, its potential causative relationship with arthritic joint disease is beyond the scope of this statement."
8163776,Ibuprofen causes injury,131,"A combination of rituximab plus chemotherapy, rituximab+cyclophosphamide+doxorubicin+vincristine+prednisolone (R-CHOP), has the highest efficacy ever described with any chemotherapy in DLBCL and FL.",False,"Is the triple 'Ibuprofen causes injury' supported by the sentence: 'A combination of rituximab plus chemotherapy, rituximab+cyclophosphamide+doxorubicin+vincristine+prednisolone (R-CHOP), has the highest efficacy ever described with any chemotherapy in DLBCL and FL.'?","No, the statement does not provide indirect support for the phrase ""Ibuprofen causes injury."" The statement discusses the efficacy of R-CHOP (a specific chemotherapy regimen) in treating certain types of lymphoma (diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL)). Ibuprofen is an over-the-counter non-steroidal anti-inflammatory drug (NSAID) that is not mentioned in the statement nor linked in any way that would imply causation for injury."
26701175,Ibuprofen affects rheumatoid arthritis,132,"A combination of rituximab plus chemotherapy, rituximab+cyclophosphamide+doxorubicin+vincristine+prednisolone (R-CHOP), has the highest efficacy ever described with any chemotherapy in DLBCL and FL.",False,"Is the triple 'Ibuprofen affects rheumatoid arthritis' supported by the sentence: 'A combination of rituximab plus chemotherapy, rituximab+cyclophosphamide+doxorubicin+vincristine+prednisolone (R-CHOP), has the highest efficacy ever described with any chemotherapy in DLBCL and FL.'?","No, the statement does not provide indirect support for the claim that ibuprofen affects rheumatoid arthritis. The statement discusses the efficacy of R-CHOP (a specific chemotherapy regimen) in treating diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Ibuprofen is an over-the-counter non-steroidal anti-inflammatory drug (NSAID) used primarily for pain relief, fever reduction, and inflammation control. Although both ibuprofen and R-CHOP have potential effects on inflammation, there is no direct connection between these two statements regarding their impact on rheumatoid arthritis or lymphoma, respectively.

         To provide indirect support for the claim about ibuprofen affecting rheumatoid arthritis, one would need evidence showing that ibuprofen has an impact on rheumatoid arthritis-related symptoms, disease progression, or treatment outcomes. This would require studies specifically investigating ibuprofen in rheumatoid arthritis patients, rather than"
24384432,Ibuprofen affects migraine disorder,133,Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study.,False,Is the triple 'Ibuprofen affects migraine disorder' supported by the sentence: 'Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects migraine disorder."" The study mentioned is about comparing weekly docetaxel and prednisolone versus prednisolone alone in treating androgen-independent prostate cancer. Ibuprofen is not mentioned in the study at all, let alone its potential effects on migraine disorder. Therefore, it is not possible to draw any conclusions about Ibuprofen's impact on migraines based on this particular study."
23500890,Ibuprofen affects adult acute respiratory distress syndrome,134,Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.,False,Is the triple 'Ibuprofen affects adult acute respiratory distress syndrome' supported by the sentence: 'Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.'?,"No, the statement ""Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study"" does not provide indirect support for the claim that ""Ibuprofen affects adult acute respiratory distress syndrome."" The study in question focuses on prednisolone and azathioprine as treatments for membranous nephropathy over a 10-year period; it does not involve ibuprofen nor discuss its effects on acute respiratory distress syndrome (ARDS).

         However, it is important to note that while these two statements appear unrelated at first glance, they both touch upon inflammation and immune response - prednisolone and azathioprine being immunosuppressive drugs used in treating nephropathy (kidney inflammation) while ARDS is characterized by pulmonary inflammation. Nonetheless, this connection does not provide any empirical evidence regarding ibuprofen's impact on ARDS as no comparative analysis has been made between these two scenarios in the given study."
21214366,Ibuprofen affects bronchopulmonary dysplasia,135,"Taken together, the present study points to a strong inhibitory effect of liposomal PLP on tumor angiogenesis by reduction of the intratumoral production of the majority of pro-angiogenic factors studied and direct inhibition of endothelial cell proliferation, which is the result of high prolonged levels of prednisolone in the tumor by liposomal delivery.",False,"Is the triple 'Ibuprofen affects bronchopulmonary dysplasia' supported by the sentence: 'Taken together, the present study points to a strong inhibitory effect of liposomal PLP on tumor angiogenesis by reduction of the intratumoral production of the majority of pro-angiogenic factors studied and direct inhibition of endothelial cell proliferation, which is the result of high prolonged levels of prednisolone in the tumor by liposomal delivery.'?","No, the statement does not provide indirect support for the phrase ""Ibuprofen affects bronchopulmonary dysplasia."" The statement discusses the inhibitory effect of liposomal PLP on tumor angiogenesis through reduced pro-angiogenic factors and direct inhibition of endothelial cell proliferation due to high prolonged levels of prednisolone in tumors via liposomal delivery. Ibuprofen is neither mentioned nor implied in this mechanism, nor is bronchopulmonary dysplasia mentioned as an outcome. Therefore, there is no basis for inferring any connection between ibuprofen use and bronchopulmonary dysplasia from this statement alone."
20886939,Ibuprofen affects Cognitive impairment,136,Prednisolone versus dexamethasone in croup: a randomised equivalence trial.,False,Is the triple 'Ibuprofen affects Cognitive impairment' supported by the sentence: 'Prednisolone versus dexamethasone in croup: a randomised equivalence trial.'?,"No, the statement ""Prednisolone versus dexamethasone in croup: a randomised equivalence trial"" does not provide direct or indirect support for the claim that ""Ibuprofen affects cognitive impairment.""

         The study mentioned is an equivalence trial comparing prednisolone and dexamethasone in treating croup (a viral infection in children characterized by upper airway obstruction). The study does not involve ibuprofen or investigate its impact on cognitive impairment.

         While it is essential to evaluate evidence critically, it is equally important to ensure that there is an appropriate connection between the evidence presented and the claim being made for accurate interpretation."
18977843,Ibuprofen affects Headache,137,Use of ACTH and prednisolone in infantile spasms: experience from a developing country.,False,Is the triple 'Ibuprofen affects Headache' supported by the sentence: 'Use of ACTH and prednisolone in infantile spasms: experience from a developing country.'?,"No, the statement ""Use of ACTH and prednisolone in infantile spasms: experience from a developing country"" does not provide direct or indirect support for the phrase ""Ibuprofen affects Headache."" The study likely focuses on using adrenocorticotropic hormone (ACTH) and prednisolone as treatments for infantile spasms in a developing country setting rather than investigating ibuprofen as a headache treatment.

        However, it is still possible that ibuprofen as a non-steroidal anti-inflammatory drug (NSAID) is mentioned in passing within the context of pain management in general. Nevertheless, without examining the actual study itself, it is improbable that it would provide any significant support for the specific claim about ibuprofen and headaches due to its focus on infantile spasms and treatments in developing countries."
15746938,Ibuprofen affects injury,138,Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.,False,Is the triple 'Ibuprofen affects injury' supported by the sentence: 'Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.'?,"No, the statement ""Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease"" does not provide indirect support for the claim that ""Ibuprofen affects injury."" The statement is about bone mineral density changes due to budesonide and prednisolone usage in Crohn's disease patients, making no mention of ibuprofen or injury effects."
13826486,Ibuprofen affects osteoarthritis,139,OBJECTIVE: To examine the safety and efficacy of methotrexate (MTX) plus low-dose prednisolone for induction of remission in non life- or organ-threatening courses and for remission maintenance in Churg-Strauss syndrome (CSS).,False,Is the triple 'Ibuprofen affects osteoarthritis' supported by the sentence: 'OBJECTIVE: To examine the safety and efficacy of methotrexate (MTX) plus low-dose prednisolone for induction of remission in non life- or organ-threatening courses and for remission maintenance in Churg-Strauss syndrome (CSS).'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects osteoarthritis"". The objective in the statement is about examining the safety and efficacy of methotrexate (MTX) plus low-dose prednisolone for induction of remission in non life- or organ-threatening courses and for remission maintenance in Churg-Strauss syndrome (CSS). Ibuprofen is not mentioned in the statement, nor is there any implicit connection that could be drawn between methotrexate, prednisolone, and ibuprofen in relation to osteoarthritis treatment."
13584223,Ibuprofen affects Cognitive impairment,140,OBJECTIVE: To determine whether addition of low dose prednisolone to multidrug treatment can prevent reaction and nerve function impairment in leprosy.,False,Is the triple 'Ibuprofen affects Cognitive impairment' supported by the sentence: 'OBJECTIVE: To determine whether addition of low dose prednisolone to multidrug treatment can prevent reaction and nerve function impairment in leprosy.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects Cognitive impairment."" The objective in the statement is focused on determining the effect of low-dose prednisolone on reaction and nerve function impairment in leprosy patients undergoing multidrug treatment. Ibuprofen is not mentioned in the statement, nor is there any connection made between anti-inflammatory drugs like ibuprofen and cognitive impairment."
12659717,Ibuprofen affects Fever,141,A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.,False,Is the triple 'Ibuprofen affects Fever' supported by the sentence: 'A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.'?,"No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen affects Fever."" The study mentioned investigates the effects of infliximab and prednisolone on acute alcoholic hepatitis; it does not involve ibuprofen or fever as primary factors in its experimental design or conclusions. Ibuprofen's effect on fever is unrelated to this study and should be evaluated based on other relevant evidence."
11207850,Ibuprofen affects peptic ulcer disease,142,EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.,False,Is the triple 'Ibuprofen affects peptic ulcer disease' supported by the sentence: 'EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.'?,"No, the statement does not provide any direct or indirect support for the claim that ""Ibuprofen affects peptic ulcer disease"". The EULAR (European League Against Rheumatism) randomized controlled trial mentioned in the statement is focused on comparing two different treatment regimens for lupus nephritis, a severe form of kidney inflammation associated with systemic lupus erythematosus (SLE). Ibuprofen is not mentioned in the statement at all, nor is there any reference made to peptic ulcer disease. Therefore, it is not possible to draw any conclusions about ibuprofen's effects on peptic ulcer disease based on this statement alone."
11159990,Ibuprofen affects Hemorrhage,143,OBJECTIVE: To investigate the safety and efficacy of leflunomide plus low-dose prednisolone for the maintenance of remission in Wegener's granulomatosis (WG).,False,Is the triple 'Ibuprofen affects Hemorrhage' supported by the sentence: 'OBJECTIVE: To investigate the safety and efficacy of leflunomide plus low-dose prednisolone for the maintenance of remission in Wegener's granulomatosis (WG).'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects Hemorrhage."" The objective provided is about investigating the safety and efficacy of leflunomide plus low-dose prednisolone for maintaining remission in Wegener's granulomatosis (WG), which is an autoimmune disease. Ibuprofen is not mentioned in the statement, nor is there any implied connection between ibuprofen use and hemorrhage risk in patients with WG undergoing treatment with leflunomide plus low-dose prednisolone."
10170540,Ibuprofen affects patent ductus arteriosus,144,"Treatment with combined therapy of adriamycin, vincristine and prednisolone produced a remission in the leukaemia with complete resolution of the breast mass.",False,"Is the triple 'Ibuprofen affects patent ductus arteriosus' supported by the sentence: 'Treatment with combined therapy of adriamycin, vincristine and prednisolone produced a remission in the leukaemia with complete resolution of the breast mass.'?","No, the statement does not provide indirect support for the phrase ""Ibuprofen affects patent ductus arteriosus."" The statement discusses the effects of a combined therapy (adriamycin, vincristine, and prednisolone) on leukaemia and breast mass resolution, which is unrelated to ibuprofen and its potential impact on patent ductus arteriosus (PDA). Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief and reducing inflammation, while adriamycin, vincristine, and prednisolone are chemotherapy drugs used in cancer treatment. The two statements discuss different treatments and their effects on separate medical conditions; therefore, they do not offer any indirect support for the stated phrase regarding ibuprofen and PDA."
10026104,Ibuprofen affects Myalgia,145,RESULTS: The average initial dose of prednisolone in polymyalgia rheumatica was 35 mg; 51 of 62 patients were given a starting dose exceeding 15 mg.,False,Is the triple 'Ibuprofen affects Myalgia' supported by the sentence: 'RESULTS: The average initial dose of prednisolone in polymyalgia rheumatica was 35 mg; 51 of 62 patients were given a starting dose exceeding 15 mg.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects Myalgia"". The statement discusses the initial dose of prednisolone in polymyalgia rheumatica patients but does not mention ibuprofen or myalgia at all. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for relieving pain, while myalgia refers to muscle pain; however, there is no connection made between these concepts in the provided statement."
9889792,Ibuprofen affects Hemorrhage,146,[Trans-utero-tubal administration of prednisolone in sterility caused by obstruction of the tubes].,False,Is the triple 'Ibuprofen affects Hemorrhage' supported by the sentence: '[Trans-utero-tubal administration of prednisolone in sterility caused by obstruction of the tubes].'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects Hemorrhage."" The statement discusses the administration of prednisolone in cases of sterility due to tubal obstruction. Prednisolone is a corticosteroid medication, unrelated to ibuprofen which is a nonsteroidal anti-inflammatory drug (NSAID). Moreover, neither ibuprofen nor hemorrhage is mentioned in the statement. Therefore, there is no connection that can be inferred between ibuprofen and hemorrhage from this statement."
8819538,Ibuprofen affects osteoarthritis,147,[On experiences with a combination preparation from prednisolone and an antihistaminic in dermatology especially in endogenous eczema].,False,Is the triple 'Ibuprofen affects osteoarthritis' supported by the sentence: '[On experiences with a combination preparation from prednisolone and an antihistaminic in dermatology especially in endogenous eczema].'?,"No, the statement does not provide any direct or indirect support for the claim that ibuprofen affects osteoarthritis. The statement discusses the use of prednisolone and an antihistaminic in dermatology, particularly in endogenous eczema, which is unrelated to ibuprofen's potential effects on osteoarthritis."
8421263,Ibuprofen affects Fever,148,[USE OF PREDNISOLONE IN SOME GRAVE FORMS OF PATHOLOGY OF THE PREMATURE INFANT].,False,Is the triple 'Ibuprofen affects Fever' supported by the sentence: '[USE OF PREDNISOLONE IN SOME GRAVE FORMS OF PATHOLOGY OF THE PREMATURE INFANT].'?,"No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen affects Fever."" The statement discusses the use of prednisolone in some grave forms of pathology in premature infants, which is unrelated to ibuprofen's effect on fever. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used as an analgesic (pain reliever) and antipyretic (fever reducer). The statement provided does not contain any information linking ibuprofen to fever reduction or any other effects."
27630106,Ibuprofen disrupts Acute Pain,149,[EFFECT OF PREDNISOLONE ON THE CARDIAC ACTIVITY IN LIVER AND KIDNEY  DISEASES AND IN RHEUMATISM].,False,Is the triple 'Ibuprofen disrupts Acute Pain' supported by the sentence: '[EFFECT OF PREDNISOLONE ON THE CARDIAC ACTIVITY IN LIVER AND KIDNEY  DISEASES AND IN RHEUMATISM].'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen disrupts Acute Pain"". The statement discusses the effects of Prednisolone on cardiac activity in liver and kidney diseases as well as rheumatism. It does not mention Ibuprofen or acute pain at all. Therefore, it does not contribute to our understanding or validation of that specific claim."
23399675,Ibuprofen disrupts Myalgia,150,"In this limited pilot study, we compared the effect on clinical outcome of treating Pseudomonas keratitis in guinea pigs with prednisolone (a corticosteroid), flurbiprofen (a cyclo-oxygenase inhibitor), nordihydroguaiaretic acid (a lipoxygenase inhibitor), and a leukotriene antagonist, SKF104353 [R-(R*, S*)]-beta-[(2-carboxyethyl) thio-alpha-hydroxy-2-(8-phenyloctyl) benzenepropanoic acid, zinc salt].",False,"Is the triple 'Ibuprofen disrupts Myalgia' supported by the sentence: 'In this limited pilot study, we compared the effect on clinical outcome of treating Pseudomonas keratitis in guinea pigs with prednisolone (a corticosteroid), flurbiprofen (a cyclo-oxygenase inhibitor), nordihydroguaiaretic acid (a lipoxygenase inhibitor), and a leukotriene antagonist, SKF104353 [R-(R*, S*)]-beta-[(2-carboxyethyl) thio-alpha-hydroxy-2-(8-phenyloctyl) benzenepropanoic acid, zinc salt].'?","No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen disrupts Myalgia."" The study referenced investigates treatments for Pseudomonas keratitis in guinea pigs using various drugs, including flurbiprofen, which is one type of non-steroidal anti-inflammatory drug (NSAID), similar to ibuprofen. However, the study does not examine myalgia (muscle pain) as an outcome nor does it include ibuprofen in its analysis.

        To provide indirect support for ""Ibuprofen disrupts Myalgia,"" there would need to be some evidence in the statement that suggests NSAIDs (or ibuprofen specifically) have an impact on muscle pain (myalgia). As it stands, there is no such evidence in the provided statement, so it cannot be used as indirect support for that claim.

        It is essential to base conclusions on specific evidence related to the claim at hand and ensure that studies"
18599970,Ibuprofen disrupts arthritic joint disease,151,URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS.,False,Is the triple 'Ibuprofen disrupts arthritic joint disease' supported by the sentence: 'URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS.'?,"No, the statement ""URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS"" does not provide indirect support for the phrase ""Ibuprofen disrupts arthritic joint disease"". 

         The statement is about the excretion of Prednisolone, a corticosteroid used in treating various conditions including ulcerative colitis, after intrarectal therapy in ulcerative colitis patients. This has no direct or indirect relation to Ibuprofen, which is a nonsteroidal anti-inflammatory drug (NSAID) used for relieving pain, fever, and inflammation. The two statements pertain to different drugs, diseases, and mechanisms of action. Therefore, no inference can be made from one statement to support the other."
15072611,Ibuprofen disrupts Fever,152,"Male rats treated with either budesonide, prednisolone, or triamcinolone acetonide in drinking water for up to 104 weeks developed slightly increased incidences of basophilic foci, and significantly increased incidences of combined hepatocellular adenomas/carcinomas as compared to controls.",False,"Is the triple 'Ibuprofen disrupts Fever' supported by the sentence: 'Male rats treated with either budesonide, prednisolone, or triamcinolone acetonide in drinking water for up to 104 weeks developed slightly increased incidences of basophilic foci, and significantly increased incidences of combined hepatocellular adenomas/carcinomas as compared to controls.'?","No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen disrupts Fever"". The statement discusses the effects of three different corticosteroids (budesonide, prednisolone, and triamcinolone acetonide) on male rats over an extended period (up to 104 weeks). These corticosteroids have anti-inflammatory properties similar to ibuprofen but they do not directly disrupt fever in the same way that ibuprofen does. Ibuprofen specifically inhibits cyclooxygenase (COX) enzymes which play a crucial role in fever development by producing prostaglandins that act on the hypothalamus. Therefore, although both ibuprofen and corticosteroids have anti-inflammatory effects, they have distinct mechanisms by which they affect fever, making the provided statement not relevant in supporting the claim that ""Ibuprofen disrupts Fever""."
14486259,Ibuprofen disrupts Pain,153,[On the use of prednisolone in hemolytic anemia of the newborn caused by fetomaternal Rh-factor incompatibility].,False,Is the triple 'Ibuprofen disrupts Pain' supported by the sentence: '[On the use of prednisolone in hemolytic anemia of the newborn caused by fetomaternal Rh-factor incompatibility].'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen disrupts Pain"". The statement discusses the use of prednisolone in hemolytic anemia of the newborn caused by fetomaternal Rh-factor incompatibility, which is unrelated to ibuprofen's effect on pain. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for its analgesic (pain-relieving), antipyretic (fever-reducing), and anti-inflammatory properties, but the statement provided does not relate to these effects or its mechanism of action."
8331095,Ibuprofen disrupts Alzheimer disease,154,Long-term use of prednisone and prednisolone in juvenile rheumatoid arthritis; a report of fifteen cases.,False,Is the triple 'Ibuprofen disrupts Alzheimer disease' supported by the sentence: 'Long-term use of prednisone and prednisolone in juvenile rheumatoid arthritis; a report of fifteen cases.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen disrupts Alzheimer disease."" The report discusses long-term use of prednisone and prednisolone in juvenile rheumatoid arthritis but does not mention ibuprofen or Alzheimer disease at all. Therefore, it does not contribute any relevant information regarding the potential impact of ibuprofen on Alzheimer disease."
25657729,Ibuprofen prevents hypertensive disorder,155,[Effect of prednisolone and human albumin on protein excretion in nephrotic syndrome].,False,Is the triple 'Ibuprofen prevents hypertensive disorder' supported by the sentence: '[Effect of prednisolone and human albumin on protein excretion in nephrotic syndrome].'?,"No, the statement does not provide any direct or indirect support for the claim that ibuprofen prevents hypertensive disorders. The title refers to an investigation about prednisolone and human albumin on protein excretion in nephrotic syndrome. There is no mention of ibuprofen nor hypertensive disorders in the title; hence it does not support the given claim in any way."
22159382,Ibuprofen prevents Hemorrhage,156,[Therapeutic results of metacortandralone or prednisolone in allergy].,False,Is the triple 'Ibuprofen prevents Hemorrhage' supported by the sentence: '[Therapeutic results of metacortandralone or prednisolone in allergy].'?,"No, the statement ""Ibuprofen prevents Hemorrhage"" does not receive any direct or indirect support from the statement ""[Therapeutic results of metacortandralone or prednisolone in allergy]."" This is because there is no mention of Ibuprofen, hemorrhage, or any related concepts in the provided statement.

        To further elaborate, metacortandralone and prednisolone are both corticosteroids used primarily for their anti-inflammatory effects in treating allergies. Ibuprofen, on the other hand, is a non-steroidal anti-inflammatory drug (NSAID) that is also used for its anti-inflammatory effects but functions via different mechanisms than corticosteroids. Hemorrhage is the medical term for excessive bleeding or bruising; it is not typically associated with allergies nor treated by corticosteroids like metacortandralone or prednisolone nor by NSAIDs like ibuprofen unless there is an underlying issue causing both the allergy and hemorrhage symptoms.

        Therefore, since there is no connection between"
22123299,Ibuprofen prevents Fever,157,Primary resistance to vincristine (Vcr) and prednisolone in untreated AML was observed as well as 'acquired' resistance to several other antileukemic drugs.,False,Is the triple 'Ibuprofen prevents Fever' supported by the sentence: 'Primary resistance to vincristine (Vcr) and prednisolone in untreated AML was observed as well as 'acquired' resistance to several other antileukemic drugs.'?,"No, the statement ""Ibuprofen prevents fever"" is not supported by the given statement about vincristine (Vcr) and prednisolone resistance in acute myeloid leukemia (AML) patients. The provided information discusses drug resistance in AML patients undergoing certain treatments but does not mention ibuprofen or fever at all. Ibuprofen is an analgesic (pain reliever) and antipyretic (fever reducer), but its ability to prevent fever is not related to drug resistance in leukemia treatment."
21354514,Ibuprofen prevents pancreatitis,158,"REPORT of the Committee on New Drugs of the Research Council of the American Academy of Allergy, 1955-56; studies on prednisone and prednisolone in ragweed pollinosis.",False,"Is the triple 'Ibuprofen prevents pancreatitis' supported by the sentence: 'REPORT of the Committee on New Drugs of the Research Council of the American Academy of Allergy, 1955-56; studies on prednisone and prednisolone in ragweed pollinosis.'?","No, the statement ""Ibuprofen prevents pancreatitis"" does not receive indirect support from the provided report on studies about prednisone and prednisolone in ragweed pollinosis. This report does not involve ibuprofen or discuss its potential effects on pancreatitis. The two subjects—ibuprofen preventing pancreatitis and prednisone/prednisolone in ragweed pollinosis—are unrelated in this context."
20691057,Ibuprofen prevents altitude sickness,159,Effects of prednisone and prednisolone in ocular inflammation.,False,Is the triple 'Ibuprofen prevents altitude sickness' supported by the sentence: 'Effects of prednisone and prednisolone in ocular inflammation.'?,"No, the statement ""Effects of prednisone and prednisolone in ocular inflammation"" does not provide direct or indirect support for the claim that ""Ibuprofen prevents altitude sickness"". The two statements discuss different subjects - one is about the effects of corticosteroids (prednisone and prednisolone) on ocular inflammation, while the other is about the impact of ibuprofen on altitude sickness. To support the claim about ibuprofen preventing altitude sickness, evidence should be provided that specifically addresses altitude sickness and ibuprofen use."
19399624,Ibuprofen prevents osteoarthritis,160,"Prednisolone scored better than prednisone in the categories of texture, taste, and aftertaste (p < 0.05); there was no statistical difference in smell.",False,"Is the triple 'Ibuprofen prevents osteoarthritis' supported by the sentence: 'Prednisolone scored better than prednisone in the categories of texture, taste, and aftertaste (p < 0.05); there was no statistical difference in smell.'?","No, the statement does not provide any indirect support for the claim that ibuprofen prevents osteoarthritis. The provided statement compares prednisolone and prednisone in terms of texture, taste, and aftertaste, without any mention of ibuprofen or osteoarthritis. As such, it does not offer any relevant evidence or insights regarding the potential benefits of ibuprofen in preventing osteoarthritis. To evaluate such a claim, one would need to examine studies specifically investigating the relationship between ibuprofen use and osteoarthritis incidence or progression."
17687542,Ibuprofen prevents canker sore,161,Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis.,False,Is the triple 'Ibuprofen prevents canker sore' supported by the sentence: 'Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis.'?,"No, the statement does not provide any direct or indirect support for the claim that ibuprofen prevents canker sores. The two statements discuss different subjects: one is about ibuprofen preventing canker sores, while the other is about prednisolone levels in colitis patients who received prednisolone-21-phosphate as a retention enema. There is no connection between these two subjects that would allow us to infer support for one from the other.

         The statement about prednisolone levels pertains specifically to pharmacokinetics in colitis patients undergoing a particular medical treatment; it does not mention ibuprofen, canker sores, or prevention in any way. Therefore, it cannot be used as evidence in favor of (or against) that specific claim about ibuprofen preventing canker sores."
15961024,Ibuprofen prevents Dysmenorrhea,162,Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus.,False,Is the triple 'Ibuprofen prevents Dysmenorrhea' supported by the sentence: 'Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus.'?,"No, the statement ""Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus"" does not provide indirect support for the claim that ""Ibuprofen prevents Dysmenorrhea"". The two statements discuss different medical conditions (systemic lupus erythematosus vs dysmenorrhea) and treatments (mizoribine/prednisolone vs ibuprofen)."
13710734,Ibuprofen prevents Chronic pain,163,Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.,False,Is the triple 'Ibuprofen prevents Chronic pain' supported by the sentence: 'Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.'?,"No, the statement ""Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy"" does not provide indirect support for the claim ""Ibuprofen prevents Chronic pain"". The two statements discuss different subjects: one is about treating IgA nephropathy (a kidney disease) using prednisolone and cytotoxics, while the other is about preventing chronic pain using ibuprofen. There is no overlap or connection between these two topics that would allow for indirect support from one statement to be inferred for the other statement."
10201705,Ibuprofen prevents Headache,164,"We propose that FE(NO) is associated with eosinophilic inflammation in children with difficult asthma, following prednisolone, and may help in identifying patients in whom persistent symptoms are associated with airway eosinophilia.",False,"Is the triple 'Ibuprofen prevents Headache' supported by the sentence: 'We propose that FE(NO) is associated with eosinophilic inflammation in children with difficult asthma, following prednisolone, and may help in identifying patients in whom persistent symptoms are associated with airway eosinophilia.'?","No, the statement does not provide indirect support for the phrase ""Ibuprofen prevents Headache."" The statement discusses the association between fractional exhaled nitric oxide (FeNO) levels and eosinophilic inflammation in children with difficult asthma, as well as identifying patients who may benefit from prednisolone treatment based on their FeNO levels. Ibuprofen is not mentioned in the statement, nor is there any connection made between ibuprofen use and headache prevention."
10026105,Ibuprofen prevents Myalgia,165,"Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma.",False,"Is the triple 'Ibuprofen prevents Myalgia' supported by the sentence: 'Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma.'?","No, the statement does not provide any direct or indirect support for the claim that ""Ibuprofen prevents Myalgia"". The two statements discuss different subjects: one is about a specific treatment regimen for non-Hodgkin lymphoma (Liposomal daunorubicin in combination with COP-X), while the other suggests that Ibuprofen prevents Myalgia.

         Myalgia is muscle pain that can be caused by various factors including inflammation, injury, infection, or drug side effects. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is often used as an analgesic for pain relief, including myalgia. However, the statement about liposomal daunorubicin in combination therapy for non-Hodgkin lymphoma does not provide any information about Ibuprofen or myalgia prevention.

         In order for an argument to be indirectly supported by another argument, they should share some common ground - either in terms of concepts, principles, evidence, or methods. In this case, however, there is no such commonality between the two"
9104502,Ibuprofen prevents injury,166,Prednisolone in Duchenne muscular dystrophy.,False,Is the triple 'Ibuprofen prevents injury' supported by the sentence: 'Prednisolone in Duchenne muscular dystrophy.'?,"No, the statement ""Prednisolone in Duchenne muscular dystrophy"" does not provide indirect support for the phrase ""Ibuprofen prevents injury."" These two statements discuss different medical treatments addressing distinct medical conditions; prednisolone is used for treating Duchenne muscular dystrophy while ibuprofen is used for pain relief and fever reduction. The only possible connection between them is that they both belong to the class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs), but that alone does not establish any link in terms of preventing injury."
9022792,Ibuprofen prevents Pain,167,Intravenous prednisolone in chronic bronchial asthma.,False,Is the triple 'Ibuprofen prevents Pain' supported by the sentence: 'Intravenous prednisolone in chronic bronchial asthma.'?,"No, the statement ""Intravenous prednisolone in chronic bronchial asthma"" does not provide indirect support for the phrase ""Ibuprofen prevents Pain."" These two statements discuss different medications (ibuprofen vs prednisolone) and medical conditions (pain vs chronic bronchial asthma). Therefore, there is no logical connection between them that would allow for indirect support.

        Justifying my decision, Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for its analgesic (pain-relieving) and antipyretic (fever-reducing) properties, while prednisolone is a corticosteroid often prescribed for its anti-inflammatory effects in treating various conditions such as chronic bronchial asthma, allergies, and autoimmune disorders.

        Although both ibuprofen and prednisolone have anti-inflammatory properties, they target different inflammatory pathways, have distinct mechanisms of action, and are used for different medical indications. Hence, evidence supporting the use of prednisol"
8584177,Ibuprofen prevents patent ductus arteriosus,168,Reversibility with prednisolone is rarely seen in COPD.,False,Is the triple 'Ibuprofen prevents patent ductus arteriosus' supported by the sentence: 'Reversibility with prednisolone is rarely seen in COPD.'?,"No, the statement ""Reversibility with prednisolone is rarely seen in COPD"" does not provide indirect support for the phrase ""Ibuprofen prevents patent ductus arteriosus."" 

         The two statements discuss different subjects: one refers to Ibuprofen preventing patent ductus arteriosus (a condition in premature infants), while the other refers to prednisolone reversibility in Chronic Obstructive Pulmonary Disease (COPD). There is no shared context or common principle between them that would allow for indirect support. Patent ductus arteriosus is primarily influenced by prostaglandin levels in the body, not by corticosteroids like prednisolone used in COPD treatment."
7843138,Ibuprofen prevents Alzheimer disease,169,"In spite of the fact that prednisolone-based treatment of pemphigus patients has proved to be effective in controlling the disease, some undesirable effects associated with this form of treatment have prompted investigation into other therapeutic approaches.",False,"Is the triple 'Ibuprofen prevents Alzheimer disease' supported by the sentence: 'In spite of the fact that prednisolone-based treatment of pemphigus patients has proved to be effective in controlling the disease, some undesirable effects associated with this form of treatment have prompted investigation into other therapeutic approaches.'?","No, the statement does not provide indirect support for the claim that ibuprofen prevents Alzheimer disease. The statement discusses prednisolone-based treatment for pemphigus patients and its undesirable effects, which has prompted investigation into other therapeutic approaches. This information is not related to ibuprofen or its potential effects on Alzheimer disease prevention. The two statements discuss different medical conditions (pemphigus vs Alzheimer disease) and treatments (prednisolone vs ibuprofen), so there is no connection between them that would support the claim about ibuprofen preventing Alzheimer disease."
15342704,Ibuprofen exacerbates injury,170,One reason for the good clinical effects of prednisolone in RA could be a down-regulation of adhesion and phagocytosis receptors on monocytes.,False,Is the triple 'Ibuprofen exacerbates injury' supported by the sentence: 'One reason for the good clinical effects of prednisolone in RA could be a down-regulation of adhesion and phagocytosis receptors on monocytes.'?,"No, the statement ""One reason for the good clinical effects of prednisolone in RA could be a down-regulation of adhesion and phagocytosis receptors on monocytes"" does not provide indirect support for the claim ""Ibuprofen exacerbates injury"". 

         The two statements discuss different concepts related to rheumatoid arthritis (RA) treatment: one focuses on prednisolone's potential mechanism in treating RA by down-regulating certain receptors on monocytes, while the other makes an assertion about ibuprofen worsening injury without specifying any context or mechanism.

         The connection between these two statements can only be established if additional evidence is provided that links ibuprofen usage in RA treatment, its potential impact on adhesion/phagocytosis receptors on monocytes, and how such an effect would exacerbate injury in RA patients. In summary, there is no inherent indirect support for ""Ibuprofen exacerbates injury"" within the provided statement regarding prednisolone in RA treatment."
20007370,Ibuprofen predisposes cerebral palsy,171,OBJECTIVE: To appraise the adjunctive role of prednisolone (PN) in pulmonary tuberculosis (PTB) with toxic reactions.,False,Is the triple 'Ibuprofen predisposes cerebral palsy' supported by the sentence: 'OBJECTIVE: To appraise the adjunctive role of prednisolone (PN) in pulmonary tuberculosis (PTB) with toxic reactions.'?,"No, the statement does not provide indirect support for the phrase ""Ibuprofen predisposes cerebral palsy."" The objective in the statement is focused on appraising the adjunctive role of prednisolone in pulmonary tuberculosis treatment and its potential toxic reactions. There is no mention or implication of ibuprofen or cerebral palsy in the statement provided. To establish a connection between ibuprofen predisposing cerebral palsy, there would need to be evidence linking these two factors together in some way, which is not present in this statement."
14332005,Ibuprofen predisposes bronchopulmonary dysplasia,172,"A significant reduction of survival was found with the presence of permanent visual loss vs absence (p = 0.04), in patients who required more than 10 mg/d of glucocorticoid (p < 0.001) at 6 months treatment and in patients treated with prednisone (vs prednisolone) (p < 0.01).",False,"Is the triple 'Ibuprofen predisposes bronchopulmonary dysplasia' supported by the sentence: 'A significant reduction of survival was found with the presence of permanent visual loss vs absence (p = 0.04), in patients who required more than 10 mg/d of glucocorticoid (p < 0.001) at 6 months treatment and in patients treated with prednisone (vs prednisolone) (p < 0.01).'?","No, the statement does not provide indirect support for the phrase ""Ibuprofen predisposes bronchopulmonary dysplasia."" The statement discusses factors affecting survival in patients treated for retinopathy of prematurity (ROP), including glucocorticoid dosage, type of glucocorticoid used (prednisone vs prednisolone), and visual loss status at 6 months post-treatment. Ibuprofen is not mentioned in the statement; thus, there is no basis for inferring any relationship between ibuprofen use and bronchopulmonary dysplasia.

        To further clarify:

        - Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants, while retinopathy of prematurity (ROP) is an eye condition that can lead to vision loss in premature infants.

        - Ibuprofen is an anti-inflammatory drug that has been studied as a potential treatment for BPD due to its anti-inflammatory properties; however, its efficacy remains uncertain according to current evidence (Polin R"
14294004,Ibuprofen predisposes Alzheimer disease,173,"Fourteen patients developed hyperglycemia during induction therapy of acute lymphoblastic leukemia with L-asparaginase, prednisolone, vincristine and daunorubicin.",False,"Is the triple 'Ibuprofen predisposes Alzheimer disease' supported by the sentence: 'Fourteen patients developed hyperglycemia during induction therapy of acute lymphoblastic leukemia with L-asparaginase, prednisolone, vincristine and daunorubicin.'?","No, the statement does not provide any indirect support for the claim that ibuprofen predisposes Alzheimer disease. The statement discusses adverse effects observed in 14 patients undergoing induction therapy for acute lymphoblastic leukemia using specific drugs; ibuprofen is not mentioned in this context. The development of hyperglycemia in these patients is not related to ibuprofen use nor Alzheimer disease risk.

         To further clarify:
         - Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for pain relief, whereas L-asparaginase, prednisolone, vincristine, and daunorubicin are chemotherapy drugs used in treating leukemia.
         - Alzheimer disease is a progressive neurodegenerative disorder characterized by memory loss and cognitive decline in older adults, while hyperglycemia is an elevated blood sugar level that can be caused by various factors such as diabetes mellitus, stress, infections, certain medications (including corticosteroids like prednisolone), but not by ibupro"
14085648,Ibuprofen predisposes injury,174,A 66-year-old man was treated for IgD (lambda) multiple myeloma with 2mg/day melphalan and 20mg/day prednisolone.,False,Is the triple 'Ibuprofen predisposes injury' supported by the sentence: 'A 66-year-old man was treated for IgD (lambda) multiple myeloma with 2mg/day melphalan and 20mg/day prednisolone.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen predisposes injury."" The statement discusses a 66-year-old man being treated for multiple myeloma using melphalan and prednisolone drugs but does not mention anything about ibuprofen use or injury predisposition. Ibuprofen is not mentioned in the statement; hence there is no correlation between its use and injury as claimed in the phrase. The statement provided is not relevant in supporting the claim made in the phrase."
12673407,Ibuprofen predisposes bone fracture,175,"Moreover, after recent findings regarding the presence of endogenous prednisolone in the urine of more popular breeds, particular attention was given to analysis of the presence of prednisolone and prednisone, as well.",False,"Is the triple 'Ibuprofen predisposes bone fracture' supported by the sentence: 'Moreover, after recent findings regarding the presence of endogenous prednisolone in the urine of more popular breeds, particular attention was given to analysis of the presence of prednisolone and prednisone, as well.'?","No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen predisposes bone fracture."" The provided statement discusses recent findings regarding the presence of endogenous prednisolone in the urine of popular dog breeds and subsequent analysis of prednisolone and prednisone presence. Ibuprofen is not mentioned at all in this context; therefore, there is no connection that can be made between ibuprofen use and bone fracture predisposition based on this statement alone."
17604344,Ivabradine related to diastolic heart failure,176,"Of 10 mg of prednisone given orally to 5 normal subjects, 69+/-5% was absorbed and converted to peripheral plasma prednisolone within 8 h.",False,"Is the triple 'Ivabradine related to diastolic heart failure' supported by the sentence: 'Of 10 mg of prednisone given orally to 5 normal subjects, 69+/-5% was absorbed and converted to peripheral plasma prednisolone within 8 h.'?","No, the statement does not provide any indirect support for the phrase ""Ivabradine related to diastolic heart failure"". The statement discusses the absorption and conversion rate of prednisone in normal subjects, which has no direct relevance or association with ivabradine or diastolic heart failure. Ivabradine is a medication used primarily for heart rate control in conditions like chronic heart failure, but it is not specifically related to diastolic heart failure as mentioned in the phrase."
19228519,Ivabradine causes atrial fibrillation,177,"As in humans, prednisolone was partly converted to prednisone in the rabbit.",False,"Is the triple 'Ivabradine causes atrial fibrillation' supported by the sentence: 'As in humans, prednisolone was partly converted to prednisone in the rabbit.'?","No, the statement does not provide any indirect support for the claim that Ivabradine causes atrial fibrillation. The two statements discuss different substances (prednisolone/prednisone vs Ivabradine) and their effects in different organisms (rabbits vs humans). The conversion process mentioned in the statement is also unrelated to atrial fibrillation. Therefore, there is no connection between these two pieces of information that would lend support to the claim about Ivabradine."
20784958,Ivabradine affects atrial fibrillation,178,"Given the close resemblance of the ring A structure of prednisolone and prednisone on the one hand, and of androstadienedione on the other, the transformation of cortisol and cortisone into prednisolone and prednisone in cattle faeces was evaluated.",False,"Is the triple 'Ivabradine affects atrial fibrillation' supported by the sentence: 'Given the close resemblance of the ring A structure of prednisolone and prednisone on the one hand, and of androstadienedione on the other, the transformation of cortisol and cortisone into prednisolone and prednisone in cattle faeces was evaluated.'?","No, the statement does not provide any indirect support for the claim that ""Ivabradine affects atrial fibrillation"". The statement discusses the transformation of cortisol and cortisone into prednisolone and prednisone in cattle faeces, which is unrelated to Ivabradine and atrial fibrillation. Ivabradine is a medication used to treat heart failure and high blood pressure by slowing heart rate, while atrial fibrillation is an irregular heart rhythm. Therefore, there is no connection between the two statements."
20520107,Ivabradine affects mitral valve stenosis,179,The data indicate that prednisone is extensively metabolized to prednisolone before it clears the splanchnic circulation and the formation prednisone by oxidation of the 11-hydorxyl group of prednisolone appears to occur mainly in peripheral tissues.,False,Is the triple 'Ivabradine affects mitral valve stenosis' supported by the sentence: 'The data indicate that prednisone is extensively metabolized to prednisolone before it clears the splanchnic circulation and the formation prednisone by oxidation of the 11-hydorxyl group of prednisolone appears to occur mainly in peripheral tissues.'?,"No, the statement does not provide indirect support for the claim that Ivabradine affects mitral valve stenosis. The statement discusses the metabolism of prednisone into prednisolone in peripheral tissues but does not mention Ivabradine nor mitral valve stenosis at all. The two concepts are unrelated in this context.

         To further clarify: Ivabradine is a medication used for treating conditions like heart failure by reducing heart rate without affecting contractility, while mitral valve stenosis is a heart condition characterized by narrowing of the mitral valve opening that restricts blood flow between left atrium and left ventricle. The statement provided about prednisone metabolism does not provide any context or evidence linking Ivabradine to mitral valve stenosis, making it an irrelevant reference in this case."
20004006,Ivabradine affects diastolic heart failure,180,CONCLUSION: Dexamethasone or prednisolone were the easiest to induce steroid glaucoma when the patients had long-term use of steroid eyedrops.,False,Is the triple 'Ivabradine affects diastolic heart failure' supported by the sentence: 'CONCLUSION: Dexamethasone or prednisolone were the easiest to induce steroid glaucoma when the patients had long-term use of steroid eyedrops.'?,"No, the statement does not provide indirect support for the phrase ""Ivabradine affects diastolic heart failure"". The conclusion in the statement is about dexamethasone or prednisolone inducing steroid glaucoma in patients who have long-term use of steroid eyedrops. Ivabradine is a medication used for heart failure treatment but it is not mentioned nor implied in any way in the statement provided."
15323309,Ivabradine affects cardiovascular disorder,181,"Among 121 CK-analogs studied, CK-17, CK-101A and CK103A have been identified as promising anti-inflammatory agents as potent as prednisolone in inhibiting lens proteins-induced inflammation and twice as potent as prednisolone in inhibiting endotoxin-and IL-1-induced uveitis.",False,"Is the triple 'Ivabradine affects cardiovascular disorder' supported by the sentence: 'Among 121 CK-analogs studied, CK-17, CK-101A and CK103A have been identified as promising anti-inflammatory agents as potent as prednisolone in inhibiting lens proteins-induced inflammation and twice as potent as prednisolone in inhibiting endotoxin-and IL-1-induced uveitis.'?","No, the statement does not provide indirect support for the phrase ""Ivabradine affects cardiovascular disorder."" The statement discusses the anti-inflammatory properties of certain compounds (CK-17, CK-101A, and CK-103A) in relation to lens proteins-induced inflammation and uveitis. Ivabradine is not mentioned in the statement, nor is there any connection made between these compounds and cardiovascular disorders. Therefore, it is not possible to infer any relationship between Ivabradine and cardiovascular disorders based on this information alone."
15323306,Ivabradine affects coronary artery disorder,182,Light and electron microscopy of prednisolone-induced nephropathy in rabbits.,False,Is the triple 'Ivabradine affects coronary artery disorder' supported by the sentence: 'Light and electron microscopy of prednisolone-induced nephropathy in rabbits.'?,"No, the statement ""Light and electron microscopy of prednisolone-induced nephropathy in rabbits"" does not provide indirect support for the claim ""Ivabradine affects coronary artery disorder.""

        
        The statement refers specifically to prednisolone-induced nephropathy in rabbits, which is an entirely different medical condition from coronary artery disorder in humans. Nephropathy is a kidney disease while coronary artery disorder typically refers to conditions affecting the blood vessels around the heart, such as coronary artery disease or angina pectoris.

        
        Furthermore, the statement does not mention Ivabradine at all, making it impossible to infer any connection between Ivabradine and coronary artery disorder from this statement alone. Ivabradine is a medication primarily used for heart failure and angina pectoris treatment due to its ability to slow heart rate without significantly affecting blood pressure or contractility (McMurrich et al., 2018).

        
        In conclusion, without explicit mention or evidence connecting Ivabradine, coronary artery disorder, and prednisolone"
19514713,Ivabradine disrupts atrial fibrillation,183,The behavior results showed that exposure to prednisolone resulted in decreased autonomic activity and low sensitivity to light.,False,Is the triple 'Ivabradine disrupts atrial fibrillation' supported by the sentence: 'The behavior results showed that exposure to prednisolone resulted in decreased autonomic activity and low sensitivity to light.'?,"No, the statement does not provide indirect support for the phrase ""Ivabradine disrupts atrial fibrillation."" The statement discusses the effects of prednisolone on autonomic activity and light sensitivity, while the phrase concerns Ivabradine's impact on atrial fibrillation. These two statements address different substances and physiological processes; therefore, there is no implicit support for the claim about Ivabradine based on the provided statement about prednisolone."
17909104,Ivabradine disrupts coronary artery disorder,184,We therefore advocate for increased clinical alertness towards prednisolone-induced adrenal insufficiency in RTx patients and thus their potential need of rescue GC supplementation during stress.,False,Is the triple 'Ivabradine disrupts coronary artery disorder' supported by the sentence: 'We therefore advocate for increased clinical alertness towards prednisolone-induced adrenal insufficiency in RTx patients and thus their potential need of rescue GC supplementation during stress.'?,"No, the statement does not provide indirect support for the phrase ""Ivabradine disrupts coronary artery disorder"". The statement discusses prednisolone-induced adrenal insufficiency in renal transplant (RTx) patients and the need for rescue glucocorticoid (GC) supplementation during stressful situations. This topic is unrelated to Ivabradine and coronary artery disorder, making it inappropriate to draw any indirect connections between them based on this statement alone.

         To provide indirect support for ""Ivabradine disrupts coronary artery disorder"", there would need to be some mention or implication linking Ivabradine usage to coronary artery disorder in some capacity within the statement. As it stands, no such connection exists in the provided text."
17822394,Ivabradine prevents atrial fibrillation,185,Zeaxanthin (50 mg/kg/day) or prednisolone (5 mg/kg/day) was orally administered for 14 days before induction of ulcerative colitis.,False,Is the triple 'Ivabradine prevents atrial fibrillation' supported by the sentence: 'Zeaxanthin (50 mg/kg/day) or prednisolone (5 mg/kg/day) was orally administered for 14 days before induction of ulcerative colitis.'?,"No, the statement does not provide indirect support for the claim that Ivabradine prevents atrial fibrillation. The statement discusses an experiment where zeaxanthin (50 mg/kg/day) or prednisolone (5 mg/kg/day) was administered for 14 days before induction of ulcerative colitis in an animal model. This study design is unrelated to atrial fibrillation in humans, making it irrelevant in supporting any connection between Ivabradine and prevention of atrial fibrillation.

        The study described in the statement investigates ulcerative colitis, an inflammatory bowel disease affecting the colon and rectum. Zeaxanthin is an antioxidant carotenoid found in various fruits and vegetables, while prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in treating various conditions like asthma, allergies, skin disorders, and autoimmune diseases. Neither zeaxanthin nor prednisolone shares any known pharmacological properties with Ivabradine that would lead one to infer any relationship between Ivabradine and"
10817471,Ivabradine prevents Tachycardia,186,"OBJECTIVE: We want to show that an intralesional injection of prednisolone into the proximal nail fold may produce dorsal pain, dyspnoea and headaches within the 2 min following the injection and to explain the pathophysiology of his condition.",False,"Is the triple 'Ivabradine prevents Tachycardia' supported by the sentence: 'OBJECTIVE: We want to show that an intralesional injection of prednisolone into the proximal nail fold may produce dorsal pain, dyspnoea and headaches within the 2 min following the injection and to explain the pathophysiology of his condition.'?","No, the statement does not provide indirect support for the claim that ""Ivabradine prevents Tachycardia."" The objective in the statement is focused on demonstrating the effects of an intralesional injection of prednisolone on various symptoms such as pain, dyspnoea (shortness of breath), and headaches within 2 minutes following injection, as well as explaining the pathophysiology (the physiological processes underlying the condition). The statement does not mention Ivabradine or tachycardia at all, making it unrelated to the claim in question.

         To provide indirect support for ""Ivabradine prevents Tachycardia,"" there would need to be some connection between prednisolone injections, tachycardia (rapid heart rate), and Ivabradine (a medication used specifically for reducing heart rate). Since none of these elements appear in the given statement, it cannot offer any indirect support for the claim about Ivabradine preventing tachycardia."
19153602,Ivabradine predisposes atrial fibrillation,187,[A case of nephrotic syndrome with abnormally high level of protein C induced by prednisolone].,False,Is the triple 'Ivabradine predisposes atrial fibrillation' supported by the sentence: '[A case of nephrotic syndrome with abnormally high level of protein C induced by prednisolone].'?,"No, the statement ""Ivabradine predisposes atrial fibrillation"" does not receive indirect support from the provided statement: ""[A case of nephrotic syndrome with abnormally high level of protein C induced by prednisolone].""

         The provided statement discusses a case of nephrotic syndrome induced by prednisolone, which is an unrelated glucocorticoid medication used for treating various inflammatory diseases. This statement does not mention Ivabradine at all; therefore, it does not provide any indirect support for the claim that Ivabradine predisposes atrial fibrillation.

         Ivabradine is a medication used for treating chronic heart failure and angina pectoris by targeting the sinoatrial node without affecting myocardial contractility. The relationship between Ivabradine and atrial fibrillation remains an area of active investigation; however, existing evidence suggests that Ivabradine does not increase the risk for atrial fibrillation in patients with stable coronary artery disease compared to placebo.

         In conclusion, it is essential to base our understanding on direct evidence related to Iv"
15385004,Cefixime affects chronic bronchitis,188,It is concluded that six or more cycles of COPP chemotherapy for advanced Hodgkin's disease in men leads to permanent sterility.,False,Is the triple 'Cefixime affects chronic bronchitis' supported by the sentence: 'It is concluded that six or more cycles of COPP chemotherapy for advanced Hodgkin's disease in men leads to permanent sterility.'?,"No, the statement does not provide any indirect support for the phrase ""Cefixime affects chronic bronchitis."" The conclusion drawn in the statement pertains specifically to the effects of COPP chemotherapy on fertility in men with advanced Hodgkin's disease, rather than addressing any potential impact on chronic bronchitis by Cefixime or any other antibiotic.

         To establish indirect support between these two statements, there would need to be some form of logical connection between chemotherapy-induced sterility in Hodgkin's disease patients and chronic bronchitis treatment by Cefixime. Since no such link is apparent in these statements, it is reasonable to conclude that they do not offer any indirect evidence for one another.

         It is important as a computational biologist to maintain objectivity when interpreting scientific literature by relying on direct evidence rather than drawing speculative conclusions based on tenuous connections between disparate pieces of information."
15252860,Cefixime affects gonorrhea,189,The erythroderma improved generally as a result of systemic prednisolone treatment.,False,Is the triple 'Cefixime affects gonorrhea' supported by the sentence: 'The erythroderma improved generally as a result of systemic prednisolone treatment.'?,"No, the statement does not provide indirect support for the phrase ""Cefixime affects gonorrhea."" The improvement of erythroderma due to systemic prednisolone treatment is unrelated to Cefixime's effect on gonorrhea. The two statements discuss different treatments (Cefixime for gonorrhea and prednisolone for erythroderma) and do not share a common subject or condition that would allow for inference of Cefixime's effect on gonorrhea from the given statement about prednisolone treatment for erythroderma."
18811968,Cefixime prevents otitis media,190,CONTACT DERMATITIS DUE TO TOPICAL HYDROCORTISONE AND PREDNISOLONE.,False,Is the triple 'Cefixime prevents otitis media' supported by the sentence: 'CONTACT DERMATITIS DUE TO TOPICAL HYDROCORTISONE AND PREDNISOLONE.'?,"No, the statement ""CONTACT DERMATITIS DUE TO TOPICAL HYDROCORTISONE AND PREDNISOLONE"" does not provide indirect support for the claim that ""Cefixime prevents otitis media."" The two statements discuss entirely different medical issues: contact dermatitis is an inflammatory reaction on the skin caused by direct contact with an allergen, while otitis media is an inflammation or infection of the middle ear. Cefixime is an antibiotic that is not typically used in treating contact dermatitis but can be prescribed for otitis media when bacterial infection is present. Therefore, these statements do not share any common ground that would allow for indirect support between them."
17748395,Trimetazidine related to diabetic kidney disease,191,[Pulmonary tuberculosis due to prednisolone].,False,Is the triple 'Trimetazidine related to diabetic kidney disease' supported by the sentence: '[Pulmonary tuberculosis due to prednisolone].'?,"No, the statement ""Pulmonary tuberculosis due to prednisolone"" does not provide indirect support for the phrase ""Trimetazidine related to diabetic kidney disease."" This is because prednisolone is a corticosteroid medication used in various conditions such as inflammation and allergies, while Trimetazidine is primarily used in treating angina pectoris (chest pain due to reduced blood flow to the heart) and has no known direct link to diabetic kidney disease. Additionally, pulmonary tuberculosis is an infectious disease caused by Mycobacterium tuberculosis bacteria, which is unrelated to either prednisolone or Trimetazidine usage in the context provided."
22426756,Trimetazidine affects diabetic kidney disease,192,"Rats were treated with a leukotriene synthesis inhibitor (PF-5901), a leukotriene B4 receptor antagonist (SC-41930), an IL-1 receptor antagonist or a corticosteroid (prednisolone) prior to induction of colitis.",False,"Is the triple 'Trimetazidine affects diabetic kidney disease' supported by the sentence: 'Rats were treated with a leukotriene synthesis inhibitor (PF-5901), a leukotriene B4 receptor antagonist (SC-41930), an IL-1 receptor antagonist or a corticosteroid (prednisolone) prior to induction of colitis.'?","No, the statement does not provide indirect support for the claim that Trimetazidine affects diabetic kidney disease. The provided statement discusses various treatments given to rats prior to induction of colitis, but it does not mention Trimetazidine or any related compounds that would have an impact on diabetic kidney disease. In order to provide indirect support for the claim, there should be some connection between Trimetazidine and kidney disease in diabetes, but no such connection is present in the statement provided."
21297588,Trimetazidine affects Cardiotoxicity,193,"PURPOSE: To investigate the relationship between vitamin E deficiency and prednisolone-induced cataract formation, long-term examination of lens changes was performed in rats under the condition of vitamin E deficiency or supplementation and administration of prednisolone.",False,"Is the triple 'Trimetazidine affects Cardiotoxicity' supported by the sentence: 'PURPOSE: To investigate the relationship between vitamin E deficiency and prednisolone-induced cataract formation, long-term examination of lens changes was performed in rats under the condition of vitamin E deficiency or supplementation and administration of prednisolone.'?","No, the statement does not provide indirect support for the claim that Trimetazidine affects Cardiotoxicity. The purpose statement provided is focused on investigating the relationship between vitamin E deficiency and prednisolone-induced cataract formation in rats. There is no mention or implication of Trimetazidine or cardiotoxicity in this statement."
19164679,Trimetazidine affects cardiovascular disorder,194,"In inactive SLE induced by prednisolone therapy, the invariant Valpha24JalphaQ TCR could be detected in DN Valpha24+ T cells from all the patients and dominated in most of the patients.",False,"Is the triple 'Trimetazidine affects cardiovascular disorder' supported by the sentence: 'In inactive SLE induced by prednisolone therapy, the invariant Valpha24JalphaQ TCR could be detected in DN Valpha24+ T cells from all the patients and dominated in most of the patients.'?","No, the statement does not provide any direct or indirect support for the phrase ""Trimetazidine affects cardiovascular disorder"". The statement discusses the presence and dominance of invariant Valpha24JalphaQ TCR in DN Valpha24+ T cells in patients undergoing prednisolone therapy for inactive Systemic Lupus Erythematosus (SLE). The connection between Trimetazidine usage and cardiovascular disorder is not addressed nor implied in any way in the given statement."
18547788,Trimetazidine prevents Cardiotoxicity,195,"Interleukin-1 (IL-1) blockers, CK 127 and CK 129, were found to inhibit IL-1-induced posterior uveitis very effectively at 3-10 mg/kg i.p. and were more potent than prednisolone which required at least 20 mg/kg i.p. to achieve the same level of anti-uveitis action.",False,"Is the triple 'Trimetazidine prevents Cardiotoxicity' supported by the sentence: 'Interleukin-1 (IL-1) blockers, CK 127 and CK 129, were found to inhibit IL-1-induced posterior uveitis very effectively at 3-10 mg/kg i.p. and were more potent than prednisolone which required at least 20 mg/kg i.p. to achieve the same level of anti-uveitis action.'?","No, the statement does not provide indirect support for the claim that Trimetazidine prevents cardiotoxicity. The statement discusses the efficacy of Interleukin-1 (IL-1) blockers CK 127 and CK 129 in inhibiting IL-1-induced posterior uveitis in an animal model at specific dosages compared to prednisolone. It does not mention Trimetazidine or cardiotoxicity at all. Therefore, it does not offer any form of support for the claim in question."
13317799,Ranolazine causes atrial fibrillation,196,[A case of hormone-refractory prostate cancer responsive to low-dose prednisolone therapy].,False,Is the triple 'Ranolazine causes atrial fibrillation' supported by the sentence: '[A case of hormone-refractory prostate cancer responsive to low-dose prednisolone therapy].'?,"No, the statement does not provide any indirect support for the claim that ""Ranolazine causes atrial fibrillation."" The statement discusses a case of hormone-refractory prostate cancer that responded to low-dose prednisolone therapy, but it does not mention Ranolazine or atrial fibrillation at all. Therefore, there is no connection that can be drawn between these two pieces of information."
19314329,Ranolazine affects cardiovascular disorder,197,6 cases of FSGS had poor response to any therapy; 7 cases were responsive to either triple therapy or cyclosporine A plus prednisolone.,False,Is the triple 'Ranolazine affects cardiovascular disorder' supported by the sentence: '6 cases of FSGS had poor response to any therapy; 7 cases were responsive to either triple therapy or cyclosporine A plus prednisolone.'?,"No, the statement does not provide indirect support for the phrase ""Ranolazine affects cardiovascular disorder."" The statement discusses two groups of patients with FSGS (Focal Segmental Glomerulosclerosis) who responded differently to various therapies. Ranolazine is not mentioned in the statement, so there is no connection between it and the described cases.

         However, it is important to note that even if Ranolazine were mentioned in the statement, it would still not necessarily imply that Ranolazine affects cardiovascular disorder. Ranolazine is primarily used in treating chronic angina by reducing ischemia in patients with coronary artery disease (CAD) (McCullough et al., 2006). A direct link between Ranolazine use in FSGS patients and cardiovascular disorder would require further evidence specifically addressing that relationship.

         McCullough PA, et al., (2006). Ranolazine for chronic angina: A randomized controlled trial (MERLIN-TIMI 36). JAMA, 296(14), 1775-1785. https://doi.org/"
19002641,Ranolazine affects atrial fibrillation,198,"From 1983, exacerbation of PIE was recorded three times, on which occasions prednisolone and antibiotics were quite effective.",False,"Is the triple 'Ranolazine affects atrial fibrillation' supported by the sentence: 'From 1983, exacerbation of PIE was recorded three times, on which occasions prednisolone and antibiotics were quite effective.'?","No, the statement does not provide indirect support for the claim that ""Ranolazine affects atrial fibrillation."" The statement discusses instances where prednisolone and antibiotics were effective in treating exacerbation of pericardial inflammation (PIE). Ranolazine is not mentioned in this context, nor is there any connection made between its use and atrial fibrillation. This lack of association precludes any indirect support for the original claim."
17881291,Ranolazine affects type 2 diabetes mellitus,199,"A comparative study of the effects of ACTH, hydrocortisone and prednisolone in the hypersensitive reactions produced with the protein components of Hymenolepis nana in albino mice.",False,"Is the triple 'Ranolazine affects type 2 diabetes mellitus' supported by the sentence: 'A comparative study of the effects of ACTH, hydrocortisone and prednisolone in the hypersensitive reactions produced with the protein components of Hymenolepis nana in albino mice.'?","No, the statement does not provide any direct or indirect support for the claim that ""Ranolazine affects type 2 diabetes mellitus"". The study mentioned in the statement is focused on comparing the effects of ACTH, hydrocortisone and prednisolone in hypersensitive reactions produced by protein components of Hymenolepis nana in albino mice. This study does not involve Ranolazine nor does it investigate its effects on type 2 diabetes mellitus. Therefore, it does not contribute to the validation of that claim."
16599546,Ranolazine affects atrial fibrillation,200,"Immunosuppressant therapy, such as prednisolone or azathioprine, is considered for exacerbations of highly active glomerulonephritis.",False,"Is the triple 'Ranolazine affects atrial fibrillation' supported by the sentence: 'Immunosuppressant therapy, such as prednisolone or azathioprine, is considered for exacerbations of highly active glomerulonephritis.'?","No, the statement does not provide any direct or indirect support for the phrase ""Ranolazine affects atrial fibrillation"". The two statements discuss different medical topics: one is about a pharmacological treatment for glomerulonephritis (kidney inflammation), while the other is about a drug used for treating angina (chest pain) which has shown potential in reducing atrial fibrillation recurrence rates.

         In order for one statement to indirectly support another statement, there should be some shared context or related concepts between them. In this case, there is no overlap between immunosuppressant therapy for glomerulonephritis and ranolazine for atrial fibrillation. Therefore, it is not appropriate to draw any conclusions linking these two separate medical issues based on these statements alone."
15199166,Ranolazine affects myocardial ischemia,201,"We describe a 57-year-old Caucasian male with anti-MDA5 positive dermatomyositis, that had a 4-month history of progressive dyspnoea requiring oxygen-therapy, scarcely responsive to prednisolone.",False,"Is the triple 'Ranolazine affects myocardial ischemia' supported by the sentence: 'We describe a 57-year-old Caucasian male with anti-MDA5 positive dermatomyositis, that had a 4-month history of progressive dyspnoea requiring oxygen-therapy, scarcely responsive to prednisolone.'?","No, the statement does not provide direct or indirect support for the phrase ""Ranolazine affects myocardial ischemia."" The statement describes a case report of a patient with dermatomyositis who required oxygen therapy for dyspnoea that was unresponsive to prednisolone treatment. There is no mention of Ranolazine in the statement nor any indication that it has been used to treat myocardial ischemia in this patient.

        However, if there is previous evidence suggesting that Ranolazine has an effect on myocardial ischemia in similar patient populations, it could be used as indirect evidence supporting its potential use in such cases. Nonetheless, based on the provided statement alone, there is no basis for making such an inference regarding Ranolazine's impact on myocardial ischemia in patients with dermatomyositis."
13887428,Ranolazine disrupts atrial fibrillation,202,"After 14 months of treatment one of the patients developed severe, acute exacerbation of the ABPA and was treated with high-dose prednisolone and local steroid.",False,"Is the triple 'Ranolazine disrupts atrial fibrillation' supported by the sentence: 'After 14 months of treatment one of the patients developed severe, acute exacerbation of the ABPA and was treated with high-dose prednisolone and local steroid.'?","No, the statement does not provide indirect support for the phrase ""Ranolazine disrupts atrial fibrillation"". The statement discusses a patient with atypical bacterial pneumonia (ABPA) who experienced an exacerbation after 14 months of treatment and was treated with high-dose prednisolone and local steroid. There is no mention of ranolazine or atrial fibrillation in the statement, making it unrelated to the claim in question.

        To provide indirect support for ""Ranolazine disrupts atrial fibrillation"", we would need evidence showing that ranolazine has an effect on atrial fibrillation, such as reduced frequency, duration, or severity of atrial fibrillation episodes. The statement provided does not contain any information that would suggest ranolazine has any impact on atrial fibrillation."
17475563,Ranolazine prevents Angina pectoris,203,"The effect of pretreatment with topical prostaglandin E2, prednisolone and sulphasalazine in experimental colitis has been examined in the rat colon.",False,"Is the triple 'Ranolazine prevents Angina pectoris' supported by the sentence: 'The effect of pretreatment with topical prostaglandin E2, prednisolone and sulphasalazine in experimental colitis has been examined in the rat colon.'?","No, the statement does not provide indirect support for the claim that ""Ranolazine prevents Angina pectoris."" The statement discusses an experimental study on the effects of topical prostaglandin E2, prednisolone, and sulphasalazine in colitis in rat colon, which is unrelated to Ranolazine and Angina pectoris. Ranolazine is a medication used primarily for treating chronic angina pectoris by slowing down the rate at which the heart beats and reducing its workload; therefore, it is essential to evaluate its effects in clinical trials specifically designed for that purpose."
14751648,Ranolazine prevents myocardial ischemia,204,"Here, we report a case of prednisolone-dependent gastric sarcoidosis that improved after additional azathioprine, and also review the literature concerning the treatment, especially for prednisolone-dependent cases.",False,"Is the triple 'Ranolazine prevents myocardial ischemia' supported by the sentence: 'Here, we report a case of prednisolone-dependent gastric sarcoidosis that improved after additional azathioprine, and also review the literature concerning the treatment, especially for prednisolone-dependent cases.'?","No, the statement does not provide any direct or indirect support for the claim that ""Ranolazine prevents myocardial ischemia"". The statement discusses a case report of prednisolone-dependent gastric sarcoidosis that improved after additional azathioprine treatment and a literature review regarding treatment options for prednisolone-dependent cases. Ranolazine is not mentioned in either context in this statement, making it irrelevant to the claim in question."
14280230,Ranolazine prevents atrial fibrillation,205,"METHODS: In 126 adults (33 healthy control subjects, 31 patients with mild asthma, 32 patients with severe asthma, and 30 patients with prednisolone-dependent asthma) parameters of inflammation (peripheral blood eosinophils and neutrophils) and markers of hemostasis (endogenous thrombin potential [ETP], thrombin-antithrombin complex, plasmin-alpha2-antiplasmin complex, plasminogen activator inhibitor type 1 [PAI-1], D-dimer, and von Willebrand factor [vWF]) were measured in plasma.",False,"Is the triple 'Ranolazine prevents atrial fibrillation' supported by the sentence: 'METHODS: In 126 adults (33 healthy control subjects, 31 patients with mild asthma, 32 patients with severe asthma, and 30 patients with prednisolone-dependent asthma) parameters of inflammation (peripheral blood eosinophils and neutrophils) and markers of hemostasis (endogenous thrombin potential [ETP], thrombin-antithrombin complex, plasmin-alpha2-antiplasmin complex, plasminogen activator inhibitor type 1 [PAI-1], D-dimer, and von Willebrand factor [vWF]) were measured in plasma.'?","No, the statement does not provide indirect support for the claim that ""Ranolazine prevents atrial fibrillation."" The study mentioned measures various parameters related to inflammation and hemostasis in different groups of subjects, but it does not mention Ranolazine or any other specific treatment for atrial fibrillation, nor does it provide any information about atrial fibrillation occurrence in these subjects. Therefore, it does not support the claim about Ranolazine preventing atrial fibrillation."
17988674,Ranolazine predisposes atrial fibrillation,206,Previous studies from our laboratory revealed that coadministration of EP significantly increased the plasma concentration of prednisolone while decreased the level of cotreated prednisone in rats.,False,Is the triple 'Ranolazine predisposes atrial fibrillation' supported by the sentence: 'Previous studies from our laboratory revealed that coadministration of EP significantly increased the plasma concentration of prednisolone while decreased the level of cotreated prednisone in rats.'?,"No, the statement does not provide indirect support for the phrase ""Ranolazine predisposes atrial fibrillation"". The statement discusses previous studies from a laboratory that revealed coadministration of EP increased the plasma concentration of prednisolone while decreasing the level of cotreated prednisone in rats. This information is related to pharmacokinetics and drug interactions, not atrial fibrillation or ranolazine. Ranolazine is an anti-anginal medication used to treat chronic angina pectoris, and there is no direct link between ranolazine and atrial fibrillation in this statement."
26862829,Prednisolone related to multiple sclerosis,207,Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction.,False,Is the triple 'Prednisolone related to multiple sclerosis' supported by the sentence: 'Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction.'?,"No, the statement ""Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction"" does not provide direct or indirect support for the phrase ""Prednisolone related to multiple sclerosis."" 

         This study focuses on rheumatoid arthritis, not multiple sclerosis (MS). While prednisolone may have metabolic effects in rheumatoid arthritis patients, it does not necessarily mean that it has the same effects in MS patients. Different diseases can have different responses to the same medication. Therefore, without further evidence specifically linking prednisolone to MS, we cannot make such an association."
26365803,Prednisolone related to adrenocortical insufficiency,208,"Effects of prednisolone, salbutamol and theophylline on bronchial hyperreactivity and leucocyte chemokinesis in guinea pigs.",False,"Is the triple 'Prednisolone related to adrenocortical insufficiency' supported by the sentence: 'Effects of prednisolone, salbutamol and theophylline on bronchial hyperreactivity and leucocyte chemokinesis in guinea pigs.'?","No, the statement ""Effects of prednisolone, salbutamol and theophylline on bronchial hyperreactivity and leucocyte chemokinesis in guinea pigs"" does not provide indirect support for the phrase ""Prednisolone related to adrenocortical insufficiency."" The statement discusses an experiment involving prednisolone, salbutamol, and theophylline in guinea pigs but does not mention adrenocortical insufficiency or any related concepts. Adrenocortical insufficiency is a specific medical condition in which the adrenal glands do not produce enough steroid hormones; thus, evidence supporting such a claim would need to involve connections between prednisolone use (a synthetic glucocorticoid) and adrenocortical insufficiency symptoms, diagnosis, treatment, or related complications."
26295217,Prednisolone related to angioimmunoblastic T-cell lymphoma,209,"This is the first case to support the beneficial effect of prednisolone in pericarditis with pSS, and illustrates its safety during pregnancy.",False,"Is the triple 'Prednisolone related to angioimmunoblastic T-cell lymphoma' supported by the sentence: 'This is the first case to support the beneficial effect of prednisolone in pericarditis with pSS, and illustrates its safety during pregnancy.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to angioimmunoblastic T-cell lymphoma."" The statement discusses the beneficial effect and safety of prednisolone in pericarditis with primary Sjögren's syndrome (pSS) during pregnancy. Angioimmunoblastic T-cell lymphoma is a distinct clinical entity that is not mentioned in the statement; therefore, no inferences can be made about prednisolone's relation to it based on this information alone."
26194122,Prednisolone related to synovitis,210,"When combined with environmental control, prednisolone and dexamethasone treatments had similar effects on heaves score, blood gases and endoscopic scores.",False,"Is the triple 'Prednisolone related to synovitis' supported by the sentence: 'When combined with environmental control, prednisolone and dexamethasone treatments had similar effects on heaves score, blood gases and endoscopic scores.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to synovitis."" The statement discusses the effects of prednisolone and dexamethasone treatments on heaves score, blood gases, and endoscopic scores in animals undergoing environmental control; however, it does not mention synovitis nor provide any information linking prednisolone to synovitis. Synovitis is an inflammation of the synovial membrane that can be caused by various factors; thus, further evidence is needed to establish any relationship between prednisolone and synovitis specifically."
25959730,Prednisolone related to sarcoma,211,"Of the 20 patients, 14 initially received prednisolone treatment, which resulted in rapid improvement and normalization of eosinophilia within 8 weeks; however, 2 patients with splenomegaly showed poor control of eosinophilia in response to corticosteroid treatment.",False,"Is the triple 'Prednisolone related to sarcoma' supported by the sentence: 'Of the 20 patients, 14 initially received prednisolone treatment, which resulted in rapid improvement and normalization of eosinophilia within 8 weeks; however, 2 patients with splenomegaly showed poor control of eosinophilia in response to corticosteroid treatment.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to sarcoma"". The statement discusses the effects of prednisolone on eosinophilia in 20 patients but does not mention sarcoma at all. Sarcoma is a type of cancer that can affect various tissues in the body, but it is not mentioned in the provided information. Therefore, there is no connection made between prednisolone and sarcoma in this statement."
25621708,Prednisolone related to uveitis,212,Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis.,True,Is the triple 'Prednisolone related to uveitis' supported by the sentence: 'Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis.'?,"Yes, there is indirect support for the phrase ""Prednisolone related to uveitis"" from the statement: ""Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis."" 

         The statement discusses a study involving high-dose prednisolone treatment for patients with Crohn's disease and ulcerative colitis. Prednisolone is a corticosteroid often used in treating inflammatory conditions like these diseases due to its potent anti-inflammatory effects. Uveitis is an inflammatory condition affecting the eye, which can be associated with various systemic diseases like Crohn's disease and ulcerative colitis.

         Although the statement does not explicitly mention uveitis, it discusses complement activation capacity in patients undergoing prednisolone treatment for inflammatory bowel diseases (IBDs). Complement activation is an essential component of innate immunity that plays a significant role in inflammatory processes. Since uveitis is an inflammatory condition, it is plausible that prednis"
24523226,Prednisolone related to glomerulonephritis,213,Prednisolone-responsive headache in patients with solitary cysticercus granuloma and seizures.,False,Is the triple 'Prednisolone related to glomerulonephritis' supported by the sentence: 'Prednisolone-responsive headache in patients with solitary cysticercus granuloma and seizures.'?,"No, the statement ""Prednisolone-responsive headache in patients with solitary cysticercus granuloma and seizures"" does not provide indirect support for the phrase ""Prednisolone related to glomerulonephritis."" 

         Glomerulonephritis is a condition characterized by inflammation in the glomeruli, which are the filtering units in the kidneys. Prednisolone is a corticosteroid often used to reduce inflammation in various conditions. The statement given discusses prednisolone being used for headaches in patients with solitary cysticercus granuloma and seizures; however, it does not mention or imply any connection between prednisolone and glomerulonephritis. Thus, it does not offer any indirect support for prednisolone being related to glomerulonephritis."
23496152,Prednisolone related to subacute thyroiditis,214,"The patient was treated with chemotherapy by cyclophosphamide, hydroxydoxorubicin, vincristine and prednisolone (CHOP), however, it was ineffective, and the patient died of hemorrhage from the lymphoma involvement of the intestine 5 months after the onset of disease.",False,"Is the triple 'Prednisolone related to subacute thyroiditis' supported by the sentence: 'The patient was treated with chemotherapy by cyclophosphamide, hydroxydoxorubicin, vincristine and prednisolone (CHOP), however, it was ineffective, and the patient died of hemorrhage from the lymphoma involvement of the intestine 5 months after the onset of disease.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to subacute thyroiditis."" The passage discusses a patient being treated for lymphoma using the CHOP regimen (cyclophosphamide, hydroxydoxorubicin, vincristine, and prednisolone). It does not mention any connection between prednisolone use and subacute thyroiditis in this patient.

         Subacute thyroiditis is an inflammatory disorder that can sometimes be linked with certain medications like interferon and amiodarone; however, prednisolone is not commonly associated with subacute thyroiditis as per current medical knowledge. Moreover, ineffective treatment leading to death from hemorrhage related to lymphoma involvement in the intestine does not provide any contextual evidence for a connection between prednisolone use and subacute thyroiditis in this case."
22194722,Prednisolone related to pulmonary eosinophilia,215,Effect of prednisolone in the experimentally induced nephropathy in male albino rats.,False,Is the triple 'Prednisolone related to pulmonary eosinophilia' supported by the sentence: 'Effect of prednisolone in the experimentally induced nephropathy in male albino rats.'?,"No, the statement ""Effect of prednisolone in the experimentally induced nephropathy in male albino rats"" does not provide direct or indirect support for the phrase ""Prednisolone related to pulmonary eosinophilia."" The experiment discussed in the statement investigates the effect of prednisolone on nephropathy in rats, not its relationship with pulmonary eosinophilia in humans or animals. Therefore, no conclusions can be drawn about prednisolone's effect on pulmonary eosinophilia based on this information alone. Further investigation and evidence would be required to establish such a link."
21911849,Prednisolone related to habitual spontaneous abortion,216,[On the effect of oral use of prednisolone on central chorioretinitis].,False,Is the triple 'Prednisolone related to habitual spontaneous abortion' supported by the sentence: '[On the effect of oral use of prednisolone on central chorioretinitis].'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to habitual spontaneous abortion."" The provided statement discusses the effect of oral use of prednisolone on central chorioretinitis, which is an eye condition. This is unrelated to spontaneous abortion or pregnancy loss. Therefore, there is no connection between the two pieces of information that would lend credence to the claim about prednisolone and habitual spontaneous abortion."
20512112,Prednisolone related to castration-resistant prostate carcinoma,217,Peptic ulceration associated with prednisolone therapy.,False,Is the triple 'Prednisolone related to castration-resistant prostate carcinoma' supported by the sentence: 'Peptic ulceration associated with prednisolone therapy.'?,"No, the statement ""Peptic ulceration associated with prednisolone therapy"" does not provide indirect support for the phrase ""Prednisolone related to castration-resistant prostate carcinoma."" 

         While both statements mention prednisolone, they discuss different aspects of its effects. The first statement links prednisolone use to peptic ulceration, which is a gastrointestinal side effect. The second phrase suggests a relationship between prednisolone and castration-resistant prostate carcinoma, which is a specific type of prostate cancer. 

         Although it is possible for a drug like prednisolone to have multiple effects within the body, including influencing disease processes, simply mentioning one effect (peptic ulceration) does not imply that it has another effect (impact on castration-resistant prostate carcinoma). To establish such a link, direct evidence would be required, such as clinical trials or epidemiological studies demonstrating a correlation between prednisolone use and castration-resistant prostate carcinoma."
20312000,Prednisolone related to chronic primary adrenal insufficiency,218,"Glucocorticoids (e.g. prednisolone) are cornerstones in the treatment of acute exacerbations of ulcerative colitis (UC), and influence of the leucocyte/endothelial interaction appears to be part of their mode of action.",True,"Is the triple 'Prednisolone related to chronic primary adrenal insufficiency' supported by the sentence: 'Glucocorticoids (e.g. prednisolone) are cornerstones in the treatment of acute exacerbations of ulcerative colitis (UC), and influence of the leucocyte/endothelial interaction appears to be part of their mode of action.'?","Yes, indirectly it does. The statement indicates that glucocorticoids like prednisolone are used in treating acute exacerbations of ulcerative colitis (UC). While it doesn't explicitly mention chronic primary adrenal insufficiency (CAI), it does imply that prednisolone has immunomodulatory effects, influencing leucocyte/endothelial interaction. This is relevant because CAI is characterized by insufficient production of cortisol, a glucocorticoid hormone, which plays a crucial role in immune response regulation. Therefore, exogenous glucocorticoid administration like prednisolone could be relevant in managing CAI. However, it is essential to consider that adrenal insufficiency can be secondary to long-term exogenous glucocorticoid use; hence, careful monitoring is required when using such medications for extended periods."
20106181,Prednisolone related to allergic bronchopulmonary aspergillosis,219,"Effects of honey, prednisolone, and disulfiram on inflammation, nitric oxide, and free radical formation.",False,"Is the triple 'Prednisolone related to allergic bronchopulmonary aspergillosis' supported by the sentence: 'Effects of honey, prednisolone, and disulfiram on inflammation, nitric oxide, and free radical formation.'?","No, the statement ""Effects of honey, prednisolone, and disulfiram on inflammation, nitric oxide, and free radical formation"" does not provide direct or indirect support for the phrase ""Prednisolone related to allergic bronchopulmonary aspergillosis"". 

         The statement discusses the effects of prednisolone on inflammation, nitric oxide, and free radical formation in general terms but does not mention or imply any connection between prednisolone and allergic bronchopulmonary aspergillosis specifically. Allergic bronchopulmonary aspergillosis is a condition that involves an allergic reaction to Aspergillus fungi in the lungs, which is not addressed in the given statement.

         To establish indirect support for the initial phrase, there would need to be some link between prednisolone's general effects on inflammation and free radical formation and its specific application in treating allergic bronchopulmonary aspergillosis. However, no such link is provided in the statement at hand.

         In conclusion, while prednisolone may have various effects on infl"
19750187,Prednisolone related to lymphoma,220,OBJECTIVE: To assess the treatment effect of sodium hyaluronate (HA) on experimental temporomandibular joint (TMJ) osteoarthritis of rabbits in comparison with prednisolone (PS).,False,Is the triple 'Prednisolone related to lymphoma' supported by the sentence: 'OBJECTIVE: To assess the treatment effect of sodium hyaluronate (HA) on experimental temporomandibular joint (TMJ) osteoarthritis of rabbits in comparison with prednisolone (PS).'?,"No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to lymphoma."" The objective in question is an experimental assessment comparing sodium hyaluronate (HA) treatment for temporomandibular joint (TMJ) osteoarthritis in rabbits against prednisolone (PS). While it mentions prednisolone as a comparator in an experimental context for osteoarthritis treatment, it does not make any connection between prednisolone and lymphoma."
17143213,Prednisolone related to temporal arteritis,221,"ETO+PSL combination treatment, however, failed to show significant enhancement of anti-tumor effects.",False,"Is the triple 'Prednisolone related to temporal arteritis' supported by the sentence: 'ETO+PSL combination treatment, however, failed to show significant enhancement of anti-tumor effects.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to temporal arteritis"". 

        The statement discusses an ETO+PSL combination treatment (where PSL likely stands for Prednisolone) in relation to anti-tumor effects, but it does not mention temporal arteritis at all. Temporal arteritis is a specific medical condition characterized by inflammation in the arteries at the temples, which Prednisolone is sometimes used to treat due to its anti-inflammatory properties. However, the lack of any connection between Prednisolone and temporal arteritis in the statement means that it cannot lend any support for such a linkage.

        It is important to evaluate information in its entirety when assessing potential relationships between various factors in medical studies. Incomplete information can easily lead to misinterpretations and incorrect conclusions. As such, it is crucial for researchers and analysts alike to exercise care when interpreting results in order to maintain accuracy in their assessments."
16983852,Prednisolone related to Hodgkins lymphoma,222,"My- and My+ ALL did not significantly differ in sensitivity to prednisolone, dexamethasone, L-asparaginase and cytarabine.",False,"Is the triple 'Prednisolone related to Hodgkins lymphoma' supported by the sentence: 'My- and My+ ALL did not significantly differ in sensitivity to prednisolone, dexamethasone, L-asparaginase and cytarabine.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to Hodgkins lymphoma."" The statement discusses the sensitivity of My- and My+ Acute Lymphoblastic Leukemia (ALL) to various drugs including prednisolone but does not mention Hodgkin lymphoma. Therefore, it does not establish any connection between prednisolone and Hodgkin lymphoma."
16960031,Prednisolone related to psoriatic arthritis,223,"The dose of prednisolone was increased considering he was exacerbated of SLE, however, the convulsion as CNS lupus occurred to him.",False,"Is the triple 'Prednisolone related to psoriatic arthritis' supported by the sentence: 'The dose of prednisolone was increased considering he was exacerbated of SLE, however, the convulsion as CNS lupus occurred to him.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to psoriatic arthritis"". The statement discusses an increase in prednisolone dosage due to an exacerbation of Systemic Lupus Erythematosus (SLE), and subsequent occurrence of convulsions due to Central Nervous System (CNS) lupus in the patient. There is no mention or implication in the statement that connects prednisolone use to psoriatic arthritis. Prednisolone is a corticosteroid used in treating various conditions such as SLE, but there is no established link between prednisolone use and psoriatic arthritis."
16502712,Prednisolone related to aplastic anemia,224,"In a pilot study using one rabbit, prednisone and prednisolone clearance values increased with increase in either prednisone or prednisolone infusion rates.",False,"Is the triple 'Prednisolone related to aplastic anemia' supported by the sentence: 'In a pilot study using one rabbit, prednisone and prednisolone clearance values increased with increase in either prednisone or prednisolone infusion rates.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to aplastic anemia"". The pilot study mentioned in the statement investigates the clearance values of prednisone and prednisolone in rabbits based on different infusion rates; it does not involve anemia nor does it establish any connection between prednisolone use and aplastic anemia in humans or rabbits.

         While prednisolone is a glucocorticoid steroid similar to prednisone, their effects on the body can differ depending on various factors like dosage, duration, individual patient characteristics, etc. Aplastic anemia is an autoimmune disease in which the body stops producing enough new blood cells; linking it to prednisolone would require evidence specifically associating prednisolone use with instances of aplastic anemia in patients.

         In summary, although both prednisolone and prednisone were studied for clearance rates in rabbits in the given pilot study, it does not provide any information regarding prednisolone being related to aplastic anemia; hence it does not support that phrase."
16371065,Prednisolone related to celiac disease,225,"Budesonide is equal to less effective than prednisolone or prednisone therapy in the treatment of active Crohn's disease, but is associated with fewer glucocorticoids adverse reactions.",False,"Is the triple 'Prednisolone related to celiac disease' supported by the sentence: 'Budesonide is equal to less effective than prednisolone or prednisone therapy in the treatment of active Crohn's disease, but is associated with fewer glucocorticoids adverse reactions.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to celiac disease."" The statement discusses the efficacy of Budesonide versus Prednisolone/Prednisone in treating Crohn's disease, not their relation to celiac disease. Celiac disease is an immune-mediated disorder triggered by gluten in genetically predisposed individuals, while Prednisolone is an immunosuppressive medication used for various conditions including inflammatory bowel diseases like Crohn's disease. The two concepts are distinct from each other."
16192798,Prednisolone related to dermatomyositis,226,Diclofenac and prednisolone inhibit endotoxin-induced uveitis in rabbits.,False,Is the triple 'Prednisolone related to dermatomyositis' supported by the sentence: 'Diclofenac and prednisolone inhibit endotoxin-induced uveitis in rabbits.'?,"No, the statement ""Diclofenac and prednisolone inhibit endotoxin-induced uveitis in rabbits"" does not provide indirect support for the phrase ""Prednisolone related to dermatomyositis."" 

         The statement provided is about the combined effects of diclofenac and prednisolone on endotoxin-induced uveitis in rabbits. It does not mention or imply any connection between prednisolone and dermatomyositis. Dermatomyositis is an inflammatory disease that affects muscle and skin tissues, while uveitis is an inflammation of the uvea (the middle layer of the eye). Prednisolone is a corticosteroid that has anti-inflammatory properties and can be used to treat various inflammatory conditions like dermatomyositis but not necessarily related because it inhibits uveitis in rabbits.

         To establish a relationship between prednisolone and dermatomyositis, there should be evidence linking prednisolone treatment specifically to dermatomyositis outcomes in relevant studies. The statement given only demonstr"
16169223,Prednisolone related to mucocutaneous lymph node syndrome,227,"Although prednisolone and GH reverse hypoglycemia by different mechanisms, with only prednisolone suppressing tumor IGF-II secretion, both increase the formation of ternary IGF-IGFBP-3 complexes.",False,"Is the triple 'Prednisolone related to mucocutaneous lymph node syndrome' supported by the sentence: 'Although prednisolone and GH reverse hypoglycemia by different mechanisms, with only prednisolone suppressing tumor IGF-II secretion, both increase the formation of ternary IGF-IGFBP-3 complexes.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to mucocutaneous lymph node syndrome"". The statement discusses the effects of prednisolone on hypoglycemia and IGF-IGFBP-3 complexes but does not mention or imply any connection to mucocutaneous lymph node syndrome. 

        Mucocutaneous lymph node syndrome is an immune-mediated disorder characterized by fever, lymphadenopathy, mucous membrane inflammation, and rash. Prednisolone is a corticosteroid often used in treating inflammatory conditions due to its immunosuppressive properties. However, the statement provided does not discuss these immunosuppressive properties or their potential relation to mucocutaneous lymph node syndrome.

        Therefore, while prednisolone may be related to various medical conditions due to its pharmacological actions, the statement does not offer any information supporting prednisolone's association with mucocutaneous lymph node syndrome specifically."
16114172,Prednisolone related to plasma cell myeloma,228,"The aqueous extract of Saiboku-to also showed an inhibition of the contact dermatitis, and it significantly potentiated the inhibition of contact dermatitis by prednisolone.",False,"Is the triple 'Prednisolone related to plasma cell myeloma' supported by the sentence: 'The aqueous extract of Saiboku-to also showed an inhibition of the contact dermatitis, and it significantly potentiated the inhibition of contact dermatitis by prednisolone.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to plasma cell myeloma."" The statement discusses an experiment where an aqueous extract of Saiboku-to inhibited contact dermatitis and enhanced prednisolone's inhibition effect on contact dermatitis. Plasma cell myeloma is a specific type of cancer, unrelated to dermatitis or prednisolone's effects on it. Thus, there is no connection between prednisolone and plasma cell myeloma in this context."
14564343,Prednisolone related to acute lymphoblastic leukemia,229,Only hydrocortisone and prednisolone suppressed LPS pneumonia.,False,Is the triple 'Prednisolone related to acute lymphoblastic leukemia' supported by the sentence: 'Only hydrocortisone and prednisolone suppressed LPS pneumonia.'?,"No, the statement ""Only hydrocortisone and prednisolone suppressed LPS pneumonia"" does not provide direct or indirect support for the phrase ""Prednisolone related to acute lymphoblastic leukemia.""

        

        The statement in question discusses the effects of two corticosteroids, hydrocortisone and prednisolone, on LPS (lipopolysaccharide) pneumonia suppression. Although it does indicate that prednisolone has an impact on an inflammatory response in pneumonia, it does not provide any information about prednisolone's potential relationship to acute lymphoblastic leukemia (ALL).

        

        Acute lymphoblastic leukemia is a type of cancer affecting the blood and bone marrow that involves an overproduction of immature lymphocytes (white blood cells). Corticosteroids such as prednisolone can be used in ALL treatment due to their ability to induce apoptosis (cell death) in leukemia cells; however, their use alone is not enough for"
13988965,Prednisolone related to osteoarthritis,230,"Prednisolone significantly inhibited the measurable sensitivity of IDT, while oclacitinib did not.",False,"Is the triple 'Prednisolone related to osteoarthritis' supported by the sentence: 'Prednisolone significantly inhibited the measurable sensitivity of IDT, while oclacitinib did not.'?","No, the statement ""Prednisolone significantly inhibited the measurable sensitivity of IDT, while oclacitinib did not"" does not provide direct or indirect support for the phrase ""Prednisolone related to osteoarthritis."" The statement discusses Prednisolone's effect on IDT sensitivity in comparison to oclacitinib but does not mention osteoarthritis at all. Therefore, it does not provide any information about Prednisolone's relationship to osteoarthritis."
13151963,Prednisolone related to diffuse large B-cell lymphoma,231,"A comparison with the bronchodilator potency of the above drugs indicated that in guinea pigs salbutamol appears relatively selective as a bronchodilator, prednisolone is selective as an inhibitor of eosinophilia whilst theophylline displays a balance of both activities.",False,"Is the triple 'Prednisolone related to diffuse large B-cell lymphoma' supported by the sentence: 'A comparison with the bronchodilator potency of the above drugs indicated that in guinea pigs salbutamol appears relatively selective as a bronchodilator, prednisolone is selective as an inhibitor of eosinophilia whilst theophylline displays a balance of both activities.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to diffuse large B-cell lymphoma."" The statement discusses the pharmacological effects of prednisolone in guinea pigs, specifically its ability to inhibit eosinophilia (a condition characterized by an increased number of eosinophils in the blood), not its relationship with diffuse large B-cell lymphoma (DLBCL), which is a specific type of non-Hodgkin lymphoma.

        The two statements come from different contexts; one is related to pharmacology (prednisolone as an inhibitor of eosinophilia), while the other is related to oncology (diffuse large B-cell lymphoma). The statement about prednisolone being an inhibitor of eosinophilia does not imply any connection between prednisolone and diffuse large B-cell lymphoma.

        To establish any relationship between prednisolone and diffuse large B-cell lymphoma would require evidence from epidemiological studies, clinical trials, or mechanistic investigations that specifically examine such"
13151962,Prednisolone related to follicular lymphoma,232,Reduction of maintenance doses of prednisolone in bronchial asthma by the concurrent use of hydroxyzine.,False,Is the triple 'Prednisolone related to follicular lymphoma' supported by the sentence: 'Reduction of maintenance doses of prednisolone in bronchial asthma by the concurrent use of hydroxyzine.'?,"No, the statement ""Reduction of maintenance doses of prednisolone in bronchial asthma by the concurrent use of hydroxyzine"" does not provide indirect support for the phrase ""Prednisolone related to follicular lymphoma."" The statement is about bronchial asthma and how maintenance doses of prednisolone can be reduced when hydroxyzine is used concurrently. It does not make any mention or implication about follicular lymphoma. To establish a relationship between prednisolone and follicular lymphoma, direct evidence would be required that specifically investigates and demonstrates such a link."
12983495,Prednisolone related to prostate cancer,233,"In contrast, cyclosporin A (CyA), FK-506 and prednisolone significantly inhibited antigen-induced airway inflammation and BHR in sensitized BN rats.",False,"Is the triple 'Prednisolone related to prostate cancer' supported by the sentence: 'In contrast, cyclosporin A (CyA), FK-506 and prednisolone significantly inhibited antigen-induced airway inflammation and BHR in sensitized BN rats.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to prostate cancer."" The provided quote discusses how prednisolone inhibits antigen-induced airway inflammation and bronchial hyperresponsiveness (BHR) in sensitized Brown Norway (BN) rats. It does not mention nor imply any connection between prednisolone and prostate cancer. Prednisolone is a corticosteroid commonly used for its anti-inflammatory effects in various conditions such as asthma, allergies, and autoimmune disorders; it is not typically associated with prostate cancer risk."
12510603,Prednisolone related to membranous glomerulonephritis,234,[Use of corticosteroids betamethasone and prednisolone in the prevention of allergic reactions in patients undergoing heart surgery with artificial blood circulation].,False,Is the triple 'Prednisolone related to membranous glomerulonephritis' supported by the sentence: '[Use of corticosteroids betamethasone and prednisolone in the prevention of allergic reactions in patients undergoing heart surgery with artificial blood circulation].'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to membranous glomerulonephritis."" The statement discusses the use of corticosteroids betamethasone and prednisolone in preventing allergic reactions in heart surgery patients but does not mention any connection between prednisolone and membranous glomerulonephritis. Membranous glomerulonephritis is a kidney disorder characterized by inflammation that may be associated with various conditions but is not explicitly linked to prednisolone in this context."
12496746,Prednisolone related to neoplasm,235,The intra-articular injection of prednisolone was shown to considerably reduce incidence of synovitis.,False,Is the triple 'Prednisolone related to neoplasm' supported by the sentence: 'The intra-articular injection of prednisolone was shown to considerably reduce incidence of synovitis.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to neoplasm"". The intra-articular injection of prednisolone reducing incidence of synovitis refers to its anti-inflammatory effects in treating joint inflammation (synovitis). Neoplasm, on the other hand, refers to an abnormal growth of cells or tissues, which can be benign or malignant (cancerous). While prednisolone is known for its immunosuppressive properties that can influence cell growth and proliferation, it does not imply that prednisolone is related to neoplasm in any direct or indirect manner based on this information alone.

         To establish such a link between prednisolone and neoplasm would require specific studies investigating prednisolone's potential carcinogenic effects, its influence on cancer progression, or its relationship with tumor growth. The statement provided focuses on prednisolone's effects on synovitis, which is unrelated to neoplasm in this context."
12428137,Prednisolone related to croup,236,"Prednisolone (100 mg/die initially, decreasing doses thereafter) led to significant reduction of infiltrates and eosinophilia.",True,"Is the triple 'Prednisolone related to croup' supported by the sentence: 'Prednisolone (100 mg/die initially, decreasing doses thereafter) led to significant reduction of infiltrates and eosinophilia.'?","Yes, there is indirect support for the statement ""Prednisolone related to croup"" based on the provided evidence. The statement ""Prednisolone (100 mg/die initially, decreasing doses thereafter) led to significant reduction of infiltrates and eosinophilia"" suggests that prednisolone has an impact on reducing inflammation (infiltrates) and immune cell (eosinophilia) counts in whatever context it was used. Croup is a condition characterized by inflammation in the upper airways, which can lead to symptoms such as stridor (noisy breathing), coughing, and difficulty breathing [1]. Prednisolone is a corticosteroid commonly used to reduce inflammation [2]. Therefore, it can be inferred that prednisolone may have beneficial effects in treating croup by reducing airway inflammation based on the given statement; however, direct evidence linking prednisolone specifically to croup treatment would strengthen this inference [3].

        
        References:
        
        
        [1] Centers for Disease Control and Prevention (CDC). Croup. https://www"
12061894,Prednisolone related to West syndrome,237,The tumour was significantly reduced by prednisolone.,False,Is the triple 'Prednisolone related to West syndrome' supported by the sentence: 'The tumour was significantly reduced by prednisolone.'?,"No, the statement ""The tumour was significantly reduced by prednisolone"" does not provide direct or indirect support for the phrase ""Prednisolone related to West syndrome"". The reason is that West syndrome is an epileptic disorder characterized by spasms, developmental delay, and a specific EEG pattern called hypsarrhythmia. The claim being evaluated here discusses the effect of prednisolone on reducing tumour size, which is not explicitly connected to West syndrome etiology or symptoms. However, it is important to note that prednisolone is an anti-inflammatory medication often used in treating various medical conditions, including some neurological disorders; thus, further investigation into the context might be necessary for more definitive conclusions."
11663099,Prednisolone related to Crohn disease,238,"Prednisolone prevented the development of colitis, but had no effect on already-developed colitis.",True,"Is the triple 'Prednisolone related to Crohn disease' supported by the sentence: 'Prednisolone prevented the development of colitis, but had no effect on already-developed colitis.'?","Yes, indirectly it does lend some support. The statement suggests that Prednisolone has an impact on preventing colitis (an inflammatory bowel disease similar to Crohn disease), implying that there might be a connection between Prednisolone and Crohn disease prevention or management. However, it's important to note that Crohn disease is not explicitly mentioned in the statement, so direct support cannot be inferred from it alone. Further investigation into clinical trials and studies specifically addressing Prednisolone's effect on Crohn disease would be necessary for stronger evidence.

        
        In order for Prednisolone to be considered as related to Crohn disease prevention or treatment, researchers would need to establish whether Crohn disease shares similar underlying inflammatory processes that Prednisolone can target effectively. This would involve analyzing clinical trial results, patient outcomes, potential side effects, dosage requirements, and other relevant factors when administering Prednisolone as part of Crohn disease therapy.

        
        Thus far, Prednisolone has been used in treating various forms of inflammatory bowel diseases such as ulcerative colitis; however, its long-term efficacy"
11638013,Prednisolone related to eosinophilic granulomatosis with polyangiitis,239,Alveolar NO concentration was increased in patients with refractory asthma (7.1 ppb) compared with mild-to-moderate asthma (3.4 ppb) and normal controls (3.4 ppb) and reduced by treatment with prednisolone.,True,Is the triple 'Prednisolone related to eosinophilic granulomatosis with polyangiitis' supported by the sentence: 'Alveolar NO concentration was increased in patients with refractory asthma (7.1 ppb) compared with mild-to-moderate asthma (3.4 ppb) and normal controls (3.4 ppb) and reduced by treatment with prednisolone.'?,"Yes, indirectly it does support that statement. The provided quote mentions that alveolar nitric oxide (NO) concentration is increased in patients with refractory asthma compared to mild-to-moderate asthma and normal controls, and it is reduced by treatment with prednisolone. This suggests that prednisolone has an effect on eosinophilic granulomatosis with polyangiitis (EGPA) as EGPA is characterized by inflammation in small-to-medium-sized blood vessels (vasculitis) which can be associated with asthma symptoms.

        Prednisolone is a type of corticosteroid that is often used in treating EGPA due to its anti-inflammatory properties. The fact that alveolar NO concentration is reduced by treatment with prednisolone in refractory asthma patients implies that prednisolone has an impact on reducing inflammation in these patients. Therefore, it can be inferred that prednisolone could potentially have beneficial effects in managing EGPA symptoms as well by reducing inflammation in blood vessels.

        However, it is important to"
11213963,Prednisolone related to leprosy,240,"Prednisolone treatment of sensory impairment of the ulnar and posterior tibial nerves detectable with the monofilament test, but not with the ballpen test, did not improve the long-term outcome in terms of recovery of touch sensibility, not did it reduce the risk of leprosy reactions or nerve function impairment beyond the initial 4-month treatment phase.",False,"Is the triple 'Prednisolone related to leprosy' supported by the sentence: 'Prednisolone treatment of sensory impairment of the ulnar and posterior tibial nerves detectable with the monofilament test, but not with the ballpen test, did not improve the long-term outcome in terms of recovery of touch sensibility, not did it reduce the risk of leprosy reactions or nerve function impairment beyond the initial 4-month treatment phase.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to leprosy."" The statement discusses a study where prednisolone was used to treat sensory impairment in patients, but it does not establish a direct link between prednisolone and leprosy. The study focuses on the effects of prednisolone on sensory impairment recovery and leprosy reactions during the initial 4-month treatment phase, not on its potential relationship with leprosy itself. Therefore, based on the provided information, there is no evidence to suggest that prednisolone is related to leprosy in any way."
11179224,Prednisolone related to alcoholic hepatitis,241,CONCLUSIONS: Predocol is an oral preparation of a poorly absorbed salt of prednisolone that is effective in reducing inflammation over short treatment periods in patients with active ulcerative colitis.,False,Is the triple 'Prednisolone related to alcoholic hepatitis' supported by the sentence: 'CONCLUSIONS: Predocol is an oral preparation of a poorly absorbed salt of prednisolone that is effective in reducing inflammation over short treatment periods in patients with active ulcerative colitis.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to alcoholic hepatitis."" The conclusion discusses the efficacy of Predocol (a preparation containing prednisolone) in treating ulcerative colitis over short periods but does not mention its relation or effect on alcoholic hepatitis.

        To further clarify:
        - Prednisolone is a synthetic glucocorticoid used in treating various conditions that involve inflammation.
        - Alcoholic hepatitis is an inflammatory condition affecting the liver due to excessive alcohol consumption.
        - Ulcerative colitis is an inflammatory bowel disease affecting the colon and rectum lining.

        Although prednisolone has anti-inflammatory properties that could theoretically benefit alcoholic hepatitis patients, no evidence is provided in the statement for such an association. Therefore, it is inappropriate to infer any connection between prednisolone and alcoholic hepatitis from the given conclusion about prednisolone in ulcerative colitis treatment."
11142916,Prednisolone related to lupus nephritis,242,"Six weeks prior to his symptoms, prednisolone (PSL) and SASP had been started because of UC aggravation.",False,"Is the triple 'Prednisolone related to lupus nephritis' supported by the sentence: 'Six weeks prior to his symptoms, prednisolone (PSL) and SASP had been started because of UC aggravation.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to lupus nephritis."" The information given indicates that prednisolone was administered for ulcerative colitis (UC) aggravation, not for lupus nephritis. Therefore, there is no connection established between prednisolone use and lupus nephritis in this context."
11037266,Prednisolone related to granulomatosis with polyangiitis,243,"When comparing organ specific, age-adjusted expected versus observed incidences after natural death of animals an increased tumor risk was found in organ systems of all treatment modalities but prednisolone.",False,"Is the triple 'Prednisolone related to granulomatosis with polyangiitis' supported by the sentence: 'When comparing organ specific, age-adjusted expected versus observed incidences after natural death of animals an increased tumor risk was found in organ systems of all treatment modalities but prednisolone.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to granulomatosis with polyangiitis"". The provided statement discusses an increased tumor risk in organ systems associated with various treatment modalities compared to natural death in animals, one of which is prednisolone. Granulomatosis with polyangiitis (GPA), formerly known as Wegener's granulomatosis, is an autoimmune disease characterized by inflammation in blood vessels and granulomas in affected organs. Prednisolone is often used as an immunosuppressive treatment for GPA but is not inherently related to its pathogenesis.

        To provide indirect support for the phrase ""Prednisolone related to granulomatosis with polyangiitis"", one would need evidence showing an association between prednisolone use and an increased risk for GPA development or progression, which is not provided in the statement."
11013570,Prednisolone related to leukemia,244,"R-CHOP chemotherapy composed of rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone which might increase the risk of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma.",False,"Is the triple 'Prednisolone related to leukemia' supported by the sentence: 'R-CHOP chemotherapy composed of rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone which might increase the risk of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to leukemia."" The statement discusses R-CHOP chemotherapy as a treatment for non-Hodgkin lymphoma, which includes prednisolone as one of its components. It then mentions an increased risk of Pneumocystis pneumonia associated with this chemotherapy regimen. There is no mention or implication of leukemia in the statement.

        To provide indirect support for ""Prednisolone related to leukemia,"" there would need to be some connection between prednisolone and leukemia in the statement, either as a cause, contributing factor, correlation, or any other form of association. In this case, no such connection exists.

        It is important to critically evaluate each claim in context and consider whether it truly supports the statement in question. This helps maintain accuracy in interpreting evidence and drawing conclusions based on that evidence."
10949449,Prednisolone related to polymyalgia rheumatica,245,"Cortisol deficiency is common in late stage HIV disease, but symptoms of fatigue and postural hypotension, as well as biochemical findings, are poor predictors of cortisol deficiency.",False,"Is the triple 'Prednisolone related to polymyalgia rheumatica' supported by the sentence: 'Cortisol deficiency is common in late stage HIV disease, but symptoms of fatigue and postural hypotension, as well as biochemical findings, are poor predictors of cortisol deficiency.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to polymyalgia rheumatica."" The connection between cortisol deficiency in late-stage HIV disease and polymyalgia rheumatica is not evident in the provided statement.

        Justification:

        1. The statement discusses cortisol deficiency in late-stage HIV disease but does not mention polymyalgia rheumatica (PMR) as a related condition.

        2. Prednisolone is often used as a treatment for PMR due to its anti-inflammatory properties; however, this statement does not establish any connection between cortisol deficiency in late-stage HIV disease and PMR treatment.

        3. Cortisol deficiency symptoms mentioned in the statement (fatigue and postural hypotension) do not specifically align with PMR symptoms (muscle pain, stiffness in shoulders/hips, weakness).

        4. The statement emphasizes that these symptoms have poor predictive value for cortisol deficiency in late-stage HIV disease; therefore, they cannot serve as an indirect link between"
10748640,Prednisolone related to infertility disorder,246,[Plasma cortisol and 17-ketosteroids in urine in relation to cardiac arrest].,False,Is the triple 'Prednisolone related to infertility disorder' supported by the sentence: '[Plasma cortisol and 17-ketosteroids in urine in relation to cardiac arrest].'?,"No, the statement ""Plasma cortisol and 17-ketosteroids in urine in relation to cardiac arrest"" does not provide indirect support for the phrase ""Prednisolone related to infertility disorder."" This is because there is no direct or implied connection between prednisolone (a synthetic glucocorticoid drug used for its anti-inflammatory effects) and infertility disorders in the provided statement. The statement only discusses plasma cortisol and 17-ketosteroids in urine in relation to cardiac arrest, which is unrelated to prednisolone or infertility disorders.

         To further clarify, prednisolone can impact hormone levels in the body due to its influence on the hypothalamic-pituitary-adrenal (HPA) axis; however, its effects on fertility remain unclear and may depend on factors such as dosage and duration of use. The statement provided does not contain any information that would allow us to draw any conclusions about prednisolone's potential relationship with infertility disorders."
10744705,"Prednisolone related to dermatitis, atopic",247,"Independence of theta and TL surface antigens and killing by thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine lymphoma.",False,"Is the triple 'Prednisolone related to dermatitis, atopic' supported by the sentence: 'Independence of theta and TL surface antigens and killing by thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine lymphoma.'?","No, the statement ""Independence of theta and TL surface antigens and killing by thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine lymphoma"" does not provide indirect support for the phrase ""Prednisolone related to dermatitis, atopic"". 

         The statement discusses the independence of certain surface antigens (theta and TL) in murine lymphoma cells and their susceptibility to various substances (thymidine, cortisol, phytohemagglutinin, cyclic AMP). Prednisolone is not mentioned in this statement, nor is there any connection made between cortisol (a glucocorticoid like prednisolone) and atopic dermatitis in humans. Prednisolone is often used in dermatological conditions as an anti-inflammatory agent; however, it is not explicitly related to atopic dermatitis in this particular statement."
10736101,Prednisolone related to Graves disease,248,"Furthermore, this treatment process demonstrated the superior anti-inflammatory effect of prednisolone over that of hydrocortisone and supported the assumption of inflammation related to CD.",True,"Is the triple 'Prednisolone related to Graves disease' supported by the sentence: 'Furthermore, this treatment process demonstrated the superior anti-inflammatory effect of prednisolone over that of hydrocortisone and supported the assumption of inflammation related to CD.'?","Yes, indirectly it does. The statement suggests that prednisolone has a superior anti-inflammatory effect compared to hydrocortisone and supports the assumption that inflammation is related to CD (presumably an abbreviation for a condition or disease). Graves disease is an autoimmune disorder that can involve inflammation. Therefore, if prednisolone is effective in treating inflammation related to CD, it could potentially also be beneficial in managing inflammation associated with Graves disease. However, this is an indirect inference and would need further investigation to confirm. It's also important to note that Graves disease is specifically characterized by hyperthyroidism, which is not necessarily associated with inflammation, so prednisolone might not be a primary treatment for Graves disease itself."
10735679,Prednisolone related to kidney disorder,249,"Ordinary least squared (OLS) regression was used to evaluate whether race moderated the associations between alcohol abuse and four biomarkers-urinary cortisol and serum dehydroepiandrosterone sulfate (DHEA-S), epinephrine and norepinephrine-and two composite summary scores, each consisting of two components that characterize the hypothalamic pituitary adrenal (HPA)-axis and sympathetic nervous systems (SNS), respectively.",False,"Is the triple 'Prednisolone related to kidney disorder' supported by the sentence: 'Ordinary least squared (OLS) regression was used to evaluate whether race moderated the associations between alcohol abuse and four biomarkers-urinary cortisol and serum dehydroepiandrosterone sulfate (DHEA-S), epinephrine and norepinephrine-and two composite summary scores, each consisting of two components that characterize the hypothalamic pituitary adrenal (HPA)-axis and sympathetic nervous systems (SNS), respectively.'?","No, the statement does not provide any direct or indirect support for the phrase ""Prednisolone related to kidney disorder."" The provided statement discusses an OLS regression study that examined race as a moderator for associations between alcohol abuse and various biomarkers related to the HPA-axis and SNS systems. Prednisolone is not mentioned in the statement at all, nor is there any information about kidney disorders. Therefore, it is not possible to make any connection between Prednisolone and kidney disorders based on this statement alone."
10715297,Prednisolone related to keratitis,250,"CONCLUSION: In patients with septic shock, low-dose hydrocortisone was associated with a lower risk of developing AF during the acute phase.",False,"Is the triple 'Prednisolone related to keratitis' supported by the sentence: 'CONCLUSION: In patients with septic shock, low-dose hydrocortisone was associated with a lower risk of developing AF during the acute phase.'?","No, the statement ""Prednisolone related to keratitis"" does not receive indirect support from the conclusion provided in the study about septic shock patients treated with low-dose hydrocortisone. The conclusion in the study refers specifically to the association between low-dose hydrocortisone and atrial fibrillation (AF) risk during the acute phase in septic shock patients.

         The two statements involve different drugs (prednisolone vs hydrocortisone) and different medical conditions (keratitis vs septic shock and atrial fibrillation). Therefore, there is no logical connection between them that would provide indirect support for prednisolone being related to keratitis based on that conclusion about hydrocortisone in septic shock patients.

         To establish any connection between prednisolone and keratitis, there would need to be specific evidence from relevant studies that demonstrate such an association between those two factors."
10703266,Prednisolone related to ulcerative colitis,251,"The incidence of psychological symptoms as somatization, obsessive-compulsive symptoms, depression, anxiety, phobia, and nonspecific symptoms is statistically increased in pregnant women with elevated morning cortisol, but in women with elevated afternoon cortisol also occurring aggressiveness and paranoia.",False,"Is the triple 'Prednisolone related to ulcerative colitis' supported by the sentence: 'The incidence of psychological symptoms as somatization, obsessive-compulsive symptoms, depression, anxiety, phobia, and nonspecific symptoms is statistically increased in pregnant women with elevated morning cortisol, but in women with elevated afternoon cortisol also occurring aggressiveness and paranoia.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to ulcerative colitis."" The provided statement discusses the psychological symptoms associated with elevated cortisol levels in pregnant women; however, it does not mention Prednisolone or ulcerative colitis. Prednisolone is a synthetic glucocorticoid often used in treating various conditions such as ulcerative colitis but is not mentioned in the statement. Therefore, it is inappropriate to draw any conclusions about Prednisolone's relationship to ulcerative colitis based on this statement alone."
10687782,Prednisolone related to hepatocellular carcinoma,252,How stress gets under the skin: cortisol and stress reactivity in psoriasis.,False,Is the triple 'Prednisolone related to hepatocellular carcinoma' supported by the sentence: 'How stress gets under the skin: cortisol and stress reactivity in psoriasis.'?,"No, the statement ""How stress gets under the skin: cortisol and stress reactivity in psoriasis"" does not provide direct or indirect support for the phrase ""Prednisolone related to hepatocellular carcinoma."" 

         Prednisolone is a synthetic glucocorticoid hormone used primarily for its anti-inflammatory effects in various medical conditions, while hepatocellular carcinoma is a type of liver cancer. The statement in question discusses cortisol (a natural glucocorticoid hormone) and stress reactivity in psoriasis - an autoimmune skin condition - but it does not make any connection between Prednisolone and hepatocellular carcinoma.

         The two subjects - Prednisolone and hepatocellular carcinoma - should be evaluated independently based on available evidence in relevant studies focusing on their relationship rather than assuming any connection based on the statement provided."
10623724,Prednisolone related to hemolytic anemia,253,Absorption of hydrocortisone from the skin reservoir in atopic dermatitis.,False,Is the triple 'Prednisolone related to hemolytic anemia' supported by the sentence: 'Absorption of hydrocortisone from the skin reservoir in atopic dermatitis.'?,"No, the statement ""Absorption of hydrocortisone from the skin reservoir in atopic dermatitis"" does not provide indirect support for the claim ""Prednisolone related to hemolytic anemia."" 

         The two statements discuss different corticosteroids (hydrocortisone vs prednisolone) and their separate effects on the body (skin absorption vs potential for causing hemolytic anemia). The absorption process of hydrocortisone in atopic dermatitis does not inherently indicate any connection to prednisolone-induced hemolytic anemia. 

         However, it is worth noting that both hydrocortisone and prednisolone belong to the class of corticosteroids that can cause various side effects, including hemolytic anemia in rare cases. Nonetheless, the given statement does not provide any evidence or indirect support for the specific claim regarding prednisolone-induced hemolytic anemia."
10576837,Prednisolone related to juvenile idiopathic arthritis,254,OBJECTIVE: To assess dexamethasone (DEX) and hydrocortisone (HC) use in premature infants over time and the association of steroid use with the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age.,False,Is the triple 'Prednisolone related to juvenile idiopathic arthritis' supported by the sentence: 'OBJECTIVE: To assess dexamethasone (DEX) and hydrocortisone (HC) use in premature infants over time and the association of steroid use with the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to juvenile idiopathic arthritis."" The objective in the statement is focused on assessing dexamethasone (DEX) and hydrocortisone (HC) use in premature infants over time and their association with bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age. Prednisolone is not mentioned in the statement, nor is there any connection made between steroid use in premature infants and juvenile idiopathic arthritis. Therefore, there is no indirect support for the phrase based on this statement alone."
10565620,Prednisolone related to nephrotic syndrome,255,Increased ratio of mRNA expression of the genes CYP17 and CYP11B1 indicates autonomous cortisol production in adrenocortical tumors.,False,Is the triple 'Prednisolone related to nephrotic syndrome' supported by the sentence: 'Increased ratio of mRNA expression of the genes CYP17 and CYP11B1 indicates autonomous cortisol production in adrenocortical tumors.'?,"No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to nephrotic syndrome."" 

         The statement discusses an increased ratio of mRNA expression of the genes CYP17 and CYP11B1 as an indicator of autonomous cortisol production in adrenocortical tumors. While Prednisolone is a glucocorticoid often used in treating nephrotic syndrome, it is not mentioned nor implied in the statement. Additionally, autonomous cortisol production may be related to various conditions but not necessarily linked to Prednisolone usage in nephrotic syndrome patients."
10531966,Prednisolone related to allergic disease,256,"It is concluded that bile acids are potent endogenous inhibitors of 11 beta-HSD and, therefore, could participate in abnormalities of cortisol metabolism observed in liver cirrhosis and extrahepatic biliary obstruction and, possibly, after ingestion of bile acids.",False,"Is the triple 'Prednisolone related to allergic disease' supported by the sentence: 'It is concluded that bile acids are potent endogenous inhibitors of 11 beta-HSD and, therefore, could participate in abnormalities of cortisol metabolism observed in liver cirrhosis and extrahepatic biliary obstruction and, possibly, after ingestion of bile acids.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to allergic disease."" The conclusion in the statement is about bile acids being potent endogenous inhibitors of 11 beta-HSD (11 beta-hydroxysteroid dehydrogenase), which could potentially influence cortisol metabolism abnormalities in certain medical conditions. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory and immunosuppressive effects in various clinical situations; it is not mentioned nor implied in the statement provided. Therefore, there is no connection between bile acids and prednisolone in terms of allergic disease."
10527508,Prednisolone related to acute myeloid leukemia,257,"The plasma cortisol concentration was significantly higher in both DD groups before treatment than in the control group, and it decreased significantly after hoof trimming in the trimmed group.",False,"Is the triple 'Prednisolone related to acute myeloid leukemia' supported by the sentence: 'The plasma cortisol concentration was significantly higher in both DD groups before treatment than in the control group, and it decreased significantly after hoof trimming in the trimmed group.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to acute myeloid leukemia."" The statement discusses plasma cortisol concentration in relation to hoof trimming in different groups, but it does not mention Prednisolone or acute myeloid leukemia. Prednisolone is a synthetic glucocorticoid often used as an anti-inflammatory and immunosuppressive agent, while acute myeloid leukemia is a type of cancer affecting blood cells. Without any connection between these elements in the provided statement, there is no basis for inferring support for the relationship between Prednisolone and acute myeloid leukemia."
10503828,Prednisolone related to seasonal allergic rhinitis,258,Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.,False,Is the triple 'Prednisolone related to seasonal allergic rhinitis' supported by the sentence: 'Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to seasonal allergic rhinitis."" 

         The statement discusses the protective effects of Hydrocortisone on blast cells in acute myeloblastic leukemia when exposed to cytosine arabinoside. This is unrelated to Prednisolone, which is another type of corticosteroid often used in treating various conditions such as allergies (including seasonal allergic rhinitis) but has no direct connection with Hydrocortisone in terms of its use in leukemia treatment.

         The two statements involve different corticosteroids being used in different medical contexts (allergies vs leukemia), so there is no reasonable basis for indirect support from one statement to the other."
10496403,Prednisolone related to Inflammation,259,Continuous subcutaneous hydrocortisone infusion in Addison's disease.,False,Is the triple 'Prednisolone related to Inflammation' supported by the sentence: 'Continuous subcutaneous hydrocortisone infusion in Addison's disease.'?,"No, the statement ""Continuous subcutaneous hydrocortisone infusion in Addison's disease"" does not provide direct or indirect support for the phrase ""Prednisolone related to Inflammation."" This is because hydrocortisone and prednisolone are different types of corticosteroids that have overlapping but distinct therapeutic uses. While both medications can be used in treating inflammation, they have different pharmacological properties that make them more suitable for certain conditions than others.

        Addison's disease is characterized by primary adrenal insufficiency leading to deficient production of cortisol and aldosterone. Continuous subcutaneous hydrocortisone infusion is used in Addison's disease management as it replaces cortisol hormone deficiency in these patients. However, it does not necessarily imply any direct relationship between hydrocortisone and inflammation in Addison's disease per se but rather addressing hormonal imbalance caused by insufficient cortisol levels in these patients.

        Prednisolone is also used for treating various inflammatory conditions due to its potent anti-inflammatory"
10118116,Prednisolone related to Prednisone,260,The current findings underline the relevance of cortisol and DHEA assessments and the need for further scrutiny of their interplay to foster our understanding of the biological basis of stress regulation in BPD.,False,Is the triple 'Prednisolone related to Prednisone' supported by the sentence: 'The current findings underline the relevance of cortisol and DHEA assessments and the need for further scrutiny of their interplay to foster our understanding of the biological basis of stress regulation in BPD.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to Prednisone."" The statement discusses cortisol and DHEA assessments in relation to stress regulation in Borderline Personality Disorder (BPD). Prednisolone and Prednisone are both corticosteroids used for their anti-inflammatory effects but unrelated to cortisol and DHEA in terms of stress regulation. Therefore, there is no connection between the two statements in question."
9924521,Prednisolone related to colitis,261,"This hypoxia-specific increase in surface beta-adrenoreceptors was significantly enhanced in the cortisol-treated erythrocytes, showing that cortisol had a significant impact on erythrocyte beta-adrenoreceptor dynamics in addition to the direct influence of hypoxia.",False,"Is the triple 'Prednisolone related to colitis' supported by the sentence: 'This hypoxia-specific increase in surface beta-adrenoreceptors was significantly enhanced in the cortisol-treated erythrocytes, showing that cortisol had a significant impact on erythrocyte beta-adrenoreceptor dynamics in addition to the direct influence of hypoxia.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to colitis."" The statement discusses the effects of cortisol on erythrocyte beta-adrenoreceptor dynamics under hypoxic conditions but does not mention prednisolone nor colitis. Prednisolone is a synthetic glucocorticoid often used in treating various inflammatory and immune-mediated disorders, while colitis is inflammation in the colon. Although both cortisol and prednisolone have anti-inflammatory properties and share some molecular targets, there is no direct connection between them in the provided statement.

         To establish indirect support for ""Prednisolone related to colitis"" from the statement, there would need to be some link between cortisol, hypoxia, beta-adrenoreceptors, and colitis or prednisolone use in treating colitis. As it stands, there is no such link in the given statement. Therefore, it does not support the claim that prednisolone is related to colitis."
9437304,Prednisolone related to systemic lupus erythematosus,262,"Congenital adrenal hyperplasia (CAH) due to deficiency of 21-hydroxylase is a disorder of the adrenal cortex characterised by cortisol deficiency, with or without aldosterone deficiency, and androgen excess.",False,"Is the triple 'Prednisolone related to systemic lupus erythematosus' supported by the sentence: 'Congenital adrenal hyperplasia (CAH) due to deficiency of 21-hydroxylase is a disorder of the adrenal cortex characterised by cortisol deficiency, with or without aldosterone deficiency, and androgen excess.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to systemic lupus erythematosus"". The statement discusses congenital adrenal hyperplasia (CAH), which is caused by deficiency of 21-hydroxylase leading to cortisol deficiency, aldosterone deficiency (in some cases), and androgen excess. Prednisolone is a synthetic glucocorticoid hormone used in various conditions such as inflammation, allergies, and autoimmune disorders like systemic lupus erythematosus (SLE). Although both CAH and SLE involve corticosteroid hormones (natural or synthetic), there is no direct connection between Prednisolone and systemic lupus erythematosus mentioned or implied in the statement."
9282196,Prednisolone related to IgA glomerulonephritis,263,"Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioids levels in nicotine dependence after naltrexone treatment.",False,"Is the triple 'Prednisolone related to IgA glomerulonephritis' supported by the sentence: 'Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioids levels in nicotine dependence after naltrexone treatment.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to IgA glomerulonephritis."" The statement discusses changes in smoking behavior and certain hormone levels after naltrexone treatment in nicotine dependence but does not mention Prednisolone or IgA glomerulonephritis at all. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in various conditions such as asthma, rheumatoid arthritis, and inflammatory bowel disease while IgA glomerulonephritis is a kidney disease characterized by inflammation in the glomeruli (filtering units) due to an abnormal buildup of immunoglobulin A (IgA) antibodies in the kidneys. Therefore, there is no connection between these two pieces of information."
9222009,Prednisolone related to hypereosinophilic syndrome,264,We hypothesize that hydrocortisone infusion in severe community-acquired pneumonia attenuates systemic inflammation and leads to earlier resolution of pneumonia and a reduction in sepsis-related complications.,False,Is the triple 'Prednisolone related to hypereosinophilic syndrome' supported by the sentence: 'We hypothesize that hydrocortisone infusion in severe community-acquired pneumonia attenuates systemic inflammation and leads to earlier resolution of pneumonia and a reduction in sepsis-related complications.'?,"No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to hypereosinophilic syndrome"". 

         The statement discusses hydrocortisone infusion in severe community-acquired pneumonia and its potential effects on systemic inflammation, pneumonia resolution, and sepsis-related complications. Hydrocortisone is a different type of corticosteroid than prednisolone, and the condition being treated, severe community-acquired pneumonia, is different from hypereosinophilic syndrome. Therefore, while both statements relate to corticosteroids and their potential effects on inflammation, they discuss different corticosteroids and conditions, providing no direct or indirect support for the connection between prednisolone and hypereosinophilic syndrome."
9216084,Prednisolone related to non-Hodgkin lymphoma,265,A prospective study was performed to investigate the combination of the aromatase inhibitor aminoglutethimide and hydrocortisone in androgen-independent prostate cancer with changes in prostate-specific antigen (PSA) level as main determinant for response.,False,Is the triple 'Prednisolone related to non-Hodgkin lymphoma' supported by the sentence: 'A prospective study was performed to investigate the combination of the aromatase inhibitor aminoglutethimide and hydrocortisone in androgen-independent prostate cancer with changes in prostate-specific antigen (PSA) level as main determinant for response.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to non-Hodgkin lymphoma."" The prospective study mentioned in the statement investigates the combination of aromatase inhibitor aminoglutethimide and hydrocortisone in treating androgen-independent prostate cancer. Prednisolone is not mentioned in the study, nor is there any connection made between the drugs used in the study (aminoglutethimide and hydrocortisone) and non-Hodgkin lymphoma. Therefore, it is inappropriate to infer any relationship between Prednisolone and non-Hodgkin lymphoma based on this statement alone."
9208405,Prednisolone related to Duchenne muscular dystrophy,266,"To investigate the time courses of the effects of the exogenous glucocorticoid agonists dexamethasone (DEX) and hydrocortisone (HYD) and a glucocorticoid antagonist (RU-38486), and to characterize the local and systemic responses in experimental AP.",False,"Is the triple 'Prednisolone related to Duchenne muscular dystrophy' supported by the sentence: 'To investigate the time courses of the effects of the exogenous glucocorticoid agonists dexamethasone (DEX) and hydrocortisone (HYD) and a glucocorticoid antagonist (RU-38486), and to characterize the local and systemic responses in experimental AP.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to Duchenne muscular dystrophy."" The statement discusses an investigation into the effects of certain glucocorticoid agonists (dexamethasone and hydrocortisone) as well as a glucocorticoid antagonist (RU-38486) in an experimental setting related to acute pancreatitis (AP). Prednisolone is not mentioned in the statement, nor is there any connection made between glucocorticoids and Duchenne muscular dystrophy in the provided context.

        To better understand the relationship between Prednisolone and Duchenne muscular dystrophy, one could look at studies specifically examining Prednisolone in relation to Duchenne muscular dystrophy for indirect support. However, based on the given statement alone, there is no connection established between Prednisolone and Duchenne muscular dystrophy."
8405261,Prednisolone related to asthma,267,[The adrenal cortex and hydrocortisone metabolism in experimental myocardial infarct].,False,Is the triple 'Prednisolone related to asthma' supported by the sentence: '[The adrenal cortex and hydrocortisone metabolism in experimental myocardial infarct].'?,"No, the statement does not provide any direct or indirect support for the phrase ""Prednisolone related to asthma."" Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in various conditions such as asthma, allergies, and autoimmune diseases. The adrenal cortex is responsible for producing hormones like cortisol (hydrocortisone), which has similar effects as Prednisolone but is naturally occurring in humans.

         The statement discusses experimental myocardial infarct (heart attack) in relation to the adrenal cortex and hydrocortisone metabolism but does not mention Prednisolone or its relationship to asthma. Therefore, it does not offer any support for the given phrase.

         However, it is important to note that Prednisolone is often used in patients who have experienced myocardial infarction due to its ability to reduce inflammation in the heart muscle; yet, that does not mean that Prednisolone is related specifically to asthma in this context."
7844202,Prednisolone related to chronic obstructive pulmonary disease,268,[Intraarticular hydrocortisone (cortril) in arthritis and osteoarthritis].,False,Is the triple 'Prednisolone related to chronic obstructive pulmonary disease' supported by the sentence: '[Intraarticular hydrocortisone (cortril) in arthritis and osteoarthritis].'?,"No, the statement does not provide any direct or indirect support for the phrase ""Prednisolone related to chronic obstructive pulmonary disease"" (COPD). The statement discusses intraarticular hydrocortisone (cortril) used in arthritis and osteoarthritis but does not mention prednisolone nor COPD. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in various conditions, while chronic obstructive pulmonary disease is characterized by airflow limitation that is not fully reversible. Although both prednisolone and hydrocortisone belong to the glucocorticoid class, they have different therapeutic indications, and evidence from one does not necessarily translate to the other. Therefore, more specific information is required to establish any connection between prednisolone and COPD."
7323744,Prednisolone related to pemphigus,269,[Use of cortisone and hydrocortisone in eye diseases].,False,Is the triple 'Prednisolone related to pemphigus' supported by the sentence: '[Use of cortisone and hydrocortisone in eye diseases].'?,"No, the statement ""Use of cortisone and hydrocortisone in eye diseases"" does not provide indirect support for the phrase ""Prednisolone related to pemphigus."" 

         Prednisolone is a synthetic glucocorticoid, which is a class of steroid hormones used for their anti-inflammatory and immunosuppressive effects (Barnes & Adcock, 2003). Cortisone and hydrocortisone are also glucocorticoids but belong to a different subcategory than prednisolone (Barnes & Adcock, 2003). 

         Although all three compounds have similar mechanisms of action in reducing inflammation, they differ in potency, duration of action, pharmacokinetics, and side effects (Barnes & Adcock, 2003). Therefore, while the statement suggests that glucocorticoids like cortisone and hydrocortisone may be used in treating eye diseases, it does not necessarily imply any connection between prednisolone specifically and pemphigus, an autoimmune disorder affecting mucous membranes and"
7262473,Prednisolone related to rheumatoid arthritis,270,[Topical use of hydrocortisone in otitis externa].,False,Is the triple 'Prednisolone related to rheumatoid arthritis' supported by the sentence: '[Topical use of hydrocortisone in otitis externa].'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to rheumatoid arthritis."" The provided statement discusses topical use of hydrocortisone in otitis externa, which is unrelated to prednisolone and rheumatoid arthritis. Prednisolone is a synthetic glucocorticoid used primarily in systemic treatment for various inflammatory diseases, while hydrocortisone is often used topically for localized conditions such as otitis externa. Rheumatoid arthritis is an autoimmune disorder characterized by joint inflammation; however, there is no direct connection established between prednisolone use and rheumatoid arthritis based on the provided statement."
7206314,Prednisolone related to pulmonary tuberculosis,271,The use of hydrocortisone in ulcerative colitis:  preliminary observations.,False,Is the triple 'Prednisolone related to pulmonary tuberculosis' supported by the sentence: 'The use of hydrocortisone in ulcerative colitis:  preliminary observations.'?,"No, the statement ""The use of hydrocortisone in ulcerative colitis: preliminary observations"" does not provide direct or indirect support for the phrase ""Prednisolone related to pulmonary tuberculosis."" 

        The statement discusses the use of hydrocortisone in treating ulcerative colitis and presents preliminary observations. Hydrocortisone is a different steroidal anti-inflammatory drug than prednisolone. Additionally, the statement does not mention pulmonary tuberculosis at all. Therefore, there is no connection between the two statements that would lend support to the idea that prednisolone is related to pulmonary tuberculosis."
8856354,Prednisolone related to Prednisone,272,It can therefore be concluded that ointments containing either only E. coli BCS or a combination of BCS and hydrocortisone provide significant relief in perianal eczema as well as in early stages of hemorrhoidal disease.,False,Is the triple 'Prednisolone related to Prednisone' supported by the sentence: 'It can therefore be concluded that ointments containing either only E. coli BCS or a combination of BCS and hydrocortisone provide significant relief in perianal eczema as well as in early stages of hemorrhoidal disease.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone related to Prednisone."" The statement discusses the therapeutic effects of ointments containing E. coli BCS (Bacteroides caccae strain) alone or in combination with hydrocortisone on perianal eczema and early stages of hemorrhoidal disease. Prednisolone and Prednisone are both corticosteroids but unrelated to E. coli BCS or hydrocortisone in terms of their chemical structures or therapeutic applications in treating skin conditions like eczema or hemorrhoids.

        To establish any connection between Prednisolone and Prednisone, one would need evidence supporting their shared mechanisms in treating specific medical conditions, their potential synergistic effects when combined with other compounds (like E. coli BCS or hydrocortisone), or other relevant information that demonstrates their relationship in clinical settings. As such, further investigation would be required to establish any relationship between Prednisolone and Prednisone based on their therapeutic applications in dermatology or gastroenterology."
26879702,Prednisolone has part acute lymphoblastic leukemia,273,The effect on cortisol supports the above conclusion and is consistent with HPA axis perturbation in opioid dependence as reported in other studies and extends these observations to stable methadone-maintained patients.,False,Is the triple 'Prednisolone has part acute lymphoblastic leukemia' supported by the sentence: 'The effect on cortisol supports the above conclusion and is consistent with HPA axis perturbation in opioid dependence as reported in other studies and extends these observations to stable methadone-maintained patients.'?,"No, the statement does not provide direct or indirect support for the phrase ""Prednisolone has part acute lymphoblastic leukemia."" The statement discusses cortisol levels in opioid dependence and methadone-maintained patients, which is unrelated to Prednisolone or acute lymphoblastic leukemia. Prednisolone is a corticosteroid medication used for various conditions, while acute lymphoblastic leukemia is a type of cancer affecting white blood cells; these topics are not connected within the provided context."
26670577,Prednisolone has part plasma cell myeloma,274,Several randomized controlled trials have evaluated the efficacy of a replacement therapy with hydrocortisone in severe sepsis.,False,Is the triple 'Prednisolone has part plasma cell myeloma' supported by the sentence: 'Several randomized controlled trials have evaluated the efficacy of a replacement therapy with hydrocortisone in severe sepsis.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Prednisolone has part plasma cell myeloma"". 

         The statement discusses randomized controlled trials that have evaluated the efficacy of hydrocortisone replacement therapy in severe sepsis. This is unrelated to Prednisolone and its potential involvement in plasma cell myeloma. Plasma cell myeloma is a type of cancer where malignant plasma cells accumulate in bone marrow leading to bone destruction and bone pain, calcium elevation, kidney problems, anemia and infections due to decreased white blood cells counts. Prednisolone is a synthetic glucocorticoid that is often used in treating various conditions like allergies, inflammation, autoimmune diseases but not plasma cell myeloma. Therefore, there is no connection between these two pieces of information."
18935086,Prednisolone coexists with Prednisone,275,[Diurnal variations in blood glucose and plasma cortisol in juvenile diabetes mellitus without ketoacidosis].,False,Is the triple 'Prednisolone coexists with Prednisone' supported by the sentence: '[Diurnal variations in blood glucose and plasma cortisol in juvenile diabetes mellitus without ketoacidosis].'?,"No, the statement ""Prednisolone coexists with Prednisone"" does not receive indirect support from the provided reference because it does not mention or imply any relationship between Prednisolone and Prednisone. The title ""Diurnal variations in blood glucose and plasma cortisol in juvenile diabetes mellitus without ketoacidosis"" refers to a study about blood glucose and plasma cortisol levels in juvenile diabetes patients without ketoacidosis. Prednisolone and Prednisone are both corticosteroids used for various medical purposes but they have different chemical structures and uses in clinical settings.

        To provide indirect support for ""Prednisolone coexists with Prednisone"", there would need to be evidence suggesting that they can be found together in some context, such as in a patient's medication regimen, in biological samples from patients undergoing treatment involving both drugs, or in some formulation produced by pharmaceutical companies for specific therapeutic purposes. The present reference does not offer any such evidence or information that would suggest their coexistence in any way."
9296680,Prednisolone derives from Prednisone,276,"OBJECTIVES: Elderly women with proximal femur fracture show abnormal persistence of increased cortisol concentrations, which could contribute to the high morbidity associated with this injury.",False,"Is the triple 'Prednisolone derives from Prednisone' supported by the sentence: 'OBJECTIVES: Elderly women with proximal femur fracture show abnormal persistence of increased cortisol concentrations, which could contribute to the high morbidity associated with this injury.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone derives from Prednisone."" The statement discusses increased cortisol concentrations in elderly women with proximal femur fractures and their potential contribution to morbidity. 

         Prednisolone and Prednisone are both corticosteroids used in various medical treatments; Prednisone is metabolized into Prednisolone in the body. However, there is no mention or implication in the statement connecting these two corticosteroids to the discussed cortisol concentration abnormalities in elderly women with proximal femur fractures."
26415442,Prednisolone derives from Prednisone,277,"From the compendium presented above, the following statements become evident: 1) Inappropriately low secretion of cortisol in relation to inflammation is a typical feature of the inflammatory disease in patients with RA.",False,"Is the triple 'Prednisolone derives from Prednisone' supported by the sentence: 'From the compendium presented above, the following statements become evident: 1) Inappropriately low secretion of cortisol in relation to inflammation is a typical feature of the inflammatory disease in patients with RA.'?","No, the statement ""Prednisolone derives from Prednisone"" is not indirectly supported by the given claim about cortisol secretion in patients with rheumatoid arthritis (RA). The statement in question is about the physiological response in RA patients, while the other statement refers to two different medications used in clinical settings.

         Prednisolone is a synthetic glucocorticoid hormone used for its anti-inflammatory effects in various clinical conditions including RA. Prednisone is another synthetic glucocorticoid that is converted into Prednisolone in vivo by enzymatic reduction in the liver after absorption from the gastrointestinal tract. Thus, Prednisolone is metabolically derived from Prednisone in the body but not in terms of chemical synthesis as suggested by the statement in question.

         In conclusion, while both drugs have therapeutic applications in RA treatment and share similar mechanisms of action, they belong to different chemical entities. The given claim does not provide any information that would suggest Prednisolone derives from Prednisone in terms of chemical synthesis or production processes."
14808035,Prednisolone physically interacts with Prednisone,278,Hydrocortisone infusion in septic shock differentially regulated the cytokine responses.,False,Is the triple 'Prednisolone physically interacts with Prednisone' supported by the sentence: 'Hydrocortisone infusion in septic shock differentially regulated the cytokine responses.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Prednisolone physically interacts with Prednisone"". The statement discusses Hydrocortisone infusion in septic shock and its effect on cytokine responses. Hydrocortisone, Prednisolone, and Prednisone are all glucocorticoids, but they do not imply physical interaction between Prednisolone and Prednisone."
9296682,Prednisolone physically interacts with Prednisone,279,"BACKGROUND: There is substantial evidence of dysregulation of cortisol secretion, hippocampal abnormalities, and memory deficits in schizophrenia and other psychotic disorders.",False,"Is the triple 'Prednisolone physically interacts with Prednisone' supported by the sentence: 'BACKGROUND: There is substantial evidence of dysregulation of cortisol secretion, hippocampal abnormalities, and memory deficits in schizophrenia and other psychotic disorders.'?","No, the statement does not provide any direct or indirect support for the phrase ""Prednisolone physically interacts with Prednisone."" The background statement discusses dysregulation of cortisol secretion, hippocampal abnormalities, and memory deficits in schizophrenia and other psychotic disorders but does not mention Prednisolone or Prednisone nor provide any information on their potential interaction. Prednisolone and Prednisone are synthetic glucocorticoids often prescribed for their anti-inflammatory effects; any interaction between these two substances would be related to their pharmacological properties rather than psychiatric disorders or cortisol secretion."
27055840,Prednisolone causes glaucoma,280,(2) One of the mechanisms of therapeutic effect of cortisol in asthma might be its inhibitory effect on CA uptake.,False,Is the triple 'Prednisolone causes glaucoma' supported by the sentence: '(2) One of the mechanisms of therapeutic effect of cortisol in asthma might be its inhibitory effect on CA uptake.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone causes glaucoma."" The mechanism mentioned in the statement refers to cortisol's inhibitory effect on cyclic AMP (CA) uptake as a potential therapeutic effect in asthma management. Prednisolone is a synthetic glucocorticoid (a type of corticosteroid) used in treating various inflammatory conditions, but it does not necessarily imply that it causes glaucoma as a side effect.

        The two statements discuss different medical conditions (asthma vs. glaucoma) and mechanisms (inhibitory effect on CA uptake vs. potential side effects) without any direct link between them. While it is essential to be aware that corticosteroids like Prednisolone can have side effects such as increased intraocular pressure leading to glaucoma in rare cases, it would require separate evidence connecting Prednisolone use specifically with glaucoma development.

        In summary, further investigation is needed before making any conclusions about Prednisolone causing glaucoma based on these statements alone. It is crucial to evaluate each claim"
26677891,Prednisolone causes uveitis,281,"OBJECTIVE: To compare cortisol levels, diurnal cycles of cortisol, and reactivity of cortisol to psychological stress in fibromyalgia (FM) and rheumatoid arthritis (RA) patients in their natural environment, and to examine the effect on results of accounting for differences among the groups in psychological stress and other lifestyle and psychosocial variables.",False,"Is the triple 'Prednisolone causes uveitis' supported by the sentence: 'OBJECTIVE: To compare cortisol levels, diurnal cycles of cortisol, and reactivity of cortisol to psychological stress in fibromyalgia (FM) and rheumatoid arthritis (RA) patients in their natural environment, and to examine the effect on results of accounting for differences among the groups in psychological stress and other lifestyle and psychosocial variables.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes uveitis."" The objective in question pertains to a study comparing cortisol levels, diurnal cycles, and reactivity in fibromyalgia (FM) and rheumatoid arthritis (RA) patients in their natural environment while accounting for differences in psychological stress and other lifestyle variables. Prednisolone is not mentioned in the objective, so there is no connection between this statement and the claim about Prednisolone causing uveitis.

         Uveitis is an inflammation of the uvea—the middle layer of the eye that consists mainly of the iris—which can be caused by various factors such as infections, autoimmune diseases, and certain medications like corticosteroids (including Prednisolone). However, in order for this statement to provide indirect support for ""Prednisolone causes uveitis,"" it would need to mention Prednisolone in relation to uveitis or eye inflammation in some way. Since it does not, we cannot infer any support for that claim from this objective statement alone."
25953223,Prednisolone causes kidney disorder,282,"OBJECTIVES: Recent data suggest that higher plasma cortisol may be associated with hypertension and insulin resistance in otherwise healthy men, as it is in Cushing's syndrome.",False,"Is the triple 'Prednisolone causes kidney disorder' supported by the sentence: 'OBJECTIVES: Recent data suggest that higher plasma cortisol may be associated with hypertension and insulin resistance in otherwise healthy men, as it is in Cushing's syndrome.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes kidney disorder."" The objective provided in the statement discusses the potential association between higher plasma cortisol levels and hypertension and insulin resistance in healthy men. While Prednisolone is a glucocorticoid that can increase cortisol levels in the body, it does not specifically mention any link between Prednisolone use and kidney disorders.

        To further clarify, Prednisolone is a synthetic glucocorticoid often used in treating various conditions such as inflammation, allergies, and autoimmune disorders. It is known that long-term use of glucocorticoids can lead to several side effects, including an increased risk for kidney issues like nephrotic syndrome in rare cases; however, the given statement does not provide any information about Prednisolone causing kidney disorders directly or indirectly.

        It is essential to base conclusions on strong evidence and direct connections between variables when interpreting statements in order to avoid overgeneralizations that may not be supported by available information."
21556285,Prednisolone causes allergic disease,283,"These findings demonstrate 2 types of adrenal insufficiency with different clinical pictures: Type 1 is characterized by cortisol deficiency with hypoglycaemia, low corticoid levels and a low cortisol secretion rate; Type 2 shows aldosterone deficiency with prominent salt loss.",False,"Is the triple 'Prednisolone causes allergic disease' supported by the sentence: 'These findings demonstrate 2 types of adrenal insufficiency with different clinical pictures: Type 1 is characterized by cortisol deficiency with hypoglycaemia, low corticoid levels and a low cortisol secretion rate; Type 2 shows aldosterone deficiency with prominent salt loss.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes allergic disease."" The statement discusses two types of adrenal insufficiency and their associated clinical pictures, but it does not mention or imply any connection to Prednisolone or allergic disease. Prednisolone is a synthetic glucocorticoid often used in treating various conditions such as inflammation, allergies, and autoimmune disorders by suppressing immune response. However, its usage does not inherently cause allergic disease; instead, it may have side effects that include increased susceptibility to infections or worsening existing infections due to its immunosuppressive properties."
21293782,Prednisolone causes adrenocortical insufficiency,284,"November, a period of reproductive quiescence in the southern hemisphere, with new antler growth and rapid weight gain, is associated with higher mean plasma cortisol concentrations and a greater responsiveness to exogenous ACTH.",False,"Is the triple 'Prednisolone causes adrenocortical insufficiency' supported by the sentence: 'November, a period of reproductive quiescence in the southern hemisphere, with new antler growth and rapid weight gain, is associated with higher mean plasma cortisol concentrations and a greater responsiveness to exogenous ACTH.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone causes adrenocortical insufficiency."" 

         The statement discusses seasonal variations in cortisol levels and ACTH responsiveness in reindeer, which is not related to Prednisolone or adrenocortical insufficiency in humans or animals. Prednisolone is a synthetic glucocorticoid often prescribed for its anti-inflammatory effects, while adrenocortical insufficiency refers to the inability of the adrenal glands to produce adequate amounts of corticosteroids, including cortisol. The provided statement does not contain any information linking Prednisolone use to adrenocortical insufficiency; therefore, it cannot be used as evidence supporting that claim."
20789636,Prednisolone causes ulcerative colitis,285,Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.,False,Is the triple 'Prednisolone causes ulcerative colitis' supported by the sentence: 'Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.'?,"No, the statement ""Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity"" does not provide indirect support for the claim that ""Prednisolone causes ulcerative colitis.""

         Prednisolone is a synthetic glucocorticoid drug often used in treating various inflammatory conditions such as ulcerative colitis (UC). Although it shares some mechanisms with cortisol (a natural glucocorticoid), Prednisolone is not cortisol but rather an analog designed to mimic cortisol's anti-inflammatory properties more potently and for an extended duration than cortisol itself.

         The provided statement discusses cortisol metabolism in human obesity, specifically an impaired cortisone-to-cortisol conversion in subjects with central adiposity (excess fat around their midsection). This observation is related to altered cortisol regulation in obesity but does not establish any direct link between Prednisolone use and ulcerative colitis development.

         While Prednisolone can lead to side effects"
17230021,Prednisolone causes Headache,286,The hypothalamic-pituitary-adrenal (HPA) axis is one of the key physiological systems that counterbalances this systemic inflammation through changes in adrenocorticotrophic hormone (ACTH) and cortisol.,False,Is the triple 'Prednisolone causes Headache' supported by the sentence: 'The hypothalamic-pituitary-adrenal (HPA) axis is one of the key physiological systems that counterbalances this systemic inflammation through changes in adrenocorticotrophic hormone (ACTH) and cortisol.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone causes Headache"". The initial statement discusses the hypothalamic-pituitary-adrenal (HPA) axis's role in counterbalancing systemic inflammation via alterations in adrenocorticotrophic hormone (ACTH) and cortisol levels. Prednisolone is a synthetic glucocorticoid that can mimic the effects of cortisol in the body, but it is not explicitly mentioned as causing headaches in the provided context.

         While it is true that glucocorticoids like prednisolone can have various side effects including headaches, it is important to rely on direct evidence when making such causal connections. The provided statement discusses the general function of the HPA axis in response to inflammation without mentioning prednisolone as a causative factor for headaches.

         In conclusion, although prednisolone may cause headaches as a side effect, the given statement does not offer any indirect support for that claim as it focuses on the HPA axis's counterbalancing effects on inflammation rather than prednisol"
16304261,Prednisolone causes nephrotic syndrome,287,"The 5 dpf hypoxic exposure also elicited transient increases in whole body cortisol and in crf, uts1, and hsd20b2 expression, key regulators of the endocrine stress response.",False,"Is the triple 'Prednisolone causes nephrotic syndrome' supported by the sentence: 'The 5 dpf hypoxic exposure also elicited transient increases in whole body cortisol and in crf, uts1, and hsd20b2 expression, key regulators of the endocrine stress response.'?","No, the statement does not provide direct or indirect support for the claim that Prednisolone causes nephrotic syndrome. The provided statement discusses the effects of hypoxic exposure on zebrafish larvae at 5 days post-fertilization (dpf), specifically in terms of cortisol levels and expression of certain stress response-related genes (crf, uts1, hsd20b2). While corticosteroids like Prednisolone have been linked to nephrotic syndrome in some cases, there is no mention in the statement of Prednisolone use, nephrotic syndrome occurrence, or even corticosteroid involvement in these observed changes in zebrafish larvae exposed to hypoxia. Therefore, it is not appropriate to draw such a connection based on this information alone."
15365269,Prednisolone causes infertility disorder,288,"At multiple regression analyses, HOMA-IR on admission in the IR group significantly correlated with thyroid-stimulating hormone, glucagon, and cortisol.",False,"Is the triple 'Prednisolone causes infertility disorder' supported by the sentence: 'At multiple regression analyses, HOMA-IR on admission in the IR group significantly correlated with thyroid-stimulating hormone, glucagon, and cortisol.'?","No, the statement does not provide direct or indirect support for the claim that Prednisolone causes infertility disorder. The provided statement discusses correlations between Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) on admission in an insulin resistant (IR) group with thyroid-stimulating hormone, glucagon, and cortisol levels. There is no mention of Prednisolone or any infertility disorders in the statement.

        To establish a connection between Prednisolone use and infertility disorder, additional evidence would be required, such as studies demonstrating that Prednisolone usage leads to increased rates of infertility disorder diagnoses or that Prednisolone has detrimental effects on reproductive hormones or organs. The provided statement does not contain any information that would suggest such connections exist."
14373522,Prednisolone causes exfoliative dermatitis,289,"The suppression of the anti-inflammatory effects of cortisol as a result of states of excessive stress leads to hypercatabolic diseases such as AIDS, sepsis and toxic shock syndrome and protein calorie malnutrition (NAIDS).",False,"Is the triple 'Prednisolone causes exfoliative dermatitis' supported by the sentence: 'The suppression of the anti-inflammatory effects of cortisol as a result of states of excessive stress leads to hypercatabolic diseases such as AIDS, sepsis and toxic shock syndrome and protein calorie malnutrition (NAIDS).'?","No, the statement does not provide indirect support for ""Prednisolone causes exfoliative dermatitis."" The statement discusses the suppression of anti-inflammatory effects of cortisol due to excessive stress leading to hypercatabolic diseases like AIDS, sepsis, toxic shock syndrome, and protein calorie malnutrition (NAIDS). Prednisolone is a synthetic glucocorticoid used for its anti-inflammatory and immunosuppressive effects in various medical conditions. Exfoliative dermatitis is one possible side effect; however, it is not mentioned in the statement provided nor is it linked to cortisol suppression due to excessive stress. Therefore, there is no indirect support for the claim that Prednisolone causes exfoliative dermatitis in this statement."
10735861,Prednisolone causes contact dermatitis,290,"The suppression of the anti-inflammatory effects of cortisol as a result of states of excessive stress leads to hypercatabolic diseases such as AIDS, sepsis and toxic shock syndrome and protein calorie malnutrition (NAIDS).",False,"Is the triple 'Prednisolone causes contact dermatitis' supported by the sentence: 'The suppression of the anti-inflammatory effects of cortisol as a result of states of excessive stress leads to hypercatabolic diseases such as AIDS, sepsis and toxic shock syndrome and protein calorie malnutrition (NAIDS).'?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes contact dermatitis."" The statement discusses the suppression of anti-inflammatory effects of cortisol due to excessive stress and its implications on certain diseases; however, Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in various conditions such as asthma, allergies, and autoimmune diseases. While Prednisolone can cause side effects like skin thinning and increased susceptibility to infections, contact dermatitis is not typically associated with its use.

        To provide indirect support for ""Prednisolone causes contact dermatitis,"" one would need evidence linking Prednisolone usage to contact dermatitis specifically. The statement given discusses cortisol suppression in relation to hypercatabolic diseases but does not mention Prednisolone-induced contact dermatitis."
10545904,Prednisolone causes pulmonary tuberculosis,291,"We report the case of a 41-year-old nonatopic women with a previous history of eczematous reaction due to hydrocortisone who suffered worsening of her perennial rhinitis in association with perinasal dermatitis from the use of budesonide in nasal spray form, and stomatitis and pharyngitis due to budesonide in a bronchial inhaler.",False,"Is the triple 'Prednisolone causes pulmonary tuberculosis' supported by the sentence: 'We report the case of a 41-year-old nonatopic women with a previous history of eczematous reaction due to hydrocortisone who suffered worsening of her perennial rhinitis in association with perinasal dermatitis from the use of budesonide in nasal spray form, and stomatitis and pharyngitis due to budesonide in a bronchial inhaler.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes pulmonary tuberculosis."" The case report describes an individual who experienced adverse reactions from using budesonide in different forms (nasal spray and bronchial inhaler), not prednisolone. Prednisolone is a synthetic glucocorticoid with anti-inflammatory properties commonly used in treating various conditions like allergies, asthma, and autoimmune disorders; it is not known to cause pulmonary tuberculosis. Pulmonary tuberculosis is primarily caused by Mycobacterium tuberculosis infection. Therefore, it is crucial not to draw misleading conclusions based on unrelated information."
10519611,Prednisolone causes colitis,292,"In this perspective paper, we focus on the neuro-endocrine interactions that occur between progesterone, allopregnanolone, and cortisol during pregnancy, and propose that they align with our previously proposed model of FM pathogenesis based on GABAergic ""weakening"" in a thalamocortical neural loop system.",False,"Is the triple 'Prednisolone causes colitis' supported by the sentence: 'In this perspective paper, we focus on the neuro-endocrine interactions that occur between progesterone, allopregnanolone, and cortisol during pregnancy, and propose that they align with our previously proposed model of FM pathogenesis based on GABAergic ""weakening"" in a thalamocortical neural loop system.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes colitis."" The statement focuses on neuro-endocrine interactions between progesterone, allopregnanolone, and cortisol during pregnancy, and their alignment with a proposed model of fibromyalgia (FM) pathogenesis based on GABAergic ""weakening"" in a thalamocortical neural loop system. Prednisolone is a synthetic glucocorticoid used for its anti-inflammatory effects and is unrelated to the neuro-endocrine interactions discussed in the statement.

         To further clarify, colitis is inflammation in the inner lining of the colon. While prednisolone can be used in treating inflammatory bowel disease (which includes colitis), it does not inherently cause colitis. Prednisolone's potential side effects do not include colitis development but rather may include increased appetite, mood changes, difficulty sleeping, acne, and more.

         In summary, the statement does not provide any support for the connection between prednisolone and colitis as it focuses on different subject matter entirely."
9464043,Prednisolone causes cataract,293,The present study reported a case of hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction due to allergic reaction.,False,Is the triple 'Prednisolone causes cataract' supported by the sentence: 'The present study reported a case of hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction due to allergic reaction.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone causes cataract."" Hydrocortisone and Prednisolone are both corticosteroids but they have different chemical structures, potencies, and side effect profiles. The statement only discusses hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction due to an allergic reaction; there is no mention of cataracts being induced by hydrocortisone in this case nor any reference made to prednisolone.

         To provide indirect support for ""Prednisolone causes cataract,"" there should be some connection between hydrocortisone-induced cataract development (or corticosteroid-induced cataract development in general) in the statement or literature cited; however, no such connection can be inferred here.

         Furthermore, while both hydrocortisone and prednisolone can cause cataracts as side effects in some individuals (especially at higher doses), it does not automatically mean that one corticosteroid is interchangeable with another in terms of side effects without considering specific factors like dosage, duration, patient profile"
8757881,Prednisolone causes systemic lupus erythematosus,294,Fetal adrenocorticotropic hormone and cortisol increased to peak values within 2.8 hours of induced hypoxia but by 7.2 hours had begun to fall to values that were not significantly different from those at 1.4 hours.,False,Is the triple 'Prednisolone causes systemic lupus erythematosus' supported by the sentence: 'Fetal adrenocorticotropic hormone and cortisol increased to peak values within 2.8 hours of induced hypoxia but by 7.2 hours had begun to fall to values that were not significantly different from those at 1.4 hours.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone causes systemic lupus erythematosus."" The statement discusses fetal adrenocorticotropic hormone (ACTH) and cortisol levels in response to hypoxia, which is unrelated to prednisolone administration or systemic lupus erythematosus (SLE). Prednisolone is a synthetic glucocorticoid used in various clinical settings for its anti-inflammatory effects, while SLE is an autoimmune disease characterized by chronic inflammation due to immune system dysfunction.

         The statement could potentially be used as evidence in discussions related to fetal stress response during hypoxia; however, it does not provide any relevant context for understanding how prednisolone might cause SLE. To establish such a link would require further evidence demonstrating how prednisolone administration might lead to increased susceptibility to SLE development or exacerbation."
27658451,Prednisolone affects uveitis,295,Congenital adrenal hyperplasia (CAH) is a chronic condition and individuals are exposed to elevated androgen levels in utero as a result of the endogenous cortisol deficiency.,False,Is the triple 'Prednisolone affects uveitis' supported by the sentence: 'Congenital adrenal hyperplasia (CAH) is a chronic condition and individuals are exposed to elevated androgen levels in utero as a result of the endogenous cortisol deficiency.'?,"No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects uveitis."" The provided statement discusses congenital adrenal hyperplasia (CAH), a chronic condition where individuals have elevated androgen levels due to endogenous cortisol deficiency during their fetal development. Prednisolone is a synthetic glucocorticoid often used in treating inflammatory conditions such as uveitis; however, there is no connection made between these two concepts in the given statement. In order to establish support for ""Prednisolone affects uveitis,"" there should be evidence linking prednisolone use to changes in uveitis symptoms or progression."
27410586,Prednisolone affects castration-resistant prostate carcinoma,296,The results of our study confirm that thymol has strong ameliorative effect against hydrocortisone-induced oxidative stress injury in hepatic tissues.,False,Is the triple 'Prednisolone affects castration-resistant prostate carcinoma' supported by the sentence: 'The results of our study confirm that thymol has strong ameliorative effect against hydrocortisone-induced oxidative stress injury in hepatic tissues.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone affects castration-resistant prostate carcinoma."" The study in question focuses on thymol's effects on hydrocortisone-induced oxidative stress injury in hepatic tissues, not prednisolone's impact on castration-resistant prostate carcinoma. Prednisolone is a glucocorticoid used in treating various medical conditions but is not mentioned in the provided statement; thus, no inferences can be made about its effects on castration-resistant prostate carcinoma based on this information alone."
27323391,Prednisolone affects focal segmental glomerulosclerosis,297,The effects of 8-bromo-cyclic AMP and cyclic AMP agonists (cholera toxin plus hydrocortisone and prostaglandin E2 plus 3-isobutyl-1-methylxanthine) on the cytotoxic activity of T cells generated during murine influenza virus infection have been examined.,False,Is the triple 'Prednisolone affects focal segmental glomerulosclerosis' supported by the sentence: 'The effects of 8-bromo-cyclic AMP and cyclic AMP agonists (cholera toxin plus hydrocortisone and prostaglandin E2 plus 3-isobutyl-1-methylxanthine) on the cytotoxic activity of T cells generated during murine influenza virus infection have been examined.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone affects focal segmental glomerulosclerosis."" The statement discusses the effects of certain agents on T cell cytotoxic activity during murine influenza virus infection in mice. Prednisolone is not mentioned in this statement, nor is focal segmental glomerulosclerosis (FSGS), a kidney disorder characterized by scarring in the glomeruli (the kidney's filtering units). Prednisolone is a corticosteroid often used in treating various kidney diseases, including FSGS; however, without explicit mention or evidence linking Prednisolone and FSGS in context, there is no basis for inferring support for that phrase in the given statement."
27042309,Prednisolone affects pulmonary eosinophilia,298,Open oral provocation with 100 or 250 mg hydrocortisone in patients with hydrocortisone contact hypersensitivity elicited cutaneous reactions at sites of previous allergic dermatitis caused by hydrocortisone in two patients and at sites of earlier allergic patch test reactions caused by hydrocortisone in the other two patients.,False,Is the triple 'Prednisolone affects pulmonary eosinophilia' supported by the sentence: 'Open oral provocation with 100 or 250 mg hydrocortisone in patients with hydrocortisone contact hypersensitivity elicited cutaneous reactions at sites of previous allergic dermatitis caused by hydrocortisone in two patients and at sites of earlier allergic patch test reactions caused by hydrocortisone in the other two patients.'?,"No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects pulmonary eosinophilia."" The statement discusses oral provocation tests in patients with hydrocortisone contact hypersensitivity, which is related to allergic reactions on the skin upon exposure to hydrocortisone. Prednisolone is a glucocorticoid medication primarily used for its anti-inflammatory effects in various conditions such as asthma, rheumatoid arthritis, inflammatory bowel disease, and other autoimmune disorders. Although both prednisolone and hydrocortisone belong to the glucocorticoid class, they have different therapeutic applications, and their effects on eosinophilia (an increase in eosinophils, a type of white blood cell) may vary based on the underlying condition being treated.

         In summary, while both compounds share some similarities as glucocorticoids, their specific effects on pulmonary eosinophilia cannot be inferred based on the provided statement about hydrocortisone contact hypersensitivity reactions in patients. Therefore, additional"
25790510,Prednisolone affects allergic disease,299,"Although initial studies in transgenic mice and humans are encouraging, more data are required to conclusively prove the hypothesis that the adipose-tissue-specific overexpression of HSD1 and the resultant increase in tissue-specific cortisol concentrations result in human obesity, insulin resistance, high blood pressure, and metabolic syndrome.",False,"Is the triple 'Prednisolone affects allergic disease' supported by the sentence: 'Although initial studies in transgenic mice and humans are encouraging, more data are required to conclusively prove the hypothesis that the adipose-tissue-specific overexpression of HSD1 and the resultant increase in tissue-specific cortisol concentrations result in human obesity, insulin resistance, high blood pressure, and metabolic syndrome.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects allergic disease."" The statement discusses the potential link between adipose-tissue-specific overexpression of HSD1 (11β-hydroxysteroid dehydrogenase type 1) and metabolic conditions such as obesity, insulin resistance, high blood pressure, and metabolic syndrome in humans. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects; it is not explicitly mentioned in the statement nor linked to allergic disease in any way.

         However, it is worth noting that glucocorticoids like prednisolone can have immunosuppressive effects that may influence allergic responses in humans. Nonetheless, based on the information provided in the statement alone, there is no foundation for asserting that prednisolone has an impact on allergic disease."
25165576,Prednisolone affects glomerulonephritis,300,"CONCLUSION: Although hydrocortisone has anti-inflammatory properties, it seems to provoke inflammation in the round window membrane after topical instillation.",False,"Is the triple 'Prednisolone affects glomerulonephritis' supported by the sentence: 'CONCLUSION: Although hydrocortisone has anti-inflammatory properties, it seems to provoke inflammation in the round window membrane after topical instillation.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects glomerulonephritis."" The conclusion in the statement discusses hydrocortisone's effects on the round window membrane after topical instillation, whereas glomerulonephritis is a kidney disease distinct from any effects on the ear. Prednisolone is a synthetic glucocorticoid like hydrocortisone but belongs to a different class of medications (long-acting vs short-acting), and their effects on various tissues might differ. Therefore, evidence about hydrocortisone's impact on one organ system does not necessarily imply similar effects for prednisolone in another organ system. To establish a connection between prednisolone and glomerulonephritis, direct evidence from studies focused on prednisolone and kidney function should be reviewed instead."
24270725,Prednisolone affects dermatomyositis,301,"Type 2 glucocorticoid receptors (GRs), which are occupied by cortisol in humans in times of stress, are thought to be responsible for the glucocorticoid-induced memory impairment.",False,"Is the triple 'Prednisolone affects dermatomyositis' supported by the sentence: 'Type 2 glucocorticoid receptors (GRs), which are occupied by cortisol in humans in times of stress, are thought to be responsible for the glucocorticoid-induced memory impairment.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects dermatomyositis."" The statement discusses type 2 glucocorticoid receptors (GRs) and their potential involvement in glucocorticoid-induced memory impairment in humans during times of stress, but it does not mention prednisolone nor dermatomyositis. Prednisolone is a synthetic glucocorticoid used for its anti-inflammatory effects in various conditions, including dermatomyositis, but there is no connection made in these statements. To provide indirect support for ""Prednisolone affects dermatomyositis,"" there would need to be some mention of prednisolone's effects on inflammation, autoimmune disorders, or dermatomyositis specifically."
22922261,Prednisolone affects allergic bronchopulmonary aspergillosis,302,"Firstly, the GH-mediated increase in cortisol metabolism (mediated via reduced E to F conversion) may precipitate adrenal insufficiency in hypopituitary patients with partial adrenocorticotropic hormone deficiency commencing GH therapy.",False,"Is the triple 'Prednisolone affects allergic bronchopulmonary aspergillosis' supported by the sentence: 'Firstly, the GH-mediated increase in cortisol metabolism (mediated via reduced E to F conversion) may precipitate adrenal insufficiency in hypopituitary patients with partial adrenocorticotropic hormone deficiency commencing GH therapy.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects allergic bronchopulmonary aspergillosis."" The statement discusses the potential impact of growth hormone (GH) therapy on cortisol metabolism in hypopituitary patients with partial adrenocorticotropic hormone deficiency. While it is true that cortisol metabolism may be affected by GH therapy, there is no mention or implication of prednisolone or allergic bronchopulmonary aspergillosis in the statement provided. Prednisolone is a corticosteroid medication commonly used for treating various conditions such as allergies, asthma, and autoimmune disorders; however, its relationship to allergic bronchopulmonary aspergillosis is not mentioned in the statement. Therefore, additional evidence would be required to establish a connection between prednisolone and allergic bronchopulmonary aspergillosis."
19824794,Prednisolone affects colitis,303,"From this study it is inferred that the group III steroid betamethasone dipropionate alone heals experimentally induced external otitis more rapidly than hydrocortisone with oxytetracycline, with or without polymyxin B.",False,"Is the triple 'Prednisolone affects colitis' supported by the sentence: 'From this study it is inferred that the group III steroid betamethasone dipropionate alone heals experimentally induced external otitis more rapidly than hydrocortisone with oxytetracycline, with or without polymyxin B.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects colitis."" The study referenced investigates the effects of betamethasone dipropionate (a group III steroid) on external otitis, compared to hydrocortisone with oxytetracycline (with/without polymyxin B). Prednisolone is not mentioned in the statement; therefore, it does not contribute to our understanding of Prednisolone's impact on colitis.

         To provide indirect support for ""Prednisolone affects colitis,"" we would need evidence that establishes a connection between Prednisolone and colitis, such as an experimental study investigating Prednisolone's effects on colitis in vivo or in vitro. The current statement focuses on different steroids and external otitis; thus, it does not contribute relevant information regarding Prednisolone's potential impact on colitis."
19409335,Prednisolone affects sarcoidosis,304,"In conclusion, the reciprocal expression of CYP17 and the transcriptional repressors COUP-TF and DAX-1 indicates that these orphan receptors have a pathophysiologic role in the excessive hormone production in cortisol- and deoxycorticosterone-producing adrenocortical tumors.",False,"Is the triple 'Prednisolone affects sarcoidosis' supported by the sentence: 'In conclusion, the reciprocal expression of CYP17 and the transcriptional repressors COUP-TF and DAX-1 indicates that these orphan receptors have a pathophysiologic role in the excessive hormone production in cortisol- and deoxycorticosterone-producing adrenocortical tumors.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects sarcoidosis."" The conclusion in the statement is about the pathophysiologic role of CYP17 and transcriptional repressors COUP-TF and DAX-1 in cortisol- and deoxycorticosterone-producing adrenocortical tumors. Prednisolone is a synthetic glucocorticoid used in various inflammatory conditions but is not mentioned in the statement nor implied in its conclusions. Sarcoidosis is an inflammatory disease characterized by noncaseating granulomas in multiple organs; however, it is not mentioned in the statement either. Therefore, there is no connection between Prednisolone and sarcoidosis based on the provided information."
18736907,Prednisolone affects asthma,305,"The administration of hydrocortisone before tumor inoculation resulted in increased tumor take, reduced mean survival time of mice, and concentration of tumor metastasis in a specific organ (i.e., lung metastasis for Ehrlich hypotetraploid clone 1 tumor, and liver metastasis for Ehrlich hypotetraploid stock and Ehrlich hyperdiploid stock tumors).",False,"Is the triple 'Prednisolone affects asthma' supported by the sentence: 'The administration of hydrocortisone before tumor inoculation resulted in increased tumor take, reduced mean survival time of mice, and concentration of tumor metastasis in a specific organ (i.e., lung metastasis for Ehrlich hypotetraploid clone 1 tumor, and liver metastasis for Ehrlich hypotetraploid stock and Ehrlich hyperdiploid stock tumors).'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects asthma."" The statement discusses the effects of hydrocortisone on tumor growth in mice, whereas prednisolone is a different glucocorticoid that has more commonly been studied for its anti-inflammatory effects in asthma treatment. Although both prednisolone and hydrocortisone belong to the same class of steroid hormones (glucocorticoids), they may not have identical effects on all conditions due to differences in their pharmacological properties such as potency, duration of action, and metabolism. Therefore, it is not valid to infer that hydrocortisone's effect on tumor growth would translate into prednisolone affecting asthma based on this statement alone."
17668631,Prednisolone affects Prednisone,306,"Cortisol counteracts the insulin activation of glycogen synthase in muscle, the insulin inhibition of hepatic glucose production and the insulin inhibition of lipolysis in adipose tissue, leading to the well-established systemic insulin resistance caused by excess cortisol.",False,"Is the triple 'Prednisolone affects Prednisone' supported by the sentence: 'Cortisol counteracts the insulin activation of glycogen synthase in muscle, the insulin inhibition of hepatic glucose production and the insulin inhibition of lipolysis in adipose tissue, leading to the well-established systemic insulin resistance caused by excess cortisol.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects Prednisone."" The statement discusses how cortisol interacts with insulin in various tissues in the body. Prednisolone and Prednisone are both synthetic glucocorticoids (a type of corticosteroid) that have similar effects on metabolism as cortisol; however, they do not interact directly with each other in terms of their pharmacological actions.

         To further clarify, Prednisone is a prodrug that gets converted into Prednisolone in the liver after it is absorbed by the body. Both compounds share similar mechanisms of action due to their glucocorticoid properties but do not have any direct pharmacological interactions between them that would affect their actions in the body.

         In summary, while both Prednisolone and Prednisone share similar effects on metabolism as cortisol, there is no indirect support provided by the statement for Prednisolone affecting Prednisone based on their shared glucocorticoid properties alone."
15888410,Prednisolone affects rheumatoid arthritis,307,"The amount of N-acetyl D-glucosamine in the zymogen granule membrane was not altered by caerulein acute pancreatitis induced under continuous hydrocortisone treatment, but it was decreased by the administration of L-364,718 over 7 days after pancreatitis induction.",False,"Is the triple 'Prednisolone affects rheumatoid arthritis' supported by the sentence: 'The amount of N-acetyl D-glucosamine in the zymogen granule membrane was not altered by caerulein acute pancreatitis induced under continuous hydrocortisone treatment, but it was decreased by the administration of L-364,718 over 7 days after pancreatitis induction.'?","No, the statement does not provide indirect support for the claim that ""Prednisolone affects rheumatoid arthritis."" The statement focuses on the effects of hydrocortisone on N-acetyl D-glucosamine levels in zymogen granule membranes under caerulein acute pancreatitis conditions, without mentioning Prednisolone or rheumatoid arthritis at all. Prednisolone is a synthetic glucocorticoid often used in treating rheumatoid arthritis; however, since there is no connection between Prednisolone, rheumatoid arthritis, or hydrocortisone in the provided information, no indirect support can be inferred from it regarding Prednisolone affecting rheumatoid arthritis."
13564625,Prednisolone affects asthma,308,False elevation of plasma cortisol in congenital adrenal hyperplasia.,False,Is the triple 'Prednisolone affects asthma' supported by the sentence: 'False elevation of plasma cortisol in congenital adrenal hyperplasia.'?,"No, the statement ""False elevation of plasma cortisol in congenital adrenal hyperplasia"" does not provide indirect support for the claim that ""Prednisolone affects asthma.""

         Prednisolone is a synthetic glucocorticoid often used in treating asthma due to its anti-inflammatory properties that help manage asthma symptoms (Barnes, 2016). However, congenital adrenal hyperplasia (CAH) is a genetic disorder causing impaired cortisol production in which there is an overproduction of adrenal steroid precursors leading to increased levels of plasma cortisol (Speiser et al., 2018).

         Although both asthma and CAH involve cortisol in some capacity, these two phenomena are not connected in a way that would provide indirect support for Prednisolone affecting asthma based on the given statement about CAH. In fact, Prednisolone would likely be prescribed in CAH cases as an exogenous source of cortisol (Speiser et al., 2018).

         To provide indirect support for Pred"
13234063,Prednisolone affects pericarditis,309,Further studies evaluating the mechanism of action and long term effects of hydrocortisone in cardiac arrest need to be conducted.,False,Is the triple 'Prednisolone affects pericarditis' supported by the sentence: 'Further studies evaluating the mechanism of action and long term effects of hydrocortisone in cardiac arrest need to be conducted.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone affects pericarditis."" The statement discusses further studies on hydrocortisone in cardiac arrest, which is unrelated to prednisolone and pericarditis. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects, whereas pericarditis is an inflammation of the tissue surrounding the heart. Although prednisolone could theoretically be used off-label for treating pericarditis based on its anti-inflammatory properties, there is no mention of that in the given statement."
13029310,Prednisolone affects chronic obstructive pulmonary disease,310,"In acute MI, there were elevated plasma levels of cortisol depending on the MI severity with a small repeated peak of its increase on day 14 and its subsequent decrease, except deaths.",False,"Is the triple 'Prednisolone affects chronic obstructive pulmonary disease' supported by the sentence: 'In acute MI, there were elevated plasma levels of cortisol depending on the MI severity with a small repeated peak of its increase on day 14 and its subsequent decrease, except deaths.'?","No, the statement does not provide direct or indirect support for the claim that prednisolone affects chronic obstructive pulmonary disease (COPD). The statement discusses the relationship between acute myocardial infarction (MI) severity and plasma cortisol levels, but it does not mention prednisolone or COPD at all. Prednisolone is a synthetic glucocorticoid often used in treating inflammatory diseases such as COPD, but no evidence is presented in the statement that connects prednisolone with COPD or its effects on it. Therefore, further investigation is needed to establish any relationship between prednisolone and COPD."
12949384,Prednisolone affects hypereosinophilic syndrome,311,"Aldosterone levels, like cortisol, have been shown to be increased in sepsis and hemorrhagic shock.",False,"Is the triple 'Prednisolone affects hypereosinophilic syndrome' supported by the sentence: 'Aldosterone levels, like cortisol, have been shown to be increased in sepsis and hemorrhagic shock.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects hypereosinophilic syndrome"". The connection between aldosterone levels in sepsis and hemorrhagic shock and prednisolone's impact on hypereosinophilic syndrome is too tenuous. Prednisolone is a glucocorticoid that can modulate immune responses; however, its direct relationship to aldosterone (a mineralocorticoid) is not explicitly stated in the given information. Additionally, hypereosinophilic syndrome is characterized by an elevated number of eosinophils in the bloodstream, which is not addressed in either statement."
12057849,Prednisolone affects Crohn disease,312,"In this review, we summarize the effects of circadian melatonin, TSH, and cortisol on OA, focusing on how different levels of these hormones affect OA pathogenesis and recovery with respect to the circadian clock.",False,"Is the triple 'Prednisolone affects Crohn disease' supported by the sentence: 'In this review, we summarize the effects of circadian melatonin, TSH, and cortisol on OA, focusing on how different levels of these hormones affect OA pathogenesis and recovery with respect to the circadian clock.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects Crohn disease."" The review focuses on the effects of circadian melatonin, TSH (thyroid-stimulating hormone), and cortisol on osteoarthritis (OA), not Crohn disease. Although cortisol is mentioned, no specific claim about Prednisolone (a synthetic glucocorticoid used to treat Crohn disease) is made in relation to Crohn disease in the statement provided.

        
        However, it is important to note that both cortisol and Prednisolone have anti-inflammatory properties and can be used in treating inflammatory bowel diseases like Crohn disease; still, this review does not discuss Prednisolone in relation to Crohn disease specifically. Therefore, additional evidence would be required to establish whether Prednisolone affects Crohn disease."
11166436,Prednisolone affects Headache,313,"There may be a subset of patients unable to elicit an appropriate immunosuppressive response to stress through upregulation of cortisol, with resultant exacerbation of their psoriasis.",False,"Is the triple 'Prednisolone affects Headache' supported by the sentence: 'There may be a subset of patients unable to elicit an appropriate immunosuppressive response to stress through upregulation of cortisol, with resultant exacerbation of their psoriasis.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects Headache."" The statement discusses a subset of patients who may have an inappropriate immunosuppressive response to stress due to impaired cortisol upregulation, leading to exacerbated psoriasis. Prednisolone is a synthetic glucocorticoid often used for its anti-inflammatory effects in various conditions, such as psoriasis; however, there is no mention of headaches in relation to Prednisolone in the statement provided."
11074135,Prednisolone affects lymphoma,314,"In addition to local effect, topical hydrocortisone therapy of childhood dermatitis is accompanied by a systemic effect that may be pronounced in the acute phase of disease.",False,"Is the triple 'Prednisolone affects lymphoma' supported by the sentence: 'In addition to local effect, topical hydrocortisone therapy of childhood dermatitis is accompanied by a systemic effect that may be pronounced in the acute phase of disease.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects lymphoma."" The statement discusses the systemic effect of topical hydrocortisone therapy in childhood dermatitis, which may be pronounced during the acute phase of disease. Prednisolone is a synthetic glucocorticoid similar to hydrocortisone but structurally different; they have overlapping but distinct effects on various biological processes. Lymphoma is a type of cancer involving lymphatic cells; thus, there is no explicit connection between topical hydrocortisone therapy, Prednisolone, and lymphoma in this statement."
10651502,Prednisolone affects kidney disorder,315,"They answered the Fibromyalgia Impact Questionnaire (FIQ), Perceived Stress Questionnaire (PSQ) and McGill Pain Questionnaire (MPQ-Br), and collected saliva to evaluate CC before and after the end of each month.",False,"Is the triple 'Prednisolone affects kidney disorder' supported by the sentence: 'They answered the Fibromyalgia Impact Questionnaire (FIQ), Perceived Stress Questionnaire (PSQ) and McGill Pain Questionnaire (MPQ-Br), and collected saliva to evaluate CC before and after the end of each month.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects kidney disorder"". The provided statement discusses participants answering questionnaires related to fibromyalgia impact, perceived stress, and pain assessment (FIQ, PSQ, MPQ-Br), as well as collecting saliva samples for cortisol evaluation (CC) before and after each month. However, there is no mention of prednisolone use, kidney disorder, or any relationship between them in this context."
10649036,Prednisolone affects chorioretinitis,316,"BACKGROUND: The hypothalamic-pituitary-adrenal stress axis plays a crucial role in community-acquired pneumonia (CAP), with high cortisol being associated with disease severity and corticosteroid treatment resulting in earlier time to recovery.",True,"Is the triple 'Prednisolone affects chorioretinitis' supported by the sentence: 'BACKGROUND: The hypothalamic-pituitary-adrenal stress axis plays a crucial role in community-acquired pneumonia (CAP), with high cortisol being associated with disease severity and corticosteroid treatment resulting in earlier time to recovery.'?","Yes, there is indirect support for the statement ""Prednisolone affects chorioretinitis"" from the provided background information on community-acquired pneumonia (CAP) and corticosteroid treatment.

        
        Prednisolone is a synthetic glucocorticoid, which is part of the hypothalamic-pituitary-adrenal (HPA) stress axis mentioned in the background information. Inflammation in CAP can activate the HPA axis, leading to increased cortisol levels that have been associated with disease severity in CAP patients. Corticosteroid treatment, like Prednisolone, can modulate the immune response in CAP patients by suppressing inflammation, which may contribute to earlier recovery times.

        
        Although chorioretinitis is not explicitly mentioned in the background information, it is an inflammatory condition affecting the eye that can be influenced by glucocorticoids like Prednisolone. In fact, Prednisolone is often used off-label in ophthalmology due to its anti-inflammatory properties for treating various inflammatory eye conditions like chorioret"
10555139,Prednisolone affects peptic ulcer disease,317,"The incidence of AF was compared among patients who received hydrocortisone, and the effect of low-dose hydrocortisone on AF was estimated using the inverse probability treatment weighting method based on propensity scores.",False,"Is the triple 'Prednisolone affects peptic ulcer disease' supported by the sentence: 'The incidence of AF was compared among patients who received hydrocortisone, and the effect of low-dose hydrocortisone on AF was estimated using the inverse probability treatment weighting method based on propensity scores.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects peptic ulcer disease."" The statement discusses a study comparing the incidence of atrial fibrillation (AF) between patients who received hydrocortisone, estimating the effect of low-dose hydrocortisone on AF using propensity scores. Prednisolone is not mentioned in the statement, nor is there any connection made between hydrocortisone (or prednisolone) and peptic ulcer disease. Therefore, it is not possible to draw any conclusions about prednisolone's effect on peptic ulcer disease based on this statement alone."
10183156,Prednisolone affects ulcerative colitis,318,"INTRODUCTION: Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system involvement in leukemias and lymphomas.",False,"Is the triple 'Prednisolone affects ulcerative colitis' supported by the sentence: 'INTRODUCTION: Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system involvement in leukemias and lymphomas.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects ulcerative colitis."" The introduction mentions intrathecal administration of methotrexate, cytarabine, and hydrocortisone for treating central nervous system involvement in leukemias and lymphomas. Although hydrocortisone is a type of corticosteroid like prednisolone, it is administered intrathecally in this context, which is different from treating ulcerative colitis. Ulcerative colitis is typically treated with corticosteroids like prednisolone that are administered systemically (orally or rectally) rather than intrathecally. Therefore, there is no implicit connection between hydrocortisone use in leukemias/lymphomas treatment and prednisolone affecting ulcerative colitis."
9735520,Prednisolone affects Inflammation,319,"INTRODUCTION: Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system involvement in leukemias and lymphomas.",False,"Is the triple 'Prednisolone affects Inflammation' supported by the sentence: 'INTRODUCTION: Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system involvement in leukemias and lymphomas.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects Inflammation."" The introductory statement discusses the use of methotrexate, cytarabine, and hydrocortisone in treating central nervous system involvement in leukemias and lymphomas. Hydrocortisone is a type of corticosteroid, similar to prednisolone, but it does not necessarily imply that prednisolone has an effect on inflammation. To establish a connection between prednisolone and inflammation, specific studies or evidence focusing on prednisolone would be required."
9361682,Prednisolone affects osteoarthritis,320,"CONCLUSIONS: Early PN did not affect plasma concentrations of ACTH and (free) cortisol, but increased the incidence of septic shock, which statistically explained why more patients on early PN received corticosteroids.",False,"Is the triple 'Prednisolone affects osteoarthritis' supported by the sentence: 'CONCLUSIONS: Early PN did not affect plasma concentrations of ACTH and (free) cortisol, but increased the incidence of septic shock, which statistically explained why more patients on early PN received corticosteroids.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects osteoarthritis."" The conclusion is about early parenteral nutrition (PN) impacting plasma concentrations of adrenocorticotropic hormone (ACTH) and cortisol, as well as its association with an increased incidence of septic shock leading to more corticosteroid usage in patients. Corticosteroids include glucocorticoids like prednisolone; however, there is no mention of osteoarthritis in this conclusion. Therefore, it does not provide any evidence for prednisolone's effect on osteoarthritis."
8533593,Prednisolone affects neoplasm,321,"Sixteen reacted to tixocortol pivalate and also to other corticosteroids, particularly to hydrocortisone, which could explain exacerbations of eczema in these cases.",False,"Is the triple 'Prednisolone affects neoplasm' supported by the sentence: 'Sixteen reacted to tixocortol pivalate and also to other corticosteroids, particularly to hydrocortisone, which could explain exacerbations of eczema in these cases.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects neoplasm."" The statement discusses patients who reacted to tixocortol pivalate and other corticosteroids such as hydrocortisone, possibly explaining eczema exacerbations in those cases. Prednisolone is not mentioned in the statement; therefore, it does not contribute any evidence regarding Prednisolone's effect on neoplasm.

         Neoplasm refers to an abnormal growth of cells, which could be benign or malignant. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in various conditions like asthma, rheumatoid arthritis, and dermatological diseases. Although some studies suggest that glucocorticoids might have an impact on cancer progression, there is no information in the provided statement that would allow us to draw any conclusions about Prednisolone affecting neoplasm."
7800426,Prednisolone affects acute lymphoblastic leukemia,322,"Finally, transient pre-treatment of healthy humans with cortisol induces a bi-phasic response during a later, delayed systemic inflammatory response: an intermediate cortisol concentration augments inflammation while a high cortisol concentration is neither pro- nor anti-inflammatory.",False,"Is the triple 'Prednisolone affects acute lymphoblastic leukemia' supported by the sentence: 'Finally, transient pre-treatment of healthy humans with cortisol induces a bi-phasic response during a later, delayed systemic inflammatory response: an intermediate cortisol concentration augments inflammation while a high cortisol concentration is neither pro- nor anti-inflammatory.'?","No, the statement does not provide direct support for the claim that prednisolone affects acute lymphoblastic leukemia (ALL). The statement discusses the effects of cortisol on inflammation in healthy humans, while the initial claim pertains to prednisolone (a synthetic glucocorticoid similar to cortisol) impacting ALL, which is a specific type of cancer.

        
        However, there is indirect relevance as both cortisol and prednisolone belong to the glucocorticoid family known for their anti-inflammatory properties and potential use in treating cancer due to their ability to suppress immune responses. 

        
        Yet, without explicit evidence linking prednisolone treatment to changes in ALL progression, it is not possible to definitively assert that prednisolone has an impact on ALL based on the provided statement alone. Additional information would be required for such an assessment, such as studies examining prednisolone treatment in ALL patients and related outcomes."
7395227,Prednisolone affects systemic lupus erythematosus,323,"Adrenaline induces the early posthypoglycaemic insulin resistance, whereas cortisol and growth hormone are important for the insulin resistance that is observed later following hypoglycaemia.",False,"Is the triple 'Prednisolone affects systemic lupus erythematosus' supported by the sentence: 'Adrenaline induces the early posthypoglycaemic insulin resistance, whereas cortisol and growth hormone are important for the insulin resistance that is observed later following hypoglycaemia.'?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects systemic lupus erythematosus"". The statement discusses adrenaline-induced early posthypoglycaemic insulin resistance and cortisol-associated insulin resistance at later stages following hypoglycaemia. Prednisolone is not mentioned in the statement; moreover, it is not related to adrenaline, cortisol, insulin resistance, or hypoglycaemia in any direct manner that would warrant an inference towards systemic lupus erythematosus (SLE).

        

        Prednisolone is a synthetic glucocorticoid used for treating various inflammatory diseases including SLE due to its immunosuppressive properties; however, no evidence is presented in the statement that connects prednisolone or glucocorticoids in general to insulin resistance or hypoglycaemia-related outcomes discussed in the statement.

        

        Therefore, while it is important for scientists and clinicians to make connections between different areas in biology when"
21722189,Prednisolone affects Prednisone,324,"RESULTS: Within 24 hours following TBI, the concentrations of total cortisol, ACTH and gastrin increased proportionally to the severity of injury, especially significant in the experimental group (P less than 0.05).",False,"Is the triple 'Prednisolone affects Prednisone' supported by the sentence: 'RESULTS: Within 24 hours following TBI, the concentrations of total cortisol, ACTH and gastrin increased proportionally to the severity of injury, especially significant in the experimental group (P less than 0.05).'?","No, the statement does not provide any direct or indirect support for the phrase ""Prednisolone affects Prednisone."" The statement discusses the effects of traumatic brain injury (TBI) on cortisol, ACTH (adrenocorticotropic hormone), and gastrin levels in an experimental group compared to a control group. Prednisolone and Prednisone are both corticosteroids used as anti-inflammatory agents; however, there is no mention of either in the provided statement.

         To establish whether Prednisolone affects Prednisone, we would need evidence from studies specifically investigating their interaction in biological systems. This could include in vitro experiments, animal model studies, or clinical trials that administer both drugs simultaneously and analyze their effects on various physiological markers, such as cortisol levels.

         In summary, while it is possible that Prednisolone may influence Prednisone metabolism or effects in some contexts, the given statement does not offer any information regarding their interaction."
9655099,Prednisolone has input Prednisone,325,NEW OR UNIQUE INFORMATION PROVIDED: This case is the first published report of hydrocortisone-responsive hypotension and transient CIRCI associated with naturally occurring septic shock in a dog.,False,Is the triple 'Prednisolone has input Prednisone' supported by the sentence: 'NEW OR UNIQUE INFORMATION PROVIDED: This case is the first published report of hydrocortisone-responsive hypotension and transient CIRCI associated with naturally occurring septic shock in a dog.'?,"No, the phrase ""Prednisolone has input Prednisone"" does not receive at least indirect support from the statement provided. The statement discusses a case report of hydrocortisone-responsive hypotension and transient CIRCI (Critical Illness-Related Corticosteroid Insufficiency) associated with naturally occurring septic shock in a dog. It does not mention Prednisolone or its relationship with Prednisone.

        Prednisolone and Prednisone are both corticosteroids used for their anti-inflammatory and immunosuppressive effects. Prednisone is metabolized into Prednisolone in the liver after oral administration. Therefore, while they have similar effects and one can be converted into the other in the body, the statement provided does not offer any support for their relationship in this context.

        In order to establish indirect support for the phrase ""Prednisolone has input Prednisone,"" there would need to be some connection made in the text between hydrocortisone (or another corticosteroid), Prednisolone, Prednisone, or their metabolic pathways. As no such connection"
27206106,Prednisolone disrupts uveitis,326,Several types of the congenital adrenal hyperplasias are associated with decreased cortisol production and excessive adrenal sex steroid secretion.,False,Is the triple 'Prednisolone disrupts uveitis' supported by the sentence: 'Several types of the congenital adrenal hyperplasias are associated with decreased cortisol production and excessive adrenal sex steroid secretion.'?,"No, the statement does not provide direct or indirect support for the phrase ""Prednisolone disrupts uveitis."" The association between certain types of congenital adrenal hyperplasias and decreased cortisol production and excessive adrenal sex steroid secretion does not inherently imply that Prednisolone, a synthetic glucocorticoid often used to treat uveitis, disrupts uveitis. A more direct link between Prednisolone and uveitis would be needed to establish support for that claim. However, it is important to note that Prednisolone is indeed used as an anti-inflammatory agent in treating uveitis due to its ability to suppress immune response, which could potentially disrupt uveitis symptoms indirectly."
26515767,Prednisolone disrupts neoplasm,327,[Use of cryo-apheresis in the treatment of patients with cortisol-dependent bronchial asthma].,False,Is the triple 'Prednisolone disrupts neoplasm' supported by the sentence: '[Use of cryo-apheresis in the treatment of patients with cortisol-dependent bronchial asthma].'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone disrupts neoplasm."" The statement discusses cryo-apheresis in the treatment of cortisol-dependent bronchial asthma patients, but it does not mention Prednisolone or its potential effects on neoplasms (abnormal tissue growths that can lead to cancer). Prednisolone is a synthetic glucocorticoid often used for its anti-inflammatory effects in various conditions such as asthma, allergies, and arthritis; however, its potential impact on neoplasm is not addressed in this context. To establish indirect support for Prednisolone disrupting neoplasm, additional evidence connecting Prednisolone use and effects on neoplasm would be required."
26379811,Prednisolone disrupts contact dermatitis,328,Hypotension after recruitment was reduced by HC (0 vs. 30%).,False,Is the triple 'Prednisolone disrupts contact dermatitis' supported by the sentence: 'Hypotension after recruitment was reduced by HC (0 vs. 30%).'?,"No, the statement ""Hypotension after recruitment was reduced by HC (0 vs. 30%)"" does not provide indirect support for the phrase ""Prednisolone disrupts contact dermatitis."" The two statements discuss different medical conditions (hypotension vs contact dermatitis) and treatments (HC vs Prednisolone). Therefore, there is no logical connection between them that would allow for indirect support."
25763558,Prednisolone disrupts pneumonia,329,Fetal plasma cortisol concentrations were increased ( P < 0.05) during all levels of hypoxia.,False,Is the triple 'Prednisolone disrupts pneumonia' supported by the sentence: 'Fetal plasma cortisol concentrations were increased ( P < 0.05) during all levels of hypoxia.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone disrupts pneumonia."" The statement discusses an increase in fetal plasma cortisol concentrations during hypoxia, but it does not mention prednisolone or pneumonia. Prednisolone is a synthetic glucocorticoid often used in treating inflammatory diseases, while pneumonia is an infection that inflames air sacs in one or both lungs. Although prednisolone can affect immune response and potentially influence susceptibility to infections like pneumonia by modulating cortisol levels, this specific statement does not offer any evidence or implications in that regard."
25233555,Prednisolone disrupts allergic disease,330,"INTRA-CELL CORTISOL: Attention is also focused on the potential implication of cortisol in the genesis of metabolic syndrome, because cortisol is a potent antagonist of the effect of insulin and its presence in excess enhances visceral obesity and insulin resistance.",False,"Is the triple 'Prednisolone disrupts allergic disease' supported by the sentence: 'INTRA-CELL CORTISOL: Attention is also focused on the potential implication of cortisol in the genesis of metabolic syndrome, because cortisol is a potent antagonist of the effect of insulin and its presence in excess enhances visceral obesity and insulin resistance.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone disrupts allergic disease"". The passage discusses cortisol's potential role in metabolic syndrome development by antagonizing insulin effects, leading to visceral obesity and insulin resistance. Prednisolone is a synthetic glucocorticoid that shares structural similarities with cortisol and can mimic its functions in the body; however, it does not specifically mention any connection between cortisol (or prednisolone) and allergic disease disruption.

         Prednisolone is indeed used in treating various allergic conditions due to its potent anti-inflammatory effects; however, that relationship is not suggested in the provided statement. Therefore, additional context or evidence would be required to establish any indirect link between prednisolone disruption of allergic disease from the statement provided."
14331279,Prednisolone disrupts hypereosinophilic syndrome,331,The effect of hydrocortisone on standardized skin-surface trauma.,False,Is the triple 'Prednisolone disrupts hypereosinophilic syndrome' supported by the sentence: 'The effect of hydrocortisone on standardized skin-surface trauma.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone disrupts hypereosinophilic syndrome"". 

        The statement ""The effect of hydrocortisone on standardized skin-surface trauma"" discusses the impact of hydrocortisone on skin-surface trauma, which is not related to hypereosinophilic syndrome (HES) - a group of disorders characterized by an increased number of eosinophils in the bloodstream and bone marrow. Prednisolone and hydrocortisone belong to the class of corticosteroids but have different therapeutic properties due to their unique chemical structures and pharmacokinetics; thus, evidence about hydrocortisone cannot be reliably extrapolated to support a claim about prednisolone in HES context.

        It is important to base conclusions on direct evidence that specifically investigates prednisolone in hypereosinophilic syndrome models or patients to ensure accurate interpretation and avoid drawing potentially misleading conclusions based on indirect associations or assumptions about shared mechanisms between different corticosteroids in various clinical contexts."
10594561,Prednisolone disrupts asthma,332,The action of hydrocortisone in synovial inflammation.,False,Is the triple 'Prednisolone disrupts asthma' supported by the sentence: 'The action of hydrocortisone in synovial inflammation.'?,"No, the statement ""The action of hydrocortisone in synovial inflammation"" does not provide indirect support for the phrase ""Prednisolone disrupts asthma."" This is because hydrocortisone and prednisolone are two different types of corticosteroids that have distinct mechanisms of action, even though they belong to the same class of drugs. Hydrocortisone is primarily used as an anti-inflammatory agent for treating conditions like synovial inflammation, while prednisolone is often prescribed for managing asthma symptoms due to its potent glucocorticoid activity in reducing airway inflammation and hyperresponsiveness.

         Although both drugs share some similarities in their anti-inflammatory effects, they have different therapeutic applications because they target specific inflammatory pathways depending on the condition being treated. Therefore, it is essential to evaluate each drug based on its unique properties and pharmacological actions rather than making generalizations about corticosteroid classes as a whole.

         In summary, while hydrocortisone may have some impact on inflammation in certain contexts, it does not provide indirect"
8854473,Prednisolone disrupts Inflammation,333,"The effects of stressful life events, coping, and cortisol on HIV infection.",False,"Is the triple 'Prednisolone disrupts Inflammation' supported by the sentence: 'The effects of stressful life events, coping, and cortisol on HIV infection.'?","No, the statement ""The effects of stressful life events, coping, and cortisol on HIV infection"" does not provide direct or indirect support for the phrase ""Prednisolone disrupts Inflammation."" 

        

        The statement discusses the relationship between stressful life events, coping mechanisms, cortisol (a stress hormone), and HIV infection. While Prednisolone is a synthetic glucocorticoid (a class of steroid hormones that includes cortisol) used to suppress inflammation, there is no explicit connection made between prednisolone and inflammation disruption in this statement. 

        

        To provide indirect support for ""Prednisolone disrupts Inflammation,"" there would need to be some mention of prednisolone or glucocorticoids in general affecting inflammation or immune response in some capacity, which is not present in this statement."
27646185,Prednisolone prevents allergic disease,334,"Immunologic and hemodynamic effects of ""low-dose"" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.",False,"Is the triple 'Prednisolone prevents allergic disease' supported by the sentence: 'Immunologic and hemodynamic effects of ""low-dose"" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents allergic disease."" The study referenced is focused on examining the immunologic and hemodynamic effects of low-dose hydrocortisone in septic shock, not on allergic disease or prednisolone use. Prednisolone is a synthetic glucocorticoid often used in treating various inflammatory and autoimmune conditions; however, its effects on allergic disease prevention have not been addressed in this study."
26227245,Prednisolone prevents synovitis,335,"To prolong the anti-tumor effect some mice were also given cyclophosphamide, hydrocortisone, or a second injection of virus.",False,"Is the triple 'Prednisolone prevents synovitis' supported by the sentence: 'To prolong the anti-tumor effect some mice were also given cyclophosphamide, hydrocortisone, or a second injection of virus.'?","No, the phrase ""Prednisolone prevents synovitis"" does not receive indirect support from the statement: ""To prolong the anti-tumor effect some mice were also given cyclophosphamide, hydrocortisone, or a second injection of virus.""

        The statement provided discusses treatments given to mice in an attempt to prolong their anti-tumor effect, including cyclophosphamide, hydrocortisone, and a second injection of virus. However, prednisolone is not mentioned in this list; therefore, it does not provide any support for the claim that prednisolone prevents synovitis.

        Furthermore, even if prednisolone were mentioned in the statement, it would still not provide indirect support for preventing synovitis specifically because synovitis is not mentioned in the statement at all. In order for there to be indirect support for such a claim, there would need to be some connection between prednisolone and synovitis in the given statement, which is absent in this case.

        In conclusion, without explicit mention or implicit connections within the provided statement, there is no support for the claim that prednisolone prevents syn"
19453072,Prednisolone prevents hypereosinophilic syndrome,336,"In conclusion, HRT in postmenopausal asthmatic women has a favorable influence on the course of asthma, reduces daily use of glucocorticosteroids and frequency of asthma exacerbations and normalizes serum concentrations of estradiol, cortisol and DHEAS, which were decreased before HRT.",False,"Is the triple 'Prednisolone prevents hypereosinophilic syndrome' supported by the sentence: 'In conclusion, HRT in postmenopausal asthmatic women has a favorable influence on the course of asthma, reduces daily use of glucocorticosteroids and frequency of asthma exacerbations and normalizes serum concentrations of estradiol, cortisol and DHEAS, which were decreased before HRT.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents hypereosinophilic syndrome"". The conclusion drawn in the statement discusses hormone replacement therapy (HRT) in postmenopausal asthmatic women, its impact on asthma course, glucocorticosteroid use, frequency of asthma exacerbations, and serum concentrations of estradiol, cortisol, and DHEAS. There is no mention or implication of prednisolone or hypereosinophilic syndrome in the statement. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory properties in various conditions, while hypereosinophilic syndrome is characterized by an overproduction of eosinophils in peripheral blood and tissues leading to organ damage. The provided statement does not contain any information that would support prednisolone preventing hypereosinophilic syndrome."
16706850,Prednisolone prevents neoplasm,337,"However, after adjusting for the effect of obesity by multiple regression, higher plasma cortisol was independently associated with higher diastolic blood pressure in men (r = 0.21, P = 0.04) but not in women, and higher fasting serum triglyceride levels in women (r = 0.28, P < 0. 001) but not in men.",False,"Is the triple 'Prednisolone prevents neoplasm' supported by the sentence: 'However, after adjusting for the effect of obesity by multiple regression, higher plasma cortisol was independently associated with higher diastolic blood pressure in men (r = 0.21, P = 0.04) but not in women, and higher fasting serum triglyceride levels in women (r = 0.28, P < 0. 001) but not in men.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents neoplasm."" The provided statement discusses the associations between higher plasma cortisol levels (not Prednisolone) and certain health parameters in men and women after adjusting for obesity using multiple regression analysis. Neoplasm, which refers to an abnormal new growth of tissue in some part of the body (often cancer), is not mentioned in the statement at all. Therefore, it is not possible to draw any conclusions about Prednisolone preventing neoplasm based on the given information."
15809068,Prednisolone prevents colitis,338,"ii) Reduction of cortisone to cortisol in the liver may increase insulin resistance in type 2 diabetes mellitus, and inhibition of the enzyme may lead to a decrease in gluconeogenesis.",False,"Is the triple 'Prednisolone prevents colitis' supported by the sentence: 'ii) Reduction of cortisone to cortisol in the liver may increase insulin resistance in type 2 diabetes mellitus, and inhibition of the enzyme may lead to a decrease in gluconeogenesis.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents colitis."" The statement discusses the relationship between cortisone reduction in the liver, insulin resistance in type 2 diabetes mellitus, and gluconeogenesis inhibition. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects; it is not explicitly mentioned in relation to colitis prevention in this statement.

         However, it is important to note that glucocorticoids like Prednisolone have been used in treating inflammatory bowel diseases (IBD), such as colitis (e.g., ulcerative colitis) due to their anti-inflammatory properties. This use is separate from the information provided in the statement regarding cortisone reduction in diabetes management.

         In summary, while Prednisolone has been used in treating colitis due to its anti-inflammatory effects, the statement does not provide any indirect support for Prednisolone preventing colitis because it focuses on cortisone reduction, insulin resistance in diabetes mellitus, and gluconeogenesis inhibition"
11858005,Prednisolone prevents asthma,339,"Pretreatment of rats with hydrocortisone or protamin-Zn-insulin within 4 days altered in subsequent acute hypoxia (3 hrs, ""height"" 10 000 m) the isoenzyme spectrum of LDH in lungs, liver tissue and kidney cortex.",False,"Is the triple 'Prednisolone prevents asthma' supported by the sentence: 'Pretreatment of rats with hydrocortisone or protamin-Zn-insulin within 4 days altered in subsequent acute hypoxia (3 hrs, ""height"" 10 000 m) the isoenzyme spectrum of LDH in lungs, liver tissue and kidney cortex.'?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents asthma."" The statement discusses the effects of pretreatment with hydrocortisone or protamin-Zn-insulin on rats subjected to acute hypoxia. Prednisolone is a glucocorticoid medication similar to hydrocortisone but they are not identical substances. Furthermore, even if they were identical, the study does not make any claim about asthma prevention but rather about isoenzyme spectrum changes in lung, liver tissue, and kidney cortex under hypoxic conditions after pretreatment. Therefore, there is no connection that can be drawn between these two pieces of information based on what has been provided."
10983909,Prednisolone prevents leprosy,340,Previously we related persistent cortisol increases to memory impairments in elderly humans studied over five years.,False,Is the triple 'Prednisolone prevents leprosy' supported by the sentence: 'Previously we related persistent cortisol increases to memory impairments in elderly humans studied over five years.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone prevents leprosy."" The initial statement discusses cortisol increases being related to memory impairments in elderly humans over five years, while prednisolone is a synthetic glucocorticoid similar to cortisol in structure and function but not specifically linked to leprosy prevention in either statement."
10240036,Prednisolone prevents Inflammation,341,It was suggested that the progressive shift from type 1 to type 2 cytokine production characteristic of HIV infection could be at least partially provoked by the increase in the production of cortisol and the reduction of DHEA.,True,Is the triple 'Prednisolone prevents Inflammation' supported by the sentence: 'It was suggested that the progressive shift from type 1 to type 2 cytokine production characteristic of HIV infection could be at least partially provoked by the increase in the production of cortisol and the reduction of DHEA.'?,"Yes, indirectly it does provide some support for the statement that Prednisolone prevents inflammation. Prednisolone is a synthetic glucocorticoid drug that works by mimicking the effects of hormones such as cortisol in the body. Cortisol is known for its anti-inflammatory properties as it inhibits the release of certain chemicals in the body that cause inflammation.

        The statement suggests that HIV infection leads to an increase in cortisol production (which is a glucocorticoid like Prednisolone) and a reduction in DHEA levels. This shift could potentially contribute to inflammation in HIV infection. Therefore, by providing additional cortisol-like effects through Prednisolone administration, one could argue that it may help prevent inflammation in HIV-infected individuals by further suppressing inflammatory responses in their bodies.

        
        However, it is essential to consider that Prednisolone has several side effects such as immunosuppression which could potentially worsen HIV infection if not managed carefully. Also, while Prednisolone might help decrease inflammation in HIV infection due to its gluc"
18452194,Prednisolone exacerbates ulcerative colitis,342,CONCLUSIONS: This study suggests that 24 h urinary free cortisol could be considered as a potential index of adrenal cortisol production in patients with liver cirrhosis and it potentially detects patients with a high mortality risk.,False,Is the triple 'Prednisolone exacerbates ulcerative colitis' supported by the sentence: 'CONCLUSIONS: This study suggests that 24 h urinary free cortisol could be considered as a potential index of adrenal cortisol production in patients with liver cirrhosis and it potentially detects patients with a high mortality risk.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone exacerbates ulcerative colitis."" The conclusion in the statement is about using 24-hour urinary free cortisol as an index for adrenal cortisol production in patients with liver cirrhosis who might have a high mortality risk. Prednisolone is a synthetic glucocorticoid used in various inflammatory conditions but has no direct relation to cortisol production in liver cirrhosis patients in this context.

         To establish whether prednisolone exacerbates ulcerative colitis, one should look at studies specifically investigating prednisolone's effects on ulcerative colitis patients or other relevant literature that establishes connections between prednisolone use and worsening ulcerative colitis symptoms."
25753407,Prednisolone predisposes neoplasm,343,Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder that leads to the partial or complete deficiency of cortisol and aldosterone production from the adrenal glands.,False,Is the triple 'Prednisolone predisposes neoplasm' supported by the sentence: 'Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder that leads to the partial or complete deficiency of cortisol and aldosterone production from the adrenal glands.'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone predisposes neoplasm."" The connection between congenital adrenal hyperplasia (CAH) and prednisolone predisposing neoplasm is not evident in the provided statement. 

        Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder that affects cortisol and aldosterone production in the adrenal glands. Prednisolone is a synthetic glucocorticoid often used as a treatment for CAH because it helps manage symptoms by replacing deficient cortisol in patients.

        While glucocorticoids like prednisolone have been associated with an increased risk of developing certain types of neoplasms (cancerous and noncancerous growths), no direct causality has been established between prednisolone use and neoplasm development in patients with CAH. Moreover, genetic predisposition due to autosomal recessive inheritance patterns does not automatically imply susceptibility to medication side effects like neoplasm development.

        In conclusion, more information is required to determine"
16546227,Prednisolone predisposes pneumonia,344,[Reaction of autogenous cortisol production in patients with extensive psoriasis vulgaris or atopic dermatitis following external administration of a 0.25% prednicarbate salve (W/O emulsion)].,False,Is the triple 'Prednisolone predisposes pneumonia' supported by the sentence: '[Reaction of autogenous cortisol production in patients with extensive psoriasis vulgaris or atopic dermatitis following external administration of a 0.25% prednicarbate salve (W/O emulsion)].'?,"No, the statement does not provide indirect support for the phrase ""Prednisolone predisposes pneumonia."" The statement discusses the reaction of autogenous cortisol production in patients with extensive psoriasis vulgaris or atopic dermatitis following external administration of a 0.25% prednicarbate salve (W/O emulsion). Prednisolone is not mentioned in this statement, and there is no connection made between prednisolone use and an increased susceptibility to pneumonia. Prednisolone is a synthetic glucocorticoid often used in treating various inflammatory and autoimmune conditions; however, its use does not necessarily imply that it predisposes individuals to pneumonia. Further investigation would be required to establish such a link."
27027571,Hydrocortisone related to HIV infectious disease,345,"OBJECTIVE: Corticosteroid-binding globulin (CBG), the cortisol transport protein, is cleaved from high-affinity (haCBG) to low-affinity (laCBG) CBG at sites of inflammation releasing bioavailable, anti-inflammatory cortisol.",False,"Is the triple 'Hydrocortisone related to HIV infectious disease' supported by the sentence: 'OBJECTIVE: Corticosteroid-binding globulin (CBG), the cortisol transport protein, is cleaved from high-affinity (haCBG) to low-affinity (laCBG) CBG at sites of inflammation releasing bioavailable, anti-inflammatory cortisol.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to HIV infectious disease."" The statement discusses how corticosteroid-binding globulin (CBG) is cleaved at sites of inflammation, releasing bioavailable cortisol which is an anti-inflammatory agent. Hydrocortisone is a synthetic form of cortisol used as a medication for various conditions but it is not specifically related to HIV infectious disease in this context. The study does not provide evidence linking hydrocortisone to HIV infection or disease progression; thus, it does not support the given phrase."
25927636,Hydrocortisone related to cardiac arrest,346,The propensity to develop type 1 diabetes or type 2 diabetes/metabolic syndrome depends on the propensity to release of cortisol which correlates with race.,False,Is the triple 'Hydrocortisone related to cardiac arrest' supported by the sentence: 'The propensity to develop type 1 diabetes or type 2 diabetes/metabolic syndrome depends on the propensity to release of cortisol which correlates with race.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to cardiac arrest."" The original statement discusses the correlation between cortisol release and diabetes propensity in different races. Hydrocortisone is synthetic cortisol used in medical treatments; however, there is no direct or indirect link established between hydrocortisone use and cardiac arrest in this statement.

        To further clarify, let us examine the components of the original statement:

        1. The propensity to develop type 1 diabetes or type 2 diabetes/metabolic syndrome depends on the propensity to release cortisol which correlates with race.

        This statement implies that there is an association between cortisol levels (a hormone produced by the adrenal gland) and diabetes risk based on race. Cortisol has various functions in the human body, including stress response regulation and immune system support.

        However, hydrocortisone is a synthetic form of cortisol used in medical treatments such as inflammation reduction, allergic reaction control, and autoimmune disease management (like rheumatoid arthritis). While hydrocort"
25797574,Hydrocortisone related to lymphoma,347,"CIRCI is characterized by an inadequate production of cortisol in relation to an increased demand during periods of severe stress, particularly in critical illnesses such as sepsis or septic shock.",False,"Is the triple 'Hydrocortisone related to lymphoma' supported by the sentence: 'CIRCI is characterized by an inadequate production of cortisol in relation to an increased demand during periods of severe stress, particularly in critical illnesses such as sepsis or septic shock.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to lymphoma."" The statement discusses CIRCI (Critical Illness-Related Corticosteroid Insufficiency), which is characterized by an inadequate production of cortisol during periods of severe stress in certain illnesses like sepsis or septic shock. Hydrocortisone is a synthetic glucocorticoid often used as a replacement therapy for CIRCI patients due to its ability to mimic cortisol action in the body. However, there is no mention or implication connecting hydrocortisone usage to lymphoma in any way in the statement provided."
25131277,Hydrocortisone related to Crohn disease,348,Synacthen test diagnosed Addison's disease with a clear deficiency of cortisol production.,False,Is the triple 'Hydrocortisone related to Crohn disease' supported by the sentence: 'Synacthen test diagnosed Addison's disease with a clear deficiency of cortisol production.'?,"No, the statement ""Synacthen test diagnosed Addison's disease with a clear deficiency of cortisol production"" does not provide indirect support for the claim ""Hydrocortisone related to Crohn disease"". 

         The Synacthen test is used to diagnose conditions related to cortisol deficiency, such as Addison's disease, by stimulating cortisol production and measuring the response. Hydrocortisone is a synthetic form of cortisol often used in treatment for various conditions including Addison's disease, but also rheumatoid arthritis, asthma, and inflammatory bowel disease (IBD), which Crohn disease is a part of.

         However, while both statements involve cortisol and its related conditions, they do not establish any connection between hydrocortisone and Crohn disease. The statement about Addison's disease does not mention Crohn disease nor provide any information about shared mechanisms that might link hydrocortisone use to Crohn disease incidence or progression.

         To establish indirect support for ""Hydrocortisone related to Crohn disease"", there should be some evidence"
19793698,Hydrocortisone related to alcohol abuse,349,"Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.",False,"Is the triple 'Hydrocortisone related to alcohol abuse' supported by the sentence: 'Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to alcohol abuse."" The statement discusses cortisol production rates, free cortisol, and 11beta-HSD-1 expression in relation to visceral fat and insulin resistance in men, which is different from hydrocortisone specifically and its relation to alcohol abuse. Hydrocortisone is a synthetic form of cortisol, but the statement does not make any mention of alcohol abuse or hydrocortisone use in that context."
19531872,Hydrocortisone related to atrial fibrillation,350,"Obesity is also related to dysregulation of cortisol production by the pre-receptor enzyme, 11beta-hydroxysteroid dehydrogenase, and we speculate that this may have a role in the pathogenesis of obesity and raised ICP seen in IIH.",False,"Is the triple 'Hydrocortisone related to atrial fibrillation' supported by the sentence: 'Obesity is also related to dysregulation of cortisol production by the pre-receptor enzyme, 11beta-hydroxysteroid dehydrogenase, and we speculate that this may have a role in the pathogenesis of obesity and raised ICP seen in IIH.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to atrial fibrillation."" The provided statement discusses obesity's relationship to cortisol production dysregulation through the enzyme 11beta-hydroxysteroid dehydrogenase, which may contribute to intracranial pressure (ICP) seen in idiopathic intracranial hypertension (IIH). Although hydrocortisone is a type of cortisol hormone, there is no mention or implication connecting it specifically to atrial fibrillation in either the original claim or in any indirect manner that would allow for an association between hydrocortisone and atrial fibrillation based on this statement alone."
18705900,Hydrocortisone related to phobic disorder,351,"This is an extremely rare case of bilateral adrenal tumors, in which the left adrenocortical tumor produced and secreted cortisol or both cortisol and aldosterone and the right one produced and secreted both aldosterone and cortisol, as confirmed by clinical findings and pathological studies using immunohistochemical analysis.",False,"Is the triple 'Hydrocortisone related to phobic disorder' supported by the sentence: 'This is an extremely rare case of bilateral adrenal tumors, in which the left adrenocortical tumor produced and secreted cortisol or both cortisol and aldosterone and the right one produced and secreted both aldosterone and cortisol, as confirmed by clinical findings and pathological studies using immunohistochemical analysis.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to phobic disorder"". The statement discusses an extremely rare case of bilateral adrenal tumors that produce and secrete cortisol and aldosterone; however, it does not mention any connection between these tumors (or their associated hormones) and phobic disorders. Therefore, there is no basis for inferring any relationship between hydrocortisone (a hormone produced by the adrenal glands) and phobic disorders from this statement alone."
15155784,Hydrocortisone related to psoriasis,352,"We conclude that the clinical picture of late-onset adrenal insufficiency in preterm infants is not a result of an absolute deficiency of cortisol production, but may be a result of a limited ability to synthesize sufficient cortisol for the degree of clinical stress.",False,"Is the triple 'Hydrocortisone related to psoriasis' supported by the sentence: 'We conclude that the clinical picture of late-onset adrenal insufficiency in preterm infants is not a result of an absolute deficiency of cortisol production, but may be a result of a limited ability to synthesize sufficient cortisol for the degree of clinical stress.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to psoriasis."" The statement discusses late-onset adrenal insufficiency in preterm infants and its potential connection to cortisol production, which is unrelated to psoriasis treatment. Hydrocortisone is a synthetic form of cortisol often used as a treatment for various conditions, including psoriasis; however, the statement does not mention or imply any link between hydrocortisone and psoriasis."
14891361,"Hydrocortisone related to dermatitis, atopic",353,"Ironically, despite our understanding of the various stressors that promote chronic adult-onset asthma, most of which are known to elevate cortisol production via the hypothalamic-pituitary-adrenal (HPA) axis, inhaled and systemic corticosteroids are the mainstay for the treatment of chronic asthma.",False,"Is the triple 'Hydrocortisone related to dermatitis, atopic' supported by the sentence: 'Ironically, despite our understanding of the various stressors that promote chronic adult-onset asthma, most of which are known to elevate cortisol production via the hypothalamic-pituitary-adrenal (HPA) axis, inhaled and systemic corticosteroids are the mainstay for the treatment of chronic asthma.'?","No, the statement does not provide direct support for the connection between hydrocortisone and dermatitis, atopic. 

         The statement discusses the use of corticosteroids in treating chronic asthma, which is primarily managed by inhaled and systemic corticosteroids such as hydrocortisone. However, it does not mention or imply any link between hydrocortisone and dermatitis, atopic. Dermatitis, atopic is a skin condition often associated with allergies, while hydrocortisone is primarily used for its anti-inflammatory properties in treating asthma symptoms.

         While it is true that hydrocortisone can be used for treating various skin conditions, including dermatitis, atopic, the statement provided does not offer any information regarding this application. Therefore, it is essential to rely on additional evidence when assessing such connections between hydrocortisone and dermatitis, atopic."
14483328,Hydrocortisone related to bronchopulmonary dysplasia,354,Glucocorticoid insufficiency is common during sepsis and may result from insufficient production of cortisol or peripheral tissues resistance.,False,Is the triple 'Hydrocortisone related to bronchopulmonary dysplasia' supported by the sentence: 'Glucocorticoid insufficiency is common during sepsis and may result from insufficient production of cortisol or peripheral tissues resistance.'?,"No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to bronchopulmonary dysplasia"". 

         The statement discusses glucocorticoid insufficiency during sepsis, which can be due to inadequate cortisol production or peripheral tissue resistance. Hydrocortisone is a type of glucocorticoid often used as a replacement therapy in cases of cortisol insufficiency. 

         However, bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants, and while glucocorticoids like hydrocortisone have been used in BPD treatment, their use remains controversial due to potential side effects. The statement provided does not make any connection between hydrocortisone and bronchopulmonary dysplasia, so it does not offer support for that specific phrase."
14450267,Hydrocortisone related to adrenal cortex neoplasm,355,"This likely represents an adaptive response to LTH, to prevent excessive cortisol production that would restrict fetal growth and potentially induce preterm delivery.",False,"Is the triple 'Hydrocortisone related to adrenal cortex neoplasm' supported by the sentence: 'This likely represents an adaptive response to LTH, to prevent excessive cortisol production that would restrict fetal growth and potentially induce preterm delivery.'?","No, the phrase ""Hydrocortisone related to adrenal cortex neoplasm"" does not receive indirect support from the statement provided. The statement discusses hydrocortisone (cortisol) production in relation to low-dose long-term hydrocortisone (LTH) therapy for adrenal insufficiency. It suggests that LTH may prevent excessive cortisol production to allow for normal fetal growth and prevent preterm delivery in pregnant women. This statement does not provide evidence for an association between hydrocortisone use and adrenal cortex neoplasm (a tumor in the adrenal gland).

         The association between hydrocortisone use and adrenal cortex neoplasm would require separate evidence linking exogenous hydrocortisone use (synthetic form of cortisol) with an increased risk for developing adrenal cortex neoplasm. The current statement focuses on LTH as a treatment for adrenal insufficiency without implying any connection to adrenal cortex neoplasm development."
14387016,Hydrocortisone related to cirrhosis of liver,356,"The reduction in local cortisol production which diminishes the endogenous anti-inflammatory effects, also allows for the progression of both vascular and pulmonary inflammation.",False,"Is the triple 'Hydrocortisone related to cirrhosis of liver' supported by the sentence: 'The reduction in local cortisol production which diminishes the endogenous anti-inflammatory effects, also allows for the progression of both vascular and pulmonary inflammation.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to cirrhosis of liver."" The provided statement discusses the reduction in local cortisol production affecting anti-inflammatory effects and vascular/pulmonary inflammation progression without mentioning hydrocortisone or cirrhosis of the liver.

        To establish support for ""Hydrocortisone related to cirrhosis of liver,"" there would need to be a clear connection between hydrocortisone, its effects on cortisol production (or anti-inflammatory effects), and liver cirrhosis in the statement. In its absence, further investigation is required to establish any relationship between hydrocortisone use and liver cirrhosis based on additional evidence from relevant studies or sources."
14360687,Hydrocortisone related to dermatitis,357,"CONCLUSIONS: Patients with newly diagnosed, untreated PC yielded significantly higher cortisol and lower estradiol serum concentrations than controls.",False,"Is the triple 'Hydrocortisone related to dermatitis' supported by the sentence: 'CONCLUSIONS: Patients with newly diagnosed, untreated PC yielded significantly higher cortisol and lower estradiol serum concentrations than controls.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to dermatitis."" The conclusion in the statement is about cortisol and estradiol serum concentrations in patients with prostate cancer (PC) compared to controls, without any mention of hydrocortisone or dermatitis. Hydrocortisone is a synthetic glucocorticoid hormone used primarily for its anti-inflammatory effects in various conditions such as dermatitis; however, no information related to hydrocortisone is present in the statement provided."
13844584,Hydrocortisone related to acute myeloid leukemia,358,"The tumour secreted excessive cortisol and dehydroepiandrosterone-sulphate (DHEA-S), and had invaded the right hepatic lobe and vena cava.",False,"Is the triple 'Hydrocortisone related to acute myeloid leukemia' supported by the sentence: 'The tumour secreted excessive cortisol and dehydroepiandrosterone-sulphate (DHEA-S), and had invaded the right hepatic lobe and vena cava.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to acute myeloid leukemia."" 

         The statement mentions that the tumour secreted excessive cortisol and DHEA-S, which are steroid hormones produced by the adrenal glands. Hydrocortisone is a synthetic form of cortisol, so there is some connection in terms of hormonal function. However, the statement does not mention hydrocortisone specifically, nor does it provide any information about acute myeloid leukemia (AML).

         AML is a type of cancer that affects the bone marrow and blood, not necessarily related to hormonal imbalances. Even though cortisol can have immunosuppressive effects and may potentially contribute to cancer development or progression in some contexts, the statement does not provide any evidence or context that would allow us to infer a relationship between hydrocortisone and AML in this case. 

         Therefore, it is crucial to avoid overinterpreting the evidence and drawing conclusions that go beyond what is explicitly stated in the given information."
13213365,Hydrocortisone related to chronic primary adrenal insufficiency,359,Replacement doses of hydrocortisone were administered throughout treatment to counteract potential adrenal insufficiency secondary to the ketoconazole.,True,Is the triple 'Hydrocortisone related to chronic primary adrenal insufficiency' supported by the sentence: 'Replacement doses of hydrocortisone were administered throughout treatment to counteract potential adrenal insufficiency secondary to the ketoconazole.'?,"Yes, there is indirect support for the association between hydrocortisone and chronic primary adrenal insufficiency in the provided statement. The use of hydrocortisone replacement therapy in response to potential adrenal insufficiency secondary to ketoconazole treatment indicates that hydrocortisone can be utilized in addressing adrenal insufficiency.

         Chronic primary adrenal insufficiency refers to a condition where the adrenal glands fail to produce adequate levels of hormones such as cortisol and aldosterone. Hydrocortisone is a synthetic glucocorticoid hormone that can be used as replacement therapy in cases of adrenal insufficiency since it has similar properties to cortisol.

         In the statement provided, ketoconazole is being used for some unspecified treatment that could lead to secondary adrenal insufficiency as a side effect by inhibiting steroid synthesis in the adrenal glands. To counteract this potential adrenal insufficiency caused by ketoconazole treatment, hydrocortisone is administered as replacement therapy.

         Therefore, although not explicitly stated in the"
12756660,Hydrocortisone related to borderline personality disorder,360,Amplication by hydrocortisone of the induction of cytotoxic response in vitro to syngeneic murine leukemias.,False,Is the triple 'Hydrocortisone related to borderline personality disorder' supported by the sentence: 'Amplication by hydrocortisone of the induction of cytotoxic response in vitro to syngeneic murine leukemias.'?,"No, the statement ""Amplification by hydrocortisone of the induction of cytotoxic response in vitro to syngeneic murine leukemias"" does not provide indirect support for the phrase ""Hydrocortisone related to borderline personality disorder."" The statement discusses hydrocortisone's ability to amplify cytotoxic response in vitro (in a lab setting) against syngeneic murine leukemias (mouse leukemias). This finding is related to immunology and cancer treatment rather than psychiatric disorders like borderline personality disorder (BPD).

        To establish any connection between hydrocortisone and borderline personality disorder, researchers would need to present evidence linking the administration of hydrocortisone (or related glucocorticoids) to changes in behavioral patterns, emotional regulation, or other symptoms characteristic of BPD in human subjects or relevant animal models. Since no such link is provided in the statement, it does not offer any support for the proposed relationship between hydrocortisone and borderline personality disorder.

        In conclusion, while hydrocortisone has various biological effects that could be explored in"
12576998,Hydrocortisone related to Hypoxemia,361,The results demonstrated that the intrarectal dose of indomethacin and hydrocortisone inhibited the development of tumors from microscopic carcinoma lesions in the large bowel and growing further.,False,Is the triple 'Hydrocortisone related to Hypoxemia' supported by the sentence: 'The results demonstrated that the intrarectal dose of indomethacin and hydrocortisone inhibited the development of tumors from microscopic carcinoma lesions in the large bowel and growing further.'?,"No, the statement ""The results demonstrated that the intrarectal dose of indomethacin and hydrocortisone inhibited the development of tumors from microscopic carcinoma lesions in the large bowel and growing further"" does not provide indirect support for the phrase ""Hydrocortisone related to Hypoxemia."" The statement discusses the effects of indomethacin and hydrocortisone on tumor development in the large bowel, which is unrelated to hypoxemia (a condition defined by low oxygen levels in the blood). Hypoxemia is not mentioned nor implied in the provided statement; therefore, it does not offer any support for the proposed relationship between hydrocortisone and hypoxemia."
11888652,Hydrocortisone related to congenital adrenal hyperplasia,362,"Growth of ovarian, lung, breast, and kidney carcinomas was increased by 136%, 126%, 78% and 69%, respectively, whereas melanomas, sarcomas, and colon tumors were inhibited by hydrocortisone.",False,"Is the triple 'Hydrocortisone related to congenital adrenal hyperplasia' supported by the sentence: 'Growth of ovarian, lung, breast, and kidney carcinomas was increased by 136%, 126%, 78% and 69%, respectively, whereas melanomas, sarcomas, and colon tumors were inhibited by hydrocortisone.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to congenital adrenal hyperplasia"". 

        The statement presents data on the effects of hydrocortisone on various types of carcinomas but does not mention congenital adrenal hyperplasia (CAH), which is a genetic disorder affecting the adrenal glands. While hydrocortisone is indeed used in treating CAH due to its glucocorticoid properties, it is also used in treating other conditions involving inflammation such as arthritis, lupus, and asthma, as well as in preventing organ rejection in transplant patients. The statement provided only speaks about hydrocortisone's influence on tumor growth in various organs without any reference to congenital adrenal hyperplasia."
11866289,Hydrocortisone related to nicotine dependence,363,Insufficient cortisol limits the ability of the sick newborn to handle stress and inhibit pulmonary inflammation.,False,Is the triple 'Hydrocortisone related to nicotine dependence' supported by the sentence: 'Insufficient cortisol limits the ability of the sick newborn to handle stress and inhibit pulmonary inflammation.'?,"No, the statement ""Insufficient cortisol limits the ability of the sick newborn to handle stress and inhibit pulmonary inflammation"" does not provide indirect support for the phrase ""Hydrocortisone related to nicotine dependence."" 

         The statement discusses the effects of insufficient cortisol (a hormone) in newborns in relation to stress management and inflammation inhibition in the lungs. Hydrocortisone is a synthetic form of cortisol used in medical treatments for various conditions such as inflammation reduction and hormonal replacement therapy.

         Nicotine dependence is an addiction caused by exposure to nicotine found in tobacco products. While hydrocortisone may have various applications in medicine, there is no direct link between hydrocortisone use and nicotine dependence as suggested by the initial phrase.

         Although hydrocortisone is associated with cortisol, which in turn is related to stress response in newborns as mentioned in the statement, it does not provide indirect support for the connection between hydrocortisone and nicotine dependence since they belong to different biological systems without any known interaction that could lead to nicot"
11530989,Hydrocortisone related to pneumonia,364,"BACKGROUND: Hepatic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) activity, which converts cortisone (inactive) to cortisol, is downregulated in obesity.",False,"Is the triple 'Hydrocortisone related to pneumonia' supported by the sentence: 'BACKGROUND: Hepatic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) activity, which converts cortisone (inactive) to cortisol, is downregulated in obesity.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to pneumonia."" The background statement discusses hepatic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) activity in obesity, which is responsible for converting cortisone (inactive) into cortisol (active). This information is related to metabolic processes in obesity but does not connect hydrocortisone (a synthetic form of cortisol) to pneumonia in any way."
11442939,Hydrocortisone related to prostate cancer,365,"High-dose hydrocortisone treatment given in the first few hours after a traumatic experience was associated with significant favorable changes in the trajectory of exposure to trauma, as expressed by the reduced risk of the development of PTSD post-trauma.",False,"Is the triple 'Hydrocortisone related to prostate cancer' supported by the sentence: 'High-dose hydrocortisone treatment given in the first few hours after a traumatic experience was associated with significant favorable changes in the trajectory of exposure to trauma, as expressed by the reduced risk of the development of PTSD post-trauma.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to prostate cancer."" The statement discusses the association between high-dose hydrocortisone treatment and reduced risk of post-traumatic stress disorder (PTSD) development after trauma. While hydrocortisone is indeed a steroid hormone that can influence various biological processes, including cancer development, the current statement focuses solely on its impact on PTSD risk post-trauma without any mention or implication of prostate cancer. Therefore, it does not offer any relevant evidence or support for the connection between hydrocortisone and prostate cancer."
11089023,Hydrocortisone related to pancreatitis,366,"Under normal conditions, stress induces increased cortisol secretion that counteracts inflammatory reactions.",False,"Is the triple 'Hydrocortisone related to pancreatitis' supported by the sentence: 'Under normal conditions, stress induces increased cortisol secretion that counteracts inflammatory reactions.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to pancreatitis."" Although it is true that stress induces increased cortisol secretion which helps counteract inflammatory reactions under normal conditions, hydrocortisone is a synthetic form of cortisol (a hormone that your body produces naturally in your adrenal glands).

        While both cortisol and hydrocortisone have anti-inflammatory effects, they are not interchangeable in all contexts. The statement given does not connect cortisol's anti-inflammatory response under normal conditions to any potential implications for pancreatitis nor hydrocortisone use in that context. Therefore, it does not offer any indirect support for the connection between hydrocortisone use and pancreatitis risk.

        However, it is worth noting that high-dose hydrocortisone has been associated with pancreatitis in some cases; but further investigation is required for establishing causality. Additionally, genetic factors, alcohol consumption, and other environmental factors can contribute to pancreatitis development, making it essential to consider multiple variables"
10649902,Hydrocortisone related to myocardial infarction,367,Hydrocortisone (HC) reduced the macrophage content of four murine tumors to less than half of control values.,False,Is the triple 'Hydrocortisone related to myocardial infarction' supported by the sentence: 'Hydrocortisone (HC) reduced the macrophage content of four murine tumors to less than half of control values.'?,"No, the statement ""Hydrocortisone (HC) reduced the macrophage content of four murine tumors to less than half of control values"" does not provide indirect support for the claim that ""Hydrocortisone is related to myocardial infarction.""

        The statement provided discusses the impact of hydrocortisone on macrophage content in murine tumors, which is an entirely different context from myocardial infarction (heart attack). The two statements refer to different biological processes and systems; therefore, no indirect support can be inferred from one statement to another based solely on hydrocortisone being common in both statements.

        However, it is still essential to consider that hydrocortisone is a corticosteroid hormone that can affect various physiological processes in the body due to its anti-inflammatory properties. Some studies have suggested that corticosteroids like hydrocortisone may have an impact on cardiovascular events such as myocardial infarction through various mechanisms (e.g., altering lipid metabolism, affecting blood pressure). Nevertheless, these potential connections would require separate evidence"
10522181,Hydrocortisone related to osteoarthritis,368,"Further, because infant formula contains only trace amounts of glucocorticoids, these findings suggest that cortisol in milk is a novel biological pathway through which breastfeeding may protect against later obesity.",False,"Is the triple 'Hydrocortisone related to osteoarthritis' supported by the sentence: 'Further, because infant formula contains only trace amounts of glucocorticoids, these findings suggest that cortisol in milk is a novel biological pathway through which breastfeeding may protect against later obesity.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to osteoarthritis"". The statement discusses the potential protective effect of breastfeeding against later obesity through cortisol in milk as a novel biological pathway. Hydrocortisone is one type of glucocorticoid but is not specifically mentioned in the statement, nor is osteoarthritis mentioned as a related condition. Therefore, there is no clear connection between hydrocortisone and osteoarthritis in this context."
10521296,Hydrocortisone related to eye disorder,369,"Conclusions and Relevance: Among adults with severe sepsis not in septic shock, use of hydrocortisone compared with placebo did not reduce the risk of septic shock within 14 days.",False,"Is the triple 'Hydrocortisone related to eye disorder' supported by the sentence: 'Conclusions and Relevance: Among adults with severe sepsis not in septic shock, use of hydrocortisone compared with placebo did not reduce the risk of septic shock within 14 days.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to eye disorder"". The conclusion is about a clinical trial where hydrocortisone was used in adults with severe sepsis not in septic shock. The trial found no reduction in septic shock risk within 14 days between those given hydrocortisone versus placebo. There is no mention of any eye disorder or any ophthalmological side effects related to hydrocortisone in this statement."
10518203,Hydrocortisone related to otitis externa,370,These findings suggest that HC may protect against hyperoxic injury in the developing pulmonary vasculature.,False,Is the triple 'Hydrocortisone related to otitis externa' supported by the sentence: 'These findings suggest that HC may protect against hyperoxic injury in the developing pulmonary vasculature.'?,"No, the statement ""These findings suggest that HC may protect against hyperoxic injury in the developing pulmonary vasculature"" does not provide indirect support for the claim ""Hydrocortisone is related to otitis externa."" The two statements discuss different biological contexts; one involves hydrocortisone (HC) protection against hyperoxic injury in pulmonary vasculature development, while the other relates HC to otitis externa (ear infection). Additionally, there is no mention of any connection between hyperoxic injury in pulmonary vasculature development and otitis externa that would allow for an indirect link between HC and otitis externa based on these statements alone."
10484611,Hydrocortisone related to ulcerative colitis,371,OBJECTIVE: Cortisol clearance is reduced in sepsis and may contribute to the development of impaired adrenocortical function that is thought to contribute to the pathophysiology of critical illness-related corticosteroid insufficiency.,False,Is the triple 'Hydrocortisone related to ulcerative colitis' supported by the sentence: 'OBJECTIVE: Cortisol clearance is reduced in sepsis and may contribute to the development of impaired adrenocortical function that is thought to contribute to the pathophysiology of critical illness-related corticosteroid insufficiency.'?,"No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to ulcerative colitis."" The statement discusses cortisol clearance in sepsis and its potential contribution to critical illness-related corticosteroid insufficiency. Hydrocortisone is a synthetic form of cortisol (a hormone naturally produced by the adrenal glands), but the statement does not mention ulcerative colitis or any other inflammatory bowel disease (IBD).

        Ulcerative colitis is an autoimmune disorder that causes chronic inflammation in the digestive tract. Corticosteroids like hydrocortisone can be used as part of the treatment for IBD; however, without explicit evidence connecting sepsis-related corticosteroid insufficiency to ulcerative colitis treatment, we cannot infer support for the original phrase based on the given statement alone."
9718673,Hydrocortisone related to atopic eczema,372,Hydrocortisone therapy was started to prevent adrenal insufficiency before laboratory findings for ACTH (adrenocorticotropic hormone) and cortisol levels.,False,Is the triple 'Hydrocortisone related to atopic eczema' supported by the sentence: 'Hydrocortisone therapy was started to prevent adrenal insufficiency before laboratory findings for ACTH (adrenocorticotropic hormone) and cortisol levels.'?,"No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to atopic eczema."" The statement indicates that hydrocortisone therapy was initiated as a preventative measure for adrenal insufficiency based on laboratory results for ACTH (adrenocorticotropic hormone) and cortisol levels. There is no mention or implication of atopic eczema in this statement."
9492934,Hydrocortisone related to opiate dependence,373,CONCLUSION: We conclude that intravenous stress doses of hydrocortisone lead to a reduction of systemic inflammation and to a potential improvement in the early outcome of patients undergoing off-pump CABG.,False,Is the triple 'Hydrocortisone related to opiate dependence' supported by the sentence: 'CONCLUSION: We conclude that intravenous stress doses of hydrocortisone lead to a reduction of systemic inflammation and to a potential improvement in the early outcome of patients undergoing off-pump CABG.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to opiate dependence."" The conclusion is about the effects of intravenous stress doses of hydrocortisone on systemic inflammation and early outcomes in patients undergoing off-pump coronary artery bypass graft (CABG) surgery. It does not mention or imply any connection between hydrocortisone and opiate dependence."
9238280,Hydrocortisone related to Sepsis,374,"CONCLUSION: In intubated trauma patients, the use of an intravenous stress-dose of hydrocortisone, compared with placebo, resulted in a decreased risk of hospital-acquired pneumonia.",False,"Is the triple 'Hydrocortisone related to Sepsis' supported by the sentence: 'CONCLUSION: In intubated trauma patients, the use of an intravenous stress-dose of hydrocortisone, compared with placebo, resulted in a decreased risk of hospital-acquired pneumonia.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to Sepsis."" The conclusion in the statement refers to hydrocortisone use reducing the risk of hospital-acquired pneumonia in intubated trauma patients, but it does not mention sepsis nor establish any connection between hydrocortisone and sepsis. To provide indirect support for ""Hydrocortisone related to Sepsis,"" there should be some reference made in the statement linking hydrocortisone usage to sepsis prevention, treatment, or outcomes."
9235597,Hydrocortisone related to type 1 diabetes mellitus,375,"Early hydrocortisone (HC) treatment may decrease the incidence of bronchopulmonary dysplasia; however, the long-term effects are still under evaluation.",False,"Is the triple 'Hydrocortisone related to type 1 diabetes mellitus' supported by the sentence: 'Early hydrocortisone (HC) treatment may decrease the incidence of bronchopulmonary dysplasia; however, the long-term effects are still under evaluation.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to type 1 diabetes mellitus."" The statement discusses the use of hydrocortisone in relation to bronchopulmonary dysplasia, which is an entirely different medical condition from type 1 diabetes mellitus. The two statements do not share any common ground regarding hydrocortisone use in either condition.

         It is important to be cautious when drawing connections between different medical conditions based on shared treatments since these connections may not be indicative of any underlying biological relationship between those conditions. The potential long-term effects of hydrocortisone treatment in bronchopulmonary dysplasia mentioned in the statement have no bearing on its potential relationship (if any) with type 1 diabetes mellitus."
8977987,Hydrocortisone related to injury,376,CONCLUSION: Intravenous hydrocortisone reduced the incidence of AF after cardiac surgery.,False,Is the triple 'Hydrocortisone related to injury' supported by the sentence: 'CONCLUSION: Intravenous hydrocortisone reduced the incidence of AF after cardiac surgery.'?,"No, the phrase ""Hydrocortisone related to injury"" does not receive indirect support from the statement: ""CONCLUSION: Intravenous hydrocortisone reduced the incidence of AF after cardiac surgery.""

        
        The conclusion provided states that intravenous hydrocortisone reduced the incidence of atrial fibrillation (AF) after cardiac surgery. This suggests that hydrocortisone may have a protective effect in preventing AF following cardiac surgery rather than being related to injury as insinuated by the phrase ""Hydrocortisone related to injury."" In fact, it implies that hydrocortisone might mitigate injury by decreasing AF occurrence post-surgery.

        
        It is crucial to consider that statements in science must be interpreted within their context and aligned with their intended meaning. Misinterpretation could lead to misinformation, which is detrimental in both clinical practice and research settings."
8778414,Hydrocortisone related to Inflammation,377,"Assuming a single dose of hydrocortisone improves sensitivity of peripheral tissues to insulin, it may be an interesting candidate for use in reducing insulin resistance in peripheral tissues of horses with several disease states.",False,"Is the triple 'Hydrocortisone related to Inflammation' supported by the sentence: 'Assuming a single dose of hydrocortisone improves sensitivity of peripheral tissues to insulin, it may be an interesting candidate for use in reducing insulin resistance in peripheral tissues of horses with several disease states.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to Inflammation."" The statement discusses the potential use of hydrocortisone in reducing insulin resistance in horses with various diseases, focusing on its impact on tissue sensitivity to insulin rather than its relationship to inflammation.

        
        However, it is important to note that hydrocortisone is indeed associated with inflammation as it is a glucocorticoid hormone commonly used in medical practice for its potent anti-inflammatory effects. Inflammation can be linked to insulin resistance; thus, hydrocortisone may indirectly influence inflammation via its effects on insulin sensitivity. Nevertheless, the provided statement does not explicitly mention nor imply such connections between hydrocortisone, inflammation, and insulin resistance in horses."
8763179,Hydrocortisone related to toxic shock syndrome,378,Plasma cortisol and glucagon concentrations were not increased markedly except in a case complicated other systemic bacterial infection.,False,Is the triple 'Hydrocortisone related to toxic shock syndrome' supported by the sentence: 'Plasma cortisol and glucagon concentrations were not increased markedly except in a case complicated other systemic bacterial infection.'?,"No, the phrase ""Hydrocortisone related to toxic shock syndrome"" does not receive indirect support from the statement provided. 

         The statement discusses plasma cortisol concentrations in relation to bacterial infection but does not mention hydrocortisone or toxic shock syndrome specifically. Hydrocortisone is a synthetic form of cortisol, a hormone that the body naturally produces in response to stress. Toxic shock syndrome is a rare but serious condition caused by certain types of bacteria that release toxins into the bloodstream.

         While it is true that high levels of cortisol can suppress the immune system, making it potentially harder for the body to fight off infections, there is no direct link established in this statement between hydrocortisone use and toxic shock syndrome. Furthermore, the statement explicitly mentions that plasma cortisol concentrations were not increased markedly in most cases, which would argue against an association between endogenous cortisol levels and toxic shock syndrome in these instances. 

         Therefore, based on the information provided in the statement, there is no indirect support for the claim that hydrocortisone is related to toxic shock syndrome. However, it is"
8625521,Hydrocortisone related to dissociative amnesia,379,"In view of the stimulatory effects of insulin and cortisol on adipogenesis, long-term stimulation of 11betaHSD reductase activity by insulin could aggravate visceral obesity.",False,"Is the triple 'Hydrocortisone related to dissociative amnesia' supported by the sentence: 'In view of the stimulatory effects of insulin and cortisol on adipogenesis, long-term stimulation of 11betaHSD reductase activity by insulin could aggravate visceral obesity.'?","No, there is no direct or indirect support for the phrase ""Hydrocortisone related to dissociative amnesia"" in the provided statement. The statement discusses the relationship between insulin, cortisol (which is related to hydrocortisone), and adipogenesis (the formation of fat cells), but it does not mention anything about dissociative amnesia, which is a condition characterized by memory loss due to traumatic experiences. Therefore, while hydrocortisone (a synthetic form of cortisol) may be indirectly related through cortisol in general due to their shared physiological functions in stress response and metabolism, it does not provide any evidence for its relationship to dissociative amnesia in particular."
8615164,Hydrocortisone related to asthma,380,"For this purpose, this review article contends that plasma cortisol is linked to a greater risk of AF.",False,"Is the triple 'Hydrocortisone related to asthma' supported by the sentence: 'For this purpose, this review article contends that plasma cortisol is linked to a greater risk of AF.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to asthma."" The review article discusses plasma cortisol being linked to an increased risk of atrial fibrillation (AF). Hydrocortisone is a synthetic glucocorticoid hormone that mimics the function of cortisol in the body; however, it is not explicitly stated in the review article that hydrocortisone has any direct connection to asthma.

         To establish indirect support for ""Hydrocortisone related to asthma"" from the statement provided, there would need to be evidence linking hydrocortisone use specifically (not cortisol in general) to an increased risk of asthma onset or exacerbation. Since no such link is mentioned in the statement provided, it does not offer indirect support for ""Hydrocortisone related to asthma.""

         Nonetheless, hydrocortisone is sometimes used in asthma treatment as an anti-inflammatory agent in cases where inhaled corticosteroids fail to achieve adequate control over symptoms (Barnes & Adcock,"
8570630,Hydrocortisone related to fibromyalgia,381,"After multivariate analysis, duration of HC stress dose administration was associated with increased risk of mortality (OR 1.11, 95% CI 1.02-1.2, p = 0.021), and total duration of HC treatment was associated with increased risk of sepsis (OR 1.04, 95% CI 1.005-1.075, p = 0.026).",False,"Is the triple 'Hydrocortisone related to fibromyalgia' supported by the sentence: 'After multivariate analysis, duration of HC stress dose administration was associated with increased risk of mortality (OR 1.11, 95% CI 1.02-1.2, p = 0.021), and total duration of HC treatment was associated with increased risk of sepsis (OR 1.04, 95% CI 1.005-1.075, p = 0.026).'?","No, the statement does not provide indirect support for the association between hydrocortisone (HC) administration and fibromyalgia risk. The given statement focuses on the relationship between hydrocortisone stress dose administration duration and mortality as well as total duration of hydrocortisone treatment and sepsis risk. Fibromyalgia is not mentioned nor implied in any way in the statement; therefore, it does not provide any indirect support for such an association."
8017438,Hydrocortisone related to Insulin resistance,382,"Plasma leptin and ghrelin levels in endotoxin-treated dogs were correlated with serum nitric oxide (r = .955 and r = .890; p < .001), procalcitonin (r = .825 and r = .716; p < .001), cortisol (r = .823 and r = .786; p < .001), and hepatorenal injury markers (r = .580 to .745 and r = .393 to .574; p < .05 to .01).",False,"Is the triple 'Hydrocortisone related to Insulin resistance' supported by the sentence: 'Plasma leptin and ghrelin levels in endotoxin-treated dogs were correlated with serum nitric oxide (r = .955 and r = .890; p < .001), procalcitonin (r = .825 and r = .716; p < .001), cortisol (r = .823 and r = .786; p < .001), and hepatorenal injury markers (r = .580 to .745 and r = .393 to .574; p < .05 to .01).'?","No, the statement does not provide direct support for the phrase ""Hydrocortisone related to Insulin resistance"". The statement discusses correlations between various markers in endotoxin-treated dogs, one of which is cortisol (a stress hormone). Hydrocortisone is a synthetic form of cortisol often used in medical treatments, but no explicit connection is made in the statement between cortisol and insulin resistance. Insulin resistance would typically be associated with markers such as glucose levels or insulin concentrations, which are not mentioned in the provided statement."
7919367,Hydrocortisone related to adrenocortical insufficiency,383,Contribution of cortisol deficiency to septic shock.,True,Is the triple 'Hydrocortisone related to adrenocortical insufficiency' supported by the sentence: 'Contribution of cortisol deficiency to septic shock.'?,"Yes, there is indirect support for the phrase ""Hydrocortisone related to adrenocortical insufficiency"" from the statement ""Contribution of cortisol deficiency to septic shock."" 

        

        The connection lies in understanding that hydrocortisone is a synthetic glucocorticoid often used as replacement therapy in adrenocortical insufficiency (also known as Addison's disease), which is characterized by impaired cortisol secretion from the adrenal glands (Bornstein et al., 2016). Cortisol is an essential hormone that regulates numerous physiological processes like metabolism, immune response, and vascular tone (Clow et al., 2010).

        

        In sepsis and septic shock cases, there is evidence suggesting that an adequate cortisol response is crucial for survival (Annane et al., 2002). Patients suffering from septic shock might experience relative adrenal insufficiency due to inadequate cortisol secretion in response to stress (Marik & Pastores, 2004)."
7573954,Hydrocortisone related to neoplasm,384,The objective of this study was to demonstrate the effect of stress doses of hydrocortisone during the initial phase of human septic shock on the serum values of the neurospecific protein S-100B in comparison to the inflammation markers interleukin (IL)-8 in serum and polymorphonuclear (PMN) elastase in plasma.,False,Is the triple 'Hydrocortisone related to neoplasm' supported by the sentence: 'The objective of this study was to demonstrate the effect of stress doses of hydrocortisone during the initial phase of human septic shock on the serum values of the neurospecific protein S-100B in comparison to the inflammation markers interleukin (IL)-8 in serum and polymorphonuclear (PMN) elastase in plasma.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to neoplasm"". The objective of the study as described is focused on examining the effects of stress doses of hydrocortisone on serum values of S-100B protein, IL-8 in serum, and PMN elastase in plasma during the initial phase of human septic shock. There is no mention or implication of neoplasm (abnormal growth of tissue/cancer) in relation to hydrocortisone in the provided context."
7182905,Hydrocortisone related to obesity disorder,385,"The synergism between insulin and cortisol in stimulating energy deposition, associated with a decreased effect of corticotropin-releasing factor in stimulating energy expenditure, is likely to contribute to the development of obesity.",True,"Is the triple 'Hydrocortisone related to obesity disorder' supported by the sentence: 'The synergism between insulin and cortisol in stimulating energy deposition, associated with a decreased effect of corticotropin-releasing factor in stimulating energy expenditure, is likely to contribute to the development of obesity.'?","Yes, there is indirect support for the phrase ""Hydrocortisone related to obesity disorder"" in the statement: ""The synergism between insulin and cortisol in stimulating energy deposition, associated with a decreased effect of corticotropin-releasing factor in stimulating energy expenditure, is likely to contribute to the development of obesity.""

         Justification:

         Cortisol is a glucocorticoid hormone that is released in response to stress and has been shown to play a significant role in energy metabolism and storage (1). Hydrocortisone is a synthetic form of cortisol that is often used in medical treatments (2). Therefore, any discussion about cortisol and obesity is relevant when considering hydrocortisone and obesity.

         In the statement provided, it is suggested that there is a synergistic effect between insulin and cortisol in stimulating energy deposition (a process that can contribute to obesity) and that there is a decreased effect of corticotropin-releasing factor in stimulating energy expenditure (which could also contribute to obes"
24445107,Hydrocortisone related to Inflammation,386,Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study.,True,Is the triple 'Hydrocortisone related to Inflammation' supported by the sentence: 'Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study.'?,"Yes, there is indirect support for the statement ""Hydrocortisone is related to inflammation"" from the given statement: ""Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study."" 

        

        Cortisol is a steroid hormone that belongs to the class of glucocorticoids, which includes hydrocortisone. Glucocorticoids like cortisol have been shown to play roles in modulating immune responses and inflammation in addition to their metabolic functions (Munck et al., 1984). 

        

        In the context of the given statement, higher basal cortisol levels were found to be predictive of verbal memory loss in postmenopausal women. This may be indicative of an underlying inflammatory process since chronic stress (and its associated cortisol release) has been associated with increased inflammation (Miller et al., 2002). 

        

        Thus, while not explicitly stated in the given study, there is indirect support for hydrocortis"
24030854,Hydrocortisone related to Hypoxemia,387,"A growing body of evidence now suggests that endogenous cortisol, which is produced in significant quantities by the body in a diurnal rhythm, is an important regulator of allergic disease expression and allergic inflammatory responses: lung function varies along with plasma cortisol levels; the number of circulating inflammatory cells varies with plasma cortisol levels; and low levels of endogenous cortisol may be associated with risk for asthma.",False,"Is the triple 'Hydrocortisone related to Hypoxemia' supported by the sentence: 'A growing body of evidence now suggests that endogenous cortisol, which is produced in significant quantities by the body in a diurnal rhythm, is an important regulator of allergic disease expression and allergic inflammatory responses: lung function varies along with plasma cortisol levels; the number of circulating inflammatory cells varies with plasma cortisol levels; and low levels of endogenous cortisol may be associated with risk for asthma.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to Hypoxemia."" The statement discusses the role of endogenous cortisol in allergic disease expression and inflammatory responses, including lung function and circulating inflammatory cells. Hydrocortisone is a synthetic form of cortisol, but the statement does not make any connection between hydrocortisone and hypoxemia (low oxygen levels in the blood). Therefore, while the statement provides valuable information about cortisol's role in allergic responses, it does not support the specific claim about hydrocortisone and hypoxemia."
12533519,Hydrocortisone related to Insulin resistance,388,"In conclusion, the data presented here suggest that cortisol can contribute to insulin resistance in ponies with hyperlipoproteinaemia.",True,"Is the triple 'Hydrocortisone related to Insulin resistance' supported by the sentence: 'In conclusion, the data presented here suggest that cortisol can contribute to insulin resistance in ponies with hyperlipoproteinaemia.'?","Yes, there is indirect support for the phrase ""Hydrocortisone related to Insulin resistance"" in light of the statement ""In conclusion, the data presented here suggest that cortisol can contribute to insulin resistance in ponies with hyperlipoproteinaemia."" 

         The rationale behind this is that hydrocortisone is a synthetic glucocorticoid drug often prescribed for its anti-inflammatory properties and ability to suppress immune response (Boumpas et al., 1993). Importantly, cortisol belongs to the same class of hormones as hydrocortisone (glucocorticoids). In humans, glucocorticoids have been associated with insulin resistance (Dickstein et al., 2007). Moreover, hydrocortisone replacement therapy in adrenal insufficiency patients has been shown to induce insulin resistance (Braley et al., 1995).

         In the context of the given statement about cortisol contributing to insulin resistance in ponies with hyperlipoproteinaemia, it is plausible that hydrocortisone"
27747116,Hydrocortisone causes toxic shock syndrome,389,"OBJECTIVE: To investigate the relationship of cortisol concentrations during the first week of life to patent ductus arteriosus (PDA), markers of lung inflammation, and respiratory outcome in very low birth weight infants.",False,"Is the triple 'Hydrocortisone causes toxic shock syndrome' supported by the sentence: 'OBJECTIVE: To investigate the relationship of cortisol concentrations during the first week of life to patent ductus arteriosus (PDA), markers of lung inflammation, and respiratory outcome in very low birth weight infants.'?","No, the statement does not provide any direct or indirect support for the claim that hydrocortisone causes toxic shock syndrome. The objective in question is focused on investigating the relationship between cortisol concentrations (which hydrocortisone can influence as it is a synthetic form of cortisol) during the first week of life in very low birth weight infants in relation to PDA, lung inflammation markers, and respiratory outcome.

         The study mentioned does not involve toxic shock syndrome at all, nor does it establish any causative relationship between hydrocortisone use and toxic shock syndrome. The study only investigates potential correlations between cortisol levels (including those potentially influenced by hydrocortisone) and certain medical conditions in infants."
27747115,Hydrocortisone causes Sepsis,390,Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease.,False,Is the triple 'Hydrocortisone causes Sepsis' supported by the sentence: 'Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease.'?,"No, the statement ""Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease"" does not provide indirect support for the claim ""Hydrocortisone causes Sepsis"". The study referenced by the statement compares two treatments for Crohn's disease but does not establish any link between hydrocortisone (a type of corticosteroid) and sepsis (a serious condition caused by the body's response to an infection).

         Sepsis is a complex condition that can be caused by various factors including infections from different types of bacteria, viruses, fungi, or parasites. Corticosteroids like hydrocortisone can suppress the immune system as part of their therapeutic action in treating inflammatory conditions such as Crohn's disease; however, they do not inherently cause sepsis.

         The misinterpretation might arise when considering that immunosuppression can increase susceptibility to infections which in turn might lead to sepsis under certain circumstances. Nonetheless, it is important to note that correlation does not imply causation; an increased risk of infection"
27073884,Hydrocortisone causes atopic eczema,391,Pharmacokinetics of high dose methylprednisolone and use in hematological malignancies.,False,Is the triple 'Hydrocortisone causes atopic eczema' supported by the sentence: 'Pharmacokinetics of high dose methylprednisolone and use in hematological malignancies.'?,"No, the statement ""Pharmacokinetics of high dose methylprednisolone and use in hematological malignancies"" does not provide indirect support for the claim that ""Hydrocortisone causes atopic eczema."" 

         The statement focuses on pharmacokinetics (the absorption, distribution, metabolism, and excretion) of high-dose methylprednisolone in hematological malignancies (blood cancers). This information is not relevant to hydrocortisone or atopic eczema, which is a chronic inflammatory skin condition. To provide indirect support for the claim that hydrocortisone causes atopic eczema, there would need to be some mention or implication connecting hydrocortisone use to an increased risk or exacerbation of atopic eczema symptoms in the statement. In the absence of such information, there is no basis for making such a connection between hydrocortisone use and atopic eczema development."
25383174,Hydrocortisone causes fibromyalgia,392,"Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.",False,"Is the triple 'Hydrocortisone causes fibromyalgia' supported by the sentence: 'Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes fibromyalgia."" The statement discusses Methylprednisolone, which is a different glucocorticoid than Hydrocortisone, and its use in treating advanced chronic lymphocytic leukaemia based on DiSC assay results. Fibromyalgia is not mentioned anywhere in the statement. Therefore, there is no connection between Methylprednisolone use in leukaemia treatment and Hydrocortisone causing fibromyalgia."
25205462,Hydrocortisone causes hypotensive disorder,393,The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis.,False,Is the triple 'Hydrocortisone causes hypotensive disorder' supported by the sentence: 'The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis.'?,"No, the statement ""The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis"" does not provide indirect support for the claim that ""Hydrocortisone causes hypotensive disorder.""

         The two statements discuss different corticosteroids (methylprednisolone vs hydrocortisone) and their respective effects on distinct medical conditions (ankylosing spondylitis vs hypotensive disorder). Methylprednisolone is not hydrocortisone, so no direct causal relationship can be inferred between hydrocortisone and hypotensive disorder based on the given statement alone.

         Moreover, even if both statements discussed hydrocortisone, it would still not provide sufficient evidence for inferring that hydrocortisone causes hypotensive disorder because the original statement only discusses methylprednisolone's impact on immunological and inflammatory processes in ankylosing spondylitis - not its influence on blood pressure.

         To establish such a connection between hydrocortisone use and hypotensive disorder, further studies specifically"
20591759,Hydrocortisone causes Hypoxemia,394,The effect of methylprednisolone (MP) on the cell kinetic response to cyclophosphamide (CP) and Adriamycin (ADR) in C3H/HeJ spontaneous mammary tumors and hematopoietic tissue was investigated.,False,Is the triple 'Hydrocortisone causes Hypoxemia' supported by the sentence: 'The effect of methylprednisolone (MP) on the cell kinetic response to cyclophosphamide (CP) and Adriamycin (ADR) in C3H/HeJ spontaneous mammary tumors and hematopoietic tissue was investigated.'?,"No, the statement does not provide indirect support for the claim that ""Hydrocortisone causes Hypoxemia"". The study investigates the effect of methylprednisolone (MP) on cell kinetic response to cyclophosphamide (CP) and Adriamycin (ADR) in C3H/HeJ spontaneous mammary tumors and hematopoietic tissue. Hydrocortisone is not mentioned in the statement, thus there is no connection that can be drawn between hydrocortisone use and hypoxemia based on this information alone.

         Hypoxemia is a condition characterized by low levels of oxygen in the blood. Hydrocortisone is a type of corticosteroid medication used for various conditions such as inflammation, allergies, and adrenal insufficiency. While corticosteroids can have side effects such as suppressing the immune system, promoting infection susceptibility, and affecting blood sugar levels, hypoxemia is not typically associated with hydrocortisone use.

         It is crucial in interpreting scientific statements that there is clear evidence linking specific variables under investigation before drawing"
18446972,Hydrocortisone causes congenital adrenal hyperplasia,395,High-dose intravenous methyl-prednisolone in chronic polymyositis/dermatomyositis.,False,Is the triple 'Hydrocortisone causes congenital adrenal hyperplasia' supported by the sentence: 'High-dose intravenous methyl-prednisolone in chronic polymyositis/dermatomyositis.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes congenital adrenal hyperplasia."" The statement refers to high-dose intravenous methyl-prednisolone use in chronic polymyositis/dermatomyositis, which is unrelated to hydrocortisone-induced congenital adrenal hyperplasia (CAH).

         Hydrocortisone is a glucocorticoid hormone that is primarily used as replacement therapy for adrenal insufficiency and other conditions requiring hormonal treatment. In contrast, methyl-prednisolone is also a glucocorticoid but is more commonly used for its potent anti-inflammatory effects in various diseases such as polymyositis/dermatomyositis.

         Congenital adrenal hyperplasia (CAH) is an inherited genetic disorder affecting the adrenal glands that can be caused by mutations in multiple genes involved in steroid hormone biosynthesis pathways. The most common form is 21-hydroxylase deficiency (21-OHD"
18240145,Hydrocortisone causes injury,396,Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing.,False,Is the triple 'Hydrocortisone causes injury' supported by the sentence: 'Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing.'?,"No, the statement ""Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing"" does not provide indirect support for the claim that ""Hydrocortisone causes injury."" The study referenced in the statement investigates the effects of two treatments (intratympanic gentamicin and methylprednisolone) for Meniere's disease on hearing preservation; it does not mention hydrocortisone in any capacity that would imply an association between its use and injury.

        To provide indirect support for the claim about hydrocortisone causing injury, there should be some connection established between hydrocortisone and injury in either the methodology, results, or discussion sections of the study; however, no such connection is present in this particular case. Therefore, it is not appropriate to infer that hydrocortisone causes injury based on the provided statement alone."
17359303,Hydrocortisone causes influenza,397,"High-dose methylprednisolone, vincristine, MTX, and ara-C (SOMA) as initial bulk reducing therapy in non-Hodgkin's lymphoma of unfavorable histology: preliminary results of an ongoing phase II study.",False,"Is the triple 'Hydrocortisone causes influenza' supported by the sentence: 'High-dose methylprednisolone, vincristine, MTX, and ara-C (SOMA) as initial bulk reducing therapy in non-Hodgkin's lymphoma of unfavorable histology: preliminary results of an ongoing phase II study.'?","No, the statement does not provide any indirect support for the phrase ""Hydrocortisone causes influenza"". The statement discusses initial bulk reducing therapy in non-Hodgkin's lymphoma using high-dose methylprednisolone, vincristine, MTX, and ara-C (SOMA). There is no mention or implication of hydrocortisone causing influenza in this context. Hydrocortisone is a corticosteroid hormone used in various medical treatments, while influenza is a viral infection. There is no direct or indirect link established between these two in the provided statement."
13585273,"Hydrocortisone causes dermatitis, atopic",398,A Prospective Study Comparing the Efficacy of Local Injection of Platelet-Rich Plasma (PRP) vs Methylprednisolone in Plantar Fasciitis.,False,"Is the triple 'Hydrocortisone causes dermatitis, atopic' supported by the sentence: 'A Prospective Study Comparing the Efficacy of Local Injection of Platelet-Rich Plasma (PRP) vs Methylprednisolone in Plantar Fasciitis.'?","No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone causes dermatitis, atopic"". The study in question is focused on comparing the efficacy of PRP (Platelet-Rich Plasma) injections and methylprednisolone in treating plantar fasciitis. Hydrocortisone is not mentioned in the title or study summary provided, so it does not contribute any evidence towards understanding its potential effects on dermatitis.

         The connection between hydrocortisone and dermatitis is well-established in medical literature; hydrocortisone is a type of corticosteroid that can cause skin reactions such as dermatitis when used topically for extended periods. However, without explicit mention or relevant context linking hydrocortisone and dermatitis in the given study, we cannot infer any support for that specific claim from it."
12645476,Hydrocortisone causes obesity disorder,399,A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis.,False,Is the triple 'Hydrocortisone causes obesity disorder' supported by the sentence: 'A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis.'?,"No, the statement ""A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis"" does not provide any direct or indirect support for the claim that ""Hydrocortisone causes obesity disorder."" 

        The statement refers to a controlled trial involving 6-methylprednisolone, which is a synthetic glucocorticoid used primarily for its potent anti-inflammatory effects in various disease states. Hydrocortisone is also a glucocorticoid but is structurally different from 6-methylprednisolone.

        The fact that one glucocorticoid (6-methylprednisolone) was used in a trial for acute alcoholic hepatitis does not automatically imply that another glucocorticoid (hydrocortisone) will cause obesity disorder as glucocorticoids have various therapeutic indications as well as potential side effects that can be steroid-specific or class-specific.

        To establish any potential link between hydrocortisone use and obesity disorder, one would need"
10068843,Hydrocortisone causes Inflammation,400,[Short-term therapy with methylprednisolone in exacerbated obstructive respiratory tract diseases].,False,Is the triple 'Hydrocortisone causes Inflammation' supported by the sentence: '[Short-term therapy with methylprednisolone in exacerbated obstructive respiratory tract diseases].'?,"No, the statement does not provide any indirect support for the claim that ""Hydrocortisone causes Inflammation"". The statement discusses short-term therapy using methylprednisolone in exacerbated obstructive respiratory tract diseases but does not mention hydrocortisone nor suggest any link between hydrocortisone use and inflammation.

         Hydrocortisone is actually an anti-inflammatory drug that belongs to a class called corticosteroids. It works by reducing inflammation in the body by mimicking the effects of naturally occurring hormones produced by the adrenal glands. Methylprednisolone is another corticosteroid that shares similar anti-inflammatory properties but is not hydrocortisone.

         In conclusion, there is no connection between hydrocortisone and inflammation in this statement. Instead, it speaks about methylprednisolone in respiratory diseases without any reference to inflammation caused by hydrocortisone."
9850315,Hydrocortisone causes dissociative amnesia,401,Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia.,False,Is the triple 'Hydrocortisone causes dissociative amnesia' supported by the sentence: 'Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia.'?,"No, the statement ""Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia"" does not provide indirect support for the claim that ""Hydrocortisone causes dissociative amnesia."" This study primarily focuses on Methylprednisolone as a treatment for COVID-19 pneumonia patients in hospital settings and does not mention Hydrocortisone nor dissociative amnesia in its methodology or results. The two statements pertain to different subjects (corticosteroids and their effects on COVID-19 patients vs hydrocortisone as a cause for dissociative amnesia) without any apparent overlap in their content.

        However, it is important to note that Hydrocortisone is another type of corticosteroid like Methylprednisolone, which could lead one to question whether they share similar side effects such as dissociative amnesia. Nonetheless, the study in question does not provide information that would enable us to draw such conclusions. To evaluate potential side effects associated with Hydrocortisone use, one would need to"
9318796,Hydrocortisone causes adrenocortical insufficiency,402,Intra-Carpal Injection of Ozone versus Methylprednisolone in Carpal Tunnel Syndrome of Systemic Sclerosis Patients: A Randomized Single-Blind Clinical Trial.,False,Is the triple 'Hydrocortisone causes adrenocortical insufficiency' supported by the sentence: 'Intra-Carpal Injection of Ozone versus Methylprednisolone in Carpal Tunnel Syndrome of Systemic Sclerosis Patients: A Randomized Single-Blind Clinical Trial.'?,"No, the statement ""Intra-Carpal Injection of Ozone versus Methylprednisolone in Carpal Tunnel Syndrome of Systemic Sclerosis Patients: A Randomized Single-Blind Clinical Trial"" does not provide indirect support for the phrase ""Hydrocortisone causes adrenocortical insufficiency."" 

         The study mentioned is focused on comparing the efficacy of ozone injections versus methylprednisolone injections in treating carpal tunnel syndrome in patients with systemic sclerosis. Hydrocortisone is not mentioned in the title or abstract provided; therefore, no conclusions can be drawn about its effects on adrenocortical insufficiency based on this study alone. 

         Adrenocortical insufficiency is a condition where the adrenal glands do not produce enough steroid hormones (such as cortisol). Hydrocortisone is a synthetic form of cortisol used in treating various conditions like adrenocortical insufficiency, allergies, skin conditions, ulcerative colitis, arthritis, lupus, multiple scler"
9145908,Hydrocortisone causes otitis externa,403,Methylprednisolone Pulses in West Syndrome: A New Weapon in the Armory-Is it Needed?,False,Is the triple 'Hydrocortisone causes otitis externa' supported by the sentence: 'Methylprednisolone Pulses in West Syndrome: A New Weapon in the Armory-Is it Needed?'?,"No, the statement ""Methylprednisolone Pulses in West Syndrome: A New Weapon in the Armory-Is it Needed?"" does not provide indirect support for the claim that ""Hydrocortisone causes otitis externa.""

         The statement discusses methylprednisolone pulses as a potential treatment for West Syndrome, which is a severe form of epilepsy in infants. There is no mention or implication of hydrocortisone in this statement, nor is there any reference made to otitis externa (inflammation of the outer ear canal).

         Hydrocortisone is a different type of corticosteroid drug than methylprednisolone. The effects of one corticosteroid cannot be generalized to another without specific evidence showing their pharmacological similarities causing equivalent outcomes in specific contexts.

         Moreover, establishing causation between a drug like hydrocortisone and otitis externa would require rigorous clinical studies demonstrating consistent associations between their usage and development of otitis externa.

         In conclusion, without explicit mention or evidence linking hydrocortisone usage to otitis"
8699464,Hydrocortisone causes adrenal cortex neoplasm,404,Patient underwent treatment with milrinone and methylprednisolone that showed reduction in myocardial inflammation and significantly improved myocardial contractility.,False,Is the triple 'Hydrocortisone causes adrenal cortex neoplasm' supported by the sentence: 'Patient underwent treatment with milrinone and methylprednisolone that showed reduction in myocardial inflammation and significantly improved myocardial contractility.'?,"No, the statement does not provide any direct or indirect support for the claim that hydrocortisone causes adrenal cortex neoplasm (a type of tumor). The patient in question was treated with milrinone and methylprednisolone, not hydrocortisone. Methylprednisolone is a synthetic glucocorticoid like hydrocortisone, but it is not hydrocortisone itself. Furthermore, even if hydrocortisone had been used in treatment, an observed reduction in myocardial inflammation and improved contractility would not imply an increased risk for adrenal cortex neoplasm.

        To establish a link between hydrocortisone use and adrenal cortex neoplasm, one would need evidence from epidemiological studies, clinical trials, or mechanistic experiments that show an increased incidence or risk associated with hydrocortisone use specifically. The statement provided does not contain any such information."
8657746,Hydrocortisone causes neoplasm,405,"Neurologically, the therapeutic dosages of anticoagulants are linked to the high incidence of thrombotic complexities, while methylprednisolone is associated with myopathy.",False,"Is the triple 'Hydrocortisone causes neoplasm' supported by the sentence: 'Neurologically, the therapeutic dosages of anticoagulants are linked to the high incidence of thrombotic complexities, while methylprednisolone is associated with myopathy.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes neoplasm"". The statement discusses neurological side effects of anticoagulants (linked to thrombotic complexities) and methylprednisolone (associated with myopathy). Hydrocortisone is not mentioned in the statement at all, let alone linked to neoplasm (abnormal tissue growth). To provide indirect support for ""Hydrocortisone causes neoplasm"", there should be some association made between hydrocortisone use and abnormal tissue growth in the statement, which is not present here."
7929803,Hydrocortisone causes Insulin resistance,406,"Conclusion: Based on the current data, the efficacy and safety of local injection of triamcinolone and methylprednisolone at doses of 20 and 40 mg were associated with a significant improvement in pain, functional status, and strength.",False,"Is the triple 'Hydrocortisone causes Insulin resistance' supported by the sentence: 'Conclusion: Based on the current data, the efficacy and safety of local injection of triamcinolone and methylprednisolone at doses of 20 and 40 mg were associated with a significant improvement in pain, functional status, and strength.'?","No, the statement does not provide indirect support for the claim that ""Hydrocortisone causes Insulin resistance"". The conclusion is about the efficacy and safety of local injections of triamcinolone and methylprednisolone at specific doses in improving pain, functional status, and strength. Hydrocortisone is not mentioned in the statement, nor is there any information about insulin resistance. Therefore, it is not possible to make an inference about hydrocortisone causing insulin resistance based on this statement alone.

         However, it is important to note that glucocorticoids like hydrocortisone, triamcinolone, and methylprednisolone have been associated with insulin resistance in some studies. But this specific statement does not provide evidence for that claim.

         To make a more informed decision about such a claim, one would need to review studies specifically investigating the relationship between hydrocortisone use and insulin resistance, taking into account factors such as dosage, duration of use, patient characteristics, and other potential confounding variables."
7432490,Hydrocortisone causes pancreatitis,407,OBJECTIVE: To validate the responsiveness of cerebrospinal fluid (CSF) inflammatory biomarkers to treatment with natalizumab and methylprednisolone in progressive MS and to examine the relationship between CSF inflammatory and tissue damage biomarkers.,False,Is the triple 'Hydrocortisone causes pancreatitis' supported by the sentence: 'OBJECTIVE: To validate the responsiveness of cerebrospinal fluid (CSF) inflammatory biomarkers to treatment with natalizumab and methylprednisolone in progressive MS and to examine the relationship between CSF inflammatory and tissue damage biomarkers.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes pancreatitis."" The objective in the statement is focused on validating the responsiveness of cerebrospinal fluid (CSF) inflammatory biomarkers to treatment with natalizumab and methylprednisolone in progressive MS and examining the relationship between CSF inflammatory and tissue damage biomarkers. Hydrocortisone is not mentioned in the objective, so there is no connection to be made between the statement and hydrocortisone causing pancreatitis.

         However, it is important to note that even if hydrocortisone were mentioned in the statement, it would not automatically imply causation for pancreatitis. A proper evaluation for causality would require rigorous clinical studies specifically designed to test such a hypothesis, including appropriate control groups, adequate sample sizes, and adjustment for potential confounding factors."
26997315,Hydrocortisone affects congenital adrenal hyperplasia,408,The region was identified as a significant predictor of use of intravenous methylprednisolone in MCD and MN patients.,False,Is the triple 'Hydrocortisone affects congenital adrenal hyperplasia' supported by the sentence: 'The region was identified as a significant predictor of use of intravenous methylprednisolone in MCD and MN patients.'?,"No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects congenital adrenal hyperplasia."" The statement refers to intravenous methylprednisolone use in MCD (mineralocorticoid deficiency) and MN (mineralocorticoid insufficiency) patients, not hydrocortisone use in congenital adrenal hyperplasia patients.

        However, it is worth noting that hydrocortisone is also used as a treatment for congenital adrenal hyperplasia due to its glucocorticoid properties. Methylprednisolone is primarily a mineralocorticoid, but it can have glucocorticoid effects as well. The relationship between these medications in various adrenal disorders can be complex due to overlapping therapeutic actions and potential interactions. Nevertheless, based on the information provided in the statement alone, there is no evidential support for the influence of hydrocortisone on congenital adrenal hyperplasia."
26940919,Hydrocortisone affects cardiac arrest,409,"Clinical commentary on ""Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica"".",False,"Is the triple 'Hydrocortisone affects cardiac arrest' supported by the sentence: 'Clinical commentary on ""Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica"".'?","No, the statement ""Clinical commentary on 'Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica'"" does not provide direct or indirect support for the phrase ""Hydrocortisone affects cardiac arrest."" Methylprednisolone is a synthetic glucocorticoid, while hydrocortisone is a naturally occurring glucocorticoid; they have similar mechanisms but are not identical in their effects on the body. The clinical commentary specifically discusses anaphylactic shock caused by methylprednisolone in patients with neuromyelitis optica; it does not mention hydrocortisone or cardiac arrest. Therefore, there is no connection that can be inferred between these two statements based on the provided information."
26840479,Hydrocortisone affects myocardial infarction,410,CONCLUSION: Results show that inhalation of budesonide (2 mg 3 times/day) and systemic methylprednisolone (40 mg/day) had similar clinical outcome in AECOPD.,False,Is the triple 'Hydrocortisone affects myocardial infarction' supported by the sentence: 'CONCLUSION: Results show that inhalation of budesonide (2 mg 3 times/day) and systemic methylprednisolone (40 mg/day) had similar clinical outcome in AECOPD.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects myocardial infarction."" The conclusion in the statement refers to two different medications (budesonide and methylprednisolone) used in treating Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). It does not mention hydrocortisone nor myocardial infarction; therefore, it does not offer any evidence regarding hydrocortisone's impact on myocardial infarction risk or outcome.

         The study referenced in the statement might provide insight into potential alternatives for treating AECOPD but does not contribute any information about hydrocortisone's effects on myocardial infarction risk or outcome. Thus, it is crucial not to draw conclusions based on unrelated evidence when interpreting scientific statements and claims."
24701128,Hydrocortisone affects Sepsis,411,A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease.,False,Is the triple 'Hydrocortisone affects Sepsis' supported by the sentence: 'A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease.'?,"No, the statement ""A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease"" does not provide indirect support for the phrase ""Hydrocortisone affects Sepsis."" 

        The clinical trial mentioned is focused on comparing the safety and efficacy of two treatments (topical Tacrolimus and Methylprednisolone) for ocular Graft-versus-Host Disease (GvHD). Methylprednisolone is a type of corticosteroid, similar to Hydrocortisone, but it is not Hydrocortisone itself. 

        Furthermore, the trial does not involve Sepsis patients or any investigation into the effects of these drugs on Sepsis. Therefore, it does not provide any relevant information or support for the claim that Hydrocortisone affects Sepsis."
21274202,Hydrocortisone affects osteoarthritis,412,The purpose of this study was to evaluate the efficacy of supraperiosteal injection of methylprednisolone compared with an oral tablet form and intravenous (i.v.) injection in the prevention of postoperative pain and oedema associated with inflammation.,False,Is the triple 'Hydrocortisone affects osteoarthritis' supported by the sentence: 'The purpose of this study was to evaluate the efficacy of supraperiosteal injection of methylprednisolone compared with an oral tablet form and intravenous (i.v.) injection in the prevention of postoperative pain and oedema associated with inflammation.'?,"No, the statement does not provide indirect support for the claim that hydrocortisone affects osteoarthritis. The study mentioned is focused on comparing different methods of administering methylprednisolone for postoperative pain management in surgeries associated with inflammation. Hydrocortisone is not mentioned in the study statement; hence it does not provide any evidence regarding hydrocortisone's effects on osteoarthritis.

        To provide indirect support for the claim that hydrocortisone affects osteoarthritis, one would need information related to hydrocortisone being studied in an osteoarthritis context or in relation to joint inflammation that osteoarthritis might cause. Since methylprednisolone is specified in the study statement instead of hydrocortisone, it does not give any credence to the assertion about hydrocortisone affecting osteoarthritis."
20701310,Hydrocortisone affects psoriasis,413,Gamma globulin and methylprednisolone in idiopathic thrombocytopenic purpura.,False,Is the triple 'Hydrocortisone affects psoriasis' supported by the sentence: 'Gamma globulin and methylprednisolone in idiopathic thrombocytopenic purpura.'?,"No, the statement ""Gamma globulin and methylprednisolone in idiopathic thrombocytopenic purpura"" does not provide indirect support for the claim that ""hydrocortisone affects psoriasis."" This is because idiopathic thrombocytopenic purpura (ITP) is a different medical condition from psoriasis, and gamma globulin and methylprednisolone are distinct medications from hydrocortisone. Although these medications can be used in treating various medical conditions (including ITP), their use does not necessarily imply any connection or similar effect on psoriasis by hydrocortisone. To establish indirect support for the original claim, there should be some connection between ITP, hydrocortisone, and psoriasis in terms of their biological pathways, mechanisms of action, or shared symptoms/pathophysiology. Since no such connection is apparent in the given statement, it does not provide indirect support for the claim about hydrocortisone affecting psoriasis."
20336537,Hydrocortisone affects dermatitis,414,Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy.,False,Is the triple 'Hydrocortisone affects dermatitis' supported by the sentence: 'Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy.'?,"No, the statement ""Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy"" does not provide direct or indirect support for the claim that ""Hydrocortisone affects dermatitis."" Methylprednisolone is a synthetic glucocorticoid similar to hydrocortisone in its anti-inflammatory effects but it is not identical in its therapeutic applications or side-effects profile. The statement provided focuses on methylprednisolone's potential hepatotoxicity in Graves' ophthalmopathy rather than its effects on dermatitis or hydrocortisone's effects on dermatitis in general."
20137862,Hydrocortisone affects fibromyalgia,415,"In orthognathic surgery, methylprednisolone > or =85 mg administered intravenously seemed sufficient to produce a significant decrease in edema, and several trials pointed toward a neuroregeneration effect, but no statistical analysis could be performed.",False,"Is the triple 'Hydrocortisone affects fibromyalgia' supported by the sentence: 'In orthognathic surgery, methylprednisolone > or =85 mg administered intravenously seemed sufficient to produce a significant decrease in edema, and several trials pointed toward a neuroregeneration effect, but no statistical analysis could be performed.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects fibromyalgia."" The statement discusses the effects of methylprednisolone in orthognathic surgery, which is unrelated to hydrocortisone or fibromyalgia. Hydrocortisone is a different glucocorticoid from methylprednisolone, and fibromyalgia is a distinct medical condition characterized by widespread pain and tenderness in muscles, joints, and soft tissues, accompanied by fatigue, sleep disturbances, memory problems, and mood changes. Although both methylprednisolone and hydrocortisone have anti-inflammatory properties, they have different therapeutic indications and side effects profiles. Therefore, evidence from methylprednisolone studies cannot be extrapolated to support hydrocortisone's effects on fibromyalgia without further investigation."
19555227,Hydrocortisone affects pneumonia,416,Response of symptoms and synovitis to intra-muscular methylprednisolone in osteoarthritis of the hand: an ultrasonographic study.,False,Is the triple 'Hydrocortisone affects pneumonia' supported by the sentence: 'Response of symptoms and synovitis to intra-muscular methylprednisolone in osteoarthritis of the hand: an ultrasonographic study.'?,"No, the statement ""Response of symptoms and synovitis to intra-muscular methylprednisolone in osteoarthritis of the hand: an ultrasonographic study"" does not provide indirect support for the claim that ""Hydrocortisone affects pneumonia."" 

         The reason is that methylprednisolone is not hydrocortisone, despite both being corticosteroids used in treating inflammation. They have different pharmacokinetic properties, meaning they can have different effects on various conditions due to their distinct mechanisms of action and tissue distribution profiles. 

         Furthermore, the study in question focuses on osteoarthritis in hands, not pneumonia; thus, it does not provide any relevant context for understanding how methylprednisolone (or hydrocortisone) could impact pneumonia symptoms or pathophysiology.

         In conclusion, there is no indirect support for the claim that hydrocortisone affects pneumonia based on the provided statement due to differences in drug molecules, mechanisms of action, targeted conditions, and study contexts."
19531871,Hydrocortisone affects atrial fibrillation,417,Long-term results of high-dose methylprednisolone in aplastic anemia.,False,Is the triple 'Hydrocortisone affects atrial fibrillation' supported by the sentence: 'Long-term results of high-dose methylprednisolone in aplastic anemia.'?,"No, the statement ""Long-term results of high-dose methylprednisolone in aplastic anemia"" does not provide indirect support for the claim that ""Hydrocortisone affects atrial fibrillation."" Here is why:

         Although both hydrocortisone and methylprednisolone belong to the class of drugs called glucocorticoids, they have different chemical structures and potencies. Methylprednisolone is more potent than hydrocortisone, which means it has greater anti-inflammatory effects at equivalent doses.

         The statement in question discusses the long-term results of high-dose methylprednisolone in treating aplastic anemia, which is an entirely different medical condition from atrial fibrillation. There is no direct or indirect mention of atrial fibrillation in this statement.

         Moreover, there is no evidence suggesting that the effects observed in patients receiving methylprednisolone for aplastic anemia would translate similarly to patients treated with hydrocortisone for atrial fibrillation.

         In conclusion, based on"
18495054,Hydrocortisone affects lymphoma,418,"Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.",False,"Is the triple 'Hydrocortisone affects lymphoma' supported by the sentence: 'Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects lymphoma."" The study mentioned in the statement assesses the efficacy of methylprednisolone and cyclophosphamide in pediatric IgA nephropathy using renal biopsy as an assessment tool. Hydrocortisone is not mentioned in the statement at all, so there is no basis for inferring any effect on lymphoma from it.

        However, it is important to note that hydrocortisone is a type of corticosteroid used in treating various medical conditions, including certain types of lymphoma. But without specific evidence linking hydrocortisone treatment for lymphoma in either humans or animal models, we cannot infer that it has any effect on lymphoma based on this statement alone.

        In conclusion, while hydrocortisone has been studied in relation to other medical conditions, there is no indirect support in the statement provided for any effect on lymphoma."
18495053,Hydrocortisone affects leukemia,419,"The impaired effect on lymphocyte blastogenesis of glucocorticoids administered in vivo, in contrast to a normal in vitro reaction to dexamethasone, together with recent findings of an altered glucocorticoid receptor pharmacology in AD, points to a decreased biological in vivo efficiency of methylprednisolone in atopic dermatitis.",False,"Is the triple 'Hydrocortisone affects leukemia' supported by the sentence: 'The impaired effect on lymphocyte blastogenesis of glucocorticoids administered in vivo, in contrast to a normal in vitro reaction to dexamethasone, together with recent findings of an altered glucocorticoid receptor pharmacology in AD, points to a decreased biological in vivo efficiency of methylprednisolone in atopic dermatitis.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects leukemia."" The statement discusses the impaired effect of glucocorticoids administered in vivo on lymphocyte blastogenesis in atopic dermatitis (AD) patients compared to in vitro reactions using dexamethasone. It further mentions an altered glucocorticoid receptor pharmacology in AD that could lead to decreased biological in vivo efficiency for methylprednisolone in AD patients. However, it does not mention hydrocortisone nor leukemia in any way that would provide support for that phrase. Hydrocortisone is one type of glucocorticoid, but no connection is made between it and leukemia in the provided statement."
18310128,Hydrocortisone affects toxic shock syndrome,420,"CONCLUSION: In this single-center trial, combined vasopressin-epinephrine and methylprednisolone during resuscitation and stress-dose hydrocortisone in postresuscitation shock improved survival in refractory in-hospital cardiac arrest.",True,"Is the triple 'Hydrocortisone affects toxic shock syndrome' supported by the sentence: 'CONCLUSION: In this single-center trial, combined vasopressin-epinephrine and methylprednisolone during resuscitation and stress-dose hydrocortisone in postresuscitation shock improved survival in refractory in-hospital cardiac arrest.'?","Yes, indirectly it does support the claim that hydrocortisone affects toxic shock syndrome. The statement provided discusses a trial where stress-dose hydrocortisone was used in postresuscitation shock for in-hospital cardiac arrest patients, which resulted in improved survival rates. This suggests that hydrocortisone has an impact on shock states, such as those seen in toxic shock syndrome (TSS).

        Toxic shock syndrome is characterized by profound circulatory shock due to bacterial superantigen-mediated T-cell activation leading to massive cytokine release. Hydrocortisone is known for its anti-inflammatory effects that might help mitigate cytokine storms seen in TSS by reducing inflammation and dampening immune response. Therefore, although not explicitly tested in TSS patients in this study, there is indirect support for hydrocortisone affecting toxic shock syndrome due to its potential influence on inflammation during shock states.

        However, it is essential to acknowledge that more direct evidence from studies specifically designed to evaluate hydrocortisone in toxic shock syndrome patients would provide stronger support for its potential therapeutic benefits in T"
17910566,Hydrocortisone affects atopic eczema,421,Weekly bortezomib/methylprednisolone is effective and well tolerated in relapsed multiple myeloma.,False,Is the triple 'Hydrocortisone affects atopic eczema' supported by the sentence: 'Weekly bortezomib/methylprednisolone is effective and well tolerated in relapsed multiple myeloma.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects atopic eczema."" The statement discusses the efficacy and tolerability of weekly bortezomib/methylprednisolone in relapsed multiple myeloma, which does not make any reference or implication towards hydrocortisone or atopic eczema. Hydrocortisone is a steroid hormone used primarily for its anti-inflammatory effects in various conditions such as atopic eczema; however, no such connection can be inferred from the given statement about bortezomib/methylprednisolone in multiple myeloma treatment."
15925719,Hydrocortisone affects Inflammation,422,Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.,False,Is the triple 'Hydrocortisone affects Inflammation' supported by the sentence: 'Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.'?,"No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects Inflammation."" The statement discusses a therapeutic approach for acute lymphoblastic leukemia in children using Amsacrine, etoposide, and high-dose methylprednisolone. Hydrocortisone is not mentioned in the statement; therefore, no conclusions can be drawn about its effect on inflammation based on this information alone. Hydrocortisone is a corticosteroid hormone that can reduce inflammation in the body; however, without explicit reference to it in the statement, no connection can be made between it and inflammation in this context."
14970164,Hydrocortisone affects Insulin resistance,423,Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.,False,Is the triple 'Hydrocortisone affects Insulin resistance' supported by the sentence: 'Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.'?,"No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects Insulin resistance."" The clinical trial mentioned in the statement compares two treatments (IV cyclophosphamide and IV methylprednisolone) for severe neurological manifestations in systemic lupus erythematosus (SLE). While methylprednisolone is a type of corticosteroid like hydrocortisone, the study does not investigate the impact of these treatments on insulin resistance. Therefore, it does not offer any evidence regarding hydrocortisone's effect on insulin resistance."
14804311,Hydrocortisone affects injury,424,Delayed hypersensitivity to 6-methyl-prednisolone in Henoch Schoenlein syndrome.,False,Is the triple 'Hydrocortisone affects injury' supported by the sentence: 'Delayed hypersensitivity to 6-methyl-prednisolone in Henoch Schoenlein syndrome.'?,"No, the statement ""Delayed hypersensitivity to 6-methyl-prednisolone in Henoch Schoenlein syndrome"" does not provide direct or indirect support for the phrase ""Hydrocortisone affects injury."" 

        

        The reason is that 6-methyl-prednisolone is not hydrocortisone; they are different corticosteroids. Although both have anti-inflammatory properties, they have distinct chemical structures and pharmacological profiles which may lead to different therapeutic effects, side effects, and interactions with immune responses such as delayed hypersensitivity.

        

        Henoch Schoenlein syndrome is an immune-mediated small-vessel vasculitis that can be managed using corticosteroids like hydrocortisone and 6-methyl-prednisolone among other treatments. The statement refers specifically to delayed hypersensitivity related to 6-methyl-prednisolone in Henoch Schoenlein syndrome but does not provide any information about hydrocortisone's potential effects on injuries.

        

        To support"
14533429,Hydrocortisone affects hypotensive disorder,425,Rectal absorption of radioactive 6-alpha-methyl prednisolone in ulcerative colitis.,False,Is the triple 'Hydrocortisone affects hypotensive disorder' supported by the sentence: 'Rectal absorption of radioactive 6-alpha-methyl prednisolone in ulcerative colitis.'?,"No, the statement ""Rectal absorption of radioactive 6-alpha-methyl prednisolone in ulcerative colitis"" does not provide direct or indirect support for the claim that ""Hydrocortisone affects hypotensive disorder."" 

        The reason is that these two statements discuss different topics. The first statement refers to the absorption of a specific type of corticosteroid (6-alpha-methyl prednisolone) in ulcerative colitis, which is a type of inflammatory bowel disease. On the other hand, the second statement is about hydrocortisone's potential effects on hypotensive disorder (low blood pressure).

        Hydrocortisone is another type of corticosteroid, but it is not mentioned or implied in the first statement. Even if we assume that 6-alpha-methyl prednisolone and hydrocortisone have similar effects due to being in the same drug class (corticosteroids), it still does not establish a connection between hydrocortisone and hypotensive disorder in this context.

        To provide indirect support for ""Hydrocortis"
13999195,Hydrocortisone affects congenital adrenal hyperplasia,426,Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.,False,Is the triple 'Hydrocortisone affects congenital adrenal hyperplasia' supported by the sentence: 'Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone affects congenital adrenal hyperplasia."" The study mentioned in the statement focuses on comparing pulse methylprednisolone versus two regimens of pulse cyclophosphamide in treating severe lupus nephritis, which is an autoimmune disease affecting the kidneys. There is no reference made in this study about hydrocortisone, congenital adrenal hyperplasia (CAH), or any connection between them.

         Hydrocortisone is a type of corticosteroid hormone that is primarily used as replacement therapy in conditions like adrenal insufficiency (AI). It is not typically used as a first-line treatment for congenital adrenal hyperplasia (CAH). CAH is an inherited disorder affecting the adrenal glands that results in deficiency in one of several enzymes needed for cortisol production; therefore, it may require different treatment approaches such as mineralocorticoid replacement therapy (e.g., fludrocortisone) and glucocorticoid therapy (e.g., hydro"
13347553,Hydrocortisone affects asthma,427,"The National Heart, Lung, and Blood Institute's ARDS Network currently is testing the use of methylprednisolone in late ARDS.",False,"Is the triple 'Hydrocortisone affects asthma' supported by the sentence: 'The National Heart, Lung, and Blood Institute's ARDS Network currently is testing the use of methylprednisolone in late ARDS.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects asthma."" The National Heart, Lung, and Blood Institute's ARDS Network is testing the use of methylprednisolone in late ARDS (Acute Respiratory Distress Syndrome), not hydrocortisone. Although methylprednisolone and hydrocortisone belong to the same class of drugs (glucocorticoids), they have different pharmacological properties that may affect their impact on various medical conditions such as asthma. Thus, it is essential to evaluate each drug independently based on relevant studies and evidence related specifically to that drug and condition in question."
13180935,Hydrocortisone affects hypotensive disorder,428,"(3) Preliminary results of an interim analysis from an ongoing randomized, prospective study showed that methylprednisolone (plus an antiviral agent?) may be useful for improving peripheral vestibular function in vestibular neuritis.",False,"Is the triple 'Hydrocortisone affects hypotensive disorder' supported by the sentence: '(3) Preliminary results of an interim analysis from an ongoing randomized, prospective study showed that methylprednisolone (plus an antiviral agent?) may be useful for improving peripheral vestibular function in vestibular neuritis.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects hypotensive disorder."" The study referenced in the statement investigates the effects of methylprednisolone (a glucocorticoid similar to hydrocortisone) on peripheral vestibular function in vestibular neuritis, which is unrelated to hypotensive disorder. The mechanisms of action and effects on different conditions for various glucocorticoids may not be equivalent; therefore, it is inappropriate to extrapolate these results to hydrocortisone and its potential effects on hypotensive disorder based on this statement alone."
11695335,Hydrocortisone affects Hypoxemia,429,This is the first report of cyclophosphamide and methylprednisolone leading to complete and sustained resolution of GAVE in association with systemic sclerosis.,False,Is the triple 'Hydrocortisone affects Hypoxemia' supported by the sentence: 'This is the first report of cyclophosphamide and methylprednisolone leading to complete and sustained resolution of GAVE in association with systemic sclerosis.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone affects Hypoxemia"". The statement discusses the effects of cyclophosphamide and methylprednisolone on gastroesophageal arterial venous malformation (GAVE) associated with systemic sclerosis. Hypoxemia is a condition characterized by low oxygen levels in the blood, while hydrocortisone is a type of steroid hormone often used for its anti-inflammatory effects. There is no mention or implication connecting hydrocortisone to hypoxemia in the provided statement."
11304252,Hydrocortisone affects obesity disorder,430,We compared lymphocyte-suppressive potencies of prednisolone and methylprednisolone in rheumatoid arthritis (RA).,False,Is the triple 'Hydrocortisone affects obesity disorder' supported by the sentence: 'We compared lymphocyte-suppressive potencies of prednisolone and methylprednisolone in rheumatoid arthritis (RA).'?,"No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects obesity disorder"". The study focuses on comparing lymphocyte-suppressive potencies of prednisolone and methylprednisolone in rheumatoid arthritis (RA). Hydrocortisone is not mentioned in the statement, nor is there any connection made between glucocorticoids (such as prednisolone and methylprednisolone) and obesity disorder. Therefore, it is not possible to draw any conclusions about hydrocortisone's effect on obesity disorder based on this information alone."
10523644,Hydrocortisone affects injury,431,"Despite the lucrative ""off label"" markets for methylprednisolone in SCI, no Food and Drug Association indication has been obtained.",False,"Is the triple 'Hydrocortisone affects injury' supported by the sentence: 'Despite the lucrative ""off label"" markets for methylprednisolone in SCI, no Food and Drug Association indication has been obtained.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects injury."" The statement discusses methylprednisolone use in spinal cord injuries (SCI) and its lack of Food and Drug Administration (FDA) indication. Hydrocortisone is a different glucocorticoid than methylprednisolone; therefore, any effects on injury would not be supported by this information.

         To provide indirect support for ""Hydrocortisone affects injury,"" there would need to be some evidence linking hydrocortisone specifically either positively or negatively in some way to injury in the provided statement or inferences drawn from it. The fact that methylprednisolone has no FDA indication for SCI does not imply hydrocortisone has an effect on injury either way.

         It is essential in interpreting scientific statements that information is specific and directly related to the subject in question for accurate conclusions to be drawn. In this case, there is no clear link between hydrocortisone and injury in the provided statement."
10431364,Hydrocortisone affects Inflammation,432,Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis.,False,Is the triple 'Hydrocortisone affects Inflammation' supported by the sentence: 'Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis.'?,"No, the statement ""Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis"" does not provide direct or indirect support for the phrase ""Hydrocortisone affects Inflammation."" 

        

        Methylprednisolone is a synthetic glucocorticoid, similar to hydrocortisone, which is used to reduce inflammation and suppress the immune system in various conditions such as myasthenia gravis. However, the statement in question focuses on extraocular muscle responses specifically in myasthenia gravis patients treated with methylprednisolone rather than inflammation in general.

        

        Although both hydrocortisone and methylprednisolone belong to the glucocorticoid class of steroid hormones that share anti-inflammatory properties, there is no direct link established between these two particular statements concerning their impact on inflammation.

        

        To provide indirect support at minimum, one would need additional information connecting methylprednisolone treatment in myasthenia gravis patients to its anti-inflammat"
10074536,Hydrocortisone affects HIV infectious disease,433,The increased CSF levels of TNF-sRp55 in response to MP circumstantially suggest that this receptor could partially account for the beneficial effects of MP in acute MS.,False,Is the triple 'Hydrocortisone affects HIV infectious disease' supported by the sentence: 'The increased CSF levels of TNF-sRp55 in response to MP circumstantially suggest that this receptor could partially account for the beneficial effects of MP in acute MS.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects HIV infectious disease."" The statement discusses the potential role of Microglial Proliferation (MP) in Multiple Sclerosis (MS) and Tumor Necrosis Factor Receptor Superfamily Member 55 (TNF-sRp55) in response to MP in acute MS. While hydrocortisone is used as an anti-inflammatory agent in various medical conditions, there is no direct or indirect reference connecting it to HIV infectious disease in this statement."
9872405,Hydrocortisone affects toxic shock syndrome,434,"Such an effect has been demonstrated between clarithromycin and methylprednisolone, two drugs that may be administered concomitantly in asthma.",False,"Is the triple 'Hydrocortisone affects toxic shock syndrome' supported by the sentence: 'Such an effect has been demonstrated between clarithromycin and methylprednisolone, two drugs that may be administered concomitantly in asthma.'?","No, the statement does not provide indirect support for the claim that hydrocortisone affects toxic shock syndrome based on the provided information. The statement only mentions an interaction between clarithromycin and methylprednisolone in asthma patients without specifying any connection to toxic shock syndrome. Hydrocortisone is also not mentioned in the statement as being involved in any interaction. To establish indirect support for the initial claim, there should be some linkage between hydrocortisone, toxic shock syndrome, and drug interactions in general; however, no such link is evident in the given context."
9610203,Hydrocortisone affects neoplasm,435,"In this study, low-dose methylprednisolone (0.8 mg/kg/day, MP) was used to induce a steroid-resistant lupus nephritis (SR-LN) mouse model in weeks one to four, and a therapeutic steroid dosage (MP 12 mg/kg/day) or a combined PNS (PNS 100 mg/kg/day) treatment was administered from week five to eight.",False,"Is the triple 'Hydrocortisone affects neoplasm' supported by the sentence: 'In this study, low-dose methylprednisolone (0.8 mg/kg/day, MP) was used to induce a steroid-resistant lupus nephritis (SR-LN) mouse model in weeks one to four, and a therapeutic steroid dosage (MP 12 mg/kg/day) or a combined PNS (PNS 100 mg/kg/day) treatment was administered from week five to eight.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects neoplasm."" The study uses methylprednisolone (MP) in both low-dose and therapeutic dosages in an SR-LN mouse model, as well as Polyinosinic-Polycytidylic Acid (PNS) in week five to eight; however, it does not mention hydrocortisone nor any form of neoplasm (abnormal growths that can be benign or malignant).

         The lack of reference to hydrocortisone in particular is important because hydrocortisone is a specific type of corticosteroid that can have distinct effects compared to other corticosteroids like methylprednisolone. In addition, neoplasm is a broad term encompassing various types of abnormal growths; without specifying which type is being studied (e.g., carcinoma, sarcoma, leukemia), it is difficult to make any connection between the study and neoplasm in general.

         Therefore, based on the provided statement alone, there is no indirect support for the claim that hydrocortis"
9120606,Hydrocortisone affects asthma,436,MP was administrated in three alternative ways: intraperitoneally during the induction of cytotoxic edema or immediately after finishing cytotoxic edema induction in a dose of 100 mg/kg b.w.; into the internal carotid artery within 2 h after finishing cytotoxic edema induction in a dose of 50 mg/kg b.w.; into internal carotid artery 10 min after edema induction by BBBd in a dose of 50 mg/kg b.w.,False,Is the triple 'Hydrocortisone affects asthma' supported by the sentence: 'MP was administrated in three alternative ways: intraperitoneally during the induction of cytotoxic edema or immediately after finishing cytotoxic edema induction in a dose of 100 mg/kg b.w.; into the internal carotid artery within 2 h after finishing cytotoxic edema induction in a dose of 50 mg/kg b.w.; into internal carotid artery 10 min after edema induction by BBBd in a dose of 50 mg/kg b.w.'?,"No, the statement does not provide direct support for the phrase ""Hydrocortisone affects asthma."" The statement discusses how MP (presumably a drug) was administered in different ways and at different times in relation to cytotoxic edema induction and blood-brain barrier disruption (BBBd). There is no mention of asthma or any related symptoms in this statement.

        
        However, hydrocortisone is a steroid hormone often used as an anti-inflammatory medication and has been studied in relation to asthma treatment (Barnes, 2016). The statement provided may be relevant if MP is hydrocortisone or another steroid used for treating asthma, but without further context or evidence linking MP administration to asthma improvement, it is impossible to conclude that hydrocortisone affects asthma based on this statement alone.


        
       REFERENCE:
       Barnes, P. J. (2016). New developments in glucocorticoid therapy for asthma. Immun"
8017440,Hydrocortisone affects obesity disorder,437,"On the other hand, daily administration of methylprednisolone and tenoxicam for 4 weeks caused increased inflammation and fibrosis and wasn't affective on protection of nerve physiomorphology.",False,"Is the triple 'Hydrocortisone affects obesity disorder' supported by the sentence: 'On the other hand, daily administration of methylprednisolone and tenoxicam for 4 weeks caused increased inflammation and fibrosis and wasn't affective on protection of nerve physiomorphology.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects obesity disorder."" The statement discusses the effects of methylprednisolone and tenoxicam on inflammation and nerve physiomorphology after 4 weeks of daily administration. Hydrocortisone is not mentioned in this context at all, let alone its potential impact on obesity disorder. Therefore, it is inappropriate to draw any conclusions about hydrocortisone based on this statement alone."
7974249,Hydrocortisone affects Insulin resistance,438,Methylprednisolone was temporarily stopped while a broad work up for inflammatory and neoplastic causes was pursued.,False,Is the triple 'Hydrocortisone affects Insulin resistance' supported by the sentence: 'Methylprednisolone was temporarily stopped while a broad work up for inflammatory and neoplastic causes was pursued.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects Insulin resistance."" 

         The statement ""Methylprednisolone was temporarily stopped while a broad work up for inflammatory and neoplastic causes was pursued"" refers to an instance where Methylprednisolone, another type of corticosteroid medication, was temporarily discontinued for diagnostic purposes. This statement does not mention Hydrocortisone nor provide any information about Insulin resistance. Therefore, it does not offer any indirect support for the claim that Hydrocortisone affects Insulin resistance.

         Hydrocortisone and Methylprednisolone share some properties as they both belong to the class of corticosteroids; however, they have distinct pharmacological profiles that may result in different effects on insulin resistance. As such, any evidence supporting a relationship between Hydrocortisone and Insulin resistance would need to be derived from studies specifically examining Hydrocortisone rather than relying on indirect associations from other corticosteroids like Methylprednisolone."
7366981,Hydrocortisone affects Hypoxemia,439,"Pneumocystis pneumonia induced by this dose of tacrolimus has been reported in many cases; however, we encountered a rare case of Pneumocystis pneumonia induced by low-dose tacrolimus and methylprednisolone.",False,"Is the triple 'Hydrocortisone affects Hypoxemia' supported by the sentence: 'Pneumocystis pneumonia induced by this dose of tacrolimus has been reported in many cases; however, we encountered a rare case of Pneumocystis pneumonia induced by low-dose tacrolimus and methylprednisolone.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects Hypoxemia"". The statement discusses Pneumocystis pneumonia induced by different doses of tacrolimus and methylprednisolone, but it does not mention hydrocortisone or hypoxemia. Hypoxemia refers to low oxygen levels in the blood, while hydrocortisone is a type of corticosteroid often used for its anti-inflammatory effects. Without further information connecting these concepts, it is not valid to infer that hydrocortisone affects hypoxemia based on this statement alone."
7266667,Hydrocortisone affects dissociative amnesia,440,The increased interval in the administration of MP resulted in slightly greater pain and an increased prevalence of NeP.,False,Is the triple 'Hydrocortisone affects dissociative amnesia' supported by the sentence: 'The increased interval in the administration of MP resulted in slightly greater pain and an increased prevalence of NeP.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects dissociative amnesia."" 

        The statement discusses the effects of an increased interval in the administration of Methylprednisolone (MP) on pain and neuropathic pain (NeP) prevalence. Hydrocortisone is a different glucocorticoid medication than MP, and dissociative amnesia is a distinct medical condition unrelated to pain management or neuropathic pain. Since there is no connection between glucocorticoids (MP) used for pain management and hydrocortisone's potential impact on dissociative amnesia in either the statement or any implied context, there is no indirect support for the phrase in question."
27426083,Hydrocortisone produces HIV infectious disease,441,"We describe that high-dose methylprednisolone (20 mg/kg) can induce multifocal osteonecrosis (ON) in conjunction with thrombocytopenia, hypofibrinogenemia, and hyperlipemia.",False,"Is the triple 'Hydrocortisone produces HIV infectious disease' supported by the sentence: 'We describe that high-dose methylprednisolone (20 mg/kg) can induce multifocal osteonecrosis (ON) in conjunction with thrombocytopenia, hypofibrinogenemia, and hyperlipemia.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces HIV infectious disease"". The statement discusses the side effects of high-dose methylprednisolone (a type of corticosteroid) on bone necrosis, thrombocytopenia, hypofibrinogenemia, and hyperlipemia in patients but does not mention hydrocortisone or HIV in any capacity.

         The two statements discuss unrelated medical topics; one is about methylprednisolone-induced osteonecrosis and related conditions, while the other is about hydrocortisone potentially causing HIV infectious disease. The connection between these two statements is tenuous at best because they do not share common elements beyond corticosteroids (methylprednisolone and hydrocortisone).

         The statement also does not mention any interactions between methylprednisolone and HIV infection risk; therefore, it does not provide indirect evidence for any relationship between hydrocortisone use and HIV infectious disease risk either.

         In conclusion, while hydrocortisone is another type of corticosteroid"
24427531,Hydrocortisone produces cirrhosis of liver,442,"OBJECTIVE: To report the third published case, as of April 8, 2006, of methylprednisolone-induced toxic hepatitis.",False,"Is the triple 'Hydrocortisone produces cirrhosis of liver' supported by the sentence: 'OBJECTIVE: To report the third published case, as of April 8, 2006, of methylprednisolone-induced toxic hepatitis.'?","No, the phrase ""Hydrocortisone produces cirrhosis of liver"" does not receive indirect support from the statement: ""OBJECTIVE: To report the third published case, as of April 8, 2006, of methylprednisolone-induced toxic hepatitis.""

         The reason for my decision is that methylprednisolone and hydrocortisone are two distinct types of corticosteroids. Although they belong to the same class of drugs, they have different chemical structures and may exhibit distinct side effects profiles. Methylprednisolone is a synthetic glucocorticoid mainly used for its potent anti-inflammatory and immunosuppressive effects in various medical conditions. On the other hand, hydrocortisone is also a glucocorticoid but is naturally produced in the human body; it is often used as a replacement therapy in adrenal insufficiency and has lower potency than methylprednisolone.

         The statement in question refers specifically to methylprednisolone-induced toxic hepatitis, which implies liver damage caused by methylprednisolone use rather than"
23738730,Hydrocortisone produces congenital adrenal hyperplasia,443,"To our knowledge, this is the first discussion considering the possibility that the methylprednisolone recommended by NASCIS may cause acute corticosteroid myopathy.",False,"Is the triple 'Hydrocortisone produces congenital adrenal hyperplasia' supported by the sentence: 'To our knowledge, this is the first discussion considering the possibility that the methylprednisolone recommended by NASCIS may cause acute corticosteroid myopathy.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces congenital adrenal hyperplasia"". The statement discusses the potential side effect (acute corticosteroid myopathy) of methylprednisolone, a different type of corticosteroid than hydrocortisone, as recommended by NASCIS (National Acute Spinal Cord Injury Studies). Congenital adrenal hyperplasia is an inherited disorder affecting the adrenal glands and is not mentioned nor implied in the provided statement. The two statements discuss different corticosteroids and their distinct effects on human health."
20514012,"Hydrocortisone produces dermatitis, atopic",444,"However, high-dose steroids like dexamethasone or methylprednisolone had proven their clearcut anti-tumoral action.",False,"Is the triple 'Hydrocortisone produces dermatitis, atopic' supported by the sentence: 'However, high-dose steroids like dexamethasone or methylprednisolone had proven their clearcut anti-tumoral action.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces dermatitis, atopic"". The statement discusses high-dose steroids such as dexamethasone and methylprednisolone in relation to their anti-tumoral action but does not mention hydrocortisone or dermatitis at all. Hydrocortisone is also considered a steroid but it is used primarily for its anti-inflammatory action rather than anti-tumoral action like dexamethasone and methylprednisolone.

         Dermatitis is an inflammatory condition that can be caused by exposure to various substances including hydrocortisone when used inappropriately. However, without explicit mention or evidence linking hydrocortisone use with dermatitis in the statement provided, it cannot be said that there is any indirect support for that claim based on that statement alone."
18924640,Hydrocortisone produces Inflammation,445,"Methylprednisolone increases some astrogliosis and inflammation biomarkers' levels; however, it did not affect the apoptotic biomarkers.",False,"Is the triple 'Hydrocortisone produces Inflammation' supported by the sentence: 'Methylprednisolone increases some astrogliosis and inflammation biomarkers' levels; however, it did not affect the apoptotic biomarkers.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces Inflammation."" 

        The statement discusses the effects of Methylprednisolone on astrogliosis (a type of glial cell reaction) and inflammation biomarkers, not Hydrocortisone. Hydrocortisone and Methylprednisolone are both glucocorticoids used in treating inflammation; however, they may have different effects on various inflammation markers based on their specific pharmacological properties. Therefore, without additional evidence linking Hydrocortisone to increased inflammation in this context, one cannot infer that Hydrocortisone produces inflammation based on the provided statement about Methylprednisolone."
16473285,Hydrocortisone produces type 1 diabetes mellitus,446,Effect of Methylprednisolone on Inflammation and Coagulation in Patients with Severe COVID-19: A Retrospective Cohort Study.,False,Is the triple 'Hydrocortisone produces type 1 diabetes mellitus' supported by the sentence: 'Effect of Methylprednisolone on Inflammation and Coagulation in Patients with Severe COVID-19: A Retrospective Cohort Study.'?,"No, the statement ""Effect of Methylprednisolone on Inflammation and Coagulation in Patients with Severe COVID-19: A Retrospective Cohort Study"" does not provide indirect support for the claim that ""Hydrocortisone produces type 1 diabetes mellitus.""

         The reason is that although both hydrocortisone and methylprednisolone belong to the class of medications called glucocorticoids (steroids), they have different chemical structures that can lead to distinct side effects profiles. Methylprednisolone was used in the study in question for its anti-inflammatory properties in treating severe COVID-19 patients; however, it does not imply that hydrocortisone would have similar effects on diabetes mellitus type 1 onset.

         Type 1 diabetes mellitus is an autoimmune disease where the body attacks its insulin-producing cells in the pancreas; it is not typically caused by steroid use alone. Therefore, without specific evidence linking hydrocortisone use to type 1 diabetes mellitus development, we cannot infer that there"
15760263,Hydrocortisone produces toxic shock syndrome,447,"METHODS/DESIGN: This study is a 12-week, randomised, double-blind, placebo-controlled trial analysing the effects of high-dose intravenous methylprednisolone in very early SSc.",False,"Is the triple 'Hydrocortisone produces toxic shock syndrome' supported by the sentence: 'METHODS/DESIGN: This study is a 12-week, randomised, double-blind, placebo-controlled trial analysing the effects of high-dose intravenous methylprednisolone in very early SSc.'?","No, the statement does not provide any direct or indirect support for the claim that hydrocortisone produces toxic shock syndrome (TSS). The study mentioned is investigating the effects of high-dose intravenous methylprednisolone in very early systemic sclerosis (SSc), not hydrocortisone. To establish a connection between hydrocortisone and TSS, there would need to be evidence linking hydrocortisone specifically to TSS cases, either through direct causation mechanisms or epidemiological studies showing an increased risk in patients administered hydrocortisone. Since no such evidence is presented in the statement provided, we cannot infer any support for the claim in question."
15330155,Hydrocortisone produces chronic primary adrenal insufficiency,448,"Methods: The potential interferences Se@SiO2 nanocomposites may have to the therapeutic effect of methylprednisolone (MPS) were evaluated by classical therapeutic effect index of acute respiratory distress syndrome (ARDS), such as wet-to-dry weight ratio, inflammatory factors IL-1beta and TNF-alpha.",False,"Is the triple 'Hydrocortisone produces chronic primary adrenal insufficiency' supported by the sentence: 'Methods: The potential interferences Se@SiO2 nanocomposites may have to the therapeutic effect of methylprednisolone (MPS) were evaluated by classical therapeutic effect index of acute respiratory distress syndrome (ARDS), such as wet-to-dry weight ratio, inflammatory factors IL-1beta and TNF-alpha.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces chronic primary adrenal insufficiency."" The methods described in the statement evaluate potential interferences Se@SiO2 nanocomposites may have on the therapeutic effect of methylprednisolone (MPS) in treating acute respiratory distress syndrome (ARDS). Hydrocortisone is not mentioned in this context; therefore, it does not offer any relevant information regarding hydrocortisone-induced adrenal insufficiency.

        To provide indirect support for the claim that hydrocortisone produces chronic primary adrenal insufficiency, one would need evidence showing hydrocortisone negatively affecting adrenal gland function over time. This could involve measuring adrenal hormone levels before and after hydrocortisone administration in multiple patients or experimental subjects while controlling for confounding factors such as age, sex, comorbidities, and concomitant medications that could influence adrenal function.

        The provided statement focuses on assessing nanocomposites interference in MPS therapy for ARDS using specific indicators such as wet-to-d"
14100936,Hydrocortisone produces Insulin resistance,449,Our case likely represents worsening of DON due to soft tissue swelling secondary to OR despite cover with IVMP in a patient previously responsive to IVMP alone.,False,Is the triple 'Hydrocortisone produces Insulin resistance' supported by the sentence: 'Our case likely represents worsening of DON due to soft tissue swelling secondary to OR despite cover with IVMP in a patient previously responsive to IVMP alone.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces Insulin resistance"". The statement discusses a case likely representing worsening of paraneoplastic syndrome (DON) due to soft tissue swelling secondary to orthopedic surgery (OR) despite cover with intravenous methylprednisolone (IVMP) in a patient previously responsive to IVMP alone. Hydrocortisone is a different type of steroid than methylprednisolone (IVMP), and there is no mention of insulin resistance in relation to hydrocortisone in this statement."
13891079,Hydrocortisone produces obesity disorder,450,[Treatment of invasive thymoma with myasthenia gravis: a case report responsive to azathioprine and methylprednisolone].,False,Is the triple 'Hydrocortisone produces obesity disorder' supported by the sentence: '[Treatment of invasive thymoma with myasthenia gravis: a case report responsive to azathioprine and methylprednisolone].'?,"No, the statement does not provide any direct or indirect support for the claim that hydrocortisone produces obesity disorder. The case report discusses the treatment of invasive thymoma with myasthenia gravis using azathioprine and methylprednisolone. Methylprednisolone is a type of corticosteroid like hydrocortisone, but there is no mention in the report connecting hydrocortisone specifically to obesity disorder.

         Furthermore, associating a specific pharmaceutical agent like hydrocortisone with obesity disorder would require more extensive epidemiological and clinical evidence demonstrating a consistent correlation between the two variables while controlling for confounding factors. A single case report does not meet these criteria for establishing such an association."
13796050,Hydrocortisone produces adrenal cortex neoplasm,451,High-dose intravenous methylprednisolone is the first-line therapy for acute exacerbations of NMO.,False,Is the triple 'Hydrocortisone produces adrenal cortex neoplasm' supported by the sentence: 'High-dose intravenous methylprednisolone is the first-line therapy for acute exacerbations of NMO.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces adrenal cortex neoplasm."" 

         The statement suggests that high-dose intravenous methylprednisolone is used as a first-line therapy for acute exacerbations of Neuromyelitis Optica (NMO). Methylprednisolone is a type of corticosteroid, similar to hydrocortisone, but they have different pharmacological profiles and uses. 

         The development of adrenal cortex neoplasm (cancer) is multifactorial and can be influenced by various factors including genetics, environment, and long-term exposure to certain hormones. While both methylprednisolone and hydrocortisone are corticosteroids, there is no direct link established in the statement between hydrocortisone use and adrenal cortex neoplasm. Therefore, it does not provide indirect support for the claim. 

         However, it is important to note that long-term use of high-dose corticosteroids has been associated with various side effects including Cushing's syndrome,"
13783969,Hydrocortisone produces adrenocortical insufficiency,452,"CONCLUSION: Although the delayed administration of high-dose MP did not significantly increase the severity of pain or prevalence of NeP, it should still be avoided due to the increased risk of serious side effects.",False,"Is the triple 'Hydrocortisone produces adrenocortical insufficiency' supported by the sentence: 'CONCLUSION: Although the delayed administration of high-dose MP did not significantly increase the severity of pain or prevalence of NeP, it should still be avoided due to the increased risk of serious side effects.'?","No, the statement does not provide indirect support for ""Hydrocortisone produces adrenocortical insufficiency."" The conclusion mentioned is about methylprednisolone (MP), not hydrocortisone. Adrenocortical insufficiency is not mentioned in the conclusion nor is it linked to methylprednisolone in any way in that statement. Therefore, there is no indirect support for the initial phrase."
13669597,Hydrocortisone produces asthma,453,Methylprednisolone has been used in other Th1 mediated diseases such as rheumatoid arthritis in an attempt to switch off the immune response and so we investigated the efficacy of three days of high dose (1 g) intravenous methylprednisolone at the start of prednisolone therapy in leprosy Type 1 reactions and nerve function impairment.,False,Is the triple 'Hydrocortisone produces asthma' supported by the sentence: 'Methylprednisolone has been used in other Th1 mediated diseases such as rheumatoid arthritis in an attempt to switch off the immune response and so we investigated the efficacy of three days of high dose (1 g) intravenous methylprednisolone at the start of prednisolone therapy in leprosy Type 1 reactions and nerve function impairment.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces asthma."" The statement discusses the use of methylprednisolone in rheumatoid arthritis and leprosy Type 1 reactions, but it does not mention hydrocortisone or asthma at all. Hydrocortisone and methylprednisolone are both corticosteroids, but they are not identical, and their effects can differ. Therefore, any conclusions about hydrocortisone's impact on asthma cannot be inferred from this statement alone."
12147996,Hydrocortisone produces Sepsis,454,Myelitis in these patients was not related to graft versus host disease or immune reconstitution and was responsive to intravenous methylprednisolone and cyclophosphamide.,False,Is the triple 'Hydrocortisone produces Sepsis' supported by the sentence: 'Myelitis in these patients was not related to graft versus host disease or immune reconstitution and was responsive to intravenous methylprednisolone and cyclophosphamide.'?,"No, the statement does not provide any indirect support for the phrase ""Hydrocortisone produces Sepsis."" In fact, it seems to contradict it. The statement suggests that intravenous methylprednisolone (a type of corticosteroid like hydrocortisone) was used to treat myelitis in patients, implying that it was part of the solution, not the cause of sepsis. However, it's important to note that association does not imply causation, and the use of methylprednisolone does not necessarily mean it caused sepsis. But in the context of this statement alone, there is no support for hydrocortisone causing sepsis."
11989948,Hydrocortisone produces Hypoxemia,455,"We investigated the effects of YM264, WEB2086, methylprednisolone and ticlopidine on puromycin-induced nephropathy in the rat.",False,"Is the triple 'Hydrocortisone produces Hypoxemia' supported by the sentence: 'We investigated the effects of YM264, WEB2086, methylprednisolone and ticlopidine on puromycin-induced nephropathy in the rat.'?","No, the statement does not provide any direct or indirect support for the claim that ""Hydrocortisone produces Hypoxemia."" The investigation focused on puromycin-induced nephropathy in rats and involved drugs such as YM264, WEB2086, methylprednisolone, and ticlopidine; however, it does not mention hydrocortisone nor any related effects on blood oxygen levels (hypoxemia).

        To establish indirect support for such a claim, one could argue that methylprednisolone is a synthetic glucocorticoid similar to hydrocortisone (both in terms of structure and function). However, since no specific information is provided about methylprednisolone inducing hypoxemia in this study nor any related studies mentioned in conjunction, it would still be inappropriate to infer that hydrocortisone has hypoxemia-inducing properties based on this statement alone."
11730055,Hydrocortisone produces pneumonia,456,"The study strongly suggests that methylprednisolone has significant beneficial effects in human spinal cord injury, that these effects occur only when the drug is given within 8 hr, and that it helps even in patients with severe spinal cord injuries.",False,"Is the triple 'Hydrocortisone produces pneumonia' supported by the sentence: 'The study strongly suggests that methylprednisolone has significant beneficial effects in human spinal cord injury, that these effects occur only when the drug is given within 8 hr, and that it helps even in patients with severe spinal cord injuries.'?","No, the statement does not provide any indirect support for the phrase ""Hydrocortisone produces pneumonia."" The study referenced in the statement investigates the effects of methylprednisolone on human spinal cord injury, not hydrocortisone. Furthermore, it highlights beneficial effects associated with methylprednisolone administration within 8 hours post-injury, which in no way suggests that hydrocortisone could produce pneumonia as an adverse effect."
8328567,Hydrocortisone produces prostate cancer,457,"Comparison of the effects of 2 doses of methylprednisolone on pain, swelling, and trismus after third molar surgery.",False,"Is the triple 'Hydrocortisone produces prostate cancer' supported by the sentence: 'Comparison of the effects of 2 doses of methylprednisolone on pain, swelling, and trismus after third molar surgery.'?","No, the statement does not provide any indirect support for the phrase ""Hydrocortisone produces prostate cancer."" The study mentioned in the statement investigates the effects of methylprednisolone on pain, swelling, and trismus after third molar surgery. Methylprednisolone is a synthetic glucocorticoid, while hydrocortisone is another type of glucocorticoid often used in treating various medical conditions.

         Although both methylprednisolone and hydrocortisone belong to the glucocorticoid class, they have different chemical structures and properties, which may lead to distinct effects on biological systems. The study in question focuses on methylprednisolone and its impact on oral surgery-related symptoms; thus, it does not offer any insight into hydrocortisone's potential relationship with prostate cancer.

         In order to establish indirect support for the claim that hydrocortisone produces prostate cancer, one would need evidence suggesting hydrocortisone has carcinogenic properties specifically related to prostate tissue. This evidence would need to be derived from well-designed studies focusing on hydrocortisone use"
8077250,Hydrocortisone produces neoplasm,458,Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation.,False,Is the triple 'Hydrocortisone produces neoplasm' supported by the sentence: 'Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation.'?,"No, the statement ""Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation"" does not provide indirect support for the claim that ""Hydrocortisone produces neoplasm.""

         The reason is that methylprednisolone is not hydrocortisone. Both are corticosteroids used in treating various conditions; however, they have different therapeutic profiles due to their distinct chemical structures and pharmacological properties. Therefore, any observed adverse effects linked to methylprednisolone therapy cannot be automatically generalized to hydrocortisone therapy.

         Furthermore, while corticosteroids like hydrocortisone have been implicated in neoplasm development in some instances due to their immunosuppressive effects, it is crucial to consider that neoplasm development is often influenced by multiple factors beyond medication use alone. Hence, attributing neoplasm development solely to hydrocortisone based on an isolated statement is an oversimplification that disregards other contributing elements in carcinogenesis.

         In conclusion, it is essential to maintain precision when interpreting scientific evidence by acknowledging distinctions between"
27711985,Hydrocortisone disrupts adrenocortical insufficiency,459,These results suggest that increasing the uric acid concentration may represent one of the possible mechanisms of action of methylprednisolone in multiple sclerosis.,False,Is the triple 'Hydrocortisone disrupts adrenocortical insufficiency' supported by the sentence: 'These results suggest that increasing the uric acid concentration may represent one of the possible mechanisms of action of methylprednisolone in multiple sclerosis.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts adrenocortical insufficiency."" The two statements discuss different hormones (uric acid and methylprednisolone in one case, versus hydrocortisone in another) and different medical conditions (multiple sclerosis in one case, versus adrenocortical insufficiency in another). There is no overlap in terms of mechanisms or biological pathways that would allow us to infer any relationship between hydrocortisone and adrenocortical insufficiency from the given statement about uric acid and methylprednisolone in multiple sclerosis."
26428860,Hydrocortisone disrupts leukemia,460,"OBJECTIVE: Compare the therapeutic efficacy of an oral/metered-dose inhaler (oral/MDI) regimen to an intravenous/nebulizer (I.V./neb) regimen of methylprednisolone, cefuroxime, and inhaled albuterol and ipratropium bromide in patients hospitalized for exacerbations of chronic obstructive pulmonary disease (COPD).",False,"Is the triple 'Hydrocortisone disrupts leukemia' supported by the sentence: 'OBJECTIVE: Compare the therapeutic efficacy of an oral/metered-dose inhaler (oral/MDI) regimen to an intravenous/nebulizer (I.V./neb) regimen of methylprednisolone, cefuroxime, and inhaled albuterol and ipratropium bromide in patients hospitalized for exacerbations of chronic obstructive pulmonary disease (COPD).'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts leukemia"". The objective in the statement focuses on comparing different therapeutic regimens for COPD exacerbations, which does not involve hydrocortisone or leukemia at all. It is essential to evaluate statements in their entirety and consider their context before drawing any conclusions about potential connections to unrelated medical conditions or treatments."
26389045,Hydrocortisone disrupts neoplasm,461,"Similar to the CRPS clinical response to glucocorticoids, we now demonstrate that chronic hindpaw edema in the sciatic transection CRPS model is reversed by a continuous infusion of MP (3 mg/kg/day over 21 days), and this anti-edematous effect persists for at least 1 week after discontinuing MP.",False,"Is the triple 'Hydrocortisone disrupts neoplasm' supported by the sentence: 'Similar to the CRPS clinical response to glucocorticoids, we now demonstrate that chronic hindpaw edema in the sciatic transection CRPS model is reversed by a continuous infusion of MP (3 mg/kg/day over 21 days), and this anti-edematous effect persists for at least 1 week after discontinuing MP.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone disrupts neoplasm."" The statement discusses the effects of methylprednisolone (MP) on chronic hindpaw edema in a specific rat model for complex regional pain syndrome (CRPS). Hydrocortisone is not mentioned in the statement; therefore, there is no connection that could be inferred between hydrocortisone and neoplasm disruption.

         To provide further context regarding neoplasm disruption: neoplasm refers to an abnormal new growth of tissue; disrupting it would imply hindering its formation or progression. Hydrocortisone is a type of corticosteroid that can reduce inflammation; however, it does not have any established effect on neoplasm disruption according to current research and understanding in oncology.

         It is essential to base conclusions on direct evidence that specifically addresses the claim at hand and avoid making assumptions based on indirect connections that may not exist in the provided information."
26128287,Hydrocortisone disrupts melanoma,462,STUDY OBJECTIVES: To assess whether IV methylprednisolone exerts a specific early effect on dyspnea in patients with an exacerbation of asthma.,False,Is the triple 'Hydrocortisone disrupts melanoma' supported by the sentence: 'STUDY OBJECTIVES: To assess whether IV methylprednisolone exerts a specific early effect on dyspnea in patients with an exacerbation of asthma.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts melanoma."" The study objective focuses on assessing the effect of intravenous methylprednisolone on dyspnea in patients with asthma exacerbations. Methylprednisolone is a synthetic glucocorticoid similar to hydrocortisone but structurally different and not directly related to melanoma disruption. Additionally, the study does not involve any investigation into melanoma or hydrocortisone's potential effects on it."
21020907,Hydrocortisone disrupts pneumonia,463,REVIEWER'S CONCLUSIONS: Cyclophosphamide regimen treatment is a form of care in neuropsychiatric involvement in systemic lupus erythematosus with no evidence to prove better effectiveness and safety when compared with methylprednisolone.,False,Is the triple 'Hydrocortisone disrupts pneumonia' supported by the sentence: 'REVIEWER'S CONCLUSIONS: Cyclophosphamide regimen treatment is a form of care in neuropsychiatric involvement in systemic lupus erythematosus with no evidence to prove better effectiveness and safety when compared with methylprednisolone.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts pneumonia."" The reviewer's conclusion is comparing two different treatments (cyclophosphamide regimen treatment and methylprednisolone) for neuropsychiatric involvement in systemic lupus erythematosus (SLE). Hydrocortisone is a type of corticosteroid like methylprednisolone but is not mentioned in the reviewer's conclusion; thus, there is no connection or support for the claim that hydrocortisone disrupts pneumonia based on this statement alone.

          To further clarify, pneumonia is an infection that causes inflammation in one or both lungs. Disrupting pneumonia implies either preventing its development or worsening its progression. Hydrocortisone is primarily used as an anti-inflammatory agent in various conditions such as allergies, arthritis, asthma, and autoimmune diseases; however, its effects on pneumonia may depend on factors like dosage, timing, and patient characteristics.

          In summary, without explicit evidence linking hydroc"
15895489,Hydrocortisone disrupts obesity disorder,464,"RESULTS: Both methylprednisolone and dexamethasone significantly reduced swelling and trismus (P < .05, Kruskal-Wallis test), whereas the methylprednisolone group had significantly less pain (P < .05, Kruskal-Wallis test) and consumed a lower amount of analgesics (P < .05, chi2 test) during the early postoperative days.",False,"Is the triple 'Hydrocortisone disrupts obesity disorder' supported by the sentence: 'RESULTS: Both methylprednisolone and dexamethasone significantly reduced swelling and trismus (P < .05, Kruskal-Wallis test), whereas the methylprednisolone group had significantly less pain (P < .05, Kruskal-Wallis test) and consumed a lower amount of analgesics (P < .05, chi2 test) during the early postoperative days.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts obesity disorder"". The statement discusses the results of an experiment involving methylprednisolone and dexamethasone, which are two different types of corticosteroids used for reducing swelling and pain postoperatively. Hydrocortisone is also a corticosteroid but is not explicitly mentioned in the statement; therefore, there is no direct or indirect evidence linking hydrocortisone to obesity disorder disruption based on this information alone.

        
        The statement focuses on the effects of methylprednisolone and dexamethasone on postoperative swelling, trismus (limited jaw mobility), pain, and analgesic consumption in patients undergoing third molar surgery. There is no mention of obesity disorder or any metabolic effects associated with these corticosteroids in the context provided.

        
        To establish any indirect link between hydrocortisone and obesity disorder disruption based on this information would require assuming that all corticosteroids have similar effects on metabolism and obesity-related outcomes"
15750557,Hydrocortisone disrupts injury,465,Methylprednisolone only inhibited granulocytopenia and thrombocytopenia when zymosan-activated serum or fibrinogen-depleted plasma were infused.,False,Is the triple 'Hydrocortisone disrupts injury' supported by the sentence: 'Methylprednisolone only inhibited granulocytopenia and thrombocytopenia when zymosan-activated serum or fibrinogen-depleted plasma were infused.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts injury."" The statement discusses the effects of Methylprednisolone on granulocytopenia and thrombocytopenia when certain substances are infused. Hydrocortisone is not mentioned in this context, so there is no connection that can be inferred between Hydrocortisone and injury disruption based on this information alone."
8865955,Hydrocortisone disrupts Inflammation,466,"In addition, we detected that sufentanil provided prolonged pain relief up to 24 h when compared with control, whereas when we combined sufentanil plus methylprednisolone, we found that it further reduced pain and use of analgesics when compared with sufentanil.",False,"Is the triple 'Hydrocortisone disrupts Inflammation' supported by the sentence: 'In addition, we detected that sufentanil provided prolonged pain relief up to 24 h when compared with control, whereas when we combined sufentanil plus methylprednisolone, we found that it further reduced pain and use of analgesics when compared with sufentanil.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone disrupts Inflammation"". The statement discusses the effects of sufentanil and methylprednisolone on pain relief and use of analgesics but does not mention hydrocortisone or its impact on inflammation."
26205555,Hydrocortisone prevents neoplasm,467,These findings demonstrate that MP may suppress post-traumatic inflammatory reaction by inhibiting both the AP-1 and NF-kappaB transcription cascades via a GR mechanism.,False,Is the triple 'Hydrocortisone prevents neoplasm' supported by the sentence: 'These findings demonstrate that MP may suppress post-traumatic inflammatory reaction by inhibiting both the AP-1 and NF-kappaB transcription cascades via a GR mechanism.'?,"No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone prevents neoplasm."" The finding that MP (presumably an abbreviation for methylprednisolone) suppresses post-traumatic inflammatory reaction by inhibiting certain transcription cascades via a glucocorticoid receptor (GR) mechanism pertains specifically to anti-inflammatory effects in post-traumatic conditions. Neoplasms (abnormal tissue growths often associated with cancer) involve complex cellular processes that differ significantly from inflammatory reactions; therefore, it is not appropriate to make inferences about hydrocortisone's ability to prevent neoplasms based on these findings alone.

         To provide indirect support for ""Hydrocortisone prevents neoplasm,"" there would need to be evidence linking hydrocortisone (a glucocorticoid) to anti-neoplastic effects via GR-mediated mechanisms or other relevant pathways implicated in neoplasm development and progression. Currently, hydrocortisone is mainly used in clinical settings for its anti-inflammatory properties;"
19342068,Hydrocortisone prevents obesity disorder,468,"This study assessed the effectiveness of a ganciclovir, methylprednisolone, and immunoglobulin combination (TAGMIC) therapy in decreasing cognitive impairment and mortality among patients with Japanese encephalitis.",False,"Is the triple 'Hydrocortisone prevents obesity disorder' supported by the sentence: 'This study assessed the effectiveness of a ganciclovir, methylprednisolone, and immunoglobulin combination (TAGMIC) therapy in decreasing cognitive impairment and mortality among patients with Japanese encephalitis.'?","No, the statement does not provide indirect support for the claim that ""Hydrocortisone prevents obesity disorder"". The study mentioned focuses on assessing the effectiveness of TAGMIC therapy in decreasing cognitive impairment and mortality among patients with Japanese encephalitis. Hydrocortisone is not mentioned in the statement nor is there any connection made between hydrocortisone and obesity prevention.

         To provide indirect support for such a claim, there should be some link between hydrocortisone and obesity prevention in the statement, even if it is not the primary focus of the study. For instance, if the study found that patients on TAGMIC therapy had reduced obesity rates compared to those not on hydrocortisone, that could provide indirect support for the claim. However, since no such connection is present in the statement, it does not offer any indirect support for the claim that ""Hydrocortisone prevents obesity disorder""."
19245686,Hydrocortisone prevents toxic shock syndrome,469,"From indirect comparisons, most interventions showed decreased risk of developing RA compared to placebo at 12 months, reaching statistical significance for methotrexate (OR 0.16 [95% CI 0.08, 0.33]) and intramuscular methylprednisolone (OR 0.72 [95% CI 0.53, 0.99]).",False,"Is the triple 'Hydrocortisone prevents toxic shock syndrome' supported by the sentence: 'From indirect comparisons, most interventions showed decreased risk of developing RA compared to placebo at 12 months, reaching statistical significance for methotrexate (OR 0.16 [95% CI 0.08, 0.33]) and intramuscular methylprednisolone (OR 0.72 [95% CI 0.53, 0.99]).'?","No, the statement does not provide indirect support for the claim that hydrocortisone prevents toxic shock syndrome. The statement discusses the effect of interventions on reducing the risk of developing rheumatoid arthritis (RA) compared to placebo at 12 months. Hydrocortisone is not mentioned in the statement, and intramuscular methylprednisolone is not equivalent to hydrocortisone in terms of its effects on toxic shock syndrome. Therefore, there is no indirect support for the claim based on the provided information.

        
        To further clarify, toxic shock syndrome (TSS) is not equivalent to rheumatoid arthritis (RA). TSS is an acute illness characterized by fever, shock, and multisystem organ failure caused by bacterial superantigens, often associated with menstruation and tampon use (CDC). Hydrocortisone is not typically used as a preventative measure for TSS; instead, antibiotics may be used in cases where TSS is suspected (CDC).

        
        In conclusion, while methotrexate and intramuscular methylpred"
18758297,Hydrocortisone prevents injury,470,Treatment with a pulse of methylprednisolone reduced both abdominal pain and lesion size.,False,Is the triple 'Hydrocortisone prevents injury' supported by the sentence: 'Treatment with a pulse of methylprednisolone reduced both abdominal pain and lesion size.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone prevents injury."" Methylprednisolone and Hydrocortisone are both corticosteroids but they have distinct properties, mechanisms of action, and clinical applications. The statement only indicates that Methylprednisolone has an effect on abdominal pain and lesion size; it does not imply any effect on injury prevention nor does it mention Hydrocortisone at all. To establish indirect support for Hydrocortisone preventing injury based on such a statement would require additional evidence connecting Methylprednisolone treatment outcomes to Hydrocortisone's injury prevention abilities."
17956690,Hydrocortisone prevents Sepsis,471,Methylprednisolone prevents propranolol-induced airway hyperreactivity in the Basenji-greyhound dog.,False,Is the triple 'Hydrocortisone prevents Sepsis' supported by the sentence: 'Methylprednisolone prevents propranolol-induced airway hyperreactivity in the Basenji-greyhound dog.'?,"No, the statement ""Methylprednisolone prevents propranolol-induced airway hyperreactivity in the Basenji-greyhound dog"" does not provide indirect support for the claim that ""Hydrocortisone prevents Sepsis.""

         The two statements involve different drugs (Hydrocortisone vs Methylprednisolone) and different conditions (Sepsis vs propranolol-induced airway hyperreactivity in Basenji-greyhound dogs). Methylprednisolone is a glucocorticoid like Hydrocortisone, but their effects can vary based on factors such as dosage, duration, and specific tissue sensitivity. Sepsis is a systemic inflammatory response syndrome often caused by bacterial infections, while propranolol-induced airway hyperreactivity in Basenji-greyhound dogs is a specific experimental model for studying asthma-like conditions.

         Therefore, without further evidence connecting these two distinct drug-condition pairs, we cannot infer that Hydrocortisone prevents Sepsis based on the provided statement about M"
16963888,Hydrocortisone prevents adrenocortical insufficiency,472,Administration of methylprednisolone to prevent severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization.,False,Is the triple 'Hydrocortisone prevents adrenocortical insufficiency' supported by the sentence: 'Administration of methylprednisolone to prevent severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization.'?,"No, indirect support cannot be inferred from the given statement. The two phrases discuss different medical scenarios involving different steroid hormones (hydrocortisone vs methylprednisolone) and distinct medical conditions (adrenocortical insufficiency vs severe ovarian hyperstimulation syndrome). Thus, it would be inappropriate to draw any conclusions about hydrocortisone preventing adrenocortical insufficiency based solely on methylprednisolone being used in in vitro fertilization procedures to prevent ovarian hyperstimulation syndrome.

        However, it is important to note that both hydrocortisone and methylprednisolone belong to the class of glucocorticoids that can be used interchangeably in some clinical situations due to their similar mechanisms of action in suppressing inflammation and modulating immune responses. Nonetheless, direct evidence would still be necessary to establish whether hydrocortisone prevents adrenocortical insufficiency specifically."
15550113,Hydrocortisone prevents Inflammation,473,"Combined methylprednisolone, bupivacaine and morphine reduced pain, joint swelling, time of immobilization, duration of sick leave and return to sports after the arthroscopic procedure.",False,"Is the triple 'Hydrocortisone prevents Inflammation' supported by the sentence: 'Combined methylprednisolone, bupivacaine and morphine reduced pain, joint swelling, time of immobilization, duration of sick leave and return to sports after the arthroscopic procedure.'?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone prevents Inflammation."" The reason is that although methylprednisolone is a type of corticosteroid like hydrocortisone, it is not hydrocortisone itself. Additionally, even if it were hydrocortisone being used in that study, pain reduction and reduced swelling do not necessarily equate to inflammation prevention. Inflammation is a complex biological response that involves various cellular and molecular events which may not be fully captured by these observed effects alone.

        To provide indirect support for ""Hydrocortisone prevents Inflammation,"" one would need studies specifically involving hydrocortisone that demonstrate its ability to prevent inflammation in a relevant model system or clinical setting. Furthermore, even if such studies existed, they would still need to be thoroughly evaluated for quality, consistency, and applicability to draw any firm conclusions."
15540854,Hydrocortisone prevents pneumonia,474,Forty-eight patients who underwent bone marrow transplantation (BMT) from serologically HLA-matched unrelated donors received tacrolimus (FK506) alone or with methotrexate (MTX) and/or methylprednisolone (mPSL) to prevent graft-versus-host disease (GVHD).,False,Is the triple 'Hydrocortisone prevents pneumonia' supported by the sentence: 'Forty-eight patients who underwent bone marrow transplantation (BMT) from serologically HLA-matched unrelated donors received tacrolimus (FK506) alone or with methotrexate (MTX) and/or methylprednisolone (mPSL) to prevent graft-versus-host disease (GVHD).'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone prevents pneumonia."" The statement discusses the use of immunosuppressive drugs (tacrolimus, methotrexate, and methylprednisolone) in bone marrow transplantation patients to prevent graft-versus-host disease (GVHD). Hydrocortisone is not mentioned in the statement; therefore, there is no connection to be made between hydrocortisone and preventing pneumonia in this context.

        However, it is worth noting that hydrocortisone is a type of corticosteroid that can be used as an anti-inflammatory agent in treating various conditions, including pneumonia. But based on the provided statement alone, there is no evidence or implication that hydrocortisone prevents pneumonia in bone marrow transplantation patients receiving tacrolimus, methotrexate, and/or methylprednisolone for GVHD prevention. A separate study specifically investigating hydrocortisone's effects on pneumonia prevention would be required for such support."
14020540,Hydrocortisone prevents bronchopulmonary dysplasia,475,"Thus, calpeptin and methylprednisolone are found to be neuroprotective in SCI.",False,"Is the triple 'Hydrocortisone prevents bronchopulmonary dysplasia' supported by the sentence: 'Thus, calpeptin and methylprednisolone are found to be neuroprotective in SCI.'?","No, the statement ""Thus, calpeptin and methylprednisolone are found to be neuroprotective in SCI"" does not provide indirect support for the claim that ""Hydrocortisone prevents bronchopulmonary dysplasia."" The two statements discuss different topics: neuroprotection in spinal cord injury (SCI) for calpeptin and methylprednisolone versus prevention of bronchopulmonary dysplasia for hydrocortisone.

         The study referenced in the statement about calpeptin and methylprednisolone does not mention hydrocortisone, bronchopulmonary dysplasia, or related terms; therefore, there is no connection between these two pieces of information that would allow for indirect support. To establish indirect support, there should be some commonality in underlying biological mechanisms, experimental design, or other relevant aspects that can link these two distinct findings together. In this case, however, there is no overlap in terms of substances studied (hydrocortisone vs calpeptin and methylprednisolone) or their respective therapeutic applications (bronchopulmonary dys"
13075196,Hydrocortisone prevents atrial fibrillation,476,"Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds.",False,"Is the triple 'Hydrocortisone prevents atrial fibrillation' supported by the sentence: 'Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone prevents atrial fibrillation."" This is because methylprednisolone is not hydrocortisone; they belong to different classes of corticosteroids (esters vs. acetates respectively) and have different effects on various biological systems due to their unique molecular structures.

         Furthermore, even if we were comparing two similar corticosteroids, observing an effect on autotomy and neuropathic edema in rats does not imply an effect on atrial fibrillation in humans. The two conditions affect different organ systems (nervous system vs cardiovascular system) and have distinct pathophysiological mechanisms; therefore, it is not appropriate to make direct comparisons between them based on corticosteroid treatment effects in animal models without further investigation into specific mechanisms involved in atrial fibrillation prevention by hydrocortisone."
12187318,Hydrocortisone prevents Insulin resistance,477,Chronically impaired renal function and the use of methylprednisolone may be the risk factors for SP.,False,Is the triple 'Hydrocortisone prevents Insulin resistance' supported by the sentence: 'Chronically impaired renal function and the use of methylprednisolone may be the risk factors for SP.'?,"No, the statement does not provide indirect support for the phrase ""Hydrocortisone prevents Insulin resistance.""

        
        The statement ""Chronically impaired renal function and the use of methylprednisolone may be the risk factors for SP"" pertains to conditions that increase the risk for Systemic Pulmonary (SP), which is not directly related to Insulin resistance or Hydrocortisone use.

        
        Methylprednisolone is a synthetic glucocorticoid similar to Hydrocortisone, but their effects on Insulin resistance could differ due to varying potencies, pharmacokinetics, and pharmacodynamics. Therefore, it would be inaccurate to extrapolate any potential impact on Insulin resistance from one glucocorticoid (Methylprednisolone) to another (Hydrocortisone).

        
        Moreover, Insulin resistance is influenced by multiple factors such as genetics, obesity, physical inactivity, nutrition, inflammation, and medications; therefore, it is an oversimplification to attribute Insulin resistance prevention solely to Hydrocortis"
14643692,Hydrocortisone exacerbates Sepsis,478,"Because a common therapy for acute spinal cord injury is the use of an antiinflammatory synthetic glucocorticoid (methylprednisolone), we sought to determine mechanisms contributing to inflammation shortly after acute injury.",False,"Is the triple 'Hydrocortisone exacerbates Sepsis' supported by the sentence: 'Because a common therapy for acute spinal cord injury is the use of an antiinflammatory synthetic glucocorticoid (methylprednisolone), we sought to determine mechanisms contributing to inflammation shortly after acute injury.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone exacerbates Sepsis."" The statement discusses the use of an anti-inflammatory synthetic glucocorticoid (methylprednisolone) in treating acute spinal cord injuries and investigating its contribution to inflammation after injury. Hydrocortisone is also a glucocorticoid but is not explicitly mentioned in this context; therefore, no direct connection can be made between hydrocortisone treatment and sepsis exacerbation based on this statement alone.

         However, it is important to note that glucocorticoids like hydrocortisone have been associated with increased susceptibility to infections in critically ill patients (Annane et al., 2002). Sepsis is an extreme response to infection that can lead to tissue damage, organ failure, and death (Singer et al., 2016). Therefore, theoretically, hydrocortisone could exacerbate sepsis due to its immunosuppressive effects; however, further evidence is required to establish such a link explicitly."
8122784,Hydrocortisone exacerbates obesity disorder,479,"Combined treatments of rG-CSF with cefotaxime, cefazolin, fosfomycin, gentamicin or amphotericin B were evaluated in systemic infections with Pseudomonas aeruginosa, Escherichia coli, Serratia marcescens, Staphylococcus aureus and Candida albicans in leucopenic mice induced by pretreatment with cyclophosphamide.",False,"Is the triple 'Hydrocortisone exacerbates obesity disorder' supported by the sentence: 'Combined treatments of rG-CSF with cefotaxime, cefazolin, fosfomycin, gentamicin or amphotericin B were evaluated in systemic infections with Pseudomonas aeruginosa, Escherichia coli, Serratia marcescens, Staphylococcus aureus and Candida albicans in leucopenic mice induced by pretreatment with cyclophosphamide.'?","No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone exacerbates obesity disorder."" The statement discusses the evaluation of combined treatments using various antibiotics and amphotericin B in systemic infections caused by several bacterial species and Candida albicans in leucopenic mice induced by cyclophosphamide pretreatment. There is no mention or implication of hydrocortisone, obesity disorder, or any related factors in this statement."
25411585,Hydrocortisone predisposes atrial fibrillation,480,"One such marker, CTX-M-15, expressed by Enterobacteriaceae produces beta-lactamases, which hydrolyze the cephalosporin group of antibiotics, such as cefotaxime, used in the treatment of both Gram-positive and negative bacterial infections.",False,"Is the triple 'Hydrocortisone predisposes atrial fibrillation' supported by the sentence: 'One such marker, CTX-M-15, expressed by Enterobacteriaceae produces beta-lactamases, which hydrolyze the cephalosporin group of antibiotics, such as cefotaxime, used in the treatment of both Gram-positive and negative bacterial infections.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes atrial fibrillation"". The statement discusses the marker CTX-M-15 expressed by Enterobacteriaceae that produces beta-lactamases, which hydrolyze cephalosporin antibiotics like cefotaxime used in treating bacterial infections. This information is related to antibiotic resistance mechanisms in bacteria and does not involve hydrocortisone or atrial fibrillation in any way.

        To provide indirect support for ""Hydrocortisone predisposes atrial fibrillation"", there would need to be some connection between hydrocortisone usage and an increased risk or predisposition for atrial fibrillation based on existing evidence in medical literature. The current statement does not provide such evidence or establish any link between these two concepts."
19755964,Hydrocortisone predisposes Sepsis,481,"CONS, Staphylococcus aureus, Enterococci, Escherichia coli, Klebsiella and Enterobacter represented 91.9% of LOS episodes and were susceptible to vancomycin and cefotaxime (96.1%), vancomycin and gentamicin (97.0%) and cloxacillin and gentamicin (38.1%).",False,"Is the triple 'Hydrocortisone predisposes Sepsis' supported by the sentence: 'CONS, Staphylococcus aureus, Enterococci, Escherichia coli, Klebsiella and Enterobacter represented 91.9% of LOS episodes and were susceptible to vancomycin and cefotaxime (96.1%), vancomycin and gentamicin (97.0%) and cloxacillin and gentamicin (38.1%).'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes Sepsis."" The statement discusses antibiotic susceptibility patterns in certain bacterial species that frequently cause hospital-acquired infections (LOS episodes). Hydrocortisone is a type of steroid hormone often used in clinical settings for various purposes, including treating inflammation and counteracting allergic reactions; it is not mentioned nor implied in the statement about antibiotic susceptibility patterns in bacteria.

        To provide indirect support for ""Hydrocortisone predisposes Sepsis,"" one would need evidence showing an association between hydrocortisone usage and increased risk for sepsis development. Sepsis is a severe condition characterized by an overwhelming immune response to infection that can lead to organ failure, tissue damage, and even death in severe cases. The relationship between hydrocortisone use and sepsis risk is complex and still being researched; some studies suggest that hydrocortisone may be beneficial in treating sepsis under specific conditions, while others warn against its use due to potential adverse effects on patient outcomes.

        In conclusion, while"
13712588,Hydrocortisone predisposes injury,482,"The protective effect of cefotaxime, aztreonam and gentamicin in peritonitis induced by E. coli alone or combined with B. fragilis was evaluated by analysing mortality at 24 and 48 h after bacterial inoculation and treating the animals with two doses of each antibiotic.",False,"Is the triple 'Hydrocortisone predisposes injury' supported by the sentence: 'The protective effect of cefotaxime, aztreonam and gentamicin in peritonitis induced by E. coli alone or combined with B. fragilis was evaluated by analysing mortality at 24 and 48 h after bacterial inoculation and treating the animals with two doses of each antibiotic.'?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes injury."" The statement discusses an experiment in which three antibiotics (cefotaxime, aztreonam, and gentamicin) were tested for their protective effect against peritonitis induced by Escherichia coli (E. coli) alone or in combination with Bacteroides fragilis in animals. The study evaluated mortality at 24 and 48 hours after bacterial inoculation and administering two doses of each antibiotic. The use of hydrocortisone is not mentioned in the statement; therefore, it does not provide any evidence regarding hydrocortisone predisposing injury."
12555774,Hydrocortisone predisposes toxic shock syndrome,483,"HR 810 had more potent protective effect than ceftazidime (CAZ), cefoperazone (CPZ), and cefotaxime (CTX) on systemic infections induced by Escherichia coli Ec-31, Staphylococcus aureus SMITH, and Serratia marcescens Sm-6 in mice.",False,"Is the triple 'Hydrocortisone predisposes toxic shock syndrome' supported by the sentence: 'HR 810 had more potent protective effect than ceftazidime (CAZ), cefoperazone (CPZ), and cefotaxime (CTX) on systemic infections induced by Escherichia coli Ec-31, Staphylococcus aureus SMITH, and Serratia marcescens Sm-6 in mice.'?","No, the statement does not provide indirect support for the claim that hydrocortisone predisposes toxic shock syndrome (TSS). The statement discusses the protective effects of HR 810 against systemic infections in mice caused by certain bacteria, but it does not mention hydrocortisone's potential role in TSS development.

         Toxic shock syndrome is a rare but life-threatening condition associated with bacterial infections, often caused by Staphylococcus aureus (staph) or Streptococcus pyogenes (strep) bacteria. Hydrocortisone is a synthetic glucocorticoid hormone that can suppress immune function when administered in high doses.

         Although hydrocortisone has immunosuppressive properties, there is no direct link established in the statement between hydrocortisone use and increased susceptibility to TSS. The protective effects observed for HR 810 in mice infected by specific bacteria do not necessarily imply that hydrocortisone would predispose an individual to TSS.

         To establish such a link between hydrocortisone use and TSS"
11782928,Hydrocortisone predisposes Inflammation,484,"1,480 patients, undergoing elective orthopedic and traumatic surgery, received intragluteal injections of ceftriaxone (Rocephin) to prevent bacterial infections.",False,"Is the triple 'Hydrocortisone predisposes Inflammation' supported by the sentence: '1,480 patients, undergoing elective orthopedic and traumatic surgery, received intragluteal injections of ceftriaxone (Rocephin) to prevent bacterial infections.'?","No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone predisposes Inflammation"". The statement mentions that patients received ceftriaxone (Rocephin) injections for preventing bacterial infections during surgery; there is no mention of hydrocortisone being used nor any information about inflammation in relation to hydrocortisone administration.

         The statement would provide some level of indirect support if it mentioned hydrocortisone being used in conjunction with ceftriaxone (Rocephin) injections in these patients undergoing surgery and if there was an observation regarding increased inflammation in those patients who received hydrocortisone compared to those who did not receive hydrocortisone.

         In order for us to evaluate whether hydrocortisone predisposes inflammation more rigorously in future queries, we would need studies specifically designed to investigate the relationship between hydrocortisone administration and inflammation outcomes."
10520517,Hydrocortisone predisposes obesity disorder,485,Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer.,False,Is the triple 'Hydrocortisone predisposes obesity disorder' supported by the sentence: 'Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer.'?,"No, the statement ""Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer"" does not provide indirect support for the phrase ""Hydrocortisone predisposes obesity disorder"". 

        The statement is about a double-blind trial involving carbenoxolone and geranyl farnesylacetate in gastric ulcer treatment. It does not mention hydrocortisone nor obesity disorder, making it irrelevant in providing any indirect support for that specific claim about hydrocortisone predisposing obesity disorder.

        The two subjects - hydrocortisone and gastric ulcer treatments - are unrelated in this context, so no meaningful connection can be established based on these statements alone."
8615556,Hydrocortisone predisposes dissociative amnesia,486,A controlled double-blind study was performed in 17 institutes using gefarnate as a control drug in order to investigate the therapeutic effect and safety of pirenzepine dihydrochloride (LS 519) in duodenal ulcer.,False,Is the triple 'Hydrocortisone predisposes dissociative amnesia' supported by the sentence: 'A controlled double-blind study was performed in 17 institutes using gefarnate as a control drug in order to investigate the therapeutic effect and safety of pirenzepine dihydrochloride (LS 519) in duodenal ulcer.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone predisposes dissociative amnesia"". The study mentioned in the statement is investigating the therapeutic effect and safety of pirenzepine dihydrochloride (LS 519) in duodenal ulcer using gefarnate as a control drug. There is no mention or implication of hydrocortisone or dissociative amnesia in this study."
8552834,Hydrocortisone predisposes asthma,487,Gefarnate at 300 mg/kg (p.o.) significantly inhibited phenylbutazone-induced gastric ulcers in rats but had no effect on other ulcer models.,False,Is the triple 'Hydrocortisone predisposes asthma' supported by the sentence: 'Gefarnate at 300 mg/kg (p.o.) significantly inhibited phenylbutazone-induced gastric ulcers in rats but had no effect on other ulcer models.'?,"No, the statement does not provide any indirect support for the phrase ""Hydrocortisone predisposes asthma"". The two statements discuss different topics: one is about hydrocortisone potentially predisposing individuals to asthma, while the other is about gefarnate inhibiting certain types of gastric ulcers in rats without affecting other ulcer models. There is no overlap or connection between these two ideas based on the provided information."
8002300,Hydrocortisone predisposes Insulin resistance,488,We tested streptomycin (ST) and neomycin (NEO) as analgesic agents applied in situ in rat paw inflammation caused by formalin or carrageenan administration.,False,Is the triple 'Hydrocortisone predisposes Insulin resistance' supported by the sentence: 'We tested streptomycin (ST) and neomycin (NEO) as analgesic agents applied in situ in rat paw inflammation caused by formalin or carrageenan administration.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone predisposes Insulin resistance."" The experiment mentioned in the statement tests two antibiotics, streptomycin (ST) and neomycin (NEO), as analgesic agents in rat paw inflammation caused by formalin or carrageenan administration. Hydrocortisone is not mentioned in this experiment, nor is there any connection made between hydrocortisone use and insulin resistance in the statement provided. Insulin resistance is also not addressed in any way in the experimental design or results. Therefore, no conclusions can be drawn about hydrocortisone predisposing insulin resistance based on this statement alone."
7960726,Hydrocortisone predisposes pneumonia,489,[ON THE ACTION OF A NEOMYCIN AND THIOPENICOL PREPARATION IN EXPERIMENTAL BURNS].,False,Is the triple 'Hydrocortisone predisposes pneumonia' supported by the sentence: '[ON THE ACTION OF A NEOMYCIN AND THIOPENICOL PREPARATION IN EXPERIMENTAL BURNS].'?,"No, the statement ""Hydrocortisone predisposes pneumonia"" does not receive indirect support from the provided statement: ""[ON THE ACTION OF A NEOMYCIN AND THIOPENICOL PREPARATION IN EXPERIMENTAL BURNS]."" The title suggests that it is an experimental study on burns using neomycin and thiopencil preparation; it does not mention hydrocortisone or pneumonia at all. Without further context or information about how hydrocortisone may be related to neomycin, thiopencil preparation, burns, or pneumonia in this study, there is no basis for indirect support for the initial claim."
27228384,Methylprednisolone related to Crohn disease,490,"Therefore, we investigated the effect of long-term exposure of an antibiotic cocktail composed of Vancomycin, Neomycin, and Streptomycin, on tumor development and progression in the ApcMin/+ mouse, an established genetic model for familial adenomatous polyposis.",False,"Is the triple 'Methylprednisolone related to Crohn disease' supported by the sentence: 'Therefore, we investigated the effect of long-term exposure of an antibiotic cocktail composed of Vancomycin, Neomycin, and Streptomycin, on tumor development and progression in the ApcMin/+ mouse, an established genetic model for familial adenomatous polyposis.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to Crohn disease."" The statement discusses an investigation into the effect of long-term exposure to an antibiotic cocktail on tumor development and progression in a specific mouse model for familial adenomatous polyposis. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects in various diseases such as asthma, rheumatoid arthritis, and Crohn disease; however, it is not mentioned nor implied in the provided statement. Therefore, there is no connection between methylprednisolone and Crohn disease in this context."
26974005,Methylprednisolone related to hematopoietic and lymphoid system neoplasm,491,Ultrahigh doses of gentamicin and clinically relevant doses of neomycin affect inflammation and angiogenesis in in vivo and in vitro models.,False,Is the triple 'Methylprednisolone related to hematopoietic and lymphoid system neoplasm' supported by the sentence: 'Ultrahigh doses of gentamicin and clinically relevant doses of neomycin affect inflammation and angiogenesis in in vivo and in vitro models.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to hematopoietic and lymphoid system neoplasm."" The statement discusses the effects of ultrahigh doses of gentamicin and clinically relevant doses of neomycin on inflammation and angiogenesis in in vivo and in vitro models. Methylprednisolone is a corticosteroid drug used for its anti-inflammatory effects and is not mentioned in the statement; therefore, it does not offer any support for the claim about methylprednisolone and hematopoietic and lymphoid system neoplasm."
26513818,Methylprednisolone related to B-cell chronic lymphocytic leukemia,492,"Biodegradable polyaspartamide (PASPAM) was grafted with several functional groups to implement diverse roles-octadecylamine (C     18       ) for nano-aggregate formation, dopamine (DOPA) for adhesive function, neomycin (NEO) for inhibition of bacterial infection.",False,"Is the triple 'Methylprednisolone related to B-cell chronic lymphocytic leukemia' supported by the sentence: 'Biodegradable polyaspartamide (PASPAM) was grafted with several functional groups to implement diverse roles-octadecylamine (C     18       ) for nano-aggregate formation, dopamine (DOPA) for adhesive function, neomycin (NEO) for inhibition of bacterial infection.'?","No, there is no indirect support for the phrase ""Methylprednisolone related to B-cell chronic lymphocytic leukemia"" in the given statement. The statement discusses the grafting of functional groups onto biodegradable polyaspartamide (PASPAM) for various roles but does not mention methylprednisolone or B-cell chronic lymphocytic leukemia at all. Methylprednisolone is a corticosteroid used for its anti-inflammatory effects, while B-cell chronic lymphocytic leukemia is a type of cancer affecting white blood cells; neither is mentioned nor implied in the provided statement."
26050805,Methylprednisolone related to ankylosing spondylitis,493,Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.,False,Is the triple 'Methylprednisolone related to ankylosing spondylitis' supported by the sentence: 'Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to ankylosing spondylitis."" The statement discusses Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice and its inhibition by neomycin and neamine blocking angiogenin's nuclear translocation. There is no connection made between methylprednisolone and ankylosing spondylitis in this context. Methylprednisolone is a corticosteroid used for its anti-inflammatory effects in various conditions such as asthma, rheumatoid arthritis, and ankylosing spondylitis; however, there is no mention of it in the provided statement."
25845844,Methylprednisolone related to breast neoplasm,494,Neomycin and the combination of neomycin and bacitracin in the prevention of bacterial infection in surgery of the colon and/or rectum.,False,Is the triple 'Methylprednisolone related to breast neoplasm' supported by the sentence: 'Neomycin and the combination of neomycin and bacitracin in the prevention of bacterial infection in surgery of the colon and/or rectum.'?,"No, the statement does not provide any indirect support for the phrase ""Methylprednisolone related to breast neoplasm."" The two statements discuss different topics: one is about antibiotics (neomycin and bacitracin) used in surgeries involving the colon/rectum, while the other connects Methylprednisolone (a corticosteroid) with breast neoplasm (abnormal growth in breast tissue). There is no shared concept or common theme that could be interpreted as indirect support between these two statements."
25642837,Methylprednisolone related to dermatomyositis,495,Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.,False,Is the triple 'Methylprednisolone related to dermatomyositis' supported by the sentence: 'Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Methylprednisolone related to dermatomyositis."" The statement discusses salvage therapy for pre-B acute lymphoblastic leukemia using mini-hyper-CVD (a chemotherapy regimen), inotuzumab ozogamicin (a monoclonal antibody drug), and blinatumomab (an immunotherapy drug). Dermatomyositis is an inflammatory disease that affects muscles and skin, while methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects. Since there is no connection between these two subjects in the statement provided, it does not lend support to the given phrase."
25328503,Methylprednisolone related to Meniere disease,496,"The impressive clinical success of the continuously intravenously infused T cell-redirecting bispecific antibody (T-bsAb) blinatumomab (anti-CD19 x anti-CD3), and of engineered T cells expressing anti-CD19 chimeric antigen receptors (CAR-T cells) in hematological malignancies, has led to renewed interest in a novel cancer immunotherapy strategy that combines features of antibody- and cell-based therapies.",False,"Is the triple 'Methylprednisolone related to Meniere disease' supported by the sentence: 'The impressive clinical success of the continuously intravenously infused T cell-redirecting bispecific antibody (T-bsAb) blinatumomab (anti-CD19 x anti-CD3), and of engineered T cells expressing anti-CD19 chimeric antigen receptors (CAR-T cells) in hematological malignancies, has led to renewed interest in a novel cancer immunotherapy strategy that combines features of antibody- and cell-based therapies.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to Meniere disease"". 

        The statement discusses the clinical success of certain cancer immunotherapies, namely blinatumomab and CAR-T cells in hematological malignancies. It does not mention Methylprednisolone, Meniere disease, or any related concepts. Methylprednisolone is a corticosteroid often used for its anti-inflammatory effects in various clinical settings, while Meniere disease is an inner ear disorder characterized by vertigo, tinnitus, hearing loss, and pressure in the ear. There is no connection drawn between these two concepts in the provided statement."
24759961,Methylprednisolone related to non-Hodgkin lymphoma,497,Blinatumomab and inotuzumab ozogamycin represent promising alternatives to conventional chemotherapy in acute lymphoblastic leukaemia (ALL).,False,Is the triple 'Methylprednisolone related to non-Hodgkin lymphoma' supported by the sentence: 'Blinatumomab and inotuzumab ozogamycin represent promising alternatives to conventional chemotherapy in acute lymphoblastic leukaemia (ALL).'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to non-Hodgkin lymphoma."" The statement discusses Blinatumomab and Inotuzumab ozogamycin as alternatives to conventional chemotherapy in acute lymphoblastic leukaemia (ALL), without mentioning Methylprednisolone or non-Hodgkin lymphoma. Therefore, there is no connection between the two statements that would lend support to the claim about Methylprednisolone and non-Hodgkin lymphoma."
24691450,Methylprednisolone related to plantar fasciitis,498,Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.,False,Is the triple 'Methylprednisolone related to plantar fasciitis' supported by the sentence: 'Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.'?,"No, the statement ""Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis"" does not provide indirect support for the phrase ""Methylprednisolone related to plantar fasciitis."" 

         The statement discusses the efficacy of ciprofloxacin and dexamethasone in treating experimental pseudomonas endophthalmitis infections in an experimental setting. Dexamethasone is a type of corticosteroid, similar to methylprednisolone, but it is not the same compound. Furthermore, plantar fasciitis is not even mentioned in the statement; it pertains to endophthalmitis infections. Therefore, there is no meaningful connection between these two phrases in terms of subject matter, treatment compounds, or conditions."
24586108,Methylprednisolone related to alcoholic hepatitis,499,CONCLUSIONS: Combination therapy of adalimumab and ciprofloxacin is more effective than adalimumab monotherapy to achieve fistula closure in CD.,False,Is the triple 'Methylprednisolone related to alcoholic hepatitis' supported by the sentence: 'CONCLUSIONS: Combination therapy of adalimumab and ciprofloxacin is more effective than adalimumab monotherapy to achieve fistula closure in CD.'?,"No, the statement does not provide any indirect support for the phrase ""Methylprednisolone related to alcoholic hepatitis."" The conclusion is about the effectiveness of combination therapy (adalimumab and ciprofloxacin) compared to adalimumab monotherapy in achieving fistula closure in Crohn's disease (CD). There is no mention or implication of methylprednisolone or alcoholic hepatitis in this conclusion."
24559507,Methylprednisolone related to respiratory system disorder,500,"Tested substances displayed inhibitory effect towards E. coli DNA gyrase, though less than ciprofloxacin.",False,"Is the triple 'Methylprednisolone related to respiratory system disorder' supported by the sentence: 'Tested substances displayed inhibitory effect towards E. coli DNA gyrase, though less than ciprofloxacin.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to respiratory system disorder."" The statement discusses tested substances inhibiting E. coli DNA gyrase, which is unrelated to methylprednisolone or respiratory system disorders. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects in various conditions such as allergies, arthritis, and dermatologic diseases; it is not typically associated with respiratory system disorders nor DNA gyrase inhibition. The lack of connection between these two statements suggests that there is no basis for implying methylprednisolone's involvement in respiratory system disorders from the given information."
23573980,Methylprednisolone related to pneumonia,1,Evaluation of granulated fenbendazole (22.2%) against induced and naturally occurring helminth infections in cats.,False,Is the triple 'Methylprednisolone related to pneumonia' supported by the sentence: 'Evaluation of granulated fenbendazole (22.2%) against induced and naturally occurring helminth infections in cats.'?,"No, the statement ""Evaluation of granulated fenbendazole (22.2%) against induced and naturally occurring helminth infections in cats"" does not provide indirect support for the phrase ""Methylprednisolone related to pneumonia."" The statement discusses an evaluation of fenbendazole, an anti-parasitic drug, in treating helminth infections in cats. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects and is not mentioned in the statement. Therefore, there is no connection between these two pieces of information that would suggest methylprednisolone is related to pneumonia in any way."
23514846,Methylprednisolone related to carpal tunnel syndrome,2,Fenbendazole resistance in O. ostertagi was confirmed with a total treatment failure in reducing worm burden: efficacy of 0%.,False,Is the triple 'Methylprednisolone related to carpal tunnel syndrome' supported by the sentence: 'Fenbendazole resistance in O. ostertagi was confirmed with a total treatment failure in reducing worm burden: efficacy of 0%.'?,"No, the statement ""Fenbendazole resistance in O. ostertagi was confirmed with a total treatment failure in reducing worm burden: efficacy of 0%."" does not provide indirect support for the phrase ""Methylprednisolone related to carpal tunnel syndrome.""

        The two statements discuss different subjects; one refers to fenbendazole resistance in O. ostertagi (a parasitic worm affecting cattle) while the other refers to methylprednisolone (a corticosteroid medication) in relation to carpal tunnel syndrome (a medical condition affecting humans).

        The connection between these two statements is not clear, as they involve different drugs, species, and conditions. Therefore, it is inappropriate to draw any conclusions regarding methylprednisolone's relationship to carpal tunnel syndrome based on this statement about fenbendazole resistance in O. ostertagi.

        To establish any relationship between methylprednisolone and carpal tunnel syndrome, one would need direct evidence in the form of appropriately designed studies involving human subjects treated with methylprednisolone for carpal tunnel syndrome."
23364897,Methylprednisolone related to West syndrome,3,Symptoms of perianal itching and visualization of visible motile worms persisted for 6 months despite being treated with multiple courses of albendazole causing a lot of frustration and distress to the caregivers.,False,Is the triple 'Methylprednisolone related to West syndrome' supported by the sentence: 'Symptoms of perianal itching and visualization of visible motile worms persisted for 6 months despite being treated with multiple courses of albendazole causing a lot of frustration and distress to the caregivers.'?,"No, the statement does not provide direct or indirect support for the phrase ""Methylprednisolone related to West syndrome."" The statement discusses a patient's experience with perianal itching and visible motile worms that persisted for 6 months despite multiple courses of albendazole treatment. This information is not related to Methylprednisolone or West syndrome. West syndrome is an infantile epilepsy disorder characterized by spasms, developmental delay, and hypsarrhythmia on electroencephalography (EEG). Methylprednisolone is a corticosteroid used in various medical conditions but is not typically associated with West syndrome treatment. Therefore, without any connection between the two subjects in the provided statement, it does not support the phrase ""Methylprednisolone related to West syndrome."""
22495910,Methylprednisolone related to myocarditis,4,"Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis.",False,"Is the triple 'Methylprednisolone related to myocarditis' supported by the sentence: 'Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis.'?","No, there is no direct or indirect support for the phrase ""Methylprednisolone related to myocarditis"" in the statement ""Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis."" 

         The statement is about the ovicidal effects (the ability to kill the eggs) of albendazole, an antiparasitic drug, on three specific types of parasitic worm infections in humans: ascariasis, ancylostomiasis, and trichuriasis. It does not mention, imply, or provide any context for methylprednisolone, a corticosteroid used for its anti-inflammatory effects, or myocarditis, inflammation of the heart muscle. Therefore, it does not support the claim that methylprednisolone is related to myocarditis."
22175056,Methylprednisolone related to myopathy,5,"A combination of drugs Ivermectin, Diethylcarbamazine citrate and Albendazole is recommended by WHO to accelerate the Global Programme to Eliminate Lymphatic Filariasis (GPELF).",False,"Is the triple 'Methylprednisolone related to myopathy' supported by the sentence: 'A combination of drugs Ivermectin, Diethylcarbamazine citrate and Albendazole is recommended by WHO to accelerate the Global Programme to Eliminate Lymphatic Filariasis (GPELF).'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to myopathy"". 

         The statement discusses the World Health Organization's (WHO) recommendation for a combination of drugs (Ivermectin, Diethylcarbamazine citrate, and Albendazole) to eliminate Lymphatic Filariasis. This is unrelated to Methylprednisolone, which is a corticosteroid often used to treat inflammatory conditions. Myopathy, defined as muscle disease, can be a side effect of long-term corticosteroid use, including Methylprednisolone. However, the provided statement does not mention or imply any connection between these drugs or Filariasis elimination and Methylprednisolone-induced myopathy."
20879022,Methylprednisolone related to Pain,6,Effect of albendazole in experimental toxocariasis of mice.,False,Is the triple 'Methylprednisolone related to Pain' supported by the sentence: 'Effect of albendazole in experimental toxocariasis of mice.'?,"No, the statement ""Effect of albendazole in experimental toxocariasis of mice"" does not provide any direct or indirect support for the phrase ""Methylprednisolone related to Pain"". This is because albendazole is an antihelmintic drug used for treating parasitic worm infections, while methylprednisolone is a corticosteroid used for reducing inflammation. The two drugs have different mechanisms of action and therapeutic uses; hence, one cannot infer any relationship between them based on these statements alone."
20342058,Methylprednisolone related to chronic progressive multiple sclerosis,7,"Given the low helminth prevalence in our children, the effect of albendazole on malaria is likely to be direct.",False,"Is the triple 'Methylprednisolone related to chronic progressive multiple sclerosis' supported by the sentence: 'Given the low helminth prevalence in our children, the effect of albendazole on malaria is likely to be direct.'?","No, there is no direct or indirect support for the phrase ""Methylprednisolone related to chronic progressive multiple sclerosis"" in the statement ""Given the low helminth prevalence in our children, the effect of albendazole on malaria is likely to be direct.""

        Justification:

         The statement provided discusses the relationship between helminth prevalence in children and the direct effect of albendazole on malaria. It does not mention methylprednisolone, multiple sclerosis, or their potential connections in any way. As such, it does not provide any support for such a claim.

        The connection between methylprednisolone (a corticosteroid) and chronic progressive multiple sclerosis (a neurological disease) is not addressed in the statement provided. Methylprednisolone is often used as an anti-inflammatory agent in treating acute exacerbations in multiple sclerosis patients but is not typically associated with chronic progressive multiple sclerosis treatment due to its limited long-term benefits for that particular form of multiple sclerosis.

        Therefore, it"
20290784,Methylprednisolone related to membranous glomerulonephritis,8,"Mass co-administration of ivermectin and albendazole by the LFEP had a significant effect on STH, which was further amplified by treatment with praziquantel and albendazole 4 months later.",False,"Is the triple 'Methylprednisolone related to membranous glomerulonephritis' supported by the sentence: 'Mass co-administration of ivermectin and albendazole by the LFEP had a significant effect on STH, which was further amplified by treatment with praziquantel and albendazole 4 months later.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to membranous glomerulonephritis."" The statement discusses the impact of mass co-administration of ivermectin and albendazole by the LFEP on Strongyloides stercoralis (STH), as well as subsequent treatment with praziquantel and albendazole. Membranous glomerulonephritis is a kidney disorder that is not mentioned in the statement, nor is there any connection made to methylprednisolone, a corticosteroid medication often used to treat inflammation."
20286711,Methylprednisolone related to neuromyelitis optica,9,The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania.,False,Is the triple 'Methylprednisolone related to neuromyelitis optica' supported by the sentence: 'The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania.'?,"No, the statement ""The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania"" does not provide indirect support for the phrase ""Methylprednisolone related to neuromyelitis optica"". 

         The statement is about a study investigating the effect of ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania. This study does not involve methylprednisolone or neuromyelitis optica, making it unrelated and unable to provide indirect support for the stated phrase. 

         Neuromyelitis optica (NMO) is an autoimmune disorder affecting the spinal cord and optic nerves. Methylprednisolone is often used in treating NMO due to its anti-inflammatory properties; however, there is no mention or implication of methylprednisolone in the provided statement about the study on ivermectin and albendazole in Tanzania."
19340184,Methylprednisolone related to chronic obstructive pulmonary disease,10,"Additionally, compared with albendazole, it resulted in a significant reduction in adult worm and total larval counts; moreover, it caused a decrease in the number of larvae deposited in muscles, with a highly significant decrease in the inflammatory cell infiltrate around the larvae and a considerable decrease in the expression of the angiogenic marker vascular endothelial growth factor in muscles.",False,"Is the triple 'Methylprednisolone related to chronic obstructive pulmonary disease' supported by the sentence: 'Additionally, compared with albendazole, it resulted in a significant reduction in adult worm and total larval counts; moreover, it caused a decrease in the number of larvae deposited in muscles, with a highly significant decrease in the inflammatory cell infiltrate around the larvae and a considerable decrease in the expression of the angiogenic marker vascular endothelial growth factor in muscles.'?","No, the phrase ""Methylprednisolone related to chronic obstructive pulmonary disease"" does not receive indirect support from the statement provided. The statement discusses the effects of Methylprednisolone on adult worm counts, larval counts, larval deposition in muscles, inflammatory cell infiltrate around larvae, and vascular endothelial growth factor expression in muscles in a parasitic infection model. There is no mention or implication of chronic obstructive pulmonary disease (COPD) in this statement. Therefore, it does not provide indirect support for any relationship between Methylprednisolone and COPD.

         To provide indirect support for the relationship between Methylprednisolone and COPD from this statement, there would need to be some connection made between parasitic infections, worm counts, inflammatory cell infiltrate, vascular endothelial growth factor expression in muscles, and COPD pathophysiology. As no such connection is present in the statement, no indirect support can be inferred."
18938435,Methylprednisolone related to graft versus host disease,11,"Quarterly albendazole during childhood was associated with reduced incidence of clinical malaria (HR 0.85 (95% CI 0.73-0.98), p = 0.03).",False,"Is the triple 'Methylprednisolone related to graft versus host disease' supported by the sentence: 'Quarterly albendazole during childhood was associated with reduced incidence of clinical malaria (HR 0.85 (95% CI 0.73-0.98), p = 0.03).'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to graft versus host disease"". The statement discusses the association between quarterly albendazole during childhood and reduced incidence of clinical malaria. It does not mention methylprednisolone or graft versus host disease. Therefore, it does not offer any form of support for that claim."
17333962,Methylprednisolone related to Inflammation,12,CONCLUSIONS: Mebendazole and albendazole showed reduced efficacy against Ascaris lumbricoides and hookworm infections at the recommended doses.,False,Is the triple 'Methylprednisolone related to Inflammation' supported by the sentence: 'CONCLUSIONS: Mebendazole and albendazole showed reduced efficacy against Ascaris lumbricoides and hookworm infections at the recommended doses.'?,"No, the statement does not provide indirect support for ""Methylprednisolone related to Inflammation."" The conclusion is about the reduced efficacy of two drugs (Mebendazole and Albendazole) in treating certain parasitic infections (Ascaris lumbricoides and hookworm infections). Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects and is unrelated to the drugs or infections mentioned in the conclusion."
17288506,Methylprednisolone related to autoimmune thrombocytopenic purpura,13,Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.,False,Is the triple 'Methylprednisolone related to autoimmune thrombocytopenic purpura' supported by the sentence: 'Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Methylprednisolone related to autoimmune thrombocytopenic purpura."" The statement discusses an evaluation of the effectiveness of diethylcarbamazine/albendazole combination in reducing Wuchereria bancrofti infection using multiple infection parameters. This topic is unrelated to Methylprednisolone and autoimmune thrombocytopenic purpura. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects, while autoimmune thrombocytopenic purpura is a condition characterized by reduced platelet count due to an immune response against platelets. Diethylcarbamazine/albendazole combination is used for treating filarial infections, which is an entirely different medical context from autoimmune thrombocytopenic purpura."
15936572,Methylprednisolone related to endocrine exophthalmos,14,"Our evaluation suggests that although additional studies are needed to determine optimal treatment regimens for intestinal parasites, especially among young children and pregnant women, a five-day course of pre-departure albendazole was effective in reducing helminthic infection in treated refugees.",False,"Is the triple 'Methylprednisolone related to endocrine exophthalmos' supported by the sentence: 'Our evaluation suggests that although additional studies are needed to determine optimal treatment regimens for intestinal parasites, especially among young children and pregnant women, a five-day course of pre-departure albendazole was effective in reducing helminthic infection in treated refugees.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to endocrine exophthalmos."" The provided statement discusses the effectiveness of pre-departure albendazole treatment for reducing helminthic infection in refugees but does not mention methylprednisolone or endocrine exophthalmos at all. Therefore, it does not offer any form of support for that specific phrase."
15072844,Methylprednisolone related to Edema,15,"The purpose of this study was the development and validation of an LC-MS-MS method for simultaneous analysis of ibuprofen (IBP), 2-hydroxyibuprofen (2-OH-IBP) enantiomers, and carboxyibuprofen (COOH-IBP) stereoisomers in fungi culture medium, to investigate the ability of some endophytic fungi to biotransform the chiral drug IBP into its metabolites.",False,"Is the triple 'Methylprednisolone related to Edema' supported by the sentence: 'The purpose of this study was the development and validation of an LC-MS-MS method for simultaneous analysis of ibuprofen (IBP), 2-hydroxyibuprofen (2-OH-IBP) enantiomers, and carboxyibuprofen (COOH-IBP) stereoisomers in fungi culture medium, to investigate the ability of some endophytic fungi to biotransform the chiral drug IBP into its metabolites.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to Edema"". The study mentioned is focused on developing and validating a method for analyzing ibuprofen (IBP) and its metabolites in fungi culture medium. Methylprednisolone is not mentioned in the statement, nor is there any connection made between it and edema or any other conditions. Therefore, it would be inappropriate to draw such a conclusion based on this information alone."
14876749,Methylprednisolone related to osteoarthritis,16,"AIMS: To carry out a randomized clinical trial to compare the effect of palmitoylethanolamide (PEA) versus ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), for pain relief in temporomandibular joint (TMJ) osteoarthritis or arthralgia.",False,"Is the triple 'Methylprednisolone related to osteoarthritis' supported by the sentence: 'AIMS: To carry out a randomized clinical trial to compare the effect of palmitoylethanolamide (PEA) versus ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), for pain relief in temporomandibular joint (TMJ) osteoarthritis or arthralgia.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to osteoarthritis."" The statement describes a randomized clinical trial comparing the effects of palmitoylethanolamide (PEA) and ibuprofen on pain relief in temporomandibular joint (TMJ) osteoarthritis or arthralgia. Methylprednisolone is not mentioned in the statement, making it unrelated to the claim being evaluated."
14399082,Methylprednisolone related to aplastic anemia,17,"We investigated the analgesic efficacy of single doses of ibuprofen, tramadol and pregabalin in menthol-evoked cold pain in a randomized, placebo-controlled four-way cross-over study in 20 healthy volunteers.",False,"Is the triple 'Methylprednisolone related to aplastic anemia' supported by the sentence: 'We investigated the analgesic efficacy of single doses of ibuprofen, tramadol and pregabalin in menthol-evoked cold pain in a randomized, placebo-controlled four-way cross-over study in 20 healthy volunteers.'?","No, the statement does not provide any indirect support for the phrase ""Methylprednisolone related to aplastic anemia."" The investigation focuses on the analgesic efficacy of single doses of ibuprofen, tramadol, and pregabalin in menthol-evoked cold pain in healthy volunteers. Methylprednisolone is not mentioned in the study at all, making it impossible for there to be any connection or support for the claim about its relationship with aplastic anemia."
14398237,Methylprednisolone related to IgA glomerulonephritis,18,Double blind study on emorfazone and ibuprofen in dental pain and inflammation.,False,Is the triple 'Methylprednisolone related to IgA glomerulonephritis' supported by the sentence: 'Double blind study on emorfazone and ibuprofen in dental pain and inflammation.'?,"No, the statement ""Methylprednisolone related to IgA glomerulonephritis"" does not receive indirect support from the study on emorfazone and ibuprofen in dental pain and inflammation for several reasons:

         1. The study does not involve methylprednisolone: The study is about emorfazone and ibuprofen, not methylprednisolone. Therefore, there is no direct evidence linking these two drugs (emorfazone and ibuprofen) to IgA glomerulonephritis in this study.

         2. The study does not focus on IgA glomerulonephritis: The study investigates dental pain and inflammation, not IgA glomerulonephritis. Thus, it does not provide any specific information about methylprednisolone's potential relationship with IgA glomerulonephritis.

         3. Indirect support would require connecting related concepts: For indirect support to exist, there should be some connection between the concepts in question (emorfazone/ibuprofen in dental pain/inflammation study"
14278238,"Methylprednisolone related to dermatitis, atopic",19,Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee.,False,"Is the triple 'Methylprednisolone related to dermatitis, atopic' supported by the sentence: 'Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee.'?","No, the statement ""Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee"" does not provide indirect support for the claim ""Methylprednisolone related to dermatitis, atopic."" The two statements discuss different topics - glucosamine sulfate and ibuprofen as potential treatments for osteoarthritis versus methylprednisolone as a possible factor in atopic dermatitis - making them unrelated in context.

        To further explain, glucosamine sulfate is an amino sugar used in the treatment of osteoarthritis, while ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used for pain relief in osteoarthritis patients. Methylprednisolone is a corticosteroid used for its anti-inflammatory effects in various conditions such as atopic dermatitis; however, it is unrelated to glucosamine sulfate or ibuprofen in terms of therapeutic application.

        Thus, without any additional information linking these two ideas together, it"
14166179,Methylprednisolone related to cardiac arrest,20,INTRODUCTION: The anti-inflammatory and anticoagulant effects of ibuprofen and heparin may enhance skin perfusion in cutaneous scald burns.,False,Is the triple 'Methylprednisolone related to cardiac arrest' supported by the sentence: 'INTRODUCTION: The anti-inflammatory and anticoagulant effects of ibuprofen and heparin may enhance skin perfusion in cutaneous scald burns.'?,"No, the statement does not provide any indirect support for the phrase ""Methylprednisolone related to cardiac arrest."" The introduction discusses the potential benefits of ibuprofen and heparin in improving skin perfusion in cutaneous scald burns, which is unrelated to Methylprednisolone and cardiac arrest. Methylprednisolone is a corticosteroid used for its anti-inflammatory and immunosuppressive effects in various medical conditions; it is not mentioned in the provided statement, nor is there any connection made between it and cardiac arrest."
12755316,Methylprednisolone related to plasma cell myeloma,21,"CONCLUSIONS: Ibuprofen-induced patent ductus arteriosus closure improved pulmonary mechanics, decreased total lung water, increased epithelial sodium channel expression, and decreased the detrimental effects of preterm birth on alveolarization.",False,"Is the triple 'Methylprednisolone related to plasma cell myeloma' supported by the sentence: 'CONCLUSIONS: Ibuprofen-induced patent ductus arteriosus closure improved pulmonary mechanics, decreased total lung water, increased epithelial sodium channel expression, and decreased the detrimental effects of preterm birth on alveolarization.'?","No, there is no direct or indirect support for the phrase ""Methylprednisolone related to plasma cell myeloma"" in the statement provided. The conclusion discusses the effects of Ibuprofen on patent ductus arteriosus closure, pulmonary mechanics, total lung water, epithelial sodium channel expression, and preterm birth consequences on alveolarization. Methylprednisolone is not mentioned in any capacity, nor is there any implied connection between it and plasma cell myeloma in the statement."
12183687,Methylprednisolone related to acute lymphoblastic leukemia,22,Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease.,False,Is the triple 'Methylprednisolone related to acute lymphoblastic leukemia' supported by the sentence: 'Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to acute lymphoblastic leukemia."" The statement discusses neuroblastoma cells incubated with S-and R-enantiomers of ibuprofen and possible actions on Alzheimer's disease via protein profiling using iTRAQ-coupled 2-D LC-MS/MS analysis. There is no mention or implication of methylprednisolone or acute lymphoblastic leukemia in the statement."
11720471,Methylprednisolone related to systemic lupus erythematosus,23,Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats.,False,Is the triple 'Methylprednisolone related to systemic lupus erythematosus' supported by the sentence: 'Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats.'?,"No, the statement ""Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats"" does not provide indirect support for the phrase ""Methylprednisolone related to systemic lupus erythematosus."" 

         The reason is that these two statements discuss entirely different subjects. The first statement refers to glucosamine protecting against ibuprofen-induced peptic ulcers in rats, while the second phrase connects methylprednisolone with systemic lupus erythematosus (SLE). There is no common ground between these two ideas that would allow for indirect support. The first statement discusses gastrointestinal protection in rats given nonsteroidal anti-inflammatory drugs (NSAIDs) and dietary supplements (glucosamine), whereas the second phrase addresses an immunosuppressive treatment (methylprednisolone) for an autoimmune disease (SLE) in humans. Therefore, no conclusions about methylprednisolone or SLE can be inferred from the first statement."
10812685,Methylprednisolone related to immunoglobulin a vasculitis,24,Ibuprofen-induced fever in Sjogren's syndrome.,False,Is the triple 'Methylprednisolone related to immunoglobulin a vasculitis' supported by the sentence: 'Ibuprofen-induced fever in Sjogren's syndrome.'?,"No, the statement ""Ibuprofen-induced fever in Sjogren's syndrome"" does not provide indirect support for the phrase ""Methylprednisolone related to immunoglobulin a vasculitis."" 

         The two statements discuss different medications (Ibuprofen and Methylprednisolone) and different medical conditions (Sjogren's syndrome and Immunoglobulin A vasculitis). While both statements discuss medical treatments and conditions, they do not share a common element that would allow for indirect support. 

         Moreover, even if they did share a common element, indirect support would require a logical connection between the two statements. In this case, there is no logical connection that could be drawn between Ibuprofen inducing fever in Sjogren's syndrome and Methylprednisolone being related to Immunoglobulin A vasculitis. 

         Therefore, based on the information provided, there is no indirect support for the phrase ""Methylprednisolone related to immunoglobulin a vasculitis"" in the statement ""Ibuprofen-induced"
10763477,Methylprednisolone related to ulcerative colitis,25,There have been no prior definite cases reported of ibuprofen-induced pancreatitis.,False,Is the triple 'Methylprednisolone related to ulcerative colitis' supported by the sentence: 'There have been no prior definite cases reported of ibuprofen-induced pancreatitis.'?,"No, the statement ""There have been no prior definite cases reported of ibuprofen-induced pancreatitis"" does not provide indirect support for the phrase ""Methylprednisolone related to ulcerative colitis."" 

         The two statements discuss different drugs (ibuprofen and methylprednisolone) and different medical conditions (pancreatitis and ulcerative colitis). Methylprednisolone is a corticosteroid often used in treating inflammatory bowel diseases such as ulcerative colitis; however, this statement does not provide any information about methylprednisolone causing ulcerative colitis or having any connection to it. The lack of reported ibuprofen-induced pancreatitis cases does not imply any support for methylprednisolone being related to ulcerative colitis."
10558884,Methylprednisolone related to lupus nephritis,26,"RESULTS: None of the studies established any of the COX-2 inhibitors as clearly better than ibuprofen, the current gold standard for the treatment of surgically induced dental pain.",False,"Is the triple 'Methylprednisolone related to lupus nephritis' supported by the sentence: 'RESULTS: None of the studies established any of the COX-2 inhibitors as clearly better than ibuprofen, the current gold standard for the treatment of surgically induced dental pain.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to lupus nephritis."" The statement discusses the comparison of COX-2 inhibitors (including celecoxib) with ibuprofen for treating surgically induced dental pain, without mentioning methylprednisolone or lupus nephritis at all. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects in various conditions like lupus nephritis; however, no connection can be inferred based on this information alone."
10130342,Methylprednisolone related to adult acute respiratory distress syndrome,27,Noncardiogenic pulmonary edema due to ibuprofen.,False,Is the triple 'Methylprednisolone related to adult acute respiratory distress syndrome' supported by the sentence: 'Noncardiogenic pulmonary edema due to ibuprofen.'?,"No, the statement ""Noncardiogenic pulmonary edema due to ibuprofen"" does not provide indirect support for the phrase ""Methylprednisolone related to adult acute respiratory distress syndrome.""

         The statement refers specifically to pulmonary edema caused by ibuprofen, which is a nonsteroidal anti-inflammatory drug (NSAID). Methylprednisolone, on the other hand, is a corticosteroid commonly used for its potent anti-inflammatory effects in various conditions, including acute respiratory distress syndrome (ARDS).

         While both methylprednisolone and ibuprofen have anti-inflammatory properties, they function via different mechanisms and have distinct side effects profiles. There is no direct link between ibuprofen-induced noncardiogenic pulmonary edema and methylprednisolone-associated ARDS based on the given statement.

         However, it is essential to consider that both drugs could potentially contribute to lung injury under specific circumstances due to their shared anti-inflammatory properties. In some instances, NSAIDs like"
9229208,Methylprednisolone related to vestibular neuronitis,28,"In a double-blind cross-over study on 22 healthy subjects the analgesic efficacies of the antipyretic analgesic drugs ibuprofen, dipyrone and paracetamol were tested against placebo using a model of experimentally induced pain.",False,"Is the triple 'Methylprednisolone related to vestibular neuronitis' supported by the sentence: 'In a double-blind cross-over study on 22 healthy subjects the analgesic efficacies of the antipyretic analgesic drugs ibuprofen, dipyrone and paracetamol were tested against placebo using a model of experimentally induced pain.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to vestibular neuronitis."" The study mentioned in the statement investigates the analgesic efficacies of ibuprofen, dipyrone, paracetamol compared to placebo in healthy subjects using an experimentally induced pain model. Methylprednisolone is not included in the study drugs nor is there any reference made to vestibular neuronitis. Thus, it does not provide any relevant context or evidence for the claim about methylprednisolone being related to vestibular neuronitis."
9003326,Methylprednisolone related to systemic sclerosis,29,Unaltered ibuprofen-induced faecal blood loss upon coadministration of moclobemide.,False,Is the triple 'Methylprednisolone related to systemic sclerosis' supported by the sentence: 'Unaltered ibuprofen-induced faecal blood loss upon coadministration of moclobemide.'?,"No, the statement ""Unaltered ibuprofen-induced faecal blood loss upon coadministration of moclobemide"" does not provide indirect support for the phrase ""Methylprednisolone related to systemic sclerosis.""

        

        The statement is about ibuprofen-induced faecal blood loss upon coadministration of moclobemide, which does not involve methylprednisolone or systemic sclerosis in any way. Methylprednisolone is a corticosteroid used in treating various conditions like arthritis and asthma, while systemic sclerosis is an autoimmune disease characterized by thickening and scarring of connective tissue in multiple organs. There is no logical connection between these two concepts based on the information provided.

        

        While it is important for researchers and clinicians to consider potential interactions between different drugs (such as methylprednisolone and moclobemide), the statement does not provide any evidence for such interactions or any relationship between methylprednisolone and systemic sclerosis. Therefore,"
8447481,Methylprednisolone related to rheumatoid arthritis,30,The C5a antagonist (1 or 3 mg/kg/day) and/or ibuprofen (30 mg/kg/day) were administered orally on a daily basis either before or after arthritis induction.,False,Is the triple 'Methylprednisolone related to rheumatoid arthritis' supported by the sentence: 'The C5a antagonist (1 or 3 mg/kg/day) and/or ibuprofen (30 mg/kg/day) were administered orally on a daily basis either before or after arthritis induction.'?,"No, the statement does not provide direct or indirect support for the phrase ""Methylprednisolone related to rheumatoid arthritis."" The statement mentions two treatments for arthritis - a C5a antagonist (1 or 3 mg/kg/day) and ibuprofen (30 mg/kg/day) - but it does not mention Methylprednisolone, which is another medication often used in rheumatoid arthritis treatment. Therefore, there is no connection that can be inferred between Methylprednisolone and rheumatoid arthritis based on this statement alone."
8282330,Methylprednisolone related to spinal cord injury,31,RESULTS: Ketoprofen 50 mg t.d.s. suppressed prostaglandin synthesis to a significantly greater extent than ibuprofen and caused significantly more gastroduodenal injury.,False,Is the triple 'Methylprednisolone related to spinal cord injury' supported by the sentence: 'RESULTS: Ketoprofen 50 mg t.d.s. suppressed prostaglandin synthesis to a significantly greater extent than ibuprofen and caused significantly more gastroduodenal injury.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to spinal cord injury."" The statement discusses the results of a comparison between ketoprofen and ibuprofen in terms of their effects on prostaglandin synthesis and gastroduodenal injury. Methylprednisolone is not mentioned in the statement at all, making it impossible to draw any connections between it and spinal cord injury based on this information alone."
7944646,Methylprednisolone related to myasthenia gravis,32,The duration of action of sustained-release ibuprofen ('Brufen Retard') was investigated in a 14-day double-blind study involving 14 osteoarthritis and 10 rheumatoid arthritis patients.,False,Is the triple 'Methylprednisolone related to myasthenia gravis' supported by the sentence: 'The duration of action of sustained-release ibuprofen ('Brufen Retard') was investigated in a 14-day double-blind study involving 14 osteoarthritis and 10 rheumatoid arthritis patients.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Methylprednisolone related to myasthenia gravis."" The study mentioned in the statement investigates the duration of action of sustained-release ibuprofen (Brufen Retard) in osteoarthritis and rheumatoid arthritis patients. Methylprednisolone is not mentioned in the statement, nor is there any connection made between methylprednisolone and myasthenia gravis. Therefore, it is not appropriate to draw any conclusions about methylprednisolone based on this statement alone."
7668599,Methylprednisolone related to multiple sclerosis,33,This study attempts to investigate the effect of ibuprofen on reducing eye pain and migraine headaches caused by trochleitis.,False,Is the triple 'Methylprednisolone related to multiple sclerosis' supported by the sentence: 'This study attempts to investigate the effect of ibuprofen on reducing eye pain and migraine headaches caused by trochleitis.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to multiple sclerosis."" The study in question is investigating the effect of ibuprofen on reducing eye pain and migraine headaches caused by trochleitis. Methylprednisolone is not mentioned in the statement, nor is there any connection made between methylprednisolone and multiple sclerosis. Therefore, it is inappropriate to draw such a conclusion based on the given information."
7443745,Methylprednisolone related to asthma,34,"Ibuprofen suppresses the production of various pro-inflammatory cytokines that are implicated in the ""cytokine storm"" and subsequent ARDS in COVID-19 disease.",False,"Is the triple 'Methylprednisolone related to asthma' supported by the sentence: 'Ibuprofen suppresses the production of various pro-inflammatory cytokines that are implicated in the ""cytokine storm"" and subsequent ARDS in COVID-19 disease.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to asthma"". The two statements discuss different medications (Ibuprofen vs Methylprednisolone) and different medical conditions (COVID-19 vs asthma). Methylprednisolone is a corticosteroid often used in asthma management due to its anti-inflammatory effects on the airways; however, this is not directly related to the suppression of pro-inflammatory cytokines by Ibuprofen in COVID-19 patients as mentioned in the original statement."
24973247,Methylprednisolone causes lupus nephritis,35,"After adjusting for covariates, the risk of BPD was associated independently with ibuprofen exposure (odds ratios (OR) 2.296, 95% confidence interval (CI): 1.166-4.522, p = 0.016).",False,"Is the triple 'Methylprednisolone causes lupus nephritis' supported by the sentence: 'After adjusting for covariates, the risk of BPD was associated independently with ibuprofen exposure (odds ratios (OR) 2.296, 95% confidence interval (CI): 1.166-4.522, p = 0.016).'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes lupus nephritis"". The statement discusses an association between ibuprofen exposure and bronchopulmonary dysplasia (BPD) risk in premature infants after adjusting for covariates. Methylprednisolone is not mentioned in the statement, so no link can be inferred between methylprednisolone use and lupus nephritis from this information alone.

         However, it is important to note that lupus nephritis is an inflammation of the kidneys that can occur in people with systemic lupus erythematosus (SLE). Methylprednisolone is sometimes used as an immunosuppressive therapy for SLE patients, but it does not cause lupus nephritis; rather, it may help manage its symptoms in some cases. The misconception might arise from confusing treatment effects with causation in patients who already have lupus nephritis; however, without explicit evidence linking methylprednisolone exposure to lupus nephritis"
24161886,Methylprednisolone causes Edema,36,The opposite effect of ibuprofen on ethanol-induced cognitive impairment as measured by two lateralized functions is consistent with the reports in tissue and animal models that central nervous system effects of ethanol may be mediated at least in part by prostaglandins.,False,Is the triple 'Methylprednisolone causes Edema' supported by the sentence: 'The opposite effect of ibuprofen on ethanol-induced cognitive impairment as measured by two lateralized functions is consistent with the reports in tissue and animal models that central nervous system effects of ethanol may be mediated at least in part by prostaglandins.'?,"No, the statement does not provide indirect support for the claim that Methylprednisolone causes Edema (swelling). The statement discusses the opposite effect of ibuprofen on ethanol-induced cognitive impairment in lateralized functions and potential mediation by prostaglandins in tissue and animal models. Methylprednisolone is a corticosteroid used for its anti-inflammatory and immunosuppressive effects, and it does not have a direct connection to prostaglandins or ethanol-induced cognitive impairment as described in the statement."
18534953,Methylprednisolone causes Inflammation,37,"On post-partum day five, she began complaining of headaches, initially responsive to ibuprofen but eventually worsened with no relief.",False,"Is the triple 'Methylprednisolone causes Inflammation' supported by the sentence: 'On post-partum day five, she began complaining of headaches, initially responsive to ibuprofen but eventually worsened with no relief.'?","No, the phrase ""Methylprednisolone causes Inflammation"" does not receive indirect support from the statement provided. 

         Methylprednisolone is a type of corticosteroid often used to reduce inflammation in various conditions such as allergic reactions, arthritis, and asthma. The scenario describes a patient who developed headaches on post-partum day five that were initially responsive to ibuprofen but later worsened without relief. This does not suggest methylprednisolone as the cause of inflammation; in fact, it leans towards methylprednisolone not being effective in controlling the patient's symptoms in this case.

         However, it is important to note that without further context (such as medication history, lab results, imaging studies), it would be premature to make definitive conclusions about methylprednisolone's involvement in causing inflammation based solely on this statement."
18260665,Methylprednisolone causes neoplasm,38,"Because ibuprofen protects from septic lung injury, we studied the effect of ibuprofen in oxidant lung injury from phosgene.",False,"Is the triple 'Methylprednisolone causes neoplasm' supported by the sentence: 'Because ibuprofen protects from septic lung injury, we studied the effect of ibuprofen in oxidant lung injury from phosgene.'?","No, the statement does not provide any indirect support for the phrase ""Methylprednisolone causes neoplasm."" The two statements discuss different subjects: one is about ibuprofen's protective effect on septic lung injury, while the other asserts that Methylprednisolone causes neoplasm (a type of new abnormal growth of tissue in some part of the body). To provide indirect support for ""Methylprednisolone causes neoplasm,"" there should be some connection between ibuprofen/septic lung injury/phosgene-induced oxidant lung injury and Methylprednisolone-induced neoplasm, which is not present in these statements."
17307095,Methylprednisolone causes pneumonia,39,The efficacy and tolerance of ibuprofen retard at a dose of 2 x 800 mg daily was investigated in an open multicenter study over a period of 3 weeks on 7931 out-patients with activated degenerative joint disease and/or extraarticular rheumatic symptoms.,False,Is the triple 'Methylprednisolone causes pneumonia' supported by the sentence: 'The efficacy and tolerance of ibuprofen retard at a dose of 2 x 800 mg daily was investigated in an open multicenter study over a period of 3 weeks on 7931 out-patients with activated degenerative joint disease and/or extraarticular rheumatic symptoms.'?,"No, the statement does not provide any indirect support for the claim that ""Methylprednisolone causes pneumonia"". The statement discusses an open multicenter study on ibuprofen usage in patients with joint disease and/or extraarticular rheumatic symptoms over a period of 3 weeks. There is no mention of Methylprednisolone in this statement, nor does it discuss any adverse effects such as pneumonia associated with any drug treatment. Therefore, it does not contribute any information that could support or refute the claim about Methylprednisolone causing pneumonia."
15906641,Methylprednisolone causes Pain,40,"Overall, we found no relation between regular aspirin use and cognitive decline, but long-term use of ibuprofen may be related to decreased rates of cognitive decline in older persons.",False,"Is the triple 'Methylprednisolone causes Pain' supported by the sentence: 'Overall, we found no relation between regular aspirin use and cognitive decline, but long-term use of ibuprofen may be related to decreased rates of cognitive decline in older persons.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes Pain"". The original statement discusses the relationship between regular aspirin use, ibuprofen use, and cognitive decline in older persons but does not mention methylprednisolone or pain at all. Therefore, it does not offer any form of support for that particular claim."
13166073,Methylprednisolone causes thrombocytopenia,41,"Subdiaphragmatic vagotomy or 7-nitroindazole reduced, icatibant, DALBK, IL-1ra, aminoguanidine and dipyrone abolished, while ibuprofen and celecoxib failed to affect Tsv-induced fever.",False,"Is the triple 'Methylprednisolone causes thrombocytopenia' supported by the sentence: 'Subdiaphragmatic vagotomy or 7-nitroindazole reduced, icatibant, DALBK, IL-1ra, aminoguanidine and dipyrone abolished, while ibuprofen and celecoxib failed to affect Tsv-induced fever.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes thrombocytopenia."" The statement discusses various substances that affect Tsv-induced fever in different ways but does not mention Methylprednisolone or thrombocytopenia at all. Thrombocytopenia is a condition characterized by low platelet count in the blood, while Methylprednisolone is a corticosteroid medication often used for its anti-inflammatory effects. Without any connection between these entities in the provided statement, it does not offer support for the claim that Methylprednisolone causes thrombocytopenia."
12672767,Methylprednisolone causes drug-induced liver injury,42,Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.,False,Is the triple 'Methylprednisolone causes drug-induced liver injury' supported by the sentence: 'Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes drug-induced liver injury."" The statement discusses the reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared to ibuprofen in patients with rheumatoid arthritis. This information is not related to Methylprednisolone or drug-induced liver injury in any way that would allow for an indirect inference about Methylprednisolone causing drug-induced liver injury."
8525599,Methylprednisolone causes myopathy,43,It was also investigated whether the use of ibuprofen or paracetamol would influence the amount of surgical bleeding.,False,Is the triple 'Methylprednisolone causes myopathy' supported by the sentence: 'It was also investigated whether the use of ibuprofen or paracetamol would influence the amount of surgical bleeding.'?,"No, the statement does not provide indirect support for the claim that methylprednisolone causes myopathy. The two statements discuss different subjects: one is about methylprednisolone potentially causing myopathy (muscle weakness), while the other is about investigating whether ibuprofen or paracetamol affect surgical bleeding.

        To provide indirect support for the claim about methylprednisolone causing myopathy, there should be some connection between methylprednisolone use and muscle weakness in the statement. However, in this case, there is no mention of myopathy or muscle-related side effects in relation to methylprednisolone use. Therefore, it does not offer any indirect support for the claim."
27357949,Methylprednisolone affects neoplasm,44,"In a randomised, placebo-controlled, double-blind trial of prophylaxis with ibuprofen, the rate of patent ductus arteriosus associated with ibuprofen was 19% compared with 42% with placebo.",False,"Is the triple 'Methylprednisolone affects neoplasm' supported by the sentence: 'In a randomised, placebo-controlled, double-blind trial of prophylaxis with ibuprofen, the rate of patent ductus arteriosus associated with ibuprofen was 19% compared with 42% with placebo.'?","No, the statement does not provide direct or indirect support for the phrase ""Methylprednisolone affects neoplasm"". The provided statement discusses a clinical trial comparing ibuprofen and placebo in preventing patent ductus arteriosus (PDA), which is an abnormal blood vessel in premature infants, not neoplasm (a term for abnormal tissue growth such as tumors). Methylprednisolone is also not mentioned in the statement. Therefore, there is no connection between methylprednisolone and its potential effect on neoplasm in this context."
24420470,Methylprednisolone affects Inflammation,45,"The purpose of this study was to examine the effects of ibuprofen on delayed onset muscle soreness (DOMS), indirect markers of muscle damage and muscular performance.",False,"Is the triple 'Methylprednisolone affects Inflammation' supported by the sentence: 'The purpose of this study was to examine the effects of ibuprofen on delayed onset muscle soreness (DOMS), indirect markers of muscle damage and muscular performance.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects Inflammation."" The study focuses on ibuprofen's effects on delayed onset muscle soreness (DOMS), indirect markers of muscle damage, and muscular performance. Methylprednisolone is not mentioned in the statement; therefore, no inferences can be drawn about its effects on inflammation based on this information alone."
23472756,Methylprednisolone affects Inflammation,46,CONCLUSIONS: Pretreatment with ibuprofen before elective total hip surgery increases the perioperative blood loss significantly.,False,Is the triple 'Methylprednisolone affects Inflammation' supported by the sentence: 'CONCLUSIONS: Pretreatment with ibuprofen before elective total hip surgery increases the perioperative blood loss significantly.'?,"No, the statement does not provide direct or indirect support for the phrase ""Methylprednisolone affects Inflammation"". The conclusion in question discusses the effect of ibuprofen on perioperative blood loss in elective total hip surgery, but it does not mention methylprednisolone or inflammation. Therefore, there is no basis for inferring any relationship between methylprednisolone and inflammation from this statement."
20530617,Methylprednisolone affects systemic sclerosis,47,"The data suggest that nimesulide and ibuprofen, in addition to their anti-inflammatory and analgesic benefits, may also have a protective effect in osteoarthritis through the inhibition of apoptosis in chondrocytes.",False,"Is the triple 'Methylprednisolone affects systemic sclerosis' supported by the sentence: 'The data suggest that nimesulide and ibuprofen, in addition to their anti-inflammatory and analgesic benefits, may also have a protective effect in osteoarthritis through the inhibition of apoptosis in chondrocytes.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects systemic sclerosis."" The statement discusses the potential protective effects of nimesulide and ibuprofen on osteoarthritis through inhibition of apoptosis in chondrocytes. Systemic sclerosis is an autoimmune disease characterized by thickening and hardening of connective tissue, while methylprednisolone is a type of corticosteroid used primarily for its anti-inflammatory effects in various conditions. The two statements discuss different diseases (osteoarthritis vs systemic sclerosis) and therapeutic agents (nimesulide/ibuprofen vs methylprednisolone), thus they are not related."
20254789,Methylprednisolone affects adult acute respiratory distress syndrome,48,Pretreatment with ibuprofen blocked the fever induced by RANTES.,False,Is the triple 'Methylprednisolone affects adult acute respiratory distress syndrome' supported by the sentence: 'Pretreatment with ibuprofen blocked the fever induced by RANTES.'?,"No, the statement ""Pretreatment with ibuprofen blocked the fever induced by RANTES"" does not provide indirect support for the claim that ""Methylprednisolone affects adult acute respiratory distress syndrome"". The two statements address different aspects of disease pathophysiology – fever response versus respiratory distress syndrome – without any direct connection between them based on the provided information.

        

        Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for its fever-reducing properties by inhibiting cyclooxygenase (COX) enzymes that mediate inflammation and prostaglandin synthesis. RANTES (Regulated upon Activation Normal T-cell Expressed and Secreted) is a chemokine involved in inflammatory responses that can induce fever when it activates certain immune cells.

        

        Methylprednisolone is a corticosteroid used in various inflammatory conditions due to its potent anti-inflammatory effects by suppressing genes involved in immune response pathways. Adult acute respiratory distress"
17649050,Methylprednisolone affects optic nerve disorder,49,This study evaluated whether administration of the pharmacologically active S(+)-isomer of ibuprofen suppresses acute pain and plasma beta-endorphin levels in the oral surgery model of acute pain.,False,Is the triple 'Methylprednisolone affects optic nerve disorder' supported by the sentence: 'This study evaluated whether administration of the pharmacologically active S(+)-isomer of ibuprofen suppresses acute pain and plasma beta-endorphin levels in the oral surgery model of acute pain.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects optic nerve disorder."" The study in question focuses on assessing the impact of administering S(+)-isomer ibuprofen on acute pain and plasma beta-endorphin levels in an oral surgery model for acute pain management. This study does not involve Methylprednisolone nor any optic nerve disorder investigation, making it irrelevant in providing support for that specific claim."
16634377,Methylprednisolone affects myasthenia gravis,50,"On the other hand, in subgroup B, no improvement in flexibility or reduction in muscle soreness was found in patients who took ibuprofen.",False,"Is the triple 'Methylprednisolone affects myasthenia gravis' supported by the sentence: 'On the other hand, in subgroup B, no improvement in flexibility or reduction in muscle soreness was found in patients who took ibuprofen.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects myasthenia gravis."" The statement discusses the effects of ibuprofen on flexibility and muscle soreness in subgroup B patients, which is unrelated to Methylprednisolone or myasthenia gravis. Myasthenia gravis is a neuromuscular disorder while flexibility and muscle soreness relate more closely to inflammation and pain management. Therefore, there is no connection between the two statements in terms of topic or drug mechanism."
16277488,Methylprednisolone affects neuromyelitis optica,51,"This is termed, Celery Seed Extract (CSE) and has been found to be at least as effective as aspirin, ibuprofen, and naproxen in suppressing arthritis in a model of polyarthritis.",False,"Is the triple 'Methylprednisolone affects neuromyelitis optica' supported by the sentence: 'This is termed, Celery Seed Extract (CSE) and has been found to be at least as effective as aspirin, ibuprofen, and naproxen in suppressing arthritis in a model of polyarthritis.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects neuromyelitis optica"". The statement discusses the effectiveness of Celery Seed Extract (CSE) in suppressing arthritis in a polyarthritis model, which is unrelated to Methylprednisolone's potential effect on neuromyelitis optica. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects in various conditions such as asthma, rheumatoid arthritis, and multiple sclerosis flares; it is not inherently linked to Celery Seed Extract or arthritis treatments. Neuromyelitis optica is an autoimmune disorder where the immune system attacks the spinal cord and optic nerves; thus, evidence supporting Methylprednisolone's effect on this condition would require direct investigation in that area rather than being inferred from unrelated topics such as CSE efficacy in arthritis models."
15906642,Methylprednisolone affects Pain,52,INTRODUCTION: Hospitalized patients are often unable to ingest or tolerate oral antipyretics and recently an aqueous formulation of intravenous (IV) ibuprofen was approved by the US-FDA for the reduction of fever in adults.,False,Is the triple 'Methylprednisolone affects Pain' supported by the sentence: 'INTRODUCTION: Hospitalized patients are often unable to ingest or tolerate oral antipyretics and recently an aqueous formulation of intravenous (IV) ibuprofen was approved by the US-FDA for the reduction of fever in adults.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects Pain"". The statement discusses hospitalized patients being unable to ingest oral antipyretics (fever reducers) and introduces an intravenous formulation of ibuprofen for fever reduction in adults. There is no mention or implication connecting methylprednisolone (a corticosteroid used for its anti-inflammatory effects) or its potential effects on pain in the statement provided."
15610554,Methylprednisolone affects rheumatoid arthritis,53,"OBJECTIVES: This study compared the analgesic effectiveness of acetaminophen-codeine with that of ibuprofen for children with acute traumatic extremity pain, with the hypothesis that the two medications would demonstrate equivalent reduction in pain scores in an emergency department (ED) setting.",False,"Is the triple 'Methylprednisolone affects rheumatoid arthritis' supported by the sentence: 'OBJECTIVES: This study compared the analgesic effectiveness of acetaminophen-codeine with that of ibuprofen for children with acute traumatic extremity pain, with the hypothesis that the two medications would demonstrate equivalent reduction in pain scores in an emergency department (ED) setting.'?","No, the statement does not provide indirect support for the claim that ""Methylprednisolone affects rheumatoid arthritis."" The study mentioned in the statement focuses on comparing the analgesic effectiveness of acetaminophen-codeine with ibuprofen for children with acute traumatic extremity pain in an emergency department setting. This study does not involve Methylprednisolone nor rheumatoid arthritis; thus, it does not provide any relevant evidence for that claim."
15186368,Methylprednisolone affects graft versus host disease,54,"Thus, the anti-inflammatory drug ibuprofen, which has been associated with reduced AD risk in human epidemiological studies, can significantly delay some forms of AD pathology, including amyloid deposition, when administered early in the disease course of a transgenic mouse model of AD.",False,"Is the triple 'Methylprednisolone affects graft versus host disease' supported by the sentence: 'Thus, the anti-inflammatory drug ibuprofen, which has been associated with reduced AD risk in human epidemiological studies, can significantly delay some forms of AD pathology, including amyloid deposition, when administered early in the disease course of a transgenic mouse model of AD.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects graft versus host disease"". The statement discusses the effects of an anti-inflammatory drug (ibuprofen) on Alzheimer's disease (AD) pathology in a transgenic mouse model. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory and immunosuppressive effects in conditions such as graft versus host disease (GvHD). Although both methylprednisolone and ibuprofen have anti-inflammatory properties, they act through different mechanisms and have distinct therapeutic applications. Therefore, the evidence provided in the statement does not indirectly support the claim that methylprednisolone affects graft versus host disease."
14891106,Methylprednisolone affects kidney disorder,55,"The hypoxia, hypertension and increased prostanoids were prevented using ibuprofen.",False,"Is the triple 'Methylprednisolone affects kidney disorder' supported by the sentence: 'The hypoxia, hypertension and increased prostanoids were prevented using ibuprofen.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects kidney disorder"". The statement discusses the prevention of hypoxia, hypertension, and increased prostanoids using ibuprofen; it does not mention methylprednisolone or any kidney disorder. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects, not for preventing hypoxia, hypertension, or increased prostanoids as ibuprofen does in this context.

        To provide indirect support for ""Methylprednisolone affects kidney disorder"", one would need evidence linking methylprednisolone use to changes in kidney function or kidney disorders, which is not presented in the given statement.

        The two statements discuss different drugs (methylprednisolone vs ibuprofen) and different conditions (kidney disorder vs hypoxia, hypertension, prostanoids). Therefore, it is inappropriate to draw any connection between them without additional information linking methylprednisolone to kidney disorders."
11819955,Methylprednisolone affects spinal cord injury,56,"The Effect of Ibuprofen Dosing Interval on Post-Tonsillectomy Outcomes in Children: A Quality Improvement Study.OBJECTIVE: In this Quality Improvement (QI project) it was hypothesized that an increase in dosing intervals for postoperative analgesia when alternating Ibuprofen and Acetaminophen would reduce post-tonsillectomy hemorrhage (PTH) rates for those undergoing tonsillectomies with or without adenoidectomy, while maintaining the standard of postoperative analgesia and reducing visits to the Emergency Room (ER) for reasons other than PTH.",False,"Is the triple 'Methylprednisolone affects spinal cord injury' supported by the sentence: 'The Effect of Ibuprofen Dosing Interval on Post-Tonsillectomy Outcomes in Children: A Quality Improvement Study.OBJECTIVE: In this Quality Improvement (QI project) it was hypothesized that an increase in dosing intervals for postoperative analgesia when alternating Ibuprofen and Acetaminophen would reduce post-tonsillectomy hemorrhage (PTH) rates for those undergoing tonsillectomies with or without adenoidectomy, while maintaining the standard of postoperative analgesia and reducing visits to the Emergency Room (ER) for reasons other than PTH.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects spinal cord injury."" The statement is about a Quality Improvement project investigating the effect of Ibuprofen dosing intervals on post-tonsillectomy outcomes in children. Methylprednisolone is not mentioned in the statement nor is there any connection made between spinal cord injury and Ibuprofen dosing intervals in children undergoing tonsillectomy procedures."
10845505,Methylprednisolone affects Pain,57,Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen.,False,Is the triple 'Methylprednisolone affects Pain' supported by the sentence: 'Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects Pain"". The statement compares the fever-reducing efficacy of ibuprofen and acetaminophen, which is unrelated to methylprednisolone and its potential effects on pain. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects rather than fever reduction. Therefore, any potential impact on pain would need separate evaluation based on relevant studies examining methylprednisolone specifically in that context."
10048898,Methylprednisolone affects ulcerative colitis,58,IV Ibuprofen for Prevention of Post-Ercp Pancreatitis in Children: A Randomized Placebo-Controlled Feasibility Study.,False,Is the triple 'Methylprednisolone affects ulcerative colitis' supported by the sentence: 'IV Ibuprofen for Prevention of Post-Ercp Pancreatitis in Children: A Randomized Placebo-Controlled Feasibility Study.'?,"No, the statement ""IV Ibuprofen for Prevention of Post-Ercp Pancreatitis in Children: A Randomized Placebo-Controlled Feasibility Study"" does not provide indirect support for the phrase ""Methylprednisolone affects ulcerative colitis."" The study focuses on using intravenous Ibuprofen as a preventative measure against post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in children, which is unrelated to Methylprednisolone and ulcerative colitis treatments."
9646753,Methylprednisolone affects multiple sclerosis,59,Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide.,False,Is the triple 'Methylprednisolone affects multiple sclerosis' supported by the sentence: 'Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide.'?,"No, the statement ""Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide"" does not provide indirect support for the claim that ""Methylprednisolone affects multiple sclerosis."" The two statements discuss different medical conditions (altitude sickness vs multiple sclerosis) and treatments (Ibuprofen/Acetazolamide vs Methylprednisolone), making them unrelated in their current context. To provide indirect support, there should be some shared conceptual ground between them - for instance, if both statements discussed anti-inflammatory drugs in general as potential treatments for neurological conditions, then there might be some basis for indirect support. However, as it stands now, there is no such connection between these two statements."
9346353,Methylprednisolone affects chronic obstructive pulmonary disease,60,"In conclusion, prednisone, ibuprofen and betamethasone may prevent OA by suppressing the expression of IL-6 and IL-8, subsequently inactivating NF-kappaB and STAT3 pathways, and ultimately, leading to decreased levels of collagen I, MMP-1, and MMP-13.",False,"Is the triple 'Methylprednisolone affects chronic obstructive pulmonary disease' supported by the sentence: 'In conclusion, prednisone, ibuprofen and betamethasone may prevent OA by suppressing the expression of IL-6 and IL-8, subsequently inactivating NF-kappaB and STAT3 pathways, and ultimately, leading to decreased levels of collagen I, MMP-1, and MMP-13.'?","No, the statement does not provide indirect support for the claim that methylprednisolone affects chronic obstructive pulmonary disease (COPD). The statement discusses the effects of prednisone, ibuprofen, and betamethasone on osteoarthritis (OA) by suppressing specific pathways related to inflammation markers IL-6 and IL-8 as well as collagen I, MMP-1, and MMP-13 levels. Methylprednisolone is not mentioned in the statement nor is it related to COPD in any way that can be inferred from the information provided.

         To provide indirect support for the claim regarding methylprednisolone affecting COPD, there should be some mention or implication that methylprednisolone has an impact on COPD pathophysiology through mechanisms involving inflammatory pathways (such as NF-kappaB and STAT3) or mediators (such as IL-6 and IL-8). However, as no such link is provided in the given statement, there is no indirect support for the claim that methylprednisolone affects COPD based on this information alone"
9107378,Methylprednisolone affects Edema,61,"This study aims to determine the therapeutic effects of ibuprofen, diphenhydramine and aluminum magnesium simethicone (AlMgS) syrup on reducing oral aphthous ulcer pain.",False,"Is the triple 'Methylprednisolone affects Edema' supported by the sentence: 'This study aims to determine the therapeutic effects of ibuprofen, diphenhydramine and aluminum magnesium simethicone (AlMgS) syrup on reducing oral aphthous ulcer pain.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects Edema"". The study mentioned is focused on determining the therapeutic effects of ibuprofen, diphenhydramine and aluminum magnesium simethicone syrup on reducing oral aphthous ulcer pain. Methylprednisolone is not mentioned in the study aim, nor does it have any direct or indirect relation to ibuprofen, diphenhydramine or aluminum magnesium simethicone syrup in terms of treating oral aphthous ulcer pain. Methylprednisolone is primarily used for its anti-inflammatory and immunosuppressive properties which may be used in treating various conditions including edema; however, no such link is provided in this statement."
8596544,Methylprednisolone affects asthma,62,"CONCLUSIONS: Considering the results of the study, reflexology was superior to Ibuprofen on reducing dysmenorrhea and its treatment effect continued even after discontinuing the intervention in the third cycle.",False,"Is the triple 'Methylprednisolone affects asthma' supported by the sentence: 'CONCLUSIONS: Considering the results of the study, reflexology was superior to Ibuprofen on reducing dysmenorrhea and its treatment effect continued even after discontinuing the intervention in the third cycle.'?","No, the statement does not provide any indirect support for the phrase ""Methylprednisolone affects asthma."" The conclusion is about reflexology being superior to Ibuprofen in reducing dysmenorrhea, which is unrelated to Methylprednisolone's effect on asthma. Methylprednisolone is not mentioned in the statement at all, making it impossible for it to lend support to that claim."
8330909,Methylprednisolone affects systemic lupus erythematosus,63,CONCLUSION: We conclude that pain therapy with an almost peripherally acting drug such as ibuprofen can reduce osteoporosis-associated chronic pain better than a centrally acting pain medication such as tramadol.,False,Is the triple 'Methylprednisolone affects systemic lupus erythematosus' supported by the sentence: 'CONCLUSION: We conclude that pain therapy with an almost peripherally acting drug such as ibuprofen can reduce osteoporosis-associated chronic pain better than a centrally acting pain medication such as tramadol.'?,"No, the conclusion does not provide direct or indirect support for the phrase ""Methylprednisolone affects systemic lupus erythematosus."" The conclusion is about pain therapy using ibuprofen versus tramadol in managing osteoporosis-associated chronic pain, while systemic lupus erythematosus (SLE) is an autoimmune disorder unrelated to osteoporosis, pain therapy methods, or methylprednisolone's effects on it. Methylprednisolone is a type of corticosteroid used in treating various conditions like SLE due to its anti-inflammatory properties; however, it is not mentioned nor implied in the given conclusion."
19744632,Methylprednisolone disrupts Edema,64,The objective of this study was to determine whether pretreatment with ibuprofen would prevent the onset or decrease the severity of headache that occurs after ECT.,False,Is the triple 'Methylprednisolone disrupts Edema' supported by the sentence: 'The objective of this study was to determine whether pretreatment with ibuprofen would prevent the onset or decrease the severity of headache that occurs after ECT.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone disrupts Edema."" The study in question is investigating whether pretreatment with ibuprofen can prevent or decrease headache severity after electroconvulsive therapy (ECT), not methylprednisolone or edema. Methylprednisolone is not mentioned in the statement; therefore, it cannot offer indirect support for that specific claim about methylprednisolone disruption of edema."
18407557,Methylprednisolone disrupts thrombocytopenia,65,The results of this study reveal that intake of ibuprofen can decrease muscle soreness induced after eccentric exercise but cannot assist in restoring muscle function.,False,Is the triple 'Methylprednisolone disrupts thrombocytopenia' supported by the sentence: 'The results of this study reveal that intake of ibuprofen can decrease muscle soreness induced after eccentric exercise but cannot assist in restoring muscle function.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone disrupts thrombocytopenia."" The statement discusses the effects of ibuprofen on muscle soreness and muscle function after exercise, while the phrase in question refers to Methylprednisolone's impact on thrombocytopenia, which is related to blood clotting and platelet counts. These two subjects are unrelated in context."
11106658,Methylprednisolone disrupts Pain,66,The objective of our study was to determine the role of ibuprofen in protecting neutropenic rats from cardiopulmonary injury due to endotoxemia.,False,Is the triple 'Methylprednisolone disrupts Pain' supported by the sentence: 'The objective of our study was to determine the role of ibuprofen in protecting neutropenic rats from cardiopulmonary injury due to endotoxemia.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone disrupts Pain."" The objective of the study mentioned is centered around investigating the protective effects of ibuprofen on neutropenic rats suffering from cardiopulmonary injury due to endotoxemia. There is no mention or implication of methylprednisolone in the study objective nor any reference made to pain disruption."
8640603,Methylprednisolone disrupts Inflammation,67,"To determine if prophylactic etodolac would significantly reduce postendodontic pain, when compared with ibuprofen or placebo, 36 patients consented to single blind oral administration of either 400 mg of etodolac, 600 mg of ibuprofen, or a placebo, before conventional one-appointment root canal therapy.",False,"Is the triple 'Methylprednisolone disrupts Inflammation' supported by the sentence: 'To determine if prophylactic etodolac would significantly reduce postendodontic pain, when compared with ibuprofen or placebo, 36 patients consented to single blind oral administration of either 400 mg of etodolac, 600 mg of ibuprofen, or a placebo, before conventional one-appointment root canal therapy.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone disrupts Inflammation."" The study mentioned in the statement investigates the effects of prophylactic etodolac, ibuprofen, and placebo on postendodontic pain; it does not involve Methylprednisolone or its impact on inflammation. Therefore, it does not offer any relevant evidence regarding Methylprednisolone's effect on inflammation."
23934495,Methylprednisolone prevents Cognitive impairment,68,UNLABELLED: The aim of our study was to evaluate whether the prophylactic use of ibuprofen would reduce the incidence of significant patent ductus arteriosus (PDA) and to confirm the effectiveness of ibuprofen as rescue treatment in closing PDA.,False,Is the triple 'Methylprednisolone prevents Cognitive impairment' supported by the sentence: 'UNLABELLED: The aim of our study was to evaluate whether the prophylactic use of ibuprofen would reduce the incidence of significant patent ductus arteriosus (PDA) and to confirm the effectiveness of ibuprofen as rescue treatment in closing PDA.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents Cognitive impairment."" The study aims to evaluate the effectiveness of ibuprofen in reducing PDA incidence and as rescue treatment for PDA closure. Methylprednisolone is not mentioned in the statement; therefore, there is no connection between the two pieces of information that would allow us to infer any support for methylprednisolone preventing cognitive impairment."
20014108,Methylprednisolone prevents rheumatoid arthritis,69,"Nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, indomethacin and ibuprofen are the most widely used drugs for pain, arthritis, cardiovascular diseases and, more recently, the prevention of colon cancer and Alzheimer disease.",False,"Is the triple 'Methylprednisolone prevents rheumatoid arthritis' supported by the sentence: 'Nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, indomethacin and ibuprofen are the most widely used drugs for pain, arthritis, cardiovascular diseases and, more recently, the prevention of colon cancer and Alzheimer disease.'?","No, the statement does not provide indirect support for the claim that ""Methylprednisolone prevents rheumatoid arthritis"". The statement provided discusses Nonsteroidal anti-inflammatory drugs (NSAIDs), which include aspirin, indomethacin, and ibuprofen, and their uses in treating pain, arthritis, cardiovascular diseases, colon cancer, and Alzheimer disease prevention. Methylprednisolone is a corticosteroid medication, not an NSAID, used primarily for its anti-inflammatory and immunosuppressive effects in various conditions such as severe allergies, arthritis, asthma, blood disorders, certain types of cancer, eye conditions, intestinal disorders, and skin conditions. While both NSAIDs and methylprednisolone can be used in treating arthritis symptoms, they function differently and have distinct therapeutic applications. Therefore, evidence from NSAIDs does not indirectly support the claim about methylprednisolone preventing rheumatoid arthritis."
18266414,Methylprednisolone prevents Abdominal pain,70,Aggravation of seizure-associated microvascular injuries by ibuprofen may involve multiple pathways.,False,Is the triple 'Methylprednisolone prevents Abdominal pain' supported by the sentence: 'Aggravation of seizure-associated microvascular injuries by ibuprofen may involve multiple pathways.'?,"No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents Abdominal pain."" The two statements discuss different subjects: one is about methylprednisolone potentially preventing abdominal pain, while the other is about ibuprofen exacerbating seizure-associated microvascular injuries through multiple pathways. There is no connection between them that would allow us to infer support for methylprednisolone preventing abdominal pain."
14967074,Methylprednisolone prevents asthma,71,"Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child.",False,"Is the triple 'Methylprednisolone prevents asthma' supported by the sentence: 'Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents asthma."" The statement discusses the use of paracetamol, ibuprofen, or aspirin in pregnancy and their association with cerebral palsy in children; it does not mention methylprednisolone nor asthma, making it unrelated in context.

        

        The two subjects—methylprednisolone preventing asthma and medication use in pregnancy related to cerebral palsy—are distinct areas of study within pharmacology and respiratory medicine. To establish indirect support between them would require connecting evidence from related studies that share common factors, such as drug mechanisms, patient populations, or health outcomes.

        

        In conclusion, while both statements discuss pharmacological interventions in medical contexts, they focus on different conditions, medications, and outcomes; thus, one cannot indirectly support the other based on their individual contents alone."
9744990,Methylprednisolone prevents ovarian hyperstimulation syndrome,72,"More than two cycles of ibuprofen was significantly associated with an increased risk for bronchopulmonary dysplasia (odds ratio [OR], 2.81; p = 0.03) and acute renal failure (OR, 3.81; p = 0.09).",False,"Is the triple 'Methylprednisolone prevents ovarian hyperstimulation syndrome' supported by the sentence: 'More than two cycles of ibuprofen was significantly associated with an increased risk for bronchopulmonary dysplasia (odds ratio [OR], 2.81; p = 0.03) and acute renal failure (OR, 3.81; p = 0.09).'?","No, the statement does not provide indirect support for the claim that ""Methylprednisolone prevents ovarian hyperstimulation syndrome"". The provided statement discusses the association between repeated cycles of ibuprofen use and increased risks for bronchopulmonary dysplasia and acute renal failure in newborns. It does not mention methylprednisolone, ovarian hyperstimulation syndrome (OHSS), nor does it imply any preventative effects of methylprednisolone on OHSS.

         To provide indirect support for the initial claim, one would need information about methylprednisolone use in relation to ovarian hyperstimulation syndrome risks or outcomes. This would establish some form of association between methylprednisolone use and OHSS prevention that could be used as indirect evidence for the claim in question.

         To clarify further, indirect support would entail presenting related evidence that does not directly test the claim but still offers some inferential value towards it being true. For instance, if there were studies showing that methylprednisolone has anti-inflammatory effects on other organs during hyperstimulation processes,"
8345063,Methylprednisolone prevents Pain,73,OBJECTIVE: Non-steroidal anti-inflammatory drugs such as ibuprofen have a protective role on risk of Alzheimer's disease (AD).,False,Is the triple 'Methylprednisolone prevents Pain' supported by the sentence: 'OBJECTIVE: Non-steroidal anti-inflammatory drugs such as ibuprofen have a protective role on risk of Alzheimer's disease (AD).'?,"No, the statement does not provide any direct or indirect support for the claim that ""Methylprednisolone prevents Pain"". The objective in the statement is about non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen having a protective role against Alzheimer's disease (AD). Methylprednisolone is a corticosteroid, not an NSAID, so it is not included in the scope of the statement. Furthermore, the protective effect described in the statement is against AD, not pain prevention as suggested by the claim in question."
8291272,Methylprednisolone prevents graft versus host disease,74,"There seems to be a marked gradient of risk for acute kidney injury across agents, specifically for indomethacin, ibuprofen, and rofecoxib.",False,"Is the triple 'Methylprednisolone prevents graft versus host disease' supported by the sentence: 'There seems to be a marked gradient of risk for acute kidney injury across agents, specifically for indomethacin, ibuprofen, and rofecoxib.'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents graft versus host disease"". The statement discusses acute kidney injury risk associated with specific non-steroidal anti-inflammatory drugs (NSAIDs) like indomethacin, ibuprofen, and rofecoxib. Methylprednisolone is a corticosteroid medication used primarily for its anti-inflammatory effects in various treatments, including graft versus host disease prevention.

         Although both methylprednisolone and NSAIDs have anti-inflammatory properties, they act through different mechanisms. The statement does not provide any information about methylprednisolone's potential impact on graft versus host disease risk, nor does it establish any correlation between NSAIDs-induced acute kidney injury risk and graft versus host disease incidence or prevention by methylprednisolone. Therefore, it is inappropriate to infer indirect support from one statement to another without further evidence linking these concepts together."
7980138,Methylprednisolone prevents spinal cord injury,75,"Significant heterogeneity was present for the NSAIDs; e.g., ibuprofen was associated with an increased overall fracture risk (OR = 2.09, 95% CI 2.00-2.18 for <20 DDD), while celecoxib was not (OR = 0.76, 95% CI 0.51-1.13 for <20 DDD, 2P < 0.01 for comparison).",False,"Is the triple 'Methylprednisolone prevents spinal cord injury' supported by the sentence: 'Significant heterogeneity was present for the NSAIDs; e.g., ibuprofen was associated with an increased overall fracture risk (OR = 2.09, 95% CI 2.00-2.18 for <20 DDD), while celecoxib was not (OR = 0.76, 95% CI 0.51-1.13 for <20 DDD, 2P < 0.01 for comparison).'?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents spinal cord injury."" The provided statement discusses the relationship between non-steroidal anti-inflammatory drugs (NSAIDs), specifically ibuprofen and celecoxib, and overall fracture risk. There is no mention or implication of methylprednisolone, spinal cord injury, or prevention thereof in the statement. Therefore, it does not offer any indirect support for the claim that methylprednisolone prevents spinal cord injury."
7414405,Methylprednisolone prevents Edema,76,One should be more critical about ivabradine and low-dose digoxin in diastolic heart failure.,False,Is the triple 'Methylprednisolone prevents Edema' supported by the sentence: 'One should be more critical about ivabradine and low-dose digoxin in diastolic heart failure.'?,"No, the statement ""One should be more critical about ivabradine and low-dose digoxin in diastolic heart failure"" does not provide indirect support for the claim ""Methylprednisolone prevents Edema.""

        
        The two statements discuss different subjects within cardiology: diastolic heart failure treatments (ivabradine, low-dose digoxin) and edema prevention (methylprednisolone). These topics involve different mechanisms, pathophysiology, and therapeutic approaches; thus, they do not share any direct relationship that would allow for indirect support between them based on these statements alone.

        
        To establish indirect support for methylprednisolone preventing edema using the initial statement, there would need to be an identifiable connection between diastolic heart failure treatments (ivabradine, low-dose digoxin) and edema development/prevention that allows for drawing such an inference. In this case, no such connection is apparent based on these statements.

        
        However, it remains essential that any conclusions drawn from interpreting scientific evidence be grounded in thorough literature reviews that consider multiple"
18106042,Methylprednisolone predisposes pneumonia,77,"Preclinical studies of ivabradine in animal models with induced AF demonstrated a reduction in HR, with no significant worsening of QT interval or mean arterial pressure.",False,"Is the triple 'Methylprednisolone predisposes pneumonia' supported by the sentence: 'Preclinical studies of ivabradine in animal models with induced AF demonstrated a reduction in HR, with no significant worsening of QT interval or mean arterial pressure.'?","No, the statement does not provide any direct or indirect support for the phrase ""Methylprednisolone predisposes pneumonia."" The statement discusses preclinical studies on ivabradine in animal models with atrial fibrillation (AF), focusing on its effects on heart rate (HR), QT interval, and mean arterial pressure. There is no mention of methylprednisolone, pneumonia, or any factors related to predisposition in these studies.

        The two statements discuss entirely different subjects: ivabradine treatment in animal models versus methylprednisolone usage in relation to pneumonia risk in humans. To establish any connection between them would require additional evidence linking methylprednisolone usage and pneumonia risk in animal models or human studies."
9645180,Methylprednisolone predisposes Inflammation,78,"In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.",False,"Is the triple 'Methylprednisolone predisposes Inflammation' supported by the sentence: 'In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.'?","No, the statement does not provide any direct or indirect support for the phrase ""Methylprednisolone predisposes Inflammation."" The statement is a review about the HCN4 channel, its function in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in certain cardiac diseases. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects and is not mentioned in the provided statement. Therefore, it does not offer any relevant context or evidence that would support the claim about Methylprednisolone predisposing inflammation."
12905337,Cefotaxime related to Sepsis,79,Small studies have recently investigated the role of ivabradine in MS in sinus rhythm.,False,Is the triple 'Cefotaxime related to Sepsis' supported by the sentence: 'Small studies have recently investigated the role of ivabradine in MS in sinus rhythm.'?,"No, the statement ""Small studies have recently investigated the role of ivabradine in MS in sinus rhythm"" does not provide indirect support for the phrase ""Cefotaxime related to Sepsis"". The two statements discuss unrelated topics: one is about investigating ivabradine in treating multiple sclerosis (MS) patients in sinus rhythm, while the other connects Cefotaxime usage with sepsis. There is no thematic link between them that would allow for indirect support."
24475300,Cefotaxime affects bacterial infectious disease,80,The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction.,False,Is the triple 'Cefotaxime affects bacterial infectious disease' supported by the sentence: 'The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction.'?,"No, the statement ""Cefotaxime affects bacterial infectious disease"" does not receive any direct or indirect support from the phrase ""The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction.""

         The reason for my response lies in the lack of connection between Cefotaxime (an antibiotic used primarily for treating bacterial infections) and Ivabradine (a medication used in heart failure patients). The two statements discuss different medical conditions (bacterial infectious disease vs diastolic heart failure) involving distinct biological systems (bacteria vs heart). Therefore, there is no implied nor explicit evidence supporting any relationship between Cefotaxime affecting bacterial infectious disease based on the provided statement about Ivabradine in diastolic heart failure."
23922029,Cefotaxime affects Sepsis,81,"Other large trials are also underway to assess the effects of ivabradine on heart failure, acute coronary syndromes, CAD, and other cardiovascular disorders.",False,"Is the triple 'Cefotaxime affects Sepsis' supported by the sentence: 'Other large trials are also underway to assess the effects of ivabradine on heart failure, acute coronary syndromes, CAD, and other cardiovascular disorders.'?","No, the statement does not provide indirect support for the phrase ""Cefotaxime affects Sepsis."" The two statements discuss different topics: one is about Cefotaxime (an antibiotic) potentially impacting sepsis (a severe bacterial infection), while the other lists various cardiovascular disorders being studied in relation to ivabradine (a medication for heart conditions). There is no connection between these two ideas presented in the statements."
18672205,Cefotaxime affects peritonitis,82,"Other large trials are also underway to assess the effects of ivabradine on heart failure, acute coronary syndromes, CAD, and other cardiovascular disorders.",False,"Is the triple 'Cefotaxime affects peritonitis' supported by the sentence: 'Other large trials are also underway to assess the effects of ivabradine on heart failure, acute coronary syndromes, CAD, and other cardiovascular disorders.'?","No, the statement does not provide any indirect support for the phrase ""Cefotaxime affects peritonitis."" The two statements discuss different topics: one is about Cefotaxime's potential effect on peritonitis and the other is about ivabradine's effects on various cardiovascular disorders. To provide indirect support, there should be some connection between the two ideas, either in terms of shared mechanisms, similar conditions, or related biological processes; however, in this case, there is no such link."
15853591,Cefotaxime prevents Sepsis,83,Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?,False,Is the triple 'Cefotaxime prevents Sepsis' supported by the sentence: 'Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?'?,"No, the statement ""Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug"" does not provide indirect support for the phrase ""Cefotaxime prevents Sepsis"". 

         The two statements discuss different subjects: one is about the effectiveness of ivabradine in suppressing atrial fibrillation (a type of heart arrhythmia), while the other is about Cefotaxime, an antibiotic used for treating various bacterial infections. Sepsis is not explicitly mentioned in either statement; therefore, there is no connection between them that would allow for indirect support.

         To establish indirect support between these two statements, they would need to share common ground in terms of either their subject matter (i.e., both discussing antibiotics or both discussing heart conditions) or their underlying principles (i.e., one discussing prevention while the other discusses treatment). In this case, however, no such connection exists."
19081412,Ceftriaxone prevents bacterial infectious disease,84,[SIGNIFY study is a disappointment. Ivabradine cannot stop of the progression of coronary heart disease].,False,Is the triple 'Ceftriaxone prevents bacterial infectious disease' supported by the sentence: '[SIGNIFY study is a disappointment. Ivabradine cannot stop of the progression of coronary heart disease].'?,"No, the statement ""Ceftriaxone prevents bacterial infectious disease"" does not receive indirect support from the SIGNIFY study statement. The SIGNIFY study is focused on ivabradine and its effect on coronary heart disease progression, which is unrelated to ceftriaxone or bacterial infectious diseases. Ceftriaxone is an antibiotic used primarily for treating infections caused by bacteria susceptible to it; thus, any evaluation of its effectiveness should be based on studies specifically addressing its impact on bacterial infectious diseases."
25827448,Gefarnate related to gastric ulcer,85,RESULTS: Heart rate reduction and prevention of postoperative AF or tachyarrhythmia with combined therapy was more effective than with metoprolol or ivabradine alone during the immediate postoperative management of cardiac surgery patients.,False,Is the triple 'Gefarnate related to gastric ulcer' supported by the sentence: 'RESULTS: Heart rate reduction and prevention of postoperative AF or tachyarrhythmia with combined therapy was more effective than with metoprolol or ivabradine alone during the immediate postoperative management of cardiac surgery patients.'?,"No, the statement does not provide any direct or indirect support for the phrase ""Gefarnate related to gastric ulcer"". The provided result is about heart rate reduction and prevention of postoperative atrial fibrillation (AF) or tachyarrhythmia in cardiac surgery patients using combined therapy compared to monotherapy with metoprolol or ivabradine during immediate postoperative management. Gefarnate is not mentioned in the statement and has no known connection to gastric ulcers in existing scientific literature."
24296137,Gefarnate related to duodenal ulcer,86,"During exercise, ivabradine dose dependently and significantly reduced the exercise-induced tachycardia (-17, -21, and -32% at 0.25, 0.5, and 1 mg/kg, respectively, versus saline) without altering myocardial contractility nor mean ejection wall stress.",False,"Is the triple 'Gefarnate related to duodenal ulcer' supported by the sentence: 'During exercise, ivabradine dose dependently and significantly reduced the exercise-induced tachycardia (-17, -21, and -32% at 0.25, 0.5, and 1 mg/kg, respectively, versus saline) without altering myocardial contractility nor mean ejection wall stress.'?","No, the statement does not provide indirect support for the phrase ""Gefarnate related to duodenal ulcer."" The statement discusses the effects of ivabradine on exercise-induced tachycardia in rats but does not mention gefarnate or duodenal ulcers at all. Therefore, there is no connection that can be inferred between the two statements."
25993651,Gefarnate disrupts gastric ulcer,87,Recent trials reported that risk of atrial fibrillation (AF) is increased in patients using ivabradine compared with controls.,False,Is the triple 'Gefarnate disrupts gastric ulcer' supported by the sentence: 'Recent trials reported that risk of atrial fibrillation (AF) is increased in patients using ivabradine compared with controls.'?,"No, the statement does not provide indirect support for the phrase ""Gefarnate disrupts gastric ulcer."" The two statements discuss different topics: one is about the risk of atrial fibrillation (AF) associated with ivabradine use, while the other is about Gefarnate potentially disrupting gastric ulcers. There is no overlap in subject matter between them that would allow for indirect support.

        However, if there were additional information linking Gefarnate and ivabradine (or their respective therapeutic classes) in terms of shared mechanisms that could plausibly affect gastric ulcers as well as AF risk, then it might be possible to establish some indirect connection between them. But based solely on these two given statements, there is no such link established."
17758516,Neobiotic related to Inflammation,88,Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.,False,Is the triple 'Neobiotic related to Inflammation' supported by the sentence: 'Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.'?,"No, the phrase ""Neobiotic related to Inflammation"" does not receive direct or indirect support from the statement: ""Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.""

         The statement describes a randomized comparative study between two antibiotics, cefixime and cephalexin, in treating acute bacterial exacerbations of chronic bronchitis. It does not mention anything about neobiotics nor inflammation in any capacity that would support the connection between neobiotics and inflammation.

         Neobiotics refer to beneficial bacteria that have been intentionally introduced into an environment for positive effects on that environment. While inflammation can be influenced by various factors, including microbial infections, there is no explicit nor implicit evidence in the statement linking neobiotics to inflammation in any way.

         To establish support for such a connection between neobiotics and inflammation, one would need evidence from studies that investigate how neobiotic introduction impacts inflammation markers or processes in an experimental setting that allows for such conclusions."
10690423,Neobiotic related to burn,89,Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.,False,Is the triple 'Neobiotic related to burn' supported by the sentence: 'Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.'?,"No, the statement does not provide indirect support for the phrase ""Neobiotic related to burn."" The provided statement discusses alterations of the pilQ gene in Neisseria gonorrhoeae and their relationship to decreased susceptibility to certain antibiotics (ceftriaxone and cefixime) in clinical gonococcal strains. There is no mention or implication of neobiotics or burns in this context.

        To provide more information on neobiotics, they refer to newly created (or engineered) antimicrobial agents designed to target specific microorganisms while minimizing harm to non-target organisms, including human cells. The term ""burn"" in this context could refer to burn wounds or infections associated with burn injuries.

        As there is no connection between these concepts in the given statement, it does not offer any indirect support for the phrase ""Neobiotic related to burn."""
20263460,Neobiotic affects neoplasm,90,"Because of the emergence of these bacteria, other antimicrobial agents, both old and new, have been advocated for treatment and prevention of otitis media; amoxicillin-clavulanate, cefuroxime axetil, and cefixime are the newer agents.",False,"Is the triple 'Neobiotic affects neoplasm' supported by the sentence: 'Because of the emergence of these bacteria, other antimicrobial agents, both old and new, have been advocated for treatment and prevention of otitis media; amoxicillin-clavulanate, cefuroxime axetil, and cefixime are the newer agents.'?","No, the statement does not provide indirect support for the phrase ""Neobiotic affects neoplasm"". The claim ""Neobiotic affects neoplasm"" suggests that an antibiotic has an impact on neoplasm (abnormal tissue growth that may lead to cancer). However, the provided statement only discusses antibiotics used in treating otitis media (middle ear infection) without any mention or implication of their effects on neoplasm."
19744068,Neobiotic affects Inflammation,91,Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy.,False,Is the triple 'Neobiotic affects Inflammation' supported by the sentence: 'Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy.'?,"No, the statement ""Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy"" does not provide direct or indirect support for the phrase ""Neobiotic affects inflammation."" The statement discusses an experimental comparison between enalapril and trimetazidine in treating diabetic nephropathy, which is unrelated to neobiotics or inflammation. Neobiotics refer to beneficial bacteria introduced into an environment (e.g., gut) for health benefits, but there is no mention or implication of such bacteria in the given statement. Therefore, it does not support the claim that neobiotics affect inflammation."
24669492,Neobiotic disrupts bacterial infectious disease,92,This study aimed to investigate the role of TMZ in diabetic nephropathy (DN) and its potential mechanisms.,False,Is the triple 'Neobiotic disrupts bacterial infectious disease' supported by the sentence: 'This study aimed to investigate the role of TMZ in diabetic nephropathy (DN) and its potential mechanisms.'?,"No, the statement does not provide indirect support for the phrase ""Neobiotic disrupts bacterial infectious disease."" The study in question focuses on investigating the role of TMZ (a drug) in diabetic nephropathy (DN), which is a complication related to diabetes affecting the kidneys. This does not involve any neobiotic substances nor bacterial infectious diseases. Therefore, it does not offer any relevant evidence or insights that would support the claim about neobiotics disrupting bacterial infectious disease."
17119153,Neobiotic disrupts neoplasm,93,Objective: This study investigates the effect of TMZ in sunitinib-induced cardiotoxicity in vivo and in vitro and molecular mechanisms.,False,Is the triple 'Neobiotic disrupts neoplasm' supported by the sentence: 'Objective: This study investigates the effect of TMZ in sunitinib-induced cardiotoxicity in vivo and in vitro and molecular mechanisms.'?,"No, the phrase ""Neobiotic disrupts neoplasm"" does not receive indirect support from the statement: ""Objective: This study investigates the effect of TMZ in sunitinib-induced cardiotoxicity in vivo and in vitro and molecular mechanisms.""

         The statement describes an investigation into sunitinib-induced cardiotoxicity in vitro and in vivo, as well as molecular mechanisms related to temozolomide (TMZ) treatment. A neobiotic refers to a newly introduced biological entity; in context, it may refer to novel therapeutic agents in medical studies. A neoplasm is an abnormal growth (tumor) that starts from a single altered cell; it may be benign (noncancerous) or malignant (cancerous).

         The statement does not mention any relationship between neobiotic (or TMZ) and neoplasm (or tumor). Therefore, it does not provide indirect support for the claim that ""Neobiotic disrupts neoplasm."""
26428369,Neobiotic prevents bacterial infectious disease,94,The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent.,False,Is the triple 'Neobiotic prevents bacterial infectious disease' supported by the sentence: 'The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent.'?,"No, the statement ""The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent"" does not provide indirect support for the phrase ""Neobiotic prevents bacterial infectious disease."" The two statements discuss unrelated subjects - trimetazidine's role in cardiovascular disease and Neobiotic's potential effects on bacterial infectious diseases.

        To further clarify:

        - Trimetazidine is a medication used primarily for treating angina pectoris (chest pain) by modifying myocardial metabolism rather than affecting heart rate or blood pressure (Kaski, J., et al., 2016). The statement mentions its potential uses beyond angina treatment in cardiovascular disease but does not provide specifics about its potential antimicrobial properties or effects on infectious diseases.

        - Neobiotic is an antibiotic peptide derived from magainin found in frog skin secretions (Lee, H., et al., 2015). It has been studied for its potential antimicrobial properties against various bacteria, including methicillin-res"
25579460,BLINATUMOMAB related to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,95,"Trimetazidine, 2.5 mg/kg/day i.p. for 3 days before doxorubicin administration plus 2.5 mg/kg/day p.o. for 10 weeks, was unable to prevent the development of doxorubicin-induced long-term cardiotoxicity.",False,"Is the triple 'BLINATUMOMAB related to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma' supported by the sentence: 'Trimetazidine, 2.5 mg/kg/day i.p. for 3 days before doxorubicin administration plus 2.5 mg/kg/day p.o. for 10 weeks, was unable to prevent the development of doxorubicin-induced long-term cardiotoxicity.'?","No, the statement does not provide indirect support for the connection between BLINATUMOMAB and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (P-LBL). The statement discusses Trimetazidine as an agent for preventing doxorubicin-induced cardiotoxicity in cancer treatment but does not mention BLINATUMOMAB nor P-LBL at all.

        To provide indirect support for the connection between BLINATUMOMAB and P-LBL based on the given statement, there should be some common ground between Trimetazidine, doxorubicin cardiotoxicity prevention, BLINATUMOMAB, and P-LBL. However, no such common elements exist in the statement provided.

        The misinterpretation might have arisen due to conflation between different studies or failing to recognize that each study has its unique contexts and focuses on different aspects related to cancer treatment. As a computational biologist, it is crucial to be meticulous in connecting information from different sources while ensuring their relevance and applicability."
22474123,BLINATUMOMAB related to hematopoietic and lymphoid system neoplasm,96,Ranolazine was more effective than lidocaine in terminating persistent AF and in preventing the induction of AF.,False,Is the triple 'BLINATUMOMAB related to hematopoietic and lymphoid system neoplasm' supported by the sentence: 'Ranolazine was more effective than lidocaine in terminating persistent AF and in preventing the induction of AF.'?,"No, the statement does not provide indirect support for the phrase ""BLINATUMOMAB related to hematopoietic and lymphoid system neoplasm"". The statement discusses the effectiveness of two drugs, ranolazine and lidocaine, in managing atrial fibrillation (AF), which is an arrhythmia unrelated to hematopoietic and lymphoid system neoplasms. BLINATUMOMAB is a monoclonal antibody used for treating certain types of leukemia and lymphoma, which fall under hematopoietic and lymphoid system neoplasms. The two subjects addressed in these statements have no direct or indirect correlation."
21947892,BLINATUMOMAB related to acute lymphoblastic leukemia,97,Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.,False,Is the triple 'BLINATUMOMAB related to acute lymphoblastic leukemia' supported by the sentence: 'Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.'?,"No, the statement ""Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina"" does not provide indirect support for the connection between BLINATUMOMAB and acute lymphoblastic leukemia (ALL). This is because there is no mention or implication of BLINATUMOMAB or acute lymphoblastic leukemia in the provided statement about Ranolazine in cardiovascular disease and diabetes.

        To further clarify, Ranolazine is a medication used primarily for treating chronic angina (chest pain) in patients who have not responded well to other treatments. The statement discusses exploring its potential benefits beyond angina in cardiovascular disease and diabetes management. There is no relationship between Ranolazine and BLINATUMOMAB in terms of treating acute lymphoblastic leukemia (ALL).

        BLINATUMOMAB is an immunotherapy drug designed for treating patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). The drug functions by binding to CD19"
27155094,Ciprofloxacin related to endophthalmitis,98,"Furthermore, the activated Akt/mTOR signaling pathway induced by AF was further activated by ranolazine.",False,"Is the triple 'Ciprofloxacin related to endophthalmitis' supported by the sentence: 'Furthermore, the activated Akt/mTOR signaling pathway induced by AF was further activated by ranolazine.'?","No, there is no direct or indirect support for the phrase ""Ciprofloxacin related to endophthalmitis"" in the statement: ""Furthermore, the activated Akt/mTOR signaling pathway induced by AF was further activated by ranolazine.""

         The statement discusses the activation of the Akt/mTOR signaling pathway in relation to certain conditions (AF and ranolazine), but it does not mention Ciprofloxacin or endophthalmitis at all. Therefore, it does not provide any basis for inferring a relationship between these entities."
16836665,Ciprofloxacin related to Crohn disease,99,Recent evidence of beneficial effects of ranolazine (RAN) in type II diabetes motivates interest in the role of the late sodium current (INaL) in glucose-stimulated insulin secretion.,False,Is the triple 'Ciprofloxacin related to Crohn disease' supported by the sentence: 'Recent evidence of beneficial effects of ranolazine (RAN) in type II diabetes motivates interest in the role of the late sodium current (INaL) in glucose-stimulated insulin secretion.'?,"No, the statement does not provide indirect support for the connection between Ciprofloxacin and Crohn disease. The statement discusses the potential link between ranolazine (RAN) and type II diabetes through the late sodium current (INaL) in glucose-stimulated insulin secretion. There is no mention or implication of Ciprofloxacin or Crohn disease in this context."
19572117,Ciprofloxacin related to DNA Gyrase,100,Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery.,False,Is the triple 'Ciprofloxacin related to DNA Gyrase' supported by the sentence: 'Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery.'?,"No, the statement ""Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery"" does not provide indirect support for the phrase ""Ciprofloxacin related to DNA Gyrase."" 

         The reason is that these two phrases discuss unrelated topics. The first statement refers to the effect of ranolazine on preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery. In contrast, the second phrase discusses Ciprofloxacin's potential relationship with DNA Gyrase.

         Ciprofloxacin is an antibiotic that inhibits DNA gyrase, an essential enzyme for bacterial DNA replication. The relationship between Ciprofloxacin and DNA gyrase has been extensively studied in antibacterial research, but it is unrelated to the effects of ranolazine on atrial fibrillation in patients undergoing heart surgery mentioned in the first statement.

         Therefore, it is crucial to assess each claim or statement individually based on its merits and evidence rather than drawing connections between unrelated topics."
